Psyllid ID: psy1812
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | 2.2.26 [Sep-21-2011] | |||||||
| Q61241 | 365 | Testis-specific serine/th | yes | N/A | 0.470 | 0.391 | 0.474 | 1e-39 | |
| Q3SZW1 | 367 | Testis-specific serine/th | yes | N/A | 0.605 | 0.501 | 0.404 | 1e-39 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.605 | 0.513 | 0.409 | 6e-39 | |
| Q96PF2 | 358 | Testis-specific serine/th | yes | N/A | 0.605 | 0.513 | 0.4 | 7e-39 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.605 | 0.501 | 0.4 | 4e-38 | |
| Q9D411 | 328 | Testis-specific serine/th | no | N/A | 0.503 | 0.466 | 0.441 | 2e-37 | |
| Q6SA08 | 328 | Testis-specific serine/th | no | N/A | 0.483 | 0.448 | 0.445 | 1e-35 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.595 | 0.675 | 0.357 | 2e-34 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.595 | 0.675 | 0.357 | 3e-33 | |
| Q925K9 | 273 | Testis-specific serine/th | no | N/A | 0.473 | 0.527 | 0.435 | 2e-30 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 164 bits (414), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 75/158 (47%), Positives = 107/158 (67%), Gaps = 15/158 (9%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR +LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLILSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQ 228
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (413), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 83/205 (40%), Positives = 126/205 (61%), Gaps = 21/205 (10%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK----EHRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ ++ ++ + +ILSH
Sbjct: 247 DLIYRMLQPD--VTRRLHIDEILSH 269
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 84/205 (40%), Positives = 129/205 (62%), Gaps = 21/205 (10%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
R++I M GDLL+ IK G + E AR F Q+ + ++Y H
Sbjct: 85 RIYIVMELGVQGDLLEFIKCRGALHEDVARKMFRQLSSAVKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR VLS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSGRIVLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDS++K++ + Q H+V + + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQK----EHRVDFPRSKNLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ +++ D+ + ++ + +ILSH
Sbjct: 247 DLI-YRILQPDV-NRRLHIDEILSH 269
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 82/205 (40%), Positives = 126/205 (61%), Gaps = 21/205 (10%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
R++I M GDLL+ IK G + E AR F Q+ + ++Y H
Sbjct: 85 RIYIIMELGVQGDLLEFIKCQGALHEDVARKMFRQLSSAVKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
+I HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR +LS+T+CGSAAYAAPEV+
Sbjct: 131 DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDSNGRIILSKTFCGSAAYAAPEVLQSI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDS+++++ + Q H+V + + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRIQK----EHRVDFPRSKNLTCECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ +S ++ + +ILSH
Sbjct: 247 DLIYRMLQPD--VSQRLHIDEILSH 269
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 82/205 (40%), Positives = 124/205 (60%), Gaps = 21/205 (10%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M A GDLL+ IK G + E AR F Q+ ++Y H
Sbjct: 85 KVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKC+N+L+ K FN+K++DF F++ C+ D GR LS+T+CGS AYAAPEV+ G
Sbjct: 131 DVVHRDLKCDNLLLDKDFNIKLSDFSFSKRCLRDDSGRMALSKTFCGSPAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK----EHRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ H ++ ++ ++ + +ILSH
Sbjct: 247 DLIYHMLQPD--VNRRLHIDEILSH 269
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 79/179 (44%), Positives = 109/179 (60%), Gaps = 26/179 (14%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + ++ RV+I + A GD+L+ I+R G AE+ A WFSQM G+ YLH
Sbjct: 86 INFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIAYLH----- 140
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG-------RRV--- 110
SK I HRDLK EN+L+ KR NVKI+DFGFA+ + R++
Sbjct: 141 ---------SKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSL 191
Query: 111 --LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
LS+TYCGS AYA PE++ G PYNP L+D WS+GVI + ++ A +PFDD+NLK+L +E
Sbjct: 192 SHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRE 250
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (379), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 77/173 (44%), Positives = 106/173 (61%), Gaps = 26/173 (15%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
++ RV+I + A GD+L+ I+R G +E A WFSQ+ G+ YLH
Sbjct: 92 IESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIAYLH----------- 140
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG-------RRV-----LSRT 114
SK+I HRDLK EN+L+ K NVKI+DFGFA+ + R+V LS+T
Sbjct: 141 ---SKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQT 197
Query: 115 YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
YCGS AYA PE++ G PYNP L+D WS+GVI + ++ A +PFDD+NLK+L +E
Sbjct: 198 YCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRE 250
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 73/204 (35%), Positives = 121/204 (59%), Gaps = 23/204 (11%)
Query: 1 MQVHSILQRG-PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+QV+ +L+ ++++ M A+ GD+ D + GP+ ES A+ F QM+ + Y H
Sbjct: 71 IQVYEMLESADGKIYLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRYCH---- 126
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+AHRDLKCEN L+ + FN+K+ DFGFA+ V + RR LS+T+CGS
Sbjct: 127 ----------GCGVAHRDLKCENALL-QGFNLKLTDFGFAK--VLPKSRRELSQTFCGST 173
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNI-----LS 174
AYAAPEV+ G P++ K D+WS+GV+ ++ML A++PFDD+++ ++ +Q + L
Sbjct: 174 AYAAPEVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLG 233
Query: 175 HQVKVKDILSHQVKVKDILSHQVK 198
+ +D+L ++ IL ++
Sbjct: 234 ISTECQDLLKRLLEPDMILRPSIE 257
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (358), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 73/204 (35%), Positives = 119/204 (58%), Gaps = 23/204 (11%)
Query: 1 MQVHSILQRG-PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+QV+ +L+ ++ + M A+ GD+ D + GP+ ES A+ F QM+ + Y H
Sbjct: 71 IQVYEMLESADGKICLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRYCH---- 126
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+AHRDLKCEN L+ + FN+K+ DFGFA+ V + R LS+T+CGS
Sbjct: 127 ----------GCGVAHRDLKCENALL-QGFNLKLTDFGFAK--VLPKSHRELSQTFCGST 173
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNI-----LS 174
AYAAPEV+ G P++ K D+WS+GV+ ++ML A++PFDD+++ ++ +Q + LS
Sbjct: 174 AYAAPEVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLS 233
Query: 175 HQVKVKDILSHQVKVKDILSHQVK 198
+D+L ++ IL ++
Sbjct: 234 ISADCQDLLKRLLEPDMILRPSIE 257
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q925K9|TSSK6_MOUSE Testis-specific serine/threonine-protein kinase 6 OS=Mus musculus GN=Tssk6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (333), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 71/163 (43%), Positives = 97/163 (59%), Gaps = 19/163 (11%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++I M A DLL ++R G + S AR FSQ+ + YLH +H
Sbjct: 85 KLYIVMEAAAT-DLLQAVQRNGRIPGSQARELFSQIAGAVRYLH----DH---------- 129
Query: 72 NIAHRDLKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L++ VKI DFGF R G LS TYCGSAAYA+PEV+ G
Sbjct: 130 HLVHRDLKCENVLLSPDERRVKITDFGFGR---QAHGYPDLSTTYCGSAAYASPEVLLGI 186
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNIL 173
PY+PK D+WSLGV+ ++M+ MPFDDS++ L + Q +L
Sbjct: 187 PYDPKKYDVWSLGVVLYVMVTGCMPFDDSDIAGLPRRQKRGVL 229
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | ||||||
| 340714143 | 365 | PREDICTED: testis-specific serine/threon | 0.703 | 0.586 | 0.513 | 3e-72 | |
| 110756729 | 363 | PREDICTED: testis-specific serine/threon | 0.703 | 0.589 | 0.513 | 5e-72 | |
| 383859581 | 365 | PREDICTED: testis-specific serine/threon | 0.713 | 0.594 | 0.512 | 1e-71 | |
| 332019228 | 360 | Testis-specific serine/threonine-protein | 0.713 | 0.602 | 0.508 | 1e-71 | |
| 91085661 | 349 | PREDICTED: similar to CG14305 CG14305-PA | 0.710 | 0.618 | 0.5 | 2e-71 | |
| 242013931 | 328 | cAMP-dependent protein kinase catalytic | 0.631 | 0.585 | 0.603 | 7e-71 | |
| 307200436 | 313 | Testis-specific serine/threonine-protein | 0.713 | 0.693 | 0.505 | 1e-70 | |
| 322789320 | 335 | hypothetical protein SINV_02445 [Solenop | 0.654 | 0.594 | 0.513 | 1e-69 | |
| 358031582 | 346 | testis-specific serine/threonine-protein | 0.740 | 0.650 | 0.487 | 1e-69 | |
| 357608284 | 344 | hypothetical protein KGM_17405 [Danaus p | 0.661 | 0.584 | 0.516 | 1e-69 |
| >gi|340714143|ref|XP_003395591.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Bombus terrestris] gi|350417499|ref|XP_003491452.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 278 bits (710), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 147/286 (51%), Positives = 176/286 (61%), Gaps = 72/286 (25%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMRYADNGDLLD +KR G V E ++ WF QM +GL YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRYADNGDLLDFVKRNGVVPEQQSKLWFRQMASGLHYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
KNIAHRDLKCENIL++++FNVK+ADFGFAR+CVD EGRRVLS TYCGSAA
Sbjct: 140 ---------GKNIAHRDLKCENILLSRKFNVKLADFGFARFCVDHEGRRVLSETYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLAD+WSLG+I FIMLNA+MPFDDSNLK+L K+Q S + +V+
Sbjct: 191 YAAPEVVSGTPYNPKLADVWSLGIILFIMLNASMPFDDSNLKKLLKDQMSRNWMFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
+ +S K I+ H
Sbjct: 251 ETVS--ALAKSIVKH--------------------------------------------- 263
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQ---KLVHS 283
ILEPDIT R+ L+ + H+W+R K K PG +LVHS
Sbjct: 264 ---ILEPDITLRLTLERVLGHEWVRTK-----KEKPGSLTGRLVHS 301
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|110756729|ref|XP_394567.3| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Apis mellifera] gi|380026013|ref|XP_003696756.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 277 bits (708), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 147/286 (51%), Positives = 176/286 (61%), Gaps = 72/286 (25%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMRYADNGDLLD +KR G V E ++ WF QM +GL YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRYADNGDLLDFVKRNGVVPEQQSKLWFRQMASGLHYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
KNIAHRDLKCENIL++++FNVK+ADFGFAR+CVD EGRRVLS TYCGSAA
Sbjct: 140 ---------GKNIAHRDLKCENILLSRKFNVKLADFGFARFCVDHEGRRVLSETYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLAD+WSLG+I FIMLNA+MPFDDSNLK+L K+Q S + +V+
Sbjct: 191 YAAPEVVSGTPYNPKLADVWSLGIILFIMLNASMPFDDSNLKKLLKDQMSRNWMFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
+ +S K I+ H
Sbjct: 251 ETVS--ALAKSIVKH--------------------------------------------- 263
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQ---KLVHS 283
ILEPDIT R+ L+ + H+W+R K K PG +LVHS
Sbjct: 264 ---ILEPDITLRLTLERVLGHEWVRTK-----KEKPGSLTGRLVHS 301
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383859581|ref|XP_003705272.1| PREDICTED: testis-specific serine/threonine-protein kinase 1-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 145/283 (51%), Positives = 176/283 (62%), Gaps = 66/283 (23%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMRYADNGDLLD + R G V E ++ WF QM +GL YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRYADNGDLLDFVDRNGAVPEQQSKLWFRQMASGLHYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
KNIAHRDLKCENIL++++FNVK+ADFGFAR+CVD EGRRVLS+TYCGSAA
Sbjct: 140 ---------GKNIAHRDLKCENILLSRKFNVKLADFGFARFCVDHEGRRVLSKTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLAD+WSLG+I FIMLNA+MPFDDSNL++L K+Q S + +V+
Sbjct: 191 YAAPEVVSGTPYNPKLADVWSLGIILFIMLNASMPFDDSNLQKLLKDQMSRNWMFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D +S K I+ H
Sbjct: 251 DTVS--ALAKSIVKH--------------------------------------------- 263
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHS 283
ILEPDIT R+ L+ + H+W+R K + L G +LVHS
Sbjct: 264 ---ILEPDITLRLTLERVLGHEWVRTKKE-KPTSLTG-RLVHS 301
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019228|gb|EGI59738.1| Testis-specific serine/threonine-protein kinase 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 144/283 (50%), Positives = 174/283 (61%), Gaps = 66/283 (23%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMRYADNGDLLD +K G V E +R WF QM +GL YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRYADNGDLLDFVKSNGVVPEQQSRLWFRQMASGLHYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SKNIAHRDLKCENIL++++FNVK+ADFGFAR+C+D EGRRVLS+TYCGSAA
Sbjct: 140 ---------SKNIAHRDLKCENILLSRKFNVKLADFGFARFCMDHEGRRVLSQTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV++G PYNPKLAD+WSLG+I FIMLN MPFDD NL +L K+Q S + +V+
Sbjct: 191 YAAPEVVAGTPYNPKLADVWSLGIILFIMLNGTMPFDDENLPKLLKDQISRNWVFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D +S K N+
Sbjct: 251 DTVSTLAK--------------------------------------------------NI 260
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHS 283
V QILEPDIT R+ L+ + H+W+R + R L G +LVHS
Sbjct: 261 VRQILEPDITLRLTLERVLGHEWVRARK-DRTGFLAG-RLVHS 301
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91085661|ref|XP_971409.1| PREDICTED: similar to CG14305 CG14305-PA [Tribolium castaneum] gi|270010094|gb|EFA06542.1| hypothetical protein TcasGA2_TC009447 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 275 bits (702), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 142/284 (50%), Positives = 179/284 (63%), Gaps = 68/284 (23%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRG RVFIFMRYADNGDLLD IK+ + E A+ WF QM +GL+YLH
Sbjct: 85 VQVHSILQRGSRVFIFMRYADNGDLLDFIKKNSIIPEPQAKIWFRQMASGLQYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SKNIAHRDLKCENIL+++RFNVKIADFGFAR+CVD + RR+LS+TYCGSAA
Sbjct: 140 ---------SKNIAHRDLKCENILLSRRFNVKIADFGFARFCVDSDNRRILSQTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV++G PYNPKL+D+WSLG+I FIMLNA+MPFDD+NL++L K+Q + + +V+
Sbjct: 191 YAAPEVVNGTPYNPKLSDVWSLGIILFIMLNASMPFDDTNLRKLLKDQMTKNWVFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D LS VK +L
Sbjct: 251 DTLSSTVK--------------------------------------------------SL 260
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPG-QKLVHS 283
V +LEPD+T R+ LD + AH+WLR K + +V P +L+HS
Sbjct: 261 VRHLLEPDLTLRLTLDRVMAHEWLRVK---KERVSPLIGRLIHS 301
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242013931|ref|XP_002427652.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212512082|gb|EEB14914.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 273 bits (698), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 128/212 (60%), Positives = 166/212 (78%), Gaps = 20/212 (9%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMR+ADNGDLLD +KR G + E A+ WF QM++GL+YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRFADNGDLLDFVKRTGIIPEHQAKLWFRQMISGLQYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
K+IAHRDLKCENIL++KRFNVK+ADFGFARYC+D +G R+LS TYCGSAA
Sbjct: 140 ---------DKDIAHRDLKCENILLSKRFNVKLADFGFARYCIDNDGHRILSHTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLADIWSLG+I FIMLNA+MPFDDSNL++L ++QTS + + KV+
Sbjct: 191 YAAPEVVSGTPYNPKLADIWSLGIILFIMLNASMPFDDSNLRKLLRDQTSKNWTFRTKVR 250
Query: 181 DILSHQVK--VKDI----LSHQVKVKDILSHQ 206
+ +S K VK I L+ +++++++++H+
Sbjct: 251 ESVSPLAKTLVKQILEPDLTKRLRLENLVNHE 282
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307200436|gb|EFN80645.1| Testis-specific serine/threonine-protein kinase 1 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 272 bits (696), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 143/283 (50%), Positives = 176/283 (62%), Gaps = 66/283 (23%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRG RVFIFMRYADNGDLLD +K G V E +R WF QM +GL YLH
Sbjct: 85 IQVHSILQRGSRVFIFMRYADNGDLLDFVKNNGIVPEQQSRLWFRQMASGLHYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SKNIAHRDLKCENIL++++FNVK+ADFGFAR+CVD GRRVLS+TYCGSAA
Sbjct: 140 ---------SKNIAHRDLKCENILLSRKFNVKLADFGFARFCVDHSGRRVLSQTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV++G PYNPKLAD+WSLG+I FIMLNA MPFDD+NL++L K+Q S+ + +V+
Sbjct: 191 YAAPEVVAGTPYNPKLADVWSLGIILFIMLNARMPFDDANLRKLLKDQISHNWIFRSRVR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D +S K N+
Sbjct: 251 DTVSALAK--------------------------------------------------NI 260
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHS 283
V QILEPDIT R+ L+ + H+W+R + + L G +LVHS
Sbjct: 261 VRQILEPDITLRLTLERVLGHEWVRARKE-KTGSLAG-RLVHS 301
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322789320|gb|EFZ14632.1| hypothetical protein SINV_02445 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 269 bits (688), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 135/263 (51%), Positives = 163/263 (61%), Gaps = 64/263 (24%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
QVHSILQRGPRVFIFMRYADNGDLLD +K G V E +R WF QM +GL YLH
Sbjct: 100 QVHSILQRGPRVFIFMRYADNGDLLDFVKNNGMVPEQQSRLWFRQMASGLHYLH------ 153
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SKNIAHRDLKCENIL++++FNVK+ADFGFAR+C+D EGRRVLS+TYCGSAAY
Sbjct: 154 --------SKNIAHRDLKCENILLSRKFNVKLADFGFARFCMDHEGRRVLSQTYCGSAAY 205
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
AAPEV++G PYNPKLAD+WSLG+I FIMLN MPFDD N ++L K+Q S + +V+D
Sbjct: 206 AAPEVVAGTPYNPKLADVWSLGIILFIMLNGTMPFDDENPRKLLKDQISRNWVFRSRVRD 265
Query: 182 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241
+S K N+V
Sbjct: 266 TVSALAK--------------------------------------------------NIV 275
Query: 242 GQILEPDITKRIRLDAIKAHDWL 264
QILEPDIT R+ L+ + H+W+
Sbjct: 276 RQILEPDITLRLTLERVLCHEWM 298
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|358031582|ref|NP_001239602.1| testis-specific serine/threonine-protein kinase-like [Bombyx mori] gi|356582739|gb|AET21260.1| TSSK [Bombyx mori] | Back alignment and taxonomy information |
|---|
Score = 269 bits (688), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 142/291 (48%), Positives = 178/291 (61%), Gaps = 66/291 (22%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMRYADNGDLLD IKR G V E+ A+ WF QM +GL+YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRYADNGDLLDFIKRNGVVPENQAKLWFRQMASGLQYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SKNIAHRDLKCENIL+++RFNVK+ADFGFAR+C D E RRVLS+TYCGSAA
Sbjct: 140 ---------SKNIAHRDLKCENILLSRRFNVKLADFGFARFCTDGENRRVLSQTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLAD+ SLG+I FIMLN +MPFDD+NL++L
Sbjct: 191 YAAPEVVSGTPYNPKLADVXSLGIILFIMLNGSMPFDDTNLRKL---------------- 234
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
+KD +S + +++D +S K++
Sbjct: 235 ----------------------------LKDQMSRNXVFRS------RIRDSVSPAAKSI 260
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSNLSVKQTP 291
V ILEPDIT R+ LD + +H+W R + ++ +LV S S +P
Sbjct: 261 VRHILEPDITLRLTLDRVLSHEWTRPRKDKSASLM--GRLVQSAPSAPHSP 309
|
Source: Bombyx mori Species: Bombyx mori Genus: Bombyx Family: Bombycidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357608284|gb|EHJ65907.1| hypothetical protein KGM_17405 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 269 bits (687), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 137/265 (51%), Positives = 168/265 (63%), Gaps = 64/265 (24%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+QVHSILQRGPRVFIFMR+ADNGDLL+ IKR G V E+ A+ WF QM +GL+YLH
Sbjct: 85 IQVHSILQRGPRVFIFMRHADNGDLLEFIKRNGVVPENQAKLWFRQMASGLQYLH----- 139
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SKNIAHRDLKCENIL+++RFNVK+ADFGFAR+C D + RRVLS+TYCGSAA
Sbjct: 140 ---------SKNIAHRDLKCENILLSRRFNVKLADFGFARFCTDGDNRRVLSQTYCGSAA 190
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+SG PYNPKLAD+WSLG+I FIMLNA+MPFDDSN ++L K+Q S + +++
Sbjct: 191 YAAPEVVSGTPYNPKLADVWSLGIILFIMLNASMPFDDSNHRKLLKDQMSRNWVFRSRIR 250
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D +S K I+ H
Sbjct: 251 DTVS--AAAKSIVRH--------------------------------------------- 263
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
ILEPDIT R+ LD + +H+W R
Sbjct: 264 ---ILEPDITLRLTLDRVLSHEWTR 285
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | ||||||
| FB|FBgn0038630 | 302 | CG14305 [Drosophila melanogast | 0.572 | 0.576 | 0.590 | 4.2e-61 | |
| UNIPROTKB|I3LBD3 | 340 | TSSK4 "Uncharacterized protein | 0.549 | 0.491 | 0.441 | 4e-37 | |
| UNIPROTKB|H9GWF8 | 368 | TSSK1B "Uncharacterized protei | 0.585 | 0.483 | 0.432 | 4.9e-37 | |
| UNIPROTKB|F1RK80 | 364 | TSSK1B "Uncharacterized protei | 0.605 | 0.505 | 0.409 | 8e-37 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.605 | 0.501 | 0.409 | 1e-36 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.605 | 0.501 | 0.409 | 1e-36 | |
| MGI|MGI:1347557 | 365 | Tssk1 "testis-specific serine | 0.605 | 0.504 | 0.404 | 1e-36 | |
| RGD|1307352 | 365 | Tssk1b "testis-specific serine | 0.605 | 0.504 | 0.409 | 1e-36 | |
| UNIPROTKB|D4A7Q4 | 339 | D4A7Q4 "Uncharacterized protei | 0.542 | 0.486 | 0.436 | 1e-36 | |
| UNIPROTKB|E2R1G2 | 358 | TSSK2 "Uncharacterized protein | 0.605 | 0.513 | 0.409 | 2.7e-36 |
| FB|FBgn0038630 CG14305 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 4.2e-61, Sum P(2) = 4.2e-61
Identities = 111/188 (59%), Positives = 141/188 (75%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q+HSILQRGP++FIFMRYA+NGDLL HIKR+GP+ E ++ WF QM L+YLH
Sbjct: 92 IQIHSILQRGPKIFIFMRYAENGDLLSHIKRSGPIDEKQSKIWFFQMSKALKYLH----- 146
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ +IAHRDLKCENIL++KR N+K+ADFGFARYC D GR + S TYCGSAA
Sbjct: 147 ---------NLDIAHRDLKCENILLSKRLNIKLADFGFARYCRDDNGREMKSETYCGSAA 197
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEV+ G PY+PKLAD WSLGVI FIM+NA MPFDDSNL +L ++Q + + + K++
Sbjct: 198 YAAPEVVCGRPYDPKLADAWSLGVILFIMMNAKMPFDDSNLTKLLEDQRNRKFAFRRKLQ 257
Query: 181 DILSHQVK 188
+ +S Q K
Sbjct: 258 ETISAQAK 265
|
|
| UNIPROTKB|I3LBD3 TSSK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 372 (136.0 bits), Expect = 4.0e-37, Sum P(2) = 4.0e-37
Identities = 80/181 (44%), Positives = 109/181 (60%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
+ ++ RV+I + A GD+L+ I+R G +E A WFSQM G+ YLH + H P
Sbjct: 89 YQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQMTLGIAYLHSKGIVHRP 148
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV------------L 111
PS + A RDLK EN+L+ KR NVKI+DFGFA+ + R L
Sbjct: 149 LLT--PSLSAAGRDLKLENLLLDKRENVKISDFGFAKMVPSNQPVRSSPSYRQMNCFNHL 206
Query: 112 SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
S+TYCGS AYA PE++ G PYNP L+D WS+GVI + ++ A +PFDD+NLK+L KE
Sbjct: 207 SQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLKETQKE 266
Query: 172 I 172
+
Sbjct: 267 V 267
|
|
| UNIPROTKB|H9GWF8 TSSK1B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 398 (145.2 bits), Expect = 4.9e-37, P = 4.9e-37
Identities = 87/201 (43%), Positives = 128/201 (63%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALHEDDARRKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
+I HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF---KEQTSNI-LSHQV--KVKDILS 184
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ KE N LS + + KD++
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPLSKHLTGECKDLIY 250
Query: 185 HQVKVKDILSHQVKVKDILSH 205
++ D+ + ++ + +ILSH
Sbjct: 251 RMLQ-PDV-NRRLHIDEILSH 269
|
|
| UNIPROTKB|F1RK80 TSSK1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
Identities = 84/205 (40%), Positives = 127/205 (61%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DM 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
+I HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKE----HRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + ++LSH
Sbjct: 247 DLIYRMLQ-PDV-NRRLHIDEVLSH 269
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
Identities = 84/205 (40%), Positives = 127/205 (61%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKE----HRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + +ILSH
Sbjct: 247 DLIYRMLQ-PDV-TRRLHIDEILSH 269
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
Identities = 84/205 (40%), Positives = 127/205 (61%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKE----HRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + +ILSH
Sbjct: 247 DLIYRMLQ-PDV-TRRLHIDEILSH 269
|
|
| MGI|MGI:1347557 Tssk1 "testis-specific serine kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
Identities = 83/205 (40%), Positives = 128/205 (62%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR +LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLILSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKE----HRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + +IL+H
Sbjct: 247 DLIYRMLQ-PDV-NRRLHIDEILNH 269
|
|
| RGD|1307352 Tssk1b "testis-specific serine kinase 1B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
Identities = 84/205 (40%), Positives = 127/205 (61%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
++ HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDSN+K++ + Q H+V + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKE----HRVNFPRSKHLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + +ILSH
Sbjct: 247 DLIYRMLQ-PDV-NRRLHIDEILSH 269
|
|
| UNIPROTKB|D4A7Q4 D4A7Q4 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 359 (131.4 bits), Expect = 1.0e-36, Sum P(2) = 1.0e-36
Identities = 79/181 (43%), Positives = 110/181 (60%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
+ ++ RV+I + A GD+L+ I+R G +E+ A WFSQM G+ YLH + H
Sbjct: 89 YQAIETTSRVYIILELAQGGDVLEWIQRYGACSETLAGKWFSQMALGIAYLHSKGIVHR- 147
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV------------L 111
T PS + A RDLK EN+L+ KR NVKI+DFGFA+ + R L
Sbjct: 148 LT---PSLSAAGRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVRSSPSYRQMNCLSHL 204
Query: 112 SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
S+TYCGS AYA PE++ G PYNP L+D WS+GVI + ++ A +PFDD+NLK+L +E
Sbjct: 205 SQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKE 264
Query: 172 I 172
+
Sbjct: 265 V 265
|
|
| UNIPROTKB|E2R1G2 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 391 (142.7 bits), Expect = 2.7e-36, P = 2.7e-36
Identities = 84/205 (40%), Positives = 128/205 (62%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+I M GDLL+ IK G + E +AR F Q+ + ++Y H
Sbjct: 85 KVYIVMELGVQGDLLEFIKTRGALHEDDARRKFHQLSSAIKYCH--------------DL 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN 130
+I HRDLKCEN+L+ K FN+K++DFGF++ C+ D GR LS+T+CGSAAYAAPEV+ G
Sbjct: 131 DIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLTLSKTFCGSAAYAAPEVLQGI 190
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
PY PK+ DIWSLGVI +IM+ +MP+DDS++K++ + Q H+V + + K
Sbjct: 191 PYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKE----HRVDFPRSKNLTGECK 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSH 215
D++ ++ D+ + ++ + +ILSH
Sbjct: 247 DLIYRMLQ-PDV-NRRLHIDEILSH 269
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 304 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-23 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 9e-49
Identities = 64/167 (38%), Positives = 92/167 (55%), Gaps = 20/167 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++++ + + ++++ M Y + GDL D +K+ G ++E AR + Q+L+ LEYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH----- 114
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
SK I HRDLK ENIL+ + +VK+ADFG AR E T+ G+
Sbjct: 115 ---------SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPE 161
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
Y APEV+ G Y DIWSLGVI + +L PF D L +LFK
Sbjct: 162 YMAPEVLLGKGYGKA-VDIWSLGVILYELLTGKPPFPGDDQLLELFK 207
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 57/160 (35%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ + +++ M Y + GDL D++ R GP++E A+ Q+L GLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH----- 115
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S I HRDLK ENIL+ + VKIADFG A+ T+ G+
Sbjct: 116 ---------SNGIIHRDLKPENILLDENGVVKIADFGLAK---KLLKSSSSLTTFVGTPW 163
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
Y APEV+ G D+WSLGVI + +L PF N
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGEN 203
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 19/151 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREIT 59
++++ + + +++ M Y + G L D +K G ++E Q+L GLEYLH
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---- 109
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
S I HRDLK ENIL+ VK+ADFG ++ + L +T G+
Sbjct: 110 ----------SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGT 156
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIM 149
AY APEV+ G Y + +DIWSLGVI + +
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-37
Identities = 56/169 (33%), Positives = 79/169 (46%), Gaps = 34/169 (20%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTP 63
+ ++ I M YAD GDL IK+ P E WF Q+ L+YLH
Sbjct: 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-------- 120
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLS------RTYCG 117
S+ I HRD+K +NI +T VK+ DFG + +VLS +T G
Sbjct: 121 ------SRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------KVLSSTVDLAKTVVG 165
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
+ Y +PE+ PYN K +DIWSLG + + + PF+ NL +L
Sbjct: 166 TPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-35
Identities = 58/183 (31%), Positives = 96/183 (52%), Gaps = 24/183 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++++ + YA G+L H+ + G +E AR + ++++ LEYLH S
Sbjct: 67 KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH--------------SL 112
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I +RDLK ENIL+ ++K+ DFG A+ + R T+CG+ Y APEV+ G
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLGKG 169
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
Y K D WSLGV+ + ML PF + K++++ IL ++ + LS + +D
Sbjct: 170 YG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE----KILKDPLRFPEFLS--PEARD 222
Query: 192 ILS 194
++S
Sbjct: 223 LIS 225
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 18/151 (11%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
IF+ Y G L +K+ G + E R + Q+L GL YLH S I
Sbjct: 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH--------------SNGIV 123
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
HRD+K NIL+ VK+ADFG A+ + + + G+ + APEVI G Y
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 135 KLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
ADIWSLG M P+ S L
Sbjct: 183 A-ADIWSLGCTVIEMATGKPPW--SELGNPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 4e-34
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 32/172 (18%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++ + YA NG+LL +I++ G + E R + +++L LEYLH SK
Sbjct: 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH--------------SK 121
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFAR---------------YCVDKEGRRVLSR--T 114
I HRDLK ENIL+ K ++KI DFG A+ +D + + R +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 115 YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
+ G+A Y +PE+++ P +D+W+LG I + ML PF SN F+
Sbjct: 182 FVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 28/194 (14%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R+F M Y + GDL+ HI+R+G E AR + ++++ GL++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH------ 113
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
+ I +RDLK +N+L+ ++KIADFG C KEG V + T+CG+
Sbjct: 114 --------ERGIIYRDLKLDNVLLDSEGHIKIADFGM---C--KEGILGGVTTSTFCGTP 160
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APE++S PY P D W+LGV+ + ML PF+ + +LF+ +IL +V+
Sbjct: 161 DYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQ----SILEDEVRY 215
Query: 180 KDILSHQVKVKDIL 193
LS + K IL
Sbjct: 216 PRWLS--KEAKSIL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 61/184 (33%), Positives = 93/184 (50%), Gaps = 37/184 (20%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M Y G+L H++++G E AR + +Q++ LEYLH S
Sbjct: 75 NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH--------------SL 120
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--CGSAAYAAPEVISG 129
+I +RDLK EN+L+ +KI DFGFA +RV RTY CG+ Y APE+I
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTLCGTPEYLAPEIILS 172
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV--------KD 181
Y K D W+LG++ + ML PF D N Q+++ IL +V+ KD
Sbjct: 173 KGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KILEGKVRFPSFFSPDAKD 227
Query: 182 ILSH 185
++ +
Sbjct: 228 LIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-28
Identities = 58/165 (35%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 5 SILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
S L++ ++I M + G L D +K + ES ++L GLEYLH
Sbjct: 65 SYLKKD-ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH-------- 115
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
S I HRD+K NIL+T VK+ DFG + T G+ + A
Sbjct: 116 ------SNGIIHRDIKAANILLTSDGEVKLIDFGL---SAQLSDTK-ARNTMVGTPYWMA 165
Query: 124 PEVISGNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
PEVI+G PY+ K ADIWSLG IT I + P+ + +K LFK
Sbjct: 166 PEVINGKPYDYK-ADIWSLG-ITAIELAEGKPPYSELPPMKALFK 208
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 62/185 (33%), Positives = 97/185 (52%), Gaps = 22/185 (11%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R++ M Y + GDL+ HI++ G E A + +++ GL +LHR
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR----- 119
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+ I +RDLK +N+++ ++KIADFG C + V +RT+CG+ Y
Sbjct: 120 ---------RGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCGTPDY 167
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE+I+ PY K D W+ GV+ + ML PFD + +LF+ +I+ H V
Sbjct: 168 IAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYPK 222
Query: 182 ILSHQ 186
LS +
Sbjct: 223 SLSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 49/154 (31%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ I + Y D G L D +K+ G + E Q+L GL+YLH + +
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK-------------R 119
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+I HRD+K N+L+ + VKIADFG ++ E T+ G+ Y +PE I G
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK---VLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
Y+ ADIWSLG+ PF F
Sbjct: 177 YSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFF 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 62/185 (33%), Positives = 97/185 (52%), Gaps = 22/185 (11%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R++ M Y + GDL+ HI++ G E +A + +++ GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH------ 118
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +N+++ ++KIADFG C + +RT+CG+ Y
Sbjct: 119 --------SKGIIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCGTPDY 167
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE+I+ PY K D W+ GV+ + ML PFD + +LF+ +I+ H V
Sbjct: 168 IAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYPK 222
Query: 182 ILSHQ 186
LS +
Sbjct: 223 SLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 59/185 (31%), Positives = 97/185 (52%), Gaps = 22/185 (11%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R++ M Y + GDL+ I++ G E +A + +++ GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH------ 118
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +N+++ ++KIADFG C + V ++T+CG+ Y
Sbjct: 119 --------SKGIIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCGTPDY 167
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE+I+ PY K D W+ GV+ + ML PF+ + +LF+ +I+ H V
Sbjct: 168 IAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAYPK 222
Query: 182 ILSHQ 186
+S +
Sbjct: 223 SMSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 51/136 (37%), Positives = 66/136 (48%), Gaps = 19/136 (13%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
I + YA+NG L IK+ GP ES + Q+L GL YLH + +
Sbjct: 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ--------------GVI 121
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
HRD+K NIL TK VK+ADFG A D + G+ + APEVI + +
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIEMSGAST 178
Query: 135 KLADIWSLGVITFIML 150
+DIWSLG T I L
Sbjct: 179 A-SDIWSLG-CTVIEL 192
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 55/158 (34%), Positives = 88/158 (55%), Gaps = 18/158 (11%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Q +F M Y + GDL+ HI+ +G E+ AR + ++++ GL++LH
Sbjct: 66 QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH------------ 113
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
K I +RDLK +N+L+ K ++KIADFG + ++ EG+ + T+CG+ Y APE++
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYIAPEIL 168
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
G YN + D WS GV+ + ML PF + +LF
Sbjct: 169 KGQKYNESV-DWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M Y GDL ++ G + E AR + ++++ LEYLH S
Sbjct: 68 LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH--------------SNG 113
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARY-CVDKEGRR----VLSRTYCGSAAYAAPEVI 127
I HRDLK +NIL+ ++K+ DFG ++ V ++ + G+ Y APEVI
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQV 187
G ++ D WSLG I + L PF +++F NIL+ +++ + +
Sbjct: 174 LGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSD 228
Query: 188 KVKDILSH 195
+ D++S
Sbjct: 229 EAIDLISK 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 19/152 (12%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M Y G+L ++ G E AR + + ++ EYLH ++
Sbjct: 68 IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH--------------NRG 113
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I +RDLK EN+L+ VK+ DFGFA+ K + T+CG+ Y APE+I Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
+ D WSLG++ + +L PF + + +
Sbjct: 170 D-FSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 58/185 (31%), Positives = 95/185 (51%), Gaps = 27/185 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M Y G+L +++ +G + S + S+++ LEYLH SK
Sbjct: 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH--------------SKE 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I +RDLK ENIL+ K ++K+ DFGFA+ D+ + T CG+ Y APEVI +
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGH 175
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK--VK 190
N K D W+LG++ + ML PF D N ++++ IL+ +++ L K +K
Sbjct: 176 N-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK----ILAGKLEFPRHLDLYAKDLIK 230
Query: 191 DILSH 195
+L
Sbjct: 231 KLLVV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 22/182 (12%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q R+ M YA+ G+L H+ R E AR + +++++ LEYLH
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH----------- 112
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S+++ +RD+K EN+++ K ++KI DFG + + +T+CG+ Y APEV
Sbjct: 113 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEV 166
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186
+ N Y + D W LGV+ + M+ +PF + + ++LF+ IL +++ LS +
Sbjct: 167 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRTLSPE 221
Query: 187 VK 188
K
Sbjct: 222 AK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 57/180 (31%), Positives = 86/180 (47%), Gaps = 26/180 (14%)
Query: 13 VFIFMRYADNG---DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+++ M Y D G D++ + E ++L GLEYLH
Sbjct: 90 LWVVMEYMDGGSLTDIITQNFV--RMNEPQIAYVCREVLQGLEYLH-------------- 133
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S+N+ HRD+K +NIL++K +VK+ADFGFA ++ +R + G+ + APEVI
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR---NSVVGTPYWMAPEVIKR 190
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMP-FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
Y PK DIWSLG++ M P + L+ LF T I +K + S + K
Sbjct: 191 KDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PPLKNPEKWSPEFK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 12 RVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
++I M Y + GDL I++ + E +Q+L L H
Sbjct: 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD-------- 126
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
P + HRDLK NI + NVK+ DFG A+ ++TY G+ Y +PE +
Sbjct: 127 -PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYVGTPYYMSPEQL 182
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
+ Y+ K +DIWSLG + + + + PF N QL
Sbjct: 183 NHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQL 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-24
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 22/167 (13%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H Q R+F M Y + GDL+ I+R+ E +R + +++ L +LHR
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---- 115
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
+ +RDLK +NIL+ + K+ADFG KEG V + T+CG+
Sbjct: 116 ----------GVIYRDLKLDNILLDAEGHCKLADFGMC-----KEGILNGVTTTTFCGTP 160
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
Y APE++ Y P + D W+LGV+ + M+ PF+ N LF+
Sbjct: 161 DYIAPEILQELEYGPSV-DWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-24
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q + L+ + IFM Y G + D +K G + E+ R + Q+L G+EYLH N
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---N 123
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRD+K NIL NVK+ DFG ++ ++ G+
Sbjct: 124 M-----------IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
+ +PEVISG Y K AD+WS+G ML P+ +
Sbjct: 173 WMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 58/182 (31%), Positives = 99/182 (54%), Gaps = 21/182 (11%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q R+ M YA+ G+L H+ R +E AR + +++++ L+YLH E
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--------- 114
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
KN+ +RDLK EN+++ K ++KI DFG + + K+G + +T+CG+ Y APEV
Sbjct: 115 ----KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATM--KTFCGTPEYLAPEV 167
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186
+ N Y + D W LGV+ + M+ +PF + + ++LF+ IL +++ LS +
Sbjct: 168 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRTLSPE 222
Query: 187 VK 188
K
Sbjct: 223 AK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Q +++ M Y + GD IK G + E A+ + ++++ G+E LH+
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ----------- 115
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
+ I HRD+K EN+L+ + ++K+ DFG +R + ++ + G+ Y APE I
Sbjct: 116 ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-------LENKKFVGTPDYLAPETI 165
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQV 177
G + K++D WSLG + F L PF +F NILS ++
Sbjct: 166 LGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD----NILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-23
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 26/154 (16%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
RV+ + + G+L H+++AG A+ + ++++ EYLH SK
Sbjct: 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH--------------SK 137
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--CGSAAYAAPEVISG 129
+I +RDLK EN+L+ + +VK+ DFGFA ++V RT+ CG+ Y APEVI
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYLAPEVIQS 189
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLK 162
+ K D W++GV+ + + PF DD+ +
Sbjct: 190 KGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-23
Identities = 56/158 (35%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 5 SILQRGPRVFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
S L +G ++ I M YA+NGDL +K R P+ E +F Q+L GL +LH
Sbjct: 67 SFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH------- 118
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
SK I HRD+K N+ + NVKI D G A+ D + T G+ Y
Sbjct: 119 -------SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANTIVGTPYYL 168
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+PE+ PYN K +D+W+LGV+ + PFD +N
Sbjct: 169 SPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 7e-23
Identities = 58/161 (36%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPV--AESNARTWFSQMLAGLEYLHREITNHTPF 64
Q R+FI M Y D GDL+ I R V +E +WF Q+ GL+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--------- 118
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNV-KIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
+ I HRD+K +NI ++K V K+ DFG AR D L+ T G+ Y +
Sbjct: 119 -----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYYLS 170
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
PE+ PYN K DIWSLG + + + PF+ +NL QL
Sbjct: 171 PEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-23
Identities = 55/181 (30%), Positives = 95/181 (52%), Gaps = 22/181 (12%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Q R+ M YA+ G+L H+ R +E AR + +++++ L YLH
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH------------ 112
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S ++ +RDLK EN+++ K ++KI DFG + + +G +T+CG+ Y APEV+
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGAT--MKTFCGTPEYLAPEVL 167
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQV 187
N Y + D W LGV+ + M+ +PF + + ++LF+ IL +++ LS +
Sbjct: 168 EDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRTLSPEA 222
Query: 188 K 188
K
Sbjct: 223 K 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 22/167 (13%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q++ Q R+F M + + GDL+ HI+++ E+ AR + +++ + L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH------ 113
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR--VLSRTYCGSA 119
K I +RDLK +N+L+ + K+ADFG KEG + T+CG+
Sbjct: 114 --------DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGIFNGKTTSTFCGTP 160
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
Y APE++ Y P D W++GV+ + ML PF+ N LF+
Sbjct: 161 DYIAPEILQEMLYGP-SVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+HS Q R+F + + GDL+ H++R + E +AR + +++ L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH------- 113
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV--LSRTYCGSAA 120
+ I +RDLK +N+L+ ++K+ D+G KEG R + T+CG+
Sbjct: 114 -------ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC-----KEGIRPGDTTSTFCGTPN 161
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN-----ILSH 175
Y APE++ G Y + D W+LGV+ F M+ PFD + + T + IL
Sbjct: 162 YIAPEILRGEDYGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
Query: 176 QVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226
Q+++ LS VK +L K L+ K + Q +DI SH
Sbjct: 221 QIRIPRSLS--VKASSVL------KGFLNKDPKERLGCHPQTGFRDIKSHP 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 24/188 (12%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q ++++ + + + G+L H++R G S AR + +++L LE LH
Sbjct: 62 FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH----------- 110
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
N+ +RDLK ENIL+ + ++ + DFG + + + + + T+CG+ Y APE+
Sbjct: 111 ---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPEL 164
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186
+ G+ Y K D W+LGV+ + ML PF D N+ +++++ IL ++ D
Sbjct: 165 LLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPDGFDR- 218
Query: 187 VKVKDILS 194
KD+L
Sbjct: 219 -DAKDLLI 225
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 19/155 (12%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+ Q +++ + GDL H+ + +E + W +++ LEYLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH------- 117
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
SK I HRD+K +NIL+ ++ +V I DF A K L+ + G+ Y
Sbjct: 118 -------SKGIIHRDIKPDNILLDEQGHVHITDFNIAT----KVTPDTLTTSTSGTPGYM 166
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157
APEV+ Y+ D WSLGV + L P+
Sbjct: 167 APEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q ++ + + Y + G+L H+ + ES R + ++++ L++LH+
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ------ 123
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
I +RD+K ENIL+ +V + DFG ++ + +E R S +CG+ Y
Sbjct: 124 --------LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYM 173
Query: 123 APEVI-SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APEVI G+ + K D WSLGV+TF +L A PF + E + IL +
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233
Query: 182 ILSHQVKVKDILSHQVKVKD 201
+S + +D + ++ KD
Sbjct: 234 TMS--AEARDFI-QKLLEKD 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 55/159 (34%), Positives = 75/159 (47%), Gaps = 25/159 (15%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
+ Q V M YA GDL+ HI +E A + + ++ GL+YLH
Sbjct: 68 FACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH-------- 118
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR--TYCGSAAY 121
I +RDLK +N+L+ VKIADFG C KEG R T+CG+ +
Sbjct: 119 ------ENKIVYRDLKLDNLLLDTEGFVKIADFGL---C--KEGMGFGDRTSTFCGTPEF 167
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF--DD 158
APEV++ Y + D W LGV+ + ML PF DD
Sbjct: 168 LAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 18/165 (10%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
++ Q +F M + + GDL+ HI+ G A + ++++ GL++LH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH------ 113
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +N+++ + ++KIADFG + V + R + T+CG+ Y
Sbjct: 114 --------SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDY 162
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
APE++ G Y + D WS GV+ + ML PF + +LF+
Sbjct: 163 IAPEILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-22
Identities = 50/135 (37%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 15 IFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
I M Y G + D +K + E Q L GLEYLH S
Sbjct: 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH--------------SNKK 120
Query: 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYN 133
HRD+K NIL+ + K+ADFG + D +R T G+ + APEVI YN
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPFWMAPEVIQEIGYN 177
Query: 134 PKLADIWSLGVITFI 148
K ADIWSLG IT I
Sbjct: 178 NK-ADIWSLG-ITAI 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-22
Identities = 49/150 (32%), Positives = 68/150 (45%), Gaps = 20/150 (13%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++IF+ G L +K+ G E R + Q+L GLEYLH
Sbjct: 74 EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH-------------- 119
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-S 128
+N HRD+K NIL+ VK+ADFG A+ V+ ++++ GS + APEVI
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF----SFAKSFKGSPYWMAPEVIAQ 175
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
Y ADIWSLG M P+
Sbjct: 176 QGGYGLA-ADIWSLGCTVLEMATGKPPWSQ 204
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 52/162 (32%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+V+IFM Y G L + ++ + E R + Q+L GL YLH S
Sbjct: 73 KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH--------------SH 118
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVD---KEGRRVLSRTYCGSAAYAAPEVIS 128
I HRD+K NI + +K+ DFG A + G V S G+ AY APEVI+
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVIT 176
Query: 129 GNPYNPKL--ADIWSLGVITFIMLNAAMPFD--DSNLKQLFK 166
G ADIWSLG + M P+ D+ + +F
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.7 bits (231), Expect = 1e-21
Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 28/268 (10%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIK---RAGPVAESNARTWFSQMLAGLEYLHREIT 59
++ Q +++ M Y D G L D +K R GP++ES A +Q+L+ LEYLH
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---- 118
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTK-RFNVKIADFGFARY---CVDKEGRRVLSRTY 115
SK I HRD+K ENIL+ + VK+ DFG A+ L T
Sbjct: 119 ----------SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 116 CGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNIL 173
G+ Y APEV+ G Y +DIWSLG+ + +L PF+ + IL
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 174 SHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233
L+ + + D+L + +++ LSH + L
Sbjct: 229 ---ELPTPSLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSSDLSHDLLAHLKL 283
Query: 234 SHQVKNLVGQILEPDITKRIRLDAIKAH 261
+ + + + + +++A
Sbjct: 284 KESDLSDLLKPDDSAPLRLSLPPSLEAL 311
|
Length = 384 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q +F M Y + GDL+ HI+ A + ++++ GL++LH
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH----------- 113
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
SK I +RDLK +NIL+ ++KIADFG + + + + + T+CG+ Y APE+
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEI 167
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
+ G YN + D WS GV+ + ML PF + ++LF+
Sbjct: 168 LLGQKYNTSV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 20/150 (13%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
GPR++I M YA+ G + + +AGP+AE ++L L+Y+H
Sbjct: 74 GPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIH-------------- 118
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS- 128
+ HRD+K NIL+T NVK+ DFG A +R T+ G+ + APEVI+
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS---TFVGTPYWMAPEVITE 175
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
G Y+ K ADIWSLG+ + M P+ D
Sbjct: 176 GKYYDTK-ADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-21
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 26/164 (15%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFS--QML-------AGLEYLHREITNHTP 63
+++ + Y + GDLLD+++++ PV S ++ S +L G+EYL
Sbjct: 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-------- 122
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
SK HRDL N L+ + VKI+DFG +R D + R + + A
Sbjct: 123 ------SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL-PIRWMA 175
Query: 124 PEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
PE + + K +D+WS GV+ + I A P+ + +++ +
Sbjct: 176 PESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLE 218
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-21
Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+HS Q R+F+ + Y + GDL+ H++R + E +AR + +++ L +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE------ 114
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV--LSRTYCGSAA 120
+ I +RDLK +N+L+ ++K+ D+G KEG + T+CG+
Sbjct: 115 --------RGIIYRDLKLDNVLLDADGHIKLTDYGMC-----KEGLGPGDTTSTFCGTPN 161
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD------DSNLKQ-LFKEQTSNIL 173
Y APE++ G Y + D W+LGV+ F M+ PFD D N + LF+ IL
Sbjct: 162 YIAPEILRGEEYGFSV-DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----IL 216
Query: 174 SHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225
+++ LS VK +L K L+ K + Q DI SH
Sbjct: 217 EKPIRIPRFLS--VKASHVL------KGFLNKDPKERLGCQPQTGFSDIKSH 260
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-21
Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 13 VFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I M Y D GDL+ IK R E WF QM G++++H
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-------------- 118
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
K + HRD+K +NI +T+ VK+ DFG AR + TY G+ Y PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENM 175
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
PYN K +DIWSLG I + + PF ++ K L
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 22/177 (12%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q +++ + Y + G+L H++R E AR + +++ + + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH------- 113
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
S NI +RDLK ENIL+ + +V + DFG + V+ E + T+CG+ Y
Sbjct: 114 -------SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYL 163
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
APEV+ PY+ + D W LG + + ML PF ++ Q++ NIL +++
Sbjct: 164 APEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY----DNILHKPLQL 215
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 6e-21
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 19/150 (12%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+G +++I M Y G LD +K G + E+ ++L GLEYLH E
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLHEE----------- 117
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
HRD+K NIL+++ +VK+ADFG + +R T+ G+ + APEVI
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR---NTFVGTPFWMAPEVIK 171
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
+ Y+ K ADIWSLG+ + P D
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-21
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 22/182 (12%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q R+ M Y + G+L H+ R +E R + +++++ L+YLH
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH----------- 112
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S I +RDLK EN+++ K ++KI DFG C + +T+CG+ Y APEV
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGL---CKEGITDAATMKTFCGTPEYLAPEV 166
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186
+ N Y + D W LGV+ + M+ +PF + + ++LF+ IL +K LS
Sbjct: 167 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEDIKFPRTLSAD 221
Query: 187 VK 188
K
Sbjct: 222 AK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 22/157 (14%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+HS Q R+F + Y + GDL+ H++R + E +AR + +++ L YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE------ 114
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRT--YCGSAA 120
+ I +RDLK +N+L+ ++K+ D+G KEG R T +CG+
Sbjct: 115 --------RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPN 161
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157
Y APE++ G Y + D W+LGV+ F M+ PFD
Sbjct: 162 YIAPEILRGEDYGFSV-DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 55/150 (36%), Positives = 80/150 (53%), Gaps = 19/150 (12%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+G +++I M Y G LD + RAGP E T ++L GL+YLH E
Sbjct: 73 KGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSE----------- 120
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
K I HRD+K N+L++++ +VK+ADFG A D + +R T+ G+ + APEVI
Sbjct: 121 --KKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIQ 174
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
+ Y+ K ADIWSLG+ + P D
Sbjct: 175 QSAYDSK-ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 50/154 (32%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 13 VFIFMRYADNGDLLDHI--KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I M Y + GDL I +R E WF Q+ L+++H
Sbjct: 74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--------------D 119
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
+ I HRD+K +NI +TK +K+ DFG AR L+RT G+ Y +PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENR 176
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
PYN K +DIW+LG + + M F+ N+K L
Sbjct: 177 PYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 22/186 (11%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q +++ + Y + G+L H++R E AR + +++ + L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH------- 113
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
S NI +RDLK ENIL+ + ++ + DFG + ++ G + T+CG+ Y
Sbjct: 114 -------SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYL 163
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDI 182
APEV+ PY+ + D W LG + + ML PF N +++ NIL+ +++K
Sbjct: 164 APEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILNKPLQLKPN 218
Query: 183 LSHQVK 188
+++ +
Sbjct: 219 ITNSAR 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+ Q G ++++ + Y G+L H++R G E A + S++ LE+LH
Sbjct: 65 LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH------- 117
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
+ I +RDLK ENIL+ + +VK+ DFG + + EG ++ T+CG+ Y
Sbjct: 118 -------QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI-HEG--TVTHTFCGTIEYM 167
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
APE++ + + K D WSLG + + ML A PF N K+
Sbjct: 168 APEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKK 207
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-20
Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 24/159 (15%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
G ++ I M YA GDL I + + E F Q+L GL+ LH
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---------- 120
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
+ I HRDLK NIL+ VKI D G + K ++ +++T G+ Y APE
Sbjct: 121 ----EQKILHRDLKSANILLVANDLVKIGDLGIS-----KVLKKNMAKTQIGTPHYMAPE 171
Query: 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
V G PY+ K +DIWSLG + + M A PF+ +++ L
Sbjct: 172 VWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 49/140 (35%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 12 RVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ I M Y D G L +K G + E +L GL YLH +
Sbjct: 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK------------- 119
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K NIL+ R +K+ DFG + V+ L++T+ G+++Y APE I GN
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAPERIQGN 174
Query: 131 PYNPKLADIWSLGVITFIML 150
Y+ K +DIWSLG ++ I L
Sbjct: 175 DYSVK-SDIWSLG-LSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 27/167 (16%)
Query: 17 MRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76
M Y + GD +K G + AR +F++ + LEYLH + I HR
Sbjct: 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH--------------NYGIVHR 125
Query: 77 DLKCENILMTKRFNVKIADFGFARYC------------VDKEGRRVLSRTYCGSAAYAAP 124
DLK +N+L+T ++K+ DFG ++ ++K+ R L + CG+ Y AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 125 EVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
EVI Y K D W++G+I + L +PF ++LF + S+
Sbjct: 186 EVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-19
Identities = 52/150 (34%), Positives = 80/150 (53%), Gaps = 19/150 (12%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+G +++I M Y G LD +K GP+ E+ T ++L GL+YLH
Sbjct: 73 KGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLH------------- 118
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
S+ HRD+K N+L++++ +VK+ADFG A D + +R T+ G+ + APEVI
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIK 174
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
+ Y+ K ADIWSLG+ + P D
Sbjct: 175 QSAYDFK-ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 54/163 (33%), Positives = 79/163 (48%), Gaps = 37/163 (22%)
Query: 13 VFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
VF +M G+L +K + P +ES R+ Q+L GL ++H+ H F
Sbjct: 76 VFEYM----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK----HGFF------ 121
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR----TYCGSAAYAAPEV 126
HRDLK EN+L++ VKIADFG A R + SR Y + Y APE+
Sbjct: 122 ----HRDLKPENLLVSGPEVVKIADFGLA--------REIRSRPPYTDYVSTRWYRAPEI 169
Query: 127 I--SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLFK 166
+ S + Y+ + DIW+LG I + F S+ + QL+K
Sbjct: 170 LLRSTS-YSSPV-DIWALGCIMAELYTLRPLFPGSSEIDQLYK 210
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 13 VFIFMRYADNGDL---LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+++ Y D+ DL LD ES + + Q+L GL+YLH
Sbjct: 75 IYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLH-------------- 117
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S I HRD+K NIL+ +K+ADFG AR K + + Y PE++ G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 130 -NPYNPKLADIWSLGVITFIMLNAAMPFDDSN----LKQLFK 166
Y P++ D+WS+G I + F S L+++F+
Sbjct: 176 ATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q ++ + + Y G++ H+ + +E R + +++ LE+LH+
Sbjct: 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK------ 123
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
I +RD+K ENIL+ +V + DFG ++ + +E R S +CG+ Y
Sbjct: 124 --------LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYM 173
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDI 182
APE+I G + K D WSLG++ F +L A PF + E + IL
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233
Query: 183 LSHQVKVKDILSHQVKVKD 201
+ + +D+L H++ KD
Sbjct: 234 IGPE--AQDLL-HKLLRKD 249
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-19
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 15 IFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
I M YA G L ++I++ + E +F Q+L L ++H +K
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--------------TKL 121
Query: 73 IAHRDLKCENILMTKRFNV-KIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I HRDLK +NIL+ K V KI DFG ++ K + T G+ Y +PE+ G P
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISPELCEGKP 177
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
YN K +DIW+LG + + + + F+ +NL L
Sbjct: 178 YNQK-SDIWALGCVLYELASLKRAFEAANLPAL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-19
Identities = 57/167 (34%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 9 RGPRVF-IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
R + IFM Y G + D +K G + ES R + Q+L G+ YLH
Sbjct: 76 RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH------------ 123
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR----YCVDKEGRRVLSRTYCGSAAYAA 123
S I HRD+K NIL NVK+ DFG ++ C+ G R ++ G+ + +
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMS 177
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD-SNLKQLFKEQT 169
PEVISG Y K AD+WSLG ML P+ + + +FK T
Sbjct: 178 PEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-19
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q +++ + Y + G+L H++R E AR + +++ + L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH------- 113
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
S NI +RDLK ENIL+ + +V + DFG + ++ + T+CG+ Y
Sbjct: 114 -------SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT---TSTFCGTPEYL 163
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDI 182
APEV+ PY+ + D W LG + + ML PF + +++ NIL+ +++K
Sbjct: 164 APEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY----DNILNKPLRLKPN 218
Query: 183 LSHQVKVKDILS---HQVKVKDILSHQVKVKDILSH 215
+S V + +L + + K L + +I +H
Sbjct: 219 IS--VSARHLLEGLLQKDRTKR-LGAKDDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-19
Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 35/172 (20%)
Query: 11 PRVFIFMRYADNG---DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+++I + + D G ++ ++R + E R QML L +LH
Sbjct: 75 NKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLH------------ 120
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR--TYCGSAAYAAPE 125
S + HRDLK NIL+T +VK+ADFG V + + L + T+ G+ + APE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFG-----VSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 126 VI-----SGNPYNPKLADIWSLGVITFIMLNAAMP--FDDSNLKQLFKEQTS 170
V+ NPY+ K ADIWSLG IT I L P + + ++ L K S
Sbjct: 174 VVACETFKDNPYDYK-ADIWSLG-ITLIELAQMEPPHHELNPMRVLLKILKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 1e-18
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 32/169 (18%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
+ P + M Y + GDLL ++++ P + F+ +A G+EYL
Sbjct: 70 CTEEEPLYIV-MEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE--------- 119
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA----- 119
SKN HRDL N L+ + VKI+DFG +R + Y
Sbjct: 120 -----SKNFIHRDLAARNCLVGENLVVKISDFGLSRD--------LYDDDYYRKRGGKLP 166
Query: 120 -AYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + + K +D+WS GV+ + I P+ + +++ +
Sbjct: 167 IRWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 214
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 22/165 (13%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAE--SNARTW--FSQMLAGLEYLHREIT 59
+ R++I M + L +H + + R W F QM+ L YLH+E
Sbjct: 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-- 132
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
K I HRDL NI++ + V I DFG A+ ++ + G+
Sbjct: 133 -----------KRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTI 177
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
Y+ PE++ PY K AD+W+ G I + M PF +N+ L
Sbjct: 178 LYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSL 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 24/191 (12%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q +++ Y G+L H+++ G +E A+ + ++++ LE+LH+
Sbjct: 65 FQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY--------- 115
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
+I +RDLK ENIL+ ++ + DFG ++ + + T+CG+ Y APEV
Sbjct: 116 -----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTTEYLAPEV 167
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV-KDILSH 185
+ K D WSLGV+ F M PF + +Q+++ NI +V+ K++LS
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR----NIAFGKVRFPKNVLSD 223
Query: 186 QVK--VKDILS 194
+ + VK +L+
Sbjct: 224 EGRQFVKGLLN 234
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 1e-18
Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
Q P ++I Y GDLLD +++ G + +A G+EYL
Sbjct: 70 CTQGEP-LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--------- 119
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAP 124
SKN HRDL N L+T+ VKI+DFG +R + + R + AP
Sbjct: 120 -----SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAP 173
Query: 125 EVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDD 158
E + + K +D+WS GV+ + I P+
Sbjct: 174 ESLKDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTW-FSQMLAGLEYLHREITNHTPFTAHLPS 70
+ I M YA+ G L D I ++ G + E W Q+++ + Y+H+
Sbjct: 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA------------- 120
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K NI +TK +K+ DFG ++ + ++ T G+ Y +PE+ G
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE---YSMAETVVGTPYYMSPELCQGV 176
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
YN K +DIW+LG + + +L FD +N L
Sbjct: 177 KYNFK-SDIWALGCVLYELLTLKRTFDATNPLNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 51/150 (34%), Positives = 77/150 (51%), Gaps = 20/150 (13%)
Query: 19 YADNGDLLDHIK---RAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
YA+ GDL IK + E A F Q+L + ++H SK++
Sbjct: 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--------------SKHMI 165
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
HRD+K NIL+ VK+ DFGF++ V RT+CG+ Y APE+ PY+
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV-GRTFCGTPYYVAPEIWRRKPYSK 224
Query: 135 KLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
K AD++SLGV+ + +L PFD N++++
Sbjct: 225 K-ADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 45/191 (23%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M Y GDL++ + R E AR + ++++ L+ +H+
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK--------------L 120
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFA--------RYCV------------------DK 105
HRD+K +NIL+ ++K+ADFG R D
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
+ RRV + + G+ Y APEV+ G PY D WSLGVI + ML PF L++ +
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 166 KEQTSNILSHQ 176
+ I++ +
Sbjct: 240 ----NKIINWK 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-18
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 33/170 (19%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNA-RTWFSQMLA-GLEYLHREITNHTP 63
+ P + + M Y GDLLD++++ P S + F+ +A G+EYL
Sbjct: 70 CTEEEPLMIV-MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-------- 120
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR------YCVDKEGRRVLSRTYCG 117
SKN HRDL N L+ + VKI+DFG +R Y +G ++ R
Sbjct: 121 ------SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIR---- 169
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + + K +D+WS GV+ + I P+ + ++ +
Sbjct: 170 ---WMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE 215
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 2e-18
Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 28/161 (17%)
Query: 12 RVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++++ Y D DL ++ KR GP++ + ++ Q+L GL Y H S
Sbjct: 72 KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--------------S 116
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA---YAAPEVI 127
I HRDLK +NIL+ + +K+ADFG AR + RTY Y APE++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAF------GIPLRTYTHEVVTLWYRAPEIL 170
Query: 128 SGNP-YNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
G+ Y+ + DIWS+G I M+ F DS + QLFK
Sbjct: 171 LGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 19/156 (12%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
IF+ Y G + + G E+ R + Q+L GL YLH ++ I
Sbjct: 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--------------NRGII 128
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYC---VDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
HRD+K NIL+ + +KI+DFG ++ + GS + APEV+
Sbjct: 129 HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS 188
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLFK 166
Y K ADIWSLG + ML PF D L+ +FK
Sbjct: 189 YTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q +++ + + + G+L H++R E AR + +++ + L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH------- 113
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV--LSRTYCGSAA 120
S NI +RDLK ENIL+ + +V + DFG KEG + T+CG+
Sbjct: 114 -------SINIVYRDLKPENILLDSQGHVVLTDFGLC-----KEGIAQSDTTTTFCGTPE 161
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEVI PY+ D W LG + + ML PF ++ +++ NIL + ++
Sbjct: 162 YLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----DNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 50/155 (32%), Positives = 72/155 (46%), Gaps = 19/155 (12%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
IF+ Y G + ++ G E R + Q+L GL YLH SK I
Sbjct: 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH--------------SKGIL 130
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI--SGNPY 132
HRDLK +N+L+ KI+DFG ++ D + + GS + APEVI Y
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGY 189
Query: 133 NPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
+ K+ DIWSLG + M P+ D+ + +FK
Sbjct: 190 SAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 52/147 (35%), Positives = 70/147 (47%), Gaps = 26/147 (17%)
Query: 15 IFMRYADNGDLLDHI-----KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
I M Y + G L D I KR G + E +L GL YLH
Sbjct: 78 IAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-------------- 122
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S+ I HRD+K NIL+T++ VK+ DFG V E L+ T+ G++ Y APE I G
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERIQG 177
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPF 156
PY+ +D+WSLG+ + PF
Sbjct: 178 KPYSIT-SDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M + + G L D I + E T +L L +LH
Sbjct: 88 GDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH-------------- 132
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
++ + HRD+K ++IL+T VK++DFGF + RR ++ G+ + APEVIS
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR 189
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMP-FDDSNLKQLFKEQTSN--ILSHQVKVKDILS-- 184
PY + DIWSLG++ M++ P F++ L+ + + + + L + KV L
Sbjct: 190 LPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF 248
Query: 185 -HQVKVKDILSHQVKVKDILSHQ 206
++ V+D + + ++L+H
Sbjct: 249 LDRMLVRDP-AQRATAAELLNHP 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 52/142 (36%), Positives = 71/142 (50%), Gaps = 21/142 (14%)
Query: 14 FIFMRYADNGDLLDHIKRAGPVA---ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++ M Y G LLD +K + P E+ T ++L GLEYLH +
Sbjct: 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--------GQI-- 124
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR-TYCGSAAYAAPEVIS- 128
HRD+K NIL+ + +VKIADFG + D R R T+ G+ + APEV+
Sbjct: 125 ----HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 129 GNPYNPKLADIWSLGVITFIML 150
+ Y+ K ADIWS G IT I L
Sbjct: 181 VHGYDFK-ADIWSFG-ITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
IFM + G + D +K G + E+ R + Q+L G+ YLH S I
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH--------------SNMIV 128
Query: 75 HRDLKCENILMTKRFNVKIADFGFAR----YCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
HRD+K NIL NVK+ DFG ++ C+ G + ++ G+ + +PEVISG
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSPEVISGE 184
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPF 156
Y K ADIWS+G ML P+
Sbjct: 185 GYGRK-ADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 43/143 (30%), Positives = 75/143 (52%), Gaps = 21/143 (14%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
++L +R P+ E+ +++ +L G+ Y+H + I HRDLK N+
Sbjct: 87 EVLRDEER--PLPEAQVKSYMRMLLKGVAYMH--------------ANGIMHRDLKPANL 130
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSL 142
L++ +KIADFG AR +E R+ S + Y APE++ G Y+P D+W++
Sbjct: 131 LISADGVLKIADFGLAR-LFSEEEPRLYSHQ-VATRWYRAPELLYGARKYDP-GVDLWAV 187
Query: 143 GVITFIMLNAAMPFD-DSNLKQL 164
G I +LN + F +++++QL
Sbjct: 188 GCIFAELLNGSPLFPGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-17
Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 17 MRYADNGDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
M + GDL HI G AR F +Q++ GLE+LH+ I
Sbjct: 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--------------RIV 117
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
+RDLK EN+L+ NV+I+D G A K G+++ + G+ Y APEV+ G Y+
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKI--KGRAGTPGYMAPEVLQGEVYDF 173
Query: 135 KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
D ++LG + M+ PF K +E L V+ D S + K
Sbjct: 174 S-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAK 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 18/156 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++H Q ++++ + + GDL + + E + + + +++ L++LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH----- 115
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S I +RDLK ENIL+ + ++K+ DFG ++ +D E + + ++CG+
Sbjct: 116 ---------SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVE 163
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
Y APEV++ + + AD WS GV+ F ML ++PF
Sbjct: 164 YMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 13 VFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I M + + GDL +K + + E+ WF Q+ L+YLH
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-------------- 120
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
K+I HRDLK +N+ +T+ +K+ D G AR E + ++ T G+ Y +PE+ S
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLIGTPYYMSPELFSNK 177
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
PYN K +D+W+LG + M F+ ++ L
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-17
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 20/155 (12%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++I M Y G LD ++ GP+ E+ T ++L GL+YLH E K
Sbjct: 76 KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSE-------------K 121
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I HRD+K N+L+++ VK+ADFG A D + +R T+ G+ + APEVI +
Sbjct: 122 KI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIKQSA 177
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
Y+ K ADIWSLG+ + P + + +K LF
Sbjct: 178 YDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 8 QRGPRVFIFMRYADNGDLLD--HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
R +++I M Y G L D + R GP++E + L GL YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---------- 118
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
HRD+K NIL+T+ +VK+ADFG + +R +++ G+ + APE
Sbjct: 119 ----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPE 171
Query: 126 VISGN---PYNPKLADIWSLGVITFIMLNAAMP--FDDSNLKQLF 165
V + Y+ K DIW+LG IT I L P FD ++ LF
Sbjct: 172 VAAVERKGGYDGK-CDIWALG-ITAIELAELQPPMFDLHPMRALF 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 26/177 (14%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ + M + D G L K+ GP+ ++ GL YL+
Sbjct: 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV------------- 122
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K NIL+ R +K+ DFG V E ++ T+ G++ Y +PE I G
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFG-----VSGELINSIADTFVGTSTYMSPERIQGG 177
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQV 187
Y K +D+WSLG+ + PF SN + + + D+L V
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSN-------IDDDGQDDPMGILDLLQQIV 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 13 VFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M Y GDLL + R E A+ + ++++ + +H
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH--------------QM 121
Query: 72 NIAHRDLKCENILMTKRFNVKIADFG-FARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
HRD+K EN+L+ + ++K+ADFG AR +K V S+ G+ Y APEV++
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK---MVNSKLPVGTPDYIAPEVLTTM 178
Query: 131 PYNPKLA-----DIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
+ K D WSLGVI + M+ PF + + + +NI++ Q
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY----NNIMNFQ 225
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 26/170 (15%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
++ + + +++ + D DL IK R + ES +++ Q+L GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----- 115
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S I HRDLK EN+L+ +K+ADFG AR R Y
Sbjct: 116 ---------SHGILHRDLKPENLLINTEGVLKLADFGLARSF------GSPVRPYTHYVV 160
Query: 121 ---YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
Y APE++ G+ DIWS+G I +L+ F S + QLFK
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 52/158 (32%), Positives = 71/158 (44%), Gaps = 24/158 (15%)
Query: 15 IFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
I + AD GDL IK + E +F Q+ + LE++H S
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--------------S 124
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
K I HRD+K N+ +T VK+ D G R+ K + + G+ Y +PE I N
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHEN 181
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFK 166
YN K +DIWSLG + + M PF D NL L K
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17 MRYADNGDLLDHI---KRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
M + GDL HI P E A + +Q+++GLE+LH+ +
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--------------RR 117
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I +RDLK EN+L+ NV+I+D G A D + + ++ Y G+ + APE++ G Y
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---TKGYAGTPGFMAPELLQGEEY 174
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
+ + D ++LGV + M+ A PF K KE IL+ V D S K
Sbjct: 175 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 23/151 (15%)
Query: 15 IFMRYADNGDL---LDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
I Y + DL L+ +K G ++E+ WF Q+L G+ Y+H+
Sbjct: 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-------------- 124
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
+ I HRDLK +NI + +KI DFG +R + G L+ T+ G+ Y +PE +
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM---GSCDLATTFTGTPYYMSPEALKHQ 180
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161
Y+ K +DIWSLG I + M A F+ N
Sbjct: 181 GYDSK-SDIWSLGCILYEMCCLAHAFEGQNF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M Y GD + G ++E +AR + ++M ++ LH
Sbjct: 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE--------------LG 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
HRDLK EN L+ ++K+ DFG ++ V V GS Y APEV+ G Y
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVLRGKGY 175
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
+ + D WSLG + + L PF S + +
Sbjct: 176 DFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETW 207
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++ IF+ Y G + D +K G + E+ R + Q+L G+ YLH S
Sbjct: 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH--------------SN 125
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFAR----YCVDKEGRRVLSRTYCGSAAYAAPEVI 127
I HRD+K NIL NVK+ DFG ++ C+ G + ++ G+ + +PEVI
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMSPEVI 181
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDD-SNLKQLFKEQT 169
SG Y K AD+WS+ ML P+ + + +FK T
Sbjct: 182 SGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+H Q ++ + + Y + G+L H+ + E + + +++ LE+LH+
Sbjct: 70 LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK------ 123
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
I +RD+K ENIL+ +V + DFG ++ + E R S +CG+ Y
Sbjct: 124 --------LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYM 173
Query: 123 APEVIS-GNPYNPKLADIWSLGVITFIMLNAAMPF 156
AP+++ G+ + K D WS+GV+ + +L A PF
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 12 RVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
++ + M Y GDL IK+ P E F Q++ L+ +H
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH------------ 186
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S+ + HRDLK NI + +K+ DFGF++ D V S ++CG+ Y APE+
Sbjct: 187 --SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS-SFCGTPYYLAPELW 243
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y+ K AD+WSLGVI + +L PF + +++ ++
Sbjct: 244 ERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
|
Length = 478 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 9 RGPRVFIFMRYADNG--DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
R R+++ Y + +LL+ P + W Q+L + Y H
Sbjct: 71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW--QLLQAIAYCHS---------- 118
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
NI HRD+K ENIL+++ +K+ DFGFAR + L+ Y + Y APE+
Sbjct: 119 ----HNIIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLT-DYVATRWYRAPEL 172
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFKEQ 168
+ G+ K D+W++G I +L+ F DS++ QL+ Q
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 52/161 (32%), Positives = 75/161 (46%), Gaps = 33/161 (20%)
Query: 13 VFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
VF FM DL IK ++ + ++ +++ L GLEYLH
Sbjct: 80 VFEFME----TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--------------N 121
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR---RVLSRTYCGSAAYAAPEVIS 128
I HRDLK N+L+ +K+ADFG AR + +V++R Y APE++
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW------YRAPELLF 175
Query: 129 G-NPYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFK 166
G Y D+WS+G I F L +PF DS++ QL K
Sbjct: 176 GARHYGVG-VDMWSVGCI-FAELLLRVPFLPGDSDIDQLGK 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 40/133 (30%), Positives = 56/133 (42%), Gaps = 46/133 (34%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+L G+++LH S I HRDLK +NIL+T VKIADFG
Sbjct: 115 QLLRGVDFLH--------------SHRIVHRDLKPQNILVTSDGQVKIADFG-------- 152
Query: 106 EGRRVLSRTYCGSAA---------YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
L+R Y A Y APEV+ + Y + D+WS+G I +
Sbjct: 153 -----LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPV-DMWSVGCIFAEL------- 199
Query: 157 DDSNLKQLFKEQT 169
+ LF+ +
Sbjct: 200 --FRRRPLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-15
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 20/157 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +F+ M Y G L D + + E+ + L LE+LH
Sbjct: 88 GDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLH-------------- 132
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+ + HRD+K +N+L+ +VK+ DFGF ++ +R T G+ + APEV++
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 189
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
Y PK+ DIWSLG++ M+ P+ + N L+ L+
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 58/174 (33%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++I M Y G L D GP++E + L GL YLH SK
Sbjct: 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH--------------SK 125
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--- 128
HRD+K NIL+T +VK+ADFG A +R +++ G+ + APEV +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAVEK 182
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMP--FDDSNLKQLFKEQTSNILSHQVKVK 180
YN +L DIW++G IT I L P FD ++ LF SN ++K K
Sbjct: 183 NGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 32/169 (18%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
+ +R R+++ + D+ L D K + ES R + Q+L G+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---------- 117
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARY-------CVDKEGRRVLSRTYCGS 118
S NI HRD+K ENIL+++ VK+ DFGFAR D Y +
Sbjct: 118 ----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD----------YVAT 163
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
Y APE++ G+ + DIW++G + ML F DS++ QL+
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 36/203 (17%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
+F+ + G + + + G E+ + Q+L GL YLH I
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--------------ENQII 125
Query: 75 HRDLKCENILM--TKRFNVKIADFGFA-RYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
HRD+K N+L+ T + ++IADFG A R G G+ A+ APEV+ G
Sbjct: 126 HRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSN----LKQLFKEQTSN----ILSH-QVKVKDI 182
Y + D+WS+G + M A P++ L +FK ++ I H ++D+
Sbjct: 185 YG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 183 L--------SHQVKVKDILSHQV 197
+ +++L H V
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPV 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 45/136 (33%), Positives = 63/136 (46%), Gaps = 23/136 (16%)
Query: 13 VFIFMRYA--DNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+F+ M Y D LLD++ P +ES + Q+L GL+YLH
Sbjct: 83 IFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHENF------------ 128
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYC-GSAAYAAPEVISG 129
I HRDLK N+L+T + +KIADFG AR G T + Y APE++ G
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLAR----TYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 130 NPYNPKLADIWSLGVI 145
D+W++G I
Sbjct: 183 CTTYTTAIDMWAVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 47/190 (24%)
Query: 17 MRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
M Y G+L ++R ++E AR + +++L LEYLH I
Sbjct: 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--------------LLGIV 125
Query: 75 HRDLKCENILMTKRFNVKIADF-------------------GFARYCVDKEGRRVL---- 111
+RDLK ENIL+ + ++ ++DF G R V+
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 112 ---SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168
S ++ G+ Y APEVISG+ + + D W+LG++ + ML PF SN + F
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETF--- 241
Query: 169 TSNILSHQVK 178
SNIL +V
Sbjct: 242 -SNILKKEVT 250
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 23/137 (16%)
Query: 12 RVFIFMRYADNG--DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++++ M Y ++ L++ +K P +S + Q+L+G+ +LH
Sbjct: 80 KIYMVMEYVEHDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH-------------- 123
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK N+L+ R +KI DFG AR + ++ + Y APE++ G
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 130 NP-YNPKLADIWSLGVI 145
Y+ + D+WS+G I
Sbjct: 181 AKEYSTAI-DMWSVGCI 196
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 43/121 (35%), Positives = 63/121 (52%), Gaps = 15/121 (12%)
Query: 53 YLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLS 112
Y+ RE A+L + HRD+K +NIL+TK VK+ DFG + GRR
Sbjct: 117 YILRETLRGL---AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--- 170
Query: 113 RTYCGSAAYAAPEVISGNPYNPKL-----ADIWSLGVITFI-MLNAAMPFDDSN-LKQLF 165
T+ G+ + APEVI+ + P +D+WSLG IT I + + P D + ++ LF
Sbjct: 171 NTFIGTPYWMAPEVIACD-EQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRALF 228
Query: 166 K 166
K
Sbjct: 229 K 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 23 GDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80
GDL HI G R F +++ GLE LHRE I +RDLK
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--------------RIVYRDLKP 130
Query: 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIW 140
ENIL+ +++I+D G A EG + R G+ Y APEV+ Y D W
Sbjct: 131 ENILLDDYGHIRISDLGLAVEI--PEGETIRGRV--GTVGYMAPEVVKNERYTFS-PDWW 185
Query: 141 SLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
LG + + M+ PF K +E + Q + + S +
Sbjct: 186 GLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M Y G L D + + E + L LE+LH
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH-------------- 132
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S + HRD+K +NIL+ +VK+ DFGF ++ +R T G+ + APEV++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 189
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVK 188
Y PK+ DIWSLG++ M+ P+ + N L+ L+ T+ + +++ + LS
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPELQNPEKLS--AI 244
Query: 189 VKDILSHQVKVKDILSHQVKVKDILSHQ 216
+D L+ +++ + + K++L H
Sbjct: 245 FRDFLNRCLEMD--VEKRGSAKELLQHP 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 32/159 (20%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
++ P +FI Y NG LL++++ R G + S + +EYL
Sbjct: 69 TKQRP-IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES--------- 118
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA----- 120
HRDL N L+ + VK++DFG ARY +D + Y S
Sbjct: 119 -----NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--------YTSSQGTKFPV 165
Query: 121 -YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFD 157
+A PEV + ++ K +D+WS GV+ + + MP++
Sbjct: 166 KWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 43/130 (33%), Positives = 62/130 (47%), Gaps = 24/130 (18%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100
+++ Q+L G+ Y H S + HRDLK +N+L+ + +K+ADFG AR
Sbjct: 102 KSYLYQLLQGIAYCH--------------SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
Query: 101 YCVDKEGRRVLSRTYCGSAA---YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF- 156
V RTY Y APE++ G+ DIWS+G I M+N F
Sbjct: 148 ------AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
Query: 157 DDSNLKQLFK 166
DS + QLF+
Sbjct: 202 GDSEIDQLFR 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-14
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M Y G L D + + E + L L++LH
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLH-------------- 132
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S + HRD+K +NIL+ +VK+ DFGF ++ +R T G+ + APEV++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 189
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
Y PK+ DIWSLG++ M+ P+ + N L+ L+
Sbjct: 190 KAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 28/163 (17%)
Query: 1 MQVHSILQRGPRVFIFM-RYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREI 58
+++ L G + + Y + DL ++ KR+ P+ A Q+L GL YLH
Sbjct: 120 IRMKDTLVSGAITCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--- 174
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
++ I HRD+K ENI + V I D G A++ V L+ G+
Sbjct: 175 -----------AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GT 219
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP---FDD 158
APEV++ + YN K ADIWS G++ F ML A P F+D
Sbjct: 220 VETNAPEVLARDKYNSK-ADIWSAGIVLFEML--AYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M Y G L D + + E + L LE+LH
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLH-------------- 133
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S + HRD+K +NIL+ +VK+ DFGF ++ +R T G+ + APEV++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
Y PK+ DIWSLG++ M+ P+ + N L+ L+
Sbjct: 191 KAYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALY 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 18/145 (12%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
IFM + G + + R GP+ E + Q+L G+ YLH + +
Sbjct: 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH--------------NNCVV 124
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYC--VDKEGRRV-LSRTYCGSAAYAAPEVISGNP 131
HRD+K N+++ +K+ DFG AR V G + ++ G+ + APEVI+ +
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 132 YNPKLADIWSLGVITFIMLNAAMPF 156
Y K +DIWS+G F M P
Sbjct: 185 YGRK-SDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 61/190 (32%), Positives = 89/190 (46%), Gaps = 28/190 (14%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
R +++I M + G L D GP++ES + L GL YLH
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH------------- 123
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
SK HRD+K NIL+T +VK+ADFG + +R +++ G+ + APEV +
Sbjct: 124 -SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAA 179
Query: 129 ---GNPYNPKLADIWSLGVITFIMLNAAMP--FDDSNLKQLFKEQTSNI----LSHQVKV 179
YN +L DIW++G IT I L P FD ++ LF SN L ++K
Sbjct: 180 VERKGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237
Query: 180 KDILSHQVKV 189
+ H VK+
Sbjct: 238 SNSFHHFVKM 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
+L S I HRD+K N+L+ R VK+ DFG + V+ +++TY G+ AY APE
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPE 163
Query: 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTS 170
ISG Y +D+WSLG+ + P+ Q+ K Q S
Sbjct: 164 RISGEQYG-IHSDVWSLGISFMELALGRFPY-----PQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 39/152 (25%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLD-HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
H + + + + + D G L HI +A+ AR Q+L+G+ YLHR
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-AR----QILSGIAYLHR------ 186
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--C---- 116
++I HRD+K N+L+ NVKIADFG + R+L++T C
Sbjct: 187 --------RHIVHRDIKPSNLLINSAKNVKIADFGVS---------RILAQTMDPCNSSV 229
Query: 117 GSAAYAAPEVISGN----PYNPKLADIWSLGV 144
G+ AY +PE I+ + Y+ DIWSLGV
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261
|
Length = 353 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 22/157 (14%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M + G L D + + + E T +L L YLH
Sbjct: 90 GEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLH-------------- 134
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGF-ARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
S+ + HRD+K ++IL+T VK++DFGF A+ D R+ L G+ + APEVIS
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYWMAPEVIS 190
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMP-FDDSNLKQL 164
PY ++ DIWSLG++ M++ P F DS ++ +
Sbjct: 191 RTPYGTEV-DIWSLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-13
Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 15 IFMRYADNGDL---LDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
I + AD GDL + H K+ + E +F Q+ + LE++H S
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--------------S 124
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
+ + HRD+K N+ +T VK+ D G R+ K + + G+ Y +PE I N
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHEN 181
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFKE 167
YN K +DIWSLG + + M PF D NL L K+
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 18/110 (16%)
Query: 37 ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADF 96
E + +++ Q+L GL Y H+ KN HRD+KC NIL+ + +K+ADF
Sbjct: 115 EDHIKSFMKQLLEGLNYCHK--------------KNFLHRDIKCSNILLNNKGQIKLADF 160
Query: 97 GFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVI 145
G AR +E R ++ + Y PE++ G Y P + D+WS G I
Sbjct: 161 GLARLYNSEESRPYTNKVI--TLWYRPPELLLGEERYGPAI-DVWSCGCI 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 47/138 (34%), Positives = 62/138 (44%), Gaps = 21/138 (15%)
Query: 21 DNGDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78
+ GDL HI G R F +++ GLE L RE I +RDL
Sbjct: 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--------------RIVYRDL 128
Query: 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLAD 138
K ENIL+ R +++I+D G A EG V R G+ Y APEVI+ Y D
Sbjct: 129 KPENILLDDRGHIRISDLGLAVQI--PEGETVRGRV--GTVGYMAPEVINNEKYTFS-PD 183
Query: 139 IWSLGVITFIMLNAAMPF 156
W LG + + M+ PF
Sbjct: 184 WWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 23/135 (17%)
Query: 24 DLLDH-----IKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78
+L++ IK P+ + + + + Q+L GL+YLH S N+ HRDL
Sbjct: 84 ELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH--------------SANVIHRDL 129
Query: 79 KCENILMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYAAPEVI-SGNPYNPKL 136
K NIL+ ++KI DFG AR D++ + L+ Y + Y APE++ S + Y K
Sbjct: 130 KPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-YVVTRWYRAPELLLSSSRYT-KA 187
Query: 137 ADIWSLGVITFIMLN 151
DIWS+G I +L
Sbjct: 188 IDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M + + G L D + E A + +L L LH
Sbjct: 89 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLH-------------- 133
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
++ + HRD+K ++IL+T VK++DFGF V KE R ++ G+ + APE+IS
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPR--RKSLVGTPYWMAPELISR 190
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMP-FDDSNLKQL 164
PY P++ DIWSLG++ M++ P F++ LK +
Sbjct: 191 LPYGPEV-DIWSLGIMVIEMVDGEPPYFNEPPLKAM 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 21 DNGDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78
+ GDL HI G R F +++ GLE LH+E I +RDL
Sbjct: 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--------------RIVYRDL 128
Query: 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLAD 138
K ENIL+ +++I+D G A + EG+ + R G+ Y APEV+ Y D
Sbjct: 129 KPENILLDDHGHIRISDLGLAVHV--PEGQTIKGRV--GTVGYMAPEVVKNERYTFS-PD 183
Query: 139 IWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNIL 173
W+LG + + M+ PF K++ +E+ ++
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRK-KKIKREEVERLV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 40/111 (36%), Positives = 52/111 (46%), Gaps = 19/111 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML G+++LH S I HRDLK NI++ +KI DFG AR
Sbjct: 126 QMLCGIKHLH--------------SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 167
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
G + Y + Y APEVI G Y + DIWS+G I M+ + F
Sbjct: 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 46/138 (33%), Positives = 63/138 (45%), Gaps = 21/138 (15%)
Query: 21 DNGDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78
+ GDL HI G R F +++L GLE LHRE N +RDL
Sbjct: 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--------------NTVYRDL 128
Query: 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLAD 138
K ENIL+ +++I+D G A EG + R G+ Y APEV++ Y D
Sbjct: 129 KPENILLDDYGHIRISDLGLAVKI--PEGESIRGRV--GTVGYMAPEVLNNQRYTLS-PD 183
Query: 139 IWSLGVITFIMLNAAMPF 156
W LG + + M+ PF
Sbjct: 184 YWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 50/148 (33%), Positives = 68/148 (45%), Gaps = 24/148 (16%)
Query: 15 IFMRYADNGDLLDHIK-RAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSK 71
IFM G L ++ + GP+ ++ F Q+L GL+YLH
Sbjct: 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--------------DN 127
Query: 72 NIAHRDLKCENILM-TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K +N+L+ T VKI+DFG ++ G + T+ G+ Y APEVI
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA---GINPCTETFTGTLQYMAPEVIDKG 184
Query: 131 P--YNPKLADIWSLGVITFIMLNAAMPF 156
P Y ADIWSLG M PF
Sbjct: 185 PRGYGAP-ADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 45/126 (35%), Positives = 61/126 (48%), Gaps = 24/126 (19%)
Query: 35 VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIA 94
+ E + QML L+YLH S I HRDLK N+L+T ++K+A
Sbjct: 107 LTEPQIQVICRQMLEALQYLH--------------SMKIIHRDLKAGNVLLTLDGDIKLA 152
Query: 95 DFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-----SGNPYNPKLADIWSLGVITFIM 149
DFG + V RR ++ G+ + APEV+ PY+ K ADIWSLG IT I
Sbjct: 153 DFGVSAKNVKTLQRR---DSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLG-ITLIE 207
Query: 150 LNAAMP 155
+ P
Sbjct: 208 MAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 28/173 (16%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESN--ARTWFSQMLAGLEYLHREI 58
+++ ++ R+++ Y D DL H+ + A++ +T+ Q+L G+ Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFN-VKIADFGFARYCVDKEGRRVLSRTYCG 117
S + HRDLK +N+L+ +R N +K+ADFG AR + RT+
Sbjct: 120 -----------SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTH 162
Query: 118 SAA---YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
Y APE++ G+ + DIWS+G I M+N F DS + +LFK
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 19/147 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G +++ M + + G L D + E A S +L L YLH
Sbjct: 91 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLH-------------- 135
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
++ + HRD+K ++IL+T +K++DFGF + +R ++ G+ + APEVIS
Sbjct: 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISR 192
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPF 156
PY ++ DIWSLG++ M++ P+
Sbjct: 193 LPYGTEV-DIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 13 VFIFMRY--ADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
V+I Y D ++L+ GP++E +AR + Q+L GL+Y+H S
Sbjct: 91 VYIVQEYMETDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIH--------------S 132
Query: 71 KNIAHRDLKCENILM-TKRFNVKIADFGFARYCVDKE--GRRVLSRTYCGSAAYAAPE-V 126
N+ HRDLK N+ + T+ +KI DFG AR VD + LS + Y +P +
Sbjct: 133 ANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLV-TKWYRSPRLL 190
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQL 164
+S N Y K D+W+ G I ML F ++ L+Q+
Sbjct: 191 LSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 24/156 (15%)
Query: 15 IFMRYADNGDLLDHI----KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
I + AD GDL I K+ + E +F Q+ + +E++H S
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--------------S 124
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
+ + HRD+K N+ +T VK+ D G R+ K + + G+ Y +PE I N
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHEN 181
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQL 164
YN K +DIWSLG + + M PF D NL L
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 33/164 (20%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q+ P ++I + +NG LL++++ R G +++ + + G+EYL R
Sbjct: 70 QQKP-LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---------- 118
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------ 120
+ HRDL N L++ VK++DFG RY +D E Y S+
Sbjct: 119 ----NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--------YTSSSGAKFPVK 166
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDD-SNLK 162
++ PEV + + Y+ K +D+WS GV+ + + MPF+ SN +
Sbjct: 167 WSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 33/76 (43%), Positives = 44/76 (57%), Gaps = 7/76 (9%)
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ HRD+K NIL+ NVK+ DFG + VD + + +R+ G AAY APE I
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRS-AGCAAYMAPERIDPPD 190
Query: 132 YNPKL---ADIWSLGV 144
NPK AD+WSLG+
Sbjct: 191 PNPKYDIRADVWSLGI 206
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 11/92 (11%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--CGSAAYAAP 124
+L S NI +RDLK EN+L+ K +K+ DFGFA+ V +RTY CG+ Y AP
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAP 197
Query: 125 EVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
E++ N + K AD W+LG+ + +L PF
Sbjct: 198 EILL-NVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 22/160 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++++ M + G + D +K + W + Y+ REI AHL +
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIA-------YICREILRGL---AHLHAH 140
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--G 129
+ HRD+K +N+L+T+ VK+ DFG + GRR T+ G+ + APEVI+
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTPYWMAPEVIACDE 197
Query: 130 NP---YNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
NP Y+ + +DIWSLG+ M A P D + ++ LF
Sbjct: 198 NPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 44/130 (33%), Positives = 60/130 (46%), Gaps = 24/130 (18%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100
+++ Q+L GL + H S + HRDLK +N+L+ +K+ADFG AR
Sbjct: 103 KSYLFQLLQGLAFCH--------------SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
Query: 101 YCVDKEGRRVLSRTYCGSAA---YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF- 156
V RTY Y APE++ G Y DIWSLG I M+ F
Sbjct: 149 ------AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202
Query: 157 DDSNLKQLFK 166
DS + QLF+
Sbjct: 203 GDSEIDQLFR 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ M Y +GDL D +K+ G ++E+ + Q++ L LH N
Sbjct: 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH--------------KHN 129
Query: 73 IAHRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I H D+K EN+L + + + D+G + + Y G+ Y +PE I G+
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS------CYDGTLDYFSPEKIKGHN 182
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDS-----NLKQLFKEQTSNI 172
Y+ D W++GV+T+ +L PF + +L+ L K Q +
Sbjct: 183 YDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 26/123 (21%)
Query: 30 KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89
R P+ + Q+L+ ++Y+H E I HRD+K EN+L+
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGE--------------GIIHRDIKTENVLVNGPE 297
Query: 90 NVKIADFG---FARYCVDKEGRRVLSRTY--CGSAAYAAPEVISGNPYNPKLADIWSLGV 144
++ + DFG FAR G Y G+ APEV++G+PY P + DIWS G+
Sbjct: 298 DICLGDFGAACFAR------GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV-DIWSAGL 350
Query: 145 ITF 147
+ F
Sbjct: 351 VIF 353
|
Length = 461 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ I M + D G L +K+AG + E ++ GL YL RE
Sbjct: 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL-RE------------KHK 124
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I HRD+K NIL+ R +K+ DFG + +D ++ ++ G+ +Y +PE + G Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 179
Query: 133 NPKLADIWSLGVITFIMLNAAMPF---DDSNLKQLFKEQ 168
+ + +DIWS+G+ M P D L+ +F
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCP 217
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 37/172 (21%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESN----------ARTWFSQMLAG 50
+++ ++ G + M GDL +++ P AE+N +++ G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 51 LEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---K 105
+ YL +K HRDL N ++ + VKI DFG R Y D K
Sbjct: 132 MAYLA--------------AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156
G+ +L + APE + + K +D+WS GV+ + M A P+
Sbjct: 178 GGKGLL------PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 31/143 (21%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
G + + M A G LL ++K+ + S+ + Q+ G+ YL
Sbjct: 67 GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE-------------- 112
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR--------YCVDKEGRRVLSRTYCGSAAY 121
SK+ HRDL N+L+ R KI+DFG +R Y GR L + Y
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL-KWY------ 165
Query: 122 AAPEVISGNPYNPKLADIWSLGV 144
APE I+ ++ K +D+WS GV
Sbjct: 166 -APECINYGKFSSK-SDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 15/123 (12%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DL I+ P+ +++ +++ Q+L GL+Y+H S N+ HRDLK N+
Sbjct: 91 DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH--------------SANVLHRDLKPGNL 136
Query: 84 LMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
L+ +KI DFG AR + + Y + Y APE++ K D+WS+
Sbjct: 137 LVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196
Query: 143 GVI 145
G I
Sbjct: 197 GCI 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 40/129 (31%), Positives = 58/129 (44%), Gaps = 15/129 (11%)
Query: 23 GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82
DL I P+ E + R + Q+L GL+Y+H S N+ HRDLK N
Sbjct: 92 SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH--------------SANVIHRDLKPSN 137
Query: 83 ILMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWS 141
+L+ + ++I DFG AR + Y + Y APE++ P D+WS
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197
Query: 142 LGVITFIML 150
+G I ML
Sbjct: 198 VGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 22/160 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++++ M + G + D IK + T + +A Y+ REI +HL
Sbjct: 83 QLWLVMEFCGAGSVTDLIK------NTKGNTLKEEWIA---YICREILRGL---SHLHQH 130
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--G 129
+ HRD+K +N+L+T+ VK+ DFG + GRR T+ G+ + APEVI+
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTPYWMAPEVIACDE 187
Query: 130 NP---YNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLF 165
NP Y+ K +D+WSLG+ M A P D + ++ LF
Sbjct: 188 NPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 28/181 (15%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q+H Q +++ M Y GDL++ + + E AR + ++++ L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH----- 159
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCV--DKEGRRVLSRTYCGS 118
S HRD+K +N+L+ K ++K+ADFG C+ D G V T G+
Sbjct: 160 ---------SMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANG-MVRCDTAVGT 206
Query: 119 AAYAAPEVI---SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSH 175
Y +PEV+ G+ Y + D WS+GV + ML PF +L + S I+ H
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMDH 262
Query: 176 Q 176
+
Sbjct: 263 K 263
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 37/101 (36%), Positives = 51/101 (50%), Gaps = 22/101 (21%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+L GL+Y+H S I HRDLK NI + + +KI DFG AR+ D+
Sbjct: 126 QILRGLKYIH--------------SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
Query: 106 EGRRVLSRTYCGSAAYAAPEVI-SGNPYNPKLADIWSLGVI 145
V +R Y APE++ + YN + DIWS+G I
Sbjct: 172 MTGYVATRW------YRAPEIMLNWMHYN-QTVDIWSVGCI 205
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 44/134 (32%), Positives = 59/134 (44%), Gaps = 27/134 (20%)
Query: 34 PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKI 93
P+ E R Q L L YLH I HRDLK NIL T ++K+
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLH--------------ENKIIHRDLKAGNILFTLDGDIKL 144
Query: 94 ADFGFARYCVDKEGRRVLSR--TYCGSAAYAAPEVI-----SGNPYNPKLADIWSLGVIT 146
ADFG V + R + R ++ G+ + APEV+ PY+ K AD+WSLG+
Sbjct: 145 ADFG-----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITL 198
Query: 147 FIMLNAAMPFDDSN 160
M P + N
Sbjct: 199 IEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 19/129 (14%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
I M + D G L +K+AG + E+ +L GL YL + I
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH-------------KIM 122
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
HRD+K NIL+ R +K+ DFG + +D ++ ++ G+ +Y +PE + G Y
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYT- 176
Query: 135 KLADIWSLG 143
+DIWSLG
Sbjct: 177 VQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREI 58
+++++++ + ++I Y G LLD +K G V + +Q+ G+ Y+ R
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-- 121
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD-----KEGRRVLSR 113
KN HRDL+ N+L+++ KIADFG AR D +EG +
Sbjct: 122 ------------KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--- 166
Query: 114 TYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPF 156
+ APE I+ + K +D+WS G++ + I+ +P+
Sbjct: 167 ----PIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPV-AESNARTWFSQMLAGLEYLHREITNH 61
+H I+ + + Y D+ DL ++ G + + N + + Q+L GL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK----- 121
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
+ I HRDLK +N+L+ ++ +K+ADFG AR + V ++TY
Sbjct: 122 ---------RKILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVVT 166
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
Y P+V+ G+ D+W +G I + M F S +K+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 30/132 (22%)
Query: 25 LLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
L + IK R P+ E +++ Q+L L+++HR I HRD+K ENI
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--------------NGIFHRDIKPENI 131
Query: 84 LMTKRFNVKIADFGFARYCVDK----EGRRVLSRTYCGSAAYAAPE-VISGNPYNPKLAD 138
L+ K +K+ADFG R K E Y + Y APE +++ Y PK+ D
Sbjct: 132 LI-KDDILKLADFGSCRGIYSKPPYTE--------YISTRWYRAPECLLTDGYYGPKM-D 181
Query: 139 IWSLGVITFIML 150
IW++G + F +L
Sbjct: 182 IWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 34/175 (19%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWF---SQMLAGLEYLHRE 57
+Q+ + R P +I + G+LLD+++ E NA +Q+ + +EYL +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEK- 122
Query: 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG 117
KN HRDL N L+ + VK+ADFG +R TY
Sbjct: 123 -------------KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--------TYTA 161
Query: 118 SAA------YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM-PFDDSNLKQLF 165
A + APE ++ N ++ K +D+W+ GV+ + + M P+ +L Q++
Sbjct: 162 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 47 MLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKE 106
+L ++YLH I HRD+K ENI + +V + DFG A + VD
Sbjct: 191 VLRAIQYLH--------------ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 107 GRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149
+ + G+ A APE+++ +PY P + DIWS G++ F M
Sbjct: 237 ANKYYG--WAGTIATNAPELLARDPYGPAV-DIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 31/183 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITN 60
+H Q +++ M Y GDLL + + + E AR + ++M+ ++ +H+
Sbjct: 65 NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---- 120
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYC--VDKEGRRVLSRTYCGS 118
HRD+K +N+L+ K ++++ADFG C + +G V S G+
Sbjct: 121 ----------LGYVHRDIKPDNVLLDKNGHIRLADFG---SCLRLLADG-TVQSNVAVGT 166
Query: 119 AAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNIL 173
Y +PE++ Y P+ D WSLGV + ML PF +L E I+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESL----VETYGKIM 221
Query: 174 SHQ 176
+H+
Sbjct: 222 NHK 224
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DL I P++ + + + Q+L GL+YLH S I HRD+K N+
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH--------------SAGILHRDIKPGNL 134
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143
L+ +KI DFG AR E + + + Y APE++ G+ + DIWS+G
Sbjct: 135 LVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVG 192
Query: 144 VITFIMLNAAMPFDDSN-LKQL 164
I +L + F + ++QL
Sbjct: 193 CIFAELLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 31/129 (24%)
Query: 50 GLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR 109
LEYLH ++ ++ HRD+K N+L+ + VK+ DFG + Y VD
Sbjct: 115 ALEYLHSKL-------------SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---- 157
Query: 110 VLSRTY-CGSAAYAAPEVIS--GNP--YNPKLADIWSLGVITFI-MLNAAMPFDD----- 158
+++T G Y APE I+ N Y+ K +D+WSLG IT I + P+D
Sbjct: 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLG-ITMIELATGRFPYDSWKTPF 214
Query: 159 SNLKQLFKE 167
LKQ+ +E
Sbjct: 215 QQLKQVVEE 223
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q+ Q +++ M Y GDL++ + V E AR + ++++ L+ +H
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH----- 159
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S HRD+K +N+L+ K ++K+ADFG ++KEG V T G+
Sbjct: 160 ---------SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEG-MVRCDTAVGTPD 208
Query: 121 YAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
Y +PEV+ G+ Y + D WS+GV + ML PF +L + S I++H+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMNHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 31/164 (18%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFS-QMLAGLEYLHREI 58
+++++++ + P ++I Y +NG L+D +K G N + Q+ G+ ++ R
Sbjct: 64 VRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD-----KEGRRVLSR 113
KN HRDL+ NIL+++ KIADFG AR D +EG +
Sbjct: 121 ------------KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--- 165
Query: 114 TYCGSAAYAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPF 156
+ APE I+ + K +D+WS G+ +T I+ +P+
Sbjct: 166 ----PIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 24/179 (13%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q+ Q +++ M Y GDL++ + V E A+ + ++++ L+ +H
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH----- 159
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S + HRD+K +N+L+ K ++K+ADFG +D+ G V T G+
Sbjct: 160 ---------SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK-MDETG-MVRCDTAVGTPD 208
Query: 121 YAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
Y +PEV+ G+ Y + D WS+GV F ML PF +L + S I+ H+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----SKIMDHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 6 ILQRGPRVFIFMRYADNGDL---LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
+L + R+++ + DL LD + + + +++ Q+L G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH------- 118
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-- 120
S+ + HRDLK +N+L+ + +K+ADFG AR + R Y
Sbjct: 119 -------SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTL 165
Query: 121 -YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y APEV+ G+P DIWS+G I M F DS + QLF+
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAE-SNARTWFSQMLAGLEYLHREITNH 61
+H I+ + + Y D DL ++ G + N + + Q+L GL Y HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR----- 122
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
+ + HRDLK +N+L+ +R +K+ADFG AR + V ++TY
Sbjct: 123 ---------RKVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVVT 167
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLK 162
Y P+V+ G+ D+W +G I F M + F S ++
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 19/123 (15%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DL I+ + +++ + + + Q+L GL+Y+H S N+ HRDLK N+
Sbjct: 94 DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--------------SANVLHRDLKPSNL 139
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-SGNPYNPKLADIWSL 142
L+ ++KI DFG AR +K Y + Y APE++ + + Y + D+WS+
Sbjct: 140 LLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLLNCSEYTTAI-DVWSV 195
Query: 143 GVI 145
G I
Sbjct: 196 GCI 198
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H Q +++ M Y GDLL + + + E AR + ++M+ ++ +H+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ----- 120
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD-KEGRRVLSRTYCGSAA 120
+ HRD+K +NILM ++++ADFG C+ E V S G+
Sbjct: 121 ---------LHYVHRDIKPDNILMDMNGHIRLADFG---SCLKLMEDGTVQSSVAVGTPD 168
Query: 121 YAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSH 175
Y +PE++ Y P+ D WSLGV + ML PF +L + + I++H
Sbjct: 169 YISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNH 223
Query: 176 QVKVK 180
+ + +
Sbjct: 224 KERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+L GL+Y+H S N+ HRDLK N+L+ ++KI DFG AR +
Sbjct: 114 QILRGLKYIH--------------SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151
Y + Y APE++ + K DIWS+G I ML+
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
VF+ +++A+ G L HI + + E + W ++M+ L+ LHRE
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE--------------G 105
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I RDL NIL+ R ++++ F D + YC APEV G
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV-GGISE 158
Query: 133 NPKLADIWSLGVITFIML 150
+ D WSLG I F +L
Sbjct: 159 ETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 24/118 (20%)
Query: 37 ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADF 96
ES + + Q+L G+ YLH +I HRD+K NIL+ + +KIADF
Sbjct: 114 ESQIKCYMLQLLEGINYLHE--------------NHILHRDIKAANILIDNQGILKIADF 159
Query: 97 GFARYCVD-----KEGRRVLSRTYCGSAA---YAAPEVISGNP-YNPKLADIWSLGVI 145
G AR K G +R Y Y PE++ G Y + DIW +G +
Sbjct: 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCV 216
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 25/117 (21%)
Query: 38 SNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFG 97
N R + Q+L GL Y H+ + + HRDLK +N+L+++R +K+ADFG
Sbjct: 103 HNVRLFLFQLLRGLAYCHQ--------------RRVLHRDLKPQNLLISERGELKLADFG 148
Query: 98 FARYCVDKEGRRVLSRTYCGSAA---YAAPEVISGNP-YNPKLADIWSLGVITFIML 150
AR + V S+TY Y P+V+ G+ Y+ L D+W +G I + M
Sbjct: 149 LAR------AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSL-DMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNG--DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREI 58
+++ +R ++++ Y + +LL+ + P R++ Q++ + + H+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP--PEKVRSYIYQLIKAIHWCHK-- 118
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+I HRD+K EN+L++ +K+ DFGFAR EG Y +
Sbjct: 119 ------------NDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVAT 164
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFKEQ 168
Y +PE++ G PY K D+WS+G I + + F +S + QLF Q
Sbjct: 165 RWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 21 DNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80
+ GDL H+ + G +E R + ++++ GLE++H ++ + +RDLK
Sbjct: 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH--------------NRFVVYRDLKP 125
Query: 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-GNPYNPKLADI 139
NIL+ + +V+I+D G A K+ G+ Y APEV+ G Y+ AD
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSS-ADW 179
Query: 140 WSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
+SLG + F +L PF K E L+ V++ D S ++K
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 28/142 (19%)
Query: 33 GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVK 92
G + +++ Q+L GL + H S N+ HRDLK +N+L+ K +K
Sbjct: 94 GDIDPEIVKSFMFQLLKGLAFCH--------------SHNVLHRDLKPQNLLINKNGELK 139
Query: 93 IADFGFARYCVDKEGRRVLSRTYCGSAA---YAAPEVISGNPYNPKLADIWSLGVITFIM 149
+ADFG AR + R Y Y P+V+ G D+WS G I +
Sbjct: 140 LADFGLAR------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
Query: 150 LNAAMPF-----DDSNLKQLFK 166
NA P D LK++F+
Sbjct: 194 ANAGRPLFPGNDVDDQLKRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 16/100 (16%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA----- 120
A+L S N+ HRDL N L+ + VK++DFG R+ +D + Y S
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--------YTSSTGTKFPV 165
Query: 121 -YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDD 158
+++PEV S + Y+ K +D+WS GV+ + + P+++
Sbjct: 166 KWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 45/135 (33%), Positives = 60/135 (44%), Gaps = 28/135 (20%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
D+L+ K+ P+ E L GL YLH S HRD+K NI
Sbjct: 103 DILEVHKK--PLQEVEIAAICHGALQGLAYLH--------------SHERIHRDIKAGNI 146
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIW 140
L+T+ VK+ADFG A + ++ G+ + APEVI Y+ K D+W
Sbjct: 147 LLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVW 198
Query: 141 SLGVITFIMLNAAMP 155
SLG IT I L P
Sbjct: 199 SLG-ITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 17/102 (16%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+L L+Y+H + N+ HRDLK +NIL +KI DFG AR +
Sbjct: 111 QLLRALKYIH--------------TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156
Query: 106 EGRRVLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVI 145
+ Y + Y APE+ + Y P + DIWS+G I
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCI 197
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 47/148 (31%), Positives = 65/148 (43%), Gaps = 34/148 (22%)
Query: 31 RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90
P++E + QML GL+Y+H S I HRDLK N+ + +
Sbjct: 110 MGHPLSEDKVQYLVYQMLCGLKYIH--------------SAGIIHRDLKPGNLAVNEDCE 155
Query: 91 VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150
+KI DFG AR+ + V++R Y APEVI + + DIWS+G I ML
Sbjct: 156 LKILDFGLARHADAEMTGYVVTRW------YRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
Query: 151 NAAMPFDDSNLKQLFK-----EQTSNIL 173
K LFK +Q + IL
Sbjct: 210 TG---------KTLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 49/170 (28%), Positives = 72/170 (42%), Gaps = 27/170 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDH-IKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H I+ + Y DL + I+ G + N R + Q+L GL Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG----- 121
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
++I HRDLK +N+L++ +K+ADFG AR + + S+TY
Sbjct: 122 ---------QHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVT 166
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITFIMLNA--AMPFDDSNLKQLFK 166
Y P+V+ G DIW G I ML A P +QL K
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 38/178 (21%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNAR---------------TWFS-QMLAGL 51
Q GP +++ + YA +G+L D ++ P E + F+ Q+ G+
Sbjct: 87 QEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145
Query: 52 EYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRR 109
E+L SK HRDL N+L+T+ +KIADFG AR + +D +
Sbjct: 146 EFL--------------ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 110 VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
R + APE + Y + +D+WS GV+ + I P+ +++LFK
Sbjct: 192 TNGRL---PVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 47/176 (26%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M + GD++ + + ++E + + ++ + ++ +H+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ--------------LG 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFG------------FARYCVD---------------- 104
HRD+K +N+L+ + +VK++DFG F R
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 105 ----KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
K+ RR L+ + G+ Y APEV YN KL D WSLGVI + ML PF
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 21/112 (18%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100
W Q L + + H N HRD+K ENIL+TK+ +K+ DFGFAR
Sbjct: 105 IIW--QTLQAVNFCH--------------KHNCIHRDVKPENILITKQGQIKLCDFGFAR 148
Query: 101 YCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLN 151
Y + Y APE++ G+ Y P + D+W++G + +L
Sbjct: 149 ILTGPGDDYT---DYVATRWYRAPELLVGDTQYGPPV-DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-10
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWF--SQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ M + GDL HI G R +Q+ G+ +LH S +
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--------------SMD 115
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I +RD+K EN+L+ + N +++D G A K+G+ + R G+ Y APE++ PY
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRA--GTNGYMAPEILKEEPY 171
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
+ + D +++G + M+ PF D K +E L +VK
Sbjct: 172 SYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 42/187 (22%), Positives = 77/187 (41%), Gaps = 47/187 (25%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M + GD++ + + + E + + ++ + ++ +H+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ--------------LG 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFA--------------------------------R 100
HRD+K +N+L+ + +VK++DFG +
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 101 YCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
K RR L+ + G+ Y APEV YN KL D WSLGVI + ML PF
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 161 LKQLFKE 167
++ +K+
Sbjct: 241 PQETYKK 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAE-SNARTWFSQMLAGLEYLHREITNH 61
+H I+ + + Y D DL ++ G N + + Q+L GL Y HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR----- 122
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
+ + HRDLK +N+L+ +R +K+ADFG AR + + ++TY
Sbjct: 123 ---------RKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVT 167
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
Y P+++ G+ D+W +G I + M F S +++
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++H+++ + P ++I + G LLD +K E + Q L L +I
Sbjct: 64 VKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD----EGS-----KQPLPKLIDFSAQIAE 113
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
A + +N HRDL+ NIL++ KIADFG AR D E
Sbjct: 114 GM---AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIK 168
Query: 121 YAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPF 156
+ APE I+ + K +D+WS G+ + I+ +P+
Sbjct: 169 WTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 22/127 (17%)
Query: 26 LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85
L + + P+ + + + Q+L GL+Y+H S + HRDLK NIL+
Sbjct: 96 LHRLLTSRPLEKQFIQYFLYQILRGLKYVH--------------SAGVVHRDLKPSNILI 141
Query: 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV-ISGNPYNPKLADIWSLGV 144
+ ++KI DFG AR D + +S Y Y APE+ ++ Y+ ++ DIWS G
Sbjct: 142 NENCDLKICDFGLAR-IQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEV-DIWSAGC 194
Query: 145 ITFIMLN 151
I ML
Sbjct: 195 IFAEMLE 201
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 17/102 (16%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-YCVD 104
+L GL Y+HR I HRD+K NIL+TK +K+ADFG AR + +
Sbjct: 127 MLLNGLYYIHR--------------NKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVI 145
K + + Y PE++ G Y P + D+W G I
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI-DMWGAGCI 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ I M + D G L +K A + E +L GL YL +
Sbjct: 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK-------------HQ 124
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I HRD+K NIL+ R +K+ DFG + +D ++ ++ G+ +Y +PE + G Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 179
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
+ + +DIWS+G+ + P + K+L
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 55/184 (29%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ M Y GD++ + R G E AR + +++ +E +H+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK--------------MG 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFA---RYCVD------------------------- 104
HRD+K +NIL+ + ++K+ DFG R+ D
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 105 ------------KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA 152
++ +R L+ + G+ Y APEV+ Y +L D WS+GVI + ML
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 240
Query: 153 AMPF 156
PF
Sbjct: 241 QPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 42/107 (39%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
HL + I HRD+K NIL+T VK+ DFG + RR T G+ + APEV
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTPFWMAPEV 199
Query: 127 IS-----GNPYNPKLADIWSLGVITFIMLNAAMP--FDDSNLKQLFK 166
I+ Y+ + D+WSLG IT I L P FD +K LFK
Sbjct: 200 IACEQQYDYSYDAR-CDVWSLG-ITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 42/152 (27%), Positives = 61/152 (40%), Gaps = 26/152 (17%)
Query: 13 VFIFMRYADNGD---LLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
V++ M Y D G L + E R ++ GL++L E
Sbjct: 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE------------ 121
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
NI HRD+K N+L+ VK+ DFG + V L++T G +Y APE I
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKS 175
Query: 130 NPYNPKL-----ADIWSLGVITFIMLNAAMPF 156
N +D+WSLG+ M P+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q++++ ++I Y G LLD +K L L + +I
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---------LRLPQLVDMAAQIAEG 115
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
A+L S+N HRDL NIL+ + KIADFG AR D E Y
Sbjct: 116 ---MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--------YTAREGA 164
Query: 121 -----YAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPF 156
+ APE + + K +D+WS G+ +T I+ +P+
Sbjct: 165 KFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 44/123 (35%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-YCVD 104
Q L GL++LH + I HRDLK ENIL+T VK+ADFG AR Y
Sbjct: 116 QFLRGLDFLH--------------ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQ 163
V+ + Y APEV+ + Y + D+WS+G I M F +S Q
Sbjct: 162 MALTPVVVTLW-----YRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQ 215
Query: 164 LFK 166
L K
Sbjct: 216 LGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 31/182 (17%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H Q +++ M Y GDLL + K + E AR + ++M+ + +H+
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---- 121
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCV--DKEGRRVLSRTYCGSA 119
+ HRD+K +N+L+ ++++ADFG C+ +++G V S G+
Sbjct: 122 ----------HYVHRDIKPDNVLLDMNGHIRLADFG---SCLKMNQDG-TVQSSVAVGTP 167
Query: 120 AYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
Y +PE++ Y P+ D WSLGV + ML PF +L + + I++
Sbjct: 168 DYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMN 222
Query: 175 HQ 176
H+
Sbjct: 223 HE 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 25/158 (15%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H I+ + + Y + DL ++ K G + N + + Q+L GL Y+H+
Sbjct: 68 LHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ----- 121
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA- 120
+ I HRDLK +N+L++ +K+ADFG AR + V S TY
Sbjct: 122 ---------RYILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNEVVT 166
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
Y P+V+ G+ D+W +G I M+ F
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 23/138 (16%)
Query: 21 DNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80
+ GDL H+ + G +E+ R + ++++ GLE++H ++ + +RDLK
Sbjct: 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH--------------NRFVVYRDLKP 125
Query: 81 ENILMTKRFNVKIADFGFA-RYCVDKEGRRVLSRTYCGSAAYAAPEVIS-GNPYNPKLAD 138
NIL+ + +V+I+D G A + K V G+ Y APEV+ G Y+ AD
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVAYDSS-AD 178
Query: 139 IWSLGVITFIMLNAAMPF 156
+SLG + F +L PF
Sbjct: 179 WFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 30/145 (20%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFS-QMLAGLEYLHREITNHTPFTA 66
Q+ P ++I M G LL +++ S AG+EYL
Sbjct: 63 QKQP-IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----------- 110
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR------YCVDKEGRRVLSRTYCGSAA 120
SKN HRDL N L+ + +KI+DFG +R Y V +++
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-------PIK 160
Query: 121 YAAPEVISGNPYNPKLADIWSLGVI 145
+ APE ++ Y + +D+WS G++
Sbjct: 161 WTAPEALNYGRYTSE-SDVWSYGIL 184
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCV-- 103
Q+L L+Y+H S N+ HRDLK NIL+ VK+ADFG AR +
Sbjct: 115 QLLKALKYIH--------------SGNVIHRDLKPSNILLNSDCRVKLADFGLAR-SLSE 159
Query: 104 --DKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ VL+ Y + Y APE++ G+ K D+WS+G I
Sbjct: 160 LEENPENPVLTD-YVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 50/178 (28%)
Query: 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
++ M Y GD++ + + E R + ++ + ++ +H
Sbjct: 77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH--------------KLGY 122
Query: 74 AHRDLKCENILMTKRFNVKIADFG------------FARYCVD----------------- 104
HRD+K +N+L+ + ++K++DFG F R
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 105 ------KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
K RR L+ + G+ Y APEV YN K D WSLGVI + ML PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 36/120 (30%), Positives = 57/120 (47%), Gaps = 25/120 (20%)
Query: 51 LEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV 110
L YL E+ I HRD+K NIL+ + N+K+ DFG + VD
Sbjct: 120 LNYLKEEL-------------KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS----- 161
Query: 111 LSRTY-CGSAAYAAPEVI---SGNPYNPKLADIWSLGVITFIMLNAAMPFD--DSNLKQL 164
+++T G Y APE I + + Y+ + +D+WSLG+ + + P+ +S QL
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 31/166 (18%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAG-----PVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
P +++ Y D+ DL + G P+ +++ Q+L G+ + H
Sbjct: 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---------- 127
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNV-KIADFGFARYCVDKEGRRVLSRTYCGSAA---Y 121
+ HRDLK +N+L+ K+ + KIAD G R + ++Y Y
Sbjct: 128 ----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVTLWY 177
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFK 166
APEV+ G+ + DIWS+G I M F DS L+QL
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 50/153 (32%), Positives = 68/153 (44%), Gaps = 26/153 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V FM D G L+ H K ++E + QML GL+Y+H +
Sbjct: 98 VMPFMG-TDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIH--------------AAG 138
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I HRDLK N+ + + +KI DFG AR + V++R Y APEVI +
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW------YRAPEVILNWMH 192
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSN-LKQL 164
+ DIWS+G I ML F + L QL
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 43/141 (30%), Positives = 60/141 (42%), Gaps = 25/141 (17%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW----FS-QMLAGLEYLHREITNHTPF 64
GP + + Y GDLL+ ++R ES FS Q+ G+ +L
Sbjct: 112 GP-ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFL---------- 157
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAP 124
SKN HRDL N+L+T VKI DFG AR ++ V + AP
Sbjct: 158 ----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWMAP 212
Query: 125 EVISGNPYNPKLADIWSLGVI 145
E I Y +D+WS G++
Sbjct: 213 ESIFNCVYT-FESDVWSYGIL 232
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
A+L +N HRDL NIL+ + K+ADFG AR + KE + S + APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKI-PYKWTAPE 174
Query: 126 VISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFKEQTSN 171
S ++ K +D+WS G++ + + +P+ N +++ + T+
Sbjct: 175 AASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 39/143 (27%), Positives = 53/143 (37%), Gaps = 28/143 (19%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
+ M DL + R + ES + Q+L GL LH
Sbjct: 97 LVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH--------------KWYFM 141
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----------YAA 123
HRDL NI + + KIADFG AR LS+ Y A
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA 201
Query: 124 PEVISG-NPYNPKLADIWSLGVI 145
PE++ G Y+ + D+WS+G I
Sbjct: 202 PELLMGAEKYHFAV-DMWSVGCI 223
|
Length = 335 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 18/134 (13%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DL ++ R+GP+ A T ++L L YLH + I HRD+K ENI
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH--------------GRGIIHRDVKTENI 216
Query: 84 LMTKRFNVKIADFGFARYC-VDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
+ + N + DFG A C +D + G+ +PE+++ +PY K DIWS
Sbjct: 217 FLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSA 273
Query: 143 GVITFIMLNAAMPF 156
G++ F M +
Sbjct: 274 GLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 31/153 (20%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-------GLEYLHREITNHTPFT 65
++I Y NG LL++++ E R SQ+L G+ YL
Sbjct: 74 IYIVTEYMSNGCLLNYLR------EHGKRFQPSQLLEMCKDVCEGMAYLE---------- 117
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
SK HRDL N L+ + VK++DFG +RY +D E + + ++ PE
Sbjct: 118 ----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPE 171
Query: 126 VISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157
V+ + ++ K +D+W+ GV+ + + + MP++
Sbjct: 172 VLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 39/151 (25%), Positives = 60/151 (39%), Gaps = 30/151 (19%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTA 66
G + + M Y +G L D+++R FS + G++YL
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----------- 126
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGSA 119
S+ HRDL NIL+ VKI+DFG A+ Y KE Y
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY---- 179
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIML 150
APE + + ++ +D+WS GV + +
Sbjct: 180 ---APECLRTSKFSSA-SDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 30/141 (21%)
Query: 44 FSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYC- 102
F ++ A +EY+H SK + HRDLK +NIL+ V I D+G A +
Sbjct: 119 FHKICATIEYVH--------------SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 103 ----------VDKEGRRVLSRT----YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148
VD+ S T G+ Y APE + G P + DI++LGVI +
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQ 223
Query: 149 MLNAAMPFDDSNLKQLFKEQT 169
ML + P+ +++
Sbjct: 224 MLTLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 21/170 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREI 58
+Q+++++ P ++I Y G LLD +K + N +Q+ AG+ Y+ R
Sbjct: 64 VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-- 120
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
N HRDL+ NIL+ KIADFG AR D E +
Sbjct: 121 ------------MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--P 166
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFKE 167
+ APE + K +D+WS G+ +T ++ +P+ N +++ ++
Sbjct: 167 IKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 59/194 (30%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q ++ M Y GD++ + R G E AR + +++ +E +H+
Sbjct: 70 FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---------- 119
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGF---------ARY---------------- 101
HRD+K +NIL+ + ++K+ DFG ++Y
Sbjct: 120 ----MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 102 ---------CVD----------KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
C D ++ +R L+ + G+ Y APEV+ Y +L D WS+
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSV 234
Query: 143 GVITFIMLNAAMPF 156
GVI + ML PF
Sbjct: 235 GVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 34/148 (22%)
Query: 12 RVFIFMRYADNGDLLDHIK-----RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
V++ YA++ DL IK + + S ++ Q+L G+ YLH +N
Sbjct: 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNW----- 128
Query: 67 HLPSKNIAHRDLKCENILMT----KRFNVKIADFGFARYCVDK-----EGRRVLSRTYCG 117
+ HRDLK NIL+ +R VKI D G AR + V+ +
Sbjct: 129 ------VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW-- 180
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVI 145
Y APE++ G + K DIW++G I
Sbjct: 181 ---YRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 40/111 (36%), Positives = 52/111 (46%), Gaps = 19/111 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML G+++LH S I HRDLK NI++ +KI DFG AR
Sbjct: 134 QMLCGIKHLH--------------SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 175
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
G + Y + Y APEVI G Y + DIWS+G I M+ + F
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 40/111 (36%), Positives = 52/111 (46%), Gaps = 19/111 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML G+++LH S I HRDLK NI++ +KI DFG AR
Sbjct: 127 QMLCGIKHLH--------------SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 168
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156
G + Y + Y APEVI G Y + DIWS+G I M+ + F
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 31/176 (17%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDL---LDHIKRAGPVAESNARTWFSQMLAGLEYLHRE 57
+++H ++ ++ + Y D DL +D G + + +++ Q+L G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYC---VDKEGRRVLSRT 114
+ HRDLK +N+L+ KR +K+ADFG AR V+ V+
Sbjct: 120 --------------RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--- 162
Query: 115 YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN----LKQLFK 166
+ Y AP+V+ G+ DIWS+G I M+ F +N L ++F+
Sbjct: 163 ---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 38/115 (33%), Positives = 54/115 (46%), Gaps = 19/115 (16%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML G+++LH S I HRDLK NI++ +KI DFG AR
Sbjct: 131 QMLCGIKHLH--------------SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 172
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+ Y + Y APEVI G Y + DIWS+G I ++ ++ F ++
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 65/222 (29%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Q ++ M Y GD++ + R E AR + +++ +E +H+
Sbjct: 70 FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---------- 119
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGF---------ARY---------------- 101
HRD+K +NIL+ ++K+ DFG ++Y
Sbjct: 120 ----MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 102 ---------CVD----------KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
C D K+ +R L+ + G+ Y APEV+ Y +L D WS+
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSV 234
Query: 143 GVITFIMLNAAMPF-----DDSNLKQLFKEQTSNILSHQVKV 179
GVI F ML PF ++ LK + E T +I QVK+
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKL 275
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 43/156 (27%), Positives = 63/156 (40%), Gaps = 33/156 (21%)
Query: 6 ILQRGPRVFIFMRYADNGDL----LDHIKRAGPVAESNART-----WFSQML-------A 49
+ P +F Y +GDL + + + AES T S L A
Sbjct: 77 CTKEQPTCMLF-EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 50 GLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR 109
G+EYL S + HRDL N L+ + VKI+DFG +R + R
Sbjct: 136 GMEYL--------------SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 110 VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
V S++ + PE I + + +DIWS GV+
Sbjct: 182 VQSKSLL-PVRWMPPEAILYGKFTTE-SDIWSFGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 27/125 (21%)
Query: 51 LEYLHREITNHTPFT-------------AHLPSKNIAHRDLKCENILMTKRFNVKIADFG 97
LEYL A+L ++N HRDL N+L+ + K+ADFG
Sbjct: 89 LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFG 148
Query: 98 FARYCVD-----KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV-ITFIMLN 151
AR + +EG + + APE N ++ K +D+WS G+ +T I+
Sbjct: 149 LARVIKEDIYEAREGAKF-------PIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTY 200
Query: 152 AAMPF 156
MP+
Sbjct: 201 GRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 40/122 (32%), Positives = 59/122 (48%), Gaps = 20/122 (16%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+L GL++LH S + HRDLK +NIL+T +K+ADFG AR
Sbjct: 118 QLLRGLDFLH--------------SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---- 159
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQL 164
++ + + Y APEV+ + Y + D+WS+G I M F S++ QL
Sbjct: 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
Query: 165 FK 166
K
Sbjct: 219 GK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG-SAAYAAPE 125
+L SK HRDL N ++ + F VK+ADFG AR DKE V + T + A E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 126 VISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSN 160
+ + K +D+WS GV+ + +M A P+ D +
Sbjct: 173 SLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWF-SQMLAGLEYLHREI 58
+Q+++++ P ++I Y G LLD +K G +Q+ +G+ Y+ R
Sbjct: 64 VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-- 120
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
N HRDL+ NIL+ + K+ADFG AR D E +
Sbjct: 121 ------------MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 166
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVI 145
+ APE + K +D+WS G++
Sbjct: 167 IKWTAPEAALYGRFTIK-SDVWSFGIL 192
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 18/102 (17%)
Query: 7 LQRGPRVFIFMRYADNGDL--LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPF 64
LQ V++ M Y GD+ L HI G E A + S++ L+YLHR
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH------- 123
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKE 106
I HRDLK +N+L++ ++K+ DFG ++ +++E
Sbjct: 124 -------GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 23 GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82
G L++I + + + + + Q+L GL+Y+H S +I HRDLK N
Sbjct: 105 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--------------SADIIHRDLKPSN 150
Query: 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
+ + + +KI DFG AR+ D+ V +R Y APE++ + + DIWS+
Sbjct: 151 LAVNEDCELKILDFGLARHTDDEMTGYVATRW------YRAPEIMLNWMHYNQTVDIWSV 204
Query: 143 GVITFIMLNAAMPF 156
G I +L F
Sbjct: 205 GCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW-FSQMLA-GLEYLHREITNHTP 63
IL G ++I M G+L++ ++ G S + FS +A G+EYL
Sbjct: 68 ILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-------- 117
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
SK + HRDL NIL+++ K++DFG AR G + + + A
Sbjct: 118 ------SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKL-PVKWTA 165
Query: 124 PEVISGNPYNPKLADIWSLGVI 145
PE + ++ K +D+WS GV+
Sbjct: 166 PEALKHKKFSSK-SDVWSYGVL 186
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 36/134 (26%), Positives = 54/134 (40%), Gaps = 31/134 (23%)
Query: 20 ADNGDLLDHIKRAGPVAESNARTW-FS-QMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77
A G LLD +++ + ++ Q+ G+ YL SK HRD
Sbjct: 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--------------SKRFIHRD 122
Query: 78 LKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
L NIL+ VKI DFG R + V +E +V A+ APE +
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-------PFAWCAPESLRTR 175
Query: 131 PYNPKLADIWSLGV 144
++ +D+W GV
Sbjct: 176 TFS-HASDVWMFGV 188
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQ-MLAGLEYLHREITNHTPFTA 66
Q+ P ++I M GD L ++ GP + + AG+EYL
Sbjct: 64 QKQP-IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE----------- 111
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS-----AAY 121
SK+ HRDL N L+T++ +KI+DFG +R +E V + T G +
Sbjct: 112 ---SKHCIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAST--GGMKQIPVKW 162
Query: 122 AAPEVISGNPYNPKLADIWSLGVI 145
APE ++ Y+ + +D+WS G++
Sbjct: 163 TAPEALNYGRYSSE-SDVWSFGIL 185
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 30 KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89
+R + ES A ++ L G Y ++ N F L SKN HRDL N+L+ +
Sbjct: 225 RRDTLINESPALSYMD--LVGFSY---QVANGMEF---LASKNCVHRDLAARNVLICEGK 276
Query: 90 NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF-I 148
VKI DFG AR + T+ + APE I N Y L+D+WS G++ + I
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYT-TLSDVWSFGILLWEI 334
Query: 149 MLNAAMPFDDSNLKQLF 165
P+ + + + F
Sbjct: 335 FTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
++ +G + M GDL +++ P E+N Q L+ + +
Sbjct: 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP----VQAPPSLKKMIQMAGEIADGM 132
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KEGRRVLSRTYCGSAA 120
A+L + HRDL N ++ + F VKI DFG R Y D K G+ +L
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------PVR 186
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ +PE + + +D+WS GV+ + I A P+ + +Q+ +
Sbjct: 187 WMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFS-QMLAGLEYLHREITNHTP 63
+LQ P ++I Y G L+D+++ R V + F+ + G+EYL
Sbjct: 69 VLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE-------- 119
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYA 122
KN HRDL N+L+++ K++DFG A+ ++ ++ +
Sbjct: 120 ------EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-------PVKWT 166
Query: 123 APEVISGNPYNPKLADIWSLGVI 145
APE + ++ K +D+WS G++
Sbjct: 167 APEALREKKFSTK-SDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 40/135 (29%), Positives = 59/135 (43%), Gaps = 22/135 (16%)
Query: 17 MRYADNGDLLDH-IKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75
M Y G L D+ K + + SQ+ G+EYL SK H
Sbjct: 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--------------SKRYVH 131
Query: 76 RDLKCENILMTKRFNVKIADFGFARYC-VDKEGRRVLSRTYCGSAA--YAAPEVISGNPY 132
RDL NIL+ VKI DFG + DKE +V G + + APE ++ + +
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV---REPGESPIFWYAPESLTESKF 188
Query: 133 NPKLADIWSLGVITF 147
+ +D+WS GV+ +
Sbjct: 189 S-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 10 GPRVFIFMRYADNGDLLD----HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
G ++++ + + G + D +KR + E + L GL++LH T
Sbjct: 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT------ 145
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
HRD+K NIL+T VK+ DFG + RR T G+ + APE
Sbjct: 146 --------IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTPFWMAPE 194
Query: 126 VIS-----GNPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLFK 166
VI+ + Y+ + D+WSLG+ + + P D + ++ LFK
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK 240
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 23/143 (16%)
Query: 13 VFIFMRYADNGDLLDHIKR--------AGPVAESNARTWFSQMLAGLEYLHREITNHTPF 64
+++ + YA +G+LLD +++ A +A S A T SQ L +
Sbjct: 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA------ADVARG 136
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS--AAYA 122
+L K HRDL NIL+ + + KIADFG +R G+ V + G +
Sbjct: 137 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWM 190
Query: 123 APEVISGNPYNPKLADIWSLGVI 145
A E ++ + Y +D+WS GV+
Sbjct: 191 AIESLNYSVYTTN-SDVWSYGVL 212
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 42/124 (33%), Positives = 59/124 (47%), Gaps = 27/124 (21%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DLL+ K+ P+ E L GL YLH S N+ HRD+K NI
Sbjct: 113 DLLEVHKK--PLQEVEIAAITHGALQGLAYLH--------------SHNMIHRDIKAGNI 156
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIW 140
L+T+ VK+ADFG A + ++ G+ + APEVI Y+ K+ D+W
Sbjct: 157 LLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVW 208
Query: 141 SLGV 144
SLG+
Sbjct: 209 SLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 23/145 (15%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML--AGLEYLHREITNHTPFTA 66
P + + M Y +NGDL +++ VAE++ S+ L + L Y+ +I +
Sbjct: 90 VDPPLCMIMEYMENGDLNQFLQKH--VAETSGLACNSKSLSFSTLLYMATQIASGM---R 144
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR------YCVDKEGRRVLS-RTYCGSA 119
+L S N HRDL N L+ K + +KIADFG +R Y +GR L R
Sbjct: 145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIR------ 197
Query: 120 AYAAPEVISGNPYNPKLADIWSLGV 144
+ A E + + K +D+W+ GV
Sbjct: 198 -WMAWESVLLGKFTTK-SDVWAFGV 220
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 38/144 (26%), Positives = 58/144 (40%), Gaps = 13/144 (9%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
+ P + +F Y ++GDL ++ GP A L L +
Sbjct: 78 TEGDPPIMVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDK---EGRRVLSRTYCGSAAY 121
+L S++ HRDL N L+ VKI DFG +R Y D G +L +
Sbjct: 137 YLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML------PIRW 190
Query: 122 AAPEVISGNPYNPKLADIWSLGVI 145
PE I + + +D+WS GV+
Sbjct: 191 MPPESIMYRKFTTE-SDVWSFGVV 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 47/135 (34%), Positives = 63/135 (46%), Gaps = 28/135 (20%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DLL+ K+ P+ E L GL YLH S N+ HRD+K NI
Sbjct: 109 DLLEVHKK--PLQEVEIAAITHGALQGLAYLH--------------SHNMIHRDIKAGNI 152
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIW 140
L+T+ VK+ADFG A + ++ G+ + APEVI Y+ K+ D+W
Sbjct: 153 LLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVW 204
Query: 141 SLGVITFIMLNAAMP 155
SLG IT I L P
Sbjct: 205 SLG-ITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 12/139 (8%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGP----VAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
P + +F Y +GDL ++ GP +AE N +Q + + ++ ++I
Sbjct: 81 PLIMVF-EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ--SQMLHIAQQIAAGM---V 134
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
+L S++ HRDL N L+ + VKI DFG +R + RV T + PE
Sbjct: 135 YLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRWMPPES 193
Query: 127 ISGNPYNPKLADIWSLGVI 145
I + + +D+WSLGV+
Sbjct: 194 IMYRKFTTE-SDVWSLGVV 211
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 30/78 (38%), Positives = 40/78 (51%), Gaps = 2/78 (2%)
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
L SKN HRDL N+L+ + VKI DFG AR + T+ + APE I
Sbjct: 253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVKWMAPESI 311
Query: 128 SGNPYNPKLADIWSLGVI 145
N Y L+D+WS G++
Sbjct: 312 FDNLYT-TLSDVWSYGIL 328
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 8/112 (7%)
Query: 66 AHLPSKNIAHRDLKCENILMTK---RFNVKIADFGFARYCVDKEG--RRVLSRT--YCGS 118
A ++ I HRDLK +NI++++ R + K+ DFG L+RT G+
Sbjct: 93 ACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTS 170
Y APE + G P P +D+++ G+I L +++ ++ +Q S
Sbjct: 153 PTYCAPEQLRGEPVTPN-SDLYAWGLIFLECLTGQRVVQGASVAEILYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 35/161 (21%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNART---WFSQMLAGLEYLHREITNHTPFTAHLP 69
+ M G LLD+++ ++ W Q+ G+ YL
Sbjct: 86 ITQLMPL---GCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLE-------------- 126
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAAP 124
K + HRDL N+L+ +VKI DFG A+ E + Y + A
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE------KEYHAEGGKVPIKWMAL 180
Query: 125 EVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQL 164
E I Y K +D+WS GV + +M A P++ ++
Sbjct: 181 ESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 24/171 (14%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIK-RAGPVAE--------SNARTWFSQMLAGLEYLHREI 58
Q GP +++ + YA G+L ++++ R P E + + F +++ + R +
Sbjct: 92 QDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+L S+ HRDL N+L+T+ +KIADFG AR D +T G
Sbjct: 151 E-------YLASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DVNNIDYYKKTTNGR 200
Query: 119 --AAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + Y + +D+WS GV+ + I P+ +++LFK
Sbjct: 201 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 22/138 (15%)
Query: 23 GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82
G L++I + +++ + + Q+L GL+Y+H S I HRDLK N
Sbjct: 103 GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH--------------SAGIIHRDLKPSN 148
Query: 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142
+ + + ++I DFG AR D+ V +R Y APE++ + + DIWS+
Sbjct: 149 VAVNEDCELRILDFGLARQADDEMTGYVATRW------YRAPEIMLNWMHYNQTVDIWSV 202
Query: 143 GVITFIMLN--AAMPFDD 158
G I +L A P +D
Sbjct: 203 GCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
++ +G + M +GDL +++ P AE+N L + + EI +
Sbjct: 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEIADGM--- 132
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KEGRRVLSRTYCGSAA 120
A+L +K HRDL N ++ F VKI DFG R Y D K G+ +L
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL------PVR 186
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + + +D+WS GV+ + I A P+ + +Q+ K
Sbjct: 187 WMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-07
Identities = 37/138 (26%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESN---ARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+++ + YA +G+LLD ++++ V E++ A + + L + +L
Sbjct: 71 LYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS--AAYAAPEVI 127
K HRDL NIL+ + + KIADFG +R G+ V + G + A E +
Sbjct: 130 QKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWMAIESL 183
Query: 128 SGNPYNPKLADIWSLGVI 145
+ + Y +D+WS GV+
Sbjct: 184 NYSVYTTN-SDVWSYGVL 200
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 19/144 (13%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVA---------ESNARTWFSQMLAGLEYLHREITNH 61
P + +F Y +GDL ++ GP A ++ SQML ++ +I +
Sbjct: 81 PLIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML----HIASQIASG 135
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+L S++ HRDL N L+ VKI DFG +R + RV T +
Sbjct: 136 M---VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 191
Query: 122 AAPEVISGNPYNPKLADIWSLGVI 145
PE I + + +D+WS GVI
Sbjct: 192 MPPESIMYRKFTTE-SDVWSFGVI 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 66 AHLPSKNIAHRDLKCENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAP 124
A++ SK I HRDLK +N+L+ +K+ DFG A+ + G+R +S Y S Y AP
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQRSVS--YICSRFYRAP 239
Query: 125 EVISGNPYNPKLADIWSLGVITFIML 150
E++ G D+WSLG I M+
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 17/111 (15%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100
R Q+L +EY+H K + HRD+K ENI + + + DFG A
Sbjct: 270 RAIMKQLLCAVEYIH--------------DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 101 YCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151
+KE R + G+ A +PE+++G+ Y ++ DIWS G+I ML+
Sbjct: 316 -PFEKE-REAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGSAAYAAP 124
+L SK HRDL N+L+T+ +KIADFG AR + +D + R + AP
Sbjct: 155 YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL---PVKWMAP 211
Query: 125 EVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
E + Y + +D+WS GV+ + I P+ +++LFK
Sbjct: 212 EALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 45/135 (33%), Positives = 61/135 (45%), Gaps = 28/135 (20%)
Query: 24 DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83
DLL+ K+ P+ E L GL YLH S N+ HRD+K NI
Sbjct: 103 DLLEVHKK--PLQEVEIAAVTHGALQGLAYLH--------------SHNMIHRDVKAGNI 146
Query: 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIW 140
L+++ VK+ DFG A + + G+ + APEVI Y+ K+ D+W
Sbjct: 147 LLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKV-DVW 198
Query: 141 SLGVITFIMLNAAMP 155
SLG IT I L P
Sbjct: 199 SLG-ITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAES---------NARTWFSQMLAGLEYLHREI 58
Q GP +++ + YA G+L ++++ P + F +++ + R +
Sbjct: 89 QDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGM 147
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+L S+ HRDL N+L+T+ +KIADFG AR D +T G
Sbjct: 148 E-------YLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---DVHNIDYYKKTTNGR 197
Query: 119 --AAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + Y + +D+WS GV+ + I P+ +++LFK
Sbjct: 198 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/85 (35%), Positives = 40/85 (47%), Gaps = 16/85 (18%)
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGSAA 120
L S+ HRDL NIL+++ VKI DFG AR Y + R L
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------- 240
Query: 121 YAAPEVISGNPYNPKLADIWSLGVI 145
+ APE I Y + +D+WS GV+
Sbjct: 241 WMAPESIFDKVYTTQ-SDVWSFGVL 264
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 1e-06
Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 40/182 (21%)
Query: 12 RVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLH--REITNHTPFT 65
+++I M + D GDL +I++ G + E Q+L L Y H ++ N
Sbjct: 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN----- 142
Query: 66 AHLPSKNIAHRDLKCENILMTK-----------------RFNVKIADFGFARYCVDKEGR 108
+ + HRDLK +NI ++ R KI DFG ++ G
Sbjct: 143 ----GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI----GI 194
Query: 109 RVLSRTYCGSAAYAAPEVI--SGNPYNPKLADIWSLGVITFIMLNAAMPFDDS-NLKQLF 165
++ + G+ Y +PE++ Y+ K +D+W+LG I + + + PF + N QL
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKANNFSQLI 253
Query: 166 KE 167
E
Sbjct: 254 SE 255
|
Length = 1021 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 34/109 (31%), Positives = 48/109 (44%), Gaps = 30/109 (27%)
Query: 19 YADNGDLLDHIKRAGP-----------VAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Y +NGDL + R P ++ S +Q+ +G++YL
Sbjct: 100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL------------- 146
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDK---EGRRVL 111
S N HRDL N L+ K + +KIADFG +R Y D +GR VL
Sbjct: 147 -SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVL 194
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 17 MRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-----GLEYLHREITNHTPFTAHLPSK 71
+ + GDL ++++ + A+ Q +A GL +LH+
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--------------A 119
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ H DL N +T +VKI D+G A E + + + APE++
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 132 YNPKLAD------IWSLGVITF-IMLNAAMPF----DDSNLKQLFKEQ 168
+ D IWSLGV + + A P+ D+ LKQ+ +EQ
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGSAAYAAP 124
+L S+ HRDL N+L+T+ +KIADFG AR + +D + R + AP
Sbjct: 149 YLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL---PVKWMAP 205
Query: 125 EVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
E + Y + +D+WS G++ + I P+ +++LFK
Sbjct: 206 EALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 12/85 (14%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG-----SAA 120
+L N HRDL NIL+ K++DFG +R D E TY
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA------TYTTKGGKIPIR 173
Query: 121 YAAPEVISGNPYNPKLADIWSLGVI 145
+ APE I+ + +D+WS G++
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIV 197
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 16/143 (11%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Q G + + M Y G L D++ + + + + Q+ G+ YLH
Sbjct: 78 QGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLH------------ 124
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S++ HRDL N+L+ VKI DFG A+ + + + A E +
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 128 SGNPYNPKLADIWSLGVITFIML 150
N ++ +D+WS GV + +L
Sbjct: 183 KENKFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 13/138 (9%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESN---ARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++I + YA G+LLD ++++ V E++ A+ + + L + ++ +L
Sbjct: 78 LYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS--AAYAAPEVI 127
K HRDL N+L+ + KIADFG +R G V + G + A E +
Sbjct: 137 EKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKTMGRLPVRWMAIESL 190
Query: 128 SGNPYNPKLADIWSLGVI 145
+ + Y K +D+WS GV+
Sbjct: 191 NYSVYTTK-SDVWSFGVL 207
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFS-QMLAGLEYLHREITNHTPFTA 66
QR P ++I M GD L +++ ++ F+ AG+ YL
Sbjct: 63 QRQP-IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----------- 110
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
SKN HRDL N L+ + +KI+DFG +R + +G S + APE
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEA 165
Query: 127 ISGNPYNPKLADIWSLGVI 145
++ Y+ + +D+WS G++
Sbjct: 166 LNYGRYSSE-SDVWSYGIL 183
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 16/126 (12%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADF--GFARYCVDKEGRRVLSRTYCGSAAYAA 123
H+ N H DL N +T VK+ D+ G +RY KE C + A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY---KEDYIETEDDKCVPLRWLA 169
Query: 124 PEVISG------NPYNPKLADIWSLGVITFIML-NAAMPFDD-SN---LKQLFKEQTSNI 172
PE++ K +++W+LGV + + NAA P+ S+ L + K+Q +
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 173 LSHQVK 178
Q++
Sbjct: 230 FKPQLE 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 29/161 (18%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAG------PVAESNARTWFSQMLAGLEYLHR 56
+++++ P ++I + G LLD +K P A +Q+ G+ Y+ R
Sbjct: 66 LYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA----AQIADGMAYIER 120
Query: 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYC 116
N HRDL+ NIL+ KIADFG AR D E +
Sbjct: 121 --------------MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF- 165
Query: 117 GSAAYAAPEVISGNPYNPKLADIWSLGVI-TFIMLNAAMPF 156
+ APE + K +D+WS G++ T ++ +P+
Sbjct: 166 -PIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD-KEGRRVLSRTYCGSAA----- 120
+L N HRDL NIL+ K++DFG +R D EG TY S
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG------TYTTSGGKIPIR 175
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE I+ + +D+WS G++ + +M P+ D + ++ K
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMK 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-06
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVA-ESNARTWFSQMLAGLEYLHREIT-------NHTPF 64
+F +M Y GDL + ++ P A S + + S GL L T
Sbjct: 86 LFEYMAY---GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG 142
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR------YCVDKEGRRVLSRTYCGS 118
A+L + HRDL N L+ + VKIADFG +R Y E + R
Sbjct: 143 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR----- 197
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154
+ PE I N Y + +D+W+ GV+ + + + M
Sbjct: 198 --WMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGM 230
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 12/137 (8%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA----GLEYLHREITNHTPFTAHL 68
VF +MR+ GDL ++ GP A+ A + +A L + + +L
Sbjct: 85 VFEYMRH---GDLNRFLRSHGPDAKILAG---GEDVAPGQLTLGQMLAIASQIASGMVYL 138
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
S + HRDL N L+ + VKI DFG +R + RV RT + PE I
Sbjct: 139 ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESIL 197
Query: 129 GNPYNPKLADIWSLGVI 145
+ + +DIWS GV+
Sbjct: 198 YRKFTTE-SDIWSFGVV 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 37/113 (32%), Positives = 49/113 (43%), Gaps = 23/113 (20%)
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGSAA 120
L SKN HRDL NIL+T KI DFG AR Y V R
Sbjct: 230 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL--------PVK 281
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLN------AAMPFDDSNLKQLFKE 167
+ APE I Y + +D+WS G++ + + + MP DS ++ KE
Sbjct: 282 WMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKE 332
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 59/188 (31%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M + GDL+ + + +E R + ++ + +E +H+
Sbjct: 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK--------------LG 121
Query: 73 IAHRDLKCENILMTKRFNVKIADFGF----------ARY-------------------CV 103
HRD+K +NIL+ + ++K++DFG A Y V
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 104 D---------------KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148
D K+ RR+++ + G+ Y APE+ Y + D WSLG I F
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFE 240
Query: 149 MLNAAMPF 156
L PF
Sbjct: 241 CLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q+ AG+EYL ++H H+DL NIL+ ++ +VKI+D G +R
Sbjct: 132 QIAAGMEYL----------SSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ RV ++ + PE I ++ +DIWS GV+
Sbjct: 178 DYYRVQPKSLL-PIRWMPPEAIMYGKFSSD-SDIWSFGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/85 (35%), Positives = 40/85 (47%), Gaps = 16/85 (18%)
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGSAA 120
L S+ HRDL NIL+++ VKI DFG AR Y + R L
Sbjct: 195 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------- 246
Query: 121 YAAPEVISGNPYNPKLADIWSLGVI 145
+ APE I Y + +D+WS GV+
Sbjct: 247 WMAPETIFDRVYTIQ-SDVWSFGVL 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 46/168 (27%), Positives = 65/168 (38%), Gaps = 31/168 (18%)
Query: 3 VHSI---LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLH--RE 57
V I +R PR FI + GDL ++ P E L + L R+
Sbjct: 72 VRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPER------PSSLTMKDLLFCARD 124
Query: 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN---VKIADFGFAR--YCVD---KEGRR 109
+ + L + HRD+ N L+T + KIADFG AR Y K GR
Sbjct: 125 VAKGCKY---LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 110 VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPF 156
+L + PE + K D+WS GV+ + I MP+
Sbjct: 182 ML------PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 18/149 (12%)
Query: 10 GPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
G + + + + G LLDH+ + + W Q+ G+ YL
Sbjct: 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH----------- 128
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
+ HR+L NIL+ V+IADFG A + + S + A E I
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT-PIKWMALESIL 184
Query: 129 GNPYNPKLADIWSLGVITFIMLN-AAMPF 156
Y + +D+WS GV + M++ A P+
Sbjct: 185 FGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 33/131 (25%), Positives = 55/131 (41%), Gaps = 15/131 (11%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74
+ M A+ G L +++ V E N Q+ G++YL N
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET--------------NFV 117
Query: 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNP 134
HRDL N+L+ + KI+DFG ++ E + APE ++ ++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 135 KLADIWSLGVI 145
K +D+WS GV+
Sbjct: 178 K-SDVWSFGVL 187
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 13/102 (12%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------ 120
+L N HRDL NIL+ K++DFG +R+ D TY S
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS----DPTYTSSLGGKIPIR 176
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPF-DDSN 160
+ APE I+ + +D+WS G++ + +M P+ D SN
Sbjct: 177 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 32/82 (39%), Positives = 43/82 (52%), Gaps = 10/82 (12%)
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA----AYAA 123
L S+ HRDL NIL+++ VKI DFG AR + K+ V GSA + A
Sbjct: 190 LASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRK----GSARLPLKWMA 244
Query: 124 PEVISGNPYNPKLADIWSLGVI 145
PE I Y + +D+WS GV+
Sbjct: 245 PESIFDKVYTTQ-SDVWSFGVL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
+L SK+ HRDL N ++ + NV +ADFG ++ + + R R + A E
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR-QGRIAKMPVKWIAIE 184
Query: 126 VISGNPYNPKLADIWSLGV 144
++ Y K +D+WS GV
Sbjct: 185 SLADRVYTTK-SDVWSFGV 202
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 14/97 (14%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA----- 120
A+L SK HRD+ N+L++ VK+ DFG +RY D+ Y S
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-------YYKASKGKLPIK 173
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPF 156
+ APE I+ + +D+W GV + I++ PF
Sbjct: 174 WMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 21/120 (17%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDK---EGRRVLSRTYCGSAAY 121
+L S N HRDL N L+ + +KIADFG +R Y D +GR VL +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRW 206
Query: 122 AAPEVISGNPYNPKLADIWSLGVITF--IMLNAAMPFDD-------SNLKQLFKEQTSNI 172
A E I + +D+W+ GV + +ML P+ + N + F++Q +
Sbjct: 207 MAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV 265
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 39/150 (26%), Positives = 58/150 (38%), Gaps = 38/150 (25%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-------GLEYLHREITNHTPFT 65
+I M + GDLL +++ A ++L G YL +
Sbjct: 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--------- 124
Query: 66 AHLPSKNIAHRDLKCENILMT-----KRFNVKIADFGFAR--YCVD---KEGRRVLSRTY 115
+ HRDL N L++ VKI DFG AR Y D KEG +L
Sbjct: 125 -----MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL---- 175
Query: 116 CGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ APE + + + +D+WS GV+
Sbjct: 176 --PVRWMAPESLLDGKFTTQ-SDVWSFGVL 202
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 18/120 (15%)
Query: 30 KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT--- 86
K+ + S ++ Q+L G+ YLH + + HRDLK NIL+
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLH--------------ANWVLHRDLKPANILVMGEG 145
Query: 87 -KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+R VKIAD GFAR + Y APE++ G + K DIW++G I
Sbjct: 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 17/86 (19%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--------YCVDKEGRRVLSRTYCGS 118
+L KN HRDL N+L+ + KI+DFG ++ Y G+ L
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------ 163
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGV 144
+ APE I+ ++ + +D+WS G+
Sbjct: 164 --WYAPECINFRKFSSR-SDVWSYGI 186
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 13/96 (13%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGS---AAY 121
+L SKN HRDL N ++ + V +ADFG ++ Y D R C S +
Sbjct: 128 YLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD------YYRQGCASKLPVKW 181
Query: 122 AAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPF 156
A E ++ N Y +D+W+ GV + IM P+
Sbjct: 182 LALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 42/170 (24%), Positives = 64/170 (37%), Gaps = 40/170 (23%)
Query: 19 YADNGDL------------LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
Y +NGDL H V+ +N Q+ +G++YL
Sbjct: 98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL------------ 145
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S N HRDL N L+ + +KIADFG +R + R+ R A +
Sbjct: 146 --ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
+ G +D+W+ GV + M L KEQ ++LS +
Sbjct: 204 LLGK--FTTASDVWAFGVTLWEMFT------------LCKEQPYSLLSDE 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 29/87 (33%), Positives = 38/87 (43%), Gaps = 16/87 (18%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGS 118
L SKN HRD+ N+L+T KI DFG AR Y V R
Sbjct: 226 DFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL--------P 277
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVI 145
+ APE I Y + +D+WS G++
Sbjct: 278 VKWMAPESIFDCVYTVQ-SDVWSYGIL 303
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 6/82 (7%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGSAAYAA 123
+L + HRDL N+L+ + +KI+DFG +R Y D +R R + A
Sbjct: 141 QYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI---PVKWMA 197
Query: 124 PEVISGNPYNPKLADIWSLGVI 145
E + + Y + +D+WS GV+
Sbjct: 198 IESLFDHIYTTQ-SDVWSFGVL 218
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 24/102 (23%), Positives = 46/102 (45%), Gaps = 19/102 (18%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCV-DKEGRRVLSRTYCG 117
++L + + H+D+ N ++ + VKI D +R +C+ D E R V
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV------- 183
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDD 158
+ A E + Y+ +D+WS GV+ + +M P+ +
Sbjct: 184 --KWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 35/109 (32%), Positives = 49/109 (44%), Gaps = 18/109 (16%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT----KRFNVKIADF 96
++ Q+L G+ YLH + + HRDLK NIL+ +R VKIAD
Sbjct: 111 KSLLYQILDGIHYLH--------------ANWVLHRDLKPANILVMGEGPERGRVKIADM 156
Query: 97 GFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
GFAR + Y APE++ G + K DIW++G I
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 1/84 (1%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
+L S+ HRDL N+L+ VKI DFG + + + + APE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 127 ISGNPYNPKLADIWSLGVITFIML 150
+ + + +D+WS GV + +L
Sbjct: 184 LIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 33/142 (23%), Positives = 61/142 (42%), Gaps = 23/142 (16%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFS-QMLAGLEYLHREITNHTP 63
I++ ++I Y G L+D+++ R V + FS + +EYL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-------- 119
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
+ N HRDL N+L+++ K++DFG + + L + A
Sbjct: 120 ------ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTA 167
Query: 124 PEVISGNPYNPKLADIWSLGVI 145
PE + ++ K +D+WS G++
Sbjct: 168 PEALREKKFSTK-SDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 30/143 (20%)
Query: 23 GDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81
G LLD+++ + + W Q+ G+ YL + HRDL
Sbjct: 93 GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--------------EVRLVHRDLAAR 138
Query: 82 NILMTKRFNVKIADFGFARYC-VDK-----EGRRVLSRTYCGSAAYAAPEVISGNPYNPK 135
N+L+ +VKI DFG AR +D+ +G +V + A E I + +
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-------PIKWMALESILHRRFTHQ 191
Query: 136 LADIWSLGVITF-IMLNAAMPFD 157
+D+WS GV + +M A P+D
Sbjct: 192 -SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 45/167 (26%), Positives = 65/167 (38%), Gaps = 34/167 (20%)
Query: 13 VFIFMRYADNGDLLD-HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
V M Y DLL H P E +L L+Y+H SK
Sbjct: 77 VSPLMAYGSCEDLLKTHFPEGLP--ELAIAFILKDVLNALDYIH--------------SK 120
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCV--DKEGRRVLSRTYCGSAAYA------- 122
HR +K +IL++ V ++ RY V K G+R R +
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKR--QRVVHDFPKSSVKNLPWL 175
Query: 123 APEVISGN--PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
+PEV+ N YN K +DI+S+G+ + N +PF D Q+ E
Sbjct: 176 SPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 16/101 (15%)
Query: 45 SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD 104
+Q+ AG+E+L S ++ H+DL N+L+ + NVKI+D G R
Sbjct: 131 TQIAAGMEFL--------------SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ +++ + + +PE I ++ +DIWS GV+
Sbjct: 177 ADYYKLMGNSLL-PIRWMSPEAIMYGKFSID-SDIWSYGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 16/85 (18%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYC--GSAA---- 120
+L ++N HRDL N ++ + V +ADFG + +++ S Y G A
Sbjct: 128 YLSNRNFIHRDLAARNCMLREDMTVCVADFGLS--------KKIYSGDYYRQGRIAKMPV 179
Query: 121 -YAAPEVISGNPYNPKLADIWSLGV 144
+ A E ++ Y K +D+W+ GV
Sbjct: 180 KWIAIESLADRVYTSK-SDVWAFGV 203
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 7/84 (8%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
HL N H DL N L+T VKI D+G + + KE V + APE+
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS-HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 127 IS---GNPY---NPKLADIWSLGV 144
+ GN K +++WSLGV
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGV 197
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 14/145 (9%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + ++ + V I Y +NG L +++ + + Q++ L R I +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGML----RGIAS 117
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ + + HRDL NIL+ K++DFG +R D +R
Sbjct: 118 GMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 121 YAAPEVISGNPYNPKLADIWSLGVI 145
+ APE I+ + +D+WS G++
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIV 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 48/158 (30%), Positives = 65/158 (41%), Gaps = 39/158 (24%)
Query: 25 LLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENIL 84
LLD I + GP + + Q L+Y H E+ HL H DLK ENIL
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--------HL-----MHTDLKPENIL 264
Query: 85 M----------TKRF------NVKIADFGFARYCVDKEGRRVLSRTYCGSAA-YAAPEVI 127
M T R V+I D G C D+ SRT S Y +PEV+
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLG---GCCDERH----SRTAIVSTRHYRSPEVV 317
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDD-SNLKQL 164
G + D+WS+G I + + + +D NL+ L
Sbjct: 318 LGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHL 354
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 27/68 (39%), Positives = 38/68 (55%), Gaps = 10/68 (14%)
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
EG R+L G+ Y APE++ G P+ P + D W+LGV F L PF+D +Q+F
Sbjct: 536 EGERIL-----GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVF 589
Query: 166 KEQTSNIL 173
+ NIL
Sbjct: 590 Q----NIL 593
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 20/109 (18%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG------SAA 120
HL + HRDL N L++ + VK+ D V + Y
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKV---SLLSLSKD-----VYNSEYYKLRNALIPLR 183
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPF----DDSNLKQL 164
+ APE + + ++ K +D+WS GV+ + + +PF D+ L +L
Sbjct: 184 WLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 36/142 (25%), Positives = 57/142 (40%), Gaps = 28/142 (19%)
Query: 23 GDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81
G LLD+++ + W Q+ G+ YL + + HRDL
Sbjct: 93 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--------------ERRLVHRDLAAR 138
Query: 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAAPEVISGNPYNPKL 136
N+L+ +VKI DFG A+ E + Y + A E I Y +
Sbjct: 139 NVLVKTPQHVKITDFGLAKLLGADE------KEYHAEGGKVPIKWMALESILHRIYTHQ- 191
Query: 137 ADIWSLGVITF-IMLNAAMPFD 157
+D+WS GV + +M + P+D
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 13/97 (13%)
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----Y 121
+L + + HRDL N+L+ +VKI DFG AR E + Y +
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE------KEYNADGGKMPIKW 177
Query: 122 AAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFD 157
A E I + + +D+WS GV + +M P+D
Sbjct: 178 MALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4721|consensus | 904 | 99.98 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| KOG0614|consensus | 732 | 99.98 | ||
| KOG0603|consensus | 612 | 99.98 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0666|consensus | 438 | 99.97 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579|consensus | 1187 | 99.97 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0608|consensus | 1034 | 99.97 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0584|consensus | 632 | 99.97 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1026|consensus | 774 | 99.97 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4645|consensus | 1509 | 99.97 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG0669|consensus | 376 | 99.97 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0695|consensus | 593 | 99.97 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0665|consensus | 369 | 99.97 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0662|consensus | 292 | 99.97 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| KOG0574|consensus | 502 | 99.96 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0670|consensus | 752 | 99.96 | ||
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1095|consensus | 1025 | 99.96 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| KOG1989|consensus | 738 | 99.96 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1290|consensus | 590 | 99.96 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| KOG0193|consensus | 678 | 99.96 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4236|consensus | 888 | 99.96 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0194|consensus | 474 | 99.96 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| KOG0577|consensus | 948 | 99.96 | ||
| KOG0668|consensus | 338 | 99.96 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1187|consensus | 361 | 99.95 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG4278|consensus | 1157 | 99.95 | ||
| KOG1027|consensus | 903 | 99.94 | ||
| KOG0196|consensus | 996 | 99.94 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG2345|consensus | 302 | 99.94 | ||
| KOG0587|consensus | 953 | 99.94 | ||
| KOG4257|consensus | 974 | 99.94 | ||
| KOG1151|consensus | 775 | 99.94 | ||
| KOG1035|consensus | 1351 | 99.94 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0200|consensus | 609 | 99.94 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1006|consensus | 361 | 99.93 | ||
| KOG0199|consensus | 1039 | 99.93 | ||
| KOG0664|consensus | 449 | 99.93 | ||
| KOG1167|consensus | 418 | 99.93 | ||
| KOG1094|consensus | 807 | 99.92 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| KOG4250|consensus | 732 | 99.91 | ||
| KOG2052|consensus | 513 | 99.91 | ||
| KOG0984|consensus | 282 | 99.9 | ||
| KOG1024|consensus | 563 | 99.89 | ||
| KOG0590|consensus | 601 | 99.89 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG3653|consensus | 534 | 99.88 | ||
| KOG1025|consensus | 1177 | 99.88 | ||
| KOG1345|consensus | 378 | 99.87 | ||
| KOG0576|consensus | 829 | 99.87 | ||
| KOG1152|consensus | 772 | 99.86 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| KOG0603|consensus | 612 | 99.83 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.77 | |
| KOG0195|consensus | 448 | 99.75 | ||
| KOG0606|consensus | 1205 | 99.73 | ||
| KOG1023|consensus | 484 | 99.72 | ||
| KOG1164|consensus | 322 | 99.69 | ||
| KOG4158|consensus | 598 | 99.68 | ||
| KOG1240|consensus | 1431 | 99.67 | ||
| KOG1033|consensus | 516 | 99.6 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.59 | |
| KOG1165|consensus | 449 | 99.56 | ||
| KOG0590|consensus | 601 | 99.54 | ||
| KOG1163|consensus | 341 | 99.48 | ||
| KOG1266|consensus | 458 | 99.46 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.44 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.44 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.42 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.4 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.39 | |
| KOG1166|consensus | 974 | 99.39 | ||
| KOG0606|consensus | 1205 | 99.3 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.29 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.25 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.13 | |
| KOG2137|consensus | 700 | 99.1 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.08 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.04 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.03 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.03 | |
| KOG0601|consensus | 524 | 99.01 | ||
| KOG1243|consensus | 690 | 99.0 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.92 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.89 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.62 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.55 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| KOG0601|consensus | 524 | 98.41 | ||
| KOG3087|consensus | 229 | 98.4 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.32 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.17 | |
| KOG3741|consensus | 655 | 98.12 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.11 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| KOG1035|consensus | 1351 | 97.82 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 97.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.11 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.97 | |
| KOG1235|consensus | 538 | 96.96 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.4 | |
| KOG0576|consensus | 829 | 96.4 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.75 | |
| KOG1826|consensus | 2724 | 94.44 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 94.43 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.01 | |
| KOG2268|consensus | 465 | 93.82 | ||
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 92.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.41 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.9 | |
| KOG1093|consensus | 725 | 91.28 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.79 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.21 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 89.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 88.39 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 87.8 | |
| PLN02236 | 344 | choline kinase | 87.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 86.28 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 83.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 83.04 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 82.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 81.02 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=320.01 Aligned_cols=203 Identities=28% Similarity=0.534 Sum_probs=179.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|+.....||||||++||+|++++-.++.+.+...+.+++|++.|+.||| +.||+||||||
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH--------------~~GI~HRDiKP 304 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH--------------SQGIIHRDIKP 304 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH--------------HcCcccccCCc
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecC---CCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 81 ENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 81 ~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
+|||+..+ ..+||+|||+++..+.. ....+.|||+.|.|||++.+.. +++.+.|+||+||++|-+++|.+|
T Consensus 305 eNILl~~~~e~~llKItDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 305 ENILLSNDAEDCLLKITDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred ceEEeccCCcceEEEecccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 99999776 56899999999876532 2577899999999999997654 445458999999999999999999
Q ss_pred CCChhHHH-HHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 156 FDDSNLKQ-LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 156 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
|.+..... ....|.++.+.+. +..+..++
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~--------------------------------------------------p~~w~~Is 410 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFG--------------------------------------------------PLQWDRIS 410 (475)
T ss_pred cccccCCccHHHHHhcCccccc--------------------------------------------------Chhhhhhh
Confidence 98776554 7777888777665 44457789
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+..+||..||..||++|||++|+|+||||+..+...
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 9999999999999999999999999999999887544
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.44 Aligned_cols=200 Identities=33% Similarity=0.567 Sum_probs=183.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|.+|+++..+|+|+||+++|+|.++|++-|.|++..+++++.+|+.||+||| ++|||||||||
T Consensus 137 vkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH--------------~~GIIHRDlKP 202 (604)
T KOG0592|consen 137 VKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH--------------SNGIIHRDLKP 202 (604)
T ss_pred EEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH--------------hcCceeccCCh
Confidence 5899999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc----------cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR----------RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
+|||+++++.+||+|||.++.+.+.... .+....++||..|++||++..+..+.. +|+|+|||++|.|+
T Consensus 203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQml 281 (604)
T KOG0592|consen 203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQML 281 (604)
T ss_pred hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHh
Confidence 9999999999999999999876543322 111256889999999999998888777 99999999999999
Q ss_pred hCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 151 NAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 151 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
.|..||.+.+..-.+++|+...+.++
T Consensus 282 aG~PPFra~NeyliFqkI~~l~y~fp------------------------------------------------------ 307 (604)
T KOG0592|consen 282 AGQPPFRAANEYLIFQKIQALDYEFP------------------------------------------------------ 307 (604)
T ss_pred cCCCCCccccHHHHHHHHHHhcccCC------------------------------------------------------
Confidence 99999999999999999998888777
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+++.+++|++++|..||.+|+|+++|.+||||.+..-
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 788999999999999999999999999999999987653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=306.07 Aligned_cols=197 Identities=28% Similarity=0.486 Sum_probs=174.6
Q ss_pred CceeeeeeeCCe-EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPR-VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+.|..++. .+|+||||+||+|.+++...+.++|.....++.+++.||.|||. +.+|+|||||
T Consensus 140 V~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~-------------~~~IIHRDIK 206 (364)
T KOG0581|consen 140 VGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE-------------ERKIIHRDIK 206 (364)
T ss_pred eeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-------------ccCeeeccCC
Confidence 689999999984 99999999999999999999999999999999999999999994 4999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+|+|++.+|.+||||||.+...... ...++.||..|||||.+.+..|+.. +||||||+.++|+++|+.||...
T Consensus 207 PsNlLvNskGeVKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 207 PSNLLVNSKGEVKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred HHHeeeccCCCEEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCc
Confidence 99999999999999999999755443 4568899999999999999999999 99999999999999999999764
Q ss_pred -----hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc-c
Q psy1812 160 -----NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI-L 233 (304)
Q Consensus 160 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 233 (304)
+..+++..|..+.. ...|.. +
T Consensus 281 ~~~~~~~~~Ll~~Iv~~pp-----------------------------------------------------P~lP~~~f 307 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPP-----------------------------------------------------PRLPEGEF 307 (364)
T ss_pred CCCCCCHHHHHHHHhcCCC-----------------------------------------------------CCCCcccC
Confidence 45556665554322 233344 8
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++++++|+..||..||.+|+|++|+++|||++....
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999999999999997665
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.83 Aligned_cols=202 Identities=32% Similarity=0.573 Sum_probs=186.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|.+|++.+++|||+|+|..++|..++++.++++|.+++++++||+.||.||| +.+|+|||||.
T Consensus 81 V~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH--------------~~~IiHRDLKL 146 (592)
T KOG0575|consen 81 VQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH--------------SLGIIHRDLKL 146 (592)
T ss_pred EeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH--------------hcCceecccch
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
.|++++++.++||+|||+|..+...+. ...+.|||+.|.|||++.+..++.. +||||+|||+|.||.|++||...+
T Consensus 147 GNlfL~~~~~VKIgDFGLAt~le~~~E---rk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 147 GNLFLNENMNVKIGDFGLATQLEYDGE---RKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred hheeecCcCcEEecccceeeeecCccc---ccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccch
Confidence 999999999999999999987664433 3567899999999999998888888 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+.+|....+..| ..++.+++||
T Consensus 223 vkety~~Ik~~~Y~~P------------------------------------------------------~~ls~~A~dL 248 (592)
T KOG0575|consen 223 VKETYNKIKLNEYSMP------------------------------------------------------SHLSAEAKDL 248 (592)
T ss_pred HHHHHHHHHhcCcccc------------------------------------------------------cccCHHHHHH
Confidence 9999999988877666 6789999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
|.+||..||.+|||++++|.|+||+....+....
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999999999997777766544
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=294.41 Aligned_cols=193 Identities=33% Similarity=0.636 Sum_probs=180.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++|++.|.+..++++||||..||.|+.++++.++|++..++.++.|++.||+||| +++|++||+||
T Consensus 107 v~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH--------------~~~iiYRDLKP 172 (355)
T KOG0616|consen 107 VKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH--------------SLDIIYRDLKP 172 (355)
T ss_pred EEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH--------------hcCeeeccCCh
Confidence 5789999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||+|++|.+||+|||+++.... ...+.|||+.|+|||++...++... +|+|||||++|||+.|..||.+.+
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecC------cEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCC
Confidence 999999999999999999986543 3567899999999999999999877 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+++.+|..+...++ ..+++++++|
T Consensus 246 ~~~iY~KI~~~~v~fP------------------------------------------------------~~fs~~~kdL 271 (355)
T KOG0616|consen 246 PIQIYEKILEGKVKFP------------------------------------------------------SYFSSDAKDL 271 (355)
T ss_pred hHHHHHHHHhCcccCC------------------------------------------------------cccCHHHHHH
Confidence 9999999998887776 7789999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.++|+.|-.+|. ...++.+||||+...
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 9999999999995 567999999999653
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=298.27 Aligned_cols=197 Identities=30% Similarity=0.619 Sum_probs=179.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++..|++++.+|+|+||+.||+|+-+|++.+.|+|..++.++.+|+.||.||| +++||||||||
T Consensus 88 v~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH--------------~~gIiyRDlKP 153 (357)
T KOG0598|consen 88 VKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH--------------SKGIIYRDLKP 153 (357)
T ss_pred eeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH--------------hCCeeeccCCH
Confidence 6789999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.++|+|||+++....... ...+.|||+.|+|||++.+.+++.. +|+||+|+++|+|++|..||.+.+
T Consensus 154 ENILLd~~GHi~LtDFgL~k~~~~~~~---~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 154 ENILLDEQGHIKLTDFGLCKEDLKDGD---ATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred HHeeecCCCcEEEeccccchhcccCCC---ccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCcc
Confidence 999999999999999999985443322 4567899999999999999999888 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......++..+....+ +..++.++++|
T Consensus 230 ~~~~~~~I~~~k~~~~-----------------------------------------------------p~~ls~~ardl 256 (357)
T KOG0598|consen 230 VKKMYDKILKGKLPLP-----------------------------------------------------PGYLSEEARDL 256 (357)
T ss_pred HHHHHHHHhcCcCCCC-----------------------------------------------------CccCCHHHHHH
Confidence 9999988887764333 24489999999
Q ss_pred HHHhcCCCCCccc----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~----t~~ell~~~wf~~~~ 268 (304)
++++|+.||++|. .+.++.+||||+...
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 9999999999996 689999999999865
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.73 Aligned_cols=195 Identities=39% Similarity=0.744 Sum_probs=180.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.....+++|||||.||+|++++.+.++++|..++.+++|++.|++||| .+||+||||||
T Consensus 83 ~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H--------------~~gi~HRDLK~ 148 (370)
T KOG0583|consen 83 IRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH--------------SRGIVHRDLKP 148 (370)
T ss_pred eEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH--------------hCCEeeCCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecC-CCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|++++.+ +++||+|||++.... .......+.+|++.|+|||++.+.. |+..++|+||+||++|.|++|+.||..
T Consensus 149 ENilld~~~~~~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 149 ENILLDGNEGNLKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred HHEEecCCCCCEEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999 999999999998653 1122567889999999999999988 988889999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc-cHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL-SHQV 237 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (304)
.+....+.++..+.+.++ ..+ +.++
T Consensus 226 ~~~~~l~~ki~~~~~~~p------------------------------------------------------~~~~S~~~ 251 (370)
T KOG0583|consen 226 SNVPNLYRKIRKGEFKIP------------------------------------------------------SYLLSPEA 251 (370)
T ss_pred ccHHHHHHHHhcCCccCC------------------------------------------------------CCcCCHHH
Confidence 988888888887766665 666 9999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
++|+.+||..||.+|+|+.++++||||+.
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999997
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=314.75 Aligned_cols=201 Identities=35% Similarity=0.673 Sum_probs=187.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++|+++++..++|+|+||++||.|+++|-+.|++++.+++.+++||+.|+.|+| ..+|+|||+||
T Consensus 75 l~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH--------------~~~icHRDLKp 140 (786)
T KOG0588|consen 75 LRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH--------------AFNICHRDLKP 140 (786)
T ss_pred eeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh--------------hhcceeccCCc
Confidence 5799999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|+|++.++++||+|||+|..-.+. ..-.+.||++.|.+||++.+.+|+..++||||.|||+|.||+|+.||++.+
T Consensus 141 ENlLLd~~~nIKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 141 ENLLLDVKNNIKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred hhhhhhcccCEeeeccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999753332 256788999999999999999999888999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
...+..++..+.+..+ .+++.++.+|
T Consensus 217 ir~LLlKV~~G~f~MP------------------------------------------------------s~Is~eaQdL 242 (786)
T KOG0588|consen 217 IRVLLLKVQRGVFEMP------------------------------------------------------SNISSEAQDL 242 (786)
T ss_pred HHHHHHHHHcCcccCC------------------------------------------------------CcCCHHHHHH
Confidence 9999999998876555 8899999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
|.+||..||.+|+|.+||++|||+........+
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 999999999999999999999999998875554
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=292.49 Aligned_cols=202 Identities=26% Similarity=0.450 Sum_probs=173.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
||||..|++..++||||||++||++..+|.+.+.|++..+++++.+++.||+-|| ..|++||||||
T Consensus 204 VKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH--------------~~gyIHRDIKP 269 (550)
T KOG0605|consen 204 VKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH--------------QLGYIHRDIKP 269 (550)
T ss_pred EEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH--------------HcCcccccCCh
Confidence 7899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCc----------------------ccc-----c-----------------ccccCcc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDK----------------------EGR-----R-----------------VLSRTYC 116 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~----------------------~~~-----~-----------------~~~~~~~ 116 (304)
+|+|||..|.+||+|||++.-+... +.. . ......+
T Consensus 270 dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StV 349 (550)
T KOG0605|consen 270 DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTV 349 (550)
T ss_pred hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhccc
Confidence 9999999999999999998432110 000 0 0001346
Q ss_pred CCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhh
Q psy1812 117 GSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQ 196 (304)
Q Consensus 117 ~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
||+-|+|||++.+..|+.. +|+||||||+||||.|..||.+.+..+.+.+|.+......
T Consensus 350 GTPDYiAPEVll~kgY~~~-cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------------- 408 (550)
T KOG0605|consen 350 GTPDYIAPEVLLGKGYGKE-CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------------- 408 (550)
T ss_pred CCccccchHHHhcCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------------
Confidence 9999999999999998877 9999999999999999999999999999999887653322
Q ss_pred hcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc---HHHHhcCccccccc
Q psy1812 197 VKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR---LDAIKAHDWLRYKS 268 (304)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~ell~~~wf~~~~ 268 (304)
......++++++|||.+||. ||++|+. ++||.+||||+...
T Consensus 409 ------------------------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 409 ------------------------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred ------------------------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 11113467999999999999 9999994 89999999999864
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=287.44 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=183.4
Q ss_pred CceeeeeeeCC-eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGP-RVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+.. .+|+|||||+. +|++.++.+ +.|++..++.|+.||+.||+|+| .+|++|||+
T Consensus 72 ikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH--------------k~GfFHRDl 136 (538)
T KOG0661|consen 72 IKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH--------------KHGFFHRDL 136 (538)
T ss_pred hhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--------------hcCcccccC
Confidence 57788888877 99999999986 999999875 47999999999999999999999 999999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+|||+..+..+||+|||+|+.+.... ..+.++.|..|+|||++.+..+.....|+||+|||++|+++-+..|.|
T Consensus 137 KPENiLi~~~~~iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 137 KPENILISGNDVIKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred ChhheEecccceeEecccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 9999999999999999999998765554 356788999999999998877665559999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+++.+|..-++......+.. +......+.-.... .....+..+ ....+.++.
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~e---g~~La~~mnf~~P~--------------~~~~~l~~L-------~p~~s~~~~ 268 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPE---GYNLASAMNFRFPQ--------------VKPSPLKDL-------LPNASSEAA 268 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchh---HHHHHHHhccCCCc--------------CCCCChHHh-------CcccCHHHH
Confidence 999999999998877665322221 11111111110000 011111111 244789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++|.+||.+||.+||||.++|+||||+.......
T Consensus 269 ~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~ 302 (538)
T KOG0661|consen 269 SLIERLLAWDPDKRPTASQALQHPFFQVGRASGS 302 (538)
T ss_pred HHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence 9999999999999999999999999998876433
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=274.04 Aligned_cols=205 Identities=30% Similarity=0.514 Sum_probs=183.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++.|+|+....+|+|+|.|+.|.|+|||...-.+++...+.+++|++.|+.||| .++||||||||
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH--------------a~~IVHRDLKp 151 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH--------------ARNIVHRDLKP 151 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH--------------HhhhhhcccCh
Confidence 4688999999999999999999999999988777999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC------CCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN------PYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+|||++.+.+++|+|||+++...+.. +-...|||+.|+|||.+..+ .|+-. .|.|+.||++|.|+.|..
T Consensus 152 ENILlddn~~i~isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~E-VD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 152 ENILLDDNMNIKISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKE-VDEWACGVIMYTLLAGCP 226 (411)
T ss_pred hheeeccccceEEeccceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccch-hhHHHHHHHHHHHHcCCC
Confidence 99999999999999999998665443 34678999999999998632 34444 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||+...+.-+...|+.+.+++. +.-+..++
T Consensus 227 PFwHRkQmlMLR~ImeGkyqF~--------------------------------------------------speWadis 256 (411)
T KOG0599|consen 227 PFWHRKQMLMLRMIMEGKYQFR--------------------------------------------------SPEWADIS 256 (411)
T ss_pred chhHHHHHHHHHHHHhcccccC--------------------------------------------------Ccchhhcc
Confidence 9999999999999999999887 44456789
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
...+|||.+||..||++|+|++|+|+||||.+....+...
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ 296 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQ 296 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccc
Confidence 9999999999999999999999999999998877655443
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.03 Aligned_cols=203 Identities=30% Similarity=0.530 Sum_probs=182.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.+..+...|||+|+++|++|..-|-....++|..+-..+.||+++|.|+| ..+|||||+||
T Consensus 73 vrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH--------------~n~IvHRDvkP 138 (355)
T KOG0033|consen 73 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH--------------SNGIVHRDLKP 138 (355)
T ss_pred eehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--------------hcCceeccCCh
Confidence 5788899999999999999999999888877777999999999999999999999 89999999999
Q ss_pred CcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
.|+++.+.. -+|++|||++.-..... .-..+.|++.|++||+++..+++-+ +|+|+-||++|.|+.|..||.
T Consensus 139 ~nllLASK~~~A~vKL~~FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 139 ENLLLASKAKGAAVKLADFGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred hheeeeeccCCCceeecccceEEEeCCcc----ccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCC
Confidence 999996544 38999999997655221 3456789999999999999999988 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+...+++.|..+.+-.+ ...++.++++.
T Consensus 214 ~~~~~rlye~I~~g~yd~~--------------------------------------------------~~~w~~is~~A 243 (355)
T KOG0033|consen 214 DEDQHRLYEQIKAGAYDYP--------------------------------------------------SPEWDTVTPEA 243 (355)
T ss_pred CccHHHHHHHHhccccCCC--------------------------------------------------CcccCcCCHHH
Confidence 9999999999999888766 45567899999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++|+++||..||.+|+|+.|+|+|||.++...+..
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As 278 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVAS 278 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcchHHHHH
Confidence 99999999999999999999999999998876554
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=291.11 Aligned_cols=199 Identities=28% Similarity=0.538 Sum_probs=171.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.|..+..+|+||||++||+|.|.+... .++|.++..++++++.||+||| ..+|+|||||.
T Consensus 333 Vnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH--------------~~gIiHrDIKS 397 (550)
T KOG0578|consen 333 VNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLH--------------ARGIIHRDIKS 397 (550)
T ss_pred HHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHH--------------hcceeeecccc
Confidence 45667777788999999999999999998765 4999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+|..+..... +..+..||+.|||||+.....|+++ .||||||+++.||+-|..||...+
T Consensus 398 DnILL~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~ 473 (550)
T KOG0578|consen 398 DNILLTMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNEN 473 (550)
T ss_pred ceeEeccCCcEEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCC
Confidence 999999999999999999976654433 4567789999999999999999999 999999999999999999998766
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......|... +... ...+..+++++++|
T Consensus 474 PlrAlyLIa~n-g~P~--------------------------------------------------lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 474 PLRALYLIATN-GTPK--------------------------------------------------LKNPEKLSPELKDF 502 (550)
T ss_pred hHHHHHHHhhc-CCCC--------------------------------------------------cCCccccCHHHHHH
Confidence 54444433322 1111 34557899999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||+.|+.+|++|.+||+||||+....
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 99999999999999999999999976654
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.43 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=190.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|.+.++|.....+++|+|||+. ++.+-|++. ..++.+.++.+++|++.|+.|+| +.+++|||||
T Consensus 64 VnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH--------------k~n~IHRDIK 128 (396)
T KOG0593|consen 64 VNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH--------------KNNCIHRDIK 128 (396)
T ss_pred HHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh--------------hcCeecccCC
Confidence 4567889999999999999998 666667663 46999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+|||++.+|.+|+||||+|+....... ..+.+..|..|+|||.+.+. .|+.+ .||||+||++.||++|...|.+
T Consensus 129 PENILit~~gvvKLCDFGFAR~L~~pgd---~YTDYVATRWYRaPELLvGDtqYG~p-VDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 129 PENILITQNGVVKLCDFGFARTLSAPGD---NYTDYVATRWYRAPELLVGDTQYGKP-VDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred hhheEEecCCcEEeccchhhHhhcCCcc---hhhhhhhhhhccChhhhcccCcCCCc-ccchhhhHHHHHHhcCCcCCCC
Confidence 9999999999999999999998764322 45678889999999999994 56666 9999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
..+.++.-.|....+.+......++..+ ..+.++. .+...+..+++.- .+.++..+.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N---------------~~F~Gv~-lP~~~~~epLe~k-------~p~~s~~~l 261 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSN---------------PFFHGVR-LPEPEHPEPLERK-------YPKISNVLL 261 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccC---------------Cceeeee-cCCCCCccchhhh-------cccchHHHH
Confidence 9988888888877776653332222211 1111111 1111222222211 155778999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCCceeccCccccCCc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSNLSVKQTP 291 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (304)
||+++||..||++|++.+|+|.|+||.+-...+.+.-..+..-.++++.++..
T Consensus 262 d~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~k~~~~~~~~~l~~k~~~ 314 (396)
T KOG0593|consen 262 DLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKAKKPNEAENSSLSKKQAK 314 (396)
T ss_pred HHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHHhcccchhhhhHhhhhhc
Confidence 99999999999999999999999999776665554444444444444444333
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=296.53 Aligned_cols=195 Identities=29% Similarity=0.551 Sum_probs=176.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++|+.|++++++|+||||+.||+ .-++++.+.|++..++.++.+++.||+||| +++|+|||||.
T Consensus 432 ~~L~~~fQT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH--------------~~~IIYRDlKL 496 (694)
T KOG0694|consen 432 VNLFSCFQTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLH--------------ENGIIYRDLKL 496 (694)
T ss_pred eecccccccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHH--------------hcCceeeecch
Confidence 478999999999999999999999 444455578999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||+|..|.+||+|||+++..-..+ ....++|||+.|+|||++.+..|+.. .|+|||||++|+||.|..||.+.+
T Consensus 497 dNiLLD~eGh~kiADFGlcKe~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 497 DNLLLDTEGHVKIADFGLCKEGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred hheEEcccCcEEecccccccccCCCC---CccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999997433222 25678999999999999999999988 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.++++..|.+....++ .+++.+..++
T Consensus 573 Eee~FdsI~~d~~~yP------------------------------------------------------~~ls~ea~~i 598 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYP------------------------------------------------------RFLSKEAIAI 598 (694)
T ss_pred HHHHHHHHhcCCCCCC------------------------------------------------------CcccHHHHHH
Confidence 9999999887766555 8899999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
|+++|..+|++|+. +++|.+||||+...
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 99999999999995 58999999999875
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=274.65 Aligned_cols=200 Identities=29% Similarity=0.459 Sum_probs=174.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
.+|..|+.++..|+|||||.||+|...+++. +.|++..++.++.+++.||+||| -.|||+||||
T Consensus 141 TLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--------------mlGivYRDLK 206 (459)
T KOG0610|consen 141 TLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--------------MLGIVYRDLK 206 (459)
T ss_pred hhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--------------hhceeeccCC
Confidence 6899999999999999999999999999874 47999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccC---------------------------------ccc-------------------
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVD---------------------------------KEG------------------- 107 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~---------------------------------~~~------------------- 107 (304)
|+||||-++|.++|+||.++..+.- ...
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 9999999999999999998742210 000
Q ss_pred -ccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhh
Q psy1812 108 -RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186 (304)
Q Consensus 108 -~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (304)
....+..++||..|+|||++.+...+.. .|||+||+++|||+.|..||.+.+..+.+..++.....++.
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~--------- 356 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE--------- 356 (459)
T ss_pred CCCccccccccccccccceeeecCCCCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------
Confidence 0012235679999999999999999887 99999999999999999999999999999988877766651
Q ss_pred hhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc----HHHHhcCc
Q psy1812 187 VKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR----LDAIKAHD 262 (304)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t----~~ell~~~ 262 (304)
...++.+++|||+++|.+||++|+. |.||.+||
T Consensus 357 -------------------------------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 357 -------------------------------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred -------------------------------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 0257889999999999999999998 99999999
Q ss_pred cccccc
Q psy1812 263 WLRYKS 268 (304)
Q Consensus 263 wf~~~~ 268 (304)
||++..
T Consensus 394 FF~gVn 399 (459)
T KOG0610|consen 394 FFEGVN 399 (459)
T ss_pred cccCCC
Confidence 999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=280.63 Aligned_cols=195 Identities=30% Similarity=0.560 Sum_probs=168.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.+|+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 58 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~ivHrDlkp 123 (323)
T cd05571 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH--------------SCDVVYRDLKL 123 (323)
T ss_pred CCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEeCCCCH
Confidence 4688899999999999999999999999998889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||++.+..++.. +|+|||||++|+|++|..||...+
T Consensus 124 ~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 124 ENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred HHEEECCCCCEEEeeCCCCcccccCCC---cccceecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999864322111 2334578999999999988888877 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+..+++++.+|
T Consensus 200 ~~~~~~~~~~~~~------------------------------------------------------~~p~~~~~~~~~l 225 (323)
T cd05571 200 HEKLFELILMEEI------------------------------------------------------RFPRTLSPEAKSL 225 (323)
T ss_pred HHHHHHHHHcCCC------------------------------------------------------CCCCCCCHHHHHH
Confidence 6555554443322 2235678999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~ 267 (304)
|.+||+.||++|| ++.++++||||+..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=272.92 Aligned_cols=237 Identities=23% Similarity=0.314 Sum_probs=185.5
Q ss_pred eeeeeee-----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 3 VHSILQR-----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 3 ~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.. -+.+|+|+|+|+ .+|.+.|+.+..++++.+..++.|++.||+|+| +.+++|||
T Consensus 86 l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH--------------SAnViHRD 150 (359)
T KOG0660|consen 86 LLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH--------------SANVIHRD 150 (359)
T ss_pred EEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhh--------------cccccccc
Confidence 4555543 467999999995 599999998888999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+|++++.+..+||+|||+++..... .+....+.+.-|..|+|||++....-.+.+.|+||+|||+.||++|+..|.
T Consensus 151 LKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 151 LKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cchhheeeccCCCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 9999999999999999999999987643 223344677889999999999766544555999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
|.+...+...+....+.........+.-..... ......... ...+. ...++.++.+
T Consensus 230 G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~-yi~slp~~p---------------~~~f~-------~~fp~a~p~A 286 (359)
T KOG0660|consen 230 GKDYVHQLQLILELLGTPSEEDLQKIRSEKARP-YIKSLPQIP---------------KQPFS-------SIFPNANPLA 286 (359)
T ss_pred CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH-HHHhCCCCC---------------CCCHH-------HHcCCCCHHH
Confidence 999999998888877766533322222111111 211111111 11111 2235789999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCC
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQ 278 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~ 278 (304)
.+||.+||.+||.+|+|++|+|+||||..-..+..+.....
T Consensus 287 idLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~ 327 (359)
T KOG0660|consen 287 IDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP 327 (359)
T ss_pred HHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence 99999999999999999999999999999999887764443
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=289.06 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=185.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|||||+|...+++|||+|.+. .+|+++|+.+. .|+...++.++.||+.||.+|| +.+|+|+||
T Consensus 251 Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--------------~l~IIHcDL 315 (586)
T KOG0667|consen 251 VRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--------------ELGIIHCDL 315 (586)
T ss_pred EEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeccC
Confidence 689999999999999999996 59999999875 6999999999999999999999 899999999
Q ss_pred CCCcEEEecCC--CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTKRF--NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|||+...+ .+||+|||.++..... ..+++.+..|+|||++.+.+|+.+ .|+||||||++||++|.+.|
T Consensus 316 KPENILL~~~~r~~vKVIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 316 KPENILLKDPKRSRIKVIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred ChhheeeccCCcCceeEEecccccccCCc------ceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCcccc
Confidence 99999997644 5999999999764432 237889999999999999999999 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhh-hhcccccccccccccc-------------hhhhhhhhhhh
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSH-QVKVKDILSHQVKVKD-------------ILSHQVKLKDI 222 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~ 222 (304)
.+.+..+++..|+...+..+.. ++........+.+. ......+......... .....+. ..
T Consensus 389 pG~ne~DQl~~I~e~lG~Pp~~---mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~--~~ 463 (586)
T KOG0667|consen 389 PGDNEYDQLARIIEVLGLPPPK---MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP--GS 463 (586)
T ss_pred CCCCHHHHHHHHHHHhCCCCHH---HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC--CC
Confidence 9999999999988877765532 33333333333333 2222211111100000 0000000 00
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccC
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVL 275 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~ 275 (304)
..............+.|||++||.+||.+|+|+.++|+||||...........
T Consensus 464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~~~~~~ 516 (586)
T KOG0667|consen 464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLERRNQS 516 (586)
T ss_pred cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccccccCCC
Confidence 00011111234567899999999999999999999999999997776544333
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.83 Aligned_cols=201 Identities=34% Similarity=0.589 Sum_probs=176.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.++.++.+|+|||||+||||.+||++.+.+++..++.++.||+.||++|| +++||||||||
T Consensus 72 V~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~--------------~~~IiHRDLKP 137 (429)
T KOG0595|consen 72 VRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH--------------ENNIIHRDLKP 137 (429)
T ss_pred eeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeccCCc
Confidence 6889999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecC------CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKR------FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
.|||++.. ..+||+|||+++++.+.. ...+.||++.|||||++....|+.+ +|+||+|+++|++++|+.
T Consensus 138 QNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~ 212 (429)
T KOG0595|consen 138 QNILLSTTARNDTSPVLKIADFGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKP 212 (429)
T ss_pred ceEEeccCCCCCCCceEEecccchhhhCCchh----HHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCC
Confidence 99999775 458999999999876443 4567899999999999999899998 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+..+.+..+..+....+ ..+..++
T Consensus 213 Pf~a~t~~eL~~~~~k~~~~~~---------------------------------------------------~~~~~~s 241 (429)
T KOG0595|consen 213 PFDAETPKELLLYIKKGNEIVP---------------------------------------------------VLPAELS 241 (429)
T ss_pred CccccCHHHHHHHHhccccccC---------------------------------------------------chhhhcc
Confidence 9999998888876655433222 1223456
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+.+.+++...|..+|.+|.+..+-..|+++......+
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~ 278 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR 278 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence 6778999999999999999999999999998887443
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=281.42 Aligned_cols=231 Identities=21% Similarity=0.327 Sum_probs=182.7
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|+|.++.... ..+|||+|||++ ||.-++.+.+ .|++.+++.+++||+.||+|+| .+||+|||
T Consensus 179 ikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH--------------~~gvlHRD 243 (560)
T KOG0600|consen 179 IKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH--------------SRGVLHRD 243 (560)
T ss_pred cceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh--------------hcCeeecc
Confidence 3556666554 799999999998 9999998865 6999999999999999999999 99999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
||.+|||||.+|.+||+|||+++++...... ..+..+-|..|+|||.+.+...+..+.|+||.|||+.||++|+..|.
T Consensus 244 IK~SNiLidn~G~LKiaDFGLAr~y~~~~~~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 244 IKGSNILIDNNGVLKIADFGLARFYTPSGSA--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred ccccceEEcCCCCEEeccccceeeccCCCCc--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 9999999999999999999999977655433 24556778999999999987655455999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..++..+|.+.++......|...... ..........+.. .+. .....++...
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP--~~~~~kp~~~y~r----------------~l~-------E~~~~~~~~~ 376 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLP--HATIFKPQQPYKR----------------RLR-------ETFKDFPASA 376 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCC--cccccCCCCcccc----------------hHH-------HHhccCCHHH
Confidence 99999999999998888764443311000 0011111111111 111 1136689999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
.+|+..||.+||.+|.||.++|+|+||...+.+.++
T Consensus 377 l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p 412 (560)
T KOG0600|consen 377 LDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDP 412 (560)
T ss_pred HHHHHHHhccCccccccHHHHhcCcccccCCCCCCc
Confidence 999999999999999999999999999666655543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=276.67 Aligned_cols=203 Identities=32% Similarity=0.454 Sum_probs=163.1
Q ss_pred CceeeeeeeCC--eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGP--RVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|++|+.....+ .++|+|||+.+|+|.+++.+.+ .+++..++.+.+|+++||.||| ++|++|+|
T Consensus 77 V~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH--------------s~g~vH~D 142 (313)
T KOG0198|consen 77 VQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH--------------SKGIVHCD 142 (313)
T ss_pred EeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeccC
Confidence 46666544443 7999999999999999999877 7999999999999999999999 99999999
Q ss_pred CCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||++|||++. ++.+||+|||.+.................||+.|+|||++..+....+.+|+|||||++.||+||..||
T Consensus 143 iK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW 222 (313)
T KOG0198|consen 143 IKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPW 222 (313)
T ss_pred cccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcc
Confidence 9999999999 799999999998765531222223445779999999999986333333499999999999999999999
Q ss_pred CC-hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DD-SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
.. .........+..... ....+..++.
T Consensus 223 ~~~~~~~~~~~~ig~~~~----------------------------------------------------~P~ip~~ls~ 250 (313)
T KOG0198|consen 223 SEFFEEAEALLLIGREDS----------------------------------------------------LPEIPDSLSD 250 (313)
T ss_pred hhhcchHHHHHHHhccCC----------------------------------------------------CCCCCcccCH
Confidence 76 333222222222110 0234567899
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++++||.+||..||.+||||+++|+|||.++...
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999999988765
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.95 Aligned_cols=227 Identities=21% Similarity=0.293 Sum_probs=183.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+.+.|+|.....+.||+||++. +|...|+... .++...++.++.+++.||+||| .+.|+|||||
T Consensus 64 i~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H--------------~~~IlHRDlK 128 (318)
T KOG0659|consen 64 IELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH--------------SKWILHRDLK 128 (318)
T ss_pred hhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH--------------hhhhhcccCC
Confidence 4578899999999999999986 9999998865 6999999999999999999999 9999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|.|+|++.+|.+||+|||+++.+...+.. .....-|..|+|||.+.|.+......|+||+||++.||+.|...|.+.
T Consensus 129 PnNLLis~~g~lKiADFGLAr~f~~p~~~---~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 129 PNNLLISSDGQLKIADFGLARFFGSPNRI---QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred ccceEEcCCCcEEeecccchhccCCCCcc---cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999987765432 222356888999999998764444499999999999999999999999
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh-hccccccccccHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL-SHQVKVKDILSHQVK 238 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (304)
++.++...+.+..+......|..+. ....+..+...- .....+....++++.
T Consensus 206 sDidQL~~If~~LGTP~~~~WP~~~---------------------------~lpdY~~~~~~P~~~~~~lf~aas~d~l 258 (318)
T KOG0659|consen 206 SDIDQLSKIFRALGTPTPDQWPEMT---------------------------SLPDYVKIQQFPKPPLNNLFPAASSDAL 258 (318)
T ss_pred chHHHHHHHHHHcCCCCcccCcccc---------------------------ccccHHHHhcCCCCccccccccccHHHH
Confidence 9999999988887776533322222 222222222110 001124456788899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
|||.+||.+||.+|+|+.|+|+|+||+..+.+..
T Consensus 259 dLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 259 DLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 9999999999999999999999999998776554
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.43 Aligned_cols=196 Identities=29% Similarity=0.539 Sum_probs=169.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++...+.+++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH--------------~~~ivH~dlkp 124 (320)
T cd05590 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--------------DKGIIYRDLKL 124 (320)
T ss_pred hceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 125 ~NIli~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 125 DNVLLDHEGHCKLADFGMCKEGIFNGK---TTSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred HHeEECCCCcEEEeeCCCCeecCcCCC---cccccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999864322111 2334578999999999988888777 999999999999999999998887
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..++.++.+|
T Consensus 201 ~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~~~~~l 226 (320)
T cd05590 201 EDDLFEAILNDEVV------------------------------------------------------YPTWLSQDAVDI 226 (320)
T ss_pred HHHHHHHHhcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 76666655443222 225578899999
Q ss_pred HHHhcCCCCCccccH------HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL------DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~------~ell~~~wf~~~~ 268 (304)
|.+||+.||.+|+++ +++++||||+...
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.71 Aligned_cols=196 Identities=30% Similarity=0.579 Sum_probs=168.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.+..++..++||||+++|+|.+++...+.+++..+..++.|++.||.||| +.+++||||||
T Consensus 56 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~HrDlkp 121 (312)
T cd05585 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH--------------KFNVIYRDLKP 121 (312)
T ss_pred eceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEeCCCCH
Confidence 4678899999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 122 ~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 122 ENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred HHeEECCCCcEEEEECcccccCccCCC---ccccccCCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCC
Confidence 999999999999999999874322211 2334578999999999988888877 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..+++.+.+|
T Consensus 198 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~l 223 (312)
T cd05585 198 VNEMYRKILQEPLR------------------------------------------------------FPDGFDRDAKDL 223 (312)
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCcCCHHHHHH
Confidence 66555554433222 235678899999
Q ss_pred HHHhcCCCCCccc---cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI---RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~---t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|| ++.++++||||+...
T Consensus 224 i~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 224 LIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 9999999999997 589999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=277.48 Aligned_cols=192 Identities=30% Similarity=0.584 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.||+|.+++.+.+.+++..++.++.|++.||+||| +.+++|+||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH~dlkp 146 (329)
T PTZ00263 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH--------------SKDIIYRDLKP 146 (329)
T ss_pred CcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCCH
Confidence 5789999999999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... .....|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 147 ~NIll~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 147 ENLLLDNKGHVKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred HHEEECCCCCEEEeeccCceEcCCC------cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999998754321 224568999999999988888776 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+... .+..++..+.+|
T Consensus 220 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~~~~~~~l 245 (329)
T PTZ00263 220 PFRIYEKILAGRLK------------------------------------------------------FPNWFDGRARDL 245 (329)
T ss_pred HHHHHHHHhcCCcC------------------------------------------------------CCCCCCHHHHHH
Confidence 66555555443222 224578889999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
|.+||+.||.+|++ ++++++||||+..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999997 7999999999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=271.49 Aligned_cols=194 Identities=32% Similarity=0.573 Sum_probs=167.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+.+|+|.+++.+.+.+++..++.++.|++.||+||| +.+++||||||
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlkp 129 (291)
T cd05612 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH--------------SKEIVYRDLKP 129 (291)
T ss_pred hhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCCH
Confidence 4678888899999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... .....|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 130 ~NIli~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 130 ENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred HHeEECCCCCEEEEecCcchhccCC------cccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998754321 223568999999999988888776 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+... .+..++..+++|
T Consensus 203 ~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~~~~~l 228 (291)
T cd05612 203 PFGIYEKILAGKLE------------------------------------------------------FPRHLDLYAKDL 228 (291)
T ss_pred HHHHHHHHHhCCcC------------------------------------------------------CCccCCHHHHHH
Confidence 66666655543322 225568899999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~~~ 269 (304)
|++||+.||.+|++ ++++++||||+....
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 99999999999995 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.71 Aligned_cols=235 Identities=25% Similarity=0.308 Sum_probs=186.7
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
-+.+|||||||++ +|...|.+.. +|.+.+++.+..|++.|++||| ...|+|||||++|+|++..
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH--------------~~wilHRDLK~SNLLm~~~ 213 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH--------------DNWILHRDLKTSNLLLSHK 213 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh--------------hceeEecccchhheeeccC
Confidence 4579999999998 9999999976 8999999999999999999999 8999999999999999999
Q ss_pred CCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q psy1812 89 FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~ 167 (304)
|.+||+|||+|+.++.... ..+..+-|..|+|||.+.+.+ |+++ .|+||+|||+.|++.++..|.+....++..+
T Consensus 214 G~lKiaDFGLAR~ygsp~k---~~T~lVVTLWYRaPELLLG~~tyst~-iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 214 GILKIADFGLAREYGSPLK---PYTPLVVTLWYRAPELLLGAKTYSTA-VDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred CcEEecccchhhhhcCCcc---cCcceEEEeeecCHHHhcCCcccCcc-hhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 9999999999997765522 344556788999999999876 5555 9999999999999999999999999999999
Q ss_pred hhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCC
Q psy1812 168 QTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEP 247 (304)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 247 (304)
|.+..+.....+|.-......+...--....++. ++.-+ .. ..+++...+||..+|.+
T Consensus 290 If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~-----------------lr~kF---~~--~~lse~g~~Lln~llt~ 347 (419)
T KOG0663|consen 290 IFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNN-----------------LRKKF---GA--LSLSEQGFDLLNKLLTY 347 (419)
T ss_pred HHHHhCCCccccCCCccccchhhccccCCCCchh-----------------hhhhc---cc--cccchhHHHHHHHHhcc
Confidence 9988887776665544443333211111111111 11000 00 11679999999999999
Q ss_pred CCCccccHHHHhcCcccccccccccccCCCCceeccCc
Q psy1812 248 DITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSNL 285 (304)
Q Consensus 248 dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~~~~~~~~ 285 (304)
||.+|.||+|+|+|+||+..+.+..+.+.....-.++.
T Consensus 348 dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~ 385 (419)
T KOG0663|consen 348 DPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQ 385 (419)
T ss_pred CccccccHHHhhcccccccCCCCCChhhcCCCcccccc
Confidence 99999999999999999999888777655544444443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=273.40 Aligned_cols=196 Identities=29% Similarity=0.569 Sum_probs=166.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++.+++||||+.||+|.+++...+.+++..+..++.|++.||+||| +.+++||||||
T Consensus 59 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivHrDlkp 124 (316)
T cd05620 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH--------------SKGIIYRDLKL 124 (316)
T ss_pred cCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ .....+|+..|+|||++.+..++.. +|+||+||++|+|++|..||.+.+
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCCC---ceeccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864221111 2345678999999999998888877 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+.... ...+..++.++.+|
T Consensus 201 ~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~l 226 (316)
T cd05620 201 EDELFESIRVDT------------------------------------------------------PHYPRWITKESKDI 226 (316)
T ss_pred HHHHHHHHHhCC------------------------------------------------------CCCCCCCCHHHHHH
Confidence 655554443221 12235578899999
Q ss_pred HHHhcCCCCCccccH-HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL-DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-~ell~~~wf~~~~ 268 (304)
|.+||..||++|+++ +++++||||+...
T Consensus 227 i~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 227 LEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 999999999999998 5899999998854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=277.51 Aligned_cols=193 Identities=26% Similarity=0.492 Sum_probs=169.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||+.||+|.+++.+.+.+++..+..++.|++.||.||| +.+++||||||
T Consensus 94 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDLkp 159 (340)
T PTZ00426 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ--------------SLNIVYRDLKP 159 (340)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEccCCCH
Confidence 5789999999999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++..... ......|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 160 ~NILl~~~~~ikL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 160 ENLLLDKDGFIKMTDFGFAKVVDT------RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred HHEEECCCCCEEEecCCCCeecCC------CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCC
Confidence 999999999999999999875432 1234578999999999988777776 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+...+ +..+++.+.++
T Consensus 233 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~~~~~~~l 258 (340)
T PTZ00426 233 PLLIYQKILEGIIYF------------------------------------------------------PKFLDNNCKHL 258 (340)
T ss_pred HHHHHHHHhcCCCCC------------------------------------------------------CCCCCHHHHHH
Confidence 666666555443322 25578899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||+.||.+|+ +++++++||||++..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999996 899999999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=274.19 Aligned_cols=196 Identities=29% Similarity=0.570 Sum_probs=167.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.|..++..++||||+++|+|..++...+.+++..++.++.|++.||+||| +.+++||||||
T Consensus 58 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH~Dlkp 123 (323)
T cd05595 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--------------SRDVVYRDIKL 123 (323)
T ss_pred cceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 4678899999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.. +|+|||||++|+|++|..||...+
T Consensus 124 ~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 124 ENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred HHEEEcCCCCEEecccHHhccccCCCC---ccccccCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864322111 2234568999999999988888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+..+++++.+|
T Consensus 200 ~~~~~~~~~~~~~------------------------------------------------------~~p~~~~~~~~~l 225 (323)
T cd05595 200 HERLFELILMEEI------------------------------------------------------RFPRTLSPEAKSL 225 (323)
T ss_pred HHHHHHHHhcCCC------------------------------------------------------CCCCCCCHHHHHH
Confidence 6555554433222 2235678999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||+.||++|+ ++.++++|+||....
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=274.42 Aligned_cols=195 Identities=29% Similarity=0.540 Sum_probs=169.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++|+|.+++...+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDikp 124 (321)
T cd05591 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH--------------RHGVIYRDLKL 124 (321)
T ss_pred cceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.+ +|+|||||++|+|++|+.||...+
T Consensus 125 ~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 125 DNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred HHeEECCCCCEEEeecccceecccCCc---cccccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCC
Confidence 999999999999999999864322221 2334568999999999988888877 999999999999999999998887
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... .+..++.++.+|
T Consensus 201 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~~~~~~~l 226 (321)
T cd05591 201 EDDLFESILHDDVL------------------------------------------------------YPVWLSKEAVSI 226 (321)
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 76666655543322 224578899999
Q ss_pred HHHhcCCCCCccc-------cHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRI-------RLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~-------t~~ell~~~wf~~~ 267 (304)
|.+||+.||++|+ +++++++||||+..
T Consensus 227 l~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=274.25 Aligned_cols=195 Identities=30% Similarity=0.556 Sum_probs=166.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+++|+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 58 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDikp 123 (328)
T cd05593 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH--------------SGKIVYRDLKL 123 (328)
T ss_pred cceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEecccCH
Confidence 4678899999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||.+.+..++.. +|+|||||++|+|++|..||...+
T Consensus 124 ~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 124 ENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred HHeEECCCCcEEEecCcCCccCCCccc---ccccccCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCC
Confidence 999999999999999999864322111 2234578999999999988888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+..+++++.+|
T Consensus 200 ~~~~~~~~~~~~~------------------------------------------------------~~p~~~~~~~~~l 225 (328)
T cd05593 200 HEKLFELILMEDI------------------------------------------------------KFPRTLSADAKSL 225 (328)
T ss_pred HHHHHHHhccCCc------------------------------------------------------cCCCCCCHHHHHH
Confidence 6555544433222 2235678899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~ 267 (304)
|.+||..||++|+ ++.++++|+||...
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=270.95 Aligned_cols=210 Identities=26% Similarity=0.422 Sum_probs=173.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|+.|..+..+|+||.||.+|++.+.++.. ..+.|..+..+++++++||.||| ..|.+||||
T Consensus 87 v~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--------------~~G~IHRdv 152 (516)
T KOG0582|consen 87 VTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--------------QNGHIHRDV 152 (516)
T ss_pred ceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--------------hcCceeccc
Confidence 57899999999999999999999999999873 45999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccc-cCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLS-RTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|+.||||+.+|.+||+|||.+........+.... .+..|+++|+|||++.+ ..|+.+ +||||||+...|+.+|..|
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aP 231 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAP 231 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCC
Confidence 9999999999999999999876555554444344 67889999999999543 357777 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|......++...-.++..+...+ ........+.++.
T Consensus 232 f~k~pPmkvLl~tLqn~pp~~~t--------------------------------------------~~~~~d~~k~~~k 267 (516)
T KOG0582|consen 232 FSKYPPMKVLLLTLQNDPPTLLT--------------------------------------------SGLDKDEDKKFSK 267 (516)
T ss_pred cccCChHHHHHHHhcCCCCCccc--------------------------------------------ccCChHHhhhhcH
Confidence 98887766654444443322210 0000111245677
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.++.++..||..||++||||+++|+|+||+....
T Consensus 268 sf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 268 SFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 9999999999999999999999999999998875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=272.34 Aligned_cols=196 Identities=33% Similarity=0.591 Sum_probs=167.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+...+.+++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 64 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivH~dlkp 129 (324)
T cd05587 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH--------------SKGIIYRDLKL 129 (324)
T ss_pred eeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 3578889999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.. +|+||+||++|+|++|+.||.+.+
T Consensus 130 ~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 130 DNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred HHeEEcCCCCEEEeecCcceecCCCCC---ceeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864321111 2234568999999999998888777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..++.++.++
T Consensus 206 ~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~~~~~l 231 (324)
T cd05587 206 EDELFQSIMEHNVS------------------------------------------------------YPKSLSKEAVSI 231 (324)
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 66666655443222 235678899999
Q ss_pred HHHhcCCCCCccccH-----HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL-----DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-----~ell~~~wf~~~~ 268 (304)
+.+||..||.+|+++ +++++||||+...
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999986 8999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=266.73 Aligned_cols=225 Identities=20% Similarity=0.348 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.++.+..+....+.+++..++.++.|++.||.||| ..+++|+||||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~i~H~dlkp 128 (287)
T cd07848 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH--------------KNDIVHRDIKP 128 (287)
T ss_pred cchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4678889999999999999998776655555567999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++......... ......++..|+|||++.+..++.. +|+|||||++|+|++|+.||.+.+
T Consensus 129 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 129 ENLLISHNDVLKLCDFGFARNLSEGSNA--NYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred HHEEEcCCCcEEEeeccCcccccccccc--cccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998754322111 2234568899999999988888776 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+.....+.+........... ....... +........ .......++.++.+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~~~------~~~~~~~~s~~~~dl 263 (287)
T cd07848 206 EIDQLFTIQKVLGPLPAEQMKLFYSNP----------RFHGLRF------PAVNHPQSL------ERRYLGILSGVLLDL 263 (287)
T ss_pred HHHHHHHHHHhhCCCCHHHHHhhhccc----------hhccccc------CcccCcccH------HHhhhcccCHHHHHH
Confidence 555544444333332211111100000 0000000 000000000 012224578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|++||++||++|||++++++||||
T Consensus 264 l~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 264 MKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=274.34 Aligned_cols=196 Identities=31% Similarity=0.572 Sum_probs=167.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~ 79 (304)
+++++.+...+..++||||+.+|+|.+++.+.+.+++..++.++.|++.||.||| + .+++|||||
T Consensus 58 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH--------------~~~~ivHrDik 123 (325)
T cd05594 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH--------------SEKNVVYRDLK 123 (325)
T ss_pred CceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hcCCEEecCCC
Confidence 4678899999999999999999999999988888999999999999999999999 5 799999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.+.
T Consensus 124 p~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 124 LENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCeEEECCCCCEEEecCCCCeecCCCCc---ccccccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCC
Confidence 9999999999999999999864322111 2234568999999999988888777 99999999999999999999877
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+..... ..+..+++++.+
T Consensus 200 ~~~~~~~~i~~~~~------------------------------------------------------~~p~~~~~~~~~ 225 (325)
T cd05594 200 DHEKLFELILMEEI------------------------------------------------------RFPRTLSPEAKS 225 (325)
T ss_pred CHHHHHHHHhcCCC------------------------------------------------------CCCCCCCHHHHH
Confidence 66555554433322 223567889999
Q ss_pred HHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
||.+||+.||++|+ ++.++++||||++..
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999997 999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=268.72 Aligned_cols=196 Identities=33% Similarity=0.668 Sum_probs=181.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++|++|++.....|||||..+|+|+||+.+.+.+++.+++.+++||..|+.|+| ..++||||||.
T Consensus 116 I~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH--------------knrVvHRDLKL 181 (668)
T KOG0611|consen 116 IQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH--------------KNRVVHRDLKL 181 (668)
T ss_pred eehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh--------------hccceecccch
Confidence 4789999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||+|.++++||+|||++.++.... ..+++||++.|.+||++.+.+|..+..|.||||+++|.|..|.+||++.+
T Consensus 182 ENILLD~N~NiKIADFGLSNly~~~k----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYADKK----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred hheeecCCCCeeeeccchhhhhcccc----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 99999999999999999998765544 46789999999999999999999888999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
...++..|.++.+..+ .-+..+.-|
T Consensus 258 hk~lvrQIs~GaYrEP-------------------------------------------------------~~PSdA~gL 282 (668)
T KOG0611|consen 258 HKRLVRQISRGAYREP-------------------------------------------------------ETPSDASGL 282 (668)
T ss_pred HHHHHHHhhcccccCC-------------------------------------------------------CCCchHHHH
Confidence 9999998888866543 346678899
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|+-||..||++|.|+.++-.|=|++-...
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeecccc
Confidence 99999999999999999999999987654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=270.83 Aligned_cols=195 Identities=28% Similarity=0.550 Sum_probs=167.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.|..++..++||||+.||+|.+++.+.+.+++..+..++.|++.||.||| +.+++||||||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dlkp 128 (323)
T cd05584 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH--------------QQGIIYRDLKP 128 (323)
T ss_pred hceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4688999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...+
T Consensus 129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 129 ENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred HHeEECCCCCEEEeeCcCCeecccCCC---cccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999864322211 2334578999999999988877776 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+.. ..+..+++.+.+|
T Consensus 205 ~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~l 230 (323)
T cd05584 205 RKKTIDKILKGKL------------------------------------------------------NLPPYLTPEARDL 230 (323)
T ss_pred HHHHHHHHHcCCC------------------------------------------------------CCCCCCCHHHHHH
Confidence 6555555443322 2235678899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~ 267 (304)
|.+||+.||++|+ +++++++||||+..
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999 89999999999865
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.94 Aligned_cols=196 Identities=33% Similarity=0.638 Sum_probs=167.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------------~~~ivH~dlkp 124 (316)
T cd05592 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH--------------KKGIIYRDLKL 124 (316)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEeCCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGEG---KASTFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCCC---ccccccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999875332221 2344578999999999988888877 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+.... ...+..++.++.+|
T Consensus 201 ~~~~~~~i~~~~------------------------------------------------------~~~~~~~~~~~~~l 226 (316)
T cd05592 201 EDELFDSILNDR------------------------------------------------------PHFPRWISKEAKDC 226 (316)
T ss_pred HHHHHHHHHcCC------------------------------------------------------CCCCCCCCHHHHHH
Confidence 655555443221 12235578899999
Q ss_pred HHHhcCCCCCccccH-HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL-DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-~ell~~~wf~~~~ 268 (304)
|.+||..||++|+++ .++++||||+...
T Consensus 227 l~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 227 LSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 999999999999986 5889999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.09 Aligned_cols=196 Identities=34% Similarity=0.643 Sum_probs=167.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++...+.+++||||+.||+|.+++.+.+.+++..+..++.|++.||.||| +.+++|+||||
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH--------------~~~ivH~dlkp 124 (318)
T cd05570 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH--------------ERGIIYRDLKL 124 (318)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEccCCCH
Confidence 4789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 125 ~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 125 DNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred HHeEECCCCcEEecccCCCeecCcCCC---cccceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999864222111 2234568999999999998888877 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+..++..+.+|
T Consensus 201 ~~~~~~~i~~~~~------------------------------------------------------~~~~~~~~~~~~l 226 (318)
T cd05570 201 EDELFQSILEDEV------------------------------------------------------RYPRWLSKEAKSI 226 (318)
T ss_pred HHHHHHHHHcCCC------------------------------------------------------CCCCcCCHHHHHH
Confidence 6555544433221 2235578899999
Q ss_pred HHHhcCCCCCccccH-----HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL-----DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-----~ell~~~wf~~~~ 268 (304)
|.+||..||++|||+ .++++||||+...
T Consensus 227 i~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=271.49 Aligned_cols=196 Identities=30% Similarity=0.564 Sum_probs=168.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.||+|.+++.+.+.+++..++.++.|++.||+||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~givH~dikp 124 (323)
T cd05575 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--------------SLNIIYRDLKP 124 (323)
T ss_pred CCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCCCCH
Confidence 5788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 125 ~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 125 ENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred HHeEECCCCcEEEeccCCCcccccCCC---ccccccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999864322111 2334568999999999988888777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..++..+.++
T Consensus 201 ~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~~~~~l 226 (323)
T cd05575 201 TAEMYDNILNKPLR------------------------------------------------------LKPNISVSARHL 226 (323)
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 66665555433222 225578899999
Q ss_pred HHHhcCCCCCccccH----HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL----DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~----~ell~~~wf~~~~ 268 (304)
|.+||+.||.+||++ .++++||||+...
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999987 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=273.92 Aligned_cols=199 Identities=29% Similarity=0.551 Sum_probs=182.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|++++....+|+|+|.-++|+|+|||.+++ .+.|+.+++++.||+.|+.|+| ...+||||||
T Consensus 80 VRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH--------------qLHVVHRDLK 145 (864)
T KOG4717|consen 80 VRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH--------------QLHVVHRDLK 145 (864)
T ss_pred eeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh--------------hhhhhcccCC
Confidence 789999999999999999999999999998865 6999999999999999999999 8899999999
Q ss_pred CCcEEE-ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILM-TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||.+ .+-|-+|+.|||++..+.+.. +..+.||+..|-|||++.+..|+.++.||||||||+|.|..|+.||..
T Consensus 146 PENVVFFEKlGlVKLTDFGFSNkf~PG~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 146 PENVVFFEKLGLVKLTDFGFSNKFQPGK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred cceeEEeeecCceEeeeccccccCCCcc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 999766 567889999999997665543 456789999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.++.+...+|+.+.+..+ ..++.+++
T Consensus 222 ANDSETLTmImDCKYtvP------------------------------------------------------shvS~eCr 247 (864)
T KOG4717|consen 222 ANDSETLTMIMDCKYTVP------------------------------------------------------SHVSKECR 247 (864)
T ss_pred ccchhhhhhhhcccccCc------------------------------------------------------hhhhHHHH
Confidence 999999999988877666 77899999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+||..||..||++|.+.++|..++|++..-..-
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 999999999999999999999999999876543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=270.07 Aligned_cols=195 Identities=31% Similarity=0.585 Sum_probs=168.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..++.+++||||+++|+|.+++...+.+++..+..++.|++.||+||| +.+++||||||+
T Consensus 65 ~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp~ 130 (323)
T cd05616 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH--------------SKGIIYRDLKLD 130 (323)
T ss_pred eEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEecCCCHH
Confidence 578889999999999999999999999998888999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+++.++.+||+|||++........ .....+|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+.
T Consensus 131 Nill~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 131 NVMLDSEGHIKIADFGMCKENMWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred HeEECCCCcEEEccCCCceecCCCCC---ccccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999864322111 2334578999999999998888877 9999999999999999999988877
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
......+...... .+..++.++.+++
T Consensus 207 ~~~~~~i~~~~~~------------------------------------------------------~p~~~s~~~~~li 232 (323)
T cd05616 207 DELFQSIMEHNVA------------------------------------------------------YPKSMSKEAVAIC 232 (323)
T ss_pred HHHHHHHHhCCCC------------------------------------------------------CCCcCCHHHHHHH
Confidence 6666665543322 2356788999999
Q ss_pred HHhcCCCCCccccH-----HHHhcCccccccc
Q psy1812 242 GQILEPDITKRIRL-----DAIKAHDWLRYKS 268 (304)
Q Consensus 242 ~~~L~~dP~~R~t~-----~ell~~~wf~~~~ 268 (304)
.+||+.||++|+++ +++++|+||+...
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999984 8999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=273.22 Aligned_cols=201 Identities=26% Similarity=0.515 Sum_probs=161.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++.+++||||+.+|+|.+++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivHrDlkp 133 (332)
T cd05614 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH--------------KLGIVYRDIKL 133 (332)
T ss_pred ccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcEecCCCH
Confidence 4678899999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++......... ......|+..|+|||.+.+.. ++.. +|+|||||++|+|++|..||...
T Consensus 134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 134 ENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred HHeEECCCCCEEEeeCcCCccccccCCC--ccccccCCccccCHHHhcCCCCCCCc-cccccchhhhhhhhcCCCCCCCC
Confidence 9999999999999999998754332211 223456899999999997654 4455 99999999999999999999643
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
........+.. .+.......+..+++.+.+
T Consensus 211 ~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 211 GERNTQSEVSR--------------------------------------------------RILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CCCCCHHHHHH--------------------------------------------------HHhcCCCCCCCCCCHHHHH
Confidence 21110010000 0011112334567899999
Q ss_pred HHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
||.+||+.||++|| +++++++||||+...
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999999 889999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=268.69 Aligned_cols=196 Identities=29% Similarity=0.552 Sum_probs=166.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++.+++||||++||+|.+++...+.+++..+..++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH--------------~~~ivHrdikp 124 (316)
T cd05619 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH--------------SKGIVYRDLKL 124 (316)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEeCCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.. +|+||+||++|+|++|..||.+.+
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGDA---KTCTFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCCC---ceeeecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864322111 2234568999999999988888877 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+.... ...+..++.++.+|
T Consensus 201 ~~~~~~~i~~~~------------------------------------------------------~~~~~~~~~~~~~l 226 (316)
T cd05619 201 EEELFQSIRMDN------------------------------------------------------PCYPRWLTREAKDI 226 (316)
T ss_pred HHHHHHHHHhCC------------------------------------------------------CCCCccCCHHHHHH
Confidence 655554433221 11224578899999
Q ss_pred HHHhcCCCCCccccHH-HHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLD-AIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~-ell~~~wf~~~~ 268 (304)
|.+||..||++|+++. ++++||||+...
T Consensus 227 i~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 227 LVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999999996 899999998854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=269.62 Aligned_cols=204 Identities=28% Similarity=0.561 Sum_probs=163.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++++|.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dlkp 124 (329)
T cd05588 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH--------------ERGIIYRDLKL 124 (329)
T ss_pred CceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 5789999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 125 ~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 125 DNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred HHeEECCCCCEEECcCccccccccCCC---ccccccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCccccc
Confidence 999999999999999999864221111 2334678999999999998888877 999999999999999999995321
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
...... . .........+.......+..++..+.++
T Consensus 201 ~~~~~~---------~------------------------------------~~~~~~~~~~~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 201 MSDNPD---------Q------------------------------------NTEDYLFQVILEKQIRIPRSLSVKASSV 235 (329)
T ss_pred cccccc---------c------------------------------------cchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 100000 0 0000001111122233456688999999
Q ss_pred HHHhcCCCCCcccc------HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR------LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t------~~ell~~~wf~~~ 267 (304)
|.+||+.||.+|+| ++++++||||+..
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999997 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=270.34 Aligned_cols=202 Identities=22% Similarity=0.388 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.++..+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH--------------~~givHrDlKp 129 (363)
T cd05628 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH--------------QLGFIHRDIKP 129 (363)
T ss_pred ceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEecCCCH
Confidence 5789999999999999999999999999998889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc--------------------------------cccccCccCCcccccccccc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR--------------------------------RVLSRTYCGSAAYAAPEVIS 128 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~PE~~~ 128 (304)
+||+++.++.+||+|||++......... .......+||+.|+|||++.
T Consensus 130 ~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred HHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 9999999999999999998643221100 00112457999999999998
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhccccccccccc
Q psy1812 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVK 208 (304)
Q Consensus 129 ~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (304)
+..++.+ +|+|||||++|+|++|..||.+.+..+...++........
T Consensus 210 ~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------- 256 (363)
T cd05628 210 QTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI-------------------------------- 256 (363)
T ss_pred CCCCCCc-hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc--------------------------------
Confidence 8888877 9999999999999999999988777666666554221111
Q ss_pred ccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCc---cccHHHHhcCccccccc
Q psy1812 209 VKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK---RIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~---R~t~~ell~~~wf~~~~ 268 (304)
......+++++++||.+|+. +|.+ ||+++++++||||++..
T Consensus 257 ------------------~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 257 ------------------FPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred ------------------CCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 00012368899999999875 4554 57999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=263.27 Aligned_cols=221 Identities=24% Similarity=0.374 Sum_probs=163.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+ +|.+++...+ .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH~dlk 130 (288)
T cd07871 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--------------KRKILHRDLK 130 (288)
T ss_pred eeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCC
Confidence 5788999999999999999975 9999997654 5799999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.+ +|+||+||++|+|++|+.||.+
T Consensus 131 p~Nil~~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 131 PQNLLINEKGELKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred HHHEEECCCCCEEECcCcceeeccCCCc---cccCceecccccChHHhcCCcccCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864332211 12334678899999998764 45555 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+..+.....+... ....... ... ......++.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~------~~~--------~~~~~~~~~~~~ 262 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSY----------LFPQYRA------QPL--------INHAPRLDTDGI 262 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhcc----------ccCccCC------Cch--------HHhCCCCCHHHH
Confidence 7766666655544433332111111100000000 0000000 000 011245688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+||.+||.+||.+|||++|+++||||
T Consensus 263 dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 263 DLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=270.58 Aligned_cols=199 Identities=30% Similarity=0.546 Sum_probs=179.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|++...+++|||+|+||+|++.|.+. .+++..+..++.|++.|++||| +.|++|||+||
T Consensus 99 v~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH--------------~~gvvHrDlKp 163 (382)
T KOG0032|consen 99 VQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH--------------SLGVVHRDLKP 163 (382)
T ss_pred EEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH--------------hCCceeccCCH
Confidence 57899999999999999999999999999887 4999999999999999999999 89999999999
Q ss_pred CcEEEecC----CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+|+|+... +.+|++|||++...... ......+||+.|+|||++.+.+++.. +|+||+||++|.|+.|..||
T Consensus 164 EN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 164 ENLLLASKDEGSGRIKLIDFGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred HHeeeccccCCCCcEEEeeCCCceEccCC----ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCC
Confidence 99999654 46999999999876651 14567889999999999998889888 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+....+.++..+.+.+. ...++.++..
T Consensus 239 ~~~~~~~~~~~i~~~~~~f~--------------------------------------------------~~~w~~is~~ 268 (382)
T KOG0032|consen 239 WGETEFEIFLAILRGDFDFT--------------------------------------------------SEPWDDISES 268 (382)
T ss_pred cCCChhHHHHHHHcCCCCCC--------------------------------------------------CCCccccCHH
Confidence 99998888888888776555 4556778999
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+++|+++||..||.+|+|+.++|+|||++....
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 999999999999999999999999999988654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=267.34 Aligned_cols=195 Identities=28% Similarity=0.532 Sum_probs=166.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.||+|..++.. +.+++..++.++.|++.||+||| +.+++||||||
T Consensus 65 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH--------------~~~ivHrdlkp 129 (324)
T cd05589 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH--------------ENKIVYRDLKL 129 (324)
T ss_pred hceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEecCCCH
Confidence 4789999999999999999999999998865 46999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||.+.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 130 ~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 130 DNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred HHeEECCCCcEEeCcccCCccCCCCCC---cccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864322111 2335678999999999988888777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..+++.+.+|
T Consensus 206 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~~~~~~~l 231 (324)
T cd05589 206 EEEVFDSIVNDEVR------------------------------------------------------YPRFLSREAISI 231 (324)
T ss_pred HHHHHHHHHhCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 66655554433222 235678899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||+.||.+|| ++.++++||||+...
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=269.15 Aligned_cols=201 Identities=25% Similarity=0.425 Sum_probs=168.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||++||+|.+++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dlkp 129 (333)
T cd05600 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH--------------ELGYIHRDLKP 129 (333)
T ss_pred ccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 5788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++..... ......|+..|+|||++.+..++.. +|+|||||++|+|++|..||...+
T Consensus 130 ~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 130 ENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred HHEEECCCCCEEEEeCcCCccccc------ccCCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCC
Confidence 999999999999999999875432 2334568999999999988888877 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+.........+ . .......+++++.+|
T Consensus 203 ~~~~~~~i~~~~~~~~~~---------------------------------------~-------~~~~~~~~s~~~~~l 236 (333)
T cd05600 203 PNETWENLKYWKETLQRP---------------------------------------V-------YDDPRFNLSDEAWDL 236 (333)
T ss_pred HHHHHHHHHhccccccCC---------------------------------------C-------CCccccccCHHHHHH
Confidence 666555443321111000 0 000013468899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|.+||..+|++|++++++++||||+...
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=262.64 Aligned_cols=200 Identities=25% Similarity=0.404 Sum_probs=162.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+++||||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~iiH~di 128 (285)
T cd05631 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--------------RERIVYRDL 128 (285)
T ss_pred EEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEeCCC
Confidence 35778888899999999999999999888653 35899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.. +|+|||||++|+|++|+.||..
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 129 KPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987543221 1234568999999999998888877 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+...... .....+..++.++.
T Consensus 204 ~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~s~~~~ 233 (285)
T cd05631 204 RKERVKREEVDRRVKE--------------------------------------------------DQEEYSEKFSEDAK 233 (285)
T ss_pred CCcchhHHHHHHHhhc--------------------------------------------------ccccCCccCCHHHH
Confidence 5432211111110000 01223356788999
Q ss_pred HHHHHhcCCCCCcccc-----HHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIR-----LDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~~~ 269 (304)
+|+.+||+.||.+|++ ++++++||||++...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 9999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.39 Aligned_cols=195 Identities=27% Similarity=0.545 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+|+|.+++.+...+++..++.++.|++.||.||| +.+++||||||
T Consensus 61 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlkp 126 (318)
T cd05582 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH--------------SLGIIYRDLKP 126 (318)
T ss_pred ccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCCCH
Confidence 5789999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||...+
T Consensus 127 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 127 ENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred HHeEECCCCcEEEeeccCCcccCCCCC---ceecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCC
Confidence 999999999999999999875433211 2334578999999999988777776 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... .+..+++.+.+|
T Consensus 203 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~~~~~~~l 228 (318)
T cd05582 203 RKETMTMILKAKLG------------------------------------------------------MPQFLSPEAQSL 228 (318)
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 65555544433222 235578899999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
|.+||+.||++||| +.++++|+||+..
T Consensus 229 i~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999999 7789999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.45 Aligned_cols=196 Identities=27% Similarity=0.525 Sum_probs=165.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++.+++||||+.+|+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH--------------~~~ivHrDlkp 124 (330)
T cd05586 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH--------------KYDIVYRDLKP 124 (330)
T ss_pred cceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCCH
Confidence 4678889999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++|+|||++........ .....+|+..|+|||.+.+.. ++.. +|+|||||++|+|++|..||.+.
T Consensus 125 ~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~-~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 125 ENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTTEYLAPEVLLDEKGYTKH-VDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred HHeEECCCCCEEEecCCcCcCCCCCCC---CccCccCCccccCHHHHcCCCCCCCc-cceeccccEEEEeccCCCCCCCC
Confidence 999999999999999999864332221 234567899999999987654 5555 99999999999999999999887
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+..+....+ ...+++.+.+
T Consensus 201 ~~~~~~~~i~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 227 (330)
T cd05586 201 DTQQMYRNIAFGKVRFP-----------------------------------------------------KNVLSDEGRQ 227 (330)
T ss_pred CHHHHHHHHHcCCCCCC-----------------------------------------------------CccCCHHHHH
Confidence 76665555443322211 1246889999
Q ss_pred HHHHhcCCCCCccc----cHHHHhcCcccccc
Q psy1812 240 LVGQILEPDITKRI----RLDAIKAHDWLRYK 267 (304)
Q Consensus 240 ll~~~L~~dP~~R~----t~~ell~~~wf~~~ 267 (304)
||.+||+.||++|| ++.++++||||+..
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=267.65 Aligned_cols=204 Identities=29% Similarity=0.562 Sum_probs=162.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++..++||||+++|+|..++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~Dikp 124 (329)
T cd05618 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--------------ERGIIYRDLKL 124 (329)
T ss_pred CceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeCCCCH
Confidence 5789999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 125 ~Nili~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~ 200 (329)
T cd05618 125 DNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred HHEEECCCCCEEEeeCCccccccCCCC---ccccccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCC
Confidence 999999999999999999864322111 2234578999999999998888877 999999999999999999995321
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
...... . .........+.......+..++..+.+|
T Consensus 201 ~~~~~~---------~------------------------------------~~~~~~~~~i~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 201 SSDNPD---------Q------------------------------------NTEDYLFQVILEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CcCCcc---------c------------------------------------ccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 000000 0 0000000111112233456788999999
Q ss_pred HHHhcCCCCCcccc------HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR------LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t------~~ell~~~wf~~~ 267 (304)
|.+||+.||++|+| +.++++||||+..
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999998 5799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.35 Aligned_cols=196 Identities=27% Similarity=0.472 Sum_probs=176.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+|+++|++..++|+|+|||.| +|+.+|+..+.++|+.+..++.+++.||+||| +.+|.|+|+||
T Consensus 64 v~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh--------------s~rilhrd~kP 128 (808)
T KOG0597|consen 64 VEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH--------------SNRILHRDMKP 128 (808)
T ss_pred hhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------hcCcccccCCc
Confidence 5789999999999999999986 99999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
.|||++.+|.+|+||||+++..... ........||+.|+|||...+.+|+.. +|+||+||++||++.|+.||....
T Consensus 129 qniLl~~~~~~KlcdFg~Ar~m~~~---t~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 129 QNILLEKGGTLKLCDFGLARAMSTN---TSVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred ceeeecCCCceeechhhhhhhcccC---ceeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHH
Confidence 9999999999999999999865542 223456679999999999999999988 999999999999999999998888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......|...... .+...+..++.|
T Consensus 205 i~~Lv~~I~~d~v~------------------------------------------------------~p~~~S~~f~nf 230 (808)
T KOG0597|consen 205 ITQLVKSILKDPVK------------------------------------------------------PPSTASSSFVNF 230 (808)
T ss_pred HHHHHHHHhcCCCC------------------------------------------------------CcccccHHHHHH
Confidence 77777777655433 336789999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|+.+|..||.+|+|.-+++.|||.+..-.
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 99999999999999999999999887644
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.87 Aligned_cols=233 Identities=24% Similarity=0.371 Sum_probs=164.6
Q ss_pred CceeeeeeeC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRG-----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++... ...++||||+. ++|.+++.+.+.+++..++.++.|++.||.||| +.+++|
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH 126 (338)
T cd07859 62 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH--------------TANVFH 126 (338)
T ss_pred eeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH--------------HCCeec
Confidence 3456665432 35899999995 699999998888999999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|||||+||+++.++.+||+|||++.................++..|+|||++.+ ..++.+ +|+|||||++|+|++|+
T Consensus 127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~ 205 (338)
T cd07859 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGK 205 (338)
T ss_pred CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCC
Confidence 999999999999999999999998754322221112234578999999999865 456666 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+.......+..............+... ........... . ....+ ......+
T Consensus 206 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~----------~-----~~~~~-------~~~~~~~ 262 (338)
T cd07859 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNE-KARRYLSSMRK----------K-----QPVPF-------SQKFPNA 262 (338)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh-hHHHHHHhhcc----------c-----CCCch-------HHhcCCC
Confidence 999877655544433332222221111100000 00000000000 0 00000 0111346
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.++|.+||..||++|||++++++||||+......+
T Consensus 263 ~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~ 301 (338)
T cd07859 263 DPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301 (338)
T ss_pred ChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence 788999999999999999999999999999998776443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=268.94 Aligned_cols=195 Identities=28% Similarity=0.537 Sum_probs=167.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.||+|..++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~givH~Dlkp 124 (325)
T cd05604 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH--------------SINIVYRDLKP 124 (325)
T ss_pred ccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCCH
Confidence 5788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 125 ~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 125 ENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred HHeEECCCCCEEEeecCCcccCCCCCC---CcccccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCC
Confidence 999999999999999999864322111 2334578999999999988888877 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+...... .....+..+.++
T Consensus 201 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~l 226 (325)
T cd05604 201 VAEMYDNILHKPLV------------------------------------------------------LRPGASLTAWSI 226 (325)
T ss_pred HHHHHHHHHcCCcc------------------------------------------------------CCCCCCHHHHHH
Confidence 66665554433221 224578889999
Q ss_pred HHHhcCCCCCccccH----HHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRL----DAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~----~ell~~~wf~~~ 267 (304)
|.+||+.+|.+||++ .++++||||+..
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999999999977 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=265.87 Aligned_cols=195 Identities=31% Similarity=0.585 Sum_probs=167.4
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+...+.+++||||++||+|.+++...+.+++..++.++.|++.||+||| +.+++||||||+
T Consensus 65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH--------------~~~ivHrDikp~ 130 (323)
T cd05615 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH--------------RRGIIYRDLKLD 130 (323)
T ss_pred heeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCHH
Confidence 578889999999999999999999999998888999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+++.++.+||+|||++........ ......|+..|+|||++.+..++.. +|+||+||++|+|++|..||.+.+.
T Consensus 131 Nill~~~~~ikL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 131 NVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred HeEECCCCCEEEeccccccccCCCCc---cccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999864322211 2334568999999999988888777 9999999999999999999988776
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
......+...... .+..++..+.+++
T Consensus 207 ~~~~~~i~~~~~~------------------------------------------------------~p~~~~~~~~~li 232 (323)
T cd05615 207 DELFQSIMEHNVS------------------------------------------------------YPKSLSKEAVSIC 232 (323)
T ss_pred HHHHHHHHhCCCC------------------------------------------------------CCccCCHHHHHHH
Confidence 6666555443222 2356788999999
Q ss_pred HHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 242 GQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 242 ~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
.+||+.+|.+|++ .+++++||||+...
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999997 57999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=266.08 Aligned_cols=195 Identities=29% Similarity=0.528 Sum_probs=166.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.+.+.+..++||||++||+|..++.+...+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~ivH~Dlkp 124 (321)
T cd05603 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH--------------SLNIIYRDLKP 124 (321)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCCH
Confidence 5788999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 125 ~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 125 ENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred HHeEECCCCCEEEccCCCCccCCCCCC---ccccccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999864322211 2334568999999999988888877 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+...+..+.++
T Consensus 201 ~~~~~~~i~~~~~------------------------------------------------------~~~~~~~~~~~~l 226 (321)
T cd05603 201 VSQMYDNILHKPL------------------------------------------------------QLPGGKTVAACDL 226 (321)
T ss_pred HHHHHHHHhcCCC------------------------------------------------------CCCCCCCHHHHHH
Confidence 6555554443322 2235578899999
Q ss_pred HHHhcCCCCCccccH----HHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRL----DAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~----~ell~~~wf~~~ 267 (304)
|.+||+.||.+|+++ .++++|+||+..
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 999999999999975 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.86 Aligned_cols=206 Identities=29% Similarity=0.502 Sum_probs=174.5
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++|+|++ ...+.+|||.|+||+|+..++..+ .|+|.++..|++||..|+.||| +.+|.
T Consensus 118 V~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--------------~~nIA 183 (400)
T KOG0604|consen 118 VSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--------------SMNIA 183 (400)
T ss_pred EEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--------------hcchh
Confidence 456777765 467999999999999999999977 4999999999999999999999 89999
Q ss_pred ecCCCCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 75 HRDLKCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 75 H~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
||||||+|+|... +..+|++|||+++...... ...+.|-|+.|.|||++...+|+.. .|+||+||++|.|+-
T Consensus 184 HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~----~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 184 HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG----DLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLC 258 (400)
T ss_pred hccCChhheeeecCCCCcceEecccccccccCCCc----cccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhc
Confidence 9999999999965 4458999999998654322 3456788999999999998889888 899999999999999
Q ss_pred CCCCCCChh----HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 152 AAMPFDDSN----LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 152 g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|..||-... ...+..+|..+.+.|+ .
T Consensus 259 GyPPFYS~hg~aispgMk~rI~~gqy~FP--------------------------------------------------~ 288 (400)
T KOG0604|consen 259 GYPPFYSNHGLAISPGMKRRIRTGQYEFP--------------------------------------------------E 288 (400)
T ss_pred CCCcccccCCccCChhHHhHhhccCccCC--------------------------------------------------C
Confidence 999994432 2355677888888777 3
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccC
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVL 275 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~ 275 (304)
.-+..+|...+|+|+++|..+|.+|+|+.++++|||.++...+-...+
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 333567999999999999999999999999999999999887654443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=269.95 Aligned_cols=202 Identities=24% Similarity=0.452 Sum_probs=165.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++.+++||||+.||+|.+++.+.+.+++..++.++.|++.||+||| +.+++||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH--------------~~~ivH~Dlkp 129 (364)
T cd05599 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH--------------KLGYIHRDIKP 129 (364)
T ss_pred cceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCCH
Confidence 5789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc-----------------------------------cccccCccCCccccccc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR-----------------------------------RVLSRTYCGSAAYAAPE 125 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~PE 125 (304)
+||+++.++.++|+|||++......... .......+||+.|+|||
T Consensus 130 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred HHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 9999999999999999998643211100 00111346899999999
Q ss_pred cccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccc
Q psy1812 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 205 (304)
Q Consensus 126 ~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
++.+..++.+ +|+|||||++|+|++|..||.+.+.......+........
T Consensus 210 ~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------- 259 (364)
T cd05599 210 VFLQTGYNKE-CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ----------------------------- 259 (364)
T ss_pred HHcCCCCCCe-eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC-----------------------------
Confidence 9988888877 9999999999999999999988776555554433211110
Q ss_pred cccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc---HHHHhcCccccccc
Q psy1812 206 QVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR---LDAIKAHDWLRYKS 268 (304)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~ell~~~wf~~~~ 268 (304)
......+++++.+||.+||. +|.+|++ ++++++||||+...
T Consensus 260 ---------------------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 260 ---------------------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 01112468899999999997 9999998 99999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=260.14 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=160.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++..+...++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+++|+
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~ 121 (280)
T cd05608 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--------------QRRIIYR 121 (280)
T ss_pred eeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccC
Confidence 4677888889999999999999999988853 346899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.+ +|+|||||++|++++|+.||
T Consensus 122 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf 197 (280)
T cd05608 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPF 197 (280)
T ss_pred CCCHHHEEECCCCCEEEeeCccceecCCCCc---cccccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865433221 2234568899999999998888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...........+...... .....+..++.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~ 227 (280)
T cd05608 198 RARGEKVENKELKQRILN--------------------------------------------------DSVTYPDKFSPA 227 (280)
T ss_pred CCCCcchhHHHHHHhhcc--------------------------------------------------cCCCCcccCCHH
Confidence 754322111111111100 012233567899
Q ss_pred HHHHHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
+.+++.+||+.||++|+ |++++++||||+...
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 99999999999999999 889999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=256.55 Aligned_cols=187 Identities=29% Similarity=0.439 Sum_probs=160.9
Q ss_pred ceee-eeeeCCe-EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 2 QVHS-ILQRGPR-VFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 2 ~~~~-~~~~~~~-~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
++|+ .|.+++. ++||||||.+|+|.+.|++. +.++|..+|.++.|++.||+++|..+. ..-|.|
T Consensus 82 qYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~----------r~~VmH 151 (375)
T KOG0591|consen 82 QYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP----------RGTVMH 151 (375)
T ss_pred HHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc----------ccceee
Confidence 4444 4445544 99999999999999999763 469999999999999999999994211 133999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||.||+++.+|.+|++|||+++.+..... ...+.+||+.||+||.+...+|+.+ |||||+||++|||+.-+.|
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t---fA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~P 227 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTT---FAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSP 227 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhcchhH---HHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999987665432 5677899999999999999999999 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc-cccc
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK-DILS 234 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (304)
|.+.+..++..+|.++.++. .| ..+|
T Consensus 228 F~g~n~~~L~~KI~qgd~~~-----------------------------------------------------~p~~~YS 254 (375)
T KOG0591|consen 228 FYGDNLLSLCKKIEQGDYPP-----------------------------------------------------LPDEHYS 254 (375)
T ss_pred cccccHHHHHHHHHcCCCCC-----------------------------------------------------CcHHHhh
Confidence 99999999999999886542 22 5579
Q ss_pred HHHHHHHHHhcCCCCCccccH
Q psy1812 235 HQVKNLVGQILEPDITKRIRL 255 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~ 255 (304)
.++..++..|++.||..||+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc
Confidence 999999999999999999985
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=266.24 Aligned_cols=195 Identities=30% Similarity=0.586 Sum_probs=166.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.||+|.+++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~giiHrDlkp 124 (325)
T cd05602 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH--------------SLNIVYRDLKP 124 (325)
T ss_pred CceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 5788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 125 ~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 125 ENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred HHeEECCCCCEEEccCCCCcccccCCC---CcccccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCC
Confidence 999999999999999999864322211 2335578999999999988888777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+..... ..+..+++.+.++
T Consensus 201 ~~~~~~~i~~~~~------------------------------------------------------~~~~~~~~~~~~l 226 (325)
T cd05602 201 TAEMYDNILNKPL------------------------------------------------------QLKPNITNSARHL 226 (325)
T ss_pred HHHHHHHHHhCCc------------------------------------------------------CCCCCCCHHHHHH
Confidence 6665554443222 1225678899999
Q ss_pred HHHhcCCCCCccccHH----HHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLD----AIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~----ell~~~wf~~~ 267 (304)
|.+||+.||.+|+++. ++++|+||...
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.29 Aligned_cols=196 Identities=29% Similarity=0.591 Sum_probs=162.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+...+.+++||||++||+|.+++...+.+++..++.++.|++.||+||| +.+++||||||
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH--------------~~~ivHrDlkp 124 (327)
T cd05617 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH--------------ERGIIYRDLKL 124 (327)
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCH
Confidence 4688999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|+..|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 125 ~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 125 DNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred HHEEEeCCCCEEEeccccceeccCCCC---ceecccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccC
Confidence 999999999999999999864222111 2334678999999999988888777 999999999999999999995321
Q ss_pred H-------HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 161 L-------KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 161 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
. ......+. ......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~------------------------------------------------------~~~~~~p~~~ 226 (327)
T cd05617 201 DNPDMNTEDYLFQVIL------------------------------------------------------EKPIRIPRFL 226 (327)
T ss_pred CCcccccHHHHHHHHH------------------------------------------------------hCCCCCCCCC
Confidence 1 11111111 1112334567
Q ss_pred cHHHHHHHHHhcCCCCCcccc------HHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIR------LDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t------~~ell~~~wf~~~~ 268 (304)
+..+.++|.+||+.||.+|++ ++++++||||+...
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 889999999999999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=269.49 Aligned_cols=202 Identities=28% Similarity=0.507 Sum_probs=167.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+.+|+|.+++.+.+.+++..++.++.|++.||+||| ..+++||||||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~giiH~Dlkp 129 (350)
T cd05573 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH--------------KLGFIHRDIKP 129 (350)
T ss_pred cchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCH
Confidence 4678889999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcc--------------------------cccccccCccCCccccccccccCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKE--------------------------GRRVLSRTYCGSAAYAAPEVISGNPYNP 134 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 134 (304)
+||+++.++.+||+|||++....... ..........|+..|+|||++.+..++.
T Consensus 130 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (350)
T cd05573 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL 209 (350)
T ss_pred HHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 99999999999999999987544322 0011223456899999999999888887
Q ss_pred CCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhh
Q psy1812 135 KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILS 214 (304)
Q Consensus 135 ~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (304)
. +|+|||||++|+|++|..||...+......++........
T Consensus 210 ~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------------- 250 (350)
T cd05573 210 E-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR-------------------------------------- 250 (350)
T ss_pred c-eeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc--------------------------------------
Confidence 7 9999999999999999999988776555555443111100
Q ss_pred hhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc-HHHHhcCccccccc
Q psy1812 215 HQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR-LDAIKAHDWLRYKS 268 (304)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-~~ell~~~wf~~~~ 268 (304)
......+++++.+||.+||. ||.+|++ ++++++||||+...
T Consensus 251 ------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 251 ------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 01112368999999999998 9999999 99999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.82 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=164.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.|.+++.+++|||||++|+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH--------------~~~ivHrDlKp 129 (382)
T cd05625 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH--------------KMGFIHRDIKP 129 (382)
T ss_pred CeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 5789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc--------------------------------------------ccccccCcc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG--------------------------------------------RRVLSRTYC 116 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~--------------------------------------------~~~~~~~~~ 116 (304)
+|||++.++.+||+|||++..+..... ........+
T Consensus 130 ~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209 (382)
T ss_pred HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 999999999999999999743210000 000112346
Q ss_pred CCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhh
Q psy1812 117 GSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQ 196 (304)
Q Consensus 117 ~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+..+...++........
T Consensus 210 gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 268 (382)
T cd05625 210 GTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------- 268 (382)
T ss_pred cCcccCCHHHhcCCCCCCe-eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------------------
Confidence 8999999999998888877 9999999999999999999987766555444433211111
Q ss_pred hcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc---HHHHhcCccccccc
Q psy1812 197 VKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR---LDAIKAHDWLRYKS 268 (304)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~ell~~~wf~~~~ 268 (304)
......+++++.++|.+|+ .+|.+|++ ++++++||||+...
T Consensus 269 ------------------------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 269 ------------------------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred ------------------------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 1111457889999999987 59999997 99999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=268.53 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=164.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++..++||||++||+|.+++.+. .+++..+..++.|++.||+||| +.+|+||||||
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDLkp 170 (370)
T cd05596 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH--------------SMGFIHRDVKP 170 (370)
T ss_pred ceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCH
Confidence 56889999999999999999999999998764 5899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++........ ......+|++.|+|||++.+.. ++.. +|+|||||++|+|++|..||
T Consensus 171 ~NILl~~~~~~kL~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 171 DNMLLDKSGHLKLADFGTCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCc-eeeeehhHHHHHHHhCCCCc
Confidence 999999999999999999875432211 1223457999999999986543 4555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+....+.++........ ......++.+
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~ 277 (370)
T cd05596 248 YADSLVGTYSKIMDHKNSLT--------------------------------------------------FPDDIEISKQ 277 (370)
T ss_pred CCCCHHHHHHHHHcCCCcCC--------------------------------------------------CCCcCCCCHH
Confidence 88777666665544321111 0011246899
Q ss_pred HHHHHHHhcCCCCCc--cccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITK--RIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~~ 268 (304)
+.+||++||..+|++ |+|++++++||||++..
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 999999999999988 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.37 Aligned_cols=201 Identities=22% Similarity=0.401 Sum_probs=162.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++..|+||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH--------------~~givHrDlkp 129 (377)
T cd05629 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH--------------KLGFIHRDIKP 129 (377)
T ss_pred ceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCH
Confidence 5789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc----------c----------------------------------ccccCcc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR----------R----------------------------------VLSRTYC 116 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~----------~----------------------------------~~~~~~~ 116 (304)
+||+++.++.+||+|||+++.+...... . ......+
T Consensus 130 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred HHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 9999999999999999998532211000 0 0001246
Q ss_pred CCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhh
Q psy1812 117 GSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQ 196 (304)
Q Consensus 117 ~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+..+.+..+........
T Consensus 210 gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 268 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY-------------------- 268 (377)
T ss_pred CCccccCHHHHccCCCCCc-eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--------------------
Confidence 8999999999988888877 9999999999999999999987766555555443211100
Q ss_pred hcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcc---ccHHHHhcCcccccc
Q psy1812 197 VKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKR---IRLDAIKAHDWLRYK 267 (304)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R---~t~~ell~~~wf~~~ 267 (304)
......++.++.+||.+||. +|.+| +|+.++++||||++.
T Consensus 269 ------------------------------~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 269 ------------------------------FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 00012468899999999998 77775 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=268.90 Aligned_cols=203 Identities=25% Similarity=0.377 Sum_probs=162.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.+.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| ..+|+||||||
T Consensus 64 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH--------------~~givHrDlKp 129 (381)
T cd05626 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH--------------KMGFIHRDIKP 129 (381)
T ss_pred eeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecCCcH
Confidence 5789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc--------------------------------------------ccccccCcc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG--------------------------------------------RRVLSRTYC 116 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~--------------------------------------------~~~~~~~~~ 116 (304)
+||+++.++.+||+|||++..+..... ........+
T Consensus 130 ~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (381)
T cd05626 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209 (381)
T ss_pred HHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence 999999999999999998753210000 000112357
Q ss_pred CCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhh
Q psy1812 117 GSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQ 196 (304)
Q Consensus 117 ~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
||..|+|||++.+..++.+ +|+|||||++|+|++|..||...+.......+........
T Consensus 210 gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 268 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQL-CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------- 268 (381)
T ss_pred CCccccCHHHHcCCCCCCc-cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC--------------------
Confidence 9999999999988888877 9999999999999999999987765544444332111110
Q ss_pred hcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcC--CCCCccccHHHHhcCccccccc
Q psy1812 197 VKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILE--PDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~--~dP~~R~t~~ell~~~wf~~~~ 268 (304)
......+++++.+||.+|+. .++..|++++++++||||+...
T Consensus 269 ------------------------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 269 ------------------------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 11113478999999999664 4555599999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=273.60 Aligned_cols=234 Identities=20% Similarity=0.267 Sum_probs=167.0
Q ss_pred ceeeeeeeC-CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCC
Q psy1812 2 QVHSILQRG-PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLK 79 (304)
Q Consensus 2 ~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~ 79 (304)
+++++|..+ +++++|||++ |++|.+++.+.+.+++..++.++.|++.||.||| . .+|+|||||
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--------------~~~gIiHrDlK 259 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--------------TELHLMHTDLK 259 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hcCCeecCCCC
Confidence 566777654 5899999998 7799999998888999999999999999999999 6 699999999
Q ss_pred CCcEEEecCC----------------CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 80 CENILMTKRF----------------NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 80 ~~nil~~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
|+|||++.++ .+||+|||.+..... .....+|+..|+|||++.+..++.+ +||||||
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlG 332 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMG 332 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcH-HHHHHHH
Confidence 9999998765 489999998753211 2335678999999999999888877 9999999
Q ss_pred HHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 144 VITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 144 ~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
|++|+|++|+.||.+.+..+....+....+.++..+...... ......+........+ .....+..+.
T Consensus 333 vil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~~ 400 (467)
T PTZ00284 333 CIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGT-EEARLLYNSAGQLRPC-----------TDPKHLARIA 400 (467)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccc-hhHHHHhhhccccccc-----------CCHHHHHhhh
Confidence 999999999999988877766666665555544322211100 0001111111000000 0000011111
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..........++.+.|||.+||.+||++|||++|+|+||||+....
T Consensus 401 ~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 401 RARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred cccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 1000000112567899999999999999999999999999987654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=266.82 Aligned_cols=200 Identities=24% Similarity=0.422 Sum_probs=163.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+.+++..++||||+++|+|.+++.+. +.+++..++.++.|++.||.||| +.+++|||||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH--------------~~~i~H~Dlk 129 (330)
T cd05601 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH--------------QMGYVHRDIK 129 (330)
T ss_pred cceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEcccCc
Confidence 46788899999999999999999999999886 67999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc------CCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS------GNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||+++.++.+||+|||++......... ......|+..|+|||++. +..++.. +|+|||||++|+|++|.
T Consensus 130 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~ 206 (330)
T cd05601 130 PENVLIDRTGHIKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGR 206 (330)
T ss_pred hHheEECCCCCEEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCC
Confidence 99999999999999999999755432211 223446899999999986 3345555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||...+....+..+........ ......+
T Consensus 207 ~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~ 236 (330)
T cd05601 207 SPFHEGTSAKTYNNIMNFQRFLK--------------------------------------------------FPEDPKV 236 (330)
T ss_pred CCCCCCCHHHHHHHHHcCCCccC--------------------------------------------------CCCCCCC
Confidence 99987766555554443211000 0111357
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
++.+.+||.+||. +|.+|||+.++++||||+...
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 8899999999998 999999999999999998643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=269.85 Aligned_cols=201 Identities=25% Similarity=0.422 Sum_probs=162.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.|.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivHrDlkp 129 (376)
T cd05598 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH--------------KMGFIHRDIKP 129 (376)
T ss_pred ceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCCCCH
Confidence 5789999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc----------------------------------------ccccccCccCCcc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG----------------------------------------RRVLSRTYCGSAA 120 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~ 120 (304)
+||+++.++.+||+|||++..+..... ........+|++.
T Consensus 130 ~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred HHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 999999999999999999742210000 0001123468999
Q ss_pred ccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhccc
Q psy1812 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVK 200 (304)
Q Consensus 121 ~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (304)
|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+..+....+........
T Consensus 210 y~aPE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------------ 264 (376)
T cd05598 210 YIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH------------------------ 264 (376)
T ss_pred ccCHHHHcCCCCCcc-eeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc------------------------
Confidence 999999988888877 9999999999999999999987765544443332211110
Q ss_pred ccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccc---cHHHHhcCcccccc
Q psy1812 201 DILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI---RLDAIKAHDWLRYK 267 (304)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~ell~~~wf~~~ 267 (304)
......+++++.+||.+|+ .+|.+|+ |+.++++||||+..
T Consensus 265 --------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 265 --------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 1111357889999999987 5999999 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.84 Aligned_cols=189 Identities=24% Similarity=0.428 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|+++..++.++||||||+.|+|.+||+. ++.+...+...++.||++|++||+ ++++|||||
T Consensus 264 V~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--------------s~~~IHRDL 329 (468)
T KOG0197|consen 264 VKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--------------SKNYIHRDL 329 (468)
T ss_pred EEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--------------hCCccchhh
Confidence 6899999999899999999999999999997 447999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
-+.||||+.+..+||+|||+++...+..-. ......-++.|.|||.+..++++.+ ||||||||+++|++| |+.||.
T Consensus 330 AARNiLV~~~~~vKIsDFGLAr~~~d~~Y~--~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 330 AARNILVDEDLVVKISDFGLARLIGDDEYT--ASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred hhhheeeccCceEEEcccccccccCCCcee--ecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCC
Confidence 999999999999999999999954332211 2223335688999999999999999 999999999999999 999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....+.+..+.++..-. .|..+++.+
T Consensus 407 ~msn~ev~~~le~GyRlp-----------------------------------------------------~P~~CP~~v 433 (468)
T KOG0197|consen 407 GMSNEEVLELLERGYRLP-----------------------------------------------------RPEGCPDEV 433 (468)
T ss_pred CCCHHHHHHHHhccCcCC-----------------------------------------------------CCCCCCHHH
Confidence 999999999888876533 357899999
Q ss_pred HHHHHHhcCCCCCccccHHHHh
Q psy1812 238 KNLVGQILEPDITKRIRLDAIK 259 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell 259 (304)
-++|..||+.+|++|||++.+.
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999998664
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=259.26 Aligned_cols=228 Identities=21% Similarity=0.319 Sum_probs=159.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.++...++||||+. ++|.+++... +.+++..++.++.|++.||+||| +.+|+|+|||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivH~dlk 130 (303)
T cd07869 66 VLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH--------------QRYILHRDLK 130 (303)
T ss_pred CeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 578999999999999999996 6898888764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||++.+.. ++.. +|+||+||++|+|++|..||.+
T Consensus 131 p~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 131 PQNLLISDTGELKLADFGLARAKSVPSH---TYSNEVVTLWYRPPDVLLGSTEYSTC-LDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred HHHEEECCCCCEEECCCCcceeccCCCc---cCCCCcccCCCCChHHHcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864322111 223456789999999987654 4555 9999999999999999999976
Q ss_pred hhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 159 SNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
.... .....+........... +......... .+..........+... .....+++.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~----~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 264 (303)
T cd07869 207 MKDIQDQLERIFLVLGTPNEDT-------------WPGVHSLPHF----KPERFTLYSPKNLRQA-----WNKLSYVNHA 264 (303)
T ss_pred CccHHHHHHHHHHHhCCCChhh-------------ccchhhcccc----ccccccccCCccHHHH-----hhccCCChHH
Confidence 5332 22222221111111000 0000000000 0000000000000000 0012356789
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+|+.+||+.||++|||++|+++||||++...
T Consensus 265 ~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 265 EDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred HHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.37 Aligned_cols=202 Identities=24% Similarity=0.434 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH--------------~~givHrDLkp 129 (360)
T cd05627 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH--------------QLGFIHRDIKP 129 (360)
T ss_pred eeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEccCCCH
Confidence 4688999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc--------------------------------ccccccCccCCcccccccccc
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG--------------------------------RRVLSRTYCGSAAYAAPEVIS 128 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~PE~~~ 128 (304)
+||+++.++.++|+|||++........ ........+|++.|+|||++.
T Consensus 130 ~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred HHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 999999999999999999864321100 000112356899999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhccccccccccc
Q psy1812 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVK 208 (304)
Q Consensus 129 ~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (304)
+..++.. +|+|||||++|+|++|..||.+.+......++........
T Consensus 210 ~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------- 256 (360)
T cd05627 210 QTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV-------------------------------- 256 (360)
T ss_pred CCCCCCc-ceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee--------------------------------
Confidence 8888877 9999999999999999999988776666555543211100
Q ss_pred ccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccc---cHHHHhcCccccccc
Q psy1812 209 VKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI---RLDAIKAHDWLRYKS 268 (304)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~ell~~~wf~~~~ 268 (304)
......++.++++||.+|+. ||.+|+ +++++++||||++..
T Consensus 257 ------------------~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 257 ------------------FPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred ------------------cCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 00012368899999999874 999999 479999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.24 Aligned_cols=196 Identities=33% Similarity=0.590 Sum_probs=178.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.|+.-.++|+||||+.||+|.-+|++-+.|.|..+..++.+|+-||-+|| ++||++||||.
T Consensus 413 ~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh--------------~kgIiYRDLKL 478 (683)
T KOG0696|consen 413 VQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH--------------SKGIIYRDLKL 478 (683)
T ss_pred HHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh--------------cCCeeeeeccc
Confidence 4678889999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.+|.+||.|||+++.-.-.. ....++|||+.|+|||++...+|+.+ +|+||+||++|||+.|+.||.+.+
T Consensus 479 DNvmLd~eGHiKi~DFGmcKEni~~~---~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 479 DNVMLDSEGHIKIADFGMCKENIFDG---VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred cceEeccCCceEeeecccccccccCC---cceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999997432222 25678999999999999999999988 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..++++.|+.....++ +.+|.++.++
T Consensus 555 E~elF~aI~ehnvsyP------------------------------------------------------KslSkEAv~i 580 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYP------------------------------------------------------KSLSKEAVAI 580 (683)
T ss_pred HHHHHHHHHHccCcCc------------------------------------------------------ccccHHHHHH
Confidence 9999999887766555 8899999999
Q ss_pred HHHhcCCCCCccccH-----HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL-----DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-----~ell~~~wf~~~~ 268 (304)
...+|...|.+|+.. +++-.||||+..-
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 999999999999953 6899999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=259.52 Aligned_cols=241 Identities=21% Similarity=0.348 Sum_probs=166.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++|+|.+++.+...+++..+..++.|++.||.|||+ ..+++|+||||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-------------~~~ivH~dlkp 132 (331)
T cd06649 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE-------------KHQIMHRDVKP 132 (331)
T ss_pred CeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-------------cCCEEcCCCCh
Confidence 57899999999999999999999999999988889999999999999999999992 24699999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++...... ......|+..|+|||.+.+..++.+ +|+|||||++|++++|+.||...+
T Consensus 133 ~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 133 SNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred hhEEEcCCCcEEEccCccccccccc-----ccccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998654322 2234568999999999988888877 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhccccccc-ccccccchhhhhhhhhhhhhcc--ccccccccHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILS-HQVKVKDILSHQVKLKDILSHQ--VKVKDILSHQV 237 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 237 (304)
..+....+................ .. ......... .................+.... ......+++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (331)
T cd06649 207 AKELEAIFGRPVVDGEEGEPHSIS----PR-----PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDF 277 (331)
T ss_pred HHHHHHHhcccccccccCCccccC----cc-----cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHH
Confidence 443322211110000000000000 00 000000000 0000000000000111111110 11123478899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||.+||++|||++++++||||+....
T Consensus 278 ~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 278 QEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 99999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=261.37 Aligned_cols=190 Identities=26% Similarity=0.401 Sum_probs=161.6
Q ss_pred CceeeeeeeCC-eEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc-eEec
Q psy1812 1 MQVHSILQRGP-RVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN-IAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~-ivH~ 76 (304)
|++++++.+.. .++|||||+++|+|.+++.. .+.++...+..++.||+.|++||| +.+ ||||
T Consensus 102 V~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--------------~~~~iIHr 167 (362)
T KOG0192|consen 102 VQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--------------SEGPIIHR 167 (362)
T ss_pred eeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--------------cCCCeeec
Confidence 57899999887 89999999999999999988 578999999999999999999999 778 9999
Q ss_pred CCCCCcEEEecCC-CeEEEeccCcccccCcccccccccCccCCcccccccccc--CCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 77 DLKCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--GNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 77 dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|||++|||++.++ ++||+|||+++....... ......||..|+|||++. ...++.+ +||||||+++|||++|.
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~---~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISKT---SMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGE 243 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeeccccc---cccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCC
Confidence 9999999999997 999999999976543321 233367999999999999 5578888 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+....+....+...... ...+..+
T Consensus 244 ~Pf~~~~~~~~~~~v~~~~~R----------------------------------------------------p~~p~~~ 271 (362)
T KOG0192|consen 244 IPFEDLAPVQVASAVVVGGLR----------------------------------------------------PPIPKEC 271 (362)
T ss_pred CCCCCCCHHHHHHHHHhcCCC----------------------------------------------------CCCCccC
Confidence 999888875555544433222 1223458
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
++.+..+|..||..||.+||++.+++.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 899999999999999999999988876
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.26 Aligned_cols=232 Identities=21% Similarity=0.295 Sum_probs=164.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|..+...++|||++. ++|..++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 146 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH--------------~~~IvHrDiKP 210 (391)
T PHA03212 146 IQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH--------------ENRIIHRDIKA 210 (391)
T ss_pred CCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCCh
Confidence 678999999999999999995 699999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~ 287 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDINAN--KYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKD 287 (391)
T ss_pred HhEEEcCCCCEEEEeCCccccccccccc--ccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcc
Confidence 9999999999999999998643322111 2334579999999999988888877 999999999999999998774321
Q ss_pred -------HHHHHHHhhhccccccchhhhhhhhhhhHHHHh-hhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 161 -------LKQLFKEQTSNILSHQVKVKDILSHQVKVKDIL-SHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 161 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.......+.......+..... .......... ........ .....+.+..+ ..
T Consensus 288 ~~~~~~~~~~~l~~i~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~--------~~ 347 (391)
T PHA03212 288 GLDGDCDSDRQIKLIIRRSGTHPNEFPI--DAQANLDEIYIGLAKKSSR----------KPGSRPLWTNL--------YE 347 (391)
T ss_pred cccccCchhHHHHHHHHHhcCChhhcCc--chhHHHHHHHHHHHhccCC----------CCCCCCCHHHH--------hh
Confidence 122233333322222210000 0000000000 00000000 00000001101 23
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
++.++.+||.+||++||.+|||++|+|+||||+....+
T Consensus 348 ~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 348 LPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 56789999999999999999999999999999886543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=265.20 Aligned_cols=199 Identities=27% Similarity=0.447 Sum_probs=162.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++.+++||||++||+|.+++... .+++..+..++.|++.||+||| +.+|+||||||
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH--------------~~~IvHrDLKp 170 (370)
T cd05621 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIH--------------SMGLIHRDVKP 170 (370)
T ss_pred eeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCH
Confidence 57889999999999999999999999999764 5899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++........ .......|++.|+|||++.+.. ++.. +|+||+||++|+|++|..||
T Consensus 171 ~NILl~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~-~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 171 DNMLLDKHGHLKLADFGTCMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred HHEEECCCCCEEEEecccceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcc-cCEEeehHHHHHHHhCCCCC
Confidence 999999999999999999875432221 1234567999999999987543 4455 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+....+.++........ ......++..
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~p~~~~~s~~ 277 (370)
T cd05621 248 YADSLVGTYSKIMDHKNSLN--------------------------------------------------FPEDVEISKH 277 (370)
T ss_pred CCCCHHHHHHHHHhCCcccC--------------------------------------------------CCCcccCCHH
Confidence 88776666655543321111 0011246889
Q ss_pred HHHHHHHhcCCCCCc--cccHHHHhcCcccccc
Q psy1812 237 VKNLVGQILEPDITK--RIRLDAIKAHDWLRYK 267 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~ 267 (304)
+++++.+||..++.+ |+|+.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865544 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.88 Aligned_cols=199 Identities=27% Similarity=0.501 Sum_probs=167.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++.+..++.++|||||++||+|.+++.. ..++++..+..++.|++.||.||| +.+|+||
T Consensus 128 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------------~~~ivHr 193 (478)
T PTZ00267 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--------------SRKMMHR 193 (478)
T ss_pred eEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEEC
Confidence 5789999999999999999999999998864 346899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||||+||+++.++.+||+|||++........ .......+|++.|+|||++.+..++.+ +|+|||||++|+|++|..||
T Consensus 194 Dlkp~NIll~~~~~~kL~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf 271 (478)
T PTZ00267 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPF 271 (478)
T ss_pred CcCHHhEEECCCCcEEEEeCcCceecCCccc-cccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999976543221 112345578999999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..+... ..+..++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~s~~ 298 (478)
T PTZ00267 272 KGPSQREIMQQVLYGKYD-----------------------------------------------------PFPCPVSSG 298 (478)
T ss_pred CCCCHHHHHHHHHhCCCC-----------------------------------------------------CCCccCCHH
Confidence 887766655554433221 112457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.+||.+||..||++|||+++++.|+|++...
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~ 330 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKYVA 330 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999997643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=254.26 Aligned_cols=217 Identities=23% Similarity=0.312 Sum_probs=162.4
Q ss_pred Cceeeeee-----eCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQ-----RGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++. ....+++||||+. ++|.+++... ..+++..++.++.|++.||.||| +.++
T Consensus 67 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~i 131 (290)
T cd07862 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--------------SHRV 131 (290)
T ss_pred ceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCe
Confidence 46677764 3457999999997 5999999764 35899999999999999999999 8999
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+|||||++|+|++|.
T Consensus 132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~ 206 (290)
T cd07862 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 206 (290)
T ss_pred eeCCCCHHHEEEcCCCCEEEccccceEeccCCc----ccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCC
Confidence 999999999999999999999999987543321 2334568999999999988888877 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+...++........... +..... ... .... ......+.. ....+
T Consensus 207 ~~f~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~----~~~---~~~~----~~~~~~~~~-------~~~~~ 259 (290)
T cd07862 207 PLFRGSSDVDQLGKILDVIGLPGEED---------WPRDVA----LPR---QAFH----SKSAQPIEK-------FVTDI 259 (290)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhh---------chhhhc----ccc---hhcc----CCCCCCHHH-------HccCC
Confidence 99988877776666654432211000 000000 000 0000 000011111 11347
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+..+.+|+.+||+.||++|||+.++|+||||
T Consensus 260 ~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 260 DELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=247.84 Aligned_cols=197 Identities=28% Similarity=0.453 Sum_probs=162.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..+...++|+||+++++|.+++...+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 67 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~i~H~dl~p 132 (263)
T cd06625 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH--------------SNMIVHRDIKG 132 (263)
T ss_pred eeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 4788999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++.................++..|+|||.+.+..++.+ +|+||||+++|++++|+.||...+
T Consensus 133 ~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred HHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999998754332211111133457789999999988877776 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... ...+..++..+.++
T Consensus 212 ~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~l 239 (263)
T cd06625 212 AMAAIFKIATQPTN----------------------------------------------------PQLPSHVSPDARNF 239 (263)
T ss_pred hHHHHHHHhccCCC----------------------------------------------------CCCCccCCHHHHHH
Confidence 44333322211100 12335678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|.+||..+|++|||+.++++|+||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=253.11 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=162.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dl 128 (285)
T cd05605 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--------------RERIVYRDL 128 (285)
T ss_pred eeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcEecCC
Confidence 46788888899999999999999999988654 35899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.. +|+||+||++|++++|..||.+
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 129 KPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCCC----ccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987543221 1234468899999999988878777 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+....... ....+..++..+.
T Consensus 204 ~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~ 233 (285)
T cd05605 204 RKEKVKREEVERRVKED--------------------------------------------------QEEYSEKFSEAAR 233 (285)
T ss_pred CchhhHHHHHHHHhhhc--------------------------------------------------ccccCcccCHHHH
Confidence 55432222221111100 1223355788999
Q ss_pred HHHHHhcCCCCCccc-----cHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRI-----RLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~~ 269 (304)
+|+.+||..||.+|| +++++++||||+....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 999999999999999 9999999999997544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=249.26 Aligned_cols=220 Identities=30% Similarity=0.461 Sum_probs=178.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++.++|+++.++|+|||-|+||.|..+|++...|+|.++..+.++|+.||.+|| .+||.|||+||
T Consensus 139 lqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH--------------~kgIAHRDlKP 204 (463)
T KOG0607|consen 139 LQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH--------------TKGIAHRDLKP 204 (463)
T ss_pred HHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh--------------hcCcccccCCc
Confidence 3578899999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCC---eEEEeccCcccccCcccc----cccccCccCCcccccccccc----CCCCCCCCchHHHHHHHHHHH
Q psy1812 81 ENILMTKRFN---VKIADFGFARYCVDKEGR----RVLSRTYCGSAAYAAPEVIS----GNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 81 ~nil~~~~~~---~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~----~~~~~~~~sDvwslG~ll~~l 149 (304)
+|||...... +||+||.+..-......- .....+.+|+..|||||+.. ...+..+..|+||||||+|.|
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 9999976544 799999987532111110 01123567999999999963 222334449999999999999
Q ss_pred HhCCCCCCCh---------------hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhh
Q psy1812 150 LNAAMPFDDS---------------NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILS 214 (304)
Q Consensus 150 l~g~~pf~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (304)
|.|..||.+. -+..+|..|..+.++++
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP-------------------------------------- 326 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP-------------------------------------- 326 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCC--------------------------------------
Confidence 9999999654 34566777888888877
Q ss_pred hhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCCceeccCcc
Q psy1812 215 HQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSNLS 286 (304)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~~~~~~~~~ 286 (304)
-.-+..++.+.+|++..+|..|+..|.++.++++|||++..... +.++.+..+.++.+
T Consensus 327 ------------dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e--kalptp~v~~r~~s 384 (463)
T KOG0607|consen 327 ------------DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE--KALPTPQVLQRNSS 384 (463)
T ss_pred ------------hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh--ccCCCCcccccCcc
Confidence 22235689999999999999999999999999999999998763 56666666655543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=250.20 Aligned_cols=194 Identities=25% Similarity=0.483 Sum_probs=159.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.|..++..++||||+++++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 137 (267)
T PHA03390 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH--------------KHNIIHNDIKL 137 (267)
T ss_pred EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCCCH
Confidence 4788999999999999999999999999988888999999999999999999999 88999999999
Q ss_pred CcEEEecCC-CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++ .++++|||++...... ....++..|+|||.+.+..++.+ +|+||+|++++++++|..||...
T Consensus 138 ~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 138 ENVLYDRAKDRIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred HHEEEeCCCCeEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999998 9999999998654321 23457889999999988888777 99999999999999999999754
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
............... .....++.+++.+.+
T Consensus 210 ~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 210 EDEELDLESLLKRQQ--------------------------------------------------KKLPFIKNVSKNAND 239 (267)
T ss_pred CcchhhHHHHHHhhc--------------------------------------------------ccCCcccccCHHHHH
Confidence 322111000000000 012223467899999
Q ss_pred HHHHhcCCCCCcccc-HHHHhcCccccc
Q psy1812 240 LVGQILEPDITKRIR-LDAIKAHDWLRY 266 (304)
Q Consensus 240 ll~~~L~~dP~~R~t-~~ell~~~wf~~ 266 (304)
||.+||+.+|.+|++ ++++|+||||++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999996 599999999974
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.62 Aligned_cols=201 Identities=30% Similarity=0.542 Sum_probs=169.6
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|+++++.++ .+.+|||+|||..|.+..- ...++ +++.+++.++++++.||+||| ..||+|||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH--------------~QgiiHRD 235 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH--------------YQGIIHRD 235 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH--------------hcCeeccc
Confidence 688999986 5689999999999887432 23344 999999999999999999999 99999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcc--cccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKE--GRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g 152 (304)
|||+|+|++.+|.+||+|||.+..+.... ..........||+.|+|||.+.+ ..++..+.||||+||.+|.++.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999999999999987552111 11111223579999999999987 44667779999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
+.||.+....+.+.+|.+.-+.++. .+.
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~----------------------------------------------------~pe 343 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPE----------------------------------------------------NPE 343 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCC----------------------------------------------------ccc
Confidence 9999999999999999988777661 124
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+...++|||.+||..||++|++..++..|||....-
T Consensus 344 ~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 344 INEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred ccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 688999999999999999999999999999998773
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.07 Aligned_cols=200 Identities=27% Similarity=0.426 Sum_probs=163.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++..++||||++||+|.+++... .+++..++.++.|++.||+||| +.+|+||||||
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDLkp 170 (371)
T cd05622 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIH--------------SMGFIHRDVKP 170 (371)
T ss_pred CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--------------HCCEEeCCCCH
Confidence 57889999999999999999999999999764 5899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++......... .....+|++.|+|||++.+.. ++.+ +|+|||||++|+|++|..||
T Consensus 171 ~NIll~~~~~ikL~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 171 DNMLLDKSGHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred HHEEECCCCCEEEEeCCceeEcCcCCcc--cccCcccCccccCHHHHhccCCCccCCCc-cceeehhHHHHHHHhCCCCC
Confidence 9999999999999999998754322211 234567999999999987543 4455 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+....+.++........ ......++..
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~ 277 (371)
T cd05622 248 YADSLVGTYSKIMNHKNSLT--------------------------------------------------FPDDNDISKE 277 (371)
T ss_pred CCCCHHHHHHHHHcCCCccc--------------------------------------------------CCCcCCCCHH
Confidence 88877666666654322111 0111357899
Q ss_pred HHHHHHHhcCCCCCc--cccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITK--RIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~~ 268 (304)
+++||.+||..++.+ |++++++++|+||++..
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 999999999844433 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=253.43 Aligned_cols=226 Identities=23% Similarity=0.372 Sum_probs=167.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+ +|.+++...+ .+++..++.++.|++.||.||| +.+++|||||
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--------------~~~ivH~dlk 131 (309)
T cd07872 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--------------RRKVLHRDLK 131 (309)
T ss_pred ceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 5789999999999999999975 8999887654 5899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||.+.+.. ++.. +|+|||||++++|++|+.||.+
T Consensus 132 p~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 132 PQNLLINERGELKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQ-IDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred HHHEEECCCCCEEECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999865332211 122345788999999987644 5555 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+..+......... . ...... .. . ......++.++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~-------~~---~----~~~~~~~~~~~~ 263 (309)
T cd07872 208 STVEDELHLIFRLLGTPTEETWPGISSNDEFKNY---N-------FPKYKP-------QP---L----INHAPRLDTEGI 263 (309)
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh---h-------cCccCC-------Cc---h----hhhccCCCHHHH
Confidence 7776666665554443332111111000000000 0 000000 00 0 011245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+||.+||+.||.+|||++|+++||||+....
T Consensus 264 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 264 ELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred HHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.05 Aligned_cols=228 Identities=24% Similarity=0.316 Sum_probs=177.1
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
|+++|++...+ .+++|+||++. +|.+++.... .++...++.++.||+.||+||| +
T Consensus 74 v~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--------------~ 138 (323)
T KOG0594|consen 74 VRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--------------S 138 (323)
T ss_pred EEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--------------h
Confidence 57889998877 89999999975 9999998855 4788899999999999999999 9
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~l 149 (304)
.+|+||||||.|+++++.|.+||+|||+++...-... .......|..|+|||++.+.. |++. .|+||+||++.||
T Consensus 139 ~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~-vDiWs~GcIfaEm 214 (323)
T KOG0594|consen 139 HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTS-VDIWSLGCIFAEM 214 (323)
T ss_pred CCeecccCCcceEEECCCCcEeeeccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCC-cchHhHHHHHHHH
Confidence 9999999999999999999999999999985442211 245566888899999999884 6666 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++++..|.+....++...|-...+......|.-.......+.. .. .+ .....+ ...
T Consensus 215 ~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~-----------f~--~~----~~~~~l-------~~~ 270 (323)
T KOG0594|consen 215 FTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAP-----------FP--KW----PGPKDL-------SSI 270 (323)
T ss_pred HhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccccccc-----------Cc--CC----CCccch-------HHh
Confidence 9999999999888888888877776664333322222111110 00 00 000000 011
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+..++...+++.+||..+|.+|.|++.+|+||||.......
T Consensus 271 ~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 271 LPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred ccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 133446899999999999999999999999999999987544
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.28 Aligned_cols=215 Identities=24% Similarity=0.290 Sum_probs=171.6
Q ss_pred eEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 12 RVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
...+||||++. +|.++++. +..++.-.++.+.+||+.||.||| +.+|+||||||.|+|+|.
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--------------~~~IcHRDIKPqNlLvD~ 160 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--------------SHGICHRDIKPQNLLVDP 160 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--------------hcCcccCCCChheEEEcC
Confidence 67899999985 99999985 457899999999999999999999 899999999999999997
Q ss_pred C-CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHH
Q psy1812 88 R-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166 (304)
Q Consensus 88 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~ 166 (304)
+ |.+||||||.|+....... ..++..+..|+|||.+.+....+.+.|+||.||++.||+.|+..|.|.+..++..
T Consensus 161 ~tg~LKicDFGSAK~L~~~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 161 DTGVLKICDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred CCCeEEeccCCcceeeccCCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 6 8899999999998766553 3467789999999999987755555999999999999999999999998888888
Q ss_pred HhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcC
Q psy1812 167 EQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILE 246 (304)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 246 (304)
.|.+..+...... +.....++. ....+.++...+.+ -.....+++..+|+.++|.
T Consensus 237 eIik~lG~Pt~e~------------I~~mn~~y~------------~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~ 291 (364)
T KOG0658|consen 237 EIIKVLGTPTRED------------IKSMNPNYT------------EFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQ 291 (364)
T ss_pred HHHHHhCCCCHHH------------HhhcCcccc------------cccCccccccccee-ecccCCCHHHHHHHHHHhc
Confidence 8887776654111 111111111 11111122221111 2446789999999999999
Q ss_pred CCCCccccHHHHhcCccccccccc
Q psy1812 247 PDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 247 ~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
++|.+|.++.|++.||||+..+.+
T Consensus 292 Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 292 YSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cChhhcCCHHHHhcchhhHHhhCc
Confidence 999999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.89 Aligned_cols=200 Identities=25% Similarity=0.401 Sum_probs=154.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++.+++||||+++|+|.+. ....+..+..++.|++.||.||| +.+++|||||+
T Consensus 135 v~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDlkp 196 (353)
T PLN00034 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLH--------------RRHIVHRDIKP 196 (353)
T ss_pred ceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecCCCH
Confidence 5788999999999999999999998653 34678889999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC----CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN----PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++........ ......|+..|+|||.+... .+...++|||||||++|+|++|+.||
T Consensus 197 ~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf 273 (353)
T PLN00034 197 SNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273 (353)
T ss_pred HHEEEcCCCCEEEcccccceecccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999875432211 12345689999999987432 23333499999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
......+....+...... .....+..++.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~ 303 (353)
T PLN00034 274 GVGRQGDWASLMCAICMS--------------------------------------------------QPPEAPATASRE 303 (353)
T ss_pred CCCCCccHHHHHHHHhcc--------------------------------------------------CCCCCCCccCHH
Confidence 643221111110000000 001223557889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+.+||.+||+.||++|||++|+++||||.......
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~ 338 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCCccc
Confidence 99999999999999999999999999999975543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=256.13 Aligned_cols=202 Identities=25% Similarity=0.449 Sum_probs=162.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+.+++.+++||||+.+|+|.+++.+ .+.+++..++.++.|++.||.||| +.+++|||||
T Consensus 64 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH--------------~~~iiHrDlk 129 (332)
T cd05623 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH--------------QLHYVHRDIK 129 (332)
T ss_pred eeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCC
Confidence 3678889999999999999999999999987 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.+||+|||++........ ......+|++.|+|||++.. ..++.+ +|+|||||++|+|++|+.
T Consensus 130 p~Nili~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 130 PDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGET 206 (332)
T ss_pred HHHEEECCCCCEEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCc-CCEEeeHHHHHHHhcCCC
Confidence 9999999999999999999864332211 12234568999999999862 345555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+..+...++......... ......++
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------------p~~~~~~s 237 (332)
T cd05623 207 PFYAESLVETYGKIMNHKERFQF-------------------------------------------------PAQVTDVS 237 (332)
T ss_pred CCCCCCHHHHHHHHhCCCccccC-------------------------------------------------CCccccCC
Confidence 99887766666655433211110 01113468
Q ss_pred HHHHHHHHHhcCCCCCc--cccHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITK--RIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~~ 268 (304)
.++.+||++||..++++ |++++++++||||++..
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 89999999999765554 68999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=252.33 Aligned_cols=232 Identities=24% Similarity=0.322 Sum_probs=151.8
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRA---------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
|++++++.. +...++||||+. ++|.+++... ..+++..++.++.|++.||.|||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-------------- 125 (317)
T cd07868 61 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-------------- 125 (317)
T ss_pred cceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 467777743 567999999996 5999988643 24899999999999999999999
Q ss_pred CCceEecCCCCCcEEE----ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHH
Q psy1812 70 SKNIAHRDLKCENILM----TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGV 144 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ 144 (304)
+.+|+||||||+||++ +.++.+||+|||++.................++..|+|||++.+.. ++.+ +|+||+||
T Consensus 126 ~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~ 204 (317)
T cd07868 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIGC 204 (317)
T ss_pred hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCch-hhHHHHHH
Confidence 8999999999999999 4567899999999976543222111223456889999999998754 5555 99999999
Q ss_pred HHHHHHhCCCCCCChhHH---------HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 145 ITFIMLNAAMPFDDSNLK---------QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 145 ll~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
++++|++|..||.+.... .....+...........+.............. ........
T Consensus 205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~------- 271 (317)
T cd07868 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMK------DFRRNTYT------- 271 (317)
T ss_pred HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhh------hhhccccC-------
Confidence 999999999999654321 12222222111111000000000000000000 00000000
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.......+ .......+..+.+||++||.+||.+|||++|+|+||||
T Consensus 272 ~~~~~~~~---~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 272 NCSLIKYM---EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cccccchH---HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000000 01112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=238.66 Aligned_cols=192 Identities=27% Similarity=0.532 Sum_probs=174.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++|++|.++.+.|+++||...|+|+..|+ .+..+++..++.++.|++.|+.|+| .++++||||
T Consensus 85 lrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--------------~k~VIhRdi 150 (281)
T KOG0580|consen 85 LRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--------------LKRVIHRDI 150 (281)
T ss_pred HhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--------------cCCcccCCC
Confidence 478999999999999999999999999999 5668999999999999999999999 999999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+|+|++..+.+|++|||-+.... ..+..+.|||..|.+||...+..++.. .|+|++|+++||++.|..||..
T Consensus 151 KpenlLlg~~~~lkiAdfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 151 KPENLLLGSAGELKIADFGWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred CHHHhccCCCCCeeccCCCceeecC-----CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhh
Confidence 9999999999999999999885432 124668899999999999999999888 9999999999999999999998
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+.+++|.+....++ ..++.++.
T Consensus 225 ~~~~etYkrI~k~~~~~p------------------------------------------------------~~is~~a~ 250 (281)
T KOG0580|consen 225 QSHSETYKRIRKVDLKFP------------------------------------------------------STISGGAA 250 (281)
T ss_pred hhhHHHHHHHHHccccCC------------------------------------------------------cccChhHH
Confidence 888888888877655444 78899999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
|||.+||..+|.+|.+..|+++|||-..
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=254.85 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=165.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|..++..++||||+++|+|.+++.+.+.+++..+..++.+++.||.|||+ ..+++|+||||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-------------~~~ivH~dlkp 132 (333)
T cd06650 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-------------KHKIMHRDVKP 132 (333)
T ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-------------cCCEEecCCCh
Confidence 57899999999999999999999999999988889999999999999999999992 25799999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... ......++..|+|||.+.+..++.+ +|+|||||++|++++|+.||....
T Consensus 133 ~Nili~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 133 SNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hhEEEcCCCCEEEeeCCcchhhhhh-----ccccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998644322 1234468899999999988777777 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc-cc-ccccccHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ-VK-VKDILSHQVK 238 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~ 238 (304)
......... ........................ .......+.. ........+.... .. ....++.++.
T Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 207 AKELELMFG-CPVEGDPAESETSPRPRPPGRPLS------SYGPDSRPPM---AIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred hhHHHHHhc-CcccCCccccccCcccCCccchhh------hhcccccccc---cHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 433322111 000000000000000000000000 0000000000 0000001111100 01 1123678999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+||.+||..||++|||++|+++|+||+....
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 9999999999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=257.10 Aligned_cols=199 Identities=28% Similarity=0.431 Sum_probs=169.5
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|-..|++...+|+||..|+||+|.-+|.+.+ .|++..++.++.+|+.||++|| ..+||+||+||
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--------------~~~iVYRDLKP 315 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--------------RRRIVYRDLKP 315 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--------------hcceeeccCCh
Confidence 4456788899999999999999999998877 7999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||+|..|.++|+|.|++..+..... .....||..|||||++.+..|+.+ .|+||+||++|+|+.|+.||....
T Consensus 316 eNILLDd~GhvRISDLGLAvei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 316 ENILLDDHGHVRISDLGLAVEIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred hheeeccCCCeEeeccceEEecCCCCc----cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhh
Confidence 999999999999999999976554432 334589999999999999999888 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......++.+....- ...++..++++++++
T Consensus 391 eKvk~eEvdrr~~~~--------------------------------------------------~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 391 EKVKREEVDRRTLED--------------------------------------------------PEEYSDKFSEEAKSL 420 (591)
T ss_pred hhhhHHHHHHHHhcc--------------------------------------------------hhhcccccCHHHHHH
Confidence 433333333222221 245668899999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~~~ 270 (304)
.+.+|+.||.+|+ .+.++.+||||+...-.
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 9999999999999 57899999999987653
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=249.38 Aligned_cols=192 Identities=32% Similarity=0.572 Sum_probs=174.5
Q ss_pred eeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEE
Q psy1812 5 SILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENIL 84 (304)
Q Consensus 5 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil 84 (304)
..|+...++|+||||.+||.|+-+|.+.+.|++..++.+..+|+.||.||| +.+||+||+|.+|.+
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH--------------s~~ivYRDlKLENLl 300 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH--------------SRNIVYRDLKLENLL 300 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh--------------hCCeeeeechhhhhe
Confidence 357788899999999999999999999999999999999999999999999 999999999999999
Q ss_pred EecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHH
Q psy1812 85 MTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164 (304)
Q Consensus 85 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~ 164 (304)
++++|.+||.|||+++....... ...++|||+.|+|||++....|+.. .|+|.+||++|||+.|+.||...+...+
T Consensus 301 LDkDGHIKitDFGLCKE~I~~g~---t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 301 LDKDGHIKITDFGLCKEEIKYGD---TTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred eccCCceEeeecccchhcccccc---eeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHH
Confidence 99999999999999975433322 5678999999999999999889877 9999999999999999999999888888
Q ss_pred HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHh
Q psy1812 165 FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQI 244 (304)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 244 (304)
+..|..+.+.++ ..++++++.||..+
T Consensus 377 FeLIl~ed~kFP------------------------------------------------------r~ls~eAktLLsGL 402 (516)
T KOG0690|consen 377 FELILMEDLKFP------------------------------------------------------RTLSPEAKTLLSGL 402 (516)
T ss_pred HHHHHhhhccCC------------------------------------------------------ccCCHHHHHHHHHH
Confidence 888777666555 88999999999999
Q ss_pred cCCCCCccc-----cHHHHhcCccccccc
Q psy1812 245 LEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 245 L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|..||.+|+ .++++.+|+||....
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 999999999 589999999998754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=248.75 Aligned_cols=201 Identities=22% Similarity=0.381 Sum_probs=158.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..+...++||||+.|++|.+++...+ .+++..+..++.|++.||+||| +.+++|+||
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivH~di 121 (277)
T cd05607 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--------------SMDIVYRDM 121 (277)
T ss_pred EEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEEccC
Confidence 467888999999999999999999999886643 5889999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.. +|+||+||++|++++|..||..
T Consensus 122 kp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 122 KPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred ChHhEEEcCCCCEEEeeceeeeecCCCc----eeeccCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987543321 1223468899999999988887777 9999999999999999999965
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+........ .......+++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~ 227 (277)
T cd05607 197 HKEKVAKEELKRRTLEDE-------------------------------------------------VKFEHQNFTEESK 227 (277)
T ss_pred CcchhhHHHHHHHhhccc-------------------------------------------------cccccccCCHHHH
Confidence 432111111111000000 0001135788999
Q ss_pred HHHHHhcCCCCCccccH----HHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRL----DAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~----~ell~~~wf~~~~~ 269 (304)
+|+.+||+.||++||++ ++++.|+||+....
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 99999999999999999 67889999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=244.70 Aligned_cols=195 Identities=29% Similarity=0.516 Sum_probs=163.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++|+||+++++|.+++.+.+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 60 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~i~H~dl~p 125 (260)
T cd05611 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH--------------QRGIIHRDIKP 125 (260)
T ss_pred eeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4688999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++..... .....++..|++||.+.+..++.. +|+||||+++|++++|..||...+
T Consensus 126 ~nil~~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 126 ENLLIDQTGHLKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred HHeEECCCCcEEEeecccceeccc-------cccCCCCcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999998864322 223457788999999988776666 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....+..+.......+ ......+++.+.++
T Consensus 198 ~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~ 227 (260)
T cd05611 198 PDAVFDNILSRRINWP--------------------------------------------------EEVKEFCSPEAVDL 227 (260)
T ss_pred HHHHHHHHHhcccCCC--------------------------------------------------CcccccCCHHHHHH
Confidence 6555444332221111 11223578899999
Q ss_pred HHHhcCCCCCccccH---HHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRL---DAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~---~ell~~~wf~~~ 267 (304)
+.+||+.+|++||++ +|+++||||+..
T Consensus 228 i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 228 INRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999999955 799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=253.20 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=159.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++++++||||+.||+|.+++.+ ...+++..++.++.|++.||+||| +.+++|||||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dlk 129 (331)
T cd05597 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH--------------QLGYVHRDIK 129 (331)
T ss_pred CceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEECCCC
Confidence 4688999999999999999999999999987 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.+||+|||++......... ......|++.|+|||++.. ..++.+ +|+||+||++|+|++|+.
T Consensus 130 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 130 PDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGET 206 (331)
T ss_pred HHHEEECCCCCEEEEECCceeecCCCCCc--cccceeccccccCHHHHhhccccccCCCCc-ceeehhhhHHHHHhhCCC
Confidence 99999999999999999998654322211 1223468999999999863 234455 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+........ .......++
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~-------------------------------------------------~~~~~~~~~ 237 (331)
T cd05597 207 PFYAESLVETYGKIMNHKEHFQ-------------------------------------------------FPPDVTDVS 237 (331)
T ss_pred CCCCCCHHHHHHHHHcCCCccc-------------------------------------------------CCCccCCCC
Confidence 9987766555544432211110 001113478
Q ss_pred HHHHHHHHHhcCCCCCc--cccHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITK--RIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~~ 268 (304)
..+++||++||..++++ |++++++++||||+...
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 89999999999765544 78999999999998753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=247.02 Aligned_cols=220 Identities=22% Similarity=0.313 Sum_probs=159.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++.+++..++||||+. ++|.+++... ..+++..++.++.|++.||+||| +.+++|+|
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~i~H~d 126 (285)
T cd07861 62 VCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--------------SRRVLHRD 126 (285)
T ss_pred eeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecC
Confidence 478999999999999999997 5999998653 46899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.+ +|+|||||+++++++|+.||
T Consensus 127 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~~l~tg~~~~ 202 (285)
T cd07861 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLWYRAPEVLLGSPRYSTP-VDIWSIGTIFAEMATKKPLF 202 (285)
T ss_pred CCHHHEEEcCCCcEEECcccceeecCCCcc---cccCCcccccccChHHhcCCCCcCcH-HHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999875432211 122335678899999986654 4555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.........+...........+............ ... .... ........++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~---~~~~--------~~~~~~~~~~~~ 257 (285)
T cd07861 203 HGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT--------------FPK---WKKG--------SLRSAVKNLDED 257 (285)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh--------------ccc---cCcc--------hhHHhcCCCCHH
Confidence 876554444333332222211111100000000000 000 0000 001112447899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+||.+||..||++|||++++++||||
T Consensus 258 ~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 258 GLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=258.09 Aligned_cols=228 Identities=25% Similarity=0.385 Sum_probs=167.3
Q ss_pred CceeeeeeeCC-----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGP-----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++...+ ..++||||+. ++|.+++...+.+++..++.++.|++.||.||| +.+++|
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~~ivH 126 (372)
T cd07853 62 LSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH--------------SAGILH 126 (372)
T ss_pred CCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeC
Confidence 45677777665 7999999996 589999988888999999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|||||+||+++.++.+||+|||++......... ......++..|+|||.+.+.. ++.+ +|+||+||++++|++|+.
T Consensus 127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~ 203 (372)
T cd07853 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESK--HMTQEVVTQYYRAPEILMGSRHYTSA-VDIWSVGCIFAELLGRRI 203 (372)
T ss_pred CCCChHHEEECCCCCEEeccccceeecccCccc--cCCCCCcCCCcCCHHHHcCCCCCCcH-HHHHhHHHHHHHHHcCCC
Confidence 999999999999999999999998754322111 223345788999999988755 4555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhh-hhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ-VKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
||.+.+..+....+......... ..+... .......... ....+....+ .......
T Consensus 204 pf~~~~~~~~~~~i~~~~g~~~~---~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~----~~~~~~~ 260 (372)
T cd07853 204 LFQAQSPIQQLDLITDLLGTPSL---EAMRSACEGARAHILRG----------------PHKPPSLPVL----YTLSSQA 260 (372)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCH---HHHHHhhHHHHHHHHhC----------------CCCCCchHHh----cccCCCC
Confidence 99888777776666554433221 000000 0000000000 0000000000 1122445
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++++.+||.+||+.||++|||++++++||||+..+.
T Consensus 261 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 261 THEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.50 Aligned_cols=197 Identities=31% Similarity=0.542 Sum_probs=177.4
Q ss_pred CceeeeeeeCCe-EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPR-VFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|.+++.|..++. ++|||+||+||+|.+.|.+.+ .|++..+..++.|++.|++||| +..|+|||
T Consensus 66 v~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--------------~~~iLHRD 131 (426)
T KOG0589|consen 66 VEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--------------ENRVLHRD 131 (426)
T ss_pred eeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--------------hhhhhccc
Confidence 456788888777 999999999999999997754 6999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
||+.||++.+++.+||+|||+++....... ...+..||+.|++||++.+.+|..+ +|+|||||++||+++-+.+|.
T Consensus 132 lK~~Nifltk~~~VkLgDfGlaK~l~~~~~---~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 132 LKCANIFLTKDKKVKLGDFGLAKILNPEDS---LASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred chhhhhhccccCceeecchhhhhhcCCchh---hhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccC
Confidence 999999999999999999999987765542 3567789999999999999999998 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+...++.++....+. ..+..++.++
T Consensus 208 a~~m~~Li~ki~~~~~~-----------------------------------------------------Plp~~ys~el 234 (426)
T KOG0589|consen 208 ASNMSELILKINRGLYS-----------------------------------------------------PLPSMYSSEL 234 (426)
T ss_pred ccchHHHHHHHhhccCC-----------------------------------------------------CCCccccHHH
Confidence 99999999999887742 3347789999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.++..||..+|..||++.++|.+|.+....
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999999999999999999999998777433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=264.60 Aligned_cols=213 Identities=23% Similarity=0.286 Sum_probs=155.3
Q ss_pred eEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 12 RVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.+++||||+.+ +|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--------------~~~IiHrDLKp~NILl~~ 205 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--------------SKFICHRDLKPQNLLIDP 205 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCcCHHHEEEcC
Confidence 57799999975 88887753 457999999999999999999999 899999999999999986
Q ss_pred CC-CeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHH
Q psy1812 88 RF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165 (304)
Q Consensus 88 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~ 165 (304)
++ .+||+|||++....... ......+++.|+|||++.+. .++.+ +|+|||||++|+|++|..||.+.+..+..
T Consensus 206 ~~~~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~ 280 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILGYPIFSGQSSVDQL 280 (440)
T ss_pred CCCceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 65 69999999997543322 22345688999999998765 46665 99999999999999999999887766666
Q ss_pred HHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhc
Q psy1812 166 KEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQIL 245 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 245 (304)
.++..............+ ...+......... ...+. ...+...++++.+||.+||
T Consensus 281 ~~i~~~~~~p~~~~~~~~------------~~~~~~~~~~~~~-------~~~l~------~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 281 VRIIQVLGTPTEDQLKEM------------NPNYADIKFPDVK-------PKDLK------KVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHhCCCCHHHHHHh------------chhhhcccCCccC-------chhHH------HHhccCCCHHHHHHHHHHC
Confidence 655544332221000000 0000000000000 00011 1123457889999999999
Q ss_pred CCCCCccccHHHHhcCcccccccc
Q psy1812 246 EPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 246 ~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..||.+|||+.|+++||||+....
T Consensus 336 ~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 336 KYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCChhHCcCHHHHhCChhHHhhhc
Confidence 999999999999999999988765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=246.54 Aligned_cols=193 Identities=33% Similarity=0.627 Sum_probs=166.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++++|.+++...+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 64 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH--------------~~~i~H~dl~p 129 (290)
T cd05580 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH--------------SLDIVYRDLKP 129 (290)
T ss_pred cceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCCCH
Confidence 4788999999999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
.||+++.++.+||+|||++...... .....++..|++||.+.+...+.. +|+||||+++++|++|..||...+
T Consensus 130 ~nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 130 ENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred HHEEECCCCCEEEeeCCCccccCCC------CCCCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998754332 223468889999999987777666 999999999999999999997776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+... .+..++..+.++
T Consensus 203 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~l~~l 228 (290)
T cd05580 203 PIQIYEKILEGKVR------------------------------------------------------FPSFFSPDAKDL 228 (290)
T ss_pred HHHHHHHHhcCCcc------------------------------------------------------CCccCCHHHHHH
Confidence 54444444433222 225568899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|+ +++++++||||+...
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=254.34 Aligned_cols=234 Identities=24% Similarity=0.389 Sum_probs=163.2
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++... ..+++||||+.+ +|.+.+.. .+++..+..++.|++.||.||| +.+|+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH--------------~~~iv 145 (359)
T cd07876 83 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLH--------------SAGII 145 (359)
T ss_pred eeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHH--------------hCCcc
Confidence 4567777543 358999999975 78777753 4889999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+|||||++|+|++|..
T Consensus 146 HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSV 220 (359)
T ss_pred cCCCCHHHEEECCCCCEEEecCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999986433211 2234568899999999998888887 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhh-hhhhccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLK-DILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (304)
||.+.+.......+................. ............... . ....+. .+...........
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----~------~~~~~~~~~~~~~~~~~~~~ 287 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP--TVRNYVENRPQYPGI-----S------FEELFPDWIFPSESERDKLK 287 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH--HHHHHHhhCCCCCCc-----c------hhhhcccccccccccccccc
Confidence 9988776666555544433322211111110 011111000000000 0 000000 0001111122345
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++++.+||.+||..||++|||+.|+|+||||+....
T Consensus 288 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 288 TSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred chhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=254.62 Aligned_cols=235 Identities=24% Similarity=0.369 Sum_probs=164.2
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++... ...++||||+++ +|.+.+.. .+++..++.++.|++.||.||| +.+++
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--------------~~giv 141 (355)
T cd07874 79 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH--------------SAGII 141 (355)
T ss_pred hceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHH--------------hCCcc
Confidence 3567766533 468999999975 78887764 4899999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.+ +|+|||||++|+|++|+.
T Consensus 142 HrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~ 216 (355)
T cd07874 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cCCCChHHEEECCCCCEEEeeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999997543221 2234568899999999988888877 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh-hhhhhccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL-KDILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (304)
||.+.+..+....+..............+. .................. ...+ ..............
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 283 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ--PTVRNYVENRPKYAGLTF-----------PKLFPDSLFPADSEHNKLK 283 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhc--HHHHHHHhcCCccccccc-----------hhhcccccccccccccccc
Confidence 998887666655554443322111111000 001111111000000000 0000 00001111222345
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+.++.+||.+||..||++|||++|+++||||+....+
T Consensus 284 ~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 284 ASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred chHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 7789999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=253.71 Aligned_cols=201 Identities=23% Similarity=0.422 Sum_probs=160.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+.+++..|+||||+.||+|.+++.+ .+.+++..++.++.|++.||+||| +.+|+|||||
T Consensus 64 ~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH--------------~~~iiHrDlk 129 (331)
T cd05624 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH--------------QLHYVHRDIK 129 (331)
T ss_pred eeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeccCc
Confidence 4678889999999999999999999999987 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.+||+|||++......... ......|++.|+|||++.+ ..++.. +|+|||||++|+|++|+.
T Consensus 130 p~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGET 206 (331)
T ss_pred hHHEEEcCCCCEEEEeccceeeccCCCce--eeccccCCcccCCHHHHhccccCCCCCCCc-ccEEeeehhhhhhhhCCC
Confidence 99999999999999999998654332211 1233568999999999865 345555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+..+...++.......+. ......++
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------------p~~~~~~~ 237 (331)
T cd05624 207 PFYAESLVETYGKIMNHEERFQF-------------------------------------------------PSHITDVS 237 (331)
T ss_pred CccCCCHHHHHHHHHcCCCcccC-------------------------------------------------CCccccCC
Confidence 99877666555554432211110 01113468
Q ss_pred HHHHHHHHHhcCCCCCc--cccHHHHhcCcccccc
Q psy1812 235 HQVKNLVGQILEPDITK--RIRLDAIKAHDWLRYK 267 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~ 267 (304)
..+.+||.+||..++++ |++++++++|+||+..
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 89999999999876654 4689999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=246.13 Aligned_cols=197 Identities=27% Similarity=0.472 Sum_probs=159.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..++..++||||+.+|+|.+++...+.+++..+..++.|++.||+||| +.+++|+||||+
T Consensus 61 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH--------------~~~ivH~dikp~ 126 (279)
T cd05633 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH--------------NRFVVYRDLKPA 126 (279)
T ss_pred EEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcCCCCCCHH
Confidence 567788888899999999999999999998888999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
||+++.++.++++|||++...... ......++..|+|||.+.+ ..++.+ +|+||+||+++++++|..||....
T Consensus 127 Nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 127 NILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred HEEECCCCCEEEccCCcceecccc-----CccCcCCCcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCC
Confidence 999999999999999998644322 1223468899999999864 446666 999999999999999999996542
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..... .+....... ....+..+++.+.++
T Consensus 201 ~~~~~-~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~l 229 (279)
T cd05633 201 TKDKH-EIDRMTLTV--------------------------------------------------NVELPDSFSPELKSL 229 (279)
T ss_pred CcCHH-HHHHHhhcC--------------------------------------------------CcCCccccCHHHHHH
Confidence 21100 000000000 022345678899999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~~ 269 (304)
|.+||..||.+|+ |++++++||||++...
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999999999999 6999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=240.63 Aligned_cols=193 Identities=32% Similarity=0.529 Sum_probs=162.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.|++|.+++... ..+++..++.++.+++.||.||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--------------~~~i~h~dl 127 (256)
T cd08529 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--------------SKKILHRDI 127 (256)
T ss_pred ehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCC
Confidence 46788888999999999999999999999875 46899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++++|||++........ ......++..|+|||+..+..++.+ +|+|||||+++++++|..||..
T Consensus 128 ~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred CcceEEEeCCCCEEEcccccceeccCccc---hhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999875543221 2234467889999999988877777 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+... ..+..++..+.
T Consensus 204 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 230 (256)
T cd08529 204 NNQGALILKIIRGVFP-----------------------------------------------------PVSQMYSQQLA 230 (256)
T ss_pred CCHHHHHHHHHcCCCC-----------------------------------------------------CCccccCHHHH
Confidence 7755555444332221 11235688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+||+.+|++||++.++++|||+
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=254.12 Aligned_cols=233 Identities=24% Similarity=0.361 Sum_probs=163.9
Q ss_pred ceeeeeee------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 2 QVHSILQR------GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 2 ~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
++++++.. ....++||||+.+ +|.+++.. .+++..++.++.|++.||+||| +.+|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH 149 (364)
T cd07875 87 GLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH--------------SAGIIH 149 (364)
T ss_pred ccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHh--------------hCCeec
Confidence 45555543 3468999999975 88888864 4889999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.+ +|+|||||++|+|++|..|
T Consensus 150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~p 224 (364)
T cd07875 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVL 224 (364)
T ss_pred CCCCHHHEEECCCCcEEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999997543221 2234568899999999988888877 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhh-hhhhcccccccccc
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLK-DILSHQVKVKDILS 234 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (304)
|.+.+..+.+.++..............+... ................ ..... .............+
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 291 (364)
T cd07875 225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT--VRTYVENRPKYAGYSF-----------EKLFPDVLFPADSEHNKLKA 291 (364)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH--HHHHHhhCCCcCCCCh-----------HhhCcccccccccccccccc
Confidence 9888777776666554433221111111100 0111000000000000 00000 00011112223356
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+++||.+||..||.+|||++++|+||||+....
T Consensus 292 ~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 292 SQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 78999999999999999999999999999986444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=248.42 Aligned_cols=200 Identities=25% Similarity=0.403 Sum_probs=159.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.|++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~iiH~di 128 (285)
T cd05630 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--------------QERIVYRDL 128 (285)
T ss_pred eeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEeCCC
Confidence 357788888899999999999999999986543 5899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.+ +|+||+||++|++++|..||..
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 129 KPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred CHHHEEECCCCCEEEeeccceeecCCCc----cccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999986433211 1223468999999999988888877 9999999999999999999975
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
..............-.. ....+..+++.+.
T Consensus 204 ~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~ 233 (285)
T cd05630 204 RKKKIKREEVERLVKEV--------------------------------------------------QEEYSEKFSPDAR 233 (285)
T ss_pred CCccchHHHHHhhhhhh--------------------------------------------------hhhcCccCCHHHH
Confidence 43211000000000000 0112245788899
Q ss_pred HHHHHhcCCCCCcccc-----HHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIR-----LDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~~~ 269 (304)
+|+.+||+.||.+||| ++++++||||+....
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 9999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=243.63 Aligned_cols=196 Identities=31% Similarity=0.581 Sum_probs=158.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..+...++||||+++++|.+++...+.+++..+..++.|++.||.+|| +.+++|+||+|
T Consensus 61 ~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh--------------~~~i~H~dikp 126 (260)
T PF00069_consen 61 VQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH--------------SKGIVHRDIKP 126 (260)
T ss_dssp CHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH--------------HTTEEESSBSG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------ccccccccccc
Confidence 4688999999999999999999999999997788999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-CCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-GNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++|+|||.+....... .......++..|.|||.+. +...+.+ +|+||+|+++++|++|..||...
T Consensus 127 ~NIl~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 127 ENILLDENGEVKLIDFGSSVKLSENN---ENFNPFVGTPEYMAPEVLQQGKKYTRK-SDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp GGEEESTTSEEEESSGTTTEESTSTT---SEBSSSSSSGGGSCHHHHTTTSSBSTH-HHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccc---ccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence 99999999999999999987531111 1334566889999999998 5556555 99999999999999999999876
Q ss_pred hHH---HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 160 NLK---QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 160 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
+.. ....+......... .......+..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~ 232 (260)
T PF00069_consen 203 NSDDQLEIIEKILKRPLPSS--------------------------------------------------SQQSREKSEE 232 (260)
T ss_dssp SHHHHHHHHHHHHHTHHHHH--------------------------------------------------TTSHTTSHHH
T ss_pred cchhhhhhhhhccccccccc--------------------------------------------------ccccchhHHH
Confidence 322 22222221111100 0001112378
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.++|.+||+.||++|||+.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.97 Aligned_cols=217 Identities=24% Similarity=0.288 Sum_probs=158.7
Q ss_pred Cceeeeeee-----CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQR-----GPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++.. +...++||||+.+ +|.+++.... .+++..++.++.|++.||.||| +.++
T Consensus 65 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~i 129 (288)
T cd07863 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--------------ANCI 129 (288)
T ss_pred eeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCe
Confidence 356666653 3568999999975 9999997643 4899999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.+ +|+||+||++|+|++|.
T Consensus 130 vH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~ 204 (288)
T cd07863 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 204 (288)
T ss_pred ecCCCCHHHEEECCCCCEEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCC
Confidence 999999999999999999999999987543221 1233457889999999988888777 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+....+...++.......... .+.......... ... ...... ......+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~---~~~----~~~~~~-------~~~~~~~ 257 (288)
T cd07863 205 PLFCGNSEADQLGKIFDLIGLPPED-------------DWPRDVTLPRGA---FSP----RGPRPV-------QSVVPEI 257 (288)
T ss_pred cCcCCCCHHHHHHHHHHHhCCCChh-------------hCcccccccccc---cCC----CCCCch-------HHhCcCc
Confidence 9998776655555544322211100 000000000000 000 000000 1122457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+..+.+||.+||.+||++|||+.+++.||||
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=251.53 Aligned_cols=247 Identities=17% Similarity=0.251 Sum_probs=164.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++..++..++||||+++|+|.+++..+ +.+++..++.++.|++.||.||| +.+++|+||
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~iiH~dl 127 (327)
T cd08227 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--------------HMGYVHRSV 127 (327)
T ss_pred eeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCC
Confidence 57899999999999999999999999999763 45899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g 152 (304)
||+||+++.++.++++||+............ .......++..|+|||++.+. .++.+ +|+|||||+++++++|
T Consensus 128 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g 206 (327)
T cd08227 128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANG 206 (327)
T ss_pred ChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHC
Confidence 9999999999999999998654322111100 011223466779999999763 46666 9999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||..............+..+........ ............. ............. ................
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 278 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTI------PAEELTMKPSRSG-ANSGLGESTTVST-PRPSNGESSSHPYNRT 278 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccch------hhhhcccCCcccC-CcCCCCcccccCC-cCccccCCcccccccc
Confidence 999977655444443333322211000000 0000000000000 0000000000000 0000000001122345
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+++++.+||.+||+.||.+|||++++++||||+.....
T Consensus 279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred cCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 68899999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=242.03 Aligned_cols=196 Identities=29% Similarity=0.461 Sum_probs=161.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+++++|.+++.+.+.+++..+..++.|++.||+||| +.+++|+||+|
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH--------------~~~ivH~di~p 134 (267)
T cd06628 69 VQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--------------NRGIIHRDIKG 134 (267)
T ss_pred eeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH--------------hcCcccccCCH
Confidence 4688899999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccccc---ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRR---VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++.++|+|||++.......... .......++..|+|||.+.+..++.. +|+|||||+++++++|..||.
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999987554211110 01123457889999999988777777 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+..... ...+..++..+
T Consensus 214 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 240 (267)
T cd06628 214 DCTQLQAIFKIGENAS-----------------------------------------------------PEIPSNISSEA 240 (267)
T ss_pred CccHHHHHHHHhccCC-----------------------------------------------------CcCCcccCHHH
Confidence 6654333332221110 12234578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.++|.+||+.||++||++.++++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=239.32 Aligned_cols=192 Identities=27% Similarity=0.516 Sum_probs=158.1
Q ss_pred ceeeeeee-CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 2 QVHSILQR-GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 2 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++.+.. +..+++||||+++++|.+++... ..+++.+++.++.+++.||.+|| +.+++|+||
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--------------~~~i~H~di 128 (257)
T cd08223 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--------------EKHILHRDL 128 (257)
T ss_pred eeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCC
Confidence 45666653 45789999999999999999763 35899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.+ +|+||+|++++++++|..||..
T Consensus 129 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 129 KTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred CchhEEEecCCcEEEecccceEEecccCC---ccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999875533221 2234567889999999988878777 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+.. ...+..+++++.
T Consensus 205 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 231 (257)
T cd08223 205 KDMNSLVYRIIEGKL-----------------------------------------------------PPMPKDYSPELG 231 (257)
T ss_pred CCHHHHHHHHHhcCC-----------------------------------------------------CCCccccCHHHH
Confidence 665544443333221 112245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+|+.+||+.+|++|||+.++++||||
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=247.84 Aligned_cols=226 Identities=22% Similarity=0.347 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+. ++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH--------------~~~i~H~dlk 131 (301)
T cd07873 67 VTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--------------RRKVLHRDLK 131 (301)
T ss_pred ceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCCCC
Confidence 578999999999999999997 5999998764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.. +|+|||||++|+|++|+.||..
T Consensus 132 p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 132 PQNLLINERGELKLADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred HHHEEECCCCcEEECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864332211 122335678999999987654 4444 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+. ....... .......... ... .......+++.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~-------~~~-------~~~~~~~~~~~~~ 263 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWP---------GILSNEE-FKSYNYPKYR-------ADC-------LHNHAPRLDSDGA 263 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhch---------hhhcccc-ccccccCccc-------ccc-------HHhhcCCCCHHHH
Confidence 76655555444333222211110 0000000 0000000000 000 0111245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+||.+||+.||.+|||++++++||||+....
T Consensus 264 ~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 264 ELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 9999999999999999999999999987664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.64 Aligned_cols=220 Identities=24% Similarity=0.368 Sum_probs=156.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++|+||+. ++|.+++.+ .+.+++..++.++.|++.||.||| ..+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------------~~~i~H~dl~ 126 (284)
T cd07839 62 VRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH--------------SHNVLHRDLK 126 (284)
T ss_pred eeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCCC
Confidence 467788888999999999997 589888875 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC-C
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF-D 157 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf-~ 157 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.+ +|+|||||++++|++|..|+ .
T Consensus 127 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 127 PQNLLINKNGELKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred HHHEEEcCCCcEEECccchhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcH-HHHHHHHHHHHHHHhcCCCCcC
Confidence 9999999999999999999875432211 122345678899999987655 4555 99999999999999998886 4
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..............+..... ... ... ......+ ......+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~~~---~~~~~~~-------~~~~~~~~~~~ 257 (284)
T cd07839 203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPD----------YKP-----YPM---YPATTSL-------VNVVPKLNSTG 257 (284)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhHHhhhccc----------ccc-----cCC---CCCcchh-------hhhcccCCHHH
Confidence 4443344443333322211100000000000 000 000 0000000 11224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+||.+||..||.+|||++++++||||
T Consensus 258 ~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 258 RDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=241.68 Aligned_cols=198 Identities=26% Similarity=0.390 Sum_probs=161.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++|+||+++++|.+++.+.+.+++..+..++.|++.||+||| +.+++|+||+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 130 (265)
T cd06631 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH--------------NNCVVHRDIKG 130 (265)
T ss_pred eeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCcCH
Confidence 4678889999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc---cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR---RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++.++|+|||++......... ........++..|+|||.+.+..++.. +|+|||||+++++++|..||.
T Consensus 131 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred HhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccc
Confidence 9999999999999999998754321111 111233468889999999988877777 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+....... ...+..++.++
T Consensus 210 ~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~ 238 (265)
T cd06631 210 SMDRLAAMFYIGAHRGLM---------------------------------------------------PRLPDSFSAAA 238 (265)
T ss_pred cCChHHHHHHhhhccCCC---------------------------------------------------CCCCCCCCHHH
Confidence 654333222221110000 12235578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+||++||..+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.72 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=167.9
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++|+.|-.+..+|++||||.||++.+.++.+..+.+..+..++++++.|+.||| ..+.+|+|||+.
T Consensus 75 ~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH--------------~~~kiHrDIKaa 140 (467)
T KOG0201|consen 75 EYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH--------------SEKKIHRDIKAA 140 (467)
T ss_pred hhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh--------------hcceeccccccc
Confidence 578889999999999999999999999998887799999999999999999999 889999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||++...|.+|++|||.+-...... .+..++.||+.|||||++.+..|+.+ +||||||++.+||++|..|+....+
T Consensus 141 nil~s~~g~vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 141 NILLSESGDVKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ceeEeccCcEEEEecceeeeeechh---hccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCc
Confidence 9999999999999999986433222 23478899999999999998899999 9999999999999999999987765
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
++.++..+ ......+...+++.+++|+
T Consensus 217 -------mrvlflIp----------------------------------------------k~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 217 -------MRVLFLIP----------------------------------------------KSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred -------ceEEEecc----------------------------------------------CCCCCccccccCHHHHHHH
Confidence 22222211 0001223356789999999
Q ss_pred HHhcCCCCCccccHHHHhcCccccccc
Q psy1812 242 GQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 242 ~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
..||+.||+.||+|.++|+|+|.+..+
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999999999865
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=257.26 Aligned_cols=231 Identities=22% Similarity=0.312 Sum_probs=164.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++.+..+...++|||++. ++|.+++...+.+++..++.++.|++.||.||| ..+|+||||||
T Consensus 149 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH--------------~~givHrDlkp 213 (392)
T PHA03207 149 INLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH--------------GRGIIHRDVKT 213 (392)
T ss_pred cceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 578899999999999999996 699999987788999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++......... .......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.+..
T Consensus 214 ~Nill~~~~~~~l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 214 ENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred HHEEEcCCCCEEEccCccccccCccccc-ccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999998754433221 12234568999999999988888877 999999999999999999996643
Q ss_pred H---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 161 L---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 161 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
. ...+..+.......+...... .......... ........ ...... ......++.++
T Consensus 292 ~~~~~~~l~~i~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~----------~~~~~~-----~~~~~~~~~~~ 351 (392)
T PHA03207 292 VKSSSSQLRSIIRCMQVHPLEFPQN--GSTNLCKHFK---QYAIVLRP----------PYTIPP-----VIRKYGMHMDV 351 (392)
T ss_pred CCCcHHHHHHHHHHhccCccccCCc--cchhHHHHHH---hhcccccC----------Cccccc-----hhhccCcchhH
Confidence 2 222333333222111100000 0000000000 00000000 000000 00012356789
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||..||++|||+.++|.||||+..+
T Consensus 352 ~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 352 EYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 9999999999999999999999999997654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=247.36 Aligned_cols=206 Identities=28% Similarity=0.448 Sum_probs=166.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.|++|.+++.+. ..+++..++.++.|++.||+||| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl 129 (316)
T cd05574 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--------------LLGIVYRDL 129 (316)
T ss_pred hhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCC
Confidence 46788899999999999999999999999764 46999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc--------------------------ccccCccCCccccccccccCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR--------------------------VLSRTYCGSAAYAAPEVISGNPY 132 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~PE~~~~~~~ 132 (304)
||+||+++.++.++|+|||++.......... .......|+..|+|||.+.+..+
T Consensus 130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 9999999999999999999986432211100 01123457888999999988877
Q ss_pred CCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccch
Q psy1812 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDI 212 (304)
Q Consensus 133 ~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (304)
+.+ +|+||||+++|++++|..||.+.+....+..+.......+
T Consensus 210 ~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------------------ 252 (316)
T cd05574 210 GSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFP------------------------------------ 252 (316)
T ss_pred Cch-HHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCC------------------------------------
Confidence 776 9999999999999999999987766555544332211111
Q ss_pred hhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc----HHHHhcCcccccccccccc
Q psy1812 213 LSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR----LDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t----~~ell~~~wf~~~~~~~~~ 273 (304)
....++..+.++|.+||..||++||| ++++++||||++.....-.
T Consensus 253 ----------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 253 ----------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred ----------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 01226889999999999999999999 9999999999987654433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=243.84 Aligned_cols=193 Identities=26% Similarity=0.479 Sum_probs=159.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..++..++||||+.||+|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|+
T Consensus 61 ~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~di~p~ 126 (278)
T cd05606 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH--------------NRFVVYRDLKPA 126 (278)
T ss_pred eeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEcCCCCHH
Confidence 567888889999999999999999999988888999999999999999999999 889999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
||+++.++.++|+|||++...... ......|+..|+|||.+.+. .++.. +|+||+||++++|++|..||....
T Consensus 127 nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 127 NILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred HEEECCCCCEEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998644322 12344688999999998754 46666 999999999999999999997652
Q ss_pred H---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 161 L---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 161 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
. .......... ....+..++..+
T Consensus 201 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~s~~~ 226 (278)
T cd05606 201 TKDKHEIDRMTLTM------------------------------------------------------AVELPDSFSPEL 226 (278)
T ss_pred ccchHHHHHHhhcc------------------------------------------------------CCCCCCcCCHHH
Confidence 2 1111111100 022234568999
Q ss_pred HHHHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
.+++.+||..+|.+|+ ++.++++||||+...
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999999999 999999999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=246.13 Aligned_cols=232 Identities=24% Similarity=0.388 Sum_probs=164.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++.+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ ..+++|+||+|
T Consensus 62 v~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-------------~~~i~H~dl~p 128 (308)
T cd06615 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE-------------KHKIMHRDVKP 128 (308)
T ss_pred CeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------hCCEEECCCCh
Confidence 57899999999999999999999999999988889999999999999999999992 36899999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++...... ......++..|++||.+.+..++.+ +|+|||||+++++++|..||...+
T Consensus 129 ~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 129 SNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred HHEEEecCCcEEEccCCCccccccc-----ccccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999998643221 2234568899999999987777776 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc-cccc-ccccHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ-VKVK-DILSHQVK 238 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~ 238 (304)
.......+............. ... ...................+.... ...+ ..++.++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~------------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (308)
T cd06615 203 AKELEAMFGRPVSEGEAKESH------------RPV------SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ 264 (308)
T ss_pred hhhHHHhhcCccccccccCCc------------ccc------cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHH
Confidence 433322221111100000000 000 000000000000000000111100 1111 23688899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+|+.+||..+|++|||++++++||||.+...
T Consensus 265 ~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 265 DFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 9999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=241.19 Aligned_cols=196 Identities=27% Similarity=0.555 Sum_probs=163.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++..++||||+++++|.+++.+...+++..+..++.|++.||+||| +.+++|+||+|
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH--------------~~~~~h~dl~~ 121 (262)
T cd05572 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH--------------NRGIIYRDLKP 121 (262)
T ss_pred eeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--------------hCCcccCCCCH
Confidence 4678888999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.. +|+||+|+++|++++|..||....
T Consensus 122 ~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 122 ENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred HHEEEcCCCCEEEeeCCcccccCccc----ccccccCCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999987554322 1233467889999999887777777 999999999999999999997765
Q ss_pred --HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 161 --LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 161 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
......++..+... ...+...++.+.
T Consensus 197 ~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~ 224 (262)
T cd05572 197 EDPMEIYNDILKGNGK----------------------------------------------------LEFPNYIDKAAK 224 (262)
T ss_pred CCHHHHHHHHhccCCC----------------------------------------------------CCCCcccCHHHH
Confidence 33344333311110 122344588999
Q ss_pred HHHHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 239 NLVGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
++|.+||..+|++|++ ++|+++||||+.-
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 9999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=241.82 Aligned_cols=200 Identities=25% Similarity=0.424 Sum_probs=161.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..++..++||||+.+++|..++.+ .+.+++..+..++.|++.||.||| +.+++|+||+
T Consensus 65 i~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--------------~~~i~H~dlk 130 (282)
T cd06643 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--------------ENKIIHRDLK 130 (282)
T ss_pred eeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCC
Confidence 4688889999999999999999999998865 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.++++|||++........ ......++..|+|||.+. +..++.. +|+||+||++|+|++|..
T Consensus 131 p~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 131 AGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEP 206 (282)
T ss_pred cccEEEccCCCEEEcccccccccccccc---ccccccccccccCHhhccccCCCCCCCCcc-chhhhHHHHHHHHccCCC
Confidence 9999999999999999999865432211 223446888999999984 3335555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+.......+....... ...+..++
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 235 (282)
T cd06643 207 PHHELNPMRVLLKIAKSEPPT---------------------------------------------------LAQPSRWS 235 (282)
T ss_pred CccccCHHHHHHHHhhcCCCC---------------------------------------------------CCCccccC
Confidence 997766544444433221100 11224567
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+.+||.+||+.||++|||+.++++||||+....
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 89999999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=246.86 Aligned_cols=232 Identities=25% Similarity=0.316 Sum_probs=151.3
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRA---------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
+++++++. .+...++||||+. ++|.+++... ..+++..++.++.|++.||.|||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-------------- 125 (317)
T cd07867 61 IALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-------------- 125 (317)
T ss_pred eeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 45677774 4568999999996 4898888532 24889999999999999999999
Q ss_pred CCceEecCCCCCcEEE----ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHH
Q psy1812 70 SKNIAHRDLKCENILM----TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGV 144 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||++ +.++.+||+|||++.................++..|+|||.+.+.. ++.+ +|+|||||
T Consensus 126 ~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlG~ 204 (317)
T cd07867 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIGC 204 (317)
T ss_pred hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcH-HHHHhHHH
Confidence 8999999999999999 4567899999999976543322111223456789999999987754 4555 99999999
Q ss_pred HHHHHHhCCCCCCChhHH---------HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 145 ITFIMLNAAMPFDDSNLK---------QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 145 ll~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
++|+|++|..||...... .....+........... +............ .... .......
T Consensus 205 il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~--~~~~-~~~~~~~ 272 (317)
T cd07867 205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKD---------WEDIRKMPEYPTL--QKDF-RRTTYAN 272 (317)
T ss_pred HHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhh---------hhhhhhcccchhh--hhhh-cccccCC
Confidence 999999999999654321 11111111111111000 1100000000000 0000 0000000
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
. .+...........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 273 ~----~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 273 S----SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred c----hhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00000011122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=243.61 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=163.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.+++|.+++...+ .+++..+..++.|++.||.||| +.+|+|+||
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------------~~~iiH~di 128 (285)
T cd05632 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--------------RENTVYRDL 128 (285)
T ss_pred eeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecCC
Confidence 357788888999999999999999999886543 6999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.+ +|+|||||+++++++|..||..
T Consensus 129 kp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 129 KPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CHHHEEECCCCCEEEecCCcceecCCCC----cccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999986533211 1234568999999999988888777 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+........ ...+..++.++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~ 233 (285)
T cd05632 204 RKEKVKREEVDRRVLETE--------------------------------------------------EVYSAKFSEEAK 233 (285)
T ss_pred CCHHHHHHHHHHhhhccc--------------------------------------------------cccCccCCHHHH
Confidence 654333322221111100 122355788899
Q ss_pred HHHHHhcCCCCCcccc-----HHHHhcCccccccccc
Q psy1812 239 NLVGQILEPDITKRIR-----LDAIKAHDWLRYKSMV 270 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~~~~ 270 (304)
+|+.+||..||++||| ++++++|+||+.....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=273.67 Aligned_cols=198 Identities=29% Similarity=0.483 Sum_probs=171.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++-.|++++++|+||||++||+|...|.+.+++++..+++++.+|+.||.-|| +.|+|||||||
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH--------------~mgyVHRDiKP 203 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH--------------SMGYVHRDIKP 203 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH--------------hccceeccCCc
Confidence 3567789999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc----C-CCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS----G-NPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~-~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
+|||+|..|.+|++|||.|-.....+. ..+..-+|||-|.+||++. + +.|+.. +|+||+||++|||+.|..|
T Consensus 204 DNvLld~~GHikLADFGsClkm~~dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 204 DNVLLDKSGHIKLADFGSCLKMDADGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred ceeEecccCcEeeccchhHHhcCCCCc--EEeccccCCCCccCHHHHHhhcCCccccCCc-cchhhhHHHHHHHHcCCCc
Confidence 999999999999999999876553222 2456678999999999985 2 346666 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhcc--ccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 156 FDDSNLKQLFKEQTSNI--LSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
|......+.+.+|++.. +.|| ....+
T Consensus 281 FYadslveTY~KIm~hk~~l~FP----------------------------------------------------~~~~V 308 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHKESLSFP----------------------------------------------------DETDV 308 (1317)
T ss_pred chHHHHHHHHHHHhchhhhcCCC----------------------------------------------------ccccc
Confidence 99999999999988762 2222 01347
Q ss_pred cHHHHHHHHHhcCCCCCcccc---HHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIR---LDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t---~~ell~~~wf~~~~ 268 (304)
|.+.++||++++.. |..|.. ++++..||||.+..
T Consensus 309 SeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 309 SEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred CHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCC
Confidence 99999999999875 889998 99999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=245.02 Aligned_cols=188 Identities=18% Similarity=0.285 Sum_probs=155.9
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++++.+ ....++||||+++|+|.+++.+.+.+++.....++.+++.||.|||+ ..+++||
T Consensus 81 v~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-------------~~~~~Hr 147 (283)
T PHA02988 81 LKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK-------------YTNKPYK 147 (283)
T ss_pred EEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh-------------cCCCCCC
Confidence 578888766 45789999999999999999988889999999999999999999993 2588899
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.+ +|+|||||++|+|++|..
T Consensus 148 dlkp~nill~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 148 NLTSVSFLVTENYKLKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred cCChhhEEECCCCcEEEcccchHhhhccc------cccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCC
Confidence 99999999999999999999998754322 123457889999999975 567776 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+.......+ .+..++
T Consensus 221 Pf~~~~~~~~~~~i~~~~~~~~----------------------------------------------------~~~~~~ 248 (283)
T PHA02988 221 PFENLTTKEIYDLIINKNNSLK----------------------------------------------------LPLDCP 248 (283)
T ss_pred CCCCCCHHHHHHHHHhcCCCCC----------------------------------------------------CCCcCc
Confidence 9988776665555443322111 123468
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+.+|+.+||+.||++|||++++++
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 89999999999999999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=245.01 Aligned_cols=227 Identities=22% Similarity=0.280 Sum_probs=166.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+ +|+|.+++.+.. .+++..++.++.|++.||.||| ..+++|+||+
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~i~H~dl~ 129 (298)
T cd07841 65 IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH--------------SNWILHRDLK 129 (298)
T ss_pred hhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecCCC
Confidence 46788899999999999999 889999998876 7999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.. +|+|||||+++++++|..+|.+
T Consensus 130 p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 130 PNNLLIASDGVLKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVG-VDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred hhhEEEcCCCCEEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcH-HHHHHHHHHHHHHHcCCccccC
Confidence 9999999999999999999875543221 122334577899999986543 4455 9999999999999999888877
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++........... +........... . . ....... .......+..+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~--------~-~-~~~~~~~-------~~~~~~~~~~~~ 259 (298)
T cd07841 206 DSDIDQLGKIFEALGTPTEEN---------WPGVTSLPDYVE--------F-K-PFPPTPL-------KQIFPAASDDAL 259 (298)
T ss_pred CccHHHHHHHHHHcCCCchhh---------hhhccccccccc--------c-c-ccCCcch-------hhhcccccHHHH
Confidence 665555544433221111000 000000000000 0 0 0000000 111245678899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+||.+||..+|++|||+.++++|+||++...+..
T Consensus 260 ~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 260 DLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred HHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 9999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=263.11 Aligned_cols=188 Identities=29% Similarity=0.510 Sum_probs=157.5
Q ss_pred eEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 12 RVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.+++||||+++|+|.+++... +.+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--------------~~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--------------SKHMIHRDIKSANILLCS 178 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCCCCHHHEEEeC
Confidence 478999999999999999753 46899999999999999999999 899999999999999999
Q ss_pred CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q psy1812 88 RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167 (304)
Q Consensus 88 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~ 167 (304)
++.+||+|||+++........ ......+|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+....+..
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~ 256 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256 (496)
T ss_pred CCCEEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999999998755432111 12345678999999999998888877 9999999999999999999988776655554
Q ss_pred hhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCC
Q psy1812 168 QTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEP 247 (304)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 247 (304)
+..+.. ...+..+++++.+++.+||+.
T Consensus 257 ~~~~~~-----------------------------------------------------~~~~~~~~~~l~~li~~~L~~ 283 (496)
T PTZ00283 257 TLAGRY-----------------------------------------------------DPLPPSISPEMQEIVTALLSS 283 (496)
T ss_pred HhcCCC-----------------------------------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 443221 112356788999999999999
Q ss_pred CCCccccHHHHhcCccccccc
Q psy1812 248 DITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 248 dP~~R~t~~ell~~~wf~~~~ 268 (304)
||.+||++.++++|||++...
T Consensus 284 dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 284 DPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ChhhCcCHHHHHhCHHHHHhh
Confidence 999999999999999987643
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=240.04 Aligned_cols=196 Identities=28% Similarity=0.413 Sum_probs=156.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.+++|.+++...+.+++..++.++.|++.||+||| ..+++|+||+|
T Consensus 69 i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dlkp 134 (267)
T cd06645 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH--------------SKGKMHRDIKG 134 (267)
T ss_pred eeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4678889999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++.++|+|||++........ ......|+..|+|||.+. ...++.+ +|+|||||++|++++|..||.
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 135 ANILLTDNGHVKLADFGVSAQITATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred HHEEECCCCCEEECcceeeeEccCccc---ccccccCcccccChhhhccccCCCCCch-hhhHHHHHHHHHHhcCCCCcc
Confidence 999999999999999999865432211 123446889999999974 3345555 999999999999999999986
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..................+ .......++..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~ 241 (267)
T cd06645 211 DLHPMRALFLMTKSNFQPP-------------------------------------------------KLKDKMKWSNSF 241 (267)
T ss_pred cccchhhHHhhhccCCCCC-------------------------------------------------cccccCCCCHHH
Confidence 5543222222111111000 000012357789
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDW 263 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~w 263 (304)
.+|+.+||+.+|++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=244.11 Aligned_cols=199 Identities=27% Similarity=0.474 Sum_probs=161.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..+...++||||+++++|.+++.+ ..+++.++..++.|++.||.||| +.+++|+||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH--------------~~gi~H~dLkp 144 (296)
T cd06654 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH--------------SNQVIHRDIKS 144 (296)
T ss_pred eeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 4678888899999999999999999999965 45899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.. +|+|||||++|++++|..||...+
T Consensus 145 ~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 145 DNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred HHEEEcCCCCEEECccccchhcccccc---ccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432211 1233467889999999988777776 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... . ...+..++..+.++
T Consensus 221 ~~~~~~~~~~~~~~-~--------------------------------------------------~~~~~~~~~~l~~l 249 (296)
T cd06654 221 PLRALYLIATNGTP-E--------------------------------------------------LQNPEKLSAIFRDF 249 (296)
T ss_pred HHHhHHHHhcCCCC-C--------------------------------------------------CCCccccCHHHHHH
Confidence 43322221111000 0 11124567889999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||..+|++|||++++++||||.....
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=243.60 Aligned_cols=203 Identities=27% Similarity=0.510 Sum_probs=164.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.|++|.+++.+.+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~p 129 (305)
T cd05609 64 VSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH--------------NYGIVHRDLKP 129 (305)
T ss_pred eeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCch
Confidence 4688899999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc------------ccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG------------RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+||+++.++.++++|||++........ .........++..|+|||.+.+..++.+ +|+|||||++|+
T Consensus 130 ~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~e 208 (305)
T cd05609 130 DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYE 208 (305)
T ss_pred HHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHH
Confidence 999999999999999998863211000 0001112356788999999988778777 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
+++|..||.+....+............+ .
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~ 237 (305)
T cd05609 209 FLVGCVPFFGDTPEELFGQVISDDIEWP---------------------------------------------------E 237 (305)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCC---------------------------------------------------C
Confidence 9999999987766555554443322211 0
Q ss_pred ccccccHHHHHHHHHhcCCCCCcccc---HHHHhcCcccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIR---LDAIKAHDWLRYKSM 269 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t---~~ell~~~wf~~~~~ 269 (304)
....++..+.++|.+||+.||++||+ +.++++||||.....
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 11246888999999999999999997 799999999977554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=241.50 Aligned_cols=201 Identities=26% Similarity=0.458 Sum_probs=164.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++|+||+.|++|.+++.. +.+++..+..++.|++.||+||| +.+++|+||+|
T Consensus 79 v~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~dl~p 143 (285)
T cd06648 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLH--------------AQGVIHRDIKS 143 (285)
T ss_pred heEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCh
Confidence 4688888999999999999999999999987 56899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|+|||.+.+..++.+ +|+|||||+++++++|..||...+
T Consensus 144 ~Nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 144 DSILLTSDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred hhEEEcCCCcEEEcccccchhhccCCc---ccccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999999999999998764332211 1233457889999999988777777 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... ...+..++..+.+|
T Consensus 220 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~l~~l 248 (285)
T cd06648 220 PLQAMKRIRDNLPPK---------------------------------------------------LKNLHKVSPRLRSF 248 (285)
T ss_pred HHHHHHHHHhcCCCC---------------------------------------------------CcccccCCHHHHHH
Confidence 544443332221000 01113367889999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+.+||..+|++|||+.++++|+||+..+.+.
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 249 LDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred HHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=241.61 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=162.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..+...++||||+++++|.+++.+. +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--------------~~~i~h~dl~ 130 (280)
T cd06611 65 VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--------------SHKVIHRDLK 130 (280)
T ss_pred eEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCC
Confidence 47889999999999999999999999999774 46999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.++|+|||.+........ ......++..|++||.+.. ..++.+ +|+||||+++|++++|..
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 131 AGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEP 206 (280)
T ss_pred hhhEEECCCCCEEEccCccchhhccccc---ccceeecchhhcCHHHHhhcccCCCCCCcc-ccHHHHHHHHHHHHhCCC
Confidence 9999999999999999998764432221 2233457889999999752 335555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+.......+....... ...+..++
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 235 (280)
T cd06611 207 PHHELNPMRVLLKILKSEPPT---------------------------------------------------LDQPSKWS 235 (280)
T ss_pred CcccCCHHHHHHHHhcCCCCC---------------------------------------------------cCCcccCC
Confidence 998776554444333221100 11224567
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+.++|.+||..+|.+|||+.++++||||+....
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 89999999999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=242.01 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=162.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++...+..++||||+++++|.+++.+.+ .+++..++.++.|++.||.||| ..+++|+||
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~di 121 (277)
T cd05577 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--------------QRRIVYRDL 121 (277)
T ss_pred eeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCC
Confidence 467888999999999999999999999998765 6999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++++|||.+....... ......++..|++||.+.+..++.. +|+||+||+++++++|+.||..
T Consensus 122 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 122 KPENVLLDDHGNVRISDLGLAVELKGGK----KIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CHHHEEECCCCCEEEccCcchhhhccCC----ccccccCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999986543211 1223457788999999988777766 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+....... ....+..+++.+.
T Consensus 197 ~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~ 226 (277)
T cd05577 197 RKEKVEKEELKRRTLEM--------------------------------------------------AVEYPDKFSPEAK 226 (277)
T ss_pred CcccccHHHHHhccccc--------------------------------------------------cccCCccCCHHHH
Confidence 54321111111111110 1223355789999
Q ss_pred HHHHHhcCCCCCccc-----cHHHHhcCccccccccc
Q psy1812 239 NLVGQILEPDITKRI-----RLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~~~ 270 (304)
++|.+||..||.+|| ++.++++||||+.....
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 999999999999999 89999999999865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=260.52 Aligned_cols=198 Identities=35% Similarity=0.635 Sum_probs=183.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
||+|.++..+..+|+||||+.+|.+++|+.+++.+.+..+..++.|+..|++||| .++|||||||+
T Consensus 118 vkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH--------------~k~ivHrdLk~ 183 (596)
T KOG0586|consen 118 VKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH--------------SKNIVHRDLKA 183 (596)
T ss_pred eeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh--------------hcceeccccch
Confidence 6899999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|++++.+.++||+|||++.++.... ...++||++.|.|||++.+..+..+.+|+||+|+++|-|+.|.+||++.+
T Consensus 184 eNilL~~~mnikIaDfgfS~~~~~~~----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 184 ENILLDENMNIKIADFGFSTFFDYGL----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred hhcccccccceeeeccccceeecccc----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 99999999999999999998765333 56789999999999999999999888999999999999999999999998
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..........+.+..+ -.++.++.++
T Consensus 260 lk~Lr~rvl~gk~rIp------------------------------------------------------~~ms~dce~l 285 (596)
T KOG0586|consen 260 LKELRPRVLRGKYRIP------------------------------------------------------FYMSCDCEDL 285 (596)
T ss_pred cccccchheeeeeccc------------------------------------------------------ceeechhHHH
Confidence 8877777777666554 5678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
|+++|.++|.+|++.+++++|.|.+.....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999988765
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=247.35 Aligned_cols=238 Identities=23% Similarity=0.323 Sum_probs=169.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|+|.++|+-.++.|||+|.+ |-+++++|.+++ +|+...++.+++|++.++++|| +.+++|.||
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--------------~~kl~HTDL 218 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--------------DLKLTHTDL 218 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--------------hcceeecCC
Confidence 57889999999999999999 669999999876 6999999999999999999999 899999999
Q ss_pred CCCcEEEec--------------------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCch
Q psy1812 79 KCENILMTK--------------------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLAD 138 (304)
Q Consensus 79 ~~~nil~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sD 138 (304)
||+|||+.. +..++++|||.+.+-.... ...+.|..|+|||++.+-+++.+ +|
T Consensus 219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~p-CD 291 (415)
T KOG0671|consen 219 KPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQP-CD 291 (415)
T ss_pred ChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCc-cC
Confidence 999999942 2237999999997543321 34567889999999999999999 99
Q ss_pred HHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhh
Q psy1812 139 IWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVK 218 (304)
Q Consensus 139 vwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (304)
|||+|||+.|+++|...|...+..+....+..-.++++..+..... ..+....-...+..-.... ..........+
T Consensus 292 vWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~-~~k~v~~~ckp 367 (415)
T KOG0671|consen 292 VWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKG-KSKYVFEPCKP 367 (415)
T ss_pred ceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccc-cchhhhcCCcc
Confidence 9999999999999999998877666444444444454422222111 0000000000000000000 00111111222
Q ss_pred hhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 219 LKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+..++. ..+..-.++.|||++||.+||.+|+|++|||.||||+...
T Consensus 368 l~~~~~----~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 368 LKKYML----QDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHhc----cCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 222221 1122345689999999999999999999999999999765
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=248.37 Aligned_cols=223 Identities=25% Similarity=0.373 Sum_probs=159.2
Q ss_pred ceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 2 QVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 2 ~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
++++++... ...+++++++ +++|.+++.. +.+++..++.++.|++.||.||| +.+|+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH 141 (343)
T cd07878 78 GLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIH--------------SAGIIH 141 (343)
T ss_pred hhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCeec
Confidence 455655432 4579999998 6799888754 46999999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|||||+||+++.++.+||+|||++..... ......++..|+|||++.+. .++.+ +|+|||||++|+|++|..
T Consensus 142 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~ 214 (343)
T cd07878 142 RDLKPSNVAVNEDCELRILDFGLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLKGKA 214 (343)
T ss_pred ccCChhhEEECCCCCEEEcCCccceecCC------CcCCccccccccCchHhcCCccCCch-hhhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999875432 12345688999999998774 45555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+..............+.... ....... .+. . ....+. ......+
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~---~-~~~~~~-------~~~~~~~ 271 (343)
T cd07878 215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH-ARKYIQS-----------LPH---M-PQQDLK-------KIFRGAN 271 (343)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh-HHHHhhc-----------ccc---c-cchhHH-------HhccCCC
Confidence 998877666555554433322211111000000 0000000 000 0 000000 1113457
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+.+.+||.+||..||.+|||+.++++||||.....+
T Consensus 272 ~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 272 PLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 789999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=241.11 Aligned_cols=201 Identities=24% Similarity=0.399 Sum_probs=159.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+..++..++||||+++++|..++... +.+++..+..++.+++.||.|||+ ..+++|+|
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------~~~i~H~d 128 (286)
T cd06622 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-------------EHNIIHRD 128 (286)
T ss_pred HhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-------------cCCEeeCC
Confidence 45778888899999999999999999999774 369999999999999999999993 36999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC------CCCCCchHHHHHHHHHHHHh
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP------YNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~sDvwslG~ll~~ll~ 151 (304)
|+|+||+++.++.++|+|||++...... ......++..|++||.+.+.. ++.. +|+|||||++|++++
T Consensus 129 l~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~~l~~ 202 (286)
T cd06622 129 VKPTNVLVNGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ-SDVWSLGLSILEMAL 202 (286)
T ss_pred CCHHHEEECCCCCEEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcc-cchHhHHHHHHHHHh
Confidence 9999999999999999999998644221 223345778899999985543 3445 999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 152 AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 152 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
|..||...........+....... ....+.
T Consensus 203 g~~pf~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~ 232 (286)
T cd06622 203 GRYPYPPETYANIFAQLSAIVDGD--------------------------------------------------PPTLPS 232 (286)
T ss_pred CCCCCCCcchhhHHHHHHHHhhcC--------------------------------------------------CCCCCc
Confidence 999996554333222211100000 022334
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.++.++.+||.+||..+|++||+++++++||||......
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 578999999999999999999999999999999887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=238.30 Aligned_cols=197 Identities=28% Similarity=0.445 Sum_probs=155.9
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.. ++..++++||+++++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||
T Consensus 67 ~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH--------------~~~i~H~~l 132 (266)
T cd06651 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH--------------SNMIVHRDI 132 (266)
T ss_pred eeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCC
Confidence 356777765 4678999999999999999998888999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++.................++..|+|||.+.+..++.. +|+||+||+++++++|+.||..
T Consensus 133 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 133 KGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred CHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccc
Confidence 999999999999999999998654321111111223457889999999988777777 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+......++..... ....+..+++.+.
T Consensus 212 ~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~ 239 (266)
T cd06651 212 YEAMAAIFKIATQPT----------------------------------------------------NPQLPSHISEHAR 239 (266)
T ss_pred cchHHHHHHHhcCCC----------------------------------------------------CCCCchhcCHHHH
Confidence 544333332221110 0122345678889
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
+++ +||..+|++|||++|+++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 56668999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=245.09 Aligned_cols=200 Identities=25% Similarity=0.464 Sum_probs=162.2
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..++..++||||+++++|.+++.+ +.+++..++.++.|++.||.||| +.+++|+||+|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH--------------~~~ivH~dlkp~ 147 (292)
T cd06658 83 DMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLH--------------NQGVIHRDIKSD 147 (292)
T ss_pred HHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecCCCHH
Confidence 456778888999999999999999998865 46899999999999999999999 889999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+++.++.++|+|||++........ ......++..|+|||.+.+..++.. +|+||||++++++++|..||...+.
T Consensus 148 Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 148 SILLTSDGRIKLSDFGFCAQVSKEVP---KRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred HEEEcCCCCEEEccCcchhhcccccc---cCceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999864432211 1233467889999999988777776 9999999999999999999977655
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
...+..+....... ......++..+.+++
T Consensus 224 ~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~li 252 (292)
T cd06658 224 LQAMRRIRDNLPPR---------------------------------------------------VKDSHKVSSVLRGFL 252 (292)
T ss_pred HHHHHHHHhcCCCc---------------------------------------------------cccccccCHHHHHHH
Confidence 44433322111000 111134678899999
Q ss_pred HHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 242 GQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 242 ~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+||..||++|||++++++||||+....+.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=243.18 Aligned_cols=199 Identities=27% Similarity=0.481 Sum_probs=163.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++|+||+.+++|.+++... .+++.++..++.+++.||.||| +.+++|+||+|
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH--------------~~~i~H~dL~p 143 (296)
T cd06655 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLH--------------ANQVIHRDIKS 143 (296)
T ss_pred eeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 46788999999999999999999999998764 5899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.. +|+|||||++|++++|..||.+.+
T Consensus 144 ~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 144 DNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred HHEEECCCCCEEEccCccchhcccccc---cCCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432211 1223457889999999988777777 999999999999999999998766
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... ...+..+++.+.+|
T Consensus 220 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~l 248 (296)
T cd06655 220 PLRALYLIATNGTPE---------------------------------------------------LQNPEKLSPIFRDF 248 (296)
T ss_pred HHHHHHHHHhcCCcc---------------------------------------------------cCCcccCCHHHHHH
Confidence 544333322111000 11224578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||..||++|||+.++++||||+....
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=238.07 Aligned_cols=199 Identities=29% Similarity=0.513 Sum_probs=162.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..+...++||||+.+++|.+++.+.+.+++..++.++.|++.||.||| ..+++|+||+|+
T Consensus 57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH--------------~~~i~H~di~~~ 122 (265)
T cd05579 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH--------------SNGIIHRDLKPD 122 (265)
T ss_pred HHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HcCeecCCCCHH
Confidence 566777888999999999999999999998778999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccc-----cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGR-----RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+++.++.++|+|||++......... ........++..|++||.......+.. +|+||||++++++++|..||
T Consensus 123 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~ 201 (265)
T cd05579 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPF 201 (265)
T ss_pred HeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999998754332110 001223457788999999988776666 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
........+..+..+....+ ....++..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~ 229 (265)
T cd05579 202 HGETPEEIFQNILNGKIEWP----------------------------------------------------EDVEVSDE 229 (265)
T ss_pred CCCCHHHHHHHHhcCCcCCC----------------------------------------------------ccccCCHH
Confidence 87776655555443222111 00124889
Q ss_pred HHHHHHHhcCCCCCccccH---HHHhcCcccccc
Q psy1812 237 VKNLVGQILEPDITKRIRL---DAIKAHDWLRYK 267 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~---~ell~~~wf~~~ 267 (304)
+.+|+.+||+.+|.+|||+ .++++||||+..
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=238.79 Aligned_cols=194 Identities=24% Similarity=0.405 Sum_probs=152.4
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 72 (304)
+++++.+.. ....++||||+.+++|.+++... ..+++..+..++.|++.||+||| +.+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--------------~~~ 131 (272)
T cd06637 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--------------QHK 131 (272)
T ss_pred eeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCC
Confidence 356666654 34689999999999999999874 36899999999999999999999 889
Q ss_pred eEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHH
Q psy1812 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITF 147 (304)
Q Consensus 73 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~ 147 (304)
++|+||+++||+++.++.++|+|||++........ ......|+..|+|||++.+ ..++.+ +|+||+||++|
T Consensus 132 ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~ 207 (272)
T cd06637 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAI 207 (272)
T ss_pred CccCCCCHHHEEECCCCCEEEccCCCceecccccc---cCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHH
Confidence 99999999999999999999999999875432211 2334568889999999863 345556 99999999999
Q ss_pred HHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 148 IMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 148 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|++|..||...........+..... ..
T Consensus 208 el~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------------------~~ 235 (272)
T cd06637 208 EMAEGAPPLCDMHPMRALFLIPRNPA----------------------------------------------------PR 235 (272)
T ss_pred HHHhCCCCccccCHHHHHHHHhcCCC----------------------------------------------------CC
Confidence 99999999965543222221111000 01
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.....++.++.+||.+||..+|.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1123467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=240.44 Aligned_cols=223 Identities=22% Similarity=0.352 Sum_probs=161.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..+...++||||++++.|..++.....+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 63 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH--------------~~~i~H~dl~p 128 (286)
T cd07847 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH--------------KHNCIHRDVKP 128 (286)
T ss_pred eeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCh
Confidence 4678899999999999999999888888877777999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++|+|||++........ ......++..|++||.+.+.. ++.+ +|+||||+++++|++|..||.+.
T Consensus 129 ~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 129 ENILITKQGQIKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred hhEEEcCCCcEEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCch-hhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876543321 122345778899999987644 5555 99999999999999999999876
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+.............. ++......... .+.. ...... ......++..+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---~~~~---~~~~~~-------~~~~~~~~~~~~~ 261 (286)
T cd07847 205 SDVDQLYLIRKTLGDLIPRHQQI----------FSTNQFFKGLS---IPEP---ETREPL-------ESKFPNISSPALS 261 (286)
T ss_pred ChHHHHHHHHHHhCCCChHHhhh----------ccccccccccc---CCCc---ccccCH-------HHHhccCCHHHHH
Confidence 65444443333222211000000 00000000000 0000 000000 0111346889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|+.+||..+|++|||+.+++.||||
T Consensus 262 li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 262 FLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHhcCCccccCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=258.06 Aligned_cols=190 Identities=31% Similarity=0.523 Sum_probs=167.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+.+.+++...+.+|||||||..|.|+.+|+..+.++......+..+|+.|++||| ...|+|||||.
T Consensus 175 I~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH--------------~hKIIHRDLKS 240 (904)
T KOG4721|consen 175 ITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH--------------LHKIIHRDLKS 240 (904)
T ss_pred eeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH--------------HhhHhhhccCC
Confidence 4577899999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
-||||..+..+||+|||-++..... +....++||..|||||+++..+.+.+ .|||||||++||||||..||.+-+
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred CceEeeccceEEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccc
Confidence 9999999999999999998754433 34567899999999999999999998 999999999999999999997766
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
...+++-+-.+.+. ..+|..+++.++-|
T Consensus 316 ssAIIwGVGsNsL~----------------------------------------------------LpvPstcP~GfklL 343 (904)
T KOG4721|consen 316 SSAIIWGVGSNSLH----------------------------------------------------LPVPSTCPDGFKLL 343 (904)
T ss_pred hheeEEeccCCccc----------------------------------------------------ccCcccCchHHHHH
Confidence 55444433333222 34557789999999
Q ss_pred HHHhcCCCCCccccHHHHhcC
Q psy1812 241 VGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~ 261 (304)
|+.||+-.|..||++++++.|
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHH
Confidence 999999999999999999998
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=236.26 Aligned_cols=195 Identities=28% Similarity=0.415 Sum_probs=158.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..+...++++||+.+++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+
T Consensus 61 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh--------------~~~i~H~dl~ 126 (256)
T cd06612 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH--------------SNKKIHRDIK 126 (256)
T ss_pred eeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCC
Confidence 4678889999999999999999999999976 446899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++|+|||++........ ......++..|++||++.+..++.+ +|+||||+++++|++|..||...
T Consensus 127 ~~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 127 AGNILLNEEGQAKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cceEEECCCCcEEEcccccchhcccCcc---ccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999875543221 2233457889999999988877777 99999999999999999999765
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
........+...... ....+..++..+.+
T Consensus 203 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~~ 231 (256)
T cd06612 203 HPMRAIFMIPNKPPP---------------------------------------------------TLSDPEKWSPEFND 231 (256)
T ss_pred chhhhhhhhccCCCC---------------------------------------------------CCCchhhcCHHHHH
Confidence 433222211110000 01112446788999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
++.+||+.||++|||++++++||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=239.59 Aligned_cols=219 Identities=24% Similarity=0.340 Sum_probs=159.3
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++.++ +..++||||+. |+|.+++... +.+++..++.++.|++.||+||| +.+++|+|
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--------------~~~i~H~d 125 (282)
T cd07831 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--------------RNGIFHRD 125 (282)
T ss_pred cceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecc
Confidence 4678888877 89999999997 5898888764 46899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|+||+++. +.+||+|||++....... ......++..|+|||.+........++|+||+||++++|++|..||.
T Consensus 126 l~p~ni~l~~-~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 126 IKPENILIKD-DILKLADFGSCRGIYSKP----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred cCHHHEEEcC-CCeEEEecccccccccCC----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 9999999999 999999999987543222 12234578899999987554433334999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+.+..+..........+....... ..... ..+. .....+ ......++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~----~~~~----~~~~~~-------~~~~~~~~~~~ 255 (282)
T cd07831 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKS----------RHMNY----NFPS----KKGTGL-------RKLLPNASAEG 255 (282)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHhhccc----------ccccc----cCcc----cccccH-------HHHcccccHHH
Confidence 87766665555443332221110000000 00000 0000 000000 01113568999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.++|.+||..+|++|||++++++||||
T Consensus 256 ~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 256 LDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHhccCcccccCHHHHhhCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=238.64 Aligned_cols=197 Identities=28% Similarity=0.471 Sum_probs=163.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..+...++|+||+.+++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh--------------~~~i~h~dl~p 126 (274)
T cd06609 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLH--------------EEGKIHRDIKA 126 (274)
T ss_pred eeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCCH
Confidence 46788888999999999999999999999875 7899999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|++||.+.+..++.+ +|+||||+++|++++|..||...+
T Consensus 127 ~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 127 ANILLSEEGDVKLADFGVSGQLTSTMS---KRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred HHEEECCCCCEEEcccccceeeccccc---ccccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCc
Confidence 999999999999999999876543321 2234457888999999988877777 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc-ccHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI-LSHQVKN 239 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (304)
.......+..... ...... ++..+.+
T Consensus 203 ~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~ 229 (274)
T cd06609 203 PMRVLFLIPKNNP-----------------------------------------------------PSLEGNKFSKPFKD 229 (274)
T ss_pred hHHHHHHhhhcCC-----------------------------------------------------CCCcccccCHHHHH
Confidence 4333332222111 111122 6788999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++.+||..+|++|||++++++||||+....
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999999999999988665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=238.93 Aligned_cols=224 Identities=24% Similarity=0.379 Sum_probs=162.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+ +++|.+++... ..+++..++.++.|++.||+||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~ 126 (286)
T cd07832 62 VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH--------------ANGIMHRDLK 126 (286)
T ss_pred cceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCcC
Confidence 47889999999999999999 99999999763 56999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++++|||++........ .......++..|+|||.+.+......++|+||+||+++++++|..+|.+.
T Consensus 127 p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 127 PANLLISADGVLKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred HHHEEEcCCCcEEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 9999999999999999999876543321 11233468889999999876554333499999999999999998888777
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+...........+..... ..++ ...... ......+. ......+..+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~~~~-------~~~~~~~~-------~~~~~~~~~~~~ 260 (286)
T cd07832 205 NDIEQLAIVFRTLGTPNEETWPGLTS---LPDY-------NKITFP-------ESKPIPLE-------EIFPDASPEALD 260 (286)
T ss_pred CHHHHHHHHHHHcCCCChHHHhhccC---cchh-------hcccCC-------CCCcchHH-------HhCCCccHHHHH
Confidence 66555554443332221101000000 0000 000000 00000010 111345789999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
||.+||..+|++|||++++++||||.
T Consensus 261 li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 261 LLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHhccChhhCCCHHHHhhCcCcC
Confidence 99999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=243.06 Aligned_cols=235 Identities=18% Similarity=0.277 Sum_probs=163.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++...+..+++|||+.+|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+|+||
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--------------~~~ivH~dl 127 (314)
T cd08216 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--------------SKGFIHRSV 127 (314)
T ss_pred hhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCC
Confidence 46788899999999999999999999999864 45899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccc----cccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGR----RVLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g 152 (304)
+|+||+++.++.++++||+.+......... ........++..|+|||++.+. .++.+ +|+|||||+++++++|
T Consensus 128 k~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g 206 (314)
T cd08216 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANG 206 (314)
T ss_pred CcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhC
Confidence 999999999999999999988644322111 0112234567789999998663 35666 9999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||..............+...... ... ............. ...................
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~ 266 (314)
T cd08216 207 HVPFKDMPATQMLLEKVRGTVPCLL------DKS-TYPLYEDSMSQSR-------------SSNEHPNNRDSVDHPYTRT 266 (314)
T ss_pred CCCCCCCCHHHHHHHHHhccCcccc------ccC-chhhhcCCcCccc-------------ccccccchhhhhhcchhhH
Confidence 9999765443332221221111100 000 0000000000000 0000000000111223345
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
++.++.+|+.+||..||++|||++++++||||+..+..
T Consensus 267 ~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 267 FSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred HHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 67899999999999999999999999999999987743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=235.06 Aligned_cols=196 Identities=27% Similarity=0.422 Sum_probs=158.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..++.++++|||+.+++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+
T Consensus 63 ~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--------------~~~i~h~dl~ 128 (262)
T cd06613 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH--------------ETGKIHRDIK 128 (262)
T ss_pred hceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------------hCCceecCCC
Confidence 57889999999999999999999999999876 68999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC---CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN---PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.++|+|||++........ ......++..|++||.+.+. .++.. +|+||||+++++|++|..||
T Consensus 129 p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 129 GANILLTEDGDVKLADFGVSAQLTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPM 204 (262)
T ss_pred hhhEEECCCCCEEECccccchhhhhhhh---ccccccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999875433211 12334578889999998766 67666 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+........ .......++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~ 235 (262)
T cd06613 205 FDLHPMRALFLISKSNFPPP-------------------------------------------------KLKDKEKWSPV 235 (262)
T ss_pred CCCCHHHHHHHHHhccCCCc-------------------------------------------------cccchhhhhHH
Confidence 77654433332222111100 00111345778
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDW 263 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~w 263 (304)
+.+|+.+||..+|.+|||+++++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=238.78 Aligned_cols=221 Identities=24% Similarity=0.334 Sum_probs=158.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+++..++||||+. ++|.+++... +.+++..++.++.|++.||+||| ..+++|+||
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------------~~~i~H~~l 126 (284)
T cd07860 62 VKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--------------SHRVLHRDL 126 (284)
T ss_pred cchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCC
Confidence 467888889999999999996 5899998663 46899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++++|||++........ ......++..|+|||.+.+......++|+|||||++|++++|..||.+
T Consensus 127 ~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 127 KPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999865432211 122334678899999987655433349999999999999999999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+......++........................ ...+ ....+. .....++..++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-------~~~~~~-------~~~~~~~~~~~ 258 (284)
T cd07860 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS-----------FPKW-------ARQDFS-------KVVPPLDEDGR 258 (284)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh-----------cccc-------cccCHH-------HHcccCCHHHH
Confidence 6655444444333222211111100000000000 0000 000000 11134678899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
++|.+||..||.+|||++++++||||
T Consensus 259 ~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 259 DLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=238.33 Aligned_cols=200 Identities=24% Similarity=0.398 Sum_probs=159.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..++..++||||+++++|..++.+ .+.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~dlk 137 (292)
T cd06644 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--------------SMKIIHRDLK 137 (292)
T ss_pred eeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--------------cCCeeecCCC
Confidence 4678888899999999999999999988765 456899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.. +|+|||||++|+|++|..
T Consensus 138 p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEP 213 (292)
T ss_pred cceEEEcCCCCEEEccCccceecccccc---ccceecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCC
Confidence 9999999999999999998764332211 1233457889999999853 334555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+......++....... ...+..++
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 242 (292)
T cd06644 214 PHHELNPMRVLLKIAKSEPPT---------------------------------------------------LSQPSKWS 242 (292)
T ss_pred CCccccHHHHHHHHhcCCCcc---------------------------------------------------CCCCcccC
Confidence 997665444333322111000 11124567
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.++.++|.+||..+|++||+++++++||||+....
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 88999999999999999999999999999986554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=235.31 Aligned_cols=193 Identities=30% Similarity=0.558 Sum_probs=161.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~~l 127 (256)
T cd08218 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--------------DRKILHRDI 127 (256)
T ss_pred eeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCCC
Confidence 467888999999999999999999999997643 5789999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++++|||++........ ......++..|+|||.+.+...+.+ +|+|||||+++++++|..||..
T Consensus 128 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 128 KSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred CHHHEEEcCCCCEEEeeccceeecCcchh---hhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccC
Confidence 99999999999999999999875433221 1223457888999999988777766 9999999999999999999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+... ..+..++.++.
T Consensus 204 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 230 (256)
T cd08218 204 GNMKNLVLKIIRGSYP-----------------------------------------------------PVSSHYSYDLR 230 (256)
T ss_pred CCHHHHHHHHhcCCCC-----------------------------------------------------CCcccCCHHHH
Confidence 6655555544433211 12345788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+||+.+|++||+++++++||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=249.04 Aligned_cols=226 Identities=25% Similarity=0.330 Sum_probs=154.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+. ++|.+++... +.+++..++.++.|++.||.||| ..+|+|||||
T Consensus 120 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDlk 184 (357)
T PHA03209 120 IRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--------------AQRIIHRDVK 184 (357)
T ss_pred cChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 578899999999999999996 5999998764 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC-CCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP-FDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p-f~~ 158 (304)
|+||+++.++.+||+|||++....... ......|+..|+|||++.+..++.+ +|+|||||++|+|+++..+ |..
T Consensus 185 p~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 185 TENIFINDVDQVCIGDLGAAQFPVVAP----AFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred HHHEEECCCCCEEEecCccccccccCc----ccccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccC
Confidence 999999999999999999986432211 1234568999999999988888877 9999999999999985544 432
Q ss_pred hhHH---------HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 159 SNLK---------QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 159 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
.... ..+..+.......+...... .............. ... ...... ....
T Consensus 260 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~---------------~~~~~~---~~~~ 319 (357)
T PHA03209 260 PPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD-PGSRLVRGFIEYAS-LER---------------QPYTRY---PCFQ 319 (357)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC-CccHHHHHHHhhcc-cCC---------------Cccccc---HHHh
Confidence 2110 11111111111111000000 00000000000000 000 000000 0000
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
...++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 320 ~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 320 RVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1245778889999999999999999999999999985
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=236.35 Aligned_cols=201 Identities=29% Similarity=0.471 Sum_probs=160.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+..++..++|||++++++|.+++.+. +.+++..++.++.|++.||.+|| +.+++|+|
T Consensus 62 ~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--------------~~~i~h~~ 127 (267)
T cd06610 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--------------SNGQIHRD 127 (267)
T ss_pred EEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCC
Confidence 35778888999999999999999999999874 35899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|+|+||+++.++.++++|||++.......... .......++..|++||.+... .++.+ +|+|||||++++|++|..|
T Consensus 128 l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p 206 (267)
T cd06610 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAP 206 (267)
T ss_pred CCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcc-cchHhHhHHHHHHHhCCCC
Confidence 99999999999999999999987554432211 112334578899999998776 45555 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|...+....+.+......... ........++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~ 238 (267)
T cd06610 207 YSKYPPMKVLMLTLQNDPPSL------------------------------------------------ETGADYKKYSK 238 (267)
T ss_pred ccccChhhhHHHHhcCCCCCc------------------------------------------------CCccccccccH
Confidence 976655444443332210000 00001145788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+.+++.+||..||++|||++++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=254.61 Aligned_cols=197 Identities=26% Similarity=0.513 Sum_probs=181.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
||+|.+|.+++++|++||-|-||+|...|...+.|.+..++.++..+++|++||| .++|++|||||
T Consensus 483 vrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH--------------~k~iIYRDLKP 548 (732)
T KOG0614|consen 483 VRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH--------------RKGIIYRDLKP 548 (732)
T ss_pred HHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH--------------hcCceeccCCh
Confidence 6899999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|.+++.+|-+||.|||+++.+.... +.+++|||+.|.|||++.....+.. +|.||||+++|||++|..||.+.+
T Consensus 549 ENllLd~~Gy~KLVDFGFAKki~~g~----KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 549 ENLLLDNRGYLKLVDFGFAKKIGSGR----KTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred hheeeccCCceEEeehhhHHHhccCC----ceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999999999999999998765543 5789999999999999999999888 999999999999999999999999
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
+...+..|.++.-. ...|..++....+|
T Consensus 624 pmktYn~ILkGid~----------------------------------------------------i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 624 PMKTYNLILKGIDK----------------------------------------------------IEFPRRITKTATDL 651 (732)
T ss_pred hHHHHHHHHhhhhh----------------------------------------------------hhcccccchhHHHH
Confidence 99999988877432 23457789999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
|+++-..+|.+|+. +.+|.+|.||.+-.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 99999999999995 88999999998743
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=255.06 Aligned_cols=186 Identities=29% Similarity=0.540 Sum_probs=159.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.++.+.|+|||.++|+.|.+.+.....+. .++..|+.+|+.|+.||| ..|+|||||||
T Consensus 379 v~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH--------------~~gvvhRDLkp 443 (612)
T KOG0603|consen 379 VKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLH--------------EQGVVHRDLKP 443 (612)
T ss_pred eeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHH--------------hcCeeecCCCh
Confidence 467899999999999999999999999998776555 888899999999999999 89999999999
Q ss_pred CcEEE-ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILM-TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+|||+ +..+.++|+|||.++..... ..+.+-|..|.|||+.....++.. +||||||+++|+||+|+.||...
T Consensus 444 ~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 444 GNILLDGSAGHLRLTYFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred hheeecCCCCcEEEEEechhhhCchh------hcccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccC
Confidence 99999 68899999999998754332 334466788999999998889888 99999999999999999999766
Q ss_pred hHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 160 NLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 160 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
... ++..++..+ .....+|.+++
T Consensus 517 P~~~ei~~~i~~~--------------------------------------------------------~~s~~vS~~AK 540 (612)
T KOG0603|consen 517 PAGIEIHTRIQMP--------------------------------------------------------KFSECVSDEAK 540 (612)
T ss_pred CchHHHHHhhcCC--------------------------------------------------------ccccccCHHHH
Confidence 544 444433322 11256899999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+||++||++||.+|+++++++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=241.41 Aligned_cols=231 Identities=23% Similarity=0.306 Sum_probs=166.8
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... +..++||||+.+ +|.+++... ..+++..++.++.|++.||.||| +.+++|+|
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~d 133 (309)
T cd07845 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH--------------ENFIIHRD 133 (309)
T ss_pred cceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCC
Confidence 4677777654 578999999974 899988764 57899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.. +|+||+||++|++++|..||
T Consensus 134 l~p~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslG~il~el~~g~~~f 209 (309)
T cd07845 134 LKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKPLL 209 (309)
T ss_pred CCHHHEEECCCCCEEECccceeeecCCccC---CCCcccccccccChhhhcCCCCcCch-HHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999875543221 112233567899999987644 5555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+.+..+..........++..+... . .......... .. .........+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~----------~~----~~~~~~~~~~~~~ 265 (309)
T cd07845 210 PGKSEIEQLDLIIQLLGTPNESIWPGFSDL---------P-LVGKFTLPKQ----------PY----NNLKHKFPWLSEA 265 (309)
T ss_pred CCCCHHHHHHHHHHhcCCCChhhchhhhcc---------c-ccccccccCC----------CC----CchHHhccccCHH
Confidence 888777766666544332221111000000 0 0000000000 00 0000111335888
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
+.+||.+||.+||++|||++++++||||+....+..+.
T Consensus 266 ~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~ 303 (309)
T cd07845 266 GLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE 303 (309)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCC
Confidence 99999999999999999999999999999888876655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=244.44 Aligned_cols=192 Identities=21% Similarity=0.394 Sum_probs=149.0
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhc-----------------------------------------------
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRA----------------------------------------------- 32 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------- 32 (304)
|++++.+.. +..+++||||+++|+|.+++...
T Consensus 74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 467777765 45689999999999999999753
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEecc
Q psy1812 33 ---------------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFG 97 (304)
Q Consensus 33 ---------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg 97 (304)
.++++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDiKp~Nil~~~~~~~kl~DfG 219 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA--------------SRKCIHRDLAARNILLSENNVVKICDFG 219 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEECCCCccceEEEcCCCcEEEeecc
Confidence 23778889999999999999999 8999999999999999999999999999
Q ss_pred CcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcccccc
Q psy1812 98 FARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQ 176 (304)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 176 (304)
+++........ .......++..|+|||++.+..++.+ +|+|||||++|+|++ |..||.+......+.........
T Consensus 220 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-- 295 (338)
T cd05102 220 LARDIYKDPDY-VRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-- 295 (338)
T ss_pred cccccccCcch-hcccCCCCCccccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC--
Confidence 98754322111 11223345678999999988888877 999999999999997 99999765432222221111000
Q ss_pred chhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHH
Q psy1812 177 VKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLD 256 (304)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ 256 (304)
...+..+++.+.+++.+||..||.+|||+.
T Consensus 296 --------------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 296 --------------------------------------------------MRAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred --------------------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 112245678899999999999999999999
Q ss_pred HHhc
Q psy1812 257 AIKA 260 (304)
Q Consensus 257 ell~ 260 (304)
++++
T Consensus 326 el~~ 329 (338)
T cd05102 326 ALVE 329 (338)
T ss_pred HHHH
Confidence 9976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=237.14 Aligned_cols=196 Identities=28% Similarity=0.413 Sum_probs=155.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.+++|.+++...+.+++..+..++.|++.||.||| +.+++|+|++|
T Consensus 69 i~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 134 (267)
T cd06646 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH--------------SKGKMHRDIKG 134 (267)
T ss_pred eeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 4678889999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.. +|+||+||++++|++|..||.
T Consensus 135 ~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~-~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 135 ANILLTDNGDVKLADFGVAAKITATIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQL-CDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred HHEEECCCCCEEECcCccceeeccccc---ccCccccCccccCHhHcccccCCCCcch-hhHHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999875532211 122345788999999984 2335555 999999999999999999986
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+.......+ .......++..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~ 241 (267)
T cd06646 211 DLHPMRALFLMSKSNFQPP-------------------------------------------------KLKDKTKWSSTF 241 (267)
T ss_pred ccchhhhheeeecCCCCCC-------------------------------------------------CCccccccCHHH
Confidence 5443222111111110000 001113467899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDW 263 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~w 263 (304)
.+||++||..+|++|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=242.78 Aligned_cols=202 Identities=26% Similarity=0.466 Sum_probs=162.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+++++|.+++.+ ..+++..+..++.+++.||.||| +.+++|+||+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH--------------~~~i~H~dL~p 143 (297)
T cd06656 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLH--------------SNQVIHRDIKS 143 (297)
T ss_pred eeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 4688999999999999999999999999965 45899999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|++||.+.+..++.. +|+|||||++|++++|..||.+.+
T Consensus 144 ~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 144 DNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred HHEEECCCCCEEECcCccceEccCCcc---CcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432211 1233467889999999988777776 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+.... .+ ....+..++..+.+|
T Consensus 220 ~~~~~~~~~~~~--~~-------------------------------------------------~~~~~~~~~~~~~~l 248 (297)
T cd06656 220 PLRALYLIATNG--TP-------------------------------------------------ELQNPERLSAVFRDF 248 (297)
T ss_pred cchheeeeccCC--CC-------------------------------------------------CCCCccccCHHHHHH
Confidence 322211111000 00 011234567889999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+.+||..+|++|||++++++||||+..+...+
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 99999999999999999999999998776443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=236.51 Aligned_cols=201 Identities=23% Similarity=0.386 Sum_probs=159.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+.+++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 66 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH--------------~~~i~H~~i~~ 131 (268)
T cd06630 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--------------ENQIIHRDVKG 131 (268)
T ss_pred ehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 4678899999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCC-CeEEEeccCcccccCcccc-cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRF-NVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++ .++|+|||.+......... ........++..|+|||.+.+..++.. +|+||+|++++++++|..||..
T Consensus 132 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred HHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCC
Confidence 999998776 5899999998655432111 111223457889999999988777776 9999999999999999999964
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+...... ......+..+++.+.
T Consensus 211 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~ 241 (268)
T cd06630 211 EKHSNHLALIFKIASA-------------------------------------------------TTAPSIPEHLSPGLR 241 (268)
T ss_pred CCCcchHHHHHHHhcc-------------------------------------------------CCCCCCchhhCHHHH
Confidence 4321111111100000 000223355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
+++.+||..+|.+|||+.++++||||+
T Consensus 242 ~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 242 DVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=237.20 Aligned_cols=220 Identities=24% Similarity=0.338 Sum_probs=160.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+++..++||||++ ++|.+++.... .+++..++.++.|++.||+||| +.+++|+||
T Consensus 61 v~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--------------~~~~~H~dl 125 (283)
T cd07835 61 VRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--------------SHRVLHRDL 125 (283)
T ss_pred cCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeCCCC
Confidence 467888899999999999995 69999998765 6899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.. ++.. +|+||||+++|++++|..||.
T Consensus 126 ~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 126 KPQNLLIDREGALKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred CHHHEEEcCCCcEEEeecccccccCCCcc---ccCccccccCCCCCceeecCcccCcH-HHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999865432211 112234578899999886654 4555 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+......++...........+..... ..+........ .. .........++..+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---------------~~-------~~~~~~~~~~~~~~ 256 (283)
T cd07835 202 GDSEIDQLFRIFRTLGTPDEDVWPGVTS---LPDYKPTFPKW---------------AR-------QDLSKVVPNLDEDG 256 (283)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhhhhh---chhhhhhcccc---------------cc-------cchhhhcCCCCHHH
Confidence 7766555554443322222111000000 00000000000 00 00011235578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.++|.+||+.+|.+|||++++++||||
T Consensus 257 ~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 257 LDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=237.69 Aligned_cols=196 Identities=22% Similarity=0.383 Sum_probs=153.2
Q ss_pred CceeeeeeeC-----CeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQRG-----PRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++... +..++||||+++|+|.++++. ...+++..++.++.|++.||+||| +.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~ 147 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--------------NN 147 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hC
Confidence 3567776543 468999999999999998863 356899999999999999999999 89
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-----CCCCCchHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-----YNPKLADIWSLGVIT 146 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~sDvwslG~ll 146 (304)
+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.... ++.+ +|+|||||++
T Consensus 148 ~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slGvi~ 223 (291)
T cd06639 148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDAR-CDVWSLGITA 223 (291)
T ss_pred CeeccCCCHHHEEEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCc-cchHHHHHHH
Confidence 999999999999999999999999999875432221 122345788999999975433 4455 9999999999
Q ss_pred HHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 147 FIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 147 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
|++++|+.||...+.......+.......
T Consensus 224 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------------------------- 252 (291)
T cd06639 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPT--------------------------------------------------- 252 (291)
T ss_pred HHHhhCCCCCCCCcHHHHHHHHhcCCCCC---------------------------------------------------
Confidence 99999999997665433333222111100
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
...+..++..+.+|+.+||..+|++||++.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 011234567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=232.38 Aligned_cols=193 Identities=28% Similarity=0.460 Sum_probs=162.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+++..+++|||+++|+|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~dl 127 (256)
T cd08221 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--------------KAGILHRDI 127 (256)
T ss_pred eEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCccccCC
Confidence 47889999999999999999999999999875 46899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.+||+|||++........ ......++..|.|||.+.+..++.. +|+||||++++++++|..||..
T Consensus 128 ~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 128 KTLNIFLTKAGLIKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred ChHhEEEeCCCCEEECcCcceEEcccccc---cccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999875433221 2234568899999999988777766 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+... .....++..+.
T Consensus 204 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 230 (256)
T cd08221 204 TNPLNLVVKIVQGNYT-----------------------------------------------------PVVSVYSSELI 230 (256)
T ss_pred CCHHHHHHHHHcCCCC-----------------------------------------------------CCccccCHHHH
Confidence 7665555544432211 11245688899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+||..+|.+||+++++++|+|+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=253.80 Aligned_cols=230 Identities=20% Similarity=0.284 Sum_probs=157.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++|||++. ++|.+++... +.+++..++.++.|++.||.||| ..+|+|||||
T Consensus 223 v~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------------~~gIvHrDLK 287 (461)
T PHA03211 223 LALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--------------GEGIIHRDIK 287 (461)
T ss_pred CcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEECcCC
Confidence 578999999999999999995 6999998764 46999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++|+|||++......... .......|+..|++||++.+..++.+ +|+|||||++|++++|..++...
T Consensus 288 P~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 288 TENVLVNGPEDICLGDFGAACFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred HHHEEECCCCCEEEcccCCceeccccccc-ccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccC
Confidence 99999999999999999998754322111 11234568999999999988888877 99999999999999987554221
Q ss_pred h--------HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 160 N--------LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 160 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
. .......+........ ...... .................... ....+. ...
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~~-~~~~~~-~~~l~~~~~~~~~~~~~~~~----------~~~~~~--------~~~ 425 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHVD-EFPQHA-GSRLVSQYRHRAARNRRPAY----------TRPAWT--------RYY 425 (461)
T ss_pred CcccccCCcHHHHHHHHHhhccccc-cCCCCc-chHHHHHHHhhhhcccCCcc----------CCcchh--------hhc
Confidence 1 1111111111110000 000000 00000000000000000000 000000 012
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
.++..+.+||.+||.+||.+|||+.|+|+||||+.+
T Consensus 426 ~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~ 461 (461)
T PHA03211 426 KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461 (461)
T ss_pred cccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence 356789999999999999999999999999999863
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=237.11 Aligned_cols=192 Identities=23% Similarity=0.373 Sum_probs=158.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++...+..+++|||+++|+|.+++... +.+++..++.++.|++.||.|||
T Consensus 71 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--------- 141 (283)
T cd05048 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--------- 141 (283)
T ss_pred ceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 46788888889999999999999999999764 45788999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.+ +|+|||||
T Consensus 142 -----~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~ 214 (283)
T cd05048 142 -----SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR-VQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGV 214 (283)
T ss_pred -----hCCeeccccccceEEEcCCCcEEECCCcceeecccccccc-ccCCCcccccccCHHHhccCcCchh-hhHHHHHH
Confidence 8999999999999999999999999999987543322111 1223456788999999988888777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|++++ |..||.+....+....+.....
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------------------------------------------- 244 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-------------------------------------------------- 244 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--------------------------------------------------
Confidence 9999998 9999987766555554433221
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+|+.+||+.||.+||++++++++
T Consensus 245 ---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 ---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.30 Aligned_cols=201 Identities=25% Similarity=0.459 Sum_probs=163.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 81 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--------------~~~ivH~dl~p 145 (297)
T cd06659 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLH--------------SQGVIHRDIKS 145 (297)
T ss_pred hhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 3678888899999999999999999998765 46899999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.+ +|+|||||++++|++|..||...+
T Consensus 146 ~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 146 DSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred HHeEEccCCcEEEeechhHhhcccccc---cccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999864332211 1234568899999999988777776 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... ......++..+.++
T Consensus 222 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~l~~~ 250 (297)
T cd06659 222 PVQAMKRLRDSPPPK---------------------------------------------------LKNAHKISPVLRDF 250 (297)
T ss_pred HHHHHHHHhccCCCC---------------------------------------------------ccccCCCCHHHHHH
Confidence 444433322110000 11124567889999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
|.+||+.+|++||+++++++||||.....+.
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 9999999999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=235.74 Aligned_cols=194 Identities=28% Similarity=0.471 Sum_probs=158.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl 78 (304)
+++++.+..++..++|+||+.+++|.+++... ..+++..++.++.|++.||.||| + .+++|+||
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~~i~H~dl 127 (265)
T cd06605 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--------------EKHKIIHRDV 127 (265)
T ss_pred hhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc--------------CCCCeecCCC
Confidence 35678888899999999999999999999876 78999999999999999999999 7 89999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.. +|+||||++++++++|..||..
T Consensus 128 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 128 KPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred CHHHEEECCCCCEEEeecccchhhHHHH-----hhcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999986543221 112567889999999988877777 9999999999999999999965
Q ss_pred hh-----HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc-
Q psy1812 159 SN-----LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI- 232 (304)
Q Consensus 159 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (304)
.+ ..+....+..... ...+..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~ 228 (265)
T cd06605 202 ENDPPDGIFELLQYIVNEPP-----------------------------------------------------PRLPSGK 228 (265)
T ss_pred cccccccHHHHHHHHhcCCC-----------------------------------------------------CCCChhh
Confidence 42 1111211111100 011122
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
++.++.++|.+||..+|++|||+.+++.||||+..
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 68889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=235.08 Aligned_cols=185 Identities=25% Similarity=0.403 Sum_probs=152.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..+...++||||+.||+|.+++.+...+++..+..++.|++.||+||| +.+++|+||||
T Consensus 48 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~dlkp 113 (237)
T cd05576 48 VCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH--------------REGIVCRDLNP 113 (237)
T ss_pred eehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCH
Confidence 4677888889999999999999999999988778999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||.+...... .....++..|++||...+..++.. +|+||+|+++|++++|..|+....
T Consensus 114 ~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~ 186 (237)
T cd05576 114 NNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENMYCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHP 186 (237)
T ss_pred HHEEEcCCCCEEEecccchhccccc------cccCCcCccccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCc
Confidence 9999999999999999987544322 122345677999999987777777 999999999999999998774321
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.. +. .. .....+..++..+.+|
T Consensus 187 ~~-----~~-~~----------------------------------------------------~~~~~~~~~~~~~~~l 208 (237)
T cd05576 187 SG-----IN-TH----------------------------------------------------TTLNIPEWVSEEARSL 208 (237)
T ss_pred hh-----cc-cc----------------------------------------------------cccCCcccCCHHHHHH
Confidence 10 00 00 0012235578899999
Q ss_pred HHHhcCCCCCccccH-----HHHhcCccc
Q psy1812 241 VGQILEPDITKRIRL-----DAIKAHDWL 264 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-----~ell~~~wf 264 (304)
|.+||+.||++|+|+ +++++||||
T Consensus 209 i~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=231.87 Aligned_cols=192 Identities=32% Similarity=0.519 Sum_probs=158.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+++++|.+++... ..+++..++.++.+++.||+||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------------~~~i~h~dl 127 (256)
T cd08220 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--------------TKLILHRDL 127 (256)
T ss_pred hheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCC
Confidence 46788888899999999999999999999774 35899999999999999999999 899999999
Q ss_pred CCCcEEEecCC-CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 79 KCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+|+||+++.++ .++++|||++....... ......++..|+|||.+.+...+.+ +|+||||++++++++|..||.
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 128 KTQNILLDKHKMVVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred CHHHEEEcCCCCEEEEccCCCceecCCCc----cccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcc
Confidence 99999998654 57999999987554321 1223457889999999988777766 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+..... ...+..++..+
T Consensus 203 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l 229 (256)
T cd08220 203 AANLPALVLKIMSGTF-----------------------------------------------------APISDRYSPDL 229 (256)
T ss_pred cCchHHHHHHHHhcCC-----------------------------------------------------CCCCCCcCHHH
Confidence 7765544443332211 12234578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+++.+||..+|.+|||++++++||||
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=235.71 Aligned_cols=195 Identities=24% Similarity=0.441 Sum_probs=153.6
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++.+... ..+++||||+++++|.+++... ..+++..++.++.|++.||.||| +
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--------------~ 131 (275)
T cd06608 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--------------E 131 (275)
T ss_pred heEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--------------c
Confidence 4677777653 4599999999999999998763 47999999999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-----CCCCCCchHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-----PYNPKLADIWSLGVI 145 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~sDvwslG~l 145 (304)
.+++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+... .++.+ +|+|||||+
T Consensus 132 ~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~i 207 (275)
T cd06608 132 NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGIT 207 (275)
T ss_pred CCcccCCCCHHHEEEccCCeEEECCCccceecccchh---hhcCccccccccCHhHhcccccccCCcccc-ccHHHhHHH
Confidence 9999999999999999999999999999865432221 23345688899999987532 34555 999999999
Q ss_pred HHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc
Q psy1812 146 TFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225 (304)
Q Consensus 146 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (304)
++++++|..||...+.......+.......
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------------------------- 237 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPT-------------------------------------------------- 237 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCC--------------------------------------------------
Confidence 999999999997654433333322211100
Q ss_pred cccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 226 QVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 226 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
...+..++..+.+||.+||..||++|||++++++|||+
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 -LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11123467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=234.03 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=158.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++...+..++||||+++++|.+++.+.+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~~ 136 (272)
T cd06629 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH--------------SKGILHRDLKA 136 (272)
T ss_pred ceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--------------hCCeeecCCCh
Confidence 4678888999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++.++++|||++........ ........++..|++||.+.... ++.+ +|+||||++++++++|..||..
T Consensus 137 ~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 137 DNLLVDADGICKISDFGISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred hhEEEcCCCeEEEeecccccccccccc-ccccccccCCccccCHHHhccccCCCCcc-chhHHHHHHHHHHHhCCCCCcC
Confidence 999999999999999999875432111 11123345788999999987654 5555 9999999999999999999965
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+......++........ ........++..+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~ 246 (272)
T cd06629 215 EEAIAAMFKLGNKRSAPP------------------------------------------------IPPDVSMNLSPVAL 246 (272)
T ss_pred cchHHHHHHhhccccCCc------------------------------------------------CCccccccCCHHHH
Confidence 544333222211100000 00111134688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
++|.+||..+|++|||++++++||||
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 247 DFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=237.43 Aligned_cols=193 Identities=24% Similarity=0.395 Sum_probs=151.3
Q ss_pred ceeeeee------eCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 2 QVHSILQ------RGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 2 ~~~~~~~------~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
++++.+. .....+++|||+.+|+|.+++... ..+++..++.++.|++.||.||| +.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------------~~~i 142 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--------------AHKV 142 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCc
Confidence 5566664 356899999999999999999764 35889999999999999999999 8999
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ 148 (304)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.. ..++.+ +|+|||||++|+
T Consensus 143 vH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~e 218 (282)
T cd06636 143 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIE 218 (282)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHH
Confidence 9999999999999999999999999864432211 2234568889999999863 345556 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|..||...........+...... ..
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~ 246 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNPPP----------------------------------------------------KL 246 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCCCC----------------------------------------------------CC
Confidence 99999999655433222211111000 11
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
....++..+.+||.+||..||.+|||+.++++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 113468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=237.34 Aligned_cols=225 Identities=22% Similarity=0.363 Sum_probs=162.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.++.+..++.+...+++..++.++.+++.||.||| ..+++|+||++
T Consensus 63 ~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~dl~~ 128 (288)
T cd07833 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH--------------SHNIIHRDIKP 128 (288)
T ss_pred eehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4678888889999999999998777766666667999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++........ .......++..|+|||++.+. .++.+ +|+||||++++++++|..||.+.
T Consensus 129 ~ni~~~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 129 ENILVSESGVLKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKP-VDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred HHeEECCCCCEEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCch-hhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999875543322 122345678889999999887 55555 99999999999999999999876
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+.......+.......... ...... ...+. .. ........+..++.++.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~--~~~~~----~~------~~~~~~~~~~~~~~~~~~ 263 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSN----------PRFAGV--AFPEP----SQ------PESLERRYPGKVSSPALD 263 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccC----------cccccc--ccCCC----CC------cHHHHHhcCCccchHHHH
Confidence 655544444333222221111100000 000000 00000 00 000011223446899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|+++||..+|++|||++++++||||
T Consensus 264 li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 264 FLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHhccCchhcccHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=236.41 Aligned_cols=198 Identities=28% Similarity=0.515 Sum_probs=159.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..+...++||||+++++|.++++.. .+++..++.++.+++.||.||| ..+++|+||+|
T Consensus 65 i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh--------------~~~i~H~dl~p 129 (277)
T cd06917 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIH--------------KVGVIHRDIKA 129 (277)
T ss_pred eeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCcCH
Confidence 46788888999999999999999999998764 7899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++++|||++........ ......++..|+|||.+.+.. ++.. +|+|||||++|+|++|..||...
T Consensus 130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 130 ANILVTNTGNVKLCDFGVAALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTK-ADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred HHEEEcCCCCEEEccCCceeecCCCcc---ccccccCCcceeCHHHhccCCccccc-hhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876543321 223346888999999986544 4555 99999999999999999999766
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+.... .+ ......++.++.+
T Consensus 206 ~~~~~~~~~~~~~--~~--------------------------------------------------~~~~~~~~~~~~~ 233 (277)
T cd06917 206 DAFRAMMLIPKSK--PP--------------------------------------------------RLEDNGYSKLLRE 233 (277)
T ss_pred ChhhhhhccccCC--CC--------------------------------------------------CCCcccCCHHHHH
Confidence 5433222111100 00 0001226788999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++.+||+.||++|||+.++++|+||+....
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999999999987664
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=237.46 Aligned_cols=195 Identities=33% Similarity=0.573 Sum_probs=163.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+++|.+++.+.+.+++..++.++.|++.||.+|| +.+++|+||+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh--------------~~~~~H~dl~~ 130 (280)
T cd05581 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH--------------SKGIIHRDLKP 130 (280)
T ss_pred hhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCCH
Confidence 3567788888999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccc-----------------cccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGR-----------------RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
+||+++.++.++++|||++......... ........++..|++||.......+.. +|+||||
T Consensus 131 ~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG 209 (280)
T cd05581 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALG 209 (280)
T ss_pred HHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHH
Confidence 9999999999999999998765433211 012233457789999999887777666 9999999
Q ss_pred HHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 144 VITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 144 ~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++++++++|..||...+....+..+....
T Consensus 210 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------------------------------------- 238 (280)
T cd05581 210 CIIYQMLTGKPPFRGSNEYLTFQKILKLE--------------------------------------------------- 238 (280)
T ss_pred HHHHHHHhCCCCCCCccHHHHHHHHHhcC---------------------------------------------------
Confidence 99999999999998776544444433222
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccH----HHHhcCccc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRL----DAIKAHDWL 264 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~ell~~~wf 264 (304)
...+..+++.+.+||.+||+.+|.+|||+ +++++||||
T Consensus 239 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 ---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22235568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=232.22 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=157.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+...+..++|+||+++++|.+++.+.+.+++..++.++.+++.||.||| +.+++|+||++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------------~~~i~H~dl~~ 127 (264)
T cd06626 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH--------------SHGIVHRDIKP 127 (264)
T ss_pred hheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 4677888889999999999999999999998878999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccccccc-ccCccCCccccccccccCCC---CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVL-SRTYCGSAAYAAPEVISGNP---YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~---~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++............ .....++..|++||.+.+.. .+.. +|+||||++++++++|..||
T Consensus 128 ~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred HHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCc
Confidence 9999999999999999998765443322111 12345788999999997765 5566 99999999999999999999
Q ss_pred CChhHHHH-HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DDSNLKQL-FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
...+.... ...+... ..+ .......++.
T Consensus 207 ~~~~~~~~~~~~~~~~--~~~-------------------------------------------------~~~~~~~~~~ 235 (264)
T cd06626 207 SELDNEFQIMFHVGAG--HKP-------------------------------------------------PIPDSLQLSP 235 (264)
T ss_pred cCCcchHHHHHHHhcC--CCC-------------------------------------------------CCCcccccCH
Confidence 65532211 1111110 000 0011123478
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+.+|+.+||..+|++|||+++++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=233.26 Aligned_cols=197 Identities=28% Similarity=0.425 Sum_probs=156.5
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.+ +..+++||||+++++|.+++.+.+.+++..+..++.|++.||+||| +.+++|+||
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~i~H~dl 132 (265)
T cd06652 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH--------------SNMIVHRDI 132 (265)
T ss_pred eeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCCC
Confidence 356777665 3578899999999999999988778999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++.................++..|+|||.+.+..++.. +|+|||||++|++++|+.||..
T Consensus 133 ~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 133 KGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred CHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCc
Confidence 999999999999999999998754322111111233457889999999988777776 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+......+...... ....+..++..+.
T Consensus 212 ~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~ 239 (265)
T cd06652 212 FEAMAAIFKIATQPT----------------------------------------------------NPVLPPHVSDHCR 239 (265)
T ss_pred cchHHHHHHHhcCCC----------------------------------------------------CCCCchhhCHHHH
Confidence 543333322221100 0122345688899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
++|.+|+. +|++||+++++++|||++
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999995 999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=236.23 Aligned_cols=198 Identities=29% Similarity=0.485 Sum_probs=162.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+.+++..++||||+.||+|.+++.. +.+++..+..++.+++.||.||| +.+++|+||+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh--------------~~~ivH~dl~p 129 (277)
T cd06640 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLH--------------SEKKIHRDIKA 129 (277)
T ss_pred eeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCcCCCh
Confidence 4688999999999999999999999999975 56899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|.|||.+.+...+.. +|+|||||++|++++|..||...+
T Consensus 130 ~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 130 ANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred hhEEEcCCCCEEEcccccceeccCCcc---ccccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999865433221 1223457788999999988777777 999999999999999999997665
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ...+..++..+.++
T Consensus 206 ~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~l 232 (277)
T cd06640 206 PMRVLFLIPKNNP-----------------------------------------------------PTLTGEFSKPFKEF 232 (277)
T ss_pred hHhHhhhhhcCCC-----------------------------------------------------CCCchhhhHHHHHH
Confidence 4333222111100 11223467789999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+.+||..+|++||+++++++|+||......
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 999999999999999999999999887753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=235.33 Aligned_cols=190 Identities=28% Similarity=0.490 Sum_probs=158.9
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..+...++|+||+.|++|.+++.....+++..+..++.|++.||.||| +.+++|+||+|+
T Consensus 64 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh--------------~~~i~h~dl~~~ 129 (258)
T cd05578 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH--------------SKGIIHRDIKPD 129 (258)
T ss_pred HHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCHH
Confidence 466778888999999999999999999988878999999999999999999999 889999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+++.++.++++|||.+....... ......++..|+|||.+.+..++.+ +|+||||+++|++++|..||.....
T Consensus 130 nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 130 NILLDEQGHVHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred HeEEcCCCCEEEeecccccccCCCc----cccccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999987544322 1234457889999999988777777 9999999999999999999976653
Q ss_pred ---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 162 ---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 162 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
........... ...+..++..+.
T Consensus 205 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~ 230 (258)
T cd05578 205 TIRDQIRAKQETAD------------------------------------------------------VLYPATWSTEAI 230 (258)
T ss_pred cHHHHHHHHhcccc------------------------------------------------------ccCcccCcHHHH
Confidence 22222111110 223355678999
Q ss_pred HHHHHhcCCCCCccccH--HHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRL--DAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~--~ell~~~wf 264 (304)
++|.+||..||.+||++ +|+++||||
T Consensus 231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 231 DAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=232.94 Aligned_cols=196 Identities=28% Similarity=0.487 Sum_probs=162.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~ 79 (304)
+++++.+..++..++||||+++++|.+++.+.+.+++..++.++.|++.|++||| + .+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh--------------~~~~~~H~~l~ 127 (264)
T cd06623 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH--------------TKRHIIHRDIK 127 (264)
T ss_pred eeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------------ccCCCccCCCC
Confidence 4678889999999999999999999999998888999999999999999999999 7 999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++++|||++........ ......++..|+|||.+....++.. +|+||||+++|++++|..||...
T Consensus 128 ~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 128 PSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred HHHEEECCCCCEEEccCccceecccCCC---cccceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999875543222 1123457889999999988777766 99999999999999999999766
Q ss_pred h---HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc-ccH
Q psy1812 160 N---LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI-LSH 235 (304)
Q Consensus 160 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (304)
+ ..+....+..... ...+.. ++.
T Consensus 204 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 230 (264)
T cd06623 204 GQPSFFELMQAICDGPP-----------------------------------------------------PSLPAEEFSP 230 (264)
T ss_pred cccCHHHHHHHHhcCCC-----------------------------------------------------CCCCcccCCH
Confidence 3 2222222221110 111233 788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
.+.++|.+||..+|++|||+.++++||||+..
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=231.43 Aligned_cols=191 Identities=34% Similarity=0.651 Sum_probs=161.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..++..++||||+.+++|.+++.....+++..+..++.|++.||.||| +.+++|+||+|+
T Consensus 57 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh--------------~~~~~H~~l~p~ 122 (250)
T cd05123 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH--------------SLGIIYRDLKPE 122 (250)
T ss_pred HHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCcc
Confidence 456788889999999999999999999998888999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+++.++.++++|||++........ ......++..|++||...+...+.. +|+||||++++++++|..||...+.
T Consensus 123 ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 123 NILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred eEEEcCCCcEEEeecCcceecccCCC---cccCCcCCccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999875433211 2334567889999999988777666 9999999999999999999977665
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
......+.... ...+..++..+.+++
T Consensus 199 ~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~l~~~i 224 (250)
T cd05123 199 KEIYEKILKDP------------------------------------------------------LRFPEFLSPEARDLI 224 (250)
T ss_pred HHHHHHHhcCC------------------------------------------------------CCCCCCCCHHHHHHH
Confidence 44444433221 223355688999999
Q ss_pred HHhcCCCCCccccH---HHHhcCccc
Q psy1812 242 GQILEPDITKRIRL---DAIKAHDWL 264 (304)
Q Consensus 242 ~~~L~~dP~~R~t~---~ell~~~wf 264 (304)
++||..||++|||+ +++++||||
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=231.59 Aligned_cols=193 Identities=30% Similarity=0.474 Sum_probs=159.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..+..+++|+||+++++|.+++.+.+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~~ 130 (258)
T cd06632 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH--------------DRNTVHRDIKG 130 (258)
T ss_pred hheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 4678888899999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++....... ......++..|++||.+.... ++.. +|+||||++++++++|..||...
T Consensus 131 ~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 131 ANILVDTNGVVKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred HHEEECCCCCEEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999987543322 123455788899999987665 6666 99999999999999999999765
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.......++.... .. ...+..++..+.+
T Consensus 206 ~~~~~~~~~~~~~-~~---------------------------------------------------~~~~~~~~~~~~~ 233 (258)
T cd06632 206 EGVAAVFKIGRSK-EL---------------------------------------------------PPIPDHLSDEAKD 233 (258)
T ss_pred cHHHHHHHHHhcc-cC---------------------------------------------------CCcCCCcCHHHHH
Confidence 5333332222100 00 1223457889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|+.+||..+|++|||+++++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=237.23 Aligned_cols=223 Identities=26% Similarity=0.388 Sum_probs=161.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++++|.++......+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~h~~l~p 128 (286)
T cd07846 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH--------------SHNIIHRDIKP 128 (286)
T ss_pred hhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 3577888889999999999999999888777667999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++++|||++........ ......++..|+|||++.+.. ++.+ +|+||||++++++++|..||...
T Consensus 129 ~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 129 ENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRA-VDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred HHEEECCCCcEEEEeeeeeeeccCCcc---ccCcccceeeccCcHHhccccccCch-HhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999875433221 223345788999999987644 4444 99999999999999999999766
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
...+....+..................... ...... ........ ....+.++..+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~ 261 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLF----------AGMRLP------EVKEIEPL-------EKRFPKLSGLVLD 261 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHh----------hccccc------cccCcchH-------HHhCCCcCHHHHH
Confidence 554444444332222110000000000000 000000 00000000 1112467899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
|+.+||..+|++|||+.++++||||
T Consensus 262 li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 262 LAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHhcCCcccchhHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=242.01 Aligned_cols=236 Identities=27% Similarity=0.370 Sum_probs=171.4
Q ss_pred ceeeeeeeCC-----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 2 QVHSILQRGP-----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 2 ~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
++++++.... ..++||||+. ++|.+++.+.+.+++..++.++.+++.||.||| +.+++|+
T Consensus 63 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH--------------~~gi~H~ 127 (330)
T cd07834 63 GLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH--------------SANVIHR 127 (330)
T ss_pred hhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecC
Confidence 4556665554 7899999997 589999988888999999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
||+|+||+++.++.++|+|||++.................++..|+|||.+.+. .++.. +|+||+|++++++++|..|
T Consensus 128 dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 128 DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred CCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcc-hhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999997654432111122334578889999999887 56666 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+..+....+.................. ........ ........+ ......++.
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~-------~~~~~~~~~ 263 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSE-KARNYLKS---------------LPKKPKKPL-------SKLFPGASP 263 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhcccc-chhhHHhh---------------cccCCcchh-------HHhcccCCH
Confidence 9888877666665554333221111000000 00000000 000000000 111234788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccCC
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLP 276 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~ 276 (304)
.+.+||.+||+.+|.+|||+++++.||||++...+.....+
T Consensus 264 ~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~ 304 (330)
T cd07834 264 EAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304 (330)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC
Confidence 99999999999999999999999999999988876554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=234.45 Aligned_cols=211 Identities=25% Similarity=0.401 Sum_probs=162.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+...+.+++||||+++++|.+++...+.+++..+..++.+++.||.|||+ ..+++|+||+|
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-------------~~~i~H~dl~p 132 (284)
T cd06620 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN-------------VHRIMHRDIKP 132 (284)
T ss_pred ceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-------------hcCeeccCCCH
Confidence 46888999999999999999999999999888889999999999999999999993 36899999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.+ +|+|||||+++++++|..||....
T Consensus 133 ~nil~~~~~~~~l~d~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 133 SNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred HHEEECCCCcEEEccCCcccchhhh-----ccCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999987643221 1223468899999999988777777 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc-cccc-ccccHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ-VKVK-DILSHQVK 238 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~ 238 (304)
..+......... .+ ....+.... ...+ ..++..+.
T Consensus 207 ~~~~~~~~~~~~-----------------~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd06620 207 IDDDGQDDPMGI-----------------LD--------------------------LLQQIVQEPPPRLPSSDFPEDLR 243 (284)
T ss_pred hhhhhhhhhhHH-----------------HH--------------------------HHHHHhhccCCCCCchhcCHHHH
Confidence 321100000000 00 000000000 0011 22677899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
+|+.+||..||++|||++++++|+||.........
T Consensus 244 ~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~ 278 (284)
T cd06620 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278 (284)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccccccccC
Confidence 99999999999999999999999999887654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=235.30 Aligned_cols=220 Identities=24% Similarity=0.325 Sum_probs=155.6
Q ss_pred CceeeeeeeCCe-----EEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPR-----VFIFMRYADNGDLLDHIKRA-----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++++..... .++||||+++ +|.+++... ..+++..++.++.|++.||.||| .
T Consensus 64 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------------~ 128 (295)
T cd07837 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--------------K 128 (295)
T ss_pred cceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--------------H
Confidence 467777776555 8999999985 899988653 35799999999999999999999 8
Q ss_pred CceEecCCCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFI 148 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ 148 (304)
.+++|+||+|+||+++. ++.++|+|||++........ ......+++.|+|||.+.+.. ++.+ +|+||||+++|+
T Consensus 129 ~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~~l~~ 204 (295)
T cd07837 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTP-VDIWSVGCIFAE 204 (295)
T ss_pred CCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCch-HHHHHHHHHHHH
Confidence 99999999999999998 88999999999875432211 112234677899999886544 4555 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|..||.+.+......++........... +........... . .. ...... ..
T Consensus 205 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~------~------~~----~~~~~~-------~~ 258 (295)
T cd07837 205 MSRKQPLFPGDSELQQLLHIFKLLGTPTEQV---WPGVSKLRDWHE------F------PQ----WKPQDL-------SR 258 (295)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHhCCCChhh---Ccchhhccchhh------c------Cc----ccchhH-------HH
Confidence 9999999987766555444433221111000 000000000000 0 00 000000 01
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
..+.++..+.+||.+||..||++|||+++++.||||+
T Consensus 259 ~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 259 AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1245788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=234.82 Aligned_cols=200 Identities=31% Similarity=0.482 Sum_probs=164.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..++..++|+||+++++|.+++.... .+++..+..++.+++.||.||| ..+++|+||+
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH--------------~~gi~H~dl~ 143 (286)
T cd06614 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--------------SQNVIHRDIK 143 (286)
T ss_pred eEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCCC
Confidence 467889999999999999999999999999876 7999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.+ +|+||||+++|++++|..||...
T Consensus 144 p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 144 SDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hhhEEEcCCCCEEECccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998865433221 1223347788999999988777777 99999999999999999999776
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+....... ...+..++..+.+
T Consensus 220 ~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~l~~ 248 (286)
T cd06614 220 PPLRALFLITTKGIPP---------------------------------------------------LKNPEKWSPEFKD 248 (286)
T ss_pred CHHHHHHHHHhcCCCC---------------------------------------------------CcchhhCCHHHHH
Confidence 5543333322211100 1111336788999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+||+.+|.+|||+.++++|+||+..+.
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 999999999999999999999999999554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=232.25 Aligned_cols=195 Identities=31% Similarity=0.475 Sum_probs=153.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPV--AESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l--~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+..++..++|+||+.+++|.+++... +.+ ++..+..++.|++.||.||| +.+++|+|
T Consensus 68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~i~h~d 133 (268)
T cd06624 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--------------DNQIVHRD 133 (268)
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH--------------HCCEeecC
Confidence 46788889999999999999999999999864 456 88999999999999999999 89999999
Q ss_pred CCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 78 LKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 78 l~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+|+||+++. ++.++|+|||++........ ......++..|+|||.+.+.. ++.+ +|+||||++++++++|..
T Consensus 134 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~-~Dv~slGvvl~~l~~g~~ 209 (268)
T cd06624 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAP-ADIWSLGCTIVEMATGKP 209 (268)
T ss_pred CCHHHEEEcCCCCeEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCch-hhhHHHHHHHHHHHhCCC
Confidence 9999999976 67899999999865432211 122345788999999986543 5555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||............. . ........+..++
T Consensus 210 p~~~~~~~~~~~~~~-~--------------------------------------------------~~~~~~~~~~~~~ 238 (268)
T cd06624 210 PFIELGEPQAAMFKV-G--------------------------------------------------MFKIHPEIPESLS 238 (268)
T ss_pred CCccccChhhhHhhh-h--------------------------------------------------hhccCCCCCcccC
Confidence 996432211100000 0 0000122345678
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+|+.+||..+|++|||+.++++||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=230.91 Aligned_cols=191 Identities=20% Similarity=0.337 Sum_probs=154.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++. ++..++||||+.+|+|.+++...+.+++..+..++.|++.||+||| +.+++|+||||
T Consensus 59 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~i~H~dlkp 123 (257)
T cd05116 59 VRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE--------------ETNFVHRDLAA 123 (257)
T ss_pred ceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecccch
Confidence 45677665 4567999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
.||+++.++.+||+|||++.................++..|+|||.+....++.. +|+|||||++|++++ |..||...
T Consensus 124 ~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 124 RNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred hhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998755433221111122234578999999987777776 999999999999998 99999877
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+..+.. ...+..++.++.+
T Consensus 203 ~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~~ 229 (257)
T cd05116 203 KGNEVTQMIESGER-----------------------------------------------------MECPQRCPPEMYD 229 (257)
T ss_pred CHHHHHHHHHCCCC-----------------------------------------------------CCCCCCCCHHHHH
Confidence 66555554443221 1223457889999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|.+||+.||++||+++++.+
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHhccCchhCcCHHHHHH
Confidence 999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=234.75 Aligned_cols=220 Identities=23% Similarity=0.355 Sum_probs=160.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+..++..++||||+.+ +|.+++...+ .+++..+..++.|++.||.||| +.+++|+|
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~h~d 125 (284)
T cd07836 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--------------ENRVLHRD 125 (284)
T ss_pred eeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--------------HCCeeeCC
Confidence 4688999999999999999985 9999987643 5899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|+||+++.++.++++|||++........ ......++..|++||.+.+.. ++.. +|+|||||+++++++|..||
T Consensus 126 l~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~~ 201 (284)
T cd07836 126 LKPQNLLINKRGELKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTS-IDIWSVGCIMAEMITGRPLF 201 (284)
T ss_pred CCHHHEEECCCCcEEEeecchhhhhcCCcc---ccccccccccccChHHhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999864432211 122345678899999986654 4455 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..............+... .... ...... ..... ......+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~~----~~~~~-------~~~~~~~~~~ 256 (284)
T cd07836 202 PGTNNEDQLLKIFRIMGTPTESTWPGISQL----------PEYK----PTFPRY----PPQDL-------QQLFPHADPL 256 (284)
T ss_pred CCCCcHHHHHHHHHHhCCCChhhHHHHhcC----------chhc----ccccCC----ChHHH-------HHHhhhcCcH
Confidence 877766655554433222111000000000 0000 000000 00000 1112346889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+++.+||+.||.+||++.++++||||
T Consensus 257 ~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 257 GIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.38 Aligned_cols=205 Identities=30% Similarity=0.478 Sum_probs=167.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPV--AESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l--~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|++.+.+..++++-|+||-++||+|.+.|+. +|++ .|..+..+.+||++||.||| +..|||||
T Consensus 635 VrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH--------------en~IVHRD 700 (1226)
T KOG4279|consen 635 VRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH--------------ENKIVHRD 700 (1226)
T ss_pred HHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh--------------hcceeecc
Confidence 5677888889999999999999999999976 6888 89999999999999999999 89999999
Q ss_pred CCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 78 LKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 78 l~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||.+|||++. .|.+||+|||-++..-. -.....++.||.-|||||++.+++ |+.. +|||||||.+.||.||+.
T Consensus 701 IKGDNVLvNTySGvlKISDFGTsKRLAg---inP~TETFTGTLQYMAPEvIDqG~RGYG~a-ADIWS~GCT~vEMATGrP 776 (1226)
T KOG4279|consen 701 IKGDNVLVNTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEVIDQGPRGYGKA-ADIWSFGCTMVEMATGRP 776 (1226)
T ss_pred ccCCcEEEeeccceEEecccccchhhcc---CCccccccccchhhhChHhhccCCcCCCch-hhhhhccceeEeeccCCC
Confidence 9999999975 57789999999875422 222567888999999999997654 4455 999999999999999999
Q ss_pred CCCC--hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 155 PFDD--SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 155 pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
||.. +....+|+- +++. .....|..
T Consensus 777 PF~ElgspqAAMFkV---GmyK--------------------------------------------------vHP~iPee 803 (1226)
T KOG4279|consen 777 PFVELGSPQAAMFKV---GMYK--------------------------------------------------VHPPIPEE 803 (1226)
T ss_pred CeeecCChhHhhhhh---ccee--------------------------------------------------cCCCCcHH
Confidence 9943 333333331 1111 12445577
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccCC
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLP 276 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~ 276 (304)
++.+++.||.+|+.+||.+||+|.++|.+||++...+..++.++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 89999999999999999999999999999999998544343333
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=229.69 Aligned_cols=192 Identities=21% Similarity=0.403 Sum_probs=160.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++..+..+++||||+++++|.+++... ..+++..++.++.|++.||.||| +.
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--------------~~ 124 (262)
T cd00192 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--------------SK 124 (262)
T ss_pred heeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--------------cC
Confidence 46788888899999999999999999999886 67999999999999999999999 89
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+++|+||+|+||+++.++.++++|||.+......... .......++..|+|||.+....++.+ +|+||+|++++++++
T Consensus 125 ~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~ 202 (262)
T cd00192 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFT 202 (262)
T ss_pred CcccCccCcceEEECCCCcEEEccccccccccccccc-ccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHh
Confidence 9999999999999999999999999999765443211 12234456788999999988777777 999999999999999
Q ss_pred -CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 -AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||......+....+..... ...+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~ 229 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKGYR-----------------------------------------------------LPKP 229 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------CCCC
Confidence 6999987766555554443211 1223
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
..++.++.+++.+||..+|++|||+.+++++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 230 EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 5568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=234.93 Aligned_cols=222 Identities=24% Similarity=0.361 Sum_probs=160.0
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... ...++||||+.+ +|.+++.... .+++..++.++.|++.||+||| +.+++|+|
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~i~H~d 131 (293)
T cd07843 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--------------DNWILHRD 131 (293)
T ss_pred EEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecc
Confidence 3567777766 899999999975 9999997754 5899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. .+.. +|+||+|+++++|++|..||
T Consensus 132 l~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~~f 207 (293)
T cd07843 132 LKTSNLLLNNRGILKICDFGLAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTA-IDMWSVGCIFAELLTKKPLF 207 (293)
T ss_pred CCHHHEEECCCCcEEEeecCceeeccCCcc---ccccccccccccCchhhcCCccccch-hhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999875543321 122345678899999987655 3555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc-ccH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI-LSH 235 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (304)
...+......++...........+..+. ... .... ..........+ ....+.. +++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-~~~~----------~~~~~~~~~~~---~~~~~~~~~~~ 264 (293)
T cd07843 208 PGKSEIDQLNKIFKLLGTPTEKIWPGFS---------ELP-GAKK----------KTFTKYPYNQL---RKKFPALSLSD 264 (293)
T ss_pred CCCChHHHHHHHHHHhCCCchHHHHHhh---------ccc-hhcc----------cccccccchhh---hccccccCCCh
Confidence 8877666655554333222111111000 000 0000 00000000000 0112222 588
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+.++|++||+.+|++|||+.|+++||||
T Consensus 265 ~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 265 NGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=241.87 Aligned_cols=235 Identities=26% Similarity=0.393 Sum_probs=167.7
Q ss_pred ceeeeee----eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 2 QVHSILQ----RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 2 ~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
++++++. .....++||||+. |+|.+++...+.+++..++.++.|++.||.||| +.+++|+|
T Consensus 68 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~d 132 (334)
T cd07855 68 AIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH--------------SANVIHRD 132 (334)
T ss_pred CHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCC
Confidence 4555554 3457999999996 699999988888999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|+|+||+++.++.+||+|||++......... ........++..|+|||.+.+. .++.+ +|+|||||++|+|++|+.|
T Consensus 133 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~Di~slG~~l~el~~g~~p 211 (334)
T cd07855 133 LKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA-IDMWSVGCIFAEMLGRRQL 211 (334)
T ss_pred CCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccc-cchHHHHHHHHHHHcCCCc
Confidence 9999999999999999999998754332211 1112344688899999998664 35555 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+.......+.......+........... ....+... . ......+ .......+.
T Consensus 212 f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~-~~~~~~~~---~------------~~~~~~~-------~~~~~~~~~ 268 (334)
T cd07855 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR-VRKYIQNL---P------------RKQPVPW-------SKIFPKASP 268 (334)
T ss_pred cCCCChHHHHHHHHHHhCCChhHhhhhhchhh-HHHHHhhc---c------------cCCCCCH-------HHHcccCCH
Confidence 98877666555555443333211111000000 00000000 0 0000000 011234688
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccC
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVL 275 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~ 275 (304)
.+.++|++||+.+|++|||++++++||||++...+.....
T Consensus 269 ~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~ 308 (334)
T cd07855 269 EALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT 308 (334)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence 9999999999999999999999999999998877665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=254.52 Aligned_cols=231 Identities=21% Similarity=0.321 Sum_probs=160.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++..++..++|++++. ++|.+++.... ......++.++.|++.||+||| +.+|+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--------------~~gIiH 290 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--------------DKKLIH 290 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--------------hCCeec
Confidence 578999999999999999995 58888886532 2446778899999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC-
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM- 154 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~- 154 (304)
|||||+|||++.++.+||+|||++..+...... ......|+..|+|||++.+..++.. +|||||||++|+|++|..
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA--FDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCccccc--ccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999765432211 2234578999999999998888877 999999999999999875
Q ss_pred CCCCh--hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 155 PFDDS--NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 155 pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
|+... +....+.++............. ......+..... ........+..++. ...
T Consensus 368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~i~~~--------------~~~~~~~~~~~~~~-----~~~ 425 (501)
T PHA03210 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPD---PPCKLFDYIDSA--------------EIDHAGHSVPPLIR-----NLG 425 (501)
T ss_pred CccCCCCCHHHHHHHHHHhcccChhhcCC---cHHHHHHHhhhh--------------hcccCccchhhHHH-----hcC
Confidence 44322 2233333333222111111100 000000000000 00000001111111 123
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
++..+.++|.+||.+||++|||+.|+|+||||+......
T Consensus 426 ~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~ 464 (501)
T PHA03210 426 LPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE 464 (501)
T ss_pred CChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence 577899999999999999999999999999998876543
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=232.11 Aligned_cols=230 Identities=24% Similarity=0.311 Sum_probs=164.9
Q ss_pred eeeee-CCeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 5 SILQR-GPRVFIFMRYADNGDLLDHIKRA-----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 5 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
.+|-+ +..+++++||.++ +|...|+-+ +.++...++.+++||+.|+.||| +.-|+||||
T Consensus 94 ~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--------------~NWvlHRDL 158 (438)
T KOG0666|consen 94 KVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--------------SNWVLHRDL 158 (438)
T ss_pred HHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--------------hhheeeccC
Confidence 34444 7899999999998 999999764 35899999999999999999999 899999999
Q ss_pred CCCcEEEecC----CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 79 KCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 79 ~~~nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||.||++..+ |.+||+|+|+++.+...-..--.....+-|..|+|||.+.+....+++.|+|++|||+.||++...
T Consensus 159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence 9999999877 899999999999765432211112334567889999999999888888999999999999999998
Q ss_pred CCCChhH---------HHHHHHhhhccccccchhhhhhhhh----hhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 155 PFDDSNL---------KQLFKEQTSNILSHQVKVKDILSHQ----VKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 155 pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
.|.+.+. .++..+|..-++......|.-+..- ...+++..... .+.+ +..
T Consensus 239 lF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~----------~n~s-------L~~ 301 (438)
T KOG0666|consen 239 LFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYY----------DNVS-------LHK 301 (438)
T ss_pred cccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhc----------Ccch-------HHH
Confidence 8866532 2344444444443333222222211 11222111100 0000 111
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+. ..+.-++...+||.+||+.||.+|+|++++|+|+||.....+
T Consensus 302 ~~~----~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 302 YYH----KHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHH----HhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 110 012235569999999999999999999999999999988654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=235.49 Aligned_cols=197 Identities=30% Similarity=0.484 Sum_probs=159.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.+++|.+++.. +.+++..++.++.+++.|+.||| +.+++|+||+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--------------~~~ivH~dl~p 129 (277)
T cd06642 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLH--------------SERKIHRDIKA 129 (277)
T ss_pred HhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--------------cCCeeccCCCh
Confidence 4677888889999999999999999999865 46899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|+|||.+.+..++.+ +|+|||||+++++++|..||....
T Consensus 130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 130 ANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred heEEEeCCCCEEEccccccccccCcch---hhhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999875443221 1223457888999999988877777 999999999999999999986554
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ......++..+.++
T Consensus 206 ~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~l 232 (277)
T cd06642 206 PMRVLFLIPKNSP-----------------------------------------------------PTLEGQYSKPFKEF 232 (277)
T ss_pred hhhHHhhhhcCCC-----------------------------------------------------CCCCcccCHHHHHH
Confidence 3322221111000 11123467789999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||..+|++|||+.++++||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 99999999999999999999999976553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=233.96 Aligned_cols=191 Identities=21% Similarity=0.375 Sum_probs=155.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~ 67 (304)
+++++++..++..++||||+++++|.+++...+ .+++..++.++.|++.||+|||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH------------ 137 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA------------ 137 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH------------
Confidence 578899999999999999999999999997643 3899999999999999999999
Q ss_pred CCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHH
Q psy1812 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF 147 (304)
Q Consensus 68 ~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~ 147 (304)
+.+++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.+ +|+|||||+++
T Consensus 138 --~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~ 213 (288)
T cd05093 138 --SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLW 213 (288)
T ss_pred --hCCeeecccCcceEEEccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHH
Confidence 89999999999999999999999999999875432211 111223345678999999988777777 99999999999
Q ss_pred HHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 148 IMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 148 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
+|++ |..||...........+..+...
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~~---------------------------------------------------- 241 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRVL---------------------------------------------------- 241 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCcC----------------------------------------------------
Confidence 9998 89999777655555544433211
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..++.++.+|+.+||+.||.+|||++++++
T Consensus 242 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 -QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112346788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=234.20 Aligned_cols=195 Identities=23% Similarity=0.421 Sum_probs=151.8
Q ss_pred Cceeeee-----eeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSIL-----QRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++ ..++..++||||++|++|.+++.. ...+++..++.++.|++.||.||| +.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~ 143 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--------------VN 143 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--------------hC
Confidence 3566765 345689999999999999998753 246899999999999999999999 88
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVIT 146 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll 146 (304)
+++|+||+|+||+++.++.++++|||++........ ......|+..|+|||++.. ..++.. +|+||+||++
T Consensus 144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvi~ 219 (286)
T cd06638 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITA 219 (286)
T ss_pred CccccCCCHHhEEECCCCCEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccch-hhhhhHHHHH
Confidence 999999999999999999999999999875433221 2234468899999999753 335555 9999999999
Q ss_pred HHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 147 FIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 147 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
|++++|..||.................. .
T Consensus 220 ~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------------------~ 248 (286)
T cd06638 220 IELGDGDPPLADLHPMRALFKIPRNPPP---------------------------------------------------T 248 (286)
T ss_pred HHHhcCCCCCCCCchhHHHhhccccCCC---------------------------------------------------c
Confidence 9999999999765443322221111000 0
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
...+..++..+.+||.+||..||++|||++++++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11123457789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.80 Aligned_cols=197 Identities=25% Similarity=0.375 Sum_probs=155.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+...+..++||||+++++|..+. .+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlkp 123 (279)
T cd06619 62 IGFYGAFFVENRISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLW--------------SLKILHRDVKP 123 (279)
T ss_pred eeEEEEEEECCEEEEEEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHH--------------HCCEeeCCCCH
Confidence 57889999999999999999999996652 4789999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.+ +|+|||||++|++++|..||....
T Consensus 124 ~Nill~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 124 SNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred HHEEECCCCCEEEeeCCcceecccc-----cccCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhc
Confidence 9999999999999999998654322 1234568899999999988878777 999999999999999999996532
Q ss_pred HHHHHH---HhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 161 LKQLFK---EQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 161 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
...... ......... .........++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~ 229 (279)
T cd06619 198 KNQGSLMPLQLLQCIVDE------------------------------------------------DPPVLPVGQFSEKF 229 (279)
T ss_pred ccccccchHHHHHHHhcc------------------------------------------------CCCCCCCCcCCHHH
Confidence 110000 000000000 00000113467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+|+.+||..+|.+||+++++++||||+....
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 99999999999999999999999999987743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.07 Aligned_cols=191 Identities=21% Similarity=0.361 Sum_probs=156.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~ 66 (304)
+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----------- 139 (280)
T cd05049 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----------- 139 (280)
T ss_pred hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-----------
Confidence 468889999999999999999999999997653 3789999999999999999999
Q ss_pred CCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHH
Q psy1812 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146 (304)
Q Consensus 67 ~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll 146 (304)
+.+++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.. +|+|||||++
T Consensus 140 ---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il 214 (280)
T cd05049 140 ---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVL 214 (280)
T ss_pred ---hCCeeccccccceEEEcCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchh-hhHHHHHHHH
Confidence 899999999999999999999999999998654322111 11223345678999999988888877 9999999999
Q ss_pred HHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc
Q psy1812 147 FIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225 (304)
Q Consensus 147 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (304)
|++++ |..||...+..+....+..+...
T Consensus 215 ~e~~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------------------- 243 (280)
T cd05049 215 WEIFTYGKQPWYGLSNEEVIECITQGRLL--------------------------------------------------- 243 (280)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCcC---------------------------------------------------
Confidence 99998 99999776665555444332221
Q ss_pred cccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 226 QVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 226 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..++..+.+++.+||..||++|||+.|+++
T Consensus 244 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 244 --QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=234.25 Aligned_cols=191 Identities=21% Similarity=0.361 Sum_probs=155.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..+...++||||+++++|.+++..++ .+++..++.++.|++.||+|||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--------- 140 (291)
T cd05094 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--------- 140 (291)
T ss_pred ceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 478899999999999999999999999997643 3789999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+++++|+||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.+ +|+|||||
T Consensus 141 -----~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 213 (291)
T cd05094 141 -----SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGV 213 (291)
T ss_pred -----hCCeeecccCcceEEEccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCch-hhHHHHHH
Confidence 89999999999999999999999999999865433221 112233456788999999988888777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||...+.......+..+...
T Consensus 214 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------- 244 (291)
T cd05094 214 ILWEIFTYGKQPWFQLSNTEVIECITQGRVL------------------------------------------------- 244 (291)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-------------------------------------------------
Confidence 9999998 99999776654444333222111
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..++..+.+++.+||+.+|++|||++++++
T Consensus 245 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 245 ----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=240.27 Aligned_cols=249 Identities=18% Similarity=0.274 Sum_probs=163.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|+++++|..++..++||||+.+++|.+++.+.. .+++..+..++.|++.||+||| +.+++|+||
T Consensus 62 v~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--------------~~~ivHrDl 127 (328)
T cd08226 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--------------QNGYIHRNI 127 (328)
T ss_pred ceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCC
Confidence 578999999999999999999999999998753 5899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g 152 (304)
||+||+++.++.++++||+.+.......... .......++..|++||++.+. .++.. +|+||+||+++++++|
T Consensus 128 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~~l~el~~g 206 (328)
T cd08226 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK-SDIYSVGITACELATG 206 (328)
T ss_pred CHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCch-hhHHHHHHHHHHHHhC
Confidence 9999999999999999997654322111110 001112345679999998764 35555 9999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||...................+..... ....................+.. ............ ......+..
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~ 279 (328)
T cd08226 207 RVPFQDMLRTQMLLQKLKGPPYSPLDITT---FPCEESRMKNSQSGVDSGIGESV-VAAGMTQTMTSE---RLRTPSSKT 279 (328)
T ss_pred CCCCCCcChHHHHHHHhcCCCCCCccccc---cchhhhhhccchhhhhcccccch-hccccccccccc---cccchhhhh
Confidence 99997765444433333222111110000 00000000000000000000000 000000000000 001112345
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+++++.+||++||..||++|||++++++||||+......
T Consensus 280 ~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 280 FSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 788999999999999999999999999999999988753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=234.37 Aligned_cols=201 Identities=26% Similarity=0.503 Sum_probs=159.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..+...++||||+++++|.+++...+.+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH--------------~~~i~H~dl~p 133 (290)
T cd05613 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH--------------KLGIIYRDIKL 133 (290)
T ss_pred hceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCH
Confidence 4578888889999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++.++|+|||++......... ......++..|++||.+.+. .++.. +|+||||+++|++++|..||..
T Consensus 134 ~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 134 ENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred HHeEECCCCCEEEeeCccceeccccccc--ccccccCCcccCChhhccCCCCCCCcc-ccHHHHHHHHHHHhcCCCCCCc
Confidence 9999999999999999998754332211 12345678899999998753 24455 9999999999999999999964
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+.... +......+..+++.+.
T Consensus 211 ~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 211 DGEKNSQAEISRRI--------------------------------------------------LKSEPPYPQEMSALAK 240 (290)
T ss_pred CCccccHHHHHHHh--------------------------------------------------hccCCCCCccCCHHHH
Confidence 32211111111100 0011222355788999
Q ss_pred HHHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 239 NLVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
+++.+||..||++|+ +++++++||||+...
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999998876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=239.02 Aligned_cols=226 Identities=23% Similarity=0.375 Sum_probs=157.2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...++|+||+. ++|.+++.. +.+++..++.++.|++.||+||| +.+++|+||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH--------------~~~ivH~dlkp~Nill~~~~~ 144 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIH--------------SANVLHRDLKPSNLLLNTNCD 144 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCHHHEEECCCCC
Confidence 46899999996 499888854 46999999999999999999999 899999999999999999999
Q ss_pred eEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhh
Q psy1812 91 VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQT 169 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~ 169 (304)
++|+|||++.................++..|+|||.+.+. .++.. +|+||+||++++|++|+.||.+.+.......+.
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~ 223 (336)
T cd07849 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223 (336)
T ss_pred EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999987554332222222345688899999987654 45555 999999999999999999998776544444333
Q ss_pred hccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCC
Q psy1812 170 SNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDI 249 (304)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 249 (304)
.............+.. ........ ..+. .....+ ......+++.+.+||.+||+.+|
T Consensus 224 ~~~~~~~~~~~~~~~~-~~~~~~~~-----------~~~~----~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 224 GVLGTPSQEDLNCIIS-LRARNYIK-----------SLPF----KPKVPW-------NKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred HHcCCCCHHHHHHhhc-hhhhhHHh-----------hcCc----CCcccH-------HHHhcccCcHHHHHHHHHcCCCh
Confidence 2222111000000000 00000000 0000 000000 00113457889999999999999
Q ss_pred CccccHHHHhcCcccccccccccccCC
Q psy1812 250 TKRIRLDAIKAHDWLRYKSMVRRKVLP 276 (304)
Q Consensus 250 ~~R~t~~ell~~~wf~~~~~~~~~~~~ 276 (304)
.+|||+.++++||||+....+....+.
T Consensus 281 ~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 281 HKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred hhCcCHHHHhcCccccccCCCCCcccC
Confidence 999999999999999988765444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=231.43 Aligned_cols=190 Identities=17% Similarity=0.351 Sum_probs=154.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+|+|.+++... +.+++..++.++.|++.||+||| +.+++|+||+
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH--------------~~~iiH~dik 134 (266)
T cd05064 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS--------------EMGYVHKGLA 134 (266)
T ss_pred CeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecccc
Confidence 57899999999999999999999999999874 47899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..
T Consensus 135 p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred HhhEEEcCCCcEEECCCcccccccccchh--cccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCc
Confidence 99999999999999999987543211110 1112234578999999988888877 999999999999875 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..+.. ...+..++..+.
T Consensus 212 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 238 (266)
T cd05064 212 MSGQDVIKAVEDGFR-----------------------------------------------------LPAPRNCPNLLH 238 (266)
T ss_pred CCHHHHHHHHHCCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 765555444432211 112345788999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||+.+|.+|||++++++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=227.74 Aligned_cols=193 Identities=32% Similarity=0.570 Sum_probs=161.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++.+..+...++|+||+++++|.+++.+. ..+++..+..++.+++.||.+|| ..+++|+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------------~~~~~H~ 127 (258)
T cd08215 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--------------SRKILHR 127 (258)
T ss_pred hheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--------------hCCEecc
Confidence 35778888889999999999999999999874 67999999999999999999999 8899999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||...+..++.. +|+||+|++++++++|..||
T Consensus 128 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~ 203 (258)
T cd08215 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPF 203 (258)
T ss_pred cCChHHeEEcCCCcEEECCccceeecccCcc---eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999875543321 2234467889999999888777776 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+..+.......... ...+..++..
T Consensus 204 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 230 (258)
T cd08215 204 EGENLLELALKILKGQY-----------------------------------------------------PPIPSQYSSE 230 (258)
T ss_pred CCCcHHHHHHHHhcCCC-----------------------------------------------------CCCCCCCCHH
Confidence 77765554444332211 1122356889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+++.+||..+|++|||+.++++||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=233.51 Aligned_cols=221 Identities=24% Similarity=0.371 Sum_probs=154.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+ +|.+++.+. +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--------------~~~i~H~dl~ 130 (291)
T cd07844 66 VTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH--------------QRRVLHRDLK 130 (291)
T ss_pred eeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecccCC
Confidence 4688999999999999999975 999998764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.+ +|+||+|+++|+|++|..||..
T Consensus 131 p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 131 PQNLLISERGELKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred HHHEEEcCCCCEEECccccccccCCCCc---cccccccccccCCcHHhhcCcccCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864322111 112234678899999987643 5555 9999999999999999999976
Q ss_pred hh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc--H
Q psy1812 159 SN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS--H 235 (304)
Q Consensus 159 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 235 (304)
.+ ..+....+............. ...... ....... ....... +. .....++ .
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~~~~~------~~~~~~~-~~-------~~~~~~~~~~ 262 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWP---------GVSSNP-EFKPYSF------PFYPPRP-LI-------NHAPRLDRIP 262 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhh---------hhhhcc-ccccccc------cccCChh-HH-------HhCcCCCCch
Confidence 54 333333332222211100000 000000 0000000 0000000 00 0011233 7
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+.+++.+||+.+|++|||++++++||||
T Consensus 263 ~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 263 HGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=236.61 Aligned_cols=200 Identities=27% Similarity=0.475 Sum_probs=161.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++|+||+++++|.+++.+. .+++..+..++.|++.||.||| +.+++|+||+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH--------------~~gi~H~dL~p 143 (293)
T cd06647 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH--------------SNQVIHRDIKS 143 (293)
T ss_pred eehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH--------------hCCEeeccCCH
Confidence 46788888999999999999999999999764 4889999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|++||.+.+..++.. +|+||||+++|++++|..||...+
T Consensus 144 ~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 144 DNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred HHEEEcCCCCEEEccCcceeccccccc---ccccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998865443221 1223457888999999988777776 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+.... .+ ....+..++..+.++
T Consensus 220 ~~~~~~~~~~~~--~~-------------------------------------------------~~~~~~~~~~~l~~l 248 (293)
T cd06647 220 PLRALYLIATNG--TP-------------------------------------------------ELQNPEKLSAIFRDF 248 (293)
T ss_pred hhhheeehhcCC--CC-------------------------------------------------CCCCccccCHHHHHH
Confidence 432221111000 00 011123467889999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+.+||..+|++||++++++.|+||+..+..
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 999999999999999999999999887743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=228.11 Aligned_cols=198 Identities=26% Similarity=0.447 Sum_probs=158.7
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++.+. .+...+++|||+++++|.+++... ..+++..++.++.+++.||.|||.. +..+.+++
T Consensus 62 ~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---------~~~~~~i~ 132 (265)
T cd08217 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR---------SDPGNTVL 132 (265)
T ss_pred ceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcC---------ccccCcce
Confidence 35666554 456789999999999999999763 5789999999999999999999921 11146899
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+|+||+++.++.+|++|||++........ ......++..|++||.+.+..++.. +|+||||++++++++|..
T Consensus 133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSP 208 (265)
T ss_pred ecCCCHHHEEEecCCCEEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999876543321 1234467889999999988777766 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+.......+..+.. ...+..++
T Consensus 209 p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~ 235 (265)
T cd08217 209 PFTARNQLQLASKIKEGKF-----------------------------------------------------RRIPYRYS 235 (265)
T ss_pred cccCcCHHHHHHHHhcCCC-----------------------------------------------------CCCccccC
Confidence 9987765444443332211 12234578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
..+.+++.+||..+|++|||++++++|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=248.21 Aligned_cols=199 Identities=24% Similarity=0.398 Sum_probs=168.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+.|-.++.+||+.|||.||-+...+-. .+.+++.++..+++|++.||.||| +.+|+|||||
T Consensus 92 vkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH--------------s~~iIHRDLK 157 (1187)
T KOG0579|consen 92 VKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH--------------SQNIIHRDLK 157 (1187)
T ss_pred HHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh--------------hcchhhhhcc
Confidence 5678888899999999999999999998866 457999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc-----cCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-----SGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+.|||++.+|.++++|||.+..... ...+..+++||+.|||||+. +..+|+.. +||||||+.+.+|..+..
T Consensus 158 AGNiL~TldGdirLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 158 AGNILLTLDGDIRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred ccceEEEecCcEeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCC
Confidence 9999999999999999998753211 12245678999999999996 44577777 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
|-...+...+..++.+...+- .-.|..++
T Consensus 234 PHhelnpMRVllKiaKSePPT---------------------------------------------------LlqPS~Ws 262 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIAKSEPPT---------------------------------------------------LLQPSHWS 262 (1187)
T ss_pred CccccchHHHHHHHhhcCCCc---------------------------------------------------ccCcchhh
Confidence 998888887777766442211 11234568
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
..+.|||.+||..||..||++.++++||||.+..
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 8999999999999999999999999999999544
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=228.55 Aligned_cols=191 Identities=21% Similarity=0.355 Sum_probs=152.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++. ++..++||||+.+|+|.+++.....+++..+..++.|++.||+||| ..+++|+||+|
T Consensus 59 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh--------------~~~i~H~di~p 123 (257)
T cd05060 59 VRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE--------------SKHFVHRDLAA 123 (257)
T ss_pred eeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------------hcCeeccCccc
Confidence 46777665 4578999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...
T Consensus 124 ~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 124 RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999998765432211111112223467999999988888777 999999999999998 99999776
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+..... ...+..++..+.+
T Consensus 203 ~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~~ 229 (257)
T cd05060 203 KGAEVIAMLESGER-----------------------------------------------------LPRPEECPQEIYS 229 (257)
T ss_pred CHHHHHHHHHcCCc-----------------------------------------------------CCCCCCCCHHHHH
Confidence 55444433322110 1122456789999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
++.+||..+|++||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=240.12 Aligned_cols=230 Identities=24% Similarity=0.391 Sum_probs=163.4
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
++++++|... ...++||||+. ++|.+.+... +++..+..++.|++.||+||| ..+++
T Consensus 78 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH--------------~~gi~ 140 (353)
T cd07850 78 IGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLH--------------SAGII 140 (353)
T ss_pred cceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHH--------------hCCee
Confidence 3566666432 46799999996 5999988754 899999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+|||||++++|++|..
T Consensus 141 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred eCCCCHHHEEECCCCCEEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999997543321 1233457889999999988888877 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh------hcccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL------SHQVK 228 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 228 (304)
||...+......++..........+...+... ............. ..+..+. .....
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~ 278 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT--VRNYVENRPKYAG---------------YSFEELFPDVLFPPDSES 278 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh--hhHHhhcCCCCCC---------------cchhhhCcccccCccccc
Confidence 99887766666665544433322221111110 0000000000000 0000000 00011
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+...++++.+||.+||..||++|||+.++|+||||+.-..
T Consensus 279 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 279 HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred ccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 12345778999999999999999999999999999985443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=243.17 Aligned_cols=200 Identities=23% Similarity=0.375 Sum_probs=156.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++||+-..++.+||||||-+. +|..+|++... ...-.++.+..|++.++.++| ..||||-|||
T Consensus 423 IqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH--------------~~gIVHSDLK 487 (677)
T KOG0596|consen 423 IQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH--------------QHGIVHSDLK 487 (677)
T ss_pred EEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH--------------HhceeecCCC
Confidence 5788888899999999999975 99999988653 443589999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-----------CCCCCchHHHHHHHHHH
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-----------YNPKLADIWSLGVITFI 148 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~sDvwslG~ll~~ 148 (304)
|.|+|+-+ |.+||+|||.+.-+.. +.........+||+.||+||.+.... .+.+ |||||+|||+|+
T Consensus 488 PANFLlVk-G~LKLIDFGIA~aI~~-DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~-SDvWSLGCILYq 564 (677)
T KOG0596|consen 488 PANFLLVK-GRLKLIDFGIANAIQP-DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK-SDVWSLGCILYQ 564 (677)
T ss_pred cccEEEEe-eeEEeeeechhcccCc-cccceeeccccCcccccCHHHHhhccccccCCCcceeecCc-cchhhhhhHHHH
Confidence 99998865 5899999999975443 33444556778999999999985322 3456 999999999999
Q ss_pred HHhCCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLNAAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|+.|+.||..-. ....+..|.......
T Consensus 565 MvYgktPf~~~~n~~aKl~aI~~P~~~I---------------------------------------------------- 592 (677)
T KOG0596|consen 565 MVYGKTPFGQIINQIAKLHAITDPNHEI---------------------------------------------------- 592 (677)
T ss_pred HHhcCCchHHHHHHHHHHHhhcCCCccc----------------------------------------------------
Confidence 999999996442 333344443321110
Q ss_pred ccccc-ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 228 KVKDI-LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 228 ~~~~~-~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.++.. -..++.++|+.||..||++|||+.++|+|||+......
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 11111 12349999999999999999999999999999985543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=231.41 Aligned_cols=197 Identities=28% Similarity=0.472 Sum_probs=161.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+.+++|.+++.. +.+++..+..++.+++.|+.+|| ..+++|+||+|
T Consensus 65 v~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~dl~p 129 (277)
T cd06641 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH--------------SEKKIHRDIKA 129 (277)
T ss_pred eEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHc--------------cCCeecCCCCH
Confidence 4688999999999999999999999999875 46899999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|++||.+.+...+.. +|+|||||+++++++|..||....
T Consensus 130 ~Ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 130 ANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred HhEEECCCCCEEEeecccceecccchh---hhccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999999865433221 1223457888999999987777766 999999999999999999997655
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ......++..+.++
T Consensus 206 ~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~ 232 (277)
T cd06641 206 PMKVLFLIPKNNP-----------------------------------------------------PTLEGNYSKPLKEF 232 (277)
T ss_pred hHHHHHHHhcCCC-----------------------------------------------------CCCCcccCHHHHHH
Confidence 4333332211100 11224567889999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||..+|.+||++.++++||||+....
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 99999999999999999999999998755
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=229.01 Aligned_cols=190 Identities=23% Similarity=0.385 Sum_probs=154.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..++..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--------------~~~i~H~dl 130 (263)
T cd05052 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--------------KKNFIHRDL 130 (263)
T ss_pred hheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeeccc
Confidence 467888989999999999999999999997643 5899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.+||+|||++......... ......++..|++||.+.+..++.. +|+|||||++|+|++ |..||.
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceee--ccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999998754432111 1112223567999999988888877 999999999999998 899998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..... ...+..++.++
T Consensus 208 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 234 (263)
T cd05052 208 GIDLSQVYELLEKGYR-----------------------------------------------------MERPEGCPPKV 234 (263)
T ss_pred CCCHHHHHHHHHCCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7665555444332210 12235578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++|||+.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=233.88 Aligned_cols=199 Identities=25% Similarity=0.454 Sum_probs=161.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.+..++..++||||+++++|.+++.+ +.+++..++.++.|++.||+||| +.+++|+||+|
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH--------------~~givH~dl~p 144 (292)
T cd06657 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLH--------------AQGVIHRDIKS 144 (292)
T ss_pred hheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 4678899999999999999999999998754 46899999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++++|||++........ ......++..|++||.+.+..++.+ +|+||+|++++++++|..||.+..
T Consensus 145 ~Nilv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 145 DSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred HHEEECCCCCEEEcccccceecccccc---cccccccCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998764432211 1223457889999999987777776 999999999999999999997765
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... . ......++..+.++
T Consensus 221 ~~~~~~~~~~~~~~-~--------------------------------------------------~~~~~~~~~~l~~l 249 (292)
T cd06657 221 PLKAMKMIRDNLPP-K--------------------------------------------------LKNLHKVSPSLKGF 249 (292)
T ss_pred HHHHHHHHHhhCCc-c--------------------------------------------------cCCcccCCHHHHHH
Confidence 54433322211100 0 01113467889999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||..+|.+||++.++++||||.....
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=249.04 Aligned_cols=203 Identities=25% Similarity=0.468 Sum_probs=164.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
||+|-.|++...+|+||||++||++..+|-+.+.|.|..+++++.++..|+++.| ..|++||||||
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH--------------kmGFIHRDiKP 757 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH--------------KMGFIHRDIKP 757 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH--------------hccceecccCc
Confidence 6899999999999999999999999999999999999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccc---------cCcc------------------------------cccccccCccCCccc
Q psy1812 81 ENILMTKRFNVKIADFGFARYC---------VDKE------------------------------GRRVLSRTYCGSAAY 121 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~---------~~~~------------------------------~~~~~~~~~~~~~~~ 121 (304)
+|||||.+|.+||.|||+|.-+ ...+ -.+...+..+||..|
T Consensus 758 DNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~ny 837 (1034)
T KOG0608|consen 758 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNY 837 (1034)
T ss_pred cceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcc
Confidence 9999999999999999998521 1000 000112345699999
Q ss_pred cccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccc
Q psy1812 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKD 201 (304)
Q Consensus 122 ~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (304)
+|||++....++-. +|+||.|||+|+|+.|+.||......+...++.+. +.
T Consensus 838 iapevl~r~g~~q~-cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw------------------~~---------- 888 (1034)
T KOG0608|consen 838 IAPEVLARTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW------------------RN---------- 888 (1034)
T ss_pred cChHHhcccCcccc-chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh------------------hh----------
Confidence 99999999888877 89999999999999999999776543333222211 11
Q ss_pred cccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccc---cHHHHhcCcccccccc
Q psy1812 202 ILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI---RLDAIKAHDWLRYKSM 269 (304)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~ell~~~wf~~~~~ 269 (304)
.+ +..+-.+++.++.++|.++.. ++++|+ -++++..||||+.+-.
T Consensus 889 --------------------~l--~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 889 --------------------FL--HIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred --------------------cc--ccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 10 122336789999999999754 688998 4778999999998754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=233.38 Aligned_cols=225 Identities=24% Similarity=0.334 Sum_probs=159.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..++..++||||+. ++|.+++.... .+++..++.++.|++.||+||| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~i~H~dl 128 (294)
T PLN00009 64 VRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--------------SHRVLHRDL 128 (294)
T ss_pred eeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCCC
Confidence 478899999999999999996 58998886644 3578899999999999999999 889999999
Q ss_pred CCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+|+||+++. ++.+|++|||++........ ......++..|+|||.+.+.. ++.+ +|+||+||+++++++|..||
T Consensus 129 ~p~nill~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~i~~~l~tg~~pf 204 (294)
T PLN00009 129 KPQNLLIDRRTNALKLADFGLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQKPLF 204 (294)
T ss_pred CcceEEEECCCCEEEEcccccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCC
Confidence 999999985 45689999999865432111 122335678899999987644 4555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+..+...++...........+. ......+........ ... ......+.+++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------~~~-------~~~~~~~~~~~~ 259 (294)
T PLN00009 205 PGDSEIDELFKIFRILGTPNEETWP---GVTSLPDYKSAFPKW---------------PPK-------DLATVVPTLEPA 259 (294)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcc---ccccchhhhhhcccC---------------CCC-------CHHHhCcCCChH
Confidence 7766554444433222111110000 000000000000000 000 001112457888
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+++.+||+.+|++||++.++++||||+....
T Consensus 260 ~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 260 GVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 999999999999999999999999999987654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=227.90 Aligned_cols=190 Identities=23% Similarity=0.401 Sum_probs=155.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+++|+|.+++... +.+++..++.++.+++.||+||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~ 127 (256)
T cd05114 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE--------------RNSFIHRDLA 127 (256)
T ss_pred eeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccccC
Confidence 47889999999999999999999999999764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.+ +|+||||+++|++++ |+.||..
T Consensus 128 p~ni~i~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYT--SSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred cceEEEcCCCeEEECCCCCccccCCCcee--ccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999998754322211 1122235568999999988777777 999999999999999 8999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.... .+...+..+.
T Consensus 205 ~~~~~~~~~i~~~~~~~-----------------------------------------------------~~~~~~~~~~ 231 (256)
T cd05114 205 KSNYEVVEMISRGFRLY-----------------------------------------------------RPKLASMTVY 231 (256)
T ss_pred CCHHHHHHHHHCCCCCC-----------------------------------------------------CCCCCCHHHH
Confidence 76666555554332111 1133567899
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++|||++++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=234.69 Aligned_cols=231 Identities=25% Similarity=0.327 Sum_probs=154.7
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRA-----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++... ..+++||||+.+ +|.+++... ..+++..++.++.|++.||.||| +.++
T Consensus 65 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i 129 (316)
T cd07842 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--------------SNWV 129 (316)
T ss_pred cceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--------------hCCE
Confidence 4688888887 889999999975 888877542 26899999999999999999999 8999
Q ss_pred EecCCCCCcEEEec----CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTK----RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFI 148 (304)
Q Consensus 74 vH~dl~~~nil~~~----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ 148 (304)
+|+||+|+||+++. ++.+|++|||++.................++..|+|||.+.+.. ++.. +|+|||||++++
T Consensus 130 ~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~ 208 (316)
T cd07842 130 LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKA-IDIWAIGCIFAE 208 (316)
T ss_pred eeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcH-HHHHHHHHHHHH
Confidence 99999999999999 89999999999875543322111223446788899999887644 5555 999999999999
Q ss_pred HHhCCCCCCChhHHH---------HHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 149 MLNAAMPFDDSNLKQ---------LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 149 ll~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|++|+.||.+.+... ....+.......................... ......... ..+
T Consensus 209 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-------~~~ 275 (316)
T cd07842 209 LLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMK------DFKTKTYPS-------NSL 275 (316)
T ss_pred HHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhh------hccCCCCCC-------ccH
Confidence 999999997654322 1111111111100000000000000000000 000000000 000
Q ss_pred hhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
... .......+..+.+++.+||..||++|||+.++++||||
T Consensus 276 ~~~----~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 276 AKW----MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHH----HHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00013567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=232.07 Aligned_cols=198 Identities=21% Similarity=0.363 Sum_probs=157.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++++......++||||+.+|+|.+++.+.+ .++...+..++.|++.||.||| +
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~ 137 (288)
T cd05061 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--------------A 137 (288)
T ss_pred eeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------------h
Confidence 468889999999999999999999999997632 2466788999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
.+++|+||||+||+++.++.++++|||+++......... ......++..|+|||.+.+..++.. +|+|||||++++++
T Consensus 138 ~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~ 215 (288)
T cd05061 138 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEIT 215 (288)
T ss_pred CCCcCCCCChheEEEcCCCcEEECcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHH
Confidence 999999999999999999999999999987543322111 1122345678999999988878777 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||.+....+....+..+.. ...
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 242 (288)
T cd05061 216 SLAEQPYQGLSNEQVLKFVMDGGY-----------------------------------------------------LDQ 242 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------CCC
Confidence 8 7889977665544443332211 111
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhc------Ccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKA------HDWLRYK 267 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~------~~wf~~~ 267 (304)
+..+++.+.+++.+||+.||++|||+.++++ ||||++.
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 2345788999999999999999999999987 8998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.43 Aligned_cols=193 Identities=32% Similarity=0.595 Sum_probs=158.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..+...++|+||+.+++|.+++.... .+++..+..++.+++.||.||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~H~dl 127 (257)
T cd08225 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--------------DRKILHRDI 127 (257)
T ss_pred hhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccC
Confidence 467788888999999999999999999997654 4799999999999999999999 889999999
Q ss_pred CCCcEEEecCCC-eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 79 KCENILMTKRFN-VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+|+||+++.++. ++++|||.+........ ......++..|+|||...+..++.. +|+||||++++++++|..||.
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 128 KSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred CHHHEEEcCCCCeEEecccccchhccCCcc---cccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCC
Confidence 999999998865 69999999875443221 1223457889999999887777776 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+..... ......++.++
T Consensus 204 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 230 (257)
T cd08225 204 GNNLHQLVLKICQGYF-----------------------------------------------------APISPNFSRDL 230 (257)
T ss_pred CccHHHHHHHHhcccC-----------------------------------------------------CCCCCCCCHHH
Confidence 7665444443322211 11124567889
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+++.+||..+|++|||+.++++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=233.81 Aligned_cols=226 Identities=22% Similarity=0.347 Sum_probs=154.8
Q ss_pred CceeeeeeeC--------CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQRG--------PRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++... ...++||||+. ++|.+++...+ .+++..++.++.|++.||+||| +.
T Consensus 74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~ 138 (310)
T cd07865 74 VNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH--------------RN 138 (310)
T ss_pred cceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HC
Confidence 3566666543 35699999996 58988887654 6899999999999999999999 88
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~l 149 (304)
+++|+||+|+||+++.++.+||+|||++.......... .......++..|+|||.+.+.. ++.+ +|+||||+++|+|
T Consensus 139 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~el 217 (310)
T cd07865 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPP-IDMWGAGCIMAEM 217 (310)
T ss_pred CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCch-hhhHHHHHHHHHH
Confidence 99999999999999999999999999987554322211 1122345678899999987654 4555 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||.+.+.......+.......+..+...... . +.+.. .. .+. ......... -.
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~---~~------~~~----~~~~~~~~~-----l~ 275 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDK---L-ELFKK---ME------LPQ----GQKRKVKER-----LK 275 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc---h-hhhhh---cc------CCC----ccchhhHHh-----cc
Confidence 999999987765554444333322222111000000 0 00000 00 000 000000000 00
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
....+..+.+||.+||..||.+|||++++++||||
T Consensus 276 ~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 276 PYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=225.56 Aligned_cols=193 Identities=31% Similarity=0.479 Sum_probs=160.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+.+++|.+++.+.+.+++..++.++.|++.||.+|| +.+++|+||+|
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~p 127 (254)
T cd06627 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH--------------EQGVIHRDIKA 127 (254)
T ss_pred cEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh--------------hCCcccCCCCH
Confidence 3677888889999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++........ ......++..|++||...+...+.. +|+||+|++++++++|..||...+
T Consensus 128 ~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 128 ANILTTKDGVVKLADFGVATKLNDVSK---DDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred HHEEECCCCCEEEeccccceecCCCcc---cccccccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999876544322 1233457889999999887776666 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......+..... ....+..++..+.++
T Consensus 204 ~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~~ 230 (254)
T cd06627 204 PMAALFRIVQDD-----------------------------------------------------HPPLPEGISPELKDF 230 (254)
T ss_pred HHHHHHHHhccC-----------------------------------------------------CCCCCCCCCHHHHHH
Confidence 333322221110 022335678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+||..+|++|||+.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=233.72 Aligned_cols=200 Identities=30% Similarity=0.552 Sum_probs=156.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+..+...++||||+.+|+|.+++...+.+++..++.++.|++.||.||| ..+++|+||+|.
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------------~~~~~H~dl~p~ 134 (288)
T cd05583 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH--------------QLGIIYRDIKLE 134 (288)
T ss_pred hhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCHH
Confidence 567788888999999999999999999988788999999999999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
||+++.++.++++|||++......... ......++..|++||.+.+.. .+.. +|+||||+++++|++|..||...
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 135 NILLDSEGHVVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred HeEECCCCCEEEEECcccccccccccc--ccccccCCccccCHHHhcCCCCCCcch-hhhHHHHHHHHHHHhCCCCcccC
Confidence 999999999999999998754332211 122345788999999987654 4555 99999999999999999999543
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+... +.......+..++..+.+
T Consensus 212 ~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~l~~ 241 (288)
T cd05583 212 GEQNSQSEISRR--------------------------------------------------ILKSKPPFPKTMSAEARD 241 (288)
T ss_pred cccchHHHHHHH--------------------------------------------------HHccCCCCCcccCHHHHH
Confidence 211111111000 000012233557889999
Q ss_pred HHHHhcCCCCCcccc---HHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRIR---LDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~t---~~ell~~~wf~~~~ 268 (304)
+|.+||+.||++||| +.++++||||+...
T Consensus 242 li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 999999999999998 56779999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=247.70 Aligned_cols=197 Identities=23% Similarity=0.436 Sum_probs=169.0
Q ss_pred CceeeeeeeCC--eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGP--RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
||+|+.+.+.. ...+|+|.+.+|+|..|+++.+.++...++.|++||+.||.|||+= ..+|+||||
T Consensus 104 irfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~------------~PPIIHRDL 171 (632)
T KOG0584|consen 104 IRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ------------DPPIIHRDL 171 (632)
T ss_pred eeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC------------CCCcccccc
Confidence 57888888754 4899999999999999999999999999999999999999999953 568999999
Q ss_pred CCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC-
Q psy1812 79 KCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF- 156 (304)
Q Consensus 79 ~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf- 156 (304)
|++||+|+. .|.+||+|+|+|...... .....+||+.|||||+.- ..|+.. .||||||++++||.|+..||
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChh
Confidence 999999976 478999999999764433 334578999999999986 568888 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..++++++..+.-+.. +.+--.++
T Consensus 245 EC~n~AQIYKKV~SGiKP~s----------------------------------------------------l~kV~dPe 272 (632)
T KOG0584|consen 245 ECTNPAQIYKKVTSGIKPAA----------------------------------------------------LSKVKDPE 272 (632)
T ss_pred hhCCHHHHHHHHHcCCCHHH----------------------------------------------------hhccCCHH
Confidence 56678899999887754322 11223789
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+++||.+||.. ..+|+|+.|+|+|+||.....
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 99999999999 999999999999999998744
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.61 Aligned_cols=190 Identities=30% Similarity=0.540 Sum_probs=157.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++.+++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+++|+||
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--------------~~~i~H~dl 126 (255)
T cd08219 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--------------EKRVLHRDI 126 (255)
T ss_pred ceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--------------hCCcccCCC
Confidence 46888999999999999999999999998753 35899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.. +|+||||+++++|++|..||..
T Consensus 127 ~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred CcceEEECCCCcEEEcccCcceeeccccc---ccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCC
Confidence 99999999999999999999875433221 1233567889999999988777777 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+.. ...+..++..+.
T Consensus 203 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 229 (255)
T cd08219 203 NSWKNLILKVCQGSY-----------------------------------------------------KPLPSHYSYELR 229 (255)
T ss_pred CCHHHHHHHHhcCCC-----------------------------------------------------CCCCcccCHHHH
Confidence 765554444433221 112245678899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+|+.+||+.||++|||+.+++.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.61 Aligned_cols=192 Identities=23% Similarity=0.402 Sum_probs=151.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc------------------------------------------------
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA------------------------------------------------ 32 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------------------------------ 32 (304)
|++++.+..++..++|||||.+|+|.+++...
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 57889999999999999999999999998642
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 33 ----------------------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 33 ----------------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
.++++..++.++.|++.||.||| +.+++||||||+||+++.++.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------------~~giiHrDLkp~Nil~~~~~~ 250 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--------------SKNCIHRDVAARNVLLTDGRV 250 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--------------HCCEEeccCchheEEEeCCCe
Confidence 13788899999999999999999 899999999999999999999
Q ss_pred eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhh
Q psy1812 91 VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQT 169 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~ 169 (304)
+||+|||++......... .......++..|+|||++.+..++.+ +|+|||||++|+|++ |..||.............
T Consensus 251 ~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~ 328 (374)
T cd05106 251 AKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328 (374)
T ss_pred EEEeeceeeeeccCCcce-eeccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH
Confidence 999999998644322111 11122335567999999988888877 999999999999997 999997654333322222
Q ss_pred hccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCC
Q psy1812 170 SNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDI 249 (304)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 249 (304)
..... ...+..+++++.+++.+||+.||
T Consensus 329 ~~~~~----------------------------------------------------~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 329 KRGYQ----------------------------------------------------MSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred HcccC----------------------------------------------------ccCCCCCCHHHHHHHHHHcCCCh
Confidence 21111 11123467899999999999999
Q ss_pred CccccHHHHhc
Q psy1812 250 TKRIRLDAIKA 260 (304)
Q Consensus 250 ~~R~t~~ell~ 260 (304)
++|||+.++++
T Consensus 357 ~~RPs~~~l~~ 367 (374)
T cd05106 357 TERPTFSQISQ 367 (374)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=260.85 Aligned_cols=204 Identities=22% Similarity=0.360 Sum_probs=155.0
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++++|.. ...+||||||+.+|+|.++|... +.+++..++.++.||+.||.|||+.-. +....+|+
T Consensus 75 Vrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~-------~~~~k~IV 147 (1021)
T PTZ00266 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD-------GPNGERVL 147 (1021)
T ss_pred CeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccc-------ccccCCce
Confidence 578888754 46799999999999999999763 569999999999999999999993200 00025699
Q ss_pred ecCCCCCcEEEec-----------------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCC--CCCCC
Q psy1812 75 HRDLKCENILMTK-----------------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPK 135 (304)
Q Consensus 75 H~dl~~~nil~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~ 135 (304)
|+||||+|||++. .+.+||+|||++....... ......|++.|+|||++.+. .++.+
T Consensus 148 HRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~K 223 (1021)
T PTZ00266 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDK 223 (1021)
T ss_pred eccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCch
Confidence 9999999999964 2348999999987543221 22345689999999998653 35566
Q ss_pred CchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 136 LADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 136 ~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|||||||++|+|++|..||...+....+........
T Consensus 224 -SDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p------------------------------------------ 260 (1021)
T PTZ00266 224 -SDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP------------------------------------------ 260 (1021)
T ss_pred -hHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC------------------------------------------
Confidence 9999999999999999999976543332222111100
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
......++.++.+||..||..+|.+||++.++|.|+|++....
T Consensus 261 -----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 261 -----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred -----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 0011345788999999999999999999999999999987654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=237.23 Aligned_cols=228 Identities=22% Similarity=0.268 Sum_probs=165.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+. |+|.+++.....+++..+..++.|++.||+||| +.+++|+||++
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH--------------~~~i~H~dl~~ 147 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH--------------KWYFMHRDLSP 147 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecccccH
Confidence 467899999999999999997 599999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc-----------ccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG-----------RRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFI 148 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ 148 (304)
+||+++.++.++++|||++........ .........++..|+|||.+.+.. ++.. +|+|||||++++
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~e 226 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAE 226 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcH-HHHHHHHHHHHH
Confidence 999999999999999999875541110 001112234677899999987654 4555 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
+++|..||.+.+..+....+........... +......... .... ....... ..
T Consensus 227 l~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~~~~~-----~~~~-----~~~~~~~-------~~ 280 (335)
T PTZ00024 227 LLTGKPLFPGENEIDQLGRIFELLGTPNEDN---------WPQAKKLPLY-----TEFT-----PRKPKDL-------KT 280 (335)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCchhh---------Ccchhhcccc-----cccC-----cCCcccH-------HH
Confidence 9999999987776655554443322211000 0000000000 0000 0000000 01
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.....+..+.++|.+||..+|++|||+++++.||||+.....
T Consensus 281 ~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 281 IFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 123467889999999999999999999999999999877654
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=254.90 Aligned_cols=190 Identities=23% Similarity=0.426 Sum_probs=167.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~ 66 (304)
||+++++..++-.++|+|||..|||.+||..+. +++..+...|+.|||.|++||.
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----------- 620 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----------- 620 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------
Confidence 789999999999999999999999999997642 2889999999999999999999
Q ss_pred CCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHH
Q psy1812 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146 (304)
Q Consensus 67 ~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll 146 (304)
+..+|||||-..|+||.++..+||+|||+++-....+-.+....+ .-+++|||||.+.++++++. |||||+||++
T Consensus 621 ---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t-~lPIRWMppEsIly~kFTte-SDVWs~GVvL 695 (774)
T KOG1026|consen 621 ---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNT-LLPIRWMPPESILYGKFTTE-SDVWSFGVVL 695 (774)
T ss_pred ---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCc-eeeeecCCHHHhhcCcccch-hhhhhhhhhh
Confidence 899999999999999999999999999999865554433322222 35689999999999999999 9999999999
Q ss_pred HHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc
Q psy1812 147 FIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225 (304)
Q Consensus 147 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (304)
||+++ |..|+.+....+.+..+..+..
T Consensus 696 WEIFsyG~QPy~glSn~EVIe~i~~g~l---------------------------------------------------- 723 (774)
T KOG1026|consen 696 WEIFSYGKQPYYGLSNQEVIECIRAGQL---------------------------------------------------- 723 (774)
T ss_pred hhhhccccCcccccchHHHHHHHHcCCc----------------------------------------------------
Confidence 99999 9999999988888888776654
Q ss_pred cccccccccHHHHHHHHHhcCCCCCccccHHHHh
Q psy1812 226 QVKVKDILSHQVKNLVGQILEPDITKRIRLDAIK 259 (304)
Q Consensus 226 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell 259 (304)
...|.+++.++.+||..||+.+|++||+++||-
T Consensus 724 -L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 724 -LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred -ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 234588999999999999999999999999884
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=230.15 Aligned_cols=192 Identities=19% Similarity=0.291 Sum_probs=153.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++......++||||+.|++|.+++.+.+ .+++..+..++.|++.||+||| +.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~i 137 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--------------ENHF 137 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCE
Confidence 467888888889999999999999999998754 4899999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 74 vH~dl~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
+|+||+|+||+++.++ .+|++|||++.......... .......+..|+|||++.+..++.+ +|+|||||++|+|+
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~ 215 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIF 215 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCcccee-cCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHH
Confidence 9999999999998765 48999999987653221110 1112234567999999988888877 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||...+.......+..... ...
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 242 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGGGR-----------------------------------------------------LDP 242 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc-----------------------------------------------------CCC
Confidence 7 9999987655444433322110 112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 34568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=227.69 Aligned_cols=191 Identities=23% Similarity=0.398 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++......++||||+.+|+|.+++... ..+++..++.++.|++.||.||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~ 127 (256)
T cd05113 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--------------SKQFIHRDLA 127 (256)
T ss_pred eeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccccC
Confidence 57889998888999999999999999999774 36899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||.+......... ......++..|++||.+.+..++.+ +|+|||||++|++++ |..||..
T Consensus 128 p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred cceEEEcCCCCEEECCCccceecCCCcee--ecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCc
Confidence 99999999999999999998754332111 1112235677999999987777777 999999999999998 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+.... .+...+..+.
T Consensus 205 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 231 (256)
T cd05113 205 FNNSETVEKVSQGLRLY-----------------------------------------------------RPHLASEKVY 231 (256)
T ss_pred CCHHHHHHHHhcCCCCC-----------------------------------------------------CCCCCCHHHH
Confidence 66555544444332211 1133578899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||..+|.+|||+.+++++
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=231.01 Aligned_cols=219 Identities=25% Similarity=0.350 Sum_probs=160.7
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++++......++||||+. ++|.+++.+. ..+++..++.++.+++.||++|| +.+++|+||+|
T Consensus 62 ~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~~l~~ 126 (282)
T cd07829 62 KLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--------------SHRILHRDLKP 126 (282)
T ss_pred HHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCh
Confidence 56777888899999999997 5999999886 57999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.+ +|+|||||+++++++|..||...
T Consensus 127 ~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 127 QNILINRDGVLKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred heEEEcCCCCEEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCcc-ccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999875433221 12223456789999998776 55555 99999999999999999999887
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+...++...........+. ...... .... ....+.. ... ....+.++..+.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~~-~~~~~~~-------~~~-------~~~~~~~~~~~~~ 257 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWP---------GVTKLP-DYKP-TFPKFPP-------KDL-------EKVLPRLDPEGID 257 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHH---------hhcccc-cccc-cccccCc-------cch-------HHhcccccHHHHH
Confidence 7666655554433322211100 000000 0000 0000000 000 1112345889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+|.+||..+|++||++++++.||||
T Consensus 258 ~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 258 LLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHhhccCcccCCCHHHHhhCcCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=223.02 Aligned_cols=193 Identities=30% Similarity=0.502 Sum_probs=157.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..+...++++||+++++|.+++... +.+++..+..++.+++.||.+|| ..+++|+||+
T Consensus 60 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------------~~~i~h~dl~ 125 (253)
T cd05122 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH--------------SNGIIHRDIK 125 (253)
T ss_pred eEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--------------cCCEecCCCC
Confidence 35788888889999999999999999999876 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.++|+|||.+........ .....++..|++||.+.+...+.. +|+||||++++++++|..||...
T Consensus 126 p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 126 AANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred HHHEEEccCCeEEEeecccccccccccc----ccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999875543321 234467889999999987776666 99999999999999999999766
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+....... ......++..+.+
T Consensus 201 ~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~ 229 (253)
T cd05122 201 PPMKALFKIATNGPPG---------------------------------------------------LRNPEKWSDEFKD 229 (253)
T ss_pred chHHHHHHHHhcCCCC---------------------------------------------------cCcccccCHHHHH
Confidence 4333332222111000 0011224788999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDW 263 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~w 263 (304)
++.+||..||++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=241.04 Aligned_cols=192 Identities=23% Similarity=0.382 Sum_probs=151.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------------------------------------- 33 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------- 33 (304)
|++++++..+...++|||||++|+|.+++.+..
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 578999999999999999999999999996532
Q ss_pred ----------------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEE
Q psy1812 34 ----------------------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85 (304)
Q Consensus 34 ----------------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~ 85 (304)
.+++..+..++.|++.||.||| +.+++|+||||+||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Dlkp~Nill 247 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--------------SKNCIHRDLAARNILL 247 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCchhhEEE
Confidence 3678889999999999999999 8999999999999999
Q ss_pred ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHH
Q psy1812 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQL 164 (304)
Q Consensus 86 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~ 164 (304)
+.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++|++++ |..||........
T Consensus 248 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~ 325 (375)
T cd05104 248 THGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSK 325 (375)
T ss_pred ECCCcEEEecCccceeccCcccc-cccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHH
Confidence 99999999999998754332111 01112334567999999988888877 999999999999998 8899976543332
Q ss_pred HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHh
Q psy1812 165 FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQI 244 (304)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 244 (304)
+.+....... ...+...+.++.+|+.+|
T Consensus 326 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~l~~li~~c 353 (375)
T cd05104 326 FYKMIKEGYR----------------------------------------------------MLSPECAPSEMYDIMKSC 353 (375)
T ss_pred HHHHHHhCcc----------------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence 2222211100 011233577899999999
Q ss_pred cCCCCCccccHHHHhc
Q psy1812 245 LEPDITKRIRLDAIKA 260 (304)
Q Consensus 245 L~~dP~~R~t~~ell~ 260 (304)
|+.||++|||+.++++
T Consensus 354 l~~dP~~RPs~~eil~ 369 (375)
T cd05104 354 WDADPLKRPTFKQIVQ 369 (375)
T ss_pred ccCChhHCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=227.92 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=164.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+.|++|..+..++|.||.|. ..+..++++ .++++|..+-++...+++||.||-+ .++|+|||+|
T Consensus 154 V~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-------------KH~viHRDvK 219 (391)
T KOG0983|consen 154 VQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-------------KHGVIHRDVK 219 (391)
T ss_pred eeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-------------hcceeecccC
Confidence 688999999999999999995 466666655 4579999999999999999999985 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|||+|+.|++|+||||.+-...+...+ ....|-+.|++||.+. ..+|+.+ +||||||+.++||.||+.||
T Consensus 220 PSNILlDe~GniKlCDFGIsGrlvdSkAh----trsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 220 PSNILLDERGNIKLCDFGISGRLVDSKAH----TRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPY 294 (391)
T ss_pred ccceEEccCCCEEeecccccceeeccccc----ccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCC
Confidence 99999999999999999998766554432 2345889999999985 3468888 99999999999999999999
Q ss_pred CChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
.+.+ +.+...++.+..-+. .....++++
T Consensus 295 ~~c~tdFe~ltkvln~ePP~---------------------------------------------------L~~~~gFSp 323 (391)
T KOG0983|consen 295 KGCKTDFEVLTKVLNEEPPL---------------------------------------------------LPGHMGFSP 323 (391)
T ss_pred CCCCccHHHHHHHHhcCCCC---------------------------------------------------CCcccCcCH
Confidence 7754 446666666532211 111244899
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+.+|+..||..|+.+||...++|+|||.+.....
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 99999999999999999999999999998876543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=229.89 Aligned_cols=192 Identities=20% Similarity=0.359 Sum_probs=152.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++++..++..++||||+.+|+|.+++.+.+ .+++..+..++.|++.||.||| +
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~ 137 (277)
T cd05062 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--------------A 137 (277)
T ss_pred eeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--------------H
Confidence 578889999999999999999999999997632 2567889999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
.+++|+||||+||+++.++.++++|||++.......... ......++..|+|||.+.+..++.. +|+|||||++|+++
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~ 215 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIA 215 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHH
Confidence 899999999999999999999999999986543222111 1112345678999999988888777 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||.+.+.......+..... ...
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 242 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL-----------------------------------------------------LDK 242 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc-----------------------------------------------------CCC
Confidence 8 7889977655444433322211 111
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 24567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=233.34 Aligned_cols=230 Identities=23% Similarity=0.354 Sum_probs=163.5
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.. +...++||||+. ++|.+++.+. .+++..++.++.|++.||.||| +.+++|+||
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH--------------~~~i~H~dl 133 (337)
T cd07852 70 VKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH--------------SGNVIHRDL 133 (337)
T ss_pred cceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCC
Confidence 467787754 447899999997 5999999776 7899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccc--cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGR--RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+|+||+++.++.+||+|||++......... ........++..|+|||.+.+......++|+||||+++|+|++|+.||
T Consensus 134 ~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf 213 (337)
T cd07852 134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213 (337)
T ss_pred CHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999998755432211 012234467889999998866443334499999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+........++..............+.... ...... ... ....... ....+.++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~------------~~~~~~~-------~~~~~~~~~~ 270 (337)
T cd07852 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPF-AATMLD---SLP------------SRPRKPL-------DELLPKASDD 270 (337)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHHhhh-HHHhhh---hcc------------cccccch-------hhhccCCCHH
Confidence 8776665555554443322211111110000 000000 000 0000000 1112347889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+|+.+||+.||++|||+.++++||||++...
T Consensus 271 l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 271 ALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 999999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=226.91 Aligned_cols=191 Identities=23% Similarity=0.411 Sum_probs=154.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++...+..++||||++|++|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dl~ 127 (256)
T cd05059 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE--------------SNGFIHRDLA 127 (256)
T ss_pred EEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccccc
Confidence 46788888899999999999999999999764 46899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+|++|||++......... ......++..|+|||.+.+..++.+ +|+||||+++|++++ |..||..
T Consensus 128 p~ni~i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred HhhEEECCCCcEEECCcccceeccccccc--ccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999998754322111 1111223457999999988888777 999999999999998 8999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..... ...+..++.++.
T Consensus 205 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 231 (256)
T cd05059 205 FSNSEVVESVSAGYR-----------------------------------------------------LYRPKLAPTEVY 231 (256)
T ss_pred CCHHHHHHHHHcCCc-----------------------------------------------------CCCCCCCCHHHH
Confidence 655444443332211 112244688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=230.08 Aligned_cols=219 Identities=25% Similarity=0.355 Sum_probs=160.0
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
++++++..++..++||||+ +|+|.+++.... .+++..++.++.|++.||.||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--------------~~~i~H~dl~ 126 (283)
T cd07830 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--------------KHGFFHRDLK 126 (283)
T ss_pred hHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCC
Confidence 5667788889999999999 789999998765 7899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.. +|+||||++++++++|..||..
T Consensus 127 ~~ni~i~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 127 PENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSP-VDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred hhhEEEcCCCCEEEeecccceeccCCC----CcCCCCCcccccCceeeecCcCcCCc-cchhhHHHHHHHHHhCCCccCC
Confidence 999999999999999999987543322 123345788899999886544 4555 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+...++........... +......... ... ..+. ...... .......+..+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~----~~~~----~~~~~~-------~~~~~~~~~~~~ 257 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQD---WPEGYKLASK------LGF----RFPQ----FAPTSL-------HQLIPNASPEAI 257 (283)
T ss_pred CChHHHHHHHHHhcCCCChhh---hhhHhhhhcc------ccc----cccc----cccccH-------HHHcccCCHHHH
Confidence 776666655554333222110 0000000000 000 0000 000000 011123378899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+|+++||..+|++|||++|++.||||
T Consensus 258 ~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 258 DLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHhcccCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=229.50 Aligned_cols=223 Identities=23% Similarity=0.301 Sum_probs=152.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+. ++|.+++... ..+++..+..++.|++.||.||| ..+++|+|||
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~i~H~dlk 130 (291)
T cd07870 66 VLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH--------------GQHILHRDLK 130 (291)
T ss_pred eEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCC
Confidence 467889999999999999996 6888877653 46788999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.. +|+|||||+++++++|..||..
T Consensus 131 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 131 PQNLLISYLGELKLADFGLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred hHHEEEcCCCcEEEeccccccccCCCCC---CCCCccccccccCCceeecCCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864332211 122334688999999987643 5555 9999999999999999999975
Q ss_pred hhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 159 SNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
.+.. +...++..............+.. .......... .........+. .. -..+..+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-------~~~~~~~~~~~---~~--~~~~~~~ 264 (291)
T cd07870 207 VSDVFEQLEKIWTVLGVPTEDTWPGVSK----------LPNYKPEWFL-------PCKPQQLRVVW---KR--LSRPPKA 264 (291)
T ss_pred chhHHHHHHHHHHHcCCCChhhhhhhhh----------cccccchhcc-------ccCCcchhhhc---cc--cCCChHH
Confidence 5432 22222221111111000000000 0000000000 00000000000 00 1136789
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+++.+||..||.+|||+++++.||||
T Consensus 265 ~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 265 EDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=236.46 Aligned_cols=228 Identities=25% Similarity=0.390 Sum_probs=161.1
Q ss_pred ceeeeeeeC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 2 QVHSILQRG-----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 2 ~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
++++++... ...++|+||+. ++|.+++...+.+++..++.++.|++.||.||| +.+++|+
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~i~H~ 132 (337)
T cd07858 68 AIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--------------SANVLHR 132 (337)
T ss_pred chHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecC
Confidence 445555432 35899999996 699999988888999999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.+ +|+|||||++++|++|..|
T Consensus 133 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLLNCSEYTTA-IDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred CCCHHHEEEcCCCCEEECcCccccccCCCcc---cccccccccCccChHHHhcCCCCCCc-ccHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999875433221 22344578899999998653 45555 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+.......+..............+... ......... .. .....+ ....+.+++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----------~~----~~~~~~-------~~~~~~~~~ 265 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNE-KARRYIRSL-----------PY----TPRQSF-------ARLFPHANP 265 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCch-hhhHHHHhc-----------Cc----ccccCH-------HHHcccCCH
Confidence 9876654444333322222111000000000 000000000 00 000000 011245788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+.+||++||+.+|.+|||++++++||||+....+.
T Consensus 266 ~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 266 LAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 999999999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=229.35 Aligned_cols=221 Identities=27% Similarity=0.364 Sum_probs=161.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++|+||+.+ +|.+++... ..+++..+..++.+++.||.||| ..+++|+||+
T Consensus 61 ~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~dl~ 125 (283)
T cd05118 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--------------SHGILHRDLK 125 (283)
T ss_pred chHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCcC
Confidence 4677888888999999999975 999988774 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++|+|||.+........ ......++..|++||.+.+. .++.+ +|+||||+++|++++|+.||..
T Consensus 126 p~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~-~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 126 PENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGDKGYSTP-VDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred HHHEEECCCCcEEEeeeeeeEecCCCcc---cccCccCcccccCcHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999875543321 12234577889999998776 45555 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++..............+.. ....... .. +. ...... ......++..+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~---~~----~~~~~~-------~~~~~~~~~~~~ 257 (283)
T cd05118 202 KSEIDQLFKIFRTLGTPDPEVWPKFTS---------LARNYKF-SF---PK----KAGMPL-------PKLFPNASPQAL 257 (283)
T ss_pred CCHHHHHHHHHHHcCCCchHhcccchh---------hhhhhhh-hh---cc----ccccCH-------HHhhhhhCHHHH
Confidence 776666555443322211000000000 0000000 00 00 000000 111245688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+||.+||+.||.+||+++++++||||
T Consensus 258 ~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 258 DLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHhccCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=229.42 Aligned_cols=197 Identities=26% Similarity=0.415 Sum_probs=154.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~ivH 75 (304)
+++++.+..++..++||||++ |+|.+++... ..+++..++.++.|++.||+||| +. +++|
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~~i~h 127 (283)
T cd06617 63 VTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--------------SKLSVIH 127 (283)
T ss_pred eeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--------------hcCCeec
Confidence 578899999999999999997 5898888652 36899999999999999999999 65 9999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC----CCCCCCCchHHHHHHHHHHHHh
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG----NPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+ ..++.+ +|+|||||++|++++
T Consensus 128 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~ 202 (283)
T cd06617 128 RDVKPSNVLINRNGQVKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELAT 202 (283)
T ss_pred CCCCHHHEEECCCCCEEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHh
Confidence 9999999999999999999999987543221 1223457888999998864 334556 999999999999999
Q ss_pred CCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 AAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||.... ..+........... ....
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~ 230 (283)
T cd06617 203 GRFPYDSWKTPFQQLKQVVEEPSP----------------------------------------------------QLPA 230 (283)
T ss_pred CCCCCCccccCHHHHHHHHhcCCC----------------------------------------------------CCCc
Confidence 999996422 11111111111000 0011
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..++.++.+||.+||..+|++|||++++++||||+....
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 346889999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=223.65 Aligned_cols=196 Identities=32% Similarity=0.467 Sum_probs=159.9
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+... ...++|+||+.+++|.+++.+...+++..++.++.+++.||.||| +.+++|+||
T Consensus 62 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~~~h~dl 127 (260)
T cd06606 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH--------------SNGIVHRDI 127 (260)
T ss_pred eeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCC
Confidence 3567777777 899999999999999999998878999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||.+......... .......++..|.+||.+.+...+.. +|+||||++++++++|..||..
T Consensus 128 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 128 KGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred CHHHEEEcCCCCEEEcccccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765443221 01234467889999999988777766 9999999999999999999976
Q ss_pred hh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 159 SN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 159 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
.+ .......+.... .....+..++..+
T Consensus 206 ~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~l 233 (260)
T cd06606 206 LGNPMAALYKIGSSG----------------------------------------------------EPPEIPEHLSEEA 233 (260)
T ss_pred CCchHHHHHhccccC----------------------------------------------------CCcCCCcccCHHH
Confidence 65 222222111100 0022335568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.+|+.+||+.+|++||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=231.97 Aligned_cols=192 Identities=22% Similarity=0.405 Sum_probs=155.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..++..++||||+.+|+|.++++.. +.+++..++.++.|++.||.|||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------- 149 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--------- 149 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---------
Confidence 47888999999999999999999999999652 35889999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||+|+||+++.++.+|++|||++.......... ......++..|+|||.+.+..++.. +|+|||||
T Consensus 150 -----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 222 (293)
T cd05053 150 -----SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGV 222 (293)
T ss_pred -----HCCccccccceeeEEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcc-cceeehhh
Confidence 8999999999999999999999999999987544322111 1112234567999999888778777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|++++ |..||......+....+.....
T Consensus 223 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 252 (293)
T cd05053 223 LLWEIFTLGGSPYPGIPVEELFKLLKEGYR-------------------------------------------------- 252 (293)
T ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--------------------------------------------------
Confidence 9999997 9999987765555544332211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+...+..+.+|+.+||..||++|||+.+++++
T Consensus 253 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 253 ---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=231.26 Aligned_cols=189 Identities=22% Similarity=0.369 Sum_probs=153.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++.+......++||||+++|+|.+++.... .+++..++.++.|++.||+|||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--------- 136 (297)
T cd05089 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--------- 136 (297)
T ss_pred hheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 468889999999999999999999999997642 4788999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||++....... .......+..|++||.+.+..++.+ +|+|||||
T Consensus 137 -----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~ 206 (297)
T cd05089 137 -----EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGV 206 (297)
T ss_pred -----HCCcccCcCCcceEEECCCCeEEECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCch-hhHHHHHH
Confidence 8999999999999999999999999999985322110 1111223457999999988777777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||..........++..+..
T Consensus 207 il~el~t~g~~pf~~~~~~~~~~~~~~~~~-------------------------------------------------- 236 (297)
T cd05089 207 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------- 236 (297)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------------------------------------------------
Confidence 9999997 9999987766555554433211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.+|+.+||..+|.+|||++++++.
T Consensus 237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11224578899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=224.54 Aligned_cols=191 Identities=23% Similarity=0.402 Sum_probs=151.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+.+++|.+++.+.+ .+++..++.++.|++.||.||| +.+++|+||+
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~i~H~dl~ 121 (252)
T cd05084 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE--------------SKHCIHRDLA 121 (252)
T ss_pred ceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccccccc
Confidence 578899999999999999999999999997654 5899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+|++|||++....... ..........+..|+|||.+.+..++.. +|+|||||++|++++ |..||..
T Consensus 122 p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 122 ARNCLVTEKNVLKISDFGMSREEEDGV-YASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred hheEEEcCCCcEEECccccCccccccc-ccccCCCCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999986433211 0001111223457999999988777777 999999999999997 8889865
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..... ...+..++..+.
T Consensus 200 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 226 (252)
T cd05084 200 LSNQQTREAIEQGVR-----------------------------------------------------LPCPELCPDAVY 226 (252)
T ss_pred cCHHHHHHHHHcCCC-----------------------------------------------------CCCcccCCHHHH
Confidence 544333222221100 112245678999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|+.+||..+|++|||+.++++
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.37 Aligned_cols=191 Identities=26% Similarity=0.430 Sum_probs=151.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++...+..++||||+++|+|.++|... ..+++..++.++.|++.||.||| +.+++|++|
T Consensus 64 ~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------------~~~iiH~~l 129 (259)
T PF07714_consen 64 VKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--------------SNNIIHGNL 129 (259)
T ss_dssp E-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--------------HTTEEEST-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------ccccccccc
Confidence 47899999888899999999999999999987 67999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+++||+++.++.+||+|||++......... ...........|+|||.+....++.+ +||||||+++||+++ |..||.
T Consensus 130 ~~~nill~~~~~~Kl~~f~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 130 SPSNILLDSNGQVKLSDFGLSRPISEKSKY-KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp SGGGEEEETTTEEEEESTTTGEETTTSSSE-EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTT
T ss_pred cccccccccccccccccccccccccccccc-cccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence 999999999999999999998765222111 12233446788999999988777777 999999999999999 789998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+...++..+.. ...+..++..+
T Consensus 208 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 234 (259)
T PF07714_consen 208 DYDNEEIIEKLKQGQR-----------------------------------------------------LPIPDNCPKDI 234 (259)
T ss_dssp TSCHHHHHHHHHTTEE-----------------------------------------------------TTSBTTSBHHH
T ss_pred cccccccccccccccc-----------------------------------------------------ceeccchhHHH
Confidence 7766665555543322 12235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.++|.+||+.||++|||++++++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=224.73 Aligned_cols=190 Identities=19% Similarity=0.328 Sum_probs=154.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..++..++||||+.+++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl 129 (261)
T cd05068 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--------------AQNYIHRDL 129 (261)
T ss_pred cceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeccC
Confidence 468889999999999999999999999997754 6899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.+ +|+||||++++++++ |+.||.
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCccc--ccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999998765422111 1111223457999999988888777 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..... ...+..++..+
T Consensus 207 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 233 (261)
T cd05068 207 GMTNAEVLQQVDQGYR-----------------------------------------------------MPCPPGCPKEL 233 (261)
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCCHHH
Confidence 7665554444332211 11124467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.+|++||+++++++
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=226.70 Aligned_cols=217 Identities=22% Similarity=0.285 Sum_probs=159.2
Q ss_pred CceeeeeeeCCe-----EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPR-----VFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++.+..... .+++|||+.+ +|.+++.+.. .+++..++.++.|++.||.||| +.++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--------------~~~i 128 (287)
T cd07838 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--------------SHRI 128 (287)
T ss_pred ceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCe
Confidence 467888877666 9999999975 8999997754 4899999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||+++||+++.++.++|+|||++....... ......++..|+|||.+.+..++.+ +|+|||||++++|++|.
T Consensus 129 ~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~ 203 (287)
T cd07838 129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRR 203 (287)
T ss_pred eeccCChhhEEEccCCCEEEeccCcceeccCCc----ccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCC
Confidence 999999999999999999999999987543321 1223346788999999988888777 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+....+...++......... . .+........ ..... ..... .......+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~------~~~~~-~~~~~-------~~~~~~~~ 256 (287)
T cd07838 204 PLFRGTSEADQLDKIFDVIGLPSE-E------------EWPRNVSLPR------SSFPS-YTPRS-------FKSFVPEI 256 (287)
T ss_pred CcccCCChHHHHHHHHHHcCCCCh-H------------hcCCCcccch------hhccc-ccccc-------hhhhhhhh
Confidence 999877666555554432211100 0 0000000000 00000 00000 01111345
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+..+.++|.+||+.||++||++++++.||||
T Consensus 257 ~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 257 CEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 7889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=233.61 Aligned_cols=189 Identities=21% Similarity=0.362 Sum_probs=152.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..++.+++||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------- 141 (303)
T cd05088 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--------- 141 (303)
T ss_pred ceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---------
Confidence 578999999999999999999999999997643 4789999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++||||||+||+++.++.+||+|||++....... .......+..|+|||.+.+..++.+ +|+|||||
T Consensus 142 -----~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 211 (303)
T cd05088 142 -----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGV 211 (303)
T ss_pred -----hCCccccccchheEEecCCCcEEeCccccCcccchhh----hcccCCCcccccCHHHHhccCCccc-ccchhhhh
Confidence 8999999999999999999999999999985321111 1111224567999999987777776 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
+++++++ |..||.+.+..+....+.....
T Consensus 212 il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 241 (303)
T cd05088 212 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------- 241 (303)
T ss_pred HHHHHHhcCCCCcccCChHHHHHHHhcCCc--------------------------------------------------
Confidence 9999998 9999976655444433221100
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.+|+.+||+.+|++||++++++++
T Consensus 242 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=231.47 Aligned_cols=198 Identities=21% Similarity=0.308 Sum_probs=151.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHhhhcccCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------------------PVAESNARTWFSQMLAGLEYLHREITNH 61 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~ 61 (304)
+++++++...+..++||||+.+|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH------ 155 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS------ 155 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH------
Confidence 578899999999999999999999999996532 3677889999999999999999
Q ss_pred CCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHH
Q psy1812 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWS 141 (304)
Q Consensus 62 ~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvws 141 (304)
+.+++|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.+ +|+||
T Consensus 156 --------~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s 225 (304)
T cd05096 156 --------SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTA-SDVWA 225 (304)
T ss_pred --------HCCccccCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCCCCch-hhhHH
Confidence 8899999999999999999999999999987543322111 1223345788999999988888877 99999
Q ss_pred HHHHHHHHHh--CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 142 LGVITFIMLN--AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 142 lG~ll~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|||++|+|++ +..||...+..+.............
T Consensus 226 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------------------------------- 262 (304)
T cd05096 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG------------------------------------------- 262 (304)
T ss_pred HHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc-------------------------------------------
Confidence 9999999987 5678876554433332211100000
Q ss_pred hhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.......+..++..+.+|+.+||..||.+|||++++.+
T Consensus 263 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 263 ---RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ---ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 00001112456789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=269.77 Aligned_cols=204 Identities=26% Similarity=0.409 Sum_probs=169.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++--+.+..+|+||||+||+|.+.++.++..+|....-+..|++.|+.||| +.|||||||||
T Consensus 1297 V~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH--------------~~gIVHRDIK~ 1362 (1509)
T KOG4645|consen 1297 VRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH--------------EHGIVHRDIKP 1362 (1509)
T ss_pred cccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH--------------hcCceecCCCc
Confidence 5778888888899999999999999999999988899999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc-ccccccCccCCccccccccccCCC---CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG-RRVLSRTYCGSAAYAAPEVISGNP---YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
.||+++.+|.+|++|||.+..+..... -........||+.|||||++.+.+ .... +||||+||++.||+||+.||
T Consensus 1363 aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A-~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1363 ANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGA-ADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred cceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcc-hhhhcccceEEEeecCCCch
Confidence 999999999999999999987655431 122335678999999999997654 3344 99999999999999999999
Q ss_pred CChhHHHH-HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DDSNLKQL-FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
...+.... +-++-.+ .....|..+++
T Consensus 1442 ~~~dne~aIMy~V~~g-----------------------------------------------------h~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAG-----------------------------------------------------HKPQIPERLSS 1468 (1509)
T ss_pred hhccchhHHHhHHhcc-----------------------------------------------------CCCCCchhhhH
Confidence 65544322 2222111 12445567999
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+.+|||..||..||++|.++.|+++|-|=+.+++..+
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s 1505 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDS 1505 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhccccccccch
Confidence 9999999999999999999999999999988876443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=227.61 Aligned_cols=191 Identities=20% Similarity=0.349 Sum_probs=154.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++++..+...++||||+.+|+|.+++.... .+++..+..++.|++.||.||| +
T Consensus 72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~ 137 (277)
T cd05032 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--------------A 137 (277)
T ss_pred eEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------------h
Confidence 478999999999999999999999999997532 3678899999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
.+++|+||+|+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++|+++
T Consensus 138 ~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~ 215 (277)
T cd05032 138 KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMA 215 (277)
T ss_pred CCccccccChheEEEcCCCCEEECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhh
Confidence 99999999999999999999999999998754432211 11223346788999999987777777 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||...+.......+..... ...
T Consensus 216 t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 242 (277)
T cd05032 216 TLAEQPYQGLSNEEVLKFVIDGGH-----------------------------------------------------LDL 242 (277)
T ss_pred ccCCCCCccCCHHHHHHHHhcCCC-----------------------------------------------------CCC
Confidence 8 8999977665444443331111 112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+..++..+.+++.+||+.+|++|||+.++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3446889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=224.62 Aligned_cols=189 Identities=22% Similarity=0.423 Sum_probs=155.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..+...++||||+++++|.+++.+. ..+++..++.++.+++.||.||| +.+++|+||
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--------------~~~i~h~dl 130 (261)
T cd05148 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--------------EQNSIHRDL 130 (261)
T ss_pred hheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecccc
Confidence 46788899999999999999999999999863 35899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.+||+|||.+........ ......++..|++||.+.+..++.. +|+||||++++++++ |..||.
T Consensus 131 ~~~nilv~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 131 AARNILVGEDLVCKVADFGLARLIKEDVY---LSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred CcceEEEcCCceEEEccccchhhcCCccc---cccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865432211 1123345678999999988777777 999999999999998 899997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+.+..+..... ...+..+++.+
T Consensus 207 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 233 (261)
T cd05148 207 GMNNHEVYDQITAGYR-----------------------------------------------------MPCPAKCPQEI 233 (261)
T ss_pred cCCHHHHHHHHHhCCc-----------------------------------------------------CCCCCCCCHHH
Confidence 7765555554442211 11224568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..||++|||++++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=227.67 Aligned_cols=191 Identities=20% Similarity=0.346 Sum_probs=154.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---------------PVAESNARTWFSQMLAGLEYLHREITNHTPFT 65 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~ 65 (304)
+++++++..+...++||||+.+|+|.+++...+ .+++..+..++.|++.||+|||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---------- 139 (280)
T cd05092 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---------- 139 (280)
T ss_pred ceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----------
Confidence 468889999999999999999999999997753 3789999999999999999999
Q ss_pred CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHH
Q psy1812 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145 (304)
Q Consensus 66 ~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~l 145 (304)
+.+++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.+ +|+|||||+
T Consensus 140 ----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~i 213 (280)
T cd05092 140 ----SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVV 213 (280)
T ss_pred ----HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhccCCcCch-hhHHHHHHH
Confidence 899999999999999999999999999998644322111 11222335678999999988888877 999999999
Q ss_pred HHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhh
Q psy1812 146 TFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILS 224 (304)
Q Consensus 146 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (304)
+|++++ |..||...........+..+..
T Consensus 214 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------------- 242 (280)
T cd05092 214 LWEIFTYGKQPWYQLSNTEAIECITQGRE--------------------------------------------------- 242 (280)
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHcCcc---------------------------------------------------
Confidence 999998 8999976655444443332211
Q ss_pred ccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 225 HQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 225 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.+|+.+||..||++||+++++++
T Consensus 243 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 --LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=225.18 Aligned_cols=190 Identities=22% Similarity=0.438 Sum_probs=153.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+..++..++||||+.+|+|.+++... ..+++..+..++.+++.||+||| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--------------~~~i~H~dl 129 (261)
T cd05072 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--------------RKNYIHRDL 129 (261)
T ss_pred eeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecccc
Confidence 46788888999999999999999999999763 46889999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.. +|+|||||++|++++ |..||.
T Consensus 130 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 130 RAANVLVSESLMCKIADFGLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred chhhEEecCCCcEEECCCccceecCCCcee--ccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCC
Confidence 999999999999999999999764332111 1122335678999999988777777 999999999999998 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..........+..... ......++.++
T Consensus 207 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 233 (261)
T cd05072 207 GMSNSDVMSALQRGYR-----------------------------------------------------MPRMENCPDEL 233 (261)
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7655544444332211 11123467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.+|++|||++++++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=224.26 Aligned_cols=191 Identities=18% Similarity=0.312 Sum_probs=151.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++. ....++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+++|+|||
T Consensus 58 i~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dlk 122 (257)
T cd05115 58 VRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--------------GKNFVHRDLA 122 (257)
T ss_pred EEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hcCeeecccc
Confidence 45677765 4578999999999999999975 446899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+|++|||++.................++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..
T Consensus 123 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred hheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCc
Confidence 99999999999999999998754332221111111223568999999987777777 999999999999996 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..+.. ...+...++++.
T Consensus 202 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 228 (257)
T cd05115 202 MKGPEVMSFIEQGKR-----------------------------------------------------LDCPAECPPEMY 228 (257)
T ss_pred CCHHHHHHHHHCCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 765554443332211 112245688999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++||++.++.+
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=223.20 Aligned_cols=192 Identities=23% Similarity=0.385 Sum_probs=154.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.. ...++||||+++|+|.+++.+.. .+++..++.++.|++.||+||| +.+++|+||
T Consensus 59 v~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~i~H~di 123 (257)
T cd05040 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--------------SKRFIHRDL 123 (257)
T ss_pred cceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--------------hCCcccccc
Confidence 467778777 89999999999999999998764 6899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.+||+|||++.................++..|+|||.+.+..++.. +|+|||||++++|++ |..||.
T Consensus 124 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 124 AARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred CcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765443221111223446778999999988778777 999999999999998 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+...... ...+..++..+
T Consensus 203 ~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~ 230 (257)
T cd05040 203 GLSGSQILKKIDKEGER----------------------------------------------------LERPEACPQDI 230 (257)
T ss_pred CCCHHHHHHHHHhcCCc----------------------------------------------------CCCCccCCHHH
Confidence 66555444433321100 11123467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++|||+.++++
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=227.69 Aligned_cols=223 Identities=25% Similarity=0.395 Sum_probs=159.8
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... +..++||||+.+ +|.+++.+. ..+++..++.++.|++.||+||| ..+++|+|
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------------~~~~~h~d 125 (287)
T cd07840 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--------------SNGILHRD 125 (287)
T ss_pred eeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecc
Confidence 3577888877 899999999975 999999775 57999999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|+||+++.++.++++|||++......... ......++..|+|||.+.+. .++.+ +|+||||++++++++|..||
T Consensus 126 l~p~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~~l~el~t~~~p~ 202 (287)
T cd07840 126 IKGSNILINNDGVLKLADFGLARPYTKRNSA--DYTNRVITLWYRPPELLLGATRYGPE-VDMWSVGCILAELFLGKPIF 202 (287)
T ss_pred CcHHHeEEcCCCCEEEccccceeeccCCCcc--cccccccccccCCceeeEccccCChH-HHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999998755443211 12233567889999987654 34555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+...........+........ .. ...........+... ....++..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~--~~~~~~~~~~~~~~~------~~~~~~~~ 259 (287)
T cd07840 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPW---------------FE--NLKPKKPYKRRLREF------FKHLIDPS 259 (287)
T ss_pred CCCChHHHHHHHHHHhCCCchhhccccccchh---------------hh--hccccccchhHHHHH------hcccCCHH
Confidence 88776665555444322221100000000000 00 000000000011111 11224889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+++.+||..+|++||+++++++||||
T Consensus 260 ~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 260 ALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=226.53 Aligned_cols=188 Identities=21% Similarity=0.364 Sum_probs=150.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++...+..++||||+++|+|.+++...+ .+++..++.++.|++.||+|||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--------- 129 (270)
T cd05047 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--------- 129 (270)
T ss_pred eeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 478899999999999999999999999997643 3789999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+|++|||++....... .......+..|+|||++....++.+ +|+|||||
T Consensus 130 -----~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~ 199 (270)
T cd05047 130 -----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGV 199 (270)
T ss_pred -----HCCEeecccccceEEEcCCCeEEECCCCCccccchhh----hccCCCCccccCChHHHccCCCCch-hhHHHHHH
Confidence 8999999999999999999999999999975321110 1112233567999999987777777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
+++++++ |..||.+.+..+....+.....
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------------------------------------------- 229 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------- 229 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCCCC--------------------------------------------------
Confidence 9999997 9999976655444443322110
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..++.++.+++.+||..+|.+|||+.++++
T Consensus 230 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0112345778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=223.27 Aligned_cols=191 Identities=32% Similarity=0.507 Sum_probs=159.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++..+...++||||+++++|.+++.+ ...+++..++.++.+++.||.||| +.+++|+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--------------~~~i~h~ 127 (256)
T cd08530 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--------------EQKILHR 127 (256)
T ss_pred hhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--------------hCCcccC
Confidence 3567788888999999999999999999977 346899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|.||+++.++.+|++|||++...... ......++..|++||.+.+..++.. +|+||+|++++++++|+.||
T Consensus 128 ~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~ 201 (256)
T cd08530 128 DLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPF 201 (256)
T ss_pred CCCcceEEEecCCcEEEeeccchhhhccC-----CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999998765433 1223457889999999988777766 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+..... ...+..++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 228 (256)
T cd08530 202 EARSMQDLRYKVQRGKY-----------------------------------------------------PPIPPIYSQD 228 (256)
T ss_pred CCCCHHHHHHHHhcCCC-----------------------------------------------------CCCchhhCHH
Confidence 87765544443332211 1122456788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+++.+||..+|++|||+.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=230.45 Aligned_cols=191 Identities=22% Similarity=0.392 Sum_probs=153.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..++.+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--------- 151 (314)
T cd05099 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--------- 151 (314)
T ss_pred eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---------
Confidence 47888898889999999999999999999763 24788999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||.+.......... ......++..|+|||.+.+..++.+ +|+||||+
T Consensus 152 -----~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~ 224 (314)
T cd05099 152 -----SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGI 224 (314)
T ss_pred -----HCCeeeccccceeEEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCcc-chhhHHHH
Confidence 8999999999999999999999999999997543322110 1111224467999999988777777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|++++ |..||.+.+..+.+..+.....
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 254 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGHR-------------------------------------------------- 254 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999999 8899987765555544332211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 255 ---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 255 ---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1122456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=226.88 Aligned_cols=192 Identities=21% Similarity=0.384 Sum_probs=154.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-----------------GPVAESNARTWFSQMLAGLEYLHREITNHTP 63 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~ 63 (304)
+++++++..+...++||||+.+++|.+++... ..+++..+..++.|++.||.|||
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-------- 141 (283)
T cd05090 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-------- 141 (283)
T ss_pred eeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--------
Confidence 46888899999999999999999999999532 23788999999999999999999
Q ss_pred CcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 64 ~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
+.+++|+||||+||+++.++.+|++|||++.......... ......++..|+|||.+.+..++.. +|+||||
T Consensus 142 ------~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG 213 (283)
T cd05090 142 ------SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFG 213 (283)
T ss_pred ------hcCeehhccccceEEEcCCCcEEeccccccccccCCccee-cccCCCccceecChHHhccCCCCch-hhhHHHH
Confidence 8899999999999999999999999999997554322111 1223345678999999988778777 9999999
Q ss_pred HHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh
Q psy1812 144 VITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI 222 (304)
Q Consensus 144 ~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (304)
|++++|++ |..||.+.........+.....
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------- 244 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL------------------------------------------------- 244 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-------------------------------------------------
Confidence 99999998 9999977655444443332211
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.+++.+||+.||.+||++.+++++
T Consensus 245 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 245 ----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11224568899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=230.89 Aligned_cols=227 Identities=22% Similarity=0.376 Sum_probs=163.1
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...++++||+. ++|.+++...+.+++..++.++.|++.||+||| +.+++|+||||+||+++.++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~givH~dlkp~Nili~~~~~ 143 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH--------------SANVLHRDLKPGNLLVNADCE 143 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCCHHHeEEcCCCC
Confidence 56889999996 699999988888999999999999999999999 899999999999999999999
Q ss_pred eEEEeccCcccccCcccc-cccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q psy1812 91 VKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 168 (304)
++|+|||++......... ........++..|+|||.+.+. .++.. +|+||+||+++++++|..||...+....+..+
T Consensus 144 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~-~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 144 LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222 (332)
T ss_pred EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence 999999998754432211 1112334688899999987664 45655 99999999999999999999887776666666
Q ss_pred hhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCC
Q psy1812 169 TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPD 248 (304)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 248 (304)
..............+..... ...... ... .....+ ......++..+.+|+.+||+.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~------------~~~~~~-------~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 223 LQVLGTPDEETLSRIGSPKA-QNYIRS---LPN------------IPKKPF-------ESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHhCCCCHHHHHhhhhhhH-HHHHHh---ccc------------cCCcch-------HhhCCCCCHHHHHHHHHHccCC
Confidence 65544333111111100000 000000 000 000000 0111345788999999999999
Q ss_pred CCccccHHHHhcCcccccccccccccCC
Q psy1812 249 ITKRIRLDAIKAHDWLRYKSMVRRKVLP 276 (304)
Q Consensus 249 P~~R~t~~ell~~~wf~~~~~~~~~~~~ 276 (304)
|++|||+++++.||||+....+.....+
T Consensus 280 P~~R~t~~~ll~~~~~~~~~~~~~~~~~ 307 (332)
T cd07857 280 PTKRISVEEALEHPYLAIWHDPDDEPVC 307 (332)
T ss_pred cccCCCHHHHhcChhhhhhcCccccccc
Confidence 9999999999999999877665444333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=228.22 Aligned_cols=200 Identities=24% Similarity=0.338 Sum_probs=152.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK-----RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++..++..+++|||+.. +|.++.. ..+.+++..+..++.+++.||+|||+ ..+++|
T Consensus 66 v~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-------------~~~i~H 131 (288)
T cd06616 66 VKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-------------ELKIIH 131 (288)
T ss_pred eeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-------------cCCeec
Confidence 5788988889999999999964 6655432 23569999999999999999999993 369999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC---CCCCCCchHHHHHHHHHHHHhC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN---PYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~sDvwslG~ll~~ll~g 152 (304)
+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. .++.. +|+||+||+++++++|
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g 206 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATG 206 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCC----ccccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhC
Confidence 9999999999999999999999986543322 12233578889999998766 46666 9999999999999999
Q ss_pred CCCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 153 AMPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 153 ~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
..||..... .+...++.....+.. ....+.
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~ 237 (288)
T cd06616 207 KFPYPKWNSVFDQLTQVVKGDPPIL-------------------------------------------------SNSEER 237 (288)
T ss_pred CCCchhcchHHHHHhhhcCCCCCcC-------------------------------------------------CCcCCC
Confidence 999965431 111111111100000 011113
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.++.++.+||.+||+.+|.+|||++++++||||+...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 4788999999999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=224.21 Aligned_cols=192 Identities=21% Similarity=0.389 Sum_probs=155.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++.+..++..++||||+.+++|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 68 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--------------~~~i~H~di~ 133 (266)
T cd05033 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS--------------EMNYVHRDLA 133 (266)
T ss_pred ceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCC
Confidence 46888898999999999999999999999764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||++......... .......++..|+|||.+.+..++.+ +|+||||++++++++ |..||..
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 134 ARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cceEEEcCCCCEEECccchhhcccccccc-eeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999865421111 01112234578999999988888777 999999999999998 9999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..... ...+..++..+.
T Consensus 212 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 238 (266)
T cd05033 212 MSNQDVIKAVEDGYR-----------------------------------------------------LPPPMDCPSALY 238 (266)
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 655444443332211 011234678899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.+|++||++++++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=222.92 Aligned_cols=229 Identities=22% Similarity=0.290 Sum_probs=177.2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
...+++||++|++ +|.-.|.+. -.|+...++.++.++++||+|+| ...|+|||+|++||||+++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH--------------r~kilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH--------------RNKILHRDMKAANVLITKD 160 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH--------------HhhHHhhcccHhhEEEcCC
Confidence 3469999999997 999999876 47999999999999999999999 7789999999999999999
Q ss_pred CCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q psy1812 89 FNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~ 167 (304)
|.+||+|||+++.++..+.. ......+.-|..|++||.+.+.+-..+..|+|..||++.+|++|...+.+.....+...
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 99999999999766544322 11233445688999999999876444449999999999999999999999888888888
Q ss_pred hhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCC
Q psy1812 168 QTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEP 247 (304)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 247 (304)
|..-.+.+...+|.....-..+.+..... ..-++...+++.++ +-.-+++..|||.+||.+
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~eP--------------l~~~~~rkv~n~~k-----p~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEP--------------LPKGQKRKVKNRLK-----PYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCC--------------CCcchhhhhhhhcc-----cccCChhHHHHHHHHhcc
Confidence 88777777655555444433333321111 00122222233322 122367899999999999
Q ss_pred CCCccccHHHHhcCccccccccccc
Q psy1812 248 DITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 248 dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
||.+|++++++++|+||...++++.
T Consensus 302 DP~kR~~ad~alnh~~F~kdp~pqa 326 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFWKDPMPQA 326 (376)
T ss_pred CcccCcchHhhhchhhhhcCCcchh
Confidence 9999999999999999999998754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=226.21 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=153.7
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++.. .+.+++||||+++++|.+++.. ...+++..+..++.|++.||.||| ..+++
T Consensus 62 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--------------~~~i~ 127 (287)
T cd06621 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--------------SRKII 127 (287)
T ss_pred eeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcc
Confidence 466777754 4579999999999999988754 345899999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++||+++.++.++|+|||++....... .....++..|++||.+.+..++.. +|+|||||++|+|++|..
T Consensus 128 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~ 201 (287)
T cd06621 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRF 201 (287)
T ss_pred cCCCCHHHEEEecCCeEEEeeccccccccccc-----cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999986443221 123456788999999988888777 999999999999999999
Q ss_pred CCCChhH-----HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 155 PFDDSNL-----KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 155 pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
||..... .+....+....... +......
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 234 (287)
T cd06621 202 PFPPEGEPPLGPIELLSYIVNMPNPE-----------------------------------------------LKDEPGN 234 (287)
T ss_pred CCCcccCCCCChHHHHHHHhcCCchh-----------------------------------------------hccCCCC
Confidence 9965521 11111111000000 0000000
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...+++.+.+||.+||..+|.+|||+.|+++||||+....
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 0234678999999999999999999999999999966553
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=222.73 Aligned_cols=196 Identities=28% Similarity=0.441 Sum_probs=157.0
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.+ ++.+++|+||+++++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH--------------~~~i~H~dl 132 (264)
T cd06653 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH--------------SNMIVHRDI 132 (264)
T ss_pred ceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCCC
Confidence 356777755 3578999999999999999988888999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+|+||+++.++.++|+|||++.................++..|+|||.+.+...+.+ +|+|||||+++++++|+.||..
T Consensus 133 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 133 KGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred CHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999998754321111111223457889999999988777776 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
........++.... . ....+..+++.+.
T Consensus 212 ~~~~~~~~~~~~~~--~--------------------------------------------------~~~~p~~~~~~~~ 239 (264)
T cd06653 212 YEAMAAIFKIATQP--T--------------------------------------------------KPMLPDGVSDACR 239 (264)
T ss_pred cCHHHHHHHHHcCC--C--------------------------------------------------CCCCCcccCHHHH
Confidence 54443333322110 0 0223466889999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+||. +|.+|||+.+++.|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=230.17 Aligned_cols=192 Identities=21% Similarity=0.362 Sum_probs=153.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..+...++||||+.+|+|.+++...+ .+++..+..++.|++.||+|||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--------- 157 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--------- 157 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---------
Confidence 468889999999999999999999999997642 4788999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.. +|+|||||
T Consensus 158 -----~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~ 230 (307)
T cd05098 158 -----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGV 230 (307)
T ss_pred -----HCCcccccccHHheEEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhccCCCCcH-HHHHHHHH
Confidence 8999999999999999999999999999986543221110 1111224468999999988777776 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||...+..+.+..+.....
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 260 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHR-------------------------------------------------- 260 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999998 8899977665554444332211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++.++.+|+.+||..+|++|||+.+++++
T Consensus 261 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 261 ---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11224567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=223.88 Aligned_cols=192 Identities=22% Similarity=0.376 Sum_probs=154.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++...+..++||||+.+++|.+++... +.+++..+..++.|++.||+||| +.+++|+||+
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--------------~~~i~H~dlk 134 (268)
T cd05063 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--------------DMNYVHRDLA 134 (268)
T ss_pred eEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccccc
Confidence 46788899999999999999999999999764 57899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||++..................+..|++||.+.+..++.+ +|+|||||++|++++ |..||..
T Consensus 135 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 135 ARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred hhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999998755432221111111223457999999988777777 999999999999997 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+.... .. ..+..++.++.
T Consensus 214 ~~~~~~~~~i~~~~-~~----------------------------------------------------~~~~~~~~~~~ 240 (268)
T cd05063 214 MSNHEVMKAINDGF-RL----------------------------------------------------PAPMDCPSAVY 240 (268)
T ss_pred CCHHHHHHHHhcCC-CC----------------------------------------------------CCCCCCCHHHH
Confidence 66555554443221 11 11134578899
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=234.47 Aligned_cols=215 Identities=26% Similarity=0.360 Sum_probs=156.6
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCe
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNV 91 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~ 91 (304)
..++|+||+ +++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH--------------~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIH--------------SAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCHHHeEECCCCCE
Confidence 489999999 6799999876 46999999999999999999999 8899999999999999999999
Q ss_pred EEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh
Q psy1812 92 KIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTS 170 (304)
Q Consensus 92 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 170 (304)
+|+|||++...... .....++..|+|||.+.+. .++.+ +|+|||||+++++++|+.||.+.+.......+..
T Consensus 158 kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 158 KILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred EEcccccccccccc------ccCCcccccccCHHHHhCCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999998754321 2334577889999998654 44555 9999999999999999999988776666665554
Q ss_pred ccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCC
Q psy1812 171 NILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250 (304)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 250 (304)
.....+..+...+... ........ ... .....+ ......++..+.+||.+||+.+|+
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~--------------~~~-~~~~~~-------~~~~~~~s~~l~dli~~~l~~~P~ 287 (343)
T cd07851 231 LVGTPDEELLQKISSE-SARNYIQS--------------LPQ-MPKKDF-------KEVFSGANPLAIDLLEKMLVLDPD 287 (343)
T ss_pred hcCCCCHHHHhhccch-hHHHHHHh--------------ccc-cCCCCH-------HHHhccCCHHHHHHHHHhCCCChh
Confidence 4332221111100000 00000000 000 000000 011134588999999999999999
Q ss_pred ccccHHHHhcCccccccccccc
Q psy1812 251 KRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 251 ~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+|||+.++++||||+.......
T Consensus 288 ~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 288 KRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred hCCCHHHHhcCCCccccCCCcc
Confidence 9999999999999998776544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=224.84 Aligned_cols=191 Identities=27% Similarity=0.505 Sum_probs=155.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
++++.+......++||||+.+++|.+++.. ...+++..++.++.|++.||.||| +.+++|+|
T Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~i~h~~ 131 (260)
T cd08222 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--------------QRRILHRD 131 (260)
T ss_pred HHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--------------HcCccccC
Confidence 566777788899999999999999998864 346899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|+||+++. +.++++|||++........ ......++..|++||.+.+..++.+ +|+||||++++++++|..||.
T Consensus 132 l~~~nili~~-~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 132 LKAKNIFLKN-NLLKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CChhheEeec-CCEeecccCceeecCCCcc---cccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCC
Confidence 9999999975 5699999999875433221 2233457888999999887777777 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..........+..+.. ...+..++.++
T Consensus 207 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 233 (260)
T cd08222 207 GQNFLSVVLRIVEGPT-----------------------------------------------------PSLPETYSRQL 233 (260)
T ss_pred CccHHHHHHHHHcCCC-----------------------------------------------------CCCcchhcHHH
Confidence 6655444443332211 11234568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
.++|.+||..+|++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=226.24 Aligned_cols=202 Identities=29% Similarity=0.585 Sum_probs=172.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
-++..|+.+.++|+|.||++||+|.-++++.+.++++.++.+..+|..||.||| ++||++||||.+
T Consensus 315 glhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh--------------~rgiiyrdlkld 380 (593)
T KOG0695|consen 315 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH--------------ERGIIYRDLKLD 380 (593)
T ss_pred ehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh--------------hcCeeeeecccc
Confidence 467789999999999999999999999999999999999999999999999999 999999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
|||++..|.+|+.|+|+++....... ...++|||+.|.|||++.+..|... .|+|+|||+++||+.|+.||+.-..
T Consensus 381 nvlldaeghikltdygmcke~l~~gd---~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred ceEEccCCceeecccchhhcCCCCCc---ccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecC
Confidence 99999999999999999975433322 4678999999999999999999988 9999999999999999999953210
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
. +-+.+.+.+.+.-++.++...|..++-.+-.+|
T Consensus 457 ~----------------------------------------------n~d~ntedylfqvilekqiriprslsvkas~vl 490 (593)
T KOG0695|consen 457 D----------------------------------------------NPDMNTEDYLFQVILEKQIRIPRSLSVKASHVL 490 (593)
T ss_pred C----------------------------------------------CcccchhHHHHHHHhhhcccccceeehhhHHHH
Confidence 0 001123344555556666777788898999999
Q ss_pred HHhcCCCCCccc------cHHHHhcCcccccc
Q psy1812 242 GQILEPDITKRI------RLDAIKAHDWLRYK 267 (304)
Q Consensus 242 ~~~L~~dP~~R~------t~~ell~~~wf~~~ 267 (304)
+.-|+.||++|. ..+++..|+||+..
T Consensus 491 kgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 491 KGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 999999999998 47899999999964
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=220.01 Aligned_cols=190 Identities=20% Similarity=0.350 Sum_probs=152.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++......++||||+.+++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+
T Consensus 55 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~~~H~dl~ 120 (250)
T cd05085 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--------------SKNCIHRDLA 120 (250)
T ss_pred CeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecccC
Confidence 46888999999999999999999999999764 35899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||++......... ......++..|+|||++.+..++.+ +|+||||+++|++++ |..||..
T Consensus 121 p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 121 ARNCLVGENNVLKISDFGMSRQEDDGIYS--SSGLKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred hheEEEcCCCeEEECCCccceeccccccc--cCCCCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999998643221110 1112234567999999987777777 999999999999998 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..... ...+..++..+.
T Consensus 198 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 224 (250)
T cd05085 198 MTNQQAREQVEKGYR-----------------------------------------------------MSCPQKCPDDVY 224 (250)
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 655444333322110 112245678999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||+.+|++||++.++++
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=228.15 Aligned_cols=193 Identities=26% Similarity=0.396 Sum_probs=155.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+. |+|.+++.. .+.+++..+..++.|++.||.||| +.+++|+||+
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH--------------~~~i~H~dl~ 142 (307)
T cd06607 78 IEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH--------------SHERIHRDIK 142 (307)
T ss_pred EEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCC
Confidence 467889999999999999997 588887764 457899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.+ +|+||||+++|++++|..||
T Consensus 143 p~nIl~~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~ 214 (307)
T cd06607 143 AGNILLTEPGTVKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPL 214 (307)
T ss_pred cccEEECCCCCEEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCC
Confidence 99999999999999999998654321 2345778899999874 3445566 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+.......+..... + ......++..
T Consensus 215 ~~~~~~~~~~~~~~~~~--~--------------------------------------------------~~~~~~~~~~ 242 (307)
T cd06607 215 FNMNAMSALYHIAQNDS--P--------------------------------------------------TLSSNDWSDY 242 (307)
T ss_pred CCccHHHHHHHHhcCCC--C--------------------------------------------------CCCchhhCHH
Confidence 77654443322221100 0 0011235778
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.++|.+||..+|++||++.+++.||||....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=221.55 Aligned_cols=186 Identities=20% Similarity=0.408 Sum_probs=150.1
Q ss_pred Cceeeee-eeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSIL-QRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+ ..++..++||||+++++|.+++.+.+ .+++..++.++.|++.||+||| +.+++|+|
T Consensus 62 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~d 127 (256)
T cd05082 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--------------ANNFVHRD 127 (256)
T ss_pred eeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeccc
Confidence 3566654 45678999999999999999998754 4889999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|+|+||+++.++.+|++|||++....... ....++..|+|||++.+..++.+ +|+|||||++|+|++ |..||
T Consensus 128 lkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~ 200 (256)
T cd05082 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred cchheEEEcCCCcEEecCCccceeccccC------CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999986432211 12234567999999988777777 999999999999997 99999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+..+.. ...+..+++.
T Consensus 201 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 227 (256)
T cd05082 201 PRIPLKDVVPRVEKGYK-----------------------------------------------------MDAPDGCPPV 227 (256)
T ss_pred CCCCHHHHHHHHhcCCC-----------------------------------------------------CCCCCCCCHH
Confidence 76665444443332210 1122457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+++.+||..+|++|||+.++++
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=221.20 Aligned_cols=186 Identities=22% Similarity=0.459 Sum_probs=153.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..+...++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 63 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--------------~~~i~H~di 128 (256)
T cd05039 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--------------EKNFVHRDL 128 (256)
T ss_pred eeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccchhc
Confidence 467888888999999999999999999998765 6899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||.+....... .....+..|+|||.+....++.+ +|+||||++++++++ |..||.
T Consensus 129 ~p~Nili~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 129 AARNVLVSEDLVAKVSDFGLAKEASQGQ------DSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ccceEEEeCCCCEEEccccccccccccc------ccCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999987552211 12234567999999987777776 999999999999997 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+..... ...+..+++.+
T Consensus 202 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 228 (256)
T cd05039 202 RIPLKDVVPHVEKGYR-----------------------------------------------------MEAPEGCPPEV 228 (256)
T ss_pred CCCHHHHHHHHhcCCC-----------------------------------------------------CCCccCCCHHH
Confidence 6655444333322110 11224568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++|||++++++
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=227.17 Aligned_cols=192 Identities=20% Similarity=0.360 Sum_probs=155.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++.+......++||||+.+|+|.+++.+.+ .++...+..++.|++.||.|||
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------- 154 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--------- 154 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---------
Confidence 468889999999999999999999999997642 3678889999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.. +|+||||+
T Consensus 155 -----~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 227 (304)
T cd05101 155 -----SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGV 227 (304)
T ss_pred -----HCCeeecccccceEEEcCCCcEEECCCccceecccccccc-cccCCCCCceeeCchhhccCCCCch-hhHHHHHH
Confidence 8999999999999999999999999999987553322111 1122345678999999988777777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|++++ |..||.+.+..+....+.....
T Consensus 228 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 257 (304)
T cd05101 228 LMWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------------- 257 (304)
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHcCCc--------------------------------------------------
Confidence 9999998 7889987766665554432211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++.++.+|+.+||..+|++|||+.++++.
T Consensus 258 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 258 ---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 11124567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=227.74 Aligned_cols=192 Identities=23% Similarity=0.385 Sum_probs=153.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+...+..++||||+.+|+|.+++.... .+++.++..++.+++.||+||| +.+++|+||
T Consensus 102 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------------~~~ivH~dl 167 (302)
T cd05055 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--------------SKNCIHRDL 167 (302)
T ss_pred ceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeehhhh
Confidence 578889999999999999999999999997643 3899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||++........ ........++..|+|||.+.+..++.+ +|+||+||++|++++ |..||.
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999999875432211 011122345678999999988888777 999999999999998 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+....+.+....... ...+...+..+
T Consensus 246 ~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~ 273 (302)
T cd05055 246 GMPVDSKFYKLIKEGYR----------------------------------------------------MAQPEHAPAEI 273 (302)
T ss_pred CCCchHHHHHHHHcCCc----------------------------------------------------CCCCCCCCHHH
Confidence 66544333322211100 11123467899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+|+.+||..+|++|||+.++++
T Consensus 274 ~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 274 YDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=227.15 Aligned_cols=200 Identities=26% Similarity=0.419 Sum_probs=155.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+. ++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++|+||+
T Consensus 77 ~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------------~~~i~H~dl~ 142 (296)
T cd06618 77 VKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-------------KHGVIHRDVK 142 (296)
T ss_pred HhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------hCCEecCCCc
Confidence 467889999999999999995 588887766 4578999999999999999999992 3699999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC----CCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP----YNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.+ +|+||||+++|+|++|+.|
T Consensus 143 p~nill~~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p 217 (296)
T cd06618 143 PSNILLDASGNVKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFP 217 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999865432211 12234678899999987553 5566 9999999999999999999
Q ss_pred CCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 156 FDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 156 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
|...... +....+....... ......++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 246 (296)
T cd06618 218 YKNCKTEFEVLTKILQEEPPS---------------------------------------------------LPPNEGFS 246 (296)
T ss_pred CCcchhHHHHHHHHhcCCCCC---------------------------------------------------CCCCCCCC
Confidence 9653321 2222222111000 00112367
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.++.+|+.+||..||++|||++++++|+||......
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 889999999999999999999999999999986653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=226.03 Aligned_cols=220 Identities=25% Similarity=0.360 Sum_probs=165.5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...|+|||+|. .+|.+.+.- .++-..+.+++.|++.|++||| +.+|+||||||+||++..+..
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lh--------------s~~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLH--------------SAGIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHH--------------hcceeecccCcccceecchhh
Confidence 46899999997 499999873 4788899999999999999999 899999999999999999999
Q ss_pred eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh
Q psy1812 91 VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTS 170 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 170 (304)
+||.|||+++..... ...+.++.+..|+|||++.+..+... +|+||+||++.||++|...|.+.+..+++.++..
T Consensus 157 lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE 231 (369)
T ss_pred eeeccchhhcccCcc----cccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence 999999999753332 24456778899999999999888887 9999999999999999999999999999988887
Q ss_pred ccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc-cccccccccHHHHHHHHHhcCCCC
Q psy1812 171 NILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH-QVKVKDILSHQVKNLVGQILEPDI 249 (304)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP 249 (304)
..+......-..+....-.-.. ....... ..-...+.+.... ...-++.-+..+++++.+||.+||
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~-~~~~y~~------------~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~p 298 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVE-NRPQYQA------------ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDP 298 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhh-cChHhhc------------cchhhhCCcccccccccCCccchHHHHHHHHHhhccCh
Confidence 7766553332222211110000 0000000 0111111111111 011113446789999999999999
Q ss_pred CccccHHHHhcCcccc
Q psy1812 250 TKRIRLDAIKAHDWLR 265 (304)
Q Consensus 250 ~~R~t~~ell~~~wf~ 265 (304)
++|.+++++|+|||++
T Consensus 299 e~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 299 EKRISVDDALRHPYIK 314 (369)
T ss_pred hhcccHHHHhcCCeee
Confidence 9999999999999998
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=222.93 Aligned_cols=192 Identities=20% Similarity=0.383 Sum_probs=154.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+++++|.+++... +.+++..+..++.|++.||.||| +.+++|+||+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~h~dlk 133 (267)
T cd05066 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--------------DMGYVHRDLA 133 (267)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeehhhc
Confidence 57889999999999999999999999999775 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||++.................++..|++||.+.+..++.+ +|+||||++++++++ |..||..
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred hhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999998765432221111112223567999999988778777 999999999999887 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..... ...+..++..+.
T Consensus 213 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 239 (267)
T cd05066 213 MSNQDVIKAIEEGYR-----------------------------------------------------LPAPMDCPAALH 239 (267)
T ss_pred CCHHHHHHHHhCCCc-----------------------------------------------------CCCCCCCCHHHH
Confidence 655444444332211 011234678899
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||+.+|++||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=226.37 Aligned_cols=198 Identities=22% Similarity=0.335 Sum_probs=153.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
+++++++..++..++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-------------- 147 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-------------- 147 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 468888888899999999999999999998765 6899999999999999999999
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
+.+++|+||||+||+++.++.++++|||++......... .......++..|+|||.+.+..++.. +|+|||||++|++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el 225 (296)
T cd05051 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEI 225 (296)
T ss_pred HcCccccccchhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHH
Confidence 899999999999999999999999999998754332211 11223345678999999988777777 9999999999999
Q ss_pred Hh--CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 150 LN--AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 150 l~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
++ +..||...+..+............. .. ...
T Consensus 226 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~--------~~~ 259 (296)
T cd05051 226 LTLCREQPYEHLTDQQVIENAGHFFRDDG--------------------------------------RQ--------IYL 259 (296)
T ss_pred HhcCCCCCCCCcChHHHHHHHHhcccccc--------------------------------------cc--------ccC
Confidence 98 6788876554444333221100000 00 001
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..++.++.+++.+||..||++|||+.++++
T Consensus 260 ~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 260 PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=210.21 Aligned_cols=225 Identities=22% Similarity=0.317 Sum_probs=175.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++...++.+.+|+|||+. +|..|... ++.+..+.++.++.|++.||.++| +.++.|||+|
T Consensus 64 vrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch--------------shnvlhrdlk 128 (292)
T KOG0662|consen 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH--------------SHNVLHRDLK 128 (292)
T ss_pred eehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh--------------hhhhhhccCC
Confidence 6889999999999999999975 99998876 567999999999999999999999 9999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|.|.+++++|.+|+.|||+++-++-.-. ......-|..|++|.++.+.+......|+||.||++.|+.. |+..|.+
T Consensus 129 pqnllin~ngelkladfglarafgipvr---cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 129 PQNLLINRNGELKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred cceEEeccCCcEEecccchhhhcCCceE---eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 9999999999999999999986543221 23344567889999999988755444999999999999998 7788899
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..++..+|....+......|.-+++. +....++......+. ...-+.++...+
T Consensus 206 ~dvddqlkrif~~lg~p~ed~wps~t~l------------------------pdyk~yp~ypattsw-sqivp~lns~gr 260 (292)
T KOG0662|consen 206 NDVDDQLKRIFRLLGTPTEDQWPSMTKL------------------------PDYKPYPIYPATTSW-SQIVPKLNSTGR 260 (292)
T ss_pred CcHHHHHHHHHHHhCCCccccCCccccC------------------------CCCcccCCccccchH-HHHhhhhcchhH
Confidence 9888888888776665543222222111 111111111111111 122255777889
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|+++++|.-+|..|++++++++||||..-+
T Consensus 261 dllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 261 DLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred HHHHHHhccCcccccCHHHHhcCccccccC
Confidence 999999999999999999999999998755
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=224.48 Aligned_cols=192 Identities=20% Similarity=0.339 Sum_probs=155.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++++++......++++||+.+++|.+++... ..+++..++.++.|++.||.|||
T Consensus 71 v~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--------- 141 (283)
T cd05091 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--------- 141 (283)
T ss_pred CeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---------
Confidence 57889999989999999999999999998532 24788899999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||+++........ .......+++.|+|||.+.+..++.. +|+|||||
T Consensus 142 -----~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~ 214 (283)
T cd05091 142 -----SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGV 214 (283)
T ss_pred -----HcCccccccchhheEecCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcc-hhHHHHHH
Confidence 899999999999999999999999999998754332211 11123345678999999988878777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++++|++ |..||.+....+....+.....
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------------------------------------------- 244 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-------------------------------------------------- 244 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--------------------------------------------------
Confidence 9999998 8889877666555554443321
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 245 ---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 11235578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=219.30 Aligned_cols=190 Identities=24% Similarity=0.430 Sum_probs=156.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.+.+..++||||+++++|.+++..... +++..++.++.|++.||.+|| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--------------~~~~~h~dl 129 (258)
T smart00219 64 VKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--------------SKNFIHRDL 129 (258)
T ss_pred heEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--------------cCCeeeccc
Confidence 4688899999999999999999999999987554 999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||++.......... .....++..|++||.+.+..++.+ +|+||+|++++++++ |..||.
T Consensus 130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYK--KKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ccceEEEccCCeEEEcccCCceecccccccc--cccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987654432211 111236788999999977777776 999999999999998 788987
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+...... ..+..++.++
T Consensus 207 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 233 (258)
T smart00219 207 GMSNEEVLEYLKKGYRL-----------------------------------------------------PKPENCPPEI 233 (258)
T ss_pred CCCHHHHHHHHhcCCCC-----------------------------------------------------CCCCcCCHHH
Confidence 76655555544433211 1123468899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=222.70 Aligned_cols=190 Identities=27% Similarity=0.439 Sum_probs=152.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++.+...+..++|+||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+++|+
T Consensus 65 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~ 130 (267)
T cd08228 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--------------SRRVMHR 130 (267)
T ss_pred eeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--------------hCCeeCC
Confidence 4678888889999999999999999998864 335899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.. +|+||+|++++++++|..||
T Consensus 131 dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~ 206 (267)
T cd08228 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred CCCHHHEEEcCCCCEEECccccceeccchhH---HHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999876543221 1223457889999999988777777 99999999999999999998
Q ss_pred CChhH--HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 157 DDSNL--KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 157 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
..... ......+..... + ......++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~--~--------------------------------------------------~~~~~~~~ 234 (267)
T cd08228 207 YGDKMNLFSLCQKIEQCDY--P--------------------------------------------------PLPTEHYS 234 (267)
T ss_pred ccccccHHHHHHHHhcCCC--C--------------------------------------------------CCChhhcC
Confidence 54421 222222221110 0 01113467
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+.+++.+||..+|++||++.++++
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 88999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=222.38 Aligned_cols=192 Identities=18% Similarity=0.349 Sum_probs=150.5
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCC
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRA------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~ 68 (304)
+++++++.... ..++||||+++|+|..++... ..+++..++.++.|++.||.|||
T Consensus 64 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH------------- 130 (273)
T cd05035 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS------------- 130 (273)
T ss_pred eeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-------------
Confidence 35666654433 489999999999999998543 25899999999999999999999
Q ss_pred CCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 69 ~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+.+++|+||||+||++++++.+||+|||+++......... ......++..|++||.+.+..++.+ +|+|||||++|+
T Consensus 131 -~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~e 207 (273)
T cd05035 131 -NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWE 207 (273)
T ss_pred -hCCeeccccchheEEECCCCeEEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHH
Confidence 8899999999999999999999999999987544322111 1112234678999999987777777 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+++ |..||.+.+..+....+..+.. .
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~ 234 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNR-----------------------------------------------------L 234 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------C
Confidence 999 8899977665554443332211 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
..+..++..+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-29 Score=226.32 Aligned_cols=194 Identities=26% Similarity=0.406 Sum_probs=156.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.++...++||||+. |+|.+++.. .+.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH--------------~~gi~H~dl~ 148 (313)
T cd06633 84 IEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--------------SHNMIHRDIK 148 (313)
T ss_pred ccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 468899999999999999996 588888865 457899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.. +|+|||||+++++++|..||
T Consensus 149 p~nili~~~~~~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~ 220 (313)
T cd06633 149 AGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPL 220 (313)
T ss_pred hhhEEECCCCCEEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999998753221 22346788999999984 3445555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+...... ......++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~ 248 (313)
T cd06633 221 FNMNAMSALYHIAQNDSP----------------------------------------------------TLQSNEWTDS 248 (313)
T ss_pred CCCChHHHHHHHHhcCCC----------------------------------------------------CCCccccCHH
Confidence 776554444333221110 0111345778
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+|+.+||+.+|.+||++.+++.||||+....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999999999999999999999999997664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=221.26 Aligned_cols=184 Identities=17% Similarity=0.255 Sum_probs=146.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..+...++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++++|+|||
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~iiH~dlk 127 (258)
T cd05078 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--------------DKGLTHGNVC 127 (258)
T ss_pred hheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCc
Confidence 568899999999999999999999999998754 5899999999999999999999 8999999999
Q ss_pred CCcEEEecCCC--------eEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTKRFN--------VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++.++. ++++|||.+..... .....++..|+|||.+.+.. ++.. +|+|||||++|+++
T Consensus 128 p~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~~l~ 199 (258)
T cd05078 128 AKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLA-ADKWSFGTTLWEIF 199 (258)
T ss_pred cceEEEecccccccCCCceEEecccccccccCC-------chhccccCCccCchhccCCCCCCch-hhHHHHHHHHHHHH
Confidence 99999987765 58999998754332 12345778899999997644 5555 99999999999999
Q ss_pred hCC-CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 NAA-MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+|. .||...+....... .... ...
T Consensus 200 ~g~~~~~~~~~~~~~~~~-~~~~------------------------------------------------------~~~ 224 (258)
T cd05078 200 SGGDKPLSALDSQKKLQF-YEDR------------------------------------------------------HQL 224 (258)
T ss_pred cCCCCChhhccHHHHHHH-HHcc------------------------------------------------------ccC
Confidence 984 66654433222111 1000 122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+...+.++.+|+.+||+.||++|||++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 23456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=231.27 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=165.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+.+-....+|||||||-.|++.+.++-. .++++.++..++++.+.||+||| ...-+|||||
T Consensus 91 VKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH--------------~~~KIHRDIK 156 (502)
T KOG0574|consen 91 VKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH--------------DLKKIHRDIK 156 (502)
T ss_pred hhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH--------------HHHHHHhhcc
Confidence 67888888888999999999999999999764 57999999999999999999999 6677999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
..|||++.+|..|+.|||.+--+.+-. .+..+.+||+.|+|||++..-.|+.. +|+||||+...||..|+.||.+-
T Consensus 157 AGNILLNT~G~AKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 157 AGNILLNTDGIAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccEEEcccchhhhhhccccchhhhhH---HhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccc
Confidence 999999999999999999985433222 24567899999999999988889988 99999999999999999999776
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.+...+-.+-... .+ . ..-|...++++.|
T Consensus 233 HPMRAIFMIPT~P--PP-----------------------------------------T--------F~KPE~WS~~F~D 261 (502)
T KOG0574|consen 233 HPMRAIFMIPTKP--PP-----------------------------------------T--------FKKPEEWSSEFND 261 (502)
T ss_pred cccceeEeccCCC--CC-----------------------------------------C--------CCChHhhhhHHHH
Confidence 5532222111100 00 0 1122446889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|+++||..+|++|.||-++++|+|.++.+.
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 999999999999999999999999998765
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=230.64 Aligned_cols=193 Identities=21% Similarity=0.380 Sum_probs=149.6
Q ss_pred Cceeeeee-eCCeEEEEEecCCCCCHHHHHHhc-----------------------------------------------
Q psy1812 1 MQVHSILQ-RGPRVFIFMRYADNGDLLDHIKRA----------------------------------------------- 32 (304)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------- 32 (304)
+++++.+. .+..++++|||+++|+|.+++...
T Consensus 74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 35667665 456789999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccC
Q psy1812 33 --------------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGF 98 (304)
Q Consensus 33 --------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~ 98 (304)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--------------~~~ivHrDikp~Nill~~~~~vkL~DfG~ 219 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA--------------SRKCIHRDLAARNILLSENNVVKICDFGL 219 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCcceEEEeCCCcEEEecccc
Confidence 25789999999999999999999 89999999999999999999999999999
Q ss_pred cccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccc
Q psy1812 99 ARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQV 177 (304)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 177 (304)
+......... .......++..|+|||.+.+..++.+ +|+|||||+++++++ |..||.+....+.+.........
T Consensus 220 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 294 (337)
T cd05054 220 ARDIYKDPDY-VRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--- 294 (337)
T ss_pred chhcccCcch-hhccCCCCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---
Confidence 9754322111 11223345678999999988888887 999999999999998 99999764332222221111000
Q ss_pred hhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHH
Q psy1812 178 KVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDA 257 (304)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~e 257 (304)
...+...++.+.+++.+||+.+|++||++++
T Consensus 295 -------------------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 295 -------------------------------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred -------------------------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0112345788999999999999999999999
Q ss_pred HhcC
Q psy1812 258 IKAH 261 (304)
Q Consensus 258 ll~~ 261 (304)
++++
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=221.95 Aligned_cols=190 Identities=29% Similarity=0.464 Sum_probs=151.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++.+..++..+++|||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+
T Consensus 65 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~ 130 (267)
T cd08229 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--------------SRRVMHR 130 (267)
T ss_pred hhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecC
Confidence 4678888889999999999999999999874 345899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.. +|+||||++++++++|..||
T Consensus 131 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~ 206 (267)
T cd08229 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred CCCHHHEEEcCCCCEEECcchhhhccccCCc---ccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999999865432221 1223467889999999988777777 99999999999999999999
Q ss_pred CChhHH--HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 157 DDSNLK--QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 157 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
.+.... .....+..... + ...+..++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~--~--------------------------------------------------~~~~~~~~ 234 (267)
T cd08229 207 YGDKMNLYSLCKKIEQCDY--P--------------------------------------------------PLPSDHYS 234 (267)
T ss_pred ccccchHHHHhhhhhcCCC--C--------------------------------------------------CCCccccc
Confidence 654321 11111111000 0 01123467
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+.+++.+||..||++|||+.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 89999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-31 Score=241.00 Aligned_cols=242 Identities=19% Similarity=0.309 Sum_probs=176.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|+++..|...+++|||+|-+ ..+|.++|++-| .+....+..++.|++.||..|- .+||+|.|
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--------------~c~vlHaD 561 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--------------KCGVLHAD 561 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--------------hcCeeecc
Confidence 46778889999999999999 579999998865 5888999999999999999999 99999999
Q ss_pred CCCCcEEEecCCC-eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFN-VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|||.|||+++... +||||||.|......... .+.-+..|.|||++.+-+|+.+ .|+||+||+||||+||+..|
T Consensus 562 IKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-----PYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 562 IKPDNILVNESKNILKLCDFGSASFASENEIT-----PYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cCccceEeccCcceeeeccCcccccccccccc-----HHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceec
Confidence 9999999987654 799999999876655432 2344567999999999999999 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcc---cccc--cccccc-cchh-hhhhhhhhhhhccccc
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKV---KDIL--SHQVKV-KDIL-SHQVKLKDILSHQVKV 229 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 229 (304)
.+.....+....+...+.++..+...-.+- ..-.+...+. +.+. ...+.. .... .+......++.. ..+
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~---dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~-q~~ 711 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFK---DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV-QRL 711 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchh---hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-CCC
Confidence 999888887777777776664442211111 1111110000 0000 000000 1111 112233333322 222
Q ss_pred c---ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 230 K---DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 230 ~---~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+ ..+-.++.+||.+||.+||++|.|..++|+||||..+
T Consensus 712 ~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 712 PDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITEK 752 (752)
T ss_pred CchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccCC
Confidence 2 2345789999999999999999999999999999753
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=226.82 Aligned_cols=212 Identities=25% Similarity=0.407 Sum_probs=149.1
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
+.+++|+||+++ +|.+++... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH--------------KKNFLHRDIKCSNILLNNKG 153 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCHHHEEECCCC
Confidence 389999999986 888888764 36899999999999999999999 88999999999999999999
Q ss_pred CeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q psy1812 90 NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168 (304)
Q Consensus 90 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 168 (304)
.+||+|||++......... ......++..|++||.+.+.. ++.+ +|+|||||++++|++|+.||...+.......+
T Consensus 154 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~-~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 154 QIKLADFGLARLYNSEESR--PYTNKVITLWYRPPELLLGEERYGPA-IDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred cEEeCcccccccccCCccc--ccccceeccCccChHHhcCCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999998754332211 112234577899999886543 4555 99999999999999999999877665555444
Q ss_pred hhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCC
Q psy1812 169 TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPD 248 (304)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 248 (304)
............. ......... .......... ........++..+.+++.+||..|
T Consensus 231 ~~~~~~~~~~~~~---------~~~~~~~~~-----------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~ 286 (302)
T cd07864 231 SRLCGSPCPAVWP---------DVIKLPYFN-----------TMKPKKQYRR----RLREEFSFIPTPALDLLDHMLTLD 286 (302)
T ss_pred HHHhCCCChhhcc---------ccccccccc-----------cccccccccc----chhhhcCCCCHHHHHHHHHHccCC
Confidence 4332221110000 000000000 0000000000 000112346889999999999999
Q ss_pred CCccccHHHHhcCccc
Q psy1812 249 ITKRIRLDAIKAHDWL 264 (304)
Q Consensus 249 P~~R~t~~ell~~~wf 264 (304)
|++|||++++++||||
T Consensus 287 P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 287 PSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhCCCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=224.86 Aligned_cols=191 Identities=20% Similarity=0.370 Sum_probs=153.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhh
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA------------------------GPVAESNARTWFSQMLAGLEYLHR 56 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~LH~ 56 (304)
+++++.+..++..++||||+.+|+|.+++... ..+++..+..++.|++.||.|||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH- 144 (290)
T cd05045 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA- 144 (290)
T ss_pred eeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-
Confidence 57888889999999999999999999998652 24788999999999999999999
Q ss_pred cccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCC
Q psy1812 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKL 136 (304)
Q Consensus 57 ~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 136 (304)
+.+++|+||+|+||+++.++.+||+|||++......... .......++..|++||.+.+..++..
T Consensus 145 -------------~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~- 209 (290)
T cd05045 145 -------------EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQ- 209 (290)
T ss_pred -------------HCCeehhhhhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchH-
Confidence 899999999999999999999999999998754332211 11223345678999999887777776
Q ss_pred chHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 137 ADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 137 sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|+||||+++++|++ |..||.+.........+.....
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------ 247 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR------------------------------------------ 247 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC------------------------------------------
Confidence 999999999999998 9999977665444433221110
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..++..+.+|+.+||+.+|++||++.++++
T Consensus 248 -----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 248 -----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1123456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=220.84 Aligned_cols=191 Identities=21% Similarity=0.348 Sum_probs=152.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++......++||||+++++|.+++.+. ..+++..+..++.|++.||.||| +.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~i 127 (269)
T cd05044 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--------------QMHF 127 (269)
T ss_pred eeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--------------hCCc
Confidence 46788888889999999999999999999753 23788999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCC-----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKRF-----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 74 vH~dl~~~nil~~~~~-----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+|+||+|+||+++.++ .++++|||++......... .......++..|+|||.+.+..++.+ +|+|||||++|+
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e 205 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWE 205 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCccccccccccccc-ccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHH
Confidence 9999999999999887 7999999998754332211 11122345678999999988888777 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|++ |..||...+..+....+..... .
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~ 232 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGR-----------------------------------------------------L 232 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCc-----------------------------------------------------c
Confidence 998 9999976655444333321110 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..++..+.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 122456788999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=222.44 Aligned_cols=192 Identities=18% Similarity=0.364 Sum_probs=154.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++.++...++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--------------~~ 136 (275)
T cd05046 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--------------NA 136 (275)
T ss_pred eeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--------------hc
Confidence 468889988899999999999999999998765 6899999999999999999999 89
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+++|+||||+||+++.++.++++|||++......... ......++..|++||.+.+...+.. +|+||||++++++++
T Consensus 137 ~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~ 213 (275)
T cd05046 137 RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY--KLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFT 213 (275)
T ss_pred CcccCcCccceEEEeCCCcEEEcccccccccCccccc--ccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHh
Confidence 9999999999999999999999999998643221111 1223345677999999887777766 999999999999998
Q ss_pred -CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 -AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||...........+..+... ...+
T Consensus 214 ~~~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~ 241 (275)
T cd05046 214 QGELPFYGLSDEEVLNRLQAGKLE----------------------------------------------------LPVP 241 (275)
T ss_pred CCCCCccccchHHHHHHHHcCCcC----------------------------------------------------CCCC
Confidence 78899765544443333222111 1112
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
..++..+.+++.+||..+|++|||+.++++.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=219.92 Aligned_cols=190 Identities=21% Similarity=0.395 Sum_probs=154.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++......++||||+.+++|.+++... +.+++..++.++.+++.||.||| +.+++|+||+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~i~h~dl~ 127 (256)
T cd05112 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE--------------SSNVIHRDLA 127 (256)
T ss_pred eeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccccc
Confidence 46888999999999999999999999999764 46899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++|+|||++......... ......++..|++||.+.+..++.. +|+||||+++|++++ |..||..
T Consensus 128 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cceEEEcCCCeEEECCCcceeecccCccc--ccCCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999998754332111 1122234578999999988777776 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..+... ..+...+..+.
T Consensus 205 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 231 (256)
T cd05112 205 RSNSEVVETINAGFRL-----------------------------------------------------YKPRLASQSVY 231 (256)
T ss_pred CCHHHHHHHHhCCCCC-----------------------------------------------------CCCCCCCHHHH
Confidence 6655544443322111 11233578899
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|+.+||+.+|++|||++++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=253.28 Aligned_cols=191 Identities=24% Similarity=0.396 Sum_probs=164.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
|++.+++-++...+|++|||.||+|..||++.+ .++......++.|+|+|++||+ ++.+
T Consensus 758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--------------~~~f 823 (1025)
T KOG1095|consen 758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--------------SKHF 823 (1025)
T ss_pred eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--------------hCCC
Confidence 578899999999999999999999999999863 4899999999999999999999 8999
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-C
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-A 152 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g 152 (304)
|||||-++|+|++....+||+|||+++-....+-.+. ...-..+..|||||.+....++++ +|||||||++||+++ |
T Consensus 824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRK-HGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred cCcchhhhheeecccCcEEEcccchhHhhhhchheec-cCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCC
Confidence 9999999999999999999999999984443332221 111245689999999999899988 999999999999999 8
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||.+.+..+++.....+.. ...|..
T Consensus 902 ~~PY~~~~n~~v~~~~~~ggR-----------------------------------------------------L~~P~~ 928 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGGR-----------------------------------------------------LDPPSY 928 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCCc-----------------------------------------------------cCCCCC
Confidence 999999988888776555542 234577
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+.++|..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 8899999999999999999999999988
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=221.74 Aligned_cols=190 Identities=22% Similarity=0.344 Sum_probs=150.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++. +...++|+||+.+|+|.+++... +.+++..+..++.|++.||.||| +.+++|+|||
T Consensus 72 v~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~iiH~dlk 136 (279)
T cd05111 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE--------------EHRMVHRNLA 136 (279)
T ss_pred ceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeccccC
Confidence 46777765 45678999999999999999764 57899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+|++|||++......... .......++..|++||.+.+..++.+ +|+|||||++|++++ |..||.+
T Consensus 137 p~nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 137 ARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cceEEEcCCCcEEEcCCccceeccCCCcc-cccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999755432211 12233456778999999988888777 999999999999998 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..+.. ...+...+..+.
T Consensus 215 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 241 (279)
T cd05111 215 MRPHEVPDLLEKGER-----------------------------------------------------LAQPQICTIDVY 241 (279)
T ss_pred CCHHHHHHHHHCCCc-----------------------------------------------------CCCCCCCCHHHH
Confidence 654333222221111 011123466789
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..||.+|||+.++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=219.66 Aligned_cols=189 Identities=21% Similarity=0.377 Sum_probs=150.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++. ++..++||||+.+|+|.+++.... .+++..+..++.+++.||.||| +.+++|+||
T Consensus 64 ~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--------------~~~i~H~dl 128 (260)
T cd05069 64 VPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--------------RMNYIHRDL 128 (260)
T ss_pred eeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeeccc
Confidence 35667664 456889999999999999997643 4789999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||.+......... ......++..|++||...+...+.. +|+||||+++|++++ |..||.
T Consensus 129 ~~~Nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 129 RAANILVGDNLVCKIADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred CcceEEEcCCCeEEECCCccceEccCCccc--ccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998754322211 1112235677999999988777777 999999999999999 899998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....+....+..... ...+..++..+
T Consensus 206 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 232 (260)
T cd05069 206 GMVNREVLEQVERGYR-----------------------------------------------------MPCPQGCPESL 232 (260)
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCcccCHHH
Confidence 7665544443332210 11124567889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.||++||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=220.17 Aligned_cols=190 Identities=23% Similarity=0.398 Sum_probs=154.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..+...++||||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||
T Consensus 64 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--------------~~~i~h~di 129 (261)
T cd05034 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--------------SRNYIHRDL 129 (261)
T ss_pred eeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCc
Confidence 468888888899999999999999999997753 6899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||++......... ......++..|+|||.+.+...+.. +|+||+|++++++++ |+.||.
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDDEYT--AREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred chheEEEcCCCCEEECccccceeccchhhh--hhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998755431111 1112234568999999988777777 999999999999998 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..... ...+...+..+
T Consensus 207 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 233 (261)
T cd05034 207 GMTNREVLEQVERGYR-----------------------------------------------------MPRPPNCPEEL 233 (261)
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7765555554433211 11123457889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++||+++++++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=228.58 Aligned_cols=226 Identities=23% Similarity=0.323 Sum_probs=162.4
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++..++ .+++||||+ +++|.+++.. +.+++..++.++.|++.||.||| ..+++
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH--------------~~gi~ 140 (343)
T cd07880 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIH--------------AAGII 140 (343)
T ss_pred cceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCee
Confidence 45677776543 469999999 7799988864 56999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||+|+||+++.++.++++|||++...... .....++..|++||.+.+. .++.. +|+||+|++++++++|.
T Consensus 141 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 141 HRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQT-VDIWSVGCIMAEMLTGK 213 (343)
T ss_pred cCCCCHHHEEEcCCCCEEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998754321 2234567889999998763 34555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+......++.......+......+.... ........... ....+ ......+
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------------~~~~~-------~~~~~~~ 270 (343)
T cd07880 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED-AKNYVKKLPRF---------------RKKDF-------RSLLPNA 270 (343)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh-HHHHHHhcccc---------------CcchH-------HHhccCC
Confidence 9998877665555555433332211111111000 00000000000 00000 1112457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.++|.+||+.||++|||+.++++||||+.......
T Consensus 271 ~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 271 NPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred ChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 888999999999999999999999999999998866433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=219.73 Aligned_cols=189 Identities=24% Similarity=0.402 Sum_probs=149.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++. +...++||||+.+++|.+++... ..+++..++.++.+++.||.||| +.+++|+||
T Consensus 64 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--------------~~~i~H~di 128 (260)
T cd05070 64 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--------------RMNYIHRDL 128 (260)
T ss_pred EEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCC
Confidence 35666664 45688999999999999999764 35899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.+ +|+||||++++++++ |..||.
T Consensus 129 ~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 129 RSANILVGDGLVCKIADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred ccceEEEeCCceEEeCCceeeeeccCcccc--cccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999998754332211 1112235567999999988777777 999999999999999 889997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..... ...+...+..+
T Consensus 206 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 232 (260)
T cd05070 206 GMNNREVLEQVERGYR-----------------------------------------------------MPCPQDCPISL 232 (260)
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCCHHH
Confidence 7665544444332110 11224567889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+|+.+||..+|++|||+.++++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=221.00 Aligned_cols=181 Identities=19% Similarity=0.345 Sum_probs=143.7
Q ss_pred eEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEE
Q psy1812 12 RVFIFMRYADNGDLLDHIKRA------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~ 85 (304)
..++||||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dlkp~Nil~ 145 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--------------SKSFIHRDLAARNCML 145 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccccchhheEE
Confidence 578999999999999988432 24889999999999999999999 8999999999999999
Q ss_pred ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHH
Q psy1812 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQL 164 (304)
Q Consensus 86 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~ 164 (304)
+.++.++|+|||++......... .......++..|++||...+..++.+ +|+|||||++|++++ |..||.+....+.
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 146 NENMNVCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred cCCCCEEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998755332211 11122345678999999988878777 999999999999999 8899977655444
Q ss_pred HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHh
Q psy1812 165 FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQI 244 (304)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 244 (304)
...+..+.. ...+..++..+.+++.+|
T Consensus 224 ~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~li~~~ 250 (272)
T cd05075 224 YDYLRQGNR-----------------------------------------------------LKQPPDCLDGLYSLMSSC 250 (272)
T ss_pred HHHHHcCCC-----------------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence 433332211 111245678899999999
Q ss_pred cCCCCCccccHHHHhcC
Q psy1812 245 LEPDITKRIRLDAIKAH 261 (304)
Q Consensus 245 L~~dP~~R~t~~ell~~ 261 (304)
|+.||++|||+.++++.
T Consensus 251 l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 251 WLLNPKDRPSFETLRCE 267 (272)
T ss_pred cCCCcccCcCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=219.45 Aligned_cols=190 Identities=30% Similarity=0.465 Sum_probs=151.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++.+..++..++||||+++|+|.+++.+. ..+++..++.++.+++.||.||| +.+++|+
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~ 130 (267)
T cd08224 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--------------SKRIMHR 130 (267)
T ss_pred eeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--------------hCCEecC
Confidence 46788888899999999999999999999752 35899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.++++|||++........ ......++..|.|||.+.+..++.. +|+|||||+++++++|..||
T Consensus 131 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~ 206 (267)
T cd08224 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred CcChhhEEECCCCcEEEeccceeeeccCCCc---ccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCc
Confidence 9999999999999999999999875433221 1223457888999999988878777 99999999999999999999
Q ss_pred CChhH--HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 157 DDSNL--KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 157 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
..... .+....+..+... ......++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~ 234 (267)
T cd08224 207 YGDKMNLYSLCKKIEKCDYP----------------------------------------------------PLPADHYS 234 (267)
T ss_pred ccCCccHHHHHhhhhcCCCC----------------------------------------------------CCChhhcC
Confidence 55431 1112111111100 00112467
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+.++|.+||..+|++|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 88999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=230.02 Aligned_cols=218 Identities=22% Similarity=0.353 Sum_probs=150.2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec-CC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK-RF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~-~~ 89 (304)
...++||||+. ++|.+++.. +.+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH--------------~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIH--------------SANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCCHHHEEEcCCCc
Confidence 46899999997 599998865 46899999999999999999999 889999999999999975 45
Q ss_pred CeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q psy1812 90 NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168 (304)
Q Consensus 90 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 168 (304)
.++++|||++.................++..|+|||.+.+. .++.+ +|+|||||+++++++|..||...+.......+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 68999999987543221111111223567889999987653 34445 99999999999999999999877765555544
Q ss_pred hhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCC
Q psy1812 169 TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPD 248 (304)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 248 (304)
................ ........ .. ........ ......++.++.+||.+||..|
T Consensus 232 ~~~~~~~~~~~~~~~~--~~~~~~~~---------~~------~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~d 287 (342)
T cd07854 232 LESVPVVREEDRNELL--NVIPSFVR---------ND------GGEPRRPL-------RDLLPGVNPEALDFLEQILTFN 287 (342)
T ss_pred HHhcCCCChHHhhhhh--hhhhhhhh---------hc------ccccCCCH-------HHHccCCCHHHHHHHHHHhCCC
Confidence 4332111100000000 00000000 00 00000000 0112357889999999999999
Q ss_pred CCccccHHHHhcCcccccccc
Q psy1812 249 ITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 249 P~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+|||++++++||||+....
T Consensus 288 P~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 288 PMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred chhccCHHHHhCCCccccccC
Confidence 999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=219.50 Aligned_cols=189 Identities=22% Similarity=0.380 Sum_probs=149.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+. +...++||||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||
T Consensus 64 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--------------~~~i~H~dl 128 (262)
T cd05071 64 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--------------RMNYVHRDL 128 (262)
T ss_pred ceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccc
Confidence 35666664 45689999999999999999763 35889999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||.+......... ......++..|++||...+..++.. +|+|||||++|++++ |..||.
T Consensus 129 ~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 129 RAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred CcccEEEcCCCcEEeccCCceeeccccccc--cccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999998755432211 1123345678999999988778777 999999999999999 888997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....+....+..... ...+..++..+
T Consensus 206 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l 232 (262)
T cd05071 206 GMVNREVLDQVERGYR-----------------------------------------------------MPCPPECPESL 232 (262)
T ss_pred CCChHHHHHHHhcCCC-----------------------------------------------------CCCccccCHHH
Confidence 6655444433322110 01124467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.+|++|||+.++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=219.79 Aligned_cols=189 Identities=23% Similarity=0.354 Sum_probs=151.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.++ ..++||||+++|+|.+++.+.. .+++..++.++.+++.||+||| +.+++|+||+
T Consensus 70 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~~~H~dl~ 134 (270)
T cd05056 70 VKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE--------------SKRFVHRDIA 134 (270)
T ss_pred hceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccccC
Confidence 4677877654 5789999999999999998744 5899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++++|||++......... ......++..|+|||.+....++.. +|+||||++++++++ |..||..
T Consensus 135 p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYY--KASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred hheEEEecCCCeEEccCceeeecccccce--ecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999998754332111 1112234567999999887777777 999999999999986 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..+.. ...+..++.++.
T Consensus 212 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 238 (270)
T cd05056 212 VKNNDVIGRIENGER-----------------------------------------------------LPMPPNCPPTLY 238 (270)
T ss_pred CCHHHHHHHHHcCCc-----------------------------------------------------CCCCCCCCHHHH
Confidence 765444443332211 112345688999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++|||+.++++
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=228.15 Aligned_cols=192 Identities=21% Similarity=0.373 Sum_probs=155.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++.+..++..++||||+.+|+|.+++.... .++...+..++.|++.||.|||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------- 151 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--------- 151 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---------
Confidence 478889999999999999999999999997632 3778889999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
..+++|+||+|+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.+ +|+||||+
T Consensus 152 -----~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 224 (334)
T cd05100 152 -----SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGV 224 (334)
T ss_pred -----HCCeeccccccceEEEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCch-hhhHHHHH
Confidence 8999999999999999999999999999987543321110 1112234567999999988888877 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||.+.+..+....+.....
T Consensus 225 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 254 (334)
T cd05100 225 LLWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------------- 254 (334)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999998 8899987766555554432211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++.++.+++.+||+.+|.+|||+.+++++
T Consensus 255 ---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 255 ---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11124567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=233.69 Aligned_cols=192 Identities=22% Similarity=0.390 Sum_probs=151.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc------------------------------------------------
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA------------------------------------------------ 32 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------------------------------ 32 (304)
|++++++..++..+||||||++|+|.++|..+
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 57899999999999999999999999998653
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 33 ------------------------------------------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 33 ------------------------------------------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
..+++..+..++.|++.||+|||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------- 254 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--------- 254 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 13678888999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||
T Consensus 255 -----~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGv 327 (400)
T cd05105 255 -----SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGI 327 (400)
T ss_pred -----hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCch-hhHHHHHH
Confidence 899999999999999999999999999998754322211 11223346678999999988888777 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||........+.........
T Consensus 328 il~ellt~g~~P~~~~~~~~~~~~~~~~~~~------------------------------------------------- 358 (400)
T cd05105 328 LLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR------------------------------------------------- 358 (400)
T ss_pred HHHHHHHCCCCCCcccchhHHHHHHHhcCCC-------------------------------------------------
Confidence 9999997 88999765332222221111100
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..++..+.+++.+||+.||++|||+.++.+
T Consensus 359 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 359 ---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 1112456889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=219.90 Aligned_cols=184 Identities=18% Similarity=0.274 Sum_probs=145.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+++|+|..++.+. +.+++..++.++.|++.||+||| +.+++|+||+
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~dlk 132 (262)
T cd05077 67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE--------------DKDLVHGNVC 132 (262)
T ss_pred eeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--------------hCCeECCCCC
Confidence 57889999889999999999999999998764 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCC-------eEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHH-
Q psy1812 80 CENILMTKRFN-------VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIML- 150 (304)
Q Consensus 80 ~~nil~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll- 150 (304)
|+||+++.++. ++++|||++..... .....++..|+|||.+.. ..++.+ +|+|||||++|+++
T Consensus 133 p~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~el~~ 204 (262)
T cd05077 133 TKNILLAREGIDGECGPFIKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIA-ADKWSFGTTLWEICY 204 (262)
T ss_pred cccEEEecCCccCCCCceeEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCch-hHHHHHHHHHHHHHh
Confidence 99999987664 89999998864322 123457788999999874 445555 99999999999998
Q ss_pred hCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 151 NAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 151 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
+|..||......+... ...... ...
T Consensus 205 ~~~~p~~~~~~~~~~~-~~~~~~------------------------------------------------------~~~ 229 (262)
T cd05077 205 NGEIPLKDKTLAEKER-FYEGQC------------------------------------------------------MLV 229 (262)
T ss_pred CCCCCCCCcchhHHHH-HHhcCc------------------------------------------------------cCC
Confidence 5888886554322211 111000 001
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...++++.+||.+||+.||++||++.+|+++
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=227.23 Aligned_cols=215 Identities=23% Similarity=0.305 Sum_probs=150.4
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
...+++||||+.+ +|.+.+... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH--------------~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH--------------ENHILHRDIKAANILIDNQ 151 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCHHHEEECCC
Confidence 3467999999975 788887654 47999999999999999999999 8999999999999999999
Q ss_pred CCeEEEeccCcccccCccccc--------ccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 89 FNVKIADFGFARYCVDKEGRR--------VLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+.++++|||++.......... .......++..|+|||.+.+.. ++.+ +|+|||||++|+|++|+.||.+.
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch-hHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999987543322110 0112234677899999886654 5555 99999999999999999999887
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+............. .+........ ............. ....+...+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~ 286 (311)
T cd07866 231 SDIDQLHLIFKLCGTPTEETWP---------GWRSLPGCEG--------VHSFTNYPRTLEE-------RFGKLGPEGLD 286 (311)
T ss_pred CHHHHHHHHHHHhCCCChhhch---------hhhhcccccc--------cccCCCCCccHHH-------HcccCChhHHH
Confidence 7666555544333222110000 0000000000 0000000000110 11335678999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
||.+||+.||.+|||+.+++.||||
T Consensus 287 ~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 287 LLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHcccCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=216.77 Aligned_cols=191 Identities=22% Similarity=0.336 Sum_probs=152.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++...+..++||||+.+++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+
T Consensus 55 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH--------------~~~i~h~di~ 120 (251)
T cd05041 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--------------SKNCIHRDLA 120 (251)
T ss_pred EEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEehhhcC
Confidence 35788899999999999999999999999764 46899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++|+|||++....... ..........+..|+|||.+.+..++.. +|+|||||+++++++ |..||..
T Consensus 121 p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 121 ARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGLKQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cceEEEcCCCcEEEeeccccccccCCc-ceeccccCcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCcc
Confidence 999999999999999999986543211 1111112234567999999988777776 999999999999998 8899977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..... ...+..++..+.
T Consensus 199 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 225 (251)
T cd05041 199 MSNQQTRERIESGYR-----------------------------------------------------MPAPQLCPEEIY 225 (251)
T ss_pred CCHHHHHHHHhcCCC-----------------------------------------------------CCCCccCCHHHH
Confidence 655444433322110 112245678999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++|||++++++
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=220.74 Aligned_cols=184 Identities=21% Similarity=0.344 Sum_probs=144.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+++|+|..++.+ .+.+++..+..++.|++.||+||| +.+++|+|||
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~iiH~dlk 144 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE--------------DKNLVHGNVC 144 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------cCCccCCCCC
Confidence 5789999999999999999999999999976 457899999999999999999999 8999999999
Q ss_pred CCcEEEecCC-------CeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHH-
Q psy1812 80 CENILMTKRF-------NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIML- 150 (304)
Q Consensus 80 ~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll- 150 (304)
|+||+++..+ .++++|||.+...... ....++..|+|||.+.+. .++.. +|+|||||++|+++
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~-~Dv~slG~~l~el~~ 216 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTA-ADKWSFGTTLLEICF 216 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcH-HHHHHHHHHHHHHHh
Confidence 9999998654 3799999987533221 123467889999988764 45555 99999999999985
Q ss_pred hCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 151 NAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 151 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
+|..||............. .. ...+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~-~~------------------------------------------------------~~~~ 241 (274)
T cd05076 217 DGEVPLKERTPSEKERFYE-KK------------------------------------------------------HRLP 241 (274)
T ss_pred CCCCCccccChHHHHHHHH-hc------------------------------------------------------cCCC
Confidence 6889997654322211110 00 1111
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...++.+.++|.+||+.+|++|||+.+++++
T Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 242 EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2345679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=246.40 Aligned_cols=182 Identities=26% Similarity=0.404 Sum_probs=150.3
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
-.+.|.||||.||.|-|+|... ..|++.++..|+.|+++|+.+||.. .-.|+|||||.+|||+..+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~------------~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL------------KPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC------------CCccchhhhhhhheEEcCC
Confidence 3689999999999999999863 3599999999999999999999954 5569999999999999999
Q ss_pred CCeEEEeccCcccccCcccccccc------cCccCCccccccccc---cCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 89 FNVKIADFGFARYCVDKEGRRVLS------RTYCGSAAYAAPEVI---SGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~~~~~~------~~~~~~~~~~~PE~~---~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|.+||||||.+............. -...-|+.|++||++ .+.+++.+ +|||+|||+||-|+....||...
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcC
Confidence 999999999987544332110000 122468999999997 46678888 99999999999999999999877
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.. ..|+++.+.++ ..+.+++.+.+
T Consensus 262 g~----laIlng~Y~~P----------------------------------------------------~~p~ys~~l~~ 285 (738)
T KOG1989|consen 262 GK----LAILNGNYSFP----------------------------------------------------PFPNYSDRLKD 285 (738)
T ss_pred cc----eeEEeccccCC----------------------------------------------------CCccHHHHHHH
Confidence 43 45666666665 22578999999
Q ss_pred HHHHhcCCCCCccccHHHHhcC
Q psy1812 240 LVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~ 261 (304)
||+.||+.||.+||++-|++..
T Consensus 286 LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 286 LIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHhccCcccCCCHHHHHHH
Confidence 9999999999999999888876
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=222.40 Aligned_cols=191 Identities=21% Similarity=0.373 Sum_probs=151.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHhhhcc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------------PVAESNARTWFSQMLAGLEYLHREI 58 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~l~~~~~~~i~~~l~~~l~~LH~~~ 58 (304)
+++++++..+...++||||+.+|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--- 147 (288)
T cd05050 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--- 147 (288)
T ss_pred heEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---
Confidence 478889999999999999999999999997532 3678889999999999999999
Q ss_pred cCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCch
Q psy1812 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLAD 138 (304)
Q Consensus 59 ~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sD 138 (304)
..+++|+||+|+||+++.++.++++|||++.......... .......+..|+|||.+.+..++.+ +|
T Consensus 148 -----------~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~D 214 (288)
T cd05050 148 -----------ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNRYTTE-SD 214 (288)
T ss_pred -----------hCCeecccccHhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCCCCch-hH
Confidence 8999999999999999999999999999986543221111 1122234567999999988888777 99
Q ss_pred HHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhh
Q psy1812 139 IWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQV 217 (304)
Q Consensus 139 vwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (304)
+|||||++|+|++ |..||.+.+..+....+..+..
T Consensus 215 v~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-------------------------------------------- 250 (288)
T cd05050 215 VWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-------------------------------------------- 250 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------------------------------------
Confidence 9999999999997 8889876655444433322211
Q ss_pred hhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 218 KLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..++..+.+|+.+||+.+|++|||+.|+++
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 251 ---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112446789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=221.08 Aligned_cols=206 Identities=21% Similarity=0.310 Sum_probs=148.7
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.. ....++||||+.+|+|.+++... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH--------------~~~i~H~dl 133 (283)
T cd05080 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLH--------------SQHYIHRDL 133 (283)
T ss_pred eeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeecccc
Confidence 356776654 34689999999999999999765 5999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.++.++|+|||++.................++..|+|||.+.+..++.+ +|+||||+++++|++|..||..
T Consensus 134 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred ChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998755432211111222345667999999988777777 9999999999999999999854
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.... +........... . ...... ..... .....+..++..+.
T Consensus 213 ~~~~--~~~~~~~~~~~~-~-------~~~~~~--------------------------~~~~~--~~~~~~~~~~~~~~ 254 (283)
T cd05080 213 PPKK--FEEMIGPKQGQM-T-------VVRLIE--------------------------LLERG--MRLPCPKNCPQEVY 254 (283)
T ss_pred Ccch--hhhhhccccccc-c-------hhhhhh--------------------------hhhcC--CCCCCCCCCCHHHH
Confidence 4311 111110000000 0 000000 00000 00122345788999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||+.+|++|||++++++
T Consensus 255 ~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 255 ILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=226.01 Aligned_cols=191 Identities=21% Similarity=0.328 Sum_probs=151.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+ ..++|+||+.+|+|.+++.... .+++..+..++.|++.||+||| +.+++|+|||
T Consensus 72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--------------~~~iiH~dlk 136 (316)
T cd05108 72 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--------------ERRLVHRDLA 136 (316)
T ss_pred CeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--------------hcCeeccccc
Confidence 4677877765 5779999999999999998753 6889999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ........+..|++||.+.+..++.+ +|+|||||++|++++ |..||.+
T Consensus 137 p~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 137 ARNVLVKTPQHVKITDFGLAKLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred hhheEecCCCcEEEccccccccccCCCcc-eeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999765432211 11122234668999999988888877 999999999999998 9999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+.... . ...+..++.++.
T Consensus 215 ~~~~~~~~~~~~~~-~----------------------------------------------------~~~~~~~~~~~~ 241 (316)
T cd05108 215 IPASEISSILEKGE-R----------------------------------------------------LPQPPICTIDVY 241 (316)
T ss_pred CCHHHHHHHHhCCC-C----------------------------------------------------CCCCCCCCHHHH
Confidence 65444332222111 0 111244677899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||..+|.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=219.11 Aligned_cols=192 Identities=20% Similarity=0.402 Sum_probs=152.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+.+|+|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH--------------~~g~~H~dl~ 133 (269)
T cd05065 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS--------------EMNYVHRDLA 133 (269)
T ss_pred ceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecccC
Confidence 47888899999999999999999999999864 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCc--cCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--CGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~--~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|+||+++.++.++++|||++................ ..+..|++||.+.+..++.+ +|+|||||+++++++ |..||
T Consensus 134 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred hheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCC
Confidence 999999999999999999987544322211111111 12457999999988888777 999999999999886 99999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+.... . ...+..++..
T Consensus 213 ~~~~~~~~~~~i~~~~-~----------------------------------------------------~~~~~~~~~~ 239 (269)
T cd05065 213 WDMSNQDVINAIEQDY-R----------------------------------------------------LPPPMDCPTA 239 (269)
T ss_pred CCCCHHHHHHHHHcCC-c----------------------------------------------------CCCcccCCHH
Confidence 7766554444432211 0 1112346778
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+++.+||..+|++||++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=217.63 Aligned_cols=192 Identities=22% Similarity=0.337 Sum_probs=147.0
Q ss_pred Cceeeeee-eCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQ-RGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++. .++..++||||+.+|+|.+++.+. ...++..+..++.|++.||.||| +.+++|+||
T Consensus 59 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl 124 (262)
T cd05058 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA--------------SKKFVHRDL 124 (262)
T ss_pred ceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccccc
Confidence 45677654 466789999999999999999764 34678888999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhC-CCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA-AMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g-~~pf 156 (304)
+|+||+++.++.+||+|||++.......... .......++..|+|||.+.+..++.+ +|+|||||++|++++| ..||
T Consensus 125 k~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 125 AARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred CcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999987543221110 01112345678999999988778777 9999999999999994 5677
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+..+.. ...+..+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 230 (262)
T cd05058 204 PDVDSFDITVYLLQGRR-----------------------------------------------------LLQPEYCPDP 230 (262)
T ss_pred CCCCHHHHHHHHhcCCC-----------------------------------------------------CCCCCcCCHH
Confidence 65544333332221110 1112345788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+++.+||..+|++||++.++++
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=217.57 Aligned_cols=189 Identities=22% Similarity=0.405 Sum_probs=150.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++. ....++||||+.+++|.+++... ..+++..+..++.|++.||+||| +.+++|+||
T Consensus 64 ~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------------~~~i~H~dl 128 (260)
T cd05067 64 VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--------------RKNYIHRDL 128 (260)
T ss_pred eeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--------------cCCeecccc
Confidence 35677664 45689999999999999999763 36899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.+ +|+||||++++++++ |+.||.
T Consensus 129 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 129 RAANILVSETLCCKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred cHHhEEEcCCCCEEEccCcceeecCCCCcc--cccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998754422111 1122345678999999988777777 999999999999998 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..... ...+...+.++
T Consensus 206 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 232 (260)
T cd05067 206 GMTNPEVIQNLERGYR-----------------------------------------------------MPRPDNCPEEL 232 (260)
T ss_pred CCChHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7765554443332211 11224467889
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.+|++|||++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=218.68 Aligned_cols=194 Identities=19% Similarity=0.278 Sum_probs=146.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++.+..+...++||||+.+|+|.+++.... .+++..+..++.|++.||+||| +.+++|
T Consensus 58 i~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH 123 (269)
T cd05042 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--------------QADFIH 123 (269)
T ss_pred ceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--------------hcCEec
Confidence 478889999999999999999999999997743 2467888999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-------CCCCCCCchHHHHHHHHHH
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-------NPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~sDvwslG~ll~~ 148 (304)
+||||+||+++.++.+||+|||++......... .......++..|+|||++.. ..++.+ +|+|||||++|+
T Consensus 124 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~e 201 (269)
T cd05042 124 SDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK-SNIWSLGVTMWE 201 (269)
T ss_pred ccccHhheEecCCCcEEEeccccccccccchhe-eccCCCCCcccccCHHHHhhccccccccccchh-hHHHHHHHHHHH
Confidence 999999999999999999999998643221111 01123345677999999743 234445 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhccc-cccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNIL-SHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
|++ |..||......+.......... ..+ .
T Consensus 202 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~ 232 (269)
T cd05042 202 LFTAADQPYPDLSDEQVLKQVVREQDIKLP-------------------------------------------------K 232 (269)
T ss_pred HHhCCCCCCCcCCHHHHHHHHhhccCccCC-------------------------------------------------C
Confidence 999 7888876654444333322211 110 0
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
......++..+.+++..|+ .||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1122457888899999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=219.68 Aligned_cols=189 Identities=22% Similarity=0.327 Sum_probs=148.7
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++++.. ...++++||+++|+|.+++... +.+++..+..++.|++.||.||| +.+++|+||||
T Consensus 73 ~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH--------------~~~iiH~dlkp 137 (279)
T cd05109 73 RLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--------------EVRLVHRDLAA 137 (279)
T ss_pred eEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecccccc
Confidence 45666654 4578999999999999999774 46999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
+||+++.++.+||+|||++.......... ......++..|++||.+.+..++.+ +|+|||||++|++++ |..||...
T Consensus 138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 138 RNVLVKSPNHVKITDFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ceEEEcCCCcEEECCCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999987654322110 1112234578999999988888777 999999999999998 89999765
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
........+..+.. ...+..++.++.+
T Consensus 216 ~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 242 (279)
T cd05109 216 PAREIPDLLEKGER-----------------------------------------------------LPQPPICTIDVYM 242 (279)
T ss_pred CHHHHHHHHHCCCc-----------------------------------------------------CCCCccCCHHHHH
Confidence 54333332222110 1112446788999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
++.+||+.||++||++.++++
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=228.45 Aligned_cols=240 Identities=25% Similarity=0.333 Sum_probs=168.9
Q ss_pred Cceeeeee----eCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQ----RGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++|.|. ++.++|+|+|++ |.+|..+|.+.. .++...++.|++|++.||.|||+ .+||+
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-------------ecgII 210 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-------------ECGII 210 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-------------hcCcc
Confidence 67888887 467999999999 779999998753 69999999999999999999997 89999
Q ss_pred ecCCCCCcEEEecCCC----------------------------------------------------------------
Q psy1812 75 HRDLKCENILMTKRFN---------------------------------------------------------------- 90 (304)
Q Consensus 75 H~dl~~~nil~~~~~~---------------------------------------------------------------- 90 (304)
|.||||+|||+..+..
T Consensus 211 HTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~ 290 (590)
T KOG1290|consen 211 HTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAG 290 (590)
T ss_pred ccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcc
Confidence 9999999999942200
Q ss_pred --------------------------------------------------------------------------------
Q psy1812 91 -------------------------------------------------------------------------------- 90 (304)
Q Consensus 91 -------------------------------------------------------------------------------- 90 (304)
T Consensus 291 ~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s 370 (590)
T KOG1290|consen 291 LEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSS 370 (590)
T ss_pred cccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCC
Confidence
Q ss_pred ----------------------eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 91 ----------------------VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 91 ----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+||.|||.++.+.. ..+..+.|.-|++||++.+..|+++ +|+||++|+++|
T Consensus 371 ~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k------hFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FE 443 (590)
T KOG1290|consen 371 PGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK------HFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFE 443 (590)
T ss_pred ccccccccccCCCCCCCccceeEEEeeccchhhhhh------hhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHH
Confidence 00000000000000 0001124566899999999999999 999999999999
Q ss_pred HHhCCCCCCChh------HHHHHHHhhhccccccchhhhhhhhhhh-HHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 149 MLNAAMPFDDSN------LKQLFKEQTSNILSHQVKVKDILSHQVK-VKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 149 ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
|+||...|.... +.+-+..|+. .-+.++..+..... .+++..+......+.. -..+.+.+
T Consensus 444 LaTGDyLFePhsG~~Y~rDEDHiA~i~E----LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~---------LK~WpL~~ 510 (590)
T KOG1290|consen 444 LATGDYLFEPHSGENYSRDEDHIALIME----LLGKIPRKIALGGKYSRDFFNRRGELRHIRR---------LKPWPLYE 510 (590)
T ss_pred hhcCceeecCCCCCCCCccHHHHHHHHH----HHhhccHHHHhcCcchHhhhccccceecccc---------cCCCcHHH
Confidence 999999885431 2222333332 22333444444432 5555555544443221 23344555
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++..+-..+.....++.+||.-||+++|.+|+||.++|+||||+....+..+.
T Consensus 511 VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~~~~~ 563 (590)
T KOG1290|consen 511 VLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGPPPSD 563 (590)
T ss_pred HHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCCcccc
Confidence 55555566677788999999999999999999999999999999888873333
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=223.12 Aligned_cols=194 Identities=26% Similarity=0.383 Sum_probs=155.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+. |+|.+++.. ...+++..+..++.+++.|+.||| +.+++|+||+
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--------------~~~i~H~dl~ 142 (308)
T cd06634 78 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--------------SHNMIHRDVK 142 (308)
T ss_pred ccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCC
Confidence 467888888999999999996 588887754 456899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.++++|||++...... ....++..|+|||.+.+ ...+.+ +|+|||||+++++++|..||
T Consensus 143 p~nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~ 214 (308)
T cd06634 143 AGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPL 214 (308)
T ss_pred HHhEEECCCCcEEECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCC
Confidence 99999999999999999998654321 23457889999999752 345555 99999999999999999998
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+...... ......++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~ 242 (308)
T cd06634 215 FNMNAMSALYHIAQNESP----------------------------------------------------ALQSGHWSEY 242 (308)
T ss_pred ccccHHHHHHHHhhcCCC----------------------------------------------------CcCcccccHH
Confidence 765443333222211110 0112356788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||..+|.+||++.++++|+|+.....
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=220.81 Aligned_cols=198 Identities=22% Similarity=0.346 Sum_probs=151.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~ 68 (304)
+++++.+...+..++||||+.+++|.+++.... .+++..+..++.|++.||+|||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH------------- 146 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA------------- 146 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-------------
Confidence 578899999999999999999999999996532 3688899999999999999999
Q ss_pred CCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 69 ~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++++
T Consensus 147 -~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~e 223 (295)
T cd05097 147 -SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWE 223 (295)
T ss_pred -hcCeeccccChhhEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHH
Confidence 899999999999999999999999999998654322211 11122345678999999988878777 999999999999
Q ss_pred HHh--CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 149 MLN--AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 149 ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
|++ +..||......+............. ... .
T Consensus 224 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------------------~~~---~ 257 (295)
T cd05097 224 MFTLCKEQPYSLLSDEQVIENTGEFFRNQG-------------------------------------------RQI---Y 257 (295)
T ss_pred HHHcCCCCCCcccChHHHHHHHHHhhhhcc-------------------------------------------ccc---c
Confidence 988 5678876555444333221100000 000 0
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.+|+.+||..||++|||++++++
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 258 LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=216.90 Aligned_cols=189 Identities=21% Similarity=0.421 Sum_probs=150.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+.. ...+++|||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||
T Consensus 64 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--------------~~~i~H~dl 128 (260)
T cd05073 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--------------QRNYIHRDL 128 (260)
T ss_pred ceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--------------hCCcccccc
Confidence 457777777 7789999999999999999763 35788899999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++++|||.+......... ......++..|+|||.+....++.. +|+|||||+++++++ |..||.
T Consensus 129 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 129 RAANILVSASLVCKIADFGLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred CcceEEEcCCCcEEECCCcceeeccCCCcc--cccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999998654322111 1122335677999999988777777 999999999999998 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..... ...+..++.++
T Consensus 206 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 232 (260)
T cd05073 206 GMSNPEVIRALERGYR-----------------------------------------------------MPRPENCPEEL 232 (260)
T ss_pred CCCHHHHHHHHhCCCC-----------------------------------------------------CCCcccCCHHH
Confidence 7665544443332211 11124567899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..+|++||+++++++
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=226.47 Aligned_cols=221 Identities=26% Similarity=0.374 Sum_probs=155.4
Q ss_pred ceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 2 QVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 2 ~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
++++++... ..+++|+||+.. +|.+++. ..+++..++.++.|++.||+||| ..+++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--------------~~~i~H 140 (342)
T cd07879 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIH--------------SAGIIH 140 (342)
T ss_pred chhheecccccCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--------------HCCccc
Confidence 456666543 357999999964 8877653 35899999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|||+|+||+++.++.++++|||++..... ......++..|+|||.+.+. .++.. +|+|||||++++|++|+.
T Consensus 141 ~dlkp~NIll~~~~~~kL~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 141 RDLKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVILNWMHYNQT-VDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred CCCCHHHEEECCCCCEEEeeCCCCcCCCC------CCCCceeeecccChhhhcCccccCch-HHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999864322 12234567889999998764 45555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+....+..+................... ....... ....+ ...+ ....+..+
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~-------~~~~-------~~~~~~~~ 270 (342)
T cd07879 214 LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA-AKSYIKS--------LPKYP-------RKDF-------STLFPKAS 270 (342)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc-hHHHHhh--------cCCcc-------cchH-------HHHhcCCC
Confidence 998877655555544432211111100000000 0000000 00000 0000 01113467
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+.+||.+||+.||.+|||+++++.||||+..+.
T Consensus 271 ~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 271 PQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 88999999999999999999999999999998775
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=223.57 Aligned_cols=229 Identities=24% Similarity=0.333 Sum_probs=161.7
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
++++++|.. ++..++|+||+ +++|.+++.. +.+++..+..++.|++.||.||| +.+++|+||+
T Consensus 72 v~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH--------------~~~iiH~dl~ 135 (328)
T cd07856 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVH--------------SAGVVHRDLK 135 (328)
T ss_pred eeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCC
Confidence 467787765 56899999999 5699888864 45889999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.++++|||.+..... ......++..|++||.+.+ ..++.. +|+|||||+++++++|..||..
T Consensus 136 p~Nili~~~~~~~l~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 136 PSNILINENCDLKICDFGLARIQDP------QMTGYVSTRYYRAPEIMLTWQKYDVE-VDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred HHHEeECCCCCEEeCccccccccCC------CcCCCcccccccCceeeeccCCcCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864322 1223456788999999766 345555 9999999999999999999977
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+.......+..+.......... ... ....... .... ....+.++..+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------------~~~~~~~-~~~~-------~~~~~~~~~~~~ 265 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTL-RFV--------------QSLPKRE-PVPF-------SEKFKNADPSAI 265 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhH-HHH--------------hhccccC-CCcH-------HHHcCCCCHHHH
Confidence 6654444433333222221111100000000 000 0000000 0000 011135688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccccccC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVL 275 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~ 275 (304)
++|.+||..+|++|||+++++.||||.....+.....
T Consensus 266 ~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~ 302 (328)
T cd07856 266 DLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302 (328)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence 9999999999999999999999999987776654433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=222.25 Aligned_cols=194 Identities=26% Similarity=0.392 Sum_probs=155.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..+...++||||+.| +|.+.+.. ...+++..+..++.+++.||.||| +.+++|+||+
T Consensus 88 v~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~dL~ 152 (317)
T cd06635 88 IEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--------------SHNMIHRDIK 152 (317)
T ss_pred EEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCC
Confidence 4678888899999999999975 88888765 457899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.+ +|+|||||++++|++|..||
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~ 224 (317)
T cd06635 153 AGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPL 224 (317)
T ss_pred cccEEECCCCCEEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999998864322 22345788899999974 3345556 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+...... ......+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~ 252 (317)
T cd06635 225 FNMNAMSALYHIAQNESP----------------------------------------------------TLQSNEWSDY 252 (317)
T ss_pred CCccHHHHHHHHHhccCC----------------------------------------------------CCCCccccHH
Confidence 766544443333322110 0111346778
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+|+.+||..+|.+||++.++++|+|+.....
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999999999966553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=219.80 Aligned_cols=207 Identities=20% Similarity=0.336 Sum_probs=148.5
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... ...++||||++|++|.+++.+.. .+++..+..++.|++.||+||| +.+++|+|
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH--------------~~gi~H~d 134 (284)
T cd05079 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--------------SRQYVHRD 134 (284)
T ss_pred eeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecc
Confidence 3566766654 67899999999999999997653 5899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|+||+++.++.++|+|||++.................++..|+|||.+.+..++.+ +|+|||||++++++++..|..
T Consensus 135 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 135 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCc
Confidence 9999999999999999999998765433221112234456778999999988777776 999999999999999876643
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
... ..+.+...... .... ....... ... ......+..++..+
T Consensus 214 ~~~--~~~~~~~~~~~-~~~~----------~~~~~~~-----------------------~~~--~~~~~~~~~~~~~~ 255 (284)
T cd05079 214 SPM--TLFLKMIGPTH-GQMT----------VTRLVRV-----------------------LEE--GKRLPRPPNCPEEV 255 (284)
T ss_pred ccc--chhhhhccccc-cccc----------HHHHHHH-----------------------HHc--CccCCCCCCCCHHH
Confidence 221 11111100000 0000 0000000 000 00012234578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+|+.+||+.+|++|||++++++
T Consensus 256 ~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 256 YQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=220.76 Aligned_cols=198 Identities=21% Similarity=0.348 Sum_probs=150.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
+++++++..+...++||||+.+|+|.+++.+.. .+++..+..++.|++.||+|||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-------------- 147 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-------------- 147 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--------------
Confidence 478899999999999999999999999997643 3667889999999999999999
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
+.+++|+||||+||+++.++.++++|||++.......... ......++..|++||...+..++.+ +|+|||||++|++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el 225 (296)
T cd05095 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEI 225 (296)
T ss_pred HCCeecccCChheEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHH
Confidence 8999999999999999999999999999987543322111 1122234678999999888888777 9999999999999
Q ss_pred Hh--CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 150 LN--AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 150 l~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
++ |..||...+..+........... ... ....
T Consensus 226 ~~~~~~~p~~~~~~~~~~~~~~~~~~~---------------------~~~-------------------------~~~~ 259 (296)
T cd05095 226 LTLCKEQPYSQLSDEQVIENTGEFFRD---------------------QGR-------------------------QVYL 259 (296)
T ss_pred HHhCCCCCccccChHHHHHHHHHHHhh---------------------ccc-------------------------cccC
Confidence 98 67888665543333211100000 000 0001
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..+++.+.+|+..||..||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 260 PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 112346788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=224.79 Aligned_cols=226 Identities=23% Similarity=0.351 Sum_probs=159.6
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++... +..+++++++ +++|.+++... .+++..++.++.|++.||+||| +.+++
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH--------------~~~iv 142 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIH--------------SADII 142 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH--------------HCCee
Confidence 3566666532 4578898887 77998888654 5999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+ ..++.+ +|+|||||+++++++|.
T Consensus 143 H~dlkp~NIll~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslG~il~el~~g~ 215 (345)
T cd07877 143 HRDLKPSNLAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGR 215 (345)
T ss_pred ecCCChHHEEEcCCCCEEEecccccccccc------cccccccCCCccCHHHHhCccCCCch-hhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999864322 1223457888999999866 345555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||...+.......+..........+...+.... ............ . ..+ .......
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------------~-~~~-------~~~~~~~ 272 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSES-ARNYIQSLTQMP--------------K-MNF-------ANVFIGA 272 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh-HHHHHHHhcccC--------------C-cch-------hhhcCCC
Confidence 9997766555555544433322211111111000 000000000000 0 000 0111245
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.+||.+||..||.+|+|+.++++||||+....+..
T Consensus 273 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 273 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred CHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 788999999999999999999999999999998766544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=216.27 Aligned_cols=191 Identities=27% Similarity=0.479 Sum_probs=154.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++..++..++||||+.|++|.+++.. ...+++..++.++.|++.||.|||+ ..+++|+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-------------~~~i~H~ 138 (269)
T cd08528 72 VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-------------EKRIVHR 138 (269)
T ss_pred eeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-------------CCceeec
Confidence 4678888899999999999999999998854 3468999999999999999999992 3789999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.. +|+||||+++|++++|..||
T Consensus 139 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~ 213 (269)
T cd08528 139 DLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPF 213 (269)
T ss_pred CCCHHHEEECCCCcEEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcc
Confidence 999999999999999999999987544322 2234567889999999988777777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+....... .....+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~ 241 (269)
T cd08528 214 YSTNMLSLATKIVEAVYEP----------------------------------------------------LPEGMYSED 241 (269)
T ss_pred cccCHHHHHHHHhhccCCc----------------------------------------------------CCcccCCHH
Confidence 7665544443333221110 011246788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+++.+||..||++||++.|+.++
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHH
Confidence 9999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=217.45 Aligned_cols=190 Identities=22% Similarity=0.323 Sum_probs=152.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.. ...++||||+.+|+|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+
T Consensus 72 ~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~i~H~di~ 136 (279)
T cd05057 72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE--------------EKRLVHRDLA 136 (279)
T ss_pred ceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEecccC
Confidence 467777776 7899999999999999999874 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... .......++..|++||.+....++.. +|+||||++++++++ |..||.+
T Consensus 137 p~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cceEEEcCCCeEEECCCcccccccCcccc-eecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999998755422111 11112223567999999987777777 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..+.. ...+...+..+.
T Consensus 215 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 241 (279)
T cd05057 215 IPAVEIPDLLEKGER-----------------------------------------------------LPQPPICTIDVY 241 (279)
T ss_pred CCHHHHHHHHhCCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 765555544443211 112244677899
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++.+||..+|++|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=215.28 Aligned_cols=182 Identities=20% Similarity=0.249 Sum_probs=143.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.. ...++||||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+++|+|||
T Consensus 64 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--------------~~~i~H~dlk 128 (259)
T cd05037 64 VKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--------------DKKLVHGNVC 128 (259)
T ss_pred hheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--------------hCCeecccCc
Confidence 457777777 77899999999999999998766 7899999999999999999999 8999999999
Q ss_pred CCcEEEecCC-------CeEEEeccCcccccCcccccccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTKRF-------NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++.++ .+|++|||++..... .....++..|+|||++.+. .++.+ +|+|||||++++++
T Consensus 129 p~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~~~~~l~ 200 (259)
T cd05037 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIA-ADKWSFGTTLLEIC 200 (259)
T ss_pred cceEEEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchh-hHHHHHHHHHHHHH
Confidence 9999999888 799999999875432 1123456789999998776 56666 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||............... ...
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~~~-------------------------------------------------------~~~ 225 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQDQ-------------------------------------------------------HRL 225 (259)
T ss_pred hCCCCCcccCCchhHHHHHhcC-------------------------------------------------------CCC
Confidence 9 57777554322211111100 001
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+......+.+++.+||..+|++|||+.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112368999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=237.25 Aligned_cols=191 Identities=25% Similarity=0.416 Sum_probs=155.8
Q ss_pred eeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCc
Q psy1812 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82 (304)
Q Consensus 4 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~n 82 (304)
.+++.+.+. .||+.+|+|-+|+.+|+-.+ .|.....+.|+.|++.|+.||| .++|+|+|||..|
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH--------------AK~IIHrDLKSnN 518 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH--------------AKNIIHRDLKSNN 518 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh--------------hhhhhhhhccccc
Confidence 355555555 99999999999999997654 6999999999999999999999 9999999999999
Q ss_pred EEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 83 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|++.+++++||+|||++..-....+. .......|...|+|||++.. .+|+.. |||||||+++|||++|..||...
T Consensus 519 IFl~~~~kVkIgDFGLatvk~~w~g~-~q~~qp~gsilwmAPEvIRmqd~nPfS~q-SDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 519 IFLHEDLKVKIGDFGLATVKTRWSGE-QQLEQPHGSLLWMAPEVIRMQDDNPFSFQ-SDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred eEEccCCcEEEecccceeeeeeeccc-cccCCCccchhhhcHHHHhhcccCCCCcc-cchhhhhHHHHHHHhCcCCcCCC
Confidence 99999999999999998643322111 12344568899999999864 457777 99999999999999999999977
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+-++++..+-++...... .......++++++
T Consensus 597 ~~dqIifmVGrG~l~pd~-------------------------------------------------s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 597 NRDQIIFMVGRGYLMPDL-------------------------------------------------SKIRSNCPKAMKR 627 (678)
T ss_pred ChhheEEEecccccCccc-------------------------------------------------hhhhccCHHHHHH
Confidence 776766666555443320 2223557789999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
|+..||++++++||++.+||.
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999987
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=214.23 Aligned_cols=185 Identities=23% Similarity=0.412 Sum_probs=148.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..+ ..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.+++||||
T Consensus 62 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~~~H~dl 126 (254)
T cd05083 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--------------SKKLVHRDL 126 (254)
T ss_pred CeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecccc
Confidence 4667777654 4799999999999999997654 4789999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
+|+||+++.++.++|+|||++...... ......+..|+|||.+.+..++.. +|+|||||+++++++ |..||.
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMG------VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred CcceEEEcCCCcEEECCCccceecccc------CCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999998643221 112234567999999988778777 999999999999997 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+..+.. ...+..++..+
T Consensus 200 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 226 (254)
T cd05083 200 KMSLKEVKECVEKGYR-----------------------------------------------------MEPPEGCPADV 226 (254)
T ss_pred cCCHHHHHHHHhCCCC-----------------------------------------------------CCCCCcCCHHH
Confidence 7665444433332211 11124568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||+.+|++||+++++++
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=215.08 Aligned_cols=195 Identities=16% Similarity=0.272 Sum_probs=146.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++.+......++||||+++|+|.+++.+. ..+++..++.++.|++.||+||| +.+++|+
T Consensus 58 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--------------~~~i~H~ 123 (268)
T cd05086 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--------------KHNFLHS 123 (268)
T ss_pred hheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--------------HCCeecc
Confidence 57888999999999999999999999999764 24667788899999999999999 8899999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-------CCCCCCchHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-------PYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~sDvwslG~ll~~l 149 (304)
||||+||+++.++.++|+|||++........ ........++..|+|||++... .++.+ +|+|||||++|+|
T Consensus 124 dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~el 201 (268)
T cd05086 124 DLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP-SNVWALGVTLWEL 201 (268)
T ss_pred CCccceEEEcCCccEEecccccccccCcchh-hhcccCCcCcccccCchhcccccCccccCCCCCc-chhHHHHHHHHHH
Confidence 9999999999999999999998753221110 0112344578899999997532 23444 9999999999999
Q ss_pred Hh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 150 LN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 150 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
++ |..||...+..+....+........ ....
T Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 233 (268)
T cd05086 202 FENAAQPYSHLSDREVLNHVIKDQQVKL------------------------------------------------FKPQ 233 (268)
T ss_pred HhCCCCCCCCCCHHHHHHHHHhhccccc------------------------------------------------CCCc
Confidence 97 5678876655444444332211000 0011
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
....+++.+.+++..|| .+|++|||++++++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 22346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=237.40 Aligned_cols=212 Identities=22% Similarity=0.267 Sum_probs=141.5
Q ss_pred eeCCeEEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCC
Q psy1812 8 QRGPRVFIFMRYADNGDLLDHIKRAGP--------------------VAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67 (304)
Q Consensus 8 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~ 67 (304)
..+...++|+||+.+++|.+++..... ..+..+..++.|++.||.|||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH------------ 272 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH------------ 272 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH------------
Confidence 356689999999999999999976431 123456789999999999999
Q ss_pred CCCCceEecCCCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC---------------
Q psy1812 68 LPSKNIAHRDLKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--------------- 131 (304)
Q Consensus 68 ~~~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--------------- 131 (304)
+.+|+||||||+|||++. ++.+||+|||++........ .......+++.|+|||.+....
T Consensus 273 --~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s 348 (566)
T PLN03225 273 --STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 348 (566)
T ss_pred --HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence 899999999999999986 57899999999974432211 1234567889999999764322
Q ss_pred -------CCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhccccccc
Q psy1812 132 -------YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILS 204 (304)
Q Consensus 132 -------~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (304)
++.+ +||||+||++|+|+++..++... ...+..+......... .+.......
T Consensus 349 p~l~~~~~~~k-~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~----------~~~~~~~~~-------- 407 (566)
T PLN03225 349 PVLWQLNLPDR-FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLV----------AWRKLVEPR-------- 407 (566)
T ss_pred chhccccCCCC-cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHH----------HHHHhhccc--------
Confidence 2222 59999999999999877664322 2222222211110000 000000000
Q ss_pred ccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 205 HQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
....+... ....+......++||.+||++||.+|||++++|+||||+.....
T Consensus 408 ----------~~~~~~~~----~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 408 ----------ASPDLRRG----FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred ----------cchhhhhh----hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 00000000 01112235567899999999999999999999999999886653
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=216.51 Aligned_cols=191 Identities=16% Similarity=0.300 Sum_probs=151.8
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRA--------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++.. +...++++||+.+|+|.+++... ..+++..++.++.+++.||+||| +.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------------~~ 136 (280)
T cd05043 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--------------KR 136 (280)
T ss_pred CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--------------HC
Confidence 456776544 57899999999999999999764 35899999999999999999999 89
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+++|+||+|+||+++.++.+|++|||+++.+....... ......++..|+|||.+.+..++.+ +|+|||||+++++++
T Consensus 137 ~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~ 214 (280)
T cd05043 137 GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMT 214 (280)
T ss_pred CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEE-eCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhc
Confidence 99999999999999999999999999997554332211 1122345678999999988777777 999999999999998
Q ss_pred -CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 -AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||...+..+....+..+.. ...+
T Consensus 215 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~ 241 (280)
T cd05043 215 LGQTPYVEIDPFEMAAYLKDGYR-----------------------------------------------------LAQP 241 (280)
T ss_pred CCCCCcCcCCHHHHHHHHHcCCC-----------------------------------------------------CCCC
Confidence 9999977665444433322210 0112
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=241.79 Aligned_cols=86 Identities=31% Similarity=0.554 Sum_probs=81.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.....+||||||+.|++|.+++...+.+++..++.++.||+.||.||| ..+|+|+||||
T Consensus 67 v~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH--------------~~gIiHrDLKP 132 (669)
T cd05610 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH--------------RHGIIHRDLKP 132 (669)
T ss_pred CeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEeCCccH
Confidence 5788899999999999999999999999988888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcc
Q psy1812 81 ENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~ 100 (304)
+|||++.++.+||+|||+++
T Consensus 133 ~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=234.98 Aligned_cols=196 Identities=32% Similarity=0.567 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|.+-..|+..++.|+|||-+. |+..+.|-. .+++++...+.++.||+.||.||| .++|||.||
T Consensus 626 V~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--------------~knIvHCDL 690 (888)
T KOG4236|consen 626 VNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--------------FKNIVHCDL 690 (888)
T ss_pred eEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--------------hcceeeccC
Confidence 456677889999999999996 577777743 568999999999999999999999 999999999
Q ss_pred CCCcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 79 KCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 79 ~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
||+|||+.... .+||||||++++++++.. .....||+.|+|||++..+.|... -|+||+|||+|--+.|..|
T Consensus 691 KPENVLLas~~~FPQvKlCDFGfARiIgEksF----RrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 691 KPENVLLASASPFPQVKLCDFGFARIIGEKSF----RRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred CchheeeccCCCCCceeeccccceeecchhhh----hhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEeccccc
Confidence 99999997653 489999999998887653 456789999999999999999888 8999999999999999999
Q ss_pred CCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 156 FDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 156 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
|...++ .++++ +..+-++ ...+..++
T Consensus 766 FNEdEdIndQIQ---NAaFMyP--------------------------------------------------p~PW~eis 792 (888)
T KOG4236|consen 766 FNEDEDINDQIQ---NAAFMYP--------------------------------------------------PNPWSEIS 792 (888)
T ss_pred CCCccchhHHhh---ccccccC--------------------------------------------------CCchhhcC
Confidence 965433 23333 2222222 33346689
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.++.|||..+|+....+|.|.++.|.|||+++...
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 99999999999999999999999999999998654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=214.12 Aligned_cols=194 Identities=19% Similarity=0.294 Sum_probs=145.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++.+.+....++||||+++|+|.+++.... ..++..+..++.|++.||.||| +.+++|
T Consensus 58 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~i~H 123 (269)
T cd05087 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--------------KNNFIH 123 (269)
T ss_pred eeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--------------HCCEec
Confidence 467888888889999999999999999997532 3567788899999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-------CCCCCCchHHHHHHHHHH
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-------PYNPKLADIWSLGVITFI 148 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~sDvwslG~ll~~ 148 (304)
+||||+||+++.++.++++|||++........ ........++..|+|||++.+. .++.+ +|+||||+++++
T Consensus 124 ~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~e 201 (269)
T cd05087 124 SDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE-SNVWSLGVTIWE 201 (269)
T ss_pred cccCcceEEEcCCCcEEECCccccccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCcc-chhHHHHHHHHH
Confidence 99999999999999999999999864322211 1112234567889999998642 23455 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhcc-ccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNI-LSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
+++ |..||......+......... ...+ .
T Consensus 202 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~ 232 (269)
T cd05087 202 LFELGSQPYRHLSDEQVLTYTVREQQLKLP-------------------------------------------------K 232 (269)
T ss_pred HHhCCCCCCCCCChHHHHHHHhhcccCCCC-------------------------------------------------C
Confidence 996 999997655443322211111 0000 0
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.......++.+.+++..|+ .+|++|||+++++.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1112345778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=209.52 Aligned_cols=193 Identities=36% Similarity=0.622 Sum_probs=157.7
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++.+......++++||+.+++|.+++.....+++..++.++.+++.++.+|| ..+++|+||+|.
T Consensus 51 ~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~~i~~~ 116 (244)
T smart00220 51 RLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLH--------------SNGIIHRDLKPE 116 (244)
T ss_pred HHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------HcCeecCCcCHH
Confidence 456677778899999999999999999988767899999999999999999999 889999999999
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC-hh
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD-SN 160 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~-~~ 160 (304)
||+++.++.++++|||.+....... ......++..|++||...+..++.+ +|+||+|++++++++|..||.. .+
T Consensus 117 ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~ 191 (244)
T smart00220 117 NILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQ 191 (244)
T ss_pred HeEECCCCcEEEccccceeeecccc----ccccccCCcCCCCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999987654432 2234457888999999987778776 9999999999999999999976 33
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
................ .....++..+.++
T Consensus 192 ~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~ 220 (244)
T smart00220 192 LLELFKKIGKPKPPFP---------------------------------------------------PPEWKISPEAKDL 220 (244)
T ss_pred HHHHHHHHhccCCCCc---------------------------------------------------cccccCCHHHHHH
Confidence 3333333222211111 0001167899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+.+||..+|++||++.++++||||
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHccCCchhccCHHHHhhCCCC
Confidence 999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=233.52 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=167.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++||+...+..++||||+|.||+|.+||++.+ .++..+...++.+.+.||+||| +++++||||-
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh--------------~k~~IHRDIA 289 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH--------------SKNCIHRDIA 289 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH--------------HCCCcchhHh
Confidence 689999999999999999999999999999987 4999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
++|+|++.++.+||+|||+++....... ......-+..|+|||.+....++.. +|||||||++||+++ |..||.+
T Consensus 290 ARNcL~~~~~~vKISDFGLs~~~~~~~~---~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 290 ARNCLYSKKGVVKISDFGLSRAGSQYVM---KKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred HHHheecCCCeEEeCccccccCCcceee---ccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCC
Confidence 9999999999999999999875432111 1112235689999999999888888 999999999999999 8899999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+...++....+..+ .+...+..+.
T Consensus 366 ~~~~~v~~kI~~~~~r~~----------------------------------------------------~~~~~p~~~~ 393 (474)
T KOG0194|consen 366 MKNYEVKAKIVKNGYRMP----------------------------------------------------IPSKTPKELA 393 (474)
T ss_pred CCHHHHHHHHHhcCccCC----------------------------------------------------CCCCCHHHHH
Confidence 999888888855433322 2345688899
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.++.+|+..+|++|||+.++.+ ++.....
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~ 422 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK--KLEALEK 422 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH--HHHHHHh
Confidence 9999999999999999998876 4444443
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=226.95 Aligned_cols=193 Identities=23% Similarity=0.393 Sum_probs=151.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------------------------------------- 33 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------- 33 (304)
|++++.+..++..++||||+.+|+|.+++..++
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 468889999999999999999999999997532
Q ss_pred ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCC
Q psy1812 34 ---------------------------------------------------PVAESNARTWFSQMLAGLEYLHREITNHT 62 (304)
Q Consensus 34 ---------------------------------------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~ 62 (304)
.+++..++.++.|++.||.|||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH------- 256 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA------- 256 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-------
Confidence 2567788899999999999999
Q ss_pred CCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHH
Q psy1812 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142 (304)
Q Consensus 63 ~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwsl 142 (304)
+.+++|+||||+||+++.++.+|++|||++.......... ......++..|++||.+.+..++.+ +|+|||
T Consensus 257 -------~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 327 (401)
T cd05107 257 -------SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTL-SDVWSF 327 (401)
T ss_pred -------cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcH-hHHHHH
Confidence 8999999999999999999999999999987543221111 1122346788999999988878777 999999
Q ss_pred HHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 143 GVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 143 G~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
||+++++++ |..||......+...........
T Consensus 328 Gvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~----------------------------------------------- 360 (401)
T cd05107 328 GILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR----------------------------------------------- 360 (401)
T ss_pred HHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-----------------------------------------------
Confidence 999999998 88998655433332221111100
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++.++.+|+.+||..+|.+||+++++++.
T Consensus 361 -----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 -----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11224568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=234.00 Aligned_cols=193 Identities=26% Similarity=0.377 Sum_probs=161.1
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
.+-+.|-.+.+.|+|||||-| +-.|.+.-. .++.+.++..|..+.+.||.||| +.+.+|||||.
T Consensus 90 eYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH--------------S~~~IHRDiKA 154 (948)
T KOG0577|consen 90 EYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--------------SHNRIHRDIKA 154 (948)
T ss_pred cccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH--------------HhhHHhhhccc
Confidence 456677788899999999975 888888654 47999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
.|||++..|.+|++|||.+.+..+ ..+++||+.|||||++. .+.|+.+ +||||||+.+.+|.-+++|+.
T Consensus 155 GNILLse~g~VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 155 GNILLSEPGLVKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred cceEecCCCeeeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCcc
Confidence 999999999999999999976554 34678999999999986 4568888 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+-....-.|..+..+- -....+++.+
T Consensus 227 nMNAMSALYHIAQNesPt----------------------------------------------------Lqs~eWS~~F 254 (948)
T KOG0577|consen 227 NMNAMSALYHIAQNESPT----------------------------------------------------LQSNEWSDYF 254 (948)
T ss_pred CchHHHHHHHHHhcCCCC----------------------------------------------------CCCchhHHHH
Confidence 877554443333222110 0124568899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++|+..||..-|++|||++++|.|+|....+.
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 99999999999999999999999999876654
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=207.32 Aligned_cols=234 Identities=17% Similarity=0.282 Sum_probs=176.2
Q ss_pred ceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 2 QVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 2 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++..+ +....+|+||+++.+....... ++.-.++.++.+++.||.|+| +.||.|||+|
T Consensus 97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCH--------------S~GImHRDVK 159 (338)
T KOG0668|consen 97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCH--------------SMGIMHRDVK 159 (338)
T ss_pred ehhhhhcCccccCchhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHH--------------hcCcccccCC
Confidence 45666654 5688999999999887776654 788899999999999999999 8999999999
Q ss_pred CCcEEEecC-CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC-C
Q psy1812 80 CENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-D 157 (304)
Q Consensus 80 ~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf-~ 157 (304)
|.||+++.. -.++++|||++.++.+.... .-+..+..|--||.+..-......-|+|||||++..|+..+.|| .
T Consensus 160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred cceeeechhhceeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 999999865 45999999999987765432 23345667788999876553333389999999999999988777 5
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..++..+|.+-.+ +.....-..+++-..............+..+..+++.+.. .-.++++
T Consensus 236 G~dN~DQLVkIakVLG---------------t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~--hl~~pea 298 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLG---------------TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQ--HLVSPEA 298 (338)
T ss_pred CCCCHHHHHHHHHHhC---------------hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccc--ccCChHH
Confidence 6666666666654433 2333333344444444444554555556666666654333 3457999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
.|||.++|..|.++|+||+|++.||||......+.+
T Consensus 299 iDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 299 IDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred HHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 999999999999999999999999999988765543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=214.87 Aligned_cols=205 Identities=21% Similarity=0.344 Sum_probs=149.0
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++.. +...++||||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+|
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH--------------~~~i~H~d 134 (284)
T cd05038 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--------------SQRYIHRD 134 (284)
T ss_pred heEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH--------------hCCeecCC
Confidence 356777766 668999999999999999997755 5899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|+||+++.++.++++|||.+.................++..|++||.+.+..++.. +|+||||+++++|++|..|+.
T Consensus 135 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcc
Confidence 9999999999999999999999765422211111122345567999999988777777 999999999999999999885
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc--cccccccccH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH--QVKVKDILSH 235 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (304)
........ +... ..... ....+...+.. ....+..++.
T Consensus 214 ~~~~~~~~--~~~~-~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd05038 214 SPPAEFLR--MIGI-AQGQM-------------------------------------IVTRLLELLKEGERLPRPPSCPD 253 (284)
T ss_pred cccchhcc--cccc-ccccc-------------------------------------cHHHHHHHHHcCCcCCCCccCCH
Confidence 53221100 0000 00000 00000000000 0111234578
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
++.+|+.+||..+|++|||+.++++
T Consensus 254 ~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 254 EVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=220.91 Aligned_cols=193 Identities=21% Similarity=0.369 Sum_probs=146.1
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhcC----------------------------------------------
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRAG---------------------------------------------- 33 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------- 33 (304)
|++++.+.. ++..++||||+++|+|.+++....
T Consensus 74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 356666654 567899999999999999996531
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeE
Q psy1812 34 ---------------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVK 92 (304)
Q Consensus 34 ---------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~k 92 (304)
.+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~i~H~dikp~Nil~~~~~~~k 219 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--------------SRKCIHRDLAARNILLSENNVVK 219 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCccCeEEEcCCCcEE
Confidence 3677888999999999999999 89999999999999999999999
Q ss_pred EEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhc
Q psy1812 93 IADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSN 171 (304)
Q Consensus 93 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~ 171 (304)
++|||++......... .......++..|+|||.+.+..++.+ +|+||||++++++++ |..||........+......
T Consensus 220 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 297 (343)
T cd05103 220 ICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297 (343)
T ss_pred EEecccccccccCcch-hhcCCCCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence 9999998754322111 11122335677999999988778777 999999999999997 89998654322222111110
Q ss_pred cccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCc
Q psy1812 172 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251 (304)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 251 (304)
... ...+...++.+.+++..||+.||++
T Consensus 298 ~~~----------------------------------------------------~~~~~~~~~~~~~~~~~cl~~~p~~ 325 (343)
T cd05103 298 GTR----------------------------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQ 325 (343)
T ss_pred cCC----------------------------------------------------CCCCCCCCHHHHHHHHHHccCChhh
Confidence 000 1112335778999999999999999
Q ss_pred cccHHHHhcC
Q psy1812 252 RIRLDAIKAH 261 (304)
Q Consensus 252 R~t~~ell~~ 261 (304)
|||+.++++|
T Consensus 326 Rps~~eil~~ 335 (343)
T cd05103 326 RPTFSELVEH 335 (343)
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=213.82 Aligned_cols=206 Identities=20% Similarity=0.322 Sum_probs=145.9
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++. ....+++||||+++|+|.+++.+. ..+++..++.++.|++.||.||| +.+++|+|
T Consensus 68 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH--------------~~~i~H~d 133 (284)
T cd05081 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--------------SKRYVHRD 133 (284)
T ss_pred eEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecc
Confidence 35566543 345789999999999999999764 46899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.++|+|||++.................++..|+|||.+.+..++.+ +|+|||||+++++++|..++.
T Consensus 134 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCC
Confidence 9999999999999999999998755332211111112223456999999988777776 999999999999999877664
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc--cccccccccH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH--QVKVKDILSH 235 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (304)
.... . +................ +.+.+.. ....+..++.
T Consensus 213 ~~~~-~-~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd05081 213 SPPA-E-FMRMMGNDKQGQMIVYH-------------------------------------LIELLKNNGRLPAPPGCPA 253 (284)
T ss_pred Ccch-h-hhhhcccccccccchHH-------------------------------------HHHHHhcCCcCCCCCCCCH
Confidence 3321 1 11111110000000000 0000000 0112345788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+.+|+.+||..+|++|||+.++++
T Consensus 254 ~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 254 EIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=215.43 Aligned_cols=191 Identities=20% Similarity=0.331 Sum_probs=148.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++... ..++++||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++|+|||
T Consensus 72 v~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------------~~~ivH~dik 136 (303)
T cd05110 72 VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--------------ERRLVHRDLA 136 (303)
T ss_pred ccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh--------------hcCeeccccc
Confidence 4677777654 5679999999999999997754 6899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... .......++..|++||.+.+..++.+ +|+|||||++|++++ |..||.+
T Consensus 137 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 137 ARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cceeeecCCCceEEccccccccccCcccc-cccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999755432211 01122335678999999988778777 999999999999997 8999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..+ .. ...+..++..+.
T Consensus 215 ~~~~~~~~~~~~~-~~----------------------------------------------------~~~~~~~~~~~~ 241 (303)
T cd05110 215 IPTREIPDLLEKG-ER----------------------------------------------------LPQPPICTIDVY 241 (303)
T ss_pred CCHHHHHHHHHCC-CC----------------------------------------------------CCCCCCCCHHHH
Confidence 5433322221111 00 111234567899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=222.47 Aligned_cols=143 Identities=29% Similarity=0.474 Sum_probs=122.2
Q ss_pred CceeeeeeeCC-eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGP-RVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|+++++|.+.+ ..+||+||+.+|+|.++|.... .++|.....|+.++|.||+|||+. +...|+|||
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~-----------~~~~iiHrD 202 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEG-----------CPPPIIHRD 202 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccC-----------CCCCEecCC
Confidence 68999999988 5999999999999999998865 899999999999999999999952 133699999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCc-cCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY-CGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||++|||+|++++.||+|||++........ ...+. .||..|++||+...+..+.+ +|||||||+++|+++|+.+.
T Consensus 203 iKssNILLD~~~~aKlsDFGLa~~~~~~~~---~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 203 IKSSNILLDEDFNAKLSDFGLAKLGPEGDT---SVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred CCHHHeeECCCCCEEccCccCcccCCcccc---ceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCccc
Confidence 999999999999999999999954332111 11122 79999999999988778777 99999999999999999777
Q ss_pred CC
Q psy1812 157 DD 158 (304)
Q Consensus 157 ~~ 158 (304)
+.
T Consensus 279 d~ 280 (361)
T KOG1187|consen 279 DQ 280 (361)
T ss_pred CC
Confidence 54
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=238.34 Aligned_cols=195 Identities=26% Similarity=0.366 Sum_probs=149.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-----------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
|++++++.+++..++||||++||+|.+++.+. ..++...+..++.|++.||+|||
T Consensus 65 Vkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-------------- 130 (932)
T PRK13184 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-------------- 130 (932)
T ss_pred CeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--------------
Confidence 57899999999999999999999999999752 23556778899999999999999
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccc---------------cccccCccCCccccccccccCCCCCC
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR---------------RVLSRTYCGSAAYAAPEVISGNPYNP 134 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---------------~~~~~~~~~~~~~~~PE~~~~~~~~~ 134 (304)
+.+++||||||+||+++.++.++|+|||++......... ........|++.|+|||.+.+..++.
T Consensus 131 s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 131 SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 889999999999999999999999999999755211100 00112346899999999998888877
Q ss_pred CCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhh
Q psy1812 135 KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILS 214 (304)
Q Consensus 135 ~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (304)
+ +|+|||||++|+|++|..||........... .....+.
T Consensus 211 k-SDIWSLGVILyELLTG~~PF~~~~~~ki~~~---~~i~~P~------------------------------------- 249 (932)
T PRK13184 211 S-TDIYALGVILYQMLTLSFPYRRKKGRKISYR---DVILSPI------------------------------------- 249 (932)
T ss_pred H-hHHHHHHHHHHHHHHCCCCCCCcchhhhhhh---hhccChh-------------------------------------
Confidence 7 9999999999999999999976433222111 0000000
Q ss_pred hhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 215 HQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.......+++.+.+++.+||..||++|++..+.+.+
T Consensus 250 -----------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 250 -----------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred -----------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000113567889999999999999999876555543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=213.67 Aligned_cols=186 Identities=18% Similarity=0.225 Sum_probs=140.8
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCe
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNV 91 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~ 91 (304)
..+++++++. .++.+.+......++..++.++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 101 YRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH--------------EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCHHHEEEcCCCcE
Confidence 4578889885 488888877666789999999999999999999 8999999999999999999999
Q ss_pred EEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH-HHHHH
Q psy1812 92 KIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL-KQLFK 166 (304)
Q Consensus 92 kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~-~~~~~ 166 (304)
+|+|||+++.+....... .......||+.|+|||+..+..++.+ +|+|||||++++|++|..||.+... .....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999997654322110 11223468999999999998888877 9999999999999999999976632 22222
Q ss_pred HhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcC
Q psy1812 167 EQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILE 246 (304)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 246 (304)
........ .+... .......++.+.+++..|+.
T Consensus 245 ~~~~~~~~----------------------------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~ 277 (294)
T PHA02882 245 AAKCDFIK----------------------------------------------RLHEG-KIKIKNANKFIYDFIECVTK 277 (294)
T ss_pred HhHHHHHH----------------------------------------------Hhhhh-hhccCCCCHHHHHHHHHHHh
Confidence 11111000 00000 00113457889999999999
Q ss_pred CCCCccccHHHHhc
Q psy1812 247 PDITKRIRLDAIKA 260 (304)
Q Consensus 247 ~dP~~R~t~~ell~ 260 (304)
.+|++||++.++++
T Consensus 278 ~~~~~rp~~~~l~~ 291 (294)
T PHA02882 278 LSYEEKPDYDALIK 291 (294)
T ss_pred CCCCCCCCHHHHHH
Confidence 99999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=205.69 Aligned_cols=191 Identities=19% Similarity=0.350 Sum_probs=146.4
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCC
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRA------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~ 68 (304)
+++++++.... ..++++||+.+|+|.+++... ..+++..++.++.|++.||+|||
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH------------- 130 (273)
T cd05074 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS------------- 130 (273)
T ss_pred ceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-------------
Confidence 45677664421 357899999999999887532 14789999999999999999999
Q ss_pred CCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 69 ~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+.+++|+||||+||+++.++.+|++|||.++......... ......++..|++||.+.+..++.. +|+|||||++|+
T Consensus 131 -~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~e 207 (273)
T cd05074 131 -SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR-QGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWE 207 (273)
T ss_pred -hCCEeecccchhhEEEcCCCCEEECcccccccccCCccee-cCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHH
Confidence 8999999999999999999999999999987543221110 1122335577999999988777776 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+++ |..||.+.+.......+..... .
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~ 234 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNR-----------------------------------------------------L 234 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCc-----------------------------------------------------C
Confidence 999 8899977665444433322110 0
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..+++.+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=221.11 Aligned_cols=190 Identities=23% Similarity=0.359 Sum_probs=162.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++.++|..+..+|||+|||..|+|.+||+++. .++.-...+++.||..|++||. .++++||||
T Consensus 326 VqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--------------kknFIHRDL 391 (1157)
T KOG4278|consen 326 VQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--------------KKNFIHRDL 391 (1157)
T ss_pred HHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--------------Hhhhhhhhh
Confidence 688999999999999999999999999998864 5788889999999999999999 999999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
-..|+|+.++..+||.|||++++.....-.. ...-.-++.|.|||.+-.+.++.+ +|||+|||++||+.| |-.||.
T Consensus 392 AARNCLVgEnhiVKvADFGLsRlMtgDTYTA--HAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 392 AARNCLVGENHIVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hhhhccccccceEEeeccchhhhhcCCceec--ccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999998654321110 011123578999999999999999 999999999999999 788999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+-+..+.+..+.++..- .-+.++++.+
T Consensus 469 GidlSqVY~LLEkgyRM-----------------------------------------------------~~PeGCPpkV 495 (1157)
T KOG4278|consen 469 GIDLSQVYGLLEKGYRM-----------------------------------------------------DGPEGCPPKV 495 (1157)
T ss_pred CccHHHHHHHHhccccc-----------------------------------------------------cCCCCCCHHH
Confidence 98888877766665432 2347899999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..||+.||+++|.+||++.|+.+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999987744
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-28 Score=231.28 Aligned_cols=200 Identities=24% Similarity=0.343 Sum_probs=153.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-P---VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~---l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
||+|+.-++....||..|.|.. +|.++++..+ . ..-...+.++.|++.||+||| +.+||||
T Consensus 566 iRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--------------sl~iVHR 630 (903)
T KOG1027|consen 566 IRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--------------SLKIVHR 630 (903)
T ss_pred EEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--------------hcccccc
Confidence 5889999999999999999986 9999998841 1 112456888999999999999 8999999
Q ss_pred CCCCCcEEEec---CC--CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 77 DLKCENILMTK---RF--NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 77 dl~~~nil~~~---~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
||||.||||.. ++ .++|+|||+++........-+...+..||-.|+|||++.......+ +|++|+||++|+.++
T Consensus 631 DLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvlt 709 (903)
T KOG1027|consen 631 DLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLT 709 (903)
T ss_pred cCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEec
Confidence 99999999977 34 4789999999876543322223446679999999999988766665 999999999999999
Q ss_pred C-CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 A-AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
| ..||.+.-. .-..|.++..... .+.
T Consensus 710 gG~HpFGd~~~--R~~NIl~~~~~L~---------------------------------------------------~L~ 736 (903)
T KOG1027|consen 710 GGSHPFGDSLE--RQANILTGNYTLV---------------------------------------------------HLE 736 (903)
T ss_pred CCccCCCchHH--hhhhhhcCcccee---------------------------------------------------eec
Confidence 5 899976532 2223333322221 000
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.....++.|||.+|++++|+.||+|.++|.||+|=...+
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 111128999999999999999999999999998865544
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=232.04 Aligned_cols=191 Identities=21% Similarity=0.382 Sum_probs=166.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++-++....+...||+|||++|+|+.||+.+ +.|+..+...+++.|+.|++||. +.++|||||-
T Consensus 693 IrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs--------------dm~YVHRDLA 758 (996)
T KOG0196|consen 693 IRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS--------------DMNYVHRDLA 758 (996)
T ss_pred EEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh--------------hcCchhhhhh
Confidence 46677888889999999999999999999886 47999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCc--cCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY--CGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~--~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
+.|||++.+..+|++|||+++...+.... ...+. .-+++|.|||.+...+++.. |||||+|+++||.++ |..||
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~--~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEA--AYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCc--cccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcc
Confidence 99999999999999999999976543311 12222 23579999999999999888 999999999999998 99999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
+.....+.+..+..+....+ |..++..
T Consensus 836 WdmSNQdVIkaIe~gyRLPp-----------------------------------------------------PmDCP~a 862 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQGYRLPP-----------------------------------------------------PMDCPAA 862 (996)
T ss_pred cccchHHHHHHHHhccCCCC-----------------------------------------------------CCCCcHH
Confidence 99999999999888765433 4678999
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+||..||+.|-.+||++.||+..
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=239.94 Aligned_cols=187 Identities=14% Similarity=0.189 Sum_probs=134.1
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
..++.+|||+ +++|.++|... +.+++..++.++.||+.||.||| +++|+||||||+|||++..+
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~gIvHrDlKP~NiLl~~~~ 117 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH--------------SQGIVVHNVRPSCFVMSSFN 117 (793)
T ss_pred chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH--------------hCCeeeccCCchhEEEcccC
Confidence 4678888988 56999999764 46999999999999999999999 89999999999999996544
Q ss_pred C-------------------eEEEeccCcccccCcccc-------------cccccCccCCccccccccccCCCCCCCCc
Q psy1812 90 N-------------------VKIADFGFARYCVDKEGR-------------RVLSRTYCGSAAYAAPEVISGNPYNPKLA 137 (304)
Q Consensus 90 ~-------------------~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~s 137 (304)
. +|++|||+++........ ........||+.|+|||++.+..++.+ +
T Consensus 118 ~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-s 196 (793)
T PLN00181 118 HVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCA-S 196 (793)
T ss_pred cEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCch-h
Confidence 4 455555555421100000 000112357888999999998888777 9
Q ss_pred hHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhh
Q psy1812 138 DIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQV 217 (304)
Q Consensus 138 DvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (304)
|||||||++|||++|..|+.... ..+..+.....+..
T Consensus 197 DVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~----------------------------------------- 233 (793)
T PLN00181 197 DVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ----------------------------------------- 233 (793)
T ss_pred hhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh-----------------------------------------
Confidence 99999999999999888764321 11111111000000
Q ss_pred hhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 218 KLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
. ........+++..||.++|.+|||+.|+++||||....
T Consensus 234 -----------~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 -----------I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred -----------h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 01133466889999999999999999999999998753
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=199.28 Aligned_cols=185 Identities=25% Similarity=0.350 Sum_probs=139.7
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eEecCCCCCcE
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IAHRDLKCENI 83 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--ivH~dl~~~ni 83 (304)
....||+++|...|+|.+.++.. ..++|.++..++.+++.||++|| +.. ++|+||||.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH--------------~~~~~yAH~DiKP~NI 160 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH--------------EKEPPYAHRDIKPANI 160 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh--------------ccCCcccccCCCccee
Confidence 34699999999999999999874 26999999999999999999999 555 99999999999
Q ss_pred EEecCCCeEEEeccCcccccCccccccc------ccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 84 LMTKRFNVKIADFGFARYCVDKEGRRVL------SRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 84 l~~~~~~~kl~dfg~~~~~~~~~~~~~~------~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
++.+.+.+.+.|||.+....-.-.++.. -.....|..|+|||.+. +...+.+ +|||||||++|.|+.|..
T Consensus 161 Lls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~s 239 (302)
T KOG2345|consen 161 LLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGES 239 (302)
T ss_pred EecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCC
Confidence 9999999999999998642211111000 01234789999999984 3446677 999999999999999999
Q ss_pred CCCChhHH--HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 155 PFDDSNLK--QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 155 pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
||...-.. .+.-.+.++.+.++ ....
T Consensus 240 Pfe~~~~~GgSlaLAv~n~q~s~P----------------------------------------------------~~~~ 267 (302)
T KOG2345|consen 240 PFERIYQQGGSLALAVQNAQISIP----------------------------------------------------NSSR 267 (302)
T ss_pred cchHHhhcCCeEEEeeeccccccC----------------------------------------------------CCCC
Confidence 99533110 00011111111111 1133
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
++..+.+|++.||..||.+||++.+++.+
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 89999999999999999999999999863
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=225.43 Aligned_cols=198 Identities=24% Similarity=0.419 Sum_probs=162.7
Q ss_pred ceeeeee-----eCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 2 QVHSILQ-----RGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 2 ~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
.+|++|. .+..+|||||||.||+.-|.+++- +.+.|..+.+|++.++.|+.||| ...++
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--------------~nkvi 145 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--------------NNKVI 145 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--------------hccee
Confidence 4566665 357899999999999999999873 47999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-----CCCCCCchHHHHHHHHHHH
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-----PYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~sDvwslG~ll~~l 149 (304)
|||+|..|||++.++.+|++|||.+.-... ......+.+||+.|||||++... .|+.. +|+||||++..||
T Consensus 146 HRDikG~NiLLT~e~~VKLvDFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEl 221 (953)
T KOG0587|consen 146 HRDIKGQNVLLTENAEVKLVDFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEM 221 (953)
T ss_pred eecccCceEEEeccCcEEEeeeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehh
Confidence 999999999999999999999999854322 22345678899999999998543 36666 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
.-|..|+.+.......-.|-..-.+ ....
T Consensus 222 adG~PPl~DmHPmraLF~IpRNPPP---------------------------------------------------kLkr 250 (953)
T KOG0587|consen 222 AEGAPPLCDMHPMRALFLIPRNPPP---------------------------------------------------KLKR 250 (953)
T ss_pred cCCCCCccCcchhhhhccCCCCCCc---------------------------------------------------cccc
Confidence 9999999877665444333322111 1233
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+...++++.+||..||..|-.+||+..++|+|||.....
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 466799999999999999999999999999999998444
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=221.21 Aligned_cols=189 Identities=23% Similarity=0.372 Sum_probs=162.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
||+.+++.+. ..|||||.++-|.|..||+.+. .++......++.||+.||.||| ++.+|||||-
T Consensus 454 ikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe--------------SkrfVHRDIA 518 (974)
T KOG4257|consen 454 IKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE--------------SKRFVHRDIA 518 (974)
T ss_pred hheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH--------------hhchhhhhhh
Confidence 5778888765 6899999999999999998865 6899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
..|||+....-+|++|||++++.....-.. .....-++.|++||.+....+++. ||||.|||++||++. |..||.+
T Consensus 519 aRNiLVsSp~CVKLaDFGLSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 519 ARNILVSSPQCVKLADFGLSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhheeecCcceeeecccchhhhccccchhh--ccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCcccc
Confidence 999999999999999999999877655432 223345789999999999999888 999999999999988 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
-...+.+..+.++.. ...|+++++.+.
T Consensus 596 vkNsDVI~~iEnGeR-----------------------------------------------------lP~P~nCPp~LY 622 (974)
T KOG4257|consen 596 VKNSDVIGHIENGER-----------------------------------------------------LPCPPNCPPALY 622 (974)
T ss_pred ccccceEEEecCCCC-----------------------------------------------------CCCCCCCChHHH
Confidence 876666666655543 345688999999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.|+.+||+++|.+||++.++.+
T Consensus 623 slmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHH
Confidence 9999999999999998876654
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=211.49 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=160.5
Q ss_pred CceeeeeeeC-CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRG-PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|++|.-+ ..+|-|+|||+|.+|.-||+.++.+++.+++.|+.||+.||.||.+. +..|+|.|||
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi------------kpPIIHYDLK 597 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI------------KPPIIHYDLK 597 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc------------CCCeeeeccC
Confidence 6899999854 57899999999999999999999999999999999999999999966 7899999999
Q ss_pred CCcEEEec---CCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCC----CCCCCCchHHHHHHHHHH
Q psy1812 80 CENILMTK---RFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGN----PYNPKLADIWSLGVITFI 148 (304)
Q Consensus 80 ~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~----~~~~~~sDvwslG~ll~~ 148 (304)
|.|||+.. -|.+||.|||++++......+. .......||..|+|||.+.-. +.+.+ .||||+|||+|.
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnK-VDVWSvGVIFyQ 676 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNK-VDVWSVGVIFYQ 676 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccc-eeeEeeehhhhh
Confidence 99999954 4679999999998765432221 123456799999999998643 24445 999999999999
Q ss_pred HHhCCCCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLNAAMPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
++.|+.||...-. .++.+. +.++... +- ..
T Consensus 677 ClYGrKPFGhnqsQQdILqe--NTIlkAt---------------------------EV--------------------qF 707 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQE--NTILKAT---------------------------EV--------------------QF 707 (775)
T ss_pred hhccCCCCCCchhHHHHHhh--hchhcce---------------------------ec--------------------cC
Confidence 9999999965422 222221 1111000 00 01
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
...+.+++++.+||++||++.-++|....++-.||||.-
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 122557999999999999999999999999999999987
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=230.38 Aligned_cols=187 Identities=30% Similarity=0.463 Sum_probs=143.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPV-AESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
-.+||=||||+.-+|.+++.++... ....+|.++++|++||.|+| +.||+||||||.||+++.+.
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--------------~~giIHRDLKP~NIFLd~~~ 734 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--------------DQGIIHRDLKPRNIFLDSRN 734 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--------------hCceeeccCCcceeEEcCCC
Confidence 4689999999987777777776544 47899999999999999999 88999999999999999999
Q ss_pred CeEEEeccCccccc------C---c--c----cccccccCccCCccccccccccCCC---CCCCCchHHHHHHHHHHHHh
Q psy1812 90 NVKIADFGFARYCV------D---K--E----GRRVLSRTYCGSAAYAAPEVISGNP---YNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 90 ~~kl~dfg~~~~~~------~---~--~----~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~sDvwslG~ll~~ll~ 151 (304)
.+||+|||++.... . . . .+....+..+||..|+|||++.+.. |+.+ +|+||||+|++||+.
T Consensus 735 ~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 735 SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEMLY 813 (1351)
T ss_pred CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch-hhhHHHHHHHHHHhc
Confidence 99999999997611 0 0 0 0111234568999999999997654 7776 999999999999976
Q ss_pred CCCCCCC-hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 AAMPFDD-SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
||.. ++-......+.++.++++ ..++
T Consensus 814 ---PF~TsMERa~iL~~LR~g~iP~~--------------------------------------------------~~f~ 840 (1351)
T KOG1035|consen 814 ---PFGTSMERASILTNLRKGSIPEP--------------------------------------------------ADFF 840 (1351)
T ss_pred ---cCCchHHHHHHHHhcccCCCCCC--------------------------------------------------cccc
Confidence 4643 333344444443333322 1122
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
..--+.-..+|+.||+.||++||||.|+|++.||-
T Consensus 841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 841 DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 33345678899999999999999999999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=192.11 Aligned_cols=168 Identities=21% Similarity=0.270 Sum_probs=128.0
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 23 GDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 23 g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
|+|.+++... +.+++.+++.++.|++.||+||| +.+ ||+||+++.++.+++ ||++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH--------------~~~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH--------------RQA------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------------hcC------CcccEeEcCccceee--ccceEe
Confidence 6999999874 46999999999999999999999 555 999999999999999 999875
Q ss_pred ccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhccccccchhh
Q psy1812 102 CVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLK-QLFKEQTSNILSHQVKVK 180 (304)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 180 (304)
.... ...|+..|+|||++.+..++.+ +|||||||++|+|++|..||...... .....+........
T Consensus 59 ~~~~--------~~~g~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 125 (176)
T smart00750 59 KTPE--------QSRVDPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---- 125 (176)
T ss_pred eccc--------cCCCcccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----
Confidence 4321 1257899999999999888877 99999999999999999999654322 22222221111100
Q ss_pred hhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH--HHHHHHHHhcCCCCCccccHHHH
Q psy1812 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH--QVKNLVGQILEPDITKRIRLDAI 258 (304)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ll~~~L~~dP~~R~t~~el 258 (304)
......+..++. .+.+|+.+||..+|.+|||+.++
T Consensus 126 -------------------------------------------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~l 162 (176)
T smart00750 126 -------------------------------------------PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHY 162 (176)
T ss_pred -------------------------------------------ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHH
Confidence 000001122333 69999999999999999999999
Q ss_pred hcCccccccc
Q psy1812 259 KAHDWLRYKS 268 (304)
Q Consensus 259 l~~~wf~~~~ 268 (304)
++|+|+....
T Consensus 163 l~~~~~~~~~ 172 (176)
T smart00750 163 LAHCRALFAE 172 (176)
T ss_pred HHHHHHHHHH
Confidence 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=222.20 Aligned_cols=192 Identities=23% Similarity=0.424 Sum_probs=156.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|.+.+.+..++.+++|+||+..|+|.+|+++.+ .++......++.||+.|++||+
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--------- 435 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--------- 435 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---------
Confidence 356677777889999999999999999998876 3889999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+..+|||||-+.|||+.++..+||+|||+++.....+....+.....-+..|+|||.+....++.+ |||||||+
T Consensus 436 -----~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI 509 (609)
T KOG0200|consen 436 -----SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGI 509 (609)
T ss_pred -----hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHH
Confidence 889999999999999999999999999999854433322111111114567999999999888888 99999999
Q ss_pred HHHHHHh-CCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI 222 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (304)
++||+++ |..||.+.. ..+.+..+..+..
T Consensus 510 ~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r------------------------------------------------- 540 (609)
T KOG0200|consen 510 LLWEIFTLGGTPYPGIPPTEELLEFLKEGNR------------------------------------------------- 540 (609)
T ss_pred HHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC-------------------------------------------------
Confidence 9999999 889998744 3344444444332
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...|..+++++.++|+.||+.+|++||++.++.+
T Consensus 541 ----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 541 ----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2334667999999999999999999999998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=213.45 Aligned_cols=200 Identities=21% Similarity=0.218 Sum_probs=138.4
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAG------------------------PVAESNARTWFSQMLAGLEYLHREITNHTPFT 65 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~ 65 (304)
++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH---------- 326 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH---------- 326 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHH----------
Confidence 356899999999999999986421 2356788999999999999999
Q ss_pred CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCC-------------
Q psy1812 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY------------- 132 (304)
Q Consensus 66 ~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~------------- 132 (304)
..+++||||||+||+++.++.+||+|||++......... ......+++.|++||.+.....
T Consensus 327 ----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l 400 (507)
T PLN03224 327 ----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALL 400 (507)
T ss_pred ----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCcceeChhhhcCCCCCCccchhhhhhhh
Confidence 889999999999999999999999999998643321110 1112234789999999854321
Q ss_pred -------C-CCCchHHHHHHHHHHHHhCCC-CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccc
Q psy1812 133 -------N-PKLADIWSLGVITFIMLNAAM-PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDIL 203 (304)
Q Consensus 133 -------~-~~~sDvwslG~ll~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (304)
. +...|+||+||++++|+++.. ||..........+....... .|... .
T Consensus 401 ~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-------------~~r~~----~------ 457 (507)
T PLN03224 401 SPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-------------RWRMY----K------ 457 (507)
T ss_pred hhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-------------HHHhh----c------
Confidence 1 112699999999999999875 77543221111110000000 00000 0
Q ss_pred cccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCC---CccccHHHHhcCccccc
Q psy1812 204 SHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDI---TKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP---~~R~t~~ell~~~wf~~ 266 (304)
.. .......+..++..+||+.+||..+| .+|+|++|+|+||||..
T Consensus 458 ----------~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 ----------GQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ----------cc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 00011225578999999999999866 68999999999999964
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=201.44 Aligned_cols=205 Identities=23% Similarity=0.316 Sum_probs=161.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
||+|+..=.++..||.||.|+ .+|..+.+. ...++|..+-.+..-.+.||.||-+ ...|+|
T Consensus 126 VkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-------------~lkiIH 191 (361)
T KOG1006|consen 126 VKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-------------ELKIIH 191 (361)
T ss_pred HHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-------------Hhhhhh
Confidence 578888888999999999996 488766654 3469999999999999999999986 789999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||+||+|||+++.|.+|+||||.+-....+- ..+...|-..|+|||.+... .|+.+ ||+||||+.+||+.||.
T Consensus 192 RDvKPSNILldr~G~vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 192 RDVKPSNILLDRHGDVKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGN 266 (361)
T ss_pred ccCChhheEEecCCCEeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCC
Confidence 9999999999999999999999986443322 22344677889999998533 47888 99999999999999999
Q ss_pred CCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.|+...+. .++...+..+..+.-. . ..---.
T Consensus 267 fPyr~w~svfeql~~Vv~gdpp~l~---------------------------~---------------------~~~~~~ 298 (361)
T KOG1006|consen 267 FPYRKWDSVFEQLCQVVIGDPPILL---------------------------F---------------------DKECVH 298 (361)
T ss_pred CCcchHHHHHHHHHHHHcCCCCeec---------------------------C---------------------cccccc
Confidence 99977653 2334434333222110 0 000023
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++..+++|+.-||..|-.+||..++++++||++.......
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 7889999999999999999999999999999998776443
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=217.03 Aligned_cols=198 Identities=22% Similarity=0.352 Sum_probs=169.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
||+|++..+ ....+|||++++|+|.+.|.+. ..|--...-.++.||+.|+.||. .+++|||||
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--------------skrlvHRDL 238 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--------------SKRLVHRDL 238 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--------------hhhhhhhhh
Confidence 578998887 6789999999999999999883 35778888899999999999999 999999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
-..|+++.....+||+|||+.+-+...+..........-...|-|||.+...+++.. ||+|++||.+|||++ |..||.
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCC
Confidence 999999999999999999999877766655433334445678999999999999988 999999999999999 889999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....++.+++..+.. ...++.++..+
T Consensus 318 G~~g~qIL~~iD~~er-----------------------------------------------------LpRPk~csedI 344 (1039)
T KOG0199|consen 318 GCRGIQILKNIDAGER-----------------------------------------------------LPRPKYCSEDI 344 (1039)
T ss_pred CCCHHHHHHhcccccc-----------------------------------------------------CCCCCCChHHH
Confidence 9998888888774433 23346788999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
.+++.+||+.+|++|||+.+|.+..++...
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999999999999999999999876655543
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-27 Score=202.58 Aligned_cols=225 Identities=22% Similarity=0.323 Sum_probs=164.0
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeE
Q psy1812 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVK 92 (304)
Q Consensus 13 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~k 92 (304)
+|+|+|.|.. +|...|-....++...++-+++||+.||+||| +.+|.||||||.|.|++.|..+|
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH--------------sA~ILHRDIKPGNLLVNSNCvLK 196 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH--------------TANILHRDIKPGNLLVNSNCILK 196 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh--------------hcchhhccCCCccEEeccCceEE
Confidence 5677888864 88888888788999999999999999999999 89999999999999999999999
Q ss_pred EEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcc
Q psy1812 93 IADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNI 172 (304)
Q Consensus 93 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 172 (304)
|||||+++.....+.. ......-|-.|++||++.+.+....+.||||+||++.|++.++..|...+..++.+.|..-.
T Consensus 197 ICDFGLARvee~d~~~--hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 197 ICDFGLARTWDQRDRL--NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred ecccccccccchhhhh--hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 9999999875544332 22334457789999999988766666999999999999999999999998888888777655
Q ss_pred ccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcc
Q psy1812 173 LSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKR 252 (304)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 252 (304)
+.....- -.......+.-... .....+.+..+.+ ..-+..-..+..+++++||.+||++|
T Consensus 275 GTPs~Ea------------Mr~ACEGAk~H~LR------~~~k~Ps~~vLYt--lsS~~~~~heav~~~~~~l~~d~dkr 334 (449)
T KOG0664|consen 275 GTPSQEA------------MKYACEGAKNHVLR------AGLRAPDTQRLYK--IASPDDKNHEAVDLLQKLLHFDPDKR 334 (449)
T ss_pred CCCcHHH------------HHHHhhhhHHHhhc------cCCCCCCccceee--ecCCcccchHHHHHHHHHhCCCCccc
Confidence 5443110 00000000000000 0001111111111 11112345678999999999999999
Q ss_pred ccHHHHhcCccccccccccccc
Q psy1812 253 IRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 253 ~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++..+++.|+++...+-..-+.
T Consensus 335 is~~~A~~~~~~~e~R~r~~sC 356 (449)
T KOG0664|consen 335 ISVEEALQHRYLEEGRLRFHSC 356 (449)
T ss_pred ccHhhhcccccccccceeeeee
Confidence 9999999999998887644443
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=203.49 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=160.2
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++.+.+.++....+||||+++.+..+++.. ++..++..+++.++.||.++| ..|||||||||+
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h--------------~~GIvHRDiKps 161 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLH--------------KNGIVHRDIKPS 161 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhh--------------ccCccccCCCcc
Confidence 566778889999999999999999998876 778999999999999999999 999999999999
Q ss_pred cEEEecC-CCeEEEeccCcccccC-c----------------------------------------ccccccccCccCCc
Q psy1812 82 NILMTKR-FNVKIADFGFARYCVD-K----------------------------------------EGRRVLSRTYCGSA 119 (304)
Q Consensus 82 nil~~~~-~~~kl~dfg~~~~~~~-~----------------------------------------~~~~~~~~~~~~~~ 119 (304)
|++.+.. +.-.|.|||++..... . ..++.......||+
T Consensus 162 NFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~ 241 (418)
T KOG1167|consen 162 NFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTP 241 (418)
T ss_pred ccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCC
Confidence 9999754 5678999999862100 0 00000111345899
Q ss_pred cccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhc
Q psy1812 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVK 198 (304)
Q Consensus 120 ~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (304)
+|+|||++...+..+.++|+||.|||+..+++++.||.... +.+...++..-.+. ....+....++. --.|.. .+
T Consensus 242 GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~-~~mrk~A~l~g~--~~l~~k-sn 317 (418)
T KOG1167|consen 242 GFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGS-AEMRKCAALPGR--ILLWQK-SN 317 (418)
T ss_pred CCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhCh-HHHHHHhhcCCc--eeeecc-cc
Confidence 99999999887766556999999999999999999985443 22333333322211 111111111111 000000 00
Q ss_pred ccccccccccccchh-hhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 199 VKDILSHQVKVKDIL-SHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 199 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...+.+......... ...............-.+.++..+.|||.+||+.||.+|+||+++|+||||.....
T Consensus 318 ~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 318 IPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 111111111111111 11111000000111112345678999999999999999999999999999995554
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=209.78 Aligned_cols=198 Identities=19% Similarity=0.309 Sum_probs=159.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++..++.+++|+||+++|+|.+|+.++.. ..-+....|+.||+.|++||. +.++||||+
T Consensus 598 veLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--------------s~nfVHrd~ 663 (807)
T KOG1094|consen 598 VELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--------------SLNFVHRDL 663 (807)
T ss_pred eEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--------------hhchhhccc
Confidence 5789999999999999999999999999998752 345667779999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh--CCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN--AAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~--g~~pf 156 (304)
.+.|+|++.++++||+|||+++.....+-.+ ......-+++|+|+|.+..++++++ ||+|+||+.+||++. ...||
T Consensus 664 a~rNcLv~~e~~iKiadfgmsR~lysg~yy~-vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 664 ATRNCLVDGEFTIKIADFGMSRNLYSGDYYR-VQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred cccceeecCcccEEecCcccccccccCCcee-eecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCch
Confidence 9999999999999999999998554443332 1223456789999999999999998 999999999999987 67899
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
....+.+............. ... -...|.-+++.
T Consensus 742 ~~lt~e~vven~~~~~~~~~------------------------------------------~~~----~l~~P~~cp~~ 775 (807)
T KOG1094|consen 742 SQLTDEQVVENAGEFFRDQG------------------------------------------RQV----VLSRPPACPQG 775 (807)
T ss_pred hhhhHHHHHHhhhhhcCCCC------------------------------------------cce----eccCCCcCcHH
Confidence 88777666554332211100 000 02344668899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.++|..||..+-.+||+++++..
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=222.40 Aligned_cols=135 Identities=18% Similarity=0.311 Sum_probs=113.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||+++|+|.++++. +++..+..++.|++.|++|||.. +..+++|||+||
T Consensus 746 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~-----------~~~~iiH~dlkp 811 (968)
T PLN00113 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCR-----------CSPAVVVGNLSP 811 (968)
T ss_pred ceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccC-----------CCCCeecCCCCH
Confidence 6899999999999999999999999999964 88999999999999999999931 145899999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++..++. ++....... .....++..|+|||++.+..++.+ +|||||||++||+++|+.||..
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCT-------DTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred HhEEECCCCceEEE-ecccccccc-------CCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCc
Confidence 99999998887765 554432111 122357889999999988888877 9999999999999999999843
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=205.87 Aligned_cols=130 Identities=28% Similarity=0.425 Sum_probs=111.3
Q ss_pred eEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec-
Q psy1812 12 RVFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK- 87 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~- 87 (304)
...+|||||.||||+.+|++. ..+++.+...++.++..|+.||| +++||||||||.||++..
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--------------En~IvHRDlKP~NIvl~~G 156 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--------------ENGIVHRDLKPGNIVLQIG 156 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--------------HcCceeccCCCCcEEEeec
Confidence 578999999999999999764 36999999999999999999999 899999999999999843
Q ss_pred -CCC--eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 88 -RFN--VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 88 -~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+|+ .||+|||.++-..+.. ......||..|++||..-..++.+..+|.|||||++|++.||..||...
T Consensus 157 edgq~IyKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 157 EDGQSIYKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCceEEeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 333 6999999998665443 5667889999999999985344444499999999999999999999443
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=191.92 Aligned_cols=135 Identities=29% Similarity=0.437 Sum_probs=114.4
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
.++|||++|.+.|+|+|||.+. .++-..+..++..++.||+|||..|++++- ...|.|||||..|||+.+++.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqg------KPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQG------KPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCC------CchhhccccccccEEEccCCc
Confidence 4799999999999999999884 588999999999999999999999998884 778999999999999999999
Q ss_pred eEEEeccCcccccCc-ccccccccCccCCccccccccccCCC-----CCCCCchHHHHHHHHHHHHhC
Q psy1812 91 VKIADFGFARYCVDK-EGRRVLSRTYCGSAAYAAPEVISGNP-----YNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~-~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~sDvwslG~ll~~ll~g 152 (304)
.-|+|+|++...... +.-.......+||.+|||||++...- -+.+.+||||||.++||++-+
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999999754433 22233456778999999999986432 124459999999999999764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=174.79 Aligned_cols=152 Identities=30% Similarity=0.475 Sum_probs=125.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++|+.+-++...||+||.|+. +|..+..+ ++.++|..+-.++..+..||.|||+ ...++||
T Consensus 108 V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-------------kL~vIHR 173 (282)
T KOG0984|consen 108 VHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-------------KLSVIHR 173 (282)
T ss_pred EEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-------------Hhhhhhc
Confidence 5788988899999999999974 88776644 5679999999999999999999996 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc----CCCCCCCCchHHHHHHHHHHHHhC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS----GNPYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~~~~sDvwslG~ll~~ll~g 152 (304)
|+||+|||++.+|.+|+||||.+-+..++-. .+...|.-.|+|||.+. ...|+.+ ||+||||+.+.||.++
T Consensus 174 DvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 174 DVKPSNILINYDGQVKICDFGISGYLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAIL 248 (282)
T ss_pred cCCcceEEEccCCcEEEcccccceeehhhhH----HHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhc
Confidence 9999999999999999999999976654322 22245677899999984 3368888 9999999999999999
Q ss_pred CCCCCCh-hHHHHHHHhhhc
Q psy1812 153 AMPFDDS-NLKQLFKEQTSN 171 (304)
Q Consensus 153 ~~pf~~~-~~~~~~~~~~~~ 171 (304)
+.||... ...++...+...
T Consensus 249 r~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 249 RFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccccccCCHHHHHHHHhcC
Confidence 9999654 344555554433
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=182.74 Aligned_cols=183 Identities=14% Similarity=0.235 Sum_probs=157.8
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRA--------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+..+.++++.++.-|+|..||..+ ..++..+...++.|++.|++||| ..+++|.||-.
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--------------~~~ViHkDiAa 424 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--------------NHGVIHKDIAA 424 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--------------hcCcccchhhh
Confidence 456889999999999999999842 24788899999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
.|.+|++...+|++|=.+++-..+.+-+. .......+..|+++|.+..+.|+.. +|+|||||++|||++ |+.|+..-
T Consensus 425 RNCvIdd~LqVkltDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 425 RNCVIDDQLQVKLTDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred hcceehhheeEEeccchhccccCcccccc-cCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999999988666554332 3334456789999999999989888 999999999999999 99999988
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
++.++...+..+.... .|-++++++..
T Consensus 503 DPfEm~~ylkdGyRla-----------------------------------------------------QP~NCPDeLf~ 529 (563)
T KOG1024|consen 503 DPFEMEHYLKDGYRLA-----------------------------------------------------QPFNCPDELFT 529 (563)
T ss_pred CHHHHHHHHhccceec-----------------------------------------------------CCCCCcHHHHH
Confidence 8888888777665432 34678999999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|-.||+..|++||+++|+..
T Consensus 530 vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 530 VMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHhcCcccCCCHHHHHH
Confidence 999999999999999999864
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=205.24 Aligned_cols=194 Identities=30% Similarity=0.489 Sum_probs=154.9
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEe
Q psy1812 16 FMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIAD 95 (304)
Q Consensus 16 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~d 95 (304)
+||||++ +|+.++...+.++..++-.++.|++.|++||| ..|+.|||+|++|+++..+|.+||+|
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h--------------~~GiahrdlK~enll~~~~g~lki~D 463 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH--------------SMGLAHRDLKLENLLVTENGILKIID 463 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH--------------hcCceeccCccccEEEecCCceEEee
Confidence 3999999 99999999888999999999999999999999 89999999999999999999999999
Q ss_pred ccCcccccCccc-ccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcccc
Q psy1812 96 FGFARYCVDKEG-RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174 (304)
Q Consensus 96 fg~~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 174 (304)
||.+..+.-... +.......+|+-.|+|||++.+..|.+...|+||.|++++.|.+|+.||......+...........
T Consensus 464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~ 543 (601)
T KOG0590|consen 464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ 543 (601)
T ss_pred cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc
Confidence 999876543322 1234567789999999999999999999999999999999999999999554332221100111100
Q ss_pred ccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcccc
Q psy1812 175 HQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIR 254 (304)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t 254 (304)
.. . ..+. ..+...++.+.+.+|.+||+++|.+|.|
T Consensus 544 ~~--------------------------------~--~~~~-----------~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 544 RN--------------------------------I--FEGP-----------NRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred cc--------------------------------c--ccCh-----------HHHHHhchhhHHHHHHHHccCChhheec
Confidence 00 0 0011 1112446888999999999999999999
Q ss_pred HHHHhcCcccccccc
Q psy1812 255 LDAIKAHDWLRYKSM 269 (304)
Q Consensus 255 ~~ell~~~wf~~~~~ 269 (304)
+++|++++||+....
T Consensus 579 i~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 579 IEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHhhChHhhhcce
Confidence 999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=165.10 Aligned_cols=159 Identities=38% Similarity=0.668 Sum_probs=136.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++......++++||+.|++|.+++... ..++...++.++.+++.++++|| ..+++|+||+
T Consensus 54 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~~~H~dl~ 119 (215)
T cd00180 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH--------------SNGIIHRDLK 119 (215)
T ss_pred eeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCC
Confidence 35677888888999999999999999999876 46899999999999999999999 8899999999
Q ss_pred CCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+.||+++. ++.++++|||.+........ ......+...|.+||..... ..+.. +|+|++|++++++
T Consensus 120 ~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~-~D~~~lg~~~~~l-------- 187 (215)
T cd00180 120 PENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEK-SDIWSLGVILYEL-------- 187 (215)
T ss_pred HhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCch-hhhHHHHHHHHHH--------
Confidence 99999999 89999999999875543321 12234567889999998776 45555 9999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+
T Consensus 188 -----------------------------------------------------------------------------~~~ 190 (215)
T cd00180 188 -----------------------------------------------------------------------------PEL 190 (215)
T ss_pred -----------------------------------------------------------------------------HHH
Confidence 157
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
.+++.+|+..+|++||++.++++++
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8899999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=184.65 Aligned_cols=139 Identities=27% Similarity=0.394 Sum_probs=113.6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
..++||++|.+.|+|.+||..+. +++.....++..++.||+|||+.+ |++-|- +.+|+|||||..|||+..+++
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~----p~~d~~-Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEEL----PRGDHH-KPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccC----CcCCCC-CCccccccccccceEEccCCc
Confidence 37999999999999999998764 899999999999999999999653 344444 789999999999999999999
Q ss_pred eEEEeccCcccccCcccccccccCccCCccccccccccCCC-----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 91 VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
.-|+|||++..+...... ......+||.+|||||++-+.. -.-++.||||+|.++||++++-.-+
T Consensus 355 ccIaDFGLAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred EEeeccceeEEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999999876643221 1233468999999999986532 2234589999999999999965433
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-23 Score=196.40 Aligned_cols=190 Identities=21% Similarity=0.335 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+|+.+++..+. +-||++|+++|+|.||++.++ ++.......+..||++|++||| ...+|||||-
T Consensus 761 ~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe--------------~qrlVHrdLa 825 (1177)
T KOG1025|consen 761 LRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE--------------EQRLVHRDLA 825 (1177)
T ss_pred HHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--------------hcchhhhhhh
Confidence 35566666554 789999999999999998764 7889999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
..|||+.+-..+||.|||+++........- ......-.+.|+|-|.+...+++.. ||||||||.+||++| |..|+.+
T Consensus 826 aRNVLVksP~hvkitdfgla~ll~~d~~ey-~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 826 ARNVLVKSPNHVKITDFGLAKLLAPDEKEY-SAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hhheeecCCCeEEEEecchhhccCcccccc-cccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCC
Confidence 999999999999999999998765443321 1122234578999999999989888 999999999999999 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....++-.-+..+.. ..-|+..+-++.
T Consensus 904 i~~~eI~dlle~geR-----------------------------------------------------LsqPpiCtiDVy 930 (1177)
T KOG1025|consen 904 IPAEEIPDLLEKGER-----------------------------------------------------LSQPPICTIDVY 930 (1177)
T ss_pred CCHHHhhHHHhcccc-----------------------------------------------------CCCCCCccHHHH
Confidence 876555544443322 233467888999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+|.+||..|+..||+++++.+
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999988754
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=173.69 Aligned_cols=192 Identities=28% Similarity=0.500 Sum_probs=139.2
Q ss_pred eeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEE
Q psy1812 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85 (304)
Q Consensus 6 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~ 85 (304)
.|+..+.+++++||++-|+|..-+..+| +.|...+.++.|+++||.||| ++++||||||.+||||
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMH--------------sknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMH--------------SKNLVHRDLKAENILI 154 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhh--------------ccchhhcccccceEEE
Confidence 4677889999999999999998887655 889999999999999999999 9999999999999999
Q ss_pred ecC--CCeEEEeccCcccccCcccccccccCccCCccccccccccCC---C--CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 86 TKR--FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN---P--YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 86 ~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~--~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
... -++|+||||.++..+.- .....-+..|-+||..... + ..+. +|+|.||++++.+++|..||..
T Consensus 155 f~~df~rvKlcDFG~t~k~g~t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps-~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKVGTT------VKYLEYVNNYHAPELCDTVVNEKLVVNPS-TDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ecCCccEEEeeecccccccCce------ehhhhhhcccCCcHHHhhccccceEeccc-ccchheeeeeeeeecCCCcchh
Confidence 542 36999999998754321 1112234567788876432 2 2355 9999999999999999999963
Q ss_pred hhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 159 SNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 159 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
... +..+.+.+....... ..-......+++.+
T Consensus 228 a~~~d~~Y~~~~~w~~rk~-----------------------------------------------~~~P~~F~~fs~~a 260 (378)
T KOG1345|consen 228 ASIMDKPYWEWEQWLKRKN-----------------------------------------------PALPKKFNPFSEKA 260 (378)
T ss_pred hhccCchHHHHHHHhcccC-----------------------------------------------ccCchhhcccCHHH
Confidence 321 111221111111000 00122235578899
Q ss_pred HHHHHHhcCCCCCcc---ccHHHHhcCccccc
Q psy1812 238 KNLVGQILEPDITKR---IRLDAIKAHDWLRY 266 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R---~t~~ell~~~wf~~ 266 (304)
.++.++-|..++++| -+++......|-..
T Consensus 261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 999999999999999 67777777777543
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=193.64 Aligned_cols=198 Identities=28% Similarity=0.407 Sum_probs=160.0
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCc
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~n 82 (304)
+++.+.....+||+||||.||+|.+..+-.+++++.++.++.++.+.|++||| +.+-+|||||..|
T Consensus 77 y~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylh--------------s~gk~hRdiKGan 142 (829)
T KOG0576|consen 77 YFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH--------------SQGKIHRDIKGAN 142 (829)
T ss_pred HHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhh--------------cCCcccccccccc
Confidence 45556667889999999999999999888899999999999999999999999 8888999999999
Q ss_pred EEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc---cCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI---SGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 83 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~---~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+++..|.+|+.|||.+--+... -.+...++||+.|++||+. +...|... +|+|++|+...|+---+.|-...
T Consensus 143 illtd~gDvklaDfgvsaqitat---i~KrksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 143 ILLTDEGDVKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred eeecccCceeecccCchhhhhhh---hhhhhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCccccc
Confidence 99999999999999987543322 2245678899999999996 34456666 99999999999998877776555
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.+......+.+..+..+ ..+.+...++.+.+
T Consensus 219 hpmr~l~LmTkS~~qpp-------------------------------------------------~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 219 HPMRALFLMTKSGFQPP-------------------------------------------------TLKDKTKWSEFFHN 249 (829)
T ss_pred chHHHHHHhhccCCCCC-------------------------------------------------cccCCccchHHHHH
Confidence 54444333333332222 02223567889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
|++.+|..+|++|||++.+|.|||..+.
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999998876
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=187.70 Aligned_cols=138 Identities=30% Similarity=0.549 Sum_probs=126.2
Q ss_pred CceeeeeeeCCeEEEEEecCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYAD-NGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+||.++|++.+++||+||-.- |.+|+++|+....++|.+++.|++|++.|+++|| +.+|||||||
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh--------------~~~ivhrdik 697 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH--------------DQGIVHRDIK 697 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc--------------ccCceecccc
Confidence 589999999999999999864 5699999999889999999999999999999999 9999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
-+||.++.+|-+|++|||.+.++.... ...+.||..|.|||++.+.+|-.+..|||++|+++|.+.....||-
T Consensus 698 denvivd~~g~~klidfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 698 DENVIVDSNGFVKLIDFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cccEEEecCCeEEEeeccchhhhcCCC-----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999999997765433 3467899999999999999998887999999999999999888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-20 Score=157.43 Aligned_cols=153 Identities=38% Similarity=0.644 Sum_probs=126.5
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++.+......++++||+++++|.+++..... +++..++.++.+++.++.+|| ..+++|+|+++
T Consensus 61 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------------~~~i~h~di~~ 126 (225)
T smart00221 61 KLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH--------------SLGIVHRDLKP 126 (225)
T ss_pred hheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 567778888899999999999999999988766 899999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc-cCCCCCCCCchHHHHHHHHHHHHhCCCCCCC-
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-SGNPYNPKLADIWSLGVITFIMLNAAMPFDD- 158 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~- 158 (304)
.||+++.++.++++|||.+......... ......+...|++||.. ....++.. +|+|+||++++++++|+.||..
T Consensus 127 ~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~-~Dv~~lG~~~~~l~~g~~pf~~~ 203 (225)
T smart00221 127 ENILLGMDGLVKLADFGLARFIHRDLAA--LLKTVKGTPFYLAPEVLLGGKGYGEA-VDIWSLGVILYELLWGPEPFSGE 203 (225)
T ss_pred HHEEEcCCCCEEEeeCceeeEecCcccc--cccceeccCCcCCHhHhcCCCCCCch-hhHHHHHHHHHHHHHCCCCcccc
Confidence 9999999999999999998765443210 12334567889999998 55666665 9999999999999999999977
Q ss_pred hhHH-HHHHHhhhc
Q psy1812 159 SNLK-QLFKEQTSN 171 (304)
Q Consensus 159 ~~~~-~~~~~~~~~ 171 (304)
.+.. .....+..+
T Consensus 204 ~~~~~~~~~~~~~~ 217 (225)
T smart00221 204 GEFTSLLSDVWSFG 217 (225)
T ss_pred chhHHHHHHHHhcC
Confidence 4444 445544444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=183.01 Aligned_cols=188 Identities=26% Similarity=0.516 Sum_probs=162.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++..|+.+...++++++..||+|...+.+...+.+.....+..+++.+++++| +.+++|+|+|+
T Consensus 60 v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh--------------~l~iiyrd~k~ 125 (612)
T KOG0603|consen 60 VKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLH--------------KLGIAYRDYKL 125 (612)
T ss_pred eeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcc--------------hhHHHHhcccc
Confidence 4678889999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.+|.+++.|||+++....... .||+..|++||++. ..... +|+||||++.+++++|..||..
T Consensus 126 enilld~~Ghi~~tdfglske~v~~~~-------~cgt~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 126 ENVLLLLEGHIKLTDFGLSKEAVKEKI-------ACGTYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred cceeecccCccccCCchhhhHhHhhhh-------cccchhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch--
Confidence 999999999999999999986554332 28999999999997 34444 8999999999999999999987
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
+....|.+ .+...|..++..+.++
T Consensus 194 --~~~~~Il~------------------------------------------------------~~~~~p~~l~~~a~~~ 217 (612)
T KOG0603|consen 194 --DTMKRILK------------------------------------------------------AELEMPRELSAEARSL 217 (612)
T ss_pred --HHHHHHhh------------------------------------------------------hccCCchhhhHHHHHH
Confidence 33333333 2345557889999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~~~~ 270 (304)
+..++..+|..|.- +.++++|+||+.....
T Consensus 218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999999999995 4799999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-17 Score=147.41 Aligned_cols=207 Identities=32% Similarity=0.514 Sum_probs=157.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++.+......+++++++.++++.+++.... .+....+..++.|++.++.|+| ..+++|||
T Consensus 61 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--------------~~~~~hrd 126 (384)
T COG0515 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--------------SKGIIHRD 126 (384)
T ss_pred eeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccC
Confidence 356777777777899999999999998887764 7999999999999999999999 88999999
Q ss_pred CCCCcEEEecCC-CeEEEeccCcccccCccccc---ccccCccCCccccccccccCC---CCCCCCchHHHHHHHHHHHH
Q psy1812 78 LKCENILMTKRF-NVKIADFGFARYCVDKEGRR---VLSRTYCGSAAYAAPEVISGN---PYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 78 l~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~---~~~~~~sDvwslG~ll~~ll 150 (304)
+||+||+++..+ .++++|||.+.......... .......++..|++||.+.+. ..... .|+|++|+++++++
T Consensus 127 ~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~-~D~~s~g~~~~~~~ 205 (384)
T COG0515 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS-SDIWSLGITLYELL 205 (384)
T ss_pred CCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCch-HhHHHHHHHHHHHH
Confidence 999999999998 69999999987544332221 123566799999999999873 45555 99999999999999
Q ss_pred hCCCCCCChhH----HHHHHHhhhcccc-ccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc
Q psy1812 151 NAAMPFDDSNL----KQLFKEQTSNILS-HQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225 (304)
Q Consensus 151 ~g~~pf~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (304)
.|..||..... ......+...... ..
T Consensus 206 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------------- 236 (384)
T COG0515 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLA------------------------------------------------- 236 (384)
T ss_pred hCCCCCCCCCccccHHHHHHHHHhcCCcccc-------------------------------------------------
Confidence 99999866543 2222222211111 00
Q ss_pred ccccc----ccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 226 QVKVK----DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 226 ~~~~~----~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
.... ......+.+++..++..+|..|.+..+...++|.........
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~ 286 (384)
T COG0515 237 -SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286 (384)
T ss_pred -cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence 0000 112367899999999999999999999998877666655433
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-18 Score=147.58 Aligned_cols=183 Identities=21% Similarity=0.337 Sum_probs=144.5
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+.+.+...+++.+|..||+.|+|++.|+... .++..++..++.+++.|+.|||+. +.-|.-.-|..
T Consensus 252 vlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl------------ep~ipr~~lns 319 (448)
T KOG0195|consen 252 VLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL------------EPMIPRFYLNS 319 (448)
T ss_pred hhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc------------chhhhhhhccc
Confidence 4566778889999999999999999998865 367889999999999999999976 55566667888
Q ss_pred CcEEEecCCCeEEE--eccCcccccCcccccccccCccCCccccccccccCCCC--CCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIA--DFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY--NPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
..|+++++.+.+|. |-.++. ......-.+.|++||.+...+- ...++|+|||++++||+.|+..||
T Consensus 320 ~hvmidedltarismad~kfsf----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 320 KHVMIDEDLTARISMADTKFSF----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred ceEEecchhhhheecccceeee----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 99999998887764 322221 1122335689999999987653 345699999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
......+.-.++.-.... ...|++++.+
T Consensus 390 adlspmecgmkialeglr----------------------------------------------------v~ippgis~h 417 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLR----------------------------------------------------VHIPPGISRH 417 (448)
T ss_pred ccCCchhhhhhhhhcccc----------------------------------------------------ccCCCCccHH
Confidence 888776665554432221 4556889999
Q ss_pred HHHHHHHhcCCCCCccccHHHHh
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIK 259 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell 259 (304)
+..|+.-|++.||.+||.++.++
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999988764
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-18 Score=168.03 Aligned_cols=183 Identities=28% Similarity=0.478 Sum_probs=144.4
Q ss_pred HHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccC------------cccccccccC
Q psy1812 47 MLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD------------KEGRRVLSRT 114 (304)
Q Consensus 47 l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~------------~~~~~~~~~~ 114 (304)
++.+++||| +.+|||+|+|++|.+|..-|.+|+.|||+.+.... .+.+......
T Consensus 152 mvla~Eylh--------------~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKq 217 (1205)
T KOG0606|consen 152 MVLAVEYLH--------------SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQ 217 (1205)
T ss_pred hhHHhHhhc--------------cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcc
Confidence 378999999 99999999999999999999999999999864321 1222223345
Q ss_pred ccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhh
Q psy1812 115 YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILS 194 (304)
Q Consensus 115 ~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (304)
.+||+.|+|||++....|+-+ .|||++|+|+|+.+-|..||.+....+++.......+..+.
T Consensus 218 vcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE----------------- 279 (1205)
T KOG0606|consen 218 VCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE----------------- 279 (1205)
T ss_pred ccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc-----------------
Confidence 689999999999999999988 99999999999999999999999999999888777665441
Q ss_pred hhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccc---cHHHHhcCccccccccc-
Q psy1812 195 HQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI---RLDAIKAHDWLRYKSMV- 270 (304)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~ell~~~wf~~~~~~- 270 (304)
. ...+++++.+++.++|..+|..|. .+-++.+|+||+..-.-
T Consensus 280 --------------------------------~--dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ 325 (1205)
T KOG0606|consen 280 --------------------------------E--DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS 325 (1205)
T ss_pred --------------------------------c--CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence 1 245789999999999999999998 45688999999876543
Q ss_pred --ccc-cCCCCceeccCccccCCccccc
Q psy1812 271 --RRK-VLPGQKLVHSNLSVKQTPKTAF 295 (304)
Q Consensus 271 --~~~-~~~~~~~~~~~~~~~~~~~~~~ 295 (304)
+.+ ..-.|....+.+....|.+..+
T Consensus 326 llRqkaefvpql~~eddtsyfdTRs~Ry 353 (1205)
T KOG0606|consen 326 LLRQKAEFVPQLESEDDTSYFDTRSDRY 353 (1205)
T ss_pred hhhhhccccccccccccchhhcccchhe
Confidence 222 2334455555555555555544
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=153.71 Aligned_cols=196 Identities=22% Similarity=0.364 Sum_probs=143.6
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++.+-+++..++|.+||..|+|.|.+.... .++.-+...++++++.|++|||.. ... +|+.++.
T Consensus 11 ~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s------------~i~-~hg~l~s 77 (484)
T KOG1023|consen 11 KFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS------------PIG-YHGALKS 77 (484)
T ss_pred hheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC------------cce-eeeeecc
Confidence 57888889999999999999999999998843 688999999999999999999942 333 9999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC---C---CCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP---Y---NPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~---~~~~sDvwslG~ll~~ll~g~~ 154 (304)
.|++++.++.+|+.|||+....... .............-|.|||.+.... . .....|+||||++++|++++..
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999998755320 0000111122446689999997641 1 3444899999999999999999
Q ss_pred CCCChh----HHHHHHHhhh-ccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 155 PFDDSN----LKQLFKEQTS-NILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 155 pf~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
||.... ..+++..+.+ +.-.+.. . + ..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP----------------------------------------~---i-----~~ 188 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRP----------------------------------------S---I-----EL 188 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCc----------------------------------------c---h-----hh
Confidence 996532 1233333333 1111110 0 0 00
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHh
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIK 259 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell 259 (304)
.....+.+..++..||..+|.+||+++++-
T Consensus 189 ~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 189 LNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred hhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 013455899999999999999999998873
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.9e-16 Score=141.69 Aligned_cols=144 Identities=28% Similarity=0.350 Sum_probs=117.8
Q ss_pred ceeeee-eeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 2 QVHSIL-QRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 2 ~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++.+ ..+...||||+.+ |.+|.++.... +.|+...+..++.|++.+|++|| +.|++||||
T Consensus 84 ~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--------------~~G~iHRDi 148 (322)
T KOG1164|consen 84 KLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--------------SKGFIHRDI 148 (322)
T ss_pred EEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--------------hcCcccCCc
Confidence 355666 4677899999999 78999988654 47999999999999999999999 999999999
Q ss_pred CCCcEEEecCC-----CeEEEeccCcc--cccCccc---ccc-c-ccCccCCccccccccccCCCCCCCCchHHHHHHHH
Q psy1812 79 KCENILMTKRF-----NVKIADFGFAR--YCVDKEG---RRV-L-SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146 (304)
Q Consensus 79 ~~~nil~~~~~-----~~kl~dfg~~~--~~~~~~~---~~~-~-~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll 146 (304)
||+|+++.... .+.+.|||+++ .+..... +.. . .....||..|.++....+...+.. .|+||++.++
T Consensus 149 Kp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l 227 (322)
T KOG1164|consen 149 KPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYML 227 (322)
T ss_pred CHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHH
Confidence 99999998653 58999999998 3322221 111 1 234569999999999999888887 9999999999
Q ss_pred HHHHhCCCCCCChhH
Q psy1812 147 FIMLNAAMPFDDSNL 161 (304)
Q Consensus 147 ~~ll~g~~pf~~~~~ 161 (304)
.+++.|..||.....
T Consensus 228 ~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 228 LELLKGSLPWEALEM 242 (322)
T ss_pred HHHhcCCCCCccccc
Confidence 999999999966553
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=141.67 Aligned_cols=180 Identities=23% Similarity=0.323 Sum_probs=130.2
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
.+.++|+||...++ +|..|+-.+. .+.-..+-++.|+++|+.||| ..|+.|||+|.+|||+.-+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~--------------~hgvAhRDlKSDNiL~Eld 377 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLH--------------KHGVAHRDLKSDNILLELD 377 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHH--------------HccchhhcccccceEEEec
Confidence 45689999999986 9999997765 566677889999999999999 8999999999999999433
Q ss_pred --C--CeEEEeccCcccccCcccc---cccccCccCCccccccccccCCC-----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 89 --F--NVKIADFGFARYCVDKEGR---RVLSRTYCGSAAYAAPEVISGNP-----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 89 --~--~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+ .+.|.|||.+--....... .+-.-...|....+|||+....+ .+..++|.|+.|.+.||+++...||
T Consensus 378 dD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPF 457 (598)
T KOG4158|consen 378 DDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPF 457 (598)
T ss_pred CCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcc
Confidence 2 3678999987422111111 01112345778889999985432 2333499999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
-+....-+-..- +. ..+ -...+..+++.
T Consensus 458 Y~rGem~L~~r~------Yq------------------------------------------e~q----LPalp~~vpp~ 485 (598)
T KOG4158|consen 458 YKRGEMLLDTRT------YQ------------------------------------------ESQ----LPALPSRVPPV 485 (598)
T ss_pred cccchheechhh------hh------------------------------------------hhh----CCCCcccCChH
Confidence 764321110000 00 000 13455778999
Q ss_pred HHHHHHHhcCCCCCccccHH
Q psy1812 237 VKNLVGQILEPDITKRIRLD 256 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ 256 (304)
+++++..+|+.||.+|+++.
T Consensus 486 ~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHHHHHHHhcCCccccCCcc
Confidence 99999999999999999865
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-17 Score=162.00 Aligned_cols=183 Identities=21% Similarity=0.255 Sum_probs=131.8
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...|||=+|..+ +|+|.|...--+...+.+.|+-|++.||.-+| ..||+|||||.+|||++.=.+
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH--------------~~gVcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH--------------KLGVCHGDIKSENILITSWNW 158 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH--------------HcCccccccccceEEEeeech
Confidence 345667778876 99999876655788899999999999999999 899999999999999999889
Q ss_pred eEEEeccCcccccCcccccccc----cCccCCccccccccccCC----------CCCCCCchHHHHHHHHHHHHh-CCCC
Q psy1812 91 VKIADFGFARYCVDKEGRRVLS----RTYCGSAAYAAPEVISGN----------PYNPKLADIWSLGVITFIMLN-AAMP 155 (304)
Q Consensus 91 ~kl~dfg~~~~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~----------~~~~~~sDvwslG~ll~~ll~-g~~p 155 (304)
+.|+||...+.+.....++.-. .+...-.+|.|||.+... +.-.++-||+|+||+++||++ |+.+
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 9999999877554443332211 122344679999998531 112334899999999999999 8899
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.-+.. +. ..++. ... ....++ +--+.
T Consensus 239 F~LSQL---~a-Yr~~~-~~~--------------------------------------~e~~Le----------~Ied~ 265 (1431)
T KOG1240|consen 239 FTLSQL---LA-YRSGN-ADD--------------------------------------PEQLLE----------KIEDV 265 (1431)
T ss_pred ccHHHH---Hh-HhccC-ccC--------------------------------------HHHHHH----------hCcCc
Confidence 964421 11 11110 000 001111 11244
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.++.+|..|++.||.+|.+|++.|+.
T Consensus 266 ~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 266 SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cHHHHHHHHHccCchhccCHHHHHHh
Confidence 78999999999999999999999986
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-16 Score=146.88 Aligned_cols=123 Identities=30% Similarity=0.457 Sum_probs=103.2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.+++|.|++|.-.+|.++|.+.. ..+...+..++.|++.|++| - +.+|+|+||.||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-k----------------~~ihrdlkp~nif~~~ 391 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-K----------------GLIHRDLKPSNIFFSD 391 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-c----------------cchhhhcccccccccc
Confidence 36899999999999999997543 46788999999999999987 2 6789999999999999
Q ss_pred CCCeEEEeccCcccccCccc---ccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 88 RFNVKIADFGFARYCVDKEG---RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 88 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+..+||+|||+..-...... .........||..|++||.+.+..|+.+ +||||||++++|++.
T Consensus 392 d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 392 DDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI 457 (516)
T ss_pred chhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH
Confidence 99999999999864333220 0112345679999999999999999988 999999999999988
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-16 Score=137.24 Aligned_cols=127 Identities=28% Similarity=0.393 Sum_probs=86.2
Q ss_pred eEEEEEecCCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEE
Q psy1812 12 RVFIFMRYADNGDLLDHIKR---AGP----VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENIL 84 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~---~~~----l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil 84 (304)
+.+++|+-+. +||.+++.- ... +.......+..|++..+++|| ..|+||+||+++|++
T Consensus 113 n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh--------------~~GlVHgdi~~~nfl 177 (288)
T PF14531_consen 113 NRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH--------------SYGLVHGDIKPENFL 177 (288)
T ss_dssp SEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--------------HTTEEEST-SGGGEE
T ss_pred hhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh--------------hcceEecccceeeEE
Confidence 4578899996 599888753 211 223344555689999999999 899999999999999
Q ss_pred EecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC--------CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 85 MTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--------PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 85 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--------~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
++.+|.+.|+||+.....+.... . ...+..|.|||..... .++.. .|.|+||+++|.|+.+..||
T Consensus 178 l~~~G~v~Lg~F~~~~r~g~~~~----~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~-~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 178 LDQDGGVFLGDFSSLVRAGTRYR----C--SEFPVAFTPPELESCAGQFGQNNAPYTFA-TDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp E-TTS-EEE--GGGEEETTEEEE----G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HH-HHHHHHHHHHHHHHHSS-ST
T ss_pred EcCCCCEEEcChHHHeecCceee----c--cCCCcccCChhhhhhhcccCcccceeeec-cCHHHHHHHHHHHHHccCCC
Confidence 99999999999988764433211 1 2344678899876432 24444 89999999999999999999
Q ss_pred CChh
Q psy1812 157 DDSN 160 (304)
Q Consensus 157 ~~~~ 160 (304)
....
T Consensus 251 ~~~~ 254 (288)
T PF14531_consen 251 GLSS 254 (288)
T ss_dssp CCCG
T ss_pred CCCC
Confidence 7653
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.9e-14 Score=124.74 Aligned_cols=152 Identities=22% Similarity=0.377 Sum_probs=125.0
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++|.+.+.+.+-.||||.+ |.+|.|+..=++ .|+...+..++.|++.-++++| ++.+|+|||||
T Consensus 88 ~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH--------------~k~LIYRDIKP 152 (449)
T KOG1165|consen 88 QVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH--------------EKDLIYRDIKP 152 (449)
T ss_pred ceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH--------------hcceeecccCc
Confidence 4566677788889999999 789998887654 6999999999999999999999 99999999999
Q ss_pred CcEEEecCCC-----eEEEeccCcccccCcccccccc----cCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 81 ENILMTKRFN-----VKIADFGFARYCVDKEGRRVLS----RTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 81 ~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+|+||.+.+. +.++|||+++.+.+.......+ ....||.+||+--...+...+.. -|+-|+|-++++.|-
T Consensus 153 dNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLR 231 (449)
T KOG1165|consen 153 DNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLR 231 (449)
T ss_pred cceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhcc
Confidence 9999977554 7899999998776655443222 34569999999888888877777 899999999999999
Q ss_pred CCCCCCChh---HHHHHHHhh
Q psy1812 152 AAMPFDDSN---LKQLFKEQT 169 (304)
Q Consensus 152 g~~pf~~~~---~~~~~~~~~ 169 (304)
|..||.+.. ..+.+++|-
T Consensus 232 GsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 232 GSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred CCCccccccCcchHHHHHHhc
Confidence 999998764 344444443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-16 Score=151.08 Aligned_cols=202 Identities=29% Similarity=0.497 Sum_probs=162.2
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHI-KRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
++++...+....+++++|..|+++.+.+ .... ..+...+..++.|+..++.|+|. ..++.|+|++
T Consensus 85 ~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-------------~~~~~h~~ik 151 (601)
T KOG0590|consen 85 HMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-------------ENGVTHRDIK 151 (601)
T ss_pred ccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-------------ccccccCCCC
Confidence 4566667788999999999999999999 5554 67888999999999999999994 6899999999
Q ss_pred CCcEEEecCC-CeEEEeccCcccccCcccccccccCccC-CccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCG-SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~-~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|.+++..+ .+++.|||++..+.............+| ++.|.+||...+..+..+..|+||.|+++.-+++|..|+.
T Consensus 152 P~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 152 PSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred CccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 9999999999 9999999999876663343334556678 9999999999887666666999999999999999999986
Q ss_pred ChhHHHHH-HHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 158 DSNLKQLF-KEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
........ ........ ......+..++..
T Consensus 232 ~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~ 261 (601)
T KOG0590|consen 232 FPSRKDGRYSSWKSNKG--------------------------------------------------RFTQLPWNSISDQ 261 (601)
T ss_pred ccccccccceeeccccc--------------------------------------------------ccccCccccCChh
Confidence 55432210 00000000 0012334668889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
..+++.+++..+|..|.+.+++..++|+..
T Consensus 262 ~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 262 AHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999999
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.3e-13 Score=114.85 Aligned_cols=144 Identities=23% Similarity=0.319 Sum_probs=114.9
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++-++.++.+-.+|||.+ |.+|.+...= .+.|+...+.-++-|++.-++|+| .++++||||||+
T Consensus 76 i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH--------------~r~fiHRDIKPd 140 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH--------------LRNFIHRDIKPD 140 (341)
T ss_pred hhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH--------------hhccccccCCcc
Confidence 344556778889999999 7899888864 357999999999999999999999 899999999999
Q ss_pred cEEEecC---CCeEEEeccCcccccCcccccc----cccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 82 NILMTKR---FNVKIADFGFARYCVDKEGRRV----LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 82 nil~~~~---~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+|..-+ ..+.++|||+++.+.+...+.. ......||.+|.+--...+...+.. -|+-|+|.+++++.-|..
T Consensus 141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~L 219 (341)
T KOG1163|consen 141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSL 219 (341)
T ss_pred ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCC
Confidence 9999654 3478999999987655433321 1234568899988777666555555 899999999999999999
Q ss_pred CCCChhHH
Q psy1812 155 PFDDSNLK 162 (304)
Q Consensus 155 pf~~~~~~ 162 (304)
||.+....
T Consensus 220 PWQglka~ 227 (341)
T KOG1163|consen 220 PWQGLKAA 227 (341)
T ss_pred cccccchh
Confidence 99876443
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-13 Score=122.41 Aligned_cols=186 Identities=20% Similarity=0.309 Sum_probs=131.5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEE
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~ 85 (304)
..+..++.|||..|+|..+|++.. .+.+..-++++.||++||.|||+. ...|+|++++.+.|++
T Consensus 144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~------------~PpiihgnlTc~tifi 211 (458)
T KOG1266|consen 144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC------------DPPIIHGNLTCDTIFI 211 (458)
T ss_pred ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc------------CCccccCCcchhheee
Confidence 456889999999999999998743 578888899999999999999976 8899999999999999
Q ss_pred ecCCCeEEEeccCcccccCcc--cccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHH-
Q psy1812 86 TKRFNVKIADFGFARYCVDKE--GRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLK- 162 (304)
Q Consensus 86 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~- 162 (304)
..+|-+|++.-.-.. +.... .+........+.+.|-+||.=.......+ +|||+||+...++..+..--..+...
T Consensus 212 q~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~ 289 (458)
T KOG1266|consen 212 QHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKV 289 (458)
T ss_pred cCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHheeccCCCccee
Confidence 999888876422111 00000 00001112235577888888665556666 99999999999998887654333221
Q ss_pred HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHH
Q psy1812 163 QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVG 242 (304)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 242 (304)
..-..+.+..+ ..-.+.-++++.
T Consensus 290 ~~ee~ia~~i~---------------------------------------------------------~len~lqr~~i~ 312 (458)
T KOG1266|consen 290 EVEENIANVII---------------------------------------------------------GLENGLQRGSIT 312 (458)
T ss_pred ehhhhhhhhee---------------------------------------------------------eccCccccCcCc
Confidence 11111111111 112344678999
Q ss_pred HhcCCCCCccccHHHHhcCccccc
Q psy1812 243 QILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 243 ~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
+||+..|+.||++++++.||-+=.
T Consensus 313 kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 313 KCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccccCCCCCCcchhhhhcCceeee
Confidence 999999999999999999986543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-13 Score=115.11 Aligned_cols=74 Identities=20% Similarity=0.279 Sum_probs=65.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeE
Q psy1812 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYL-HREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVK 92 (304)
Q Consensus 14 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~k 92 (304)
+|||||+.|+++...+...+.+++..+..++.|++.+|.++ | ..+++||||||+||+++ ++.++
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--------------~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--------------DCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCCHHHEEEE-CCcEE
Confidence 89999999887766654556799999999999999999999 8 78999999999999998 47899
Q ss_pred EEeccCcccc
Q psy1812 93 IADFGFARYC 102 (304)
Q Consensus 93 l~dfg~~~~~ 102 (304)
++|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-13 Score=126.15 Aligned_cols=98 Identities=20% Similarity=0.244 Sum_probs=75.5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC-CCCcEEEecCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL-KCENILMTKRF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl-~~~nil~~~~~ 89 (304)
+..++||||++|++|.. +.. .. ...++.+++.||.||| +.||+|||| ||+||+++.++
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH--------------~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLH--------------RAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHH--------------HCCCeeCCCCCcceEEEcCCC
Confidence 46899999999999963 211 11 1467889999999999 899999999 99999999999
Q ss_pred CeEEEeccCcccccCccccccc-----ccCccCCccccccccccC
Q psy1812 90 NVKIADFGFARYCVDKEGRRVL-----SRTYCGSAAYAAPEVISG 129 (304)
Q Consensus 90 ~~kl~dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~ 129 (304)
.++|+|||+++.+......... .....++..|++||.+.-
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999876544322111 124457788899999853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=3e-13 Score=115.00 Aligned_cols=129 Identities=17% Similarity=0.122 Sum_probs=90.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC-CCCcEEEecCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL-KCENILMTKRF 89 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl-~~~nil~~~~~ 89 (304)
+..+++|||+.|.+|.+.+.. . ...++.+++.+|.++| ..||+|+|| ||+||+++.++
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH--------------~~GIvHrDL~kp~NILv~~~g 129 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLH--------------RCGVAHNDLAKEANWLVQEDG 129 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHH--------------HCcCccCCCCCcceEEEcCCC
Confidence 346999999999998765422 1 2357789999999999 899999999 79999999999
Q ss_pred CeEEEeccCcccccCccc----------ccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 90 NVKIADFGFARYCVDKEG----------RRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 90 ~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
.++|+|||++........ ++........++.++.|+...-- ..+-.+.++++-|+.+|.++|+..+..+
T Consensus 130 ~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 130 SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 999999999975443221 00000111234555566543221 2332237899999999999999988765
Q ss_pred hh
Q psy1812 159 SN 160 (304)
Q Consensus 159 ~~ 160 (304)
.+
T Consensus 210 ~~ 211 (218)
T PRK12274 210 DN 211 (218)
T ss_pred cC
Confidence 43
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-13 Score=118.07 Aligned_cols=101 Identities=20% Similarity=0.313 Sum_probs=76.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
.+..+|||||++|.+|.++.. +++. ...+++.++..+| ..|++|+|++|+|++++.+|
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH--------------~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLH--------------QHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHH--------------HcCCccCCCChHHEEEeCCC
Confidence 457899999999999988732 3432 4568999999999 89999999999999999988
Q ss_pred CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 90 NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 90 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
++++|||........... ..+.....+..+ +|+|+||+.+..+
T Consensus 173 -i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~-~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIK-NEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchhhH---------------HHHHHHhHhccc-ccccceeEeehHH
Confidence 999999987643221110 113344456666 9999999977644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-12 Score=111.25 Aligned_cols=75 Identities=20% Similarity=0.209 Sum_probs=64.8
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCCCCcEEEecCCCe
Q psy1812 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLKCENILMTKRFNV 91 (304)
Q Consensus 13 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~~~nil~~~~~~~ 91 (304)
.++||||++|+++.........++...+..++.+++.++.++| . .|++|+||||+||+++ ++.+
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH--------------~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY--------------QEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH--------------HhCCEecCCCChhhEEEE-CCCE
Confidence 3899999998865544334456888999999999999999999 7 9999999999999999 8899
Q ss_pred EEEeccCcccc
Q psy1812 92 KIADFGFARYC 102 (304)
Q Consensus 92 kl~dfg~~~~~ 102 (304)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.2e-13 Score=134.01 Aligned_cols=136 Identities=22% Similarity=0.262 Sum_probs=112.1
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCc
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~n 82 (304)
+++.+.-.+..++|+||.+.|+|.+++...+.+++..+..++.|++..+++|| ..+||||||||+|
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH--------------~~~IIHgDiKPDN 824 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH--------------AMGIIHGDIKPDN 824 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH--------------hcceecccCCcce
Confidence 34444556778999999999999999998889999999999999999999999 8999999999999
Q ss_pred EEEec-------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 83 ILMTK-------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 83 il~~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+++.. ...++|+|||.+.-....... .+....+++-.+-++|+..|.+++.. +|.|.++.+++-||.|+.
T Consensus 825 fll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 825 FLLRREICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEeecccCCCCcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 99943 345899999988532221111 13344567778889999999999877 999999999999999874
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-12 Score=127.96 Aligned_cols=195 Identities=25% Similarity=0.367 Sum_probs=160.0
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
-.....++++|..+++|...|++.+..+++.++..+..+..++++|| ...+.|+|+++.|.++..+
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~--------------s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH--------------SSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc--------------cchhhcccccccchhhccc
Confidence 34578899999999999999999888888999999999999999999 7779999999999999999
Q ss_pred CCeEEEeccCcccccCc---------------------cccc-------ccccCccCCccccccccccCCCCCCCCchHH
Q psy1812 89 FNVKIADFGFARYCVDK---------------------EGRR-------VLSRTYCGSAAYAAPEVISGNPYNPKLADIW 140 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~---------------------~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvw 140 (304)
+..++.+|+.....+.. .... .......++..|.+||...+...... +|+|
T Consensus 941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~ 1019 (1205)
T KOG0606|consen 941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWW 1019 (1205)
T ss_pred CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhh
Confidence 99999999843221110 0000 11223458899999999999888777 8999
Q ss_pred HHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhh
Q psy1812 141 SLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLK 220 (304)
Q Consensus 141 slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (304)
++|+++++.++|..||......+.+..+.+...+.+
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p-------------------------------------------- 1055 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWP-------------------------------------------- 1055 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCC--------------------------------------------
Confidence 999999999999999999998888887776655443
Q ss_pred hhhhccccccccccHHHHHHHHHhcCCCCCccccHH---HHhcCcccccccc
Q psy1812 221 DILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLD---AIKAHDWLRYKSM 269 (304)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~---ell~~~wf~~~~~ 269 (304)
..+...+.++.+++..+|..+|.+|..+. ++-.|+||+...-
T Consensus 1056 -------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1056 -------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred -------CCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 12244688999999999999999999887 8899999988653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=105.70 Aligned_cols=82 Identities=17% Similarity=0.142 Sum_probs=65.5
Q ss_pred CceeeeeeeCC---e-EEEEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGP---R-VFIFMRY--ADNGDLLDHIKRAGPVAESNARTWFSQMLAGL-EYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~---~-~~lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l-~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++|++++++. . +.+|+|| +.+|+|.+++++. .+++. ..++.+++.++ +||| +.+|
T Consensus 64 vr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh--------------~~~I 126 (210)
T PRK10345 64 PRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLL--------------DNRI 126 (210)
T ss_pred ceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHH--------------HCCE
Confidence 57899999863 4 4478999 5579999999774 46666 35678888777 9999 8999
Q ss_pred EecCCCCCcEEEecC----CCeEEEeccCc
Q psy1812 74 AHRDLKCENILMTKR----FNVKIADFGFA 99 (304)
Q Consensus 74 vH~dl~~~nil~~~~----~~~kl~dfg~~ 99 (304)
+|+||||+||++++. +.++|+|++.+
T Consensus 127 vhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 127 VTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred eecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999999753 37999994443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-11 Score=107.77 Aligned_cols=75 Identities=20% Similarity=0.218 Sum_probs=65.5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc-eEecCCCCCcEEEecCCC
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN-IAHRDLKCENILMTKRFN 90 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~-ivH~dl~~~nil~~~~~~ 90 (304)
..++||||+.|++|...+.....+....+..++.|++.++++|| ..+ ++|+||||+||+++ ++.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~g~iiH~Dikp~NIli~-~~~ 186 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY--------------KEGELVHGDLSEYNILVH-DGK 186 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH--------------hcCCEEeCCCChhhEEEE-CCC
Confidence 45899999999888776644455677778899999999999999 888 99999999999999 889
Q ss_pred eEEEeccCccc
Q psy1812 91 VKIADFGFARY 101 (304)
Q Consensus 91 ~kl~dfg~~~~ 101 (304)
++++|||.+..
T Consensus 187 i~LiDFg~a~~ 197 (237)
T smart00090 187 VVIIDVSQSVE 197 (237)
T ss_pred EEEEEChhhhc
Confidence 99999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=98.10 Aligned_cols=76 Identities=25% Similarity=0.382 Sum_probs=67.0
Q ss_pred eeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe
Q psy1812 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT 86 (304)
Q Consensus 7 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~ 86 (304)
+...+..++||||++|++|.+++..... ....++.+++.+|.+|| ..+++|+|++|.||+++
T Consensus 68 ~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH--------------~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 68 FVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLH--------------SAGIIHGDLTTSNMILS 129 (211)
T ss_pred EEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHH--------------hCCcccCCCCcccEEEE
Confidence 3456678899999999999999876432 78899999999999999 89999999999999999
Q ss_pred cCCCeEEEeccCccc
Q psy1812 87 KRFNVKIADFGFARY 101 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~ 101 (304)
++.++++|||.+..
T Consensus 130 -~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GGKIYLIDFGLAEF 143 (211)
T ss_pred -CCCEEEEECCcccC
Confidence 78899999998864
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-11 Score=115.94 Aligned_cols=163 Identities=20% Similarity=0.331 Sum_probs=116.1
Q ss_pred HHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcc------cccccccCccC
Q psy1812 44 FSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKE------GRRVLSRTYCG 117 (304)
Q Consensus 44 ~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~ 117 (304)
+.+++.|+.|+|. +.++||++|.|++|.++.++..|++.|+++....... .....+.....
T Consensus 105 l~~v~dgl~flh~-------------sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~ 171 (700)
T KOG2137|consen 105 LGNVADGLAFLHR-------------SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQP 171 (700)
T ss_pred hhcccchhhhhcc-------------CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhcc
Confidence 3456689999996 8999999999999999999999999999875433211 01111222335
Q ss_pred CccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhh
Q psy1812 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQ 196 (304)
Q Consensus 118 ~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
...|.+||++.+..-.+. +|++|+||++|.+.. |+..+...+..... ..........
T Consensus 172 ~~~f~apE~~~~~~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~-------------------- 229 (700)
T KOG2137|consen 172 HLNFLAPEYLLGTTNTPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAG-------------------- 229 (700)
T ss_pred Ccccccchhhcccccccc-ccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccc--------------------
Confidence 678999999988666565 999999999999995 55444333211111 1111110000
Q ss_pred hcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 197 VKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
...+...+++++++-|.++|..++..||++..++..+||.+.+..
T Consensus 230 -----------------------------~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 230 -----------------------------AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred -----------------------------cccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 022336789999999999999999999999999999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-10 Score=96.14 Aligned_cols=71 Identities=25% Similarity=0.399 Sum_probs=62.1
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
..+..++||||++|++|.+++..... .++.+++.+|.+|| ..+++|+|++|.||+++ +
T Consensus 68 ~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH--------------~~gi~H~Dl~~~Nil~~-~ 125 (199)
T TIGR03724 68 DPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLH--------------KAGIVHGDLTTSNIIVR-D 125 (199)
T ss_pred ECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHH--------------HCCeecCCCCcceEEEE-C
Confidence 45567899999999999998865321 78899999999999 89999999999999999 8
Q ss_pred CCeEEEeccCccc
Q psy1812 89 FNVKIADFGFARY 101 (304)
Q Consensus 89 ~~~kl~dfg~~~~ 101 (304)
+.++++|||++..
T Consensus 126 ~~~~liDfg~a~~ 138 (199)
T TIGR03724 126 DKLYLIDFGLGKY 138 (199)
T ss_pred CcEEEEECCCCcC
Confidence 8999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.7e-10 Score=109.04 Aligned_cols=72 Identities=24% Similarity=0.360 Sum_probs=63.3
Q ss_pred eeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe
Q psy1812 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT 86 (304)
Q Consensus 7 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~ 86 (304)
...++..++||||++|++|.+++. ....++.+++.+|.+|| +.+++|||+||+||++
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH--------------~~giiHrDlkp~NILl- 461 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLH--------------KAGIVHGDLTTSNFIV- 461 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHH--------------hCCCccCCCChHHEEE-
Confidence 344567789999999999999885 35678999999999999 8999999999999999
Q ss_pred cCCCeEEEeccCccc
Q psy1812 87 KRFNVKIADFGFARY 101 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~ 101 (304)
.++.++|+|||+++.
T Consensus 462 ~~~~~~liDFGla~~ 476 (535)
T PRK09605 462 RDDRLYLIDFGLGKY 476 (535)
T ss_pred ECCcEEEEeCccccc
Confidence 677899999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.9e-10 Score=96.95 Aligned_cols=70 Identities=20% Similarity=0.350 Sum_probs=60.0
Q ss_pred EEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCe
Q psy1812 13 VFIFMRYADN-GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNV 91 (304)
Q Consensus 13 ~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~ 91 (304)
.++|||+++| .+|.+++.. ..+++.. +.+++.+|.+|| ..||+|+||||.|||++.++.+
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH--------------~~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 121 ADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFH--------------DAGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred eeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHH--------------HCCCCCCCCCchhEEEcCCCCE
Confidence 3599999997 689988865 3466543 568999999999 8999999999999999998899
Q ss_pred EEEeccCccc
Q psy1812 92 KIADFGFARY 101 (304)
Q Consensus 92 kl~dfg~~~~ 101 (304)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.3e-10 Score=95.61 Aligned_cols=72 Identities=21% Similarity=0.210 Sum_probs=61.8
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...++||||++|++|.+.... .....++.+++.++.++| ..+++|+||+|+||+++.++.
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh--------------~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAY--------------KHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHH--------------HCCCCcCCCCcccEEEcCCCc
Confidence 356899999999998765431 345678899999999999 899999999999999999999
Q ss_pred eEEEeccCcccc
Q psy1812 91 VKIADFGFARYC 102 (304)
Q Consensus 91 ~kl~dfg~~~~~ 102 (304)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.8e-10 Score=105.95 Aligned_cols=200 Identities=22% Similarity=0.256 Sum_probs=149.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLA----GLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~l~~----~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+.+..+..+...|+=+|+|. .+|..+...... ++...++..+.+... ||.++| ..+++|.
T Consensus 182 ~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h--------------s~~~~~~ 246 (524)
T KOG0601|consen 182 RDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH--------------SNNIVHD 246 (524)
T ss_pred ccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC--------------CCccccc
Confidence 44667788899999999995 699999888665 889999999999999 999999 8999999
Q ss_pred CCCCCcEEEecC-CCeEEEeccCcccccCcccccccc--cCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 77 DLKCENILMTKR-FNVKIADFGFARYCVDKEGRRVLS--RTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 77 dl~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+++.||++..+ ...+++|||+...+.......... ....+...|++||...+- +... +|++++|.++.+...+.
T Consensus 247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~-~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFA-SDIFSLGEVILEAILGS 324 (524)
T ss_pred ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchH-hhhcchhhhhHhhHhhc
Confidence 999999999999 778999999998776655332111 122577899999998653 3344 89999999999888877
Q ss_pred CCCCCh-hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDS-NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
...... +... ..+..... + ..+-..
T Consensus 325 ~~~~~g~~~~W--~~~r~~~i--p--------------------------------------------------~e~~~~ 350 (524)
T KOG0601|consen 325 HLPSVGKNSSW--SQLRQGYI--P--------------------------------------------------LEFCEG 350 (524)
T ss_pred ccccCCCCCCc--cccccccC--c--------------------------------------------------hhhhcC
Confidence 555332 1100 00000000 0 111123
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
.+..+...+..|+..+|..|+++..++++.+......++-
T Consensus 351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~ 390 (524)
T KOG0601|consen 351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHL 390 (524)
T ss_pred cchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence 4556666999999999999999999999999987766554
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-09 Score=100.76 Aligned_cols=129 Identities=14% Similarity=0.262 Sum_probs=100.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++.++.++..|||+|.+. .|..++++- ....+..-+.||+.||.+||. .++++|+++.-
T Consensus 72 l~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~-------------d~~lvHgNv~~ 133 (690)
T KOG1243|consen 72 LSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLND-------------DCNLVHGNVCK 133 (690)
T ss_pred hhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhc-------------cCCeeeccEee
Confidence 367888889999999999996 888888874 477888889999999999985 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
..|+++..|..||++|.++........ .......-..|..|+.+....++ .|.|-|||+++++++|.
T Consensus 134 ~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~~s---~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 134 DSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSEWS---IDSWGLGCLIEELFNGS 200 (690)
T ss_pred eeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccccc---hhhhhHHHHHHHHhCcc
Confidence 999999999999999988753322211 11122223345666665444332 79999999999999993
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.5e-09 Score=83.78 Aligned_cols=82 Identities=22% Similarity=0.269 Sum_probs=67.4
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
+++.++..++..+++|||+.|+++..+ +......++.+++.++..||... ..+++|+|+++.
T Consensus 57 ~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~-----------~~~i~H~Dl~~~ 118 (155)
T cd05120 57 KVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLP-----------LLVLCHGDLHPG 118 (155)
T ss_pred eEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCC-----------ceEEEecCCCcc
Confidence 456666677789999999998877654 55667778899999999999320 257999999999
Q ss_pred cEEEecCCCeEEEeccCccc
Q psy1812 82 NILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~ 101 (304)
||+++..+.+++.||+.+..
T Consensus 119 Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 119 NILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eEEEECCcEEEEEecccccC
Confidence 99999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.8e-09 Score=88.54 Aligned_cols=74 Identities=22% Similarity=0.265 Sum_probs=58.9
Q ss_pred eEEEEEecCCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCCCCcEEEecCC
Q psy1812 12 RVFIFMRYADNGDLLD-HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~~~nil~~~~~ 89 (304)
..++||||+.|+++.. .+.... .. ..+..++.+++.++.++| . .+++|+||+|+||+++ ++
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh--------------~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLY--------------REAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHh--------------hccCcCcCCCChhhEEEE-CC
Confidence 4589999999854321 122111 11 678899999999999999 6 9999999999999999 88
Q ss_pred CeEEEeccCcccc
Q psy1812 90 NVKIADFGFARYC 102 (304)
Q Consensus 90 ~~kl~dfg~~~~~ 102 (304)
.++++|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.8e-08 Score=82.74 Aligned_cols=76 Identities=17% Similarity=0.236 Sum_probs=59.6
Q ss_pred CeEEEEEecCCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 11 PRVFIFMRYADNGDLLD-HIKRAGPVAESNARTWFSQMLAGLEYL-HREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
..-+|||||+.++.+.. .+++ ..+++..+..+..+++.++..| | ..++|||||++.||++. +
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H--------------~~glVHGDLs~~NIL~~-~ 160 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYK--------------ECNLVHADLSEYNMLWH-D 160 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCHHHEEEE-C
Confidence 45689999997654422 2322 2356667788889999999999 8 88999999999999997 4
Q ss_pred CCeEEEeccCcccc
Q psy1812 89 FNVKIADFGFARYC 102 (304)
Q Consensus 89 ~~~kl~dfg~~~~~ 102 (304)
+.+.++|||.+...
T Consensus 161 ~~v~iIDF~qav~~ 174 (197)
T cd05146 161 GKVWFIDVSQSVEP 174 (197)
T ss_pred CcEEEEECCCceeC
Confidence 68999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-07 Score=78.41 Aligned_cols=71 Identities=24% Similarity=0.378 Sum_probs=59.1
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
+.....|+|||++|..|.+++... ...++..+-.-+.-|| ..+|+||||+++|+++...
T Consensus 70 D~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH--------------~~givHGDLTtsNiIl~~~ 128 (204)
T COG3642 70 DPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLH--------------KAGIVHGDLTTSNIILSGG 128 (204)
T ss_pred cCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHH--------------hcCeecCCCccceEEEeCC
Confidence 455678999999998888899775 2456667777788899 9999999999999999776
Q ss_pred CCeEEEeccCccc
Q psy1812 89 FNVKIADFGFARY 101 (304)
Q Consensus 89 ~~~kl~dfg~~~~ 101 (304)
+ +.++|||++.+
T Consensus 129 ~-i~~IDfGLg~~ 140 (204)
T COG3642 129 R-IYFIDFGLGEF 140 (204)
T ss_pred c-EEEEECCcccc
Confidence 4 99999999863
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.8e-07 Score=76.90 Aligned_cols=71 Identities=20% Similarity=0.283 Sum_probs=52.5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCe
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNV 91 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~ 91 (304)
..++||||++|.++.+. . ......+.+++.+|..||+. +....+++|+|+++.||+++ ++.+
T Consensus 65 ~~~lv~e~i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~---------~~~~~~~~HgD~~~~Nil~~-~~~~ 126 (170)
T cd05151 65 TGVLITEFIEGSELLTE----D----FSDPENLEKIAKLLKKLHSS---------PLPDLVPCHNDLLPGNFLLD-DGRL 126 (170)
T ss_pred CCeEEEEecCCCccccc----c----ccCHHHHHHHHHHHHHHhCC---------CCCCceeecCCCCcCcEEEE-CCeE
Confidence 45799999999887643 0 11234567899999999931 00012369999999999999 6789
Q ss_pred EEEeccCcc
Q psy1812 92 KIADFGFAR 100 (304)
Q Consensus 92 kl~dfg~~~ 100 (304)
+++||+.+.
T Consensus 127 ~liDf~~a~ 135 (170)
T cd05151 127 WLIDWEYAG 135 (170)
T ss_pred EEEeccccc
Confidence 999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.5e-07 Score=80.17 Aligned_cols=76 Identities=18% Similarity=0.210 Sum_probs=65.1
Q ss_pred CeEEEEEecCCCC-CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 11 PRVFIFMRYADNG-DLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 11 ~~~~lv~e~~~~g-~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
...+||||++++. +|.+++... ...+......++.+++..+..|| ..|++|+|+++.||+++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--------------~~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH--------------AAGINHRDCYICHFLLHL 173 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCcCccCCCChhhEEEec
Confidence 3588999999876 899998652 35667788899999999999999 999999999999999985
Q ss_pred -------CCCeEEEeccCcc
Q psy1812 88 -------RFNVKIADFGFAR 100 (304)
Q Consensus 88 -------~~~~kl~dfg~~~ 100 (304)
++.+.++||+.++
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred cccCCCCCceEEEEECCccc
Confidence 4568999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.1e-07 Score=88.62 Aligned_cols=76 Identities=18% Similarity=0.177 Sum_probs=58.6
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~-~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
...+|||||++|++|.++.... .... ...++..++. .+..+| ..|++|+|++|.||+++.+
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~--------------~~g~~H~D~hPgNilv~~~ 293 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL--------------RDGFFHADLHPGNIFVLKD 293 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH--------------hCCceeCCCCcccEEECCC
Confidence 3468999999999998876532 1222 2344555554 467788 8899999999999999999
Q ss_pred CCeEEEeccCccccc
Q psy1812 89 FNVKIADFGFARYCV 103 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~ 103 (304)
+.++++|||++....
T Consensus 294 g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 294 GKIIALDFGIVGRLS 308 (437)
T ss_pred CcEEEEeCCCeeECC
Confidence 999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.2e-07 Score=77.32 Aligned_cols=76 Identities=22% Similarity=0.312 Sum_probs=67.7
Q ss_pred eEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC-
Q psy1812 12 RVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF- 89 (304)
Q Consensus 12 ~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~- 89 (304)
..++|+|++++. +|.+++......+......++.+++..+.-|| ..|++|+|+++.|||++.++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH--------------~~gi~H~Dl~~~NILv~~~~~ 156 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH--------------DAGIYHGDLNPSNILVDPDDG 156 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH--------------HCcCCCCCCCcccEEEeCCCC
Confidence 568999999874 89999988655778888999999999999999 89999999999999999887
Q ss_pred --CeEEEeccCccc
Q psy1812 90 --NVKIADFGFARY 101 (304)
Q Consensus 90 --~~kl~dfg~~~~ 101 (304)
.+.++||+.++.
T Consensus 157 ~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 157 QYRFYLIDLDRMRF 170 (206)
T ss_pred ceeEEEEcchhcee
Confidence 788999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-07 Score=89.74 Aligned_cols=183 Identities=21% Similarity=0.194 Sum_probs=128.1
Q ss_pred eeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEE
Q psy1812 5 SILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENIL 84 (304)
Q Consensus 5 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil 84 (304)
..+..-.+.++=.|||+++++...+.-...+.+...+.+..|++.++.++| +..++|+|++|+||+
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~--------------s~~~~~~d~~psni~ 398 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH--------------SKLFVHLDVKPSNIL 398 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc--------------chhhhccccccccee
Confidence 344444556688899999998888755557899999999999999999999 899999999999999
Q ss_pred EecC-CCeEEEeccCcccccCcccccccccCccCCcccc--ccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC-CChh
Q psy1812 85 MTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA--APEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDSN 160 (304)
Q Consensus 85 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~--~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf-~~~~ 160 (304)
+..+ +..+++|||....+.- ........-++. ++.......+... .|++|||.-+.+.+++...- .+..
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~------~~~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~ 471 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAF------SSGVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQ 471 (524)
T ss_pred eccchhhhhccccccccccce------ecccccccccccccchhhccccccccc-cccccccccccccccCcccCccccc
Confidence 9887 6778999988753111 111122222333 3344444455566 99999999999998877433 2222
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
. ..+..+.. ........++..+
T Consensus 472 ~----~~i~~~~~------------------------------------------------------p~~~~~~~~~q~~ 493 (524)
T KOG0601|consen 472 S----LTIRSGDT------------------------------------------------------PNLPGLKLQLQVL 493 (524)
T ss_pred c----eeeecccc------------------------------------------------------cCCCchHHhhhhh
Confidence 1 11111111 1113344778889
Q ss_pred HHHhcCCCCCccccHHHHhcCccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
.+.++..++..|+.+.++..|+=|..
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999988875543
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.5e-06 Score=71.97 Aligned_cols=81 Identities=22% Similarity=0.283 Sum_probs=63.7
Q ss_pred eeeCCeEEEEEecCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcE
Q psy1812 7 LQRGPRVFIFMRYADN-GDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83 (304)
Q Consensus 7 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ni 83 (304)
|.+...-.|+|||++| .++.+++.... .....-...++..+-..+.-|| +.+++||||+.+||
T Consensus 79 ~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--------------~ndiiHGDLTTSNi 144 (229)
T KOG3087|consen 79 FIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--------------DNDIIHGDLTTSNI 144 (229)
T ss_pred EEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--------------hCCeecccccccce
Confidence 4455566799999986 48888887643 2333334788899999999999 89999999999999
Q ss_pred EEecCCC---eEEEeccCccc
Q psy1812 84 LMTKRFN---VKIADFGFARY 101 (304)
Q Consensus 84 l~~~~~~---~kl~dfg~~~~ 101 (304)
++..++. +-++|||++..
T Consensus 145 ll~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 145 LLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEecCCCcCceEEEeecchhc
Confidence 9976654 47999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-06 Score=79.10 Aligned_cols=130 Identities=15% Similarity=0.168 Sum_probs=97.6
Q ss_pred CeEEEEEecCCCCC-HHHHHHh---c---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcE
Q psy1812 11 PRVFIFMRYADNGD-LLDHIKR---A---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83 (304)
Q Consensus 11 ~~~~lv~e~~~~g~-L~~~l~~---~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ni 83 (304)
...-++|..+.|.. ...++.- . -...+..+...++.++.+...|| ..|.+-||+.++|+
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--------------~~Gh~vGDVn~~~~ 148 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--------------EHGHVVGDVNQNSF 148 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--------------hcCCcccccCccce
Confidence 34778888887652 2222211 1 13789999999999999999999 89999999999999
Q ss_pred EEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhC-CCCCC
Q psy1812 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNA-AMPFD 157 (304)
Q Consensus 84 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g-~~pf~ 157 (304)
|+++++.+.+.|-....+... + .......|...|.+||... +-..+.. +|.+.||+++++++.| +.||.
T Consensus 149 lVsd~~~V~LVdsDsfqi~~n-g---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 149 LVSDDSKVVLVDSDSFQINAN-G---TLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred eeecCceEEEEcccceeeccC-C---ceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCC
Confidence 999999999988665543311 1 1233456889999999864 2233455 8999999999999885 89997
Q ss_pred Ch
Q psy1812 158 DS 159 (304)
Q Consensus 158 ~~ 159 (304)
+-
T Consensus 224 GI 225 (637)
T COG4248 224 GI 225 (637)
T ss_pred cc
Confidence 64
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.2e-07 Score=87.56 Aligned_cols=74 Identities=20% Similarity=0.267 Sum_probs=53.4
Q ss_pred CCeEEEEEecCCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcE
Q psy1812 10 GPRVFIFMRYADNGDLLDH--IKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~--l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ni 83 (304)
.+..+|||||++|+++.++ +...+ .+.+..+..++.|+ . ..|++|+|++|.||
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f--------------~~GffHaDpHPGNI 291 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F--------------RDGFFHADMHPGNI 291 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H--------------hCCeeeCCCChHHe
Confidence 3455699999999999874 33333 13333344444443 2 46899999999999
Q ss_pred EEecCC----CeEEEeccCcccccC
Q psy1812 84 LMTKRF----NVKIADFGFARYCVD 104 (304)
Q Consensus 84 l~~~~~----~~kl~dfg~~~~~~~ 104 (304)
+++.++ .++++|||+......
T Consensus 292 lv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 292 FVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred EEecCCCCCCeEEEEecceEEECCH
Confidence 999888 899999999875543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.4e-06 Score=72.00 Aligned_cols=72 Identities=29% Similarity=0.393 Sum_probs=49.4
Q ss_pred EEEEEecCC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-hhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 13 VFIFMRYAD--NGDLLDHIKRAGPVAESNARTWFSQMLAGLEY-LHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 13 ~~lv~e~~~--~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~-LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
-+|||||+. |..+.. +.... ++......++.+++..+.. +| ..|++|||++..||+++.+
T Consensus 81 ~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~--------------~~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLH--------------KAGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp TEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHH--------------CTTEEESS-STTSEEEETT-
T ss_pred CEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHH--------------hcCceecCCChhhEEeecc-
Confidence 369999998 655544 33321 2245667777888885555 57 8999999999999999987
Q ss_pred CeEEEeccCccc
Q psy1812 90 NVKIADFGFARY 101 (304)
Q Consensus 90 ~~kl~dfg~~~~ 101 (304)
.+.++|||.+..
T Consensus 144 ~~~iIDf~qav~ 155 (188)
T PF01163_consen 144 KVYIIDFGQAVD 155 (188)
T ss_dssp CEEE--GTTEEE
T ss_pred eEEEEecCccee
Confidence 999999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-05 Score=72.10 Aligned_cols=120 Identities=18% Similarity=0.292 Sum_probs=88.6
Q ss_pred Cceeeeeee----CCeEEEEEecCCC-CCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHhhhcccC
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADN-GDLLDHIKRA---------------GPVAESNARTWFSQMLAGLEYLHREITN 60 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~---------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~ 60 (304)
|++.++|.. +.-+++|++|.++ ++|+++.-.. ...+|..+|.++.|+..||.++|
T Consensus 336 V~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----- 410 (655)
T KOG3741|consen 336 VPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----- 410 (655)
T ss_pred eehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-----
Confidence 345566652 3468999999985 5787765321 23679999999999999999999
Q ss_pred CCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHH
Q psy1812 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIW 140 (304)
Q Consensus 61 ~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvw 140 (304)
+.|+..+-|.+.+|+++.+.+++|...|....+.... -+.+.+. .+-|.-
T Consensus 411 ---------ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------------~~~le~~----Qq~D~~ 460 (655)
T KOG3741|consen 411 ---------SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------------TEPLESQ----QQNDLR 460 (655)
T ss_pred ---------hcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------------CcchhHH----hhhhHH
Confidence 8889999999999999999889988777655433221 0111111 126899
Q ss_pred HHHHHHHHHHhCCCC
Q psy1812 141 SLGVITFIMLNAAMP 155 (304)
Q Consensus 141 slG~ll~~ll~g~~p 155 (304)
.||.+++.|.+|..-
T Consensus 461 ~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 461 DLGLLLLALATGTEN 475 (655)
T ss_pred HHHHHHHHHhhcccc
Confidence 999999999998644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.1e-06 Score=69.47 Aligned_cols=90 Identities=19% Similarity=0.213 Sum_probs=67.7
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCC---Cc----------------------
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP---FT---------------------- 65 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~---~~---------------------- 65 (304)
+..++||||++|.++.+.+.. +.+++.....++.+++.+|..||+......+ ++
T Consensus 73 ~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 73 GTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 367899999999988776542 4578888899999999999999965321100 00
Q ss_pred -----------------CCCCCCceEecCCCCCcEEEec--CCCeEEEeccCccc
Q psy1812 66 -----------------AHLPSKNIAHRDLKCENILMTK--RFNVKIADFGFARY 101 (304)
Q Consensus 66 -----------------~~~~~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~~~ 101 (304)
+......++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0012578999999999999988 56688999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.1e-05 Score=69.28 Aligned_cols=67 Identities=21% Similarity=0.343 Sum_probs=53.0
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
...++||||++|..|.+... +++ .+...+..++.-|| ..|++|||+.|.|+++..+ .
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH--------------~~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLH--------------KHGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHH--------------HcCCccCCCCcCcEEEECC-c
Confidence 45679999999988876542 333 24456777899999 8999999999999998855 5
Q ss_pred eEEEeccCcc
Q psy1812 91 VKIADFGFAR 100 (304)
Q Consensus 91 ~kl~dfg~~~ 100 (304)
++++|++..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00011 Score=75.71 Aligned_cols=181 Identities=18% Similarity=0.262 Sum_probs=120.4
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC---cEEEecCCCe
Q psy1812 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE---NILMTKRFNV 91 (304)
Q Consensus 15 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~---nil~~~~~~~ 91 (304)
+..++|...++...+++-+.++....+.+..++.+|+.++|+ ....|.-+... +...+..+..
T Consensus 263 v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~--------------~~l~~v~L~~s~~~~~~~~~e~~~ 328 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS--------------LSLEHVVLSASSSKESTVDGEGVV 328 (1351)
T ss_pred HHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH--------------hccceeEEecccccccccCcccee
Confidence 344788888999999998889999999999999999999993 33333222222 2222334445
Q ss_pred EEE--eccCcccccCcccccccccCccCCccccccccccCCCCCCC-CchHHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q psy1812 92 KIA--DFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPK-LADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168 (304)
Q Consensus 92 kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~ 168 (304)
.++ ||+......... .......+..+.++|....+..... ..|+|.+|.+...+..|..+-.-... ...+
T Consensus 329 ~~sl~~~~ss~~l~d~~----~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~---~~~~ 401 (1351)
T KOG1035|consen 329 AISLSDFDSSKPLPDNE----KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV---PVSL 401 (1351)
T ss_pred ecchhhhcccccCCCcc----cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc---hhhh
Confidence 555 777776544332 2223334556677887766544322 26999999999988877654322111 0000
Q ss_pred hhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCC
Q psy1812 169 TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPD 248 (304)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 248 (304)
+ .........+++.+|+.-+
T Consensus 402 l------------------------------------------------------------~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 402 L------------------------------------------------------------DVLSTSELLDALPKCLDED 421 (1351)
T ss_pred h------------------------------------------------------------ccccchhhhhhhhhhcchh
Confidence 0 0111226888999999999
Q ss_pred CCccccHHHHhcCcccccccccccccCC
Q psy1812 249 ITKRIRLDAIKAHDWLRYKSMVRRKVLP 276 (304)
Q Consensus 249 P~~R~t~~ell~~~wf~~~~~~~~~~~~ 276 (304)
+++|+++.+++.|+|.+-+.........
T Consensus 422 ~~~Rl~~~~ll~~~f~~~~~~~~~~~~~ 449 (1351)
T KOG1035|consen 422 SEERLSALELLTHPFLRFPTDNESSEFA 449 (1351)
T ss_pred hhhccchhhhhhchhccccccccccccc
Confidence 9999999999999999988876664433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00017 Score=61.73 Aligned_cols=75 Identities=13% Similarity=0.173 Sum_probs=63.9
Q ss_pred eEEEEEecCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 12 RVFIFMRYADN-GDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 12 ~~~lv~e~~~~-g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
+.+||+|-+.| -+|.+++.+. .+.+..+...++.+++..+.-|| ..|+.|+|+-+.||+++..
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--------------~~Gv~Hgdly~khIll~~~ 164 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--------------SVNRQHGCCYVRHIYVKTE 164 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--------------HCCCcCCCCCHhheeecCC
Confidence 57899997753 4899998764 35688888999999999999999 8999999999999999877
Q ss_pred CC--eEEEeccCcc
Q psy1812 89 FN--VKIADFGFAR 100 (304)
Q Consensus 89 ~~--~kl~dfg~~~ 100 (304)
+. ++++||--++
T Consensus 165 g~~~v~lIDlEk~r 178 (216)
T PRK09902 165 GKAEAGFLDLEKSR 178 (216)
T ss_pred CCeeEEEEEhhccc
Confidence 77 8889987664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00014 Score=63.98 Aligned_cols=72 Identities=22% Similarity=0.266 Sum_probs=56.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
++-.+||||++|-.|...- ++.+....++..|+.-+..+- ..|+||||++.-||+++.+|.
T Consensus 180 nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~--------------~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAY--------------RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHH--------------HcCccccCCchheEEEecCCC
Confidence 5678999999987664432 235556666777777777666 689999999999999999999
Q ss_pred eEEEeccCccc
Q psy1812 91 VKIADFGFARY 101 (304)
Q Consensus 91 ~kl~dfg~~~~ 101 (304)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999987653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0032 Score=54.98 Aligned_cols=93 Identities=15% Similarity=0.120 Sum_probs=59.0
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc----------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT---------------- 65 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~---------------- 65 (304)
++++....++..++|||+++|.+|..... ......++.+++..+..||+...+..++.
T Consensus 56 ~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~ 129 (244)
T cd05150 56 EVIDYGSDDGRAWLLTSAVPGVPAAALWE------ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVEN 129 (244)
T ss_pred eEEEEEecCCccEEEEEeeCCccHhHhhc------ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhc
Confidence 45666666677899999999977764321 11122345555555666664321100000
Q ss_pred ----------------------------CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 66 ----------------------------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 66 ----------------------------~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
+......++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 130 GLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 01123568999999999999997777899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0013 Score=63.68 Aligned_cols=78 Identities=19% Similarity=0.221 Sum_probs=56.5
Q ss_pred CCeEEEEEecCCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 10 GPRVFIFMRYADNGDLLDH--IKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~--l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.+.-.|+|||++|..+.+. ++.. .++...+...+.++..- .+- ..|++|.|.+|.||++..
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~-g~d~k~ia~~~~~~f~~--q~~--------------~dgffHaDpHpGNi~v~~ 300 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSA-GIDRKELAELLVRAFLR--QLL--------------RDGFFHADPHPGNILVRS 300 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhc-CCCHHHHHHHHHHHHHH--HHH--------------hcCccccCCCccceEEec
Confidence 4677899999999999888 4443 35544444433333221 111 458999999999999999
Q ss_pred CCCeEEEeccCcccccC
Q psy1812 88 RFNVKIADFGFARYCVD 104 (304)
Q Consensus 88 ~~~~kl~dfg~~~~~~~ 104 (304)
+|.+-+.|||+.....+
T Consensus 301 ~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 301 DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCcEEEEcCcceecCCH
Confidence 99999999999865543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0078 Score=52.25 Aligned_cols=94 Identities=12% Similarity=0.088 Sum_probs=56.4
Q ss_pred ceeeeeeeCCeEEEEEecCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCC-----------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGD-LLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP----------------- 63 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~----------------- 63 (304)
+++++...++...+|||+++|.+ +...+. .+......++.+++..+.-||+..-...+
T Consensus 58 ~~~~~~~~~~~~glv~e~i~G~~~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~ 133 (226)
T TIGR02172 58 HPFDLVEDGGRLGLIYELIVGKRSFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDF 133 (226)
T ss_pred ceEEEEecCCeeeeeeeecCCccchhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccC
Confidence 45667777788899999999864 222221 12233333444555555555532110000
Q ss_pred Cc------------CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 64 FT------------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 64 ~~------------~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
.. .......++|+|+.+.||+++.++ +.++||+.+.
T Consensus 134 ~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 134 VPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 00 001134578999999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0031 Score=61.17 Aligned_cols=77 Identities=17% Similarity=0.245 Sum_probs=54.4
Q ss_pred CCeEEEEEecCCCCCHHH--HHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 10 GPRVFIFMRYADNGDLLD--HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~--~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.....|+||||+|..+.| +|.+.+ ++...+..-+.++..-.-+ ..|++|+|-+|.||++..
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf----------------~~GffHaDPHPGNilv~~ 336 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIF----------------KTGFFHADPHPGNILVRP 336 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHH----------------hcCCccCCCCCCcEEEec
Confidence 457899999999987754 444444 6655555444444332222 457999999999999984
Q ss_pred ----CCCeEEEeccCccccc
Q psy1812 88 ----RFNVKIADFGFARYCV 103 (304)
Q Consensus 88 ----~~~~kl~dfg~~~~~~ 103 (304)
++.+.+.|+|+.....
T Consensus 337 ~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 337 NPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCCCCccEEEEccccccccc
Confidence 5678999999986544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0044 Score=52.23 Aligned_cols=85 Identities=16% Similarity=0.108 Sum_probs=64.3
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLD---HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~---~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++++. -++|.||...+++.. .+.+....++..+..++.+++..+++|+.. ....+.-.|+
T Consensus 24 k~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~-----------~~~~~~lcDv 88 (188)
T PF12260_consen 24 KLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG-----------PLGFFYLCDV 88 (188)
T ss_pred CeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-----------CCCcEEEeec
Confidence 4555552 256889998776642 122222368999999999999999999932 1355888999
Q ss_pred CCCcEEEecCCCeEEEeccCccc
Q psy1812 79 KCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
+++|+.++.++++|+.|......
T Consensus 89 ~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 89 SPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred chHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999988754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.012 Score=51.27 Aligned_cols=31 Identities=26% Similarity=0.266 Sum_probs=26.3
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++..+...|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4568999999999999876556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.00032 Score=68.24 Aligned_cols=192 Identities=19% Similarity=0.087 Sum_probs=119.6
Q ss_pred eeeeeeCCeEEEEEecCCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 4 HSILQRGPRVFIFMRYADNG-DLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 4 ~~~~~~~~~~~lv~e~~~~g-~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++-++.+...+++++++.++ +...-+.. .-.+.+-+...+.+.-..+++++| +..-+|+|
T Consensus 300 ~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~--------------~~~~~~~d---- 361 (829)
T KOG0576|consen 300 LEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH--------------SSYKVHRD---- 361 (829)
T ss_pred cccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc--------------cccccCcc----
Confidence 34445577899999999877 22111111 112445556667777888999999 44346777
Q ss_pred cEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 82 NILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
||+..+ +..+.++|+...-+.... ...+..++..|++||+...+.+... .|.|++|+-..++.-|..|-... .
T Consensus 362 ~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P-~ 434 (829)
T KOG0576|consen 362 NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSP-P 434 (829)
T ss_pred cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCC-c
Confidence 665544 578889998875433322 4567789999999999999988887 89999997655666666554321 0
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
.....+-.+.... .+..- ..+-+..-.++.
T Consensus 435 -~~~~~~g~~p~s~------------------------------------------~L~~~-------~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 435 -AVLPMIGNGPNSP------------------------------------------MLTDK-------SAWSPVFHRDFP 464 (829)
T ss_pred -cccCCCCCCCCcc------------------------------------------ccchh-------hhcCcccccCCc
Confidence 0000000000000 00000 000011112588
Q ss_pred HHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 242 GQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 242 ~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
..|+...|..|++.-.++.|.+|+..+..
T Consensus 465 ~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred ccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 89999999999999999999999988763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.012 Score=51.49 Aligned_cols=75 Identities=19% Similarity=0.228 Sum_probs=54.5
Q ss_pred eEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC
Q psy1812 12 RVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN 90 (304)
Q Consensus 12 ~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~ 90 (304)
.-.|||||+... .-.-.|+.. ++...++..+..+++..+.-|-. ..++||+||+.-|||+. ++.
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~-------------~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYK-------------EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHH-------------hcCcccccchhhheEEE-CCe
Confidence 346999999542 111111111 23344678888899998888872 48999999999999999 789
Q ss_pred eEEEeccCccc
Q psy1812 91 VKIADFGFARY 101 (304)
Q Consensus 91 ~kl~dfg~~~~ 101 (304)
+.|+|++-+..
T Consensus 205 p~iID~~QaV~ 215 (268)
T COG1718 205 PYIIDVSQAVT 215 (268)
T ss_pred EEEEECccccc
Confidence 99999998754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.052 Score=56.16 Aligned_cols=32 Identities=19% Similarity=0.408 Sum_probs=25.7
Q ss_pred CceEecCCCCCcEEEec-CCC-eEEEeccCcccc
Q psy1812 71 KNIAHRDLKCENILMTK-RFN-VKIADFGFARYC 102 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~-~~~-~kl~dfg~~~~~ 102 (304)
..+||+|+++.||+++. ++. .-|.||.++...
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 46999999999999985 334 579999998653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.063 Score=48.18 Aligned_cols=31 Identities=29% Similarity=0.393 Sum_probs=27.4
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4679999999999999987777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.23 Score=42.23 Aligned_cols=78 Identities=21% Similarity=0.312 Sum_probs=56.8
Q ss_pred ceeeeeeeCCeEEEEEecCCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 2 QVHSILQRGPRVFIFMRYADN------GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
++|++.+++--.-+|+|.+.. -+|.+++.+. .+++ .....+.++.. +|- ...|+.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f~~---~l~--------------~~~Iv~ 141 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEFKR---YLL--------------DHHIVI 141 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHHHH---HHH--------------HcCCee
Confidence 688999998888999988754 3688888654 4666 66666666655 444 567999
Q ss_pred cCCCCCcEEEecCC----CeEEEe-ccC
Q psy1812 76 RDLKCENILMTKRF----NVKIAD-FGF 98 (304)
Q Consensus 76 ~dl~~~nil~~~~~----~~kl~d-fg~ 98 (304)
+|++|.||++..+. .+.|+| ||.
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 99999999996543 355666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.11 Score=47.48 Aligned_cols=35 Identities=14% Similarity=0.212 Sum_probs=30.6
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccccC
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD 104 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 104 (304)
...++|||+.+.|++++..+.+-|.||+++.+..+
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 46799999999999999988899999999976544
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.0052 Score=65.62 Aligned_cols=134 Identities=13% Similarity=0.136 Sum_probs=96.8
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT 86 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~ 86 (304)
...+.+++|+.+|.+++.|-++. .+.+..+-....+......-+|+.. ++ ..-.+|.++++-|.+|.
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t--------nl-g~T~v~~~Lkf~lpmIV 1374 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT--------NL-GNTNVSKSLKFTLPMIV 1374 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc--------cC-Cccchhhhhhhhcccee
Confidence 45678899999999999997753 2444444444445466666666321 12 34468999999999999
Q ss_pred cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 87 KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
.+.+++++++|+.++..+.. .......+++.|+.+++...-.++.+ +|+|..|+.+|....|..+|.
T Consensus 1375 tny~v~~gk~gLdKIknp~~---sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1375 TNYNVKLGKGGLDKIKNPVL---SFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cCCcccccccccccccCchH---hhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcccHHHH
Confidence 99999999999987322211 13345567788888888877677776 999999999998888877763
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.28 Score=44.38 Aligned_cols=28 Identities=14% Similarity=0.252 Sum_probs=21.1
Q ss_pred CCceEecCCCCCcEEEecC-CC-eEEEecc
Q psy1812 70 SKNIAHRDLKCENILMTKR-FN-VKIADFG 97 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~-~~-~kl~dfg 97 (304)
...++|||+.+.||+++.+ +. +.|.|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4578999999999999865 33 4566644
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.16 Score=47.06 Aligned_cols=73 Identities=22% Similarity=0.358 Sum_probs=57.8
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
..+.|++|++. |++|. .+. .-..+++..++++.+..+.-+.. ....=||++...||+|+ +|
T Consensus 298 ~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lek-------------kf~fehrnlt~~niLId-~G 358 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEK-------------KFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred ceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhh-------------cCCcccccccccceeee-cC
Confidence 34677788876 44542 222 24678899999999998888874 67888999999999999 99
Q ss_pred CeEEEeccCccc
Q psy1812 90 NVKIADFGFARY 101 (304)
Q Consensus 90 ~~kl~dfg~~~~ 101 (304)
++.|+||.+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999974
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.056 Score=49.37 Aligned_cols=71 Identities=17% Similarity=0.217 Sum_probs=54.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
-++-++|||++.|..|.+.-+- ..+-.+...++.-+.-|- ..|++|+|..--||++..++
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la--------------~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLA--------------NHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHH--------------HcCceecccchheeEEecCC
Confidence 3567899999998887654321 123344555666667777 88999999999999999999
Q ss_pred CeEEEeccCcc
Q psy1812 90 NVKIADFGFAR 100 (304)
Q Consensus 90 ~~kl~dfg~~~ 100 (304)
.++++||--+.
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999998654
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.12 Score=43.36 Aligned_cols=35 Identities=17% Similarity=0.254 Sum_probs=28.9
Q ss_pred CcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 64 ~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++ ....+|+|+.|.|+++..++ ++++||+.+.
T Consensus 71 ~~~~l-~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 71 EPRPL-RLAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred cCCCC-CeeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 34455 56789999999999998776 9999999985
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.25 Score=42.64 Aligned_cols=31 Identities=29% Similarity=0.482 Sum_probs=27.5
Q ss_pred CCceEecCCCCCcEEEec-CCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTK-RFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~ 100 (304)
...++|+|+.+.||+++. ++.+.++||.++.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 467999999999999998 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.28 Score=44.52 Aligned_cols=31 Identities=29% Similarity=0.376 Sum_probs=26.6
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999966556899999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.35 Score=43.58 Aligned_cols=30 Identities=27% Similarity=0.537 Sum_probs=26.4
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|||+.+.||+++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 578999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.23 Score=44.94 Aligned_cols=31 Identities=29% Similarity=0.396 Sum_probs=27.8
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++.++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.17 Score=43.03 Aligned_cols=31 Identities=32% Similarity=0.338 Sum_probs=22.3
Q ss_pred CCceEecCCCCCcEEEe-cCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMT-KRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~-~~~~~kl~dfg~~~ 100 (304)
...++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 67899999999999999 66667899998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.31 E-value=0.39 Score=43.24 Aligned_cols=31 Identities=29% Similarity=0.449 Sum_probs=27.9
Q ss_pred CCceEecCCCCCcEEEecC----CCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKR----FNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~----~~~kl~dfg~~~ 100 (304)
...++|+|+.+.||+++.+ +.+.++||.++.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 6789999999999999985 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.90 E-value=0.16 Score=44.07 Aligned_cols=64 Identities=16% Similarity=0.095 Sum_probs=45.5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
+-.+-+|+|+|..... ...-.+.. =+++|.-.|++ +.+.+|||..|+||+-++.|
T Consensus 126 ~~~yGvIlE~Cy~~~i------------~~~N~i~a-gi~~L~~fH~~------------~~~~lHGD~np~NiM~D~~G 180 (308)
T PF07387_consen 126 NYKYGVILERCYKIKI------------NFSNFITA-GIKDLMDFHSE------------NQHCLHGDCNPDNIMCDKFG 180 (308)
T ss_pred CceeEEEEeeccCccc------------chhHHHHH-hHHHHHHhhcc------------CCCeecCCCChhheeecCCC
Confidence 3467888898864221 11111111 14567788865 88999999999999999999
Q ss_pred CeEEEeccC
Q psy1812 90 NVKIADFGF 98 (304)
Q Consensus 90 ~~kl~dfg~ 98 (304)
.+|+.|=+.
T Consensus 181 ~lKlVDP~~ 189 (308)
T PF07387_consen 181 YLKLVDPVC 189 (308)
T ss_pred CEEecChhh
Confidence 999998664
|
The function of this family is unknown. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=91.28 E-value=0.19 Score=48.57 Aligned_cols=90 Identities=11% Similarity=0.042 Sum_probs=57.8
Q ss_pred CchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 136 LADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 136 ~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
++|||++|.++.++.-|...+......+....+.+.. ..+.. ...
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~----------------------------------~~~ 155 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQE----------------------------------LLS 155 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchh----------------------------------HHH
Confidence 3999999999999999887765444433333332211 11100 000
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
...++ .....++..+.+++.+|+-..|..||...++.+++-|...
T Consensus 156 ~a~e~-------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 156 TAMEH-------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHH-------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 00111 1113357778999999999999999999999999887654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.26 E-value=0.45 Score=43.77 Aligned_cols=51 Identities=29% Similarity=0.427 Sum_probs=37.1
Q ss_pred HHHHHHHHHHhhhcccCCCCCcCCCCCCc--eEecCCCCCcEEEecCCC-eEEEeccCcc
Q psy1812 44 FSQMLAGLEYLHREITNHTPFTAHLPSKN--IAHRDLKCENILMTKRFN-VKIADFGFAR 100 (304)
Q Consensus 44 ~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--ivH~dl~~~nil~~~~~~-~kl~dfg~~~ 100 (304)
..++...+..+.+....+.| ..+ +||+|+.+.||+++.+.. +.++||+.+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~lp------~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 174 RAALLAALDRLLARLPAHLP------ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHHHhhchhhCC------cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 34555566666654433443 444 999999999999998875 8899999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.29 Score=43.02 Aligned_cols=31 Identities=23% Similarity=0.330 Sum_probs=26.7
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.++ +.++||..+..
T Consensus 145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 45789999999999999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.21 E-value=0.39 Score=40.82 Aligned_cols=32 Identities=41% Similarity=0.591 Sum_probs=23.1
Q ss_pred CCceEecCCCCCcEEE-ecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILM-TKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~-~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||++ +.++.++++||.++..
T Consensus 142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 4789999999999999 8889999999999853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=89.38 E-value=0.83 Score=40.74 Aligned_cols=52 Identities=21% Similarity=0.309 Sum_probs=38.7
Q ss_pred HHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 37 ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 37 ~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
.......+..+-.++.-++.. ..-++|+|+.|+|.+.+..+.++++||..+.
T Consensus 131 ~~~~~~~~~~l~~~l~~~~~~------------~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 131 NHLLRKKLKELRRALEEVPKD------------DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred hHHHHHHHHHHHHHhhhcCCC------------ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 344444555565666665521 1569999999999999999999999999885
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=88.39 E-value=0.85 Score=41.31 Aligned_cols=31 Identities=16% Similarity=0.165 Sum_probs=28.4
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 5689999999999999999899999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=87.80 E-value=0.54 Score=39.66 Aligned_cols=31 Identities=26% Similarity=0.398 Sum_probs=25.9
Q ss_pred CCceEecCCCCCcEEEecCC-----CeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRF-----NVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~-----~~kl~dfg~~~ 100 (304)
...++|||+.+.|+++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 56899999999999997554 47899998874
|
subfamily of choline kinases |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=87.50 E-value=1.2 Score=41.22 Aligned_cols=32 Identities=28% Similarity=0.587 Sum_probs=27.5
Q ss_pred CCceEecCCCCCcEEEec-CCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTK-RFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~ 101 (304)
...++|+|+++.||+++. ++.+.++||.++..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 568999999999999986 46799999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=86.28 E-value=0.58 Score=41.87 Aligned_cols=32 Identities=22% Similarity=0.312 Sum_probs=26.5
Q ss_pred CCceEecCCCCCcEEEecCCC-eEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFN-VKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~-~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 356999999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.37 E-value=1.8 Score=39.55 Aligned_cols=29 Identities=28% Similarity=0.186 Sum_probs=24.8
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 56789999999999994 4 67899999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.04 E-value=2.1 Score=45.49 Aligned_cols=32 Identities=28% Similarity=0.337 Sum_probs=26.7
Q ss_pred CCceEecCCCCCcEEEecCC--Ce-EEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRF--NV-KIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~--~~-kl~dfg~~~~ 101 (304)
..++||+|+.+.||+++.++ .+ -|+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 56799999999999998875 45 4999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=82.49 E-value=1.9 Score=39.88 Aligned_cols=41 Identities=24% Similarity=0.156 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 37 ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 37 ~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
.+-++.++.|++.-.--+-.+ -+..+.+|-||||+|||+-.
T Consensus 274 ~~YvkfifLQiaLLyikIYel----------p~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYEL----------PCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecC----------CCcceeeecccCcCcEEEec
Confidence 456677788886643112111 11467999999999999943
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=81.02 E-value=1.5 Score=40.19 Aligned_cols=31 Identities=26% Similarity=0.491 Sum_probs=26.5
Q ss_pred CceEecCCCCCcEEEec-CCCeEEEeccCccc
Q psy1812 71 KNIAHRDLKCENILMTK-RFNVKIADFGFARY 101 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~ 101 (304)
...+|+|+.+.||+++. ++.++++||.++..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 45899999999999975 46899999998853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 304 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-30 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-30 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-27 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-27 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-27 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-27 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-27 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-27 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-26 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-24 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-22 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-19 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-04 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-53
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 72/254 (28%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M YA G++ D++ G + E AR+ F Q+++ ++Y H+ K
Sbjct: 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ--------------K 133
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I HRDLK EN+L+ N+KIADFGF+ +CG+ YAAPE+ G
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGKK 189
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
Y+ D+WSLGVI + +++ ++PFD NLK+L + +L + ++ +S +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE----RVLRGKYRIPFYMSTDCE--- 242
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
NL+ + L + K
Sbjct: 243 -----------------------------------------------NLLKRFLVLNPIK 255
Query: 252 RIRLDAIKAHDWLR 265
R L+ I W+
Sbjct: 256 RGTLEQIMKDRWIN 269
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-53
Identities = 75/265 (28%), Positives = 108/265 (40%), Gaps = 72/265 (27%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++++ ++ F+ M Y G+L D+I + G V E AR F Q+L+ ++Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH----- 128
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ HRDLK EN+L+ N KIADFG + D E RT CGS
Sbjct: 129 ---------RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPN 175
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEVISG Y DIWS GVI + +L +PFDD ++ LFK I +
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK----KIRGGVFYIP 231
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
+ L+ V L
Sbjct: 232 EYLNRSVA--------------------------------------------------TL 241
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
+ +L+ D KR + I+ H+W +
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFK 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-52
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 70/267 (26%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++ + + G ++F+ Y G+L D I+ + E +A+ +F Q++AG+ YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH----- 122
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRD+K EN+L+ +R N+KI+DFG A R+L CG+
Sbjct: 123 ---------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL-NKMCGTLP 172
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APE++ ++ + D+WS G++ ML +P+D
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD----------------------- 209
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV--KDILSHQVK 238
+ D + + +
Sbjct: 210 ------------------------------QPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265
L+ +IL + + RI + IK W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 72/254 (28%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
VF+ + LL+ KR + E AR + Q++ G +YLH
Sbjct: 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH--------------RN 134
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ HRDLK N+ + + VKI DFG A R+ + CG+ Y APEV+S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKG 191
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
++ + D+WS+G I + +L PF+ S LK+ + I ++ + ++
Sbjct: 192 HSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIPKHINPVAA--- 243
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
+L+ ++L+ D T
Sbjct: 244 -----------------------------------------------SLIQKMLQTDPTA 256
Query: 252 RIRLDAIKAHDWLR 265
R ++ + ++
Sbjct: 257 RPTINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-51
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 72/254 (28%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
VF+ + LL+ KR + E AR + Q++ G +YLH
Sbjct: 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH--------------RN 160
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ HRDLK N+ + + VKI DFG A R+ + CG+ Y APEV+S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKG 217
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
++ + D+WS+G I + +L PF+ S LK+ + I ++ + ++
Sbjct: 218 HSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIPKHINPVAA--- 269
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
+L+ ++L+ D T
Sbjct: 270 -----------------------------------------------SLIQKMLQTDPTA 282
Query: 252 RIRLDAIKAHDWLR 265
R ++ + ++
Sbjct: 283 RPTINELLNDEFFT 296
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-51
Identities = 69/255 (27%), Positives = 106/255 (41%), Gaps = 68/255 (26%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ I M YA G+L + I AG +E AR +F Q+L+G+ Y H S
Sbjct: 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH--------------SMQ 136
Query: 73 IAHRDLKCENILM--TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRDLK EN L+ + +KI DFG+++ V ++ G+ AY APEV+
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQ 192
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
Y+ K+AD+WS GV ++ML A PF+D + +++ ILS + + D +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR------ 246
Query: 191 DILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250
+S + +L+ +I D
Sbjct: 247 --ISPECC----------------------------------------HLISRIFVADPA 264
Query: 251 KRIRLDAIKAHDWLR 265
RI + IK H W
Sbjct: 265 TRISIPEIKTHSWFL 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-51
Identities = 59/264 (22%), Positives = 93/264 (35%), Gaps = 63/264 (23%)
Query: 12 RVFIFMRYADNGDLLDHI--------KRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
V+I Y +N +L + + +L Y+H E
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE------ 170
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
KNI HRD+K NILM K VK++DFG + Y VDK + G+ +
Sbjct: 171 -------KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMP 218
Query: 124 PEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD-SNLKQLFKEQTSNILSHQVKVKD 181
PE S YN DIWSLG+ ++M +PF +L +LF NI + ++
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN----NIRTKNIEYPL 274
Query: 182 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241
+H + + LS++ + +
Sbjct: 275 DRNHFLYPLTNKKSTCS-------------------------------NNFLSNEDIDFL 303
Query: 242 GQILEPDITKRIRLDAIKAHDWLR 265
L + +RI + H+WL
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLA 327
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-51
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 70/267 (26%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++ + + G ++F+ Y G+L D I+ + E +A+ +F Q++AG+ YLH
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH----- 122
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRD+K EN+L+ +R N+KI+DFG A R+L CG+
Sbjct: 123 ---------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL-NKMCGTLP 172
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APE++ ++ + D+WS G++ ML +P+D
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD----------------------- 209
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV--KDILSHQVK 238
+ D + + +
Sbjct: 210 ------------------------------QPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265
L+ +IL + + RI + IK W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-50
Identities = 56/255 (21%), Positives = 101/255 (39%), Gaps = 73/255 (28%)
Query: 12 RVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
V++ + NG++ ++K R P +E+ AR + Q++ G+ YLH S
Sbjct: 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--------------S 130
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRDL N+L+T+ N+KIADFG A + T CG+ Y +PE+ + +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRS 187
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
+ + +D+WSLG + + +L PFD +K ++ ++ LS + K
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEMPSFLSIEAK-- 240
Query: 191 DILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250
+L+ Q+L +
Sbjct: 241 ------------------------------------------------DLIHQLLRRNPA 252
Query: 251 KRIRLDAIKAHDWLR 265
R+ L ++ H ++
Sbjct: 253 DRLSLSSVLDHPFMS 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 72/265 (27%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++++ ++ +F+ M Y G+L D+I + G + E +R F Q+L+G++Y HR
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---- 134
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ HRDLK EN+L+ N KIADFG + D E RT CGS
Sbjct: 135 ----------HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPN 180
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEVISG Y DIWS GVI + +L +PFDD ++ LFK I
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTP 236
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
L+ V +L
Sbjct: 237 QYLNPSVI--------------------------------------------------SL 246
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
+ +L+ D KR + I+ H+W +
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-49
Identities = 68/265 (25%), Positives = 107/265 (40%), Gaps = 73/265 (27%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++++ ++ + + + YA G+L D+I + E R +F Q++ +EY HR
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR---- 126
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRDLK EN+L+ NVKIADFG + D +T CGS
Sbjct: 127 ----------HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPN 172
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
YAAPEVI+G Y D+WS G++ ++ML +PFDD + LFK + S +
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNSCVYVMP 228
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
D LS + +L
Sbjct: 229 DFLSPGAQ--------------------------------------------------SL 238
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
+ +++ D +RI + I+ W
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-49
Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 74/254 (29%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
R+++ + +A G+L +++ G E + T+ ++ L Y H +
Sbjct: 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH--------------ER 133
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ HRD+K EN+LM + +KIADFG++ + RR RT CG+ Y PE+I G
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRR---RTMCGTLDYLPPEMIEGKT 188
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
++ K D+W GV+ + L PFD + + + I++ +K LS
Sbjct: 189 HDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPFLS------- 236
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
K+L+ ++L +
Sbjct: 237 -------------------------------------------DGSKDLISKLLRYHPPQ 253
Query: 252 RIRLDAIKAHDWLR 265
R+ L + H W++
Sbjct: 254 RLPLKGVMEHPWVK 267
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-49
Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 72/255 (28%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ + G +++ + P++E AR +F ++ G+EYLH +
Sbjct: 113 LYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLH--------------YQK 157
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-- 130
I HRD+K N+L+ + ++KIADFG + + L G+ A+ APE +S
Sbjct: 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRK 214
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
++ K D+W++GV + + PF D + L +
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK----------------------- 251
Query: 191 DILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250
I S ++ D LKD+++ +L+ +
Sbjct: 252 -----------IKSQALEFPDQPDIAEDLKDLITR------------------MLDKNPE 282
Query: 251 KRIRLDAIKAHDWLR 265
RI + IK H W+
Sbjct: 283 SRIVVPEIKLHPWVT 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-49
Identities = 53/254 (20%), Positives = 98/254 (38%), Gaps = 74/254 (29%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
RV++ + YA G + +++ E T+ +++ L Y H SK
Sbjct: 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--------------SK 128
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+ HRD+K EN+L+ +KIADFG++ + RR CG+ Y PE+I G
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR---TDLCGTLDYLPPEMIEGRM 183
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
++ K D+WSLGV+ + L PF+ + ++ +K I + D ++
Sbjct: 184 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVEFTFPDFVT------- 231
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
++L+ ++L+ + ++
Sbjct: 232 -------------------------------------------EGARDLISRLLKHNPSQ 248
Query: 252 RIRLDAIKAHDWLR 265
R L + H W+
Sbjct: 249 RPMLREVLEHPWIT 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 56/257 (21%), Positives = 92/257 (35%), Gaps = 73/257 (28%)
Query: 12 RVFIFMRYADNG--DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++++ M Y G ++LD + A +F Q++ GLEYLH
Sbjct: 82 KMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLH-------------- 126
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
S+ I H+D+K N+L+T +KI+ G A RT GS A+ PE+ +G
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC-RTSQGSPAFQPPEIANG 185
Query: 130 N-PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
++ DIWS GV + + PF+ N+ +LF+ NI +
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE----NIGKGSYAIPGDCGPP-- 239
Query: 189 VKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPD 248
+ +L+ +LE +
Sbjct: 240 ------------------------------------------------LSDLLKGMLEYE 251
Query: 249 ITKRIRLDAIKAHDWLR 265
KR + I+ H W R
Sbjct: 252 PAKRFSIRQIRQHSWFR 268
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-46
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNH 61
I + ++I M Y + GDL I + + E +Q+ L+ HR
Sbjct: 75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---- 130
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+ HRDLK N+ + + NVK+ DFG AR ++T+ G+ Y
Sbjct: 131 -----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYY 182
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQV-KVK 180
+PE ++ YN K +DIWSLG + + + PF + K+L I + ++
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKFRRIP 237
Query: 181 DILSHQVK--VKDILSHQVK----VKDILSHQVKVKDILSHQ 216
S ++ + +L+ + V++IL + + ++ H
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-46
Identities = 59/229 (25%), Positives = 89/229 (38%), Gaps = 39/229 (17%)
Query: 5 SILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTP 63
+ +++ +FI M Y +NG L D I F Q+L L Y+H
Sbjct: 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH-------- 133
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR---------- 113
S+ I HRDLK NI + + NVKI DFG A+ L
Sbjct: 134 ------SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 114 -TYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
+ G+A Y A EV+ G YN K D++SLG+I F M+ + K+ S
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEK-IDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSV 244
Query: 172 ILSHQVKVKDILSHQVK--VKDILSHQVK----VKDILSH---QVKVKD 211
+ D K ++ ++ H + +L+ VK +D
Sbjct: 245 SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 9e-46
Identities = 44/268 (16%), Positives = 79/268 (29%), Gaps = 59/268 (22%)
Query: 12 RVFIFMRYADNGDLLDHI---KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ M + G L + A + ES ++ G+ +L
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR------------- 129
Query: 69 PSKNIAHRDLKCENILMT----KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAP 124
I HR++K NI+ + K+ DFG AR D E + G+ Y P
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHP 184
Query: 125 EVISGN--------PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
++ Y D+WS+GV + ++PF + KE
Sbjct: 185 DMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--------- 234
Query: 177 VKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236
+ +++ V+ + + + + L
Sbjct: 235 ----------------VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 237 VKNLVGQILEPDITKRIRLDAIKAHDWL 264
+ ++ ILE D K D A
Sbjct: 279 LTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-45
Identities = 52/267 (19%), Positives = 97/267 (36%), Gaps = 81/267 (30%)
Query: 1 MQVHSILQRGPRVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ + + + DL D+I GP+ E +R +F Q++A +++ H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---- 156
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILM-TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
S+ + HRD+K ENIL+ +R K+ DFG D+ + G+
Sbjct: 157 ----------SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYTDFDGT 201
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
Y+ PE IS + Y+ A +WSLG++ + M+ +PF+
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------------------- 241
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
++IL ++ + S
Sbjct: 242 DQEILEAELHFPAHV----------------------------------------SPDCC 261
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265
L+ + L P + R L+ I W++
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-45
Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 81/267 (30%)
Query: 1 MQVHSILQRGPRVFIFMRYADN-GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ +R + + + DL D I G + E AR++F Q+L + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--- 167
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILM-TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+ HRD+K ENIL+ R +K+ DFG D + + G+
Sbjct: 168 -----------CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 211
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
Y+ PE I + Y+ + A +WSLG++ + M+ +PF+
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------- 252
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
++I+ QV + +S + +
Sbjct: 253 -EEIIRGQVFFRQRVS----------------------------------------SECQ 271
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265
+L+ L + R + I+ H W++
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-45
Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 79/266 (29%)
Query: 1 MQVHSILQRGPRVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
++V I + + M +G DL I R + E A F Q+++ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---- 147
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
K+I HRD+K ENI++ + F +K+ DFG A Y + L T+CG+
Sbjct: 148 ----------LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCGTI 193
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APEV+ GNPY ++WSLGV + ++ PF + +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--------------------L 233
Query: 180 KDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239
++ + + ++S + + +
Sbjct: 234 EETVEAAIHPPYLVSKE----------------------------------------LMS 253
Query: 240 LVGQILEPDITKRIRLDAIKAHDWLR 265
LV +L+P +R L+ + W+
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+S + +FI M + D G L I+ R + + A F Q+ G++Y+H
Sbjct: 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH------ 139
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK + +RDLK NI + VKI DFG + +G+R G+ Y
Sbjct: 140 --------SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKR---TRSKGTLRY 187
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP-FDDSNLKQLFKEQT-SNILSHQVK- 178
+PE IS Y + D+++LG+I +L+ F+ S ++ S+I + K
Sbjct: 188 MSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKT 246
Query: 179 -VKDILSHQVK----VKDILSHQVKVKDILSHQVK 208
++ +LS + + +IL K +
Sbjct: 247 LLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 44/267 (16%), Positives = 79/267 (29%), Gaps = 59/267 (22%)
Query: 12 RVFIFMRYADNGDLLDHI---KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ M + G L + A + ES ++ G+ +L
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR------------- 129
Query: 69 PSKNIAHRDLKCENILMT----KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAP 124
I HR++K NI+ + K+ DFG AR D E + G+ Y P
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHP 184
Query: 125 EVISGN--------PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
++ Y D+WS+GV + ++PF + KE
Sbjct: 185 DMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--------- 234
Query: 177 VKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236
+ +++ V+ + + + + L
Sbjct: 235 ----------------VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 237 VKNLVGQILEPDITKRIRLDAIKAHDW 263
+ ++ ILE D K D A
Sbjct: 279 LTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 56/266 (21%), Positives = 92/266 (34%), Gaps = 55/266 (20%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHI---KRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
L + M Y + GDL ++ + + E RT S + + L YLH
Sbjct: 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-------- 138
Query: 64 FTAHLPSKNIAHRDLKCENILM---TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRDLK ENI++ +R KI D G+A+ E L + G+
Sbjct: 139 ------ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQ 188
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APE++ Y D WS G + F + PF + +
Sbjct: 189 YLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHG------------- 234
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
KV++ + + V D L+ VK +L + IL+ +++
Sbjct: 235 -----------------KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW 277
Query: 241 VGQILEPDITKRIRLDAIKAHDWLRY 266
+ +L +R +
Sbjct: 278 LQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-42
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 12 RVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++I M Y + GDL I E WF Q+ L+++H
Sbjct: 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-------------- 142
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+ I HRD+K +NI +TK V++ DFG AR L+R G+ Y +PE+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICEN 199
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
PYN K +DIW+LG + + + F+ ++K L
Sbjct: 200 KPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-42
Identities = 49/278 (17%), Positives = 97/278 (34%), Gaps = 82/278 (29%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M N DL +K+ + ++++ ML + +H
Sbjct: 102 YIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QH 146
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I H DLK N L+ +K+ DFG A + + V+ + G+ Y PE I
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 132 YNPKL----------ADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
+ + +D+WSLG I + M PF
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------------------------ 240
Query: 182 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL--SHQVKVKDILSHQVKN 239
I++ KL I+ +H+++ DI +++
Sbjct: 241 -----------------------------QIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPG 277
++ L+ D +RI + + AH +++ ++ ++ G
Sbjct: 272 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-42
Identities = 47/278 (16%), Positives = 94/278 (33%), Gaps = 82/278 (29%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M N DL +K+ + ++++ ML + +H
Sbjct: 83 YIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QH 127
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I H DLK N L+ +K+ DFG A + + V+ + G+ Y PE I
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 132 YNPKL----------ADIWSLGVITFIMLNAAMPFDD--SNLKQLFKEQTSNILSHQVKV 179
+ + +D+WSLG I + M PF + + +L N
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-------- 237
Query: 180 KDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239
H+++ DI +++
Sbjct: 238 ---------------------------------------------HEIEFPDIPEKDLQD 252
Query: 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPG 277
++ L+ D +RI + + AH +++ ++ ++ G
Sbjct: 253 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-41
Identities = 52/260 (20%), Positives = 100/260 (38%), Gaps = 43/260 (16%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M N DL +K+ + ++++ ML + +H
Sbjct: 130 YIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QH 174
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I H DLK N L+ +K+ DFG A + + V+ + G+ Y PE I
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQ-MQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 132 YNPKL----------ADIWSLGVITFIMLNAAMPFDD--SNLKQLFKEQTSNILSHQVKV 179
+ + +D+WSLG I + M PF + + +L N H+++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN---HEIEF 289
Query: 180 KDILSHQVKVKDILSH--QVKVKDILSHQVKVKDILSH---QVKLKDILSHQVKVKDILS 234
DI ++D+L + K +S + ++L+H Q++ + + +
Sbjct: 290 PDIPEKD--LQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQTHPVNQMAKGTTEEMK 343
Query: 235 HQVKNLVGQILEPDITKRIR 254
+ + LVG I K +
Sbjct: 344 YVLGQLVGLNSPNSILKAAK 363
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 25/164 (15%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+I + + G+L D + + E+ + +F QML ++YLH
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--------------E 257
Query: 71 KNIAHRDLKCENILMT---KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
I HRDLK EN+L++ + +KI DFG ++ + L RT CG+ Y APEV+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVL 313
Query: 128 SGN---PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168
YN D WSLGVI FI L+ PF + + K+Q
Sbjct: 314 VSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-40
Identities = 50/161 (31%), Positives = 72/161 (44%), Gaps = 24/161 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ I + AD GDL IK + E +F Q+ + LE++H
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH------------ 153
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S+ + HRD+K N+ +T VK+ D G R+ K + + G+ Y +PE I
Sbjct: 154 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERI 208
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFK 166
N YN K +DIWSLG + + M PF D NL L K
Sbjct: 209 HENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 25/164 (15%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+I + + G+L D + + E+ + +F QML ++YLH
Sbjct: 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--------------E 132
Query: 71 KNIAHRDLKCENILMT---KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
I HRDLK EN+L++ + +KI DFG ++ + L RT CG+ Y APEV+
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVL 188
Query: 128 SGN---PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168
YN D WSLGVI FI L+ PF + + K+Q
Sbjct: 189 VSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-39
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 25/160 (15%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
F+ G+L D++ ++E R +L + LH N
Sbjct: 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--------------KLN 144
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-- 130
I HRDLK ENIL+ N+K+ DFGF+ G ++ R CG+ +Y APE+I +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKL--REVCGTPSYLAPEIIECSMN 200
Query: 131 ----PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
Y + D+WS GVI + +L + PF + +
Sbjct: 201 DNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-39
Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ M G+L + + ES+A +L+ + Y H N
Sbjct: 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH--------------KLN 126
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+AHRDLK EN L +K+ DFG A K G+ + RT G+ Y +P+V+ G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMM--RTKVGTPYYVSPQVLEG 182
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y P+ D WS GV+ +++L PF ++ +
Sbjct: 183 L-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-39
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ G+L + I +E++A Q+L + Y H S
Sbjct: 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--------------SNG 125
Query: 73 IAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HR+LK EN+L+ + VK+ADFG A + + G+ Y +PEV+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAW--HGFAGTPGYLSPEVLKK 181
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
+PY+ DIW+ GVI +I+L PF D + +L+ +
Sbjct: 182 DPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-39
Identities = 50/183 (27%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ + YA NG+LL +I++ G E+ R + +++++ LEYLH K
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--------------GK 149
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I HRDLK ENIL+ + +++I DFG A+ E ++ + ++ G+A Y +PE+++
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP-ESKQARANSFVGTAQYVSPELLTEKS 208
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
K +D+W+LG I + ++ PF N +F+ I+ + + K +D
Sbjct: 209 AC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----KIIKLEYDFPEKFFP--KARD 261
Query: 192 ILS 194
++
Sbjct: 262 LVE 264
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+F+ G+L D++ ++E R+ +L + +LH + N
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH--------------ANN 220
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-- 130
I HRDLK ENIL+ ++++DFGF+ + + G ++ R CG+ Y APE++ +
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKL--RELCGTPGYLAPEILKCSMD 276
Query: 131 ----PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y + D+W+ GVI F +L + PF + +
Sbjct: 277 ETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 44/173 (25%), Positives = 63/173 (36%), Gaps = 30/173 (17%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVA---ESNARTWFSQMLAGLEYLHREITN 60
++I M+ +L D + + S F Q+ +E+LH
Sbjct: 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----- 135
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR---------YCVDKEGRRVL 111
SK + HRDLK NI T VK+ DFG +
Sbjct: 136 ---------SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 112 SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
G+ Y +PE I GN Y+ K DI+SLG+I F +L PF +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERVR 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ G+L + I +E++A Q+L + Y H S
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--------------SNG 148
Query: 73 IAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HR+LK EN+L+ + VK+ADFG A + + G+ Y +PEV+
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAW--HGFAGTPGYLSPEVLKK 204
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
+PY+ DIW+ GVI +I+L PF D + +L+ +
Sbjct: 205 DPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ M+ G+L D I G E +A Q+L+ ++YLH
Sbjct: 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH--------------ENG 126
Query: 73 IAHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK EN+L + I DFG ++ + T CG+ Y APEV++
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGTPGYVAPEVLAQ 181
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
PY+ D WS+GVIT+I+L PF + +LF++
Sbjct: 182 KPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEK 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-37
Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 23/161 (14%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
+ G +++ L H + G + E+ + L L +LH
Sbjct: 127 EEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----------- 174
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S+ + H D+K NI + R K+ DFG G Y APE+
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG----EVQEGDPRYMAPEL 227
Query: 127 ISGNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFK 166
+ G Y AD++SLG+ + N +P +QL +
Sbjct: 228 LQG-SYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-37
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 28/164 (17%)
Query: 12 RVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
++ + + G L + I+R + E + GLE +H
Sbjct: 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH------------ 151
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-YCVDKEGRRVLSR-----TYCGSAAY 121
+K AHRDLK NIL+ + D G C+ EG R + +Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 122 AAPEVISGNPY---NPKLADIWSLGVITFIMLNAAMPFDDSNLK 162
APE+ S + + + D+WSLG + + M+ P+D K
Sbjct: 210 RAPELFSVQSHCVIDER-TDVWSLGCVLYAMMFGEGPYDMVFQK 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 13 VFIFMRYADNGDLLDHI----KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
++I M + G+LL+ I R ++E QM+ L Y H
Sbjct: 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH------------- 141
Query: 69 PSKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
S+++ H+DLK ENIL +KI DFG A E S G+A Y APE
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPE 196
Query: 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
V + K DIWS GV+ + +L +PF ++L+++ ++
Sbjct: 197 VFKRD-VTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ G+L + I +E++A Q+L + + H
Sbjct: 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH--------------QMG 130
Query: 73 IAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+ HR+LK EN+L+ + VK+ADFG A + ++ + G+ Y +PEV+
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWF-GFAGTPGYLSPEVLRK 187
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
+PY D+W+ GVI +I+L PF D + +L+++
Sbjct: 188 DPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 27/166 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V + + G+L D + + E A + Q+L G+ YLH SK
Sbjct: 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH--------------SKR 128
Query: 73 IAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
IAH DLK ENI++ + +K+ DFG A + G + G+ + APE+++
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEF--KNIFGTPEFVAPEIVN 184
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
P + AD+WS+GVIT+I+L+ A PF ++ NI +
Sbjct: 185 YEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLT----NISA 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 13 VFIFMRYADNGDLLDHI--KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ + + YA G++ + A V+E++ Q+L G+ YLH
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--------------Q 149
Query: 71 KNIAHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
NI H DLK +NIL++ + ++KI DFG +R + R G+ Y APE++
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACEL--REIMGTPEYLAPEIL 205
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
+ +P D+W++G+I +++L PF + ++ + NI
Sbjct: 206 NYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYL----NISQ 247
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
V++ G+LLD I R +E A + +EYLH ++
Sbjct: 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH--------------AQ 135
Query: 72 NIAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
+ HRDLK NIL +++I DFGFA+ + G L T C +A + APEV+
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTANFVAPEVL 192
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFD---DSNLKQLFK 166
Y+ DIWSLGV+ + ML PF D +++
Sbjct: 193 ERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 21/152 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
F+ M + G+L + IK+ +E+ A ++++ + ++H
Sbjct: 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH--------------DV 125
Query: 72 NIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
+ HRDLK EN+L T +KI DFGFAR + L T C + YAAPE+++
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLK-TPCFTLHYAAPELLN 182
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
N Y+ D+WSLGVI + ML+ +PF +
Sbjct: 183 QNGYDES-CDLWSLGVILYTMLSGQVPFQSHD 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-36
Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+I G+L D I + +E +A Q+ +G+ Y+H N
Sbjct: 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH--------------KHN 141
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK ENIL+ + ++KI DFG + ++ ++ + G+A Y APEV+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM--KDRIGTAYYIAPEVLRG 197
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y+ K D+WS GVI +I+L+ PF N + K
Sbjct: 198 -TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 13 VFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+ G L++ +K+ GP++ F Q ++++HR P
Sbjct: 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPP------ 158
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLS--RTYCGSAA 120
I HRDLK EN+L++ + +K+ DFG A Y + R ++ T +
Sbjct: 159 ---IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215
Query: 121 YAAPEVI---SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
Y PE+I S P K DIW+LG I +++ PF+D +
Sbjct: 216 YRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFEDGAKLR 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 27/166 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V + + G+L D + + ++E A ++ Q+L G+ YLH +K
Sbjct: 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--------------TKK 135
Query: 73 IAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
IAH DLK ENI++ + ++K+ DFG A ++G + G+ + APE+++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEF--KNIFGTPEFVAPEIVN 191
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
P + AD+WS+GVIT+I+L+ A PF ++ NI S
Sbjct: 192 YEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITS 232
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 44/210 (20%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVA---ESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
++I M+ +L D + R + F Q+ +E+LH
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH------------- 181
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR---------TYCGSA 119
SK + HRDLK NI T VK+ DFG E + + G+
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN-----LKQLFKEQTSNILS 174
Y +PE I GN Y+ K DI+SLG+I F +L F + + + + +
Sbjct: 241 LYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFT 296
Query: 175 HQVK-----VKDILSHQVK----VKDILSH 195
+ V+D+LS DI+ +
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 62/277 (22%), Positives = 101/277 (36%), Gaps = 62/277 (22%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ + R ++ G +L HI + E A + + L++LH
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH----- 128
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLS----R 113
+K IAHRDLK ENIL VKI DF +S
Sbjct: 129 ---------NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 114 TYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQ 168
T CGSA Y APEV+ + Y+ + D+WSLGVI +I+L+ PF ++
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 169 TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228
+ Q + + I + + D K
Sbjct: 239 GEACPACQNMLFES-----------------------------IQEGKYEFPD------K 263
Query: 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265
+S K+L+ ++L D +R+ + H W++
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ + + G+L + I E +A Q+L+G+ YLH N
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH--------------KHN 166
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRD+K ENIL+ + N+KI DFG + + + ++ R G+A Y APEV+
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKL--RDRLGTAYYIAPEVLKK 222
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
YN K D+WS GVI +I+L PF N + + K+
Sbjct: 223 K-YNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ + + G+L D I G +E +A Q+L + YLH
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH--------------ENG 168
Query: 73 IAHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK EN+L +KIADFG ++ + + +T CG+ Y APE++ G
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLM--KTVCGTPGYCAPEILRG 224
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPF-DDSNLKQLFKE 167
Y P+ D+WS+G+IT+I+L PF D+ + +F+
Sbjct: 225 CAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+ Q +F M Y + GDL+ HI+ S A + ++++ GL++LH
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH------ 135
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +NIL+ K ++KIADFG + + + + + T+CG+ Y
Sbjct: 136 --------SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE++ G YN D WS GV+ + ML PF + ++LF +I
Sbjct: 185 IAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMDNPFYPR 239
Query: 182 ILSHQVKVKDILS 194
L + KD+L
Sbjct: 240 WLE--KEAKDLLV 250
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-35
Identities = 44/212 (20%), Positives = 72/212 (33%), Gaps = 60/212 (28%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVA------------------------ 36
+++ + + + + M G LLD + +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 37 ----------------ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80
E Q+ + L YLH ++ I HRD+K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--------------NQGICHRDIKP 196
Query: 81 ENILMTKR--FNVKIADFGFARYCV-DKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPK 135
EN L + F +K+ DFG ++ G T G+ + APEV++ Y PK
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 136 LADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
D WS GV+ ++L A+PF N +
Sbjct: 257 -CDAWSAGVLLHLLLMGAVPFPGVNDADTISQ 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 27/166 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V + + G+L D + + ++E A ++ Q+L G+ YLH +K
Sbjct: 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--------------TKK 135
Query: 73 IAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
IAH DLK ENI++ + ++K+ DFG A ++G + G+ + APE+++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEF--KNIFGTPEFVAPEIVN 191
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
P + AD+WS+GVIT+I+L+ A PF ++ NI +
Sbjct: 192 YEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITA 232
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V + + G+L D + + E A + Q+L G+ YLH S
Sbjct: 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--------------SLQ 134
Query: 73 IAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
IAH DLK ENI++ R +KI DFG A G + G+ + APE+++
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEF--KNIFGTPEFVAPEIVN 190
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
P + AD+WS+GVIT+I+L+ A PF ++
Sbjct: 191 YEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLAN 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 28/195 (14%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+ Q R+F M + + GDL+ HI+++ E+ AR + +++++ L +LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH------ 141
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
K I +RDLK +N+L+ + K+ADFG KEG V + T+CG+
Sbjct: 142 --------DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTTATFCGTP 188
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APE++ Y D W++GV+ + ML PF+ N LF+ IL+ +V
Sbjct: 189 DYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE----AILNDEVVY 243
Query: 180 KDILSHQVKVKDILS 194
L IL
Sbjct: 244 PTWLH--EDATGILK 256
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ G+L D I +E +A Q+L+G+ Y+H
Sbjct: 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH--------------KNK 146
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK EN+L+ + N++I DFG + + + +++ + G+A Y APEV+ G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKM--KDKIGTAYYIAPEVLHG 202
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y+ K D+WS GVI +I+L+ PF+ +N + K+
Sbjct: 203 T-YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 24/194 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ Q R+ M YA+ G+L H+ R E AR + +++++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH----- 122
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S+++ +RD+K EN+++ K ++KI DFG + + +T+CG+
Sbjct: 123 ---------SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPE 170
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEV+ N Y + D W LGV+ + M+ +PF + + ++LF+ IL +++
Sbjct: 171 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP 225
Query: 181 DILSHQVKVKDILS 194
LS + K +L+
Sbjct: 226 RTLS--PEAKSLLA 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
Q G ++++ + Y G+L ++R G E A + +++ L +LH
Sbjct: 87 IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-------- 138
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
K I +RDLK ENI++ + +VK+ DFG + + + T+CG+ Y A
Sbjct: 139 ------QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMA 189
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDIL 183
PE++ + +N + D WSLG + + ML A PF N K+ IL ++ + L
Sbjct: 190 PEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTID----KILKCKLNLPPYL 244
Query: 184 SHQVKVKDILS 194
+ + +D+L
Sbjct: 245 T--QEARDLLK 253
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVA----ESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+++ + D DL I + E+ A + Q+L L Y H
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH------------- 147
Query: 69 PSKNIAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
NI HRD+K +L+ + N VK+ FG A + + G G+ + APE
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGLVA--GGRVGTPHFMAPE 203
Query: 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
V+ PY D+W GVI FI+L+ +PF + ++LF+
Sbjct: 204 VVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEG 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 63/184 (34%), Positives = 98/184 (53%), Gaps = 27/184 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++F+ M Y + G+L ++++ A+ + +++ LEYLH SK
Sbjct: 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--------------SK 125
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
+I +RDLK ENIL+ K ++KI DFGFA+Y D + T CG+ Y APEV+S P
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKP 179
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
YN K D WS G++ + ML PF DSN + ++ IL+ +++ + VKD
Sbjct: 180 YN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFPPFFNED--VKD 232
Query: 192 ILSH 195
+LS
Sbjct: 233 LLSR 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 49/191 (25%), Positives = 93/191 (48%), Gaps = 24/191 (12%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
H Q ++++ + + GDL + + E + + + +++ L++LH
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-------- 143
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
S I +RDLK ENIL+ + ++K+ DFG ++ +D E + + ++CG+ Y A
Sbjct: 144 ------SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMA 194
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDIL 183
PEV++ + + AD WS GV+ F ML +PF + K+ IL ++ + L
Sbjct: 195 PEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MILKAKLGMPQFL 249
Query: 184 SHQVKVKDILS 194
S + + +L
Sbjct: 250 SPE--AQSLLR 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVA--ESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+ I M + G+L I+ G A E A + +++LH
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-------------- 145
Query: 70 SKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S NIAHRD+K EN+L T + +K+ DFGFA+ +T C + Y APEV
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYYVAPEV 200
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
+ Y+ D+WSLGVI +I+L PF + + + I
Sbjct: 201 LGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+I G+L D I + +E +A Q+ +G+ Y+H N
Sbjct: 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH--------------KHN 141
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK ENIL+ + ++KI DFG + ++ ++ + G+A Y APEV+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM--KDRIGTAYYIAPEVLRG 197
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y+ K D+WS GVI +I+L+ PF N + K
Sbjct: 198 T-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 24/191 (12%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
H Q +++ + Y + G+L H++R E AR + +++ + L YLH
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-------- 156
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
S NI +RDLK ENIL+ + ++ + DFG + ++ + T+CG+ Y A
Sbjct: 157 ------SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLA 207
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDIL 183
PEV+ PY+ + D W LG + + ML PF N +++ NIL+ +++K +
Sbjct: 208 PEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKPNI 262
Query: 184 SHQVKVKDILS 194
+ + +L
Sbjct: 263 T--NSARHLLE 271
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 28/195 (14%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R++ M Y + GDL+ HI++ G E +A + +++ GL +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ------ 138
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
SK I +RDLK +N+++ ++KIADFG KE V ++T+CG+
Sbjct: 139 --------SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTP 185
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APE+I+ PY K D W+ GV+ + ML PF+ + +LF+ +I+ H V
Sbjct: 186 DYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAY 240
Query: 180 KDILSHQVKVKDILS 194
+S + I
Sbjct: 241 PKSMS--KEAVAICK 253
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 27/184 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ M Y G++ H++R G +E +AR + +Q++ EYLH S
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH--------------SL 160
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
++ +RDLK EN+L+ ++ +++ DFGFA+ + + T CG+ APE+I
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKG 214
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
YN K D W+LGV+ + M PF Q+++ I+S +V+ S +KD
Sbjct: 215 YN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----KIVSGKVRFPSHFSSD--LKD 267
Query: 192 ILSH 195
+L +
Sbjct: 268 LLRN 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ M G+L D I E +A Q+L+G+ YLH N
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH--------------KHN 156
Query: 73 IAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRDLK EN+L+ + +KI DFG + + +++ + G+A Y APEV+
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKM--KERLGTAYYIAPEVLRK 212
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
Y+ K D+WS+GVI FI+L PF +++ ++
Sbjct: 213 K-YDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK 248
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 23/194 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ Q R+ M YA+ G+L H+ R +E AR + +++++ L+YLH E
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--- 267
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
KN+ +RDLK EN+++ K ++KI DFG + + +T+CG+
Sbjct: 268 ----------KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPE 314
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEV+ N Y + D W LGV+ + M+ +PF + + ++LF+ IL +++
Sbjct: 315 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFP 369
Query: 181 DILSHQVKVKDILS 194
L + K +LS
Sbjct: 370 RTLG--PEAKSLLS 381
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + + D+ + I A + E ++ Q+ L++LH S
Sbjct: 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--------------SH 121
Query: 72 NIAHRDLKCENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
NI H D++ ENI+ R + +KI +FG AR K G R + Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNF--RLLFTAPEYYAPEVHQH 177
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
+ + D+WSLG + +++L+ PF +Q+ + NI++
Sbjct: 178 DVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIE----NIMN 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 26/177 (14%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+Q++ + + + M Y D G+L D I + + E + + Q+ G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---- 204
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKR--FNVKIADFGFARYCVDKEGRRVLSRTYCG 117
I H DLK ENIL R +KI DFG AR K ++ + G
Sbjct: 205 ----------QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKL--KVNFG 250
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
+ + APEV++ + + D+WS+GVI +++L+ PF N + NIL+
Sbjct: 251 TPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLN----NILA 302
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 23/195 (11%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVA--ESNARTWFSQMLAGLEYLHREIT 59
+ + + + + + GDL HI G E+ A + +++ GLE LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---- 303
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+ I +RDLK ENIL+ +++I+D G A + + + + G+
Sbjct: 304 ----------RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTV 349
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APEV+ Y D W+LG + + M+ PF K +E + +
Sbjct: 350 GYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408
Query: 180 KDILSHQVKVKDILS 194
+ S + + + S
Sbjct: 409 SERFS--PQARSLCS 421
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-33
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVA--ESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
+ I M D G+L I+ G A E A + ++YLH
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-------------- 178
Query: 70 SKNIAHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S NIAHRD+K EN+L T + +K+ DFGFA+ T C + Y APEV
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEV 234
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+ Y+ D+WSLGVI +I+L PF ++
Sbjct: 235 LGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNH 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 49/170 (28%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
++ ++ GP V IFM + G L IK+ G + E A + Q L GLEYLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH------ 167
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKR-FNVKIADFGFARYCVDKEGRRVLSR--TYCGS 118
++ I H D+K +N+L++ + DFG A + L G+
Sbjct: 168 --------TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFI-MLNAAMPF-DDSNLKQLFK 166
+ APEV+ G P + K DIWS + MLN P+ K
Sbjct: 220 ETHMAPEVVMGKPCDAK-VDIWSSC-CMMLHMLNGCHPWTQYFRGPLCLK 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + + + G+L D I ++E+ + Q GL+++H
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--------------EH 168
Query: 72 NIAHRDLKCENILMTKR--FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+I H D+K ENI+ + +VKI DFG A E + + +A +AAPE++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDR 224
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
P D+W++GV+ +++L+ PF + + + N+
Sbjct: 225 EPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKR 264
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 24/193 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q+HS Q R++ M Y + GDL+ HI++ G E +A + +++ GL +L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ------ 459
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +N+++ ++KIADFG + + ++T+CG+ Y
Sbjct: 460 --------SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 508
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE+I+ PY K D W+ GV+ + ML PF+ + +LF+ +I+ H V
Sbjct: 509 IAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAYPK 563
Query: 182 ILSHQVKVKDILS 194
+S + I
Sbjct: 564 SMS--KEAVAICK 574
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + + G+L + + ++E A + Q+ GL ++H
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--------------EN 274
Query: 72 NIAHRDLKCENILMTKRF--NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
N H DLK ENI+ T + +K+ DFG + + V + G+A +AAPEV G
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSV--KVTTGTAEFAAPEVAEG 330
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
P D+WS+GV+++I+L+ PF N + + N+ S
Sbjct: 331 KPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLR----NVKSCD 372
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 37/204 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+HS Q R+F + Y + GDL+ H++R + E +AR + +++ L YLH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH------ 127
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
+ I +RDLK +N+L+ ++K+ D+G KEG + T+CG+
Sbjct: 128 --------ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTP 174
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF---------DDSNLKQLFKEQTS 170
Y APE++ G Y D W+LGV+ F M+ PF D + LF+
Sbjct: 175 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---- 229
Query: 171 NILSHQVKVKDILSHQVKVKDILS 194
IL Q+++ LS VK +L
Sbjct: 230 VILEKQIRIPRSLS--VKAASVLK 251
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-32
Identities = 26/192 (13%), Positives = 57/192 (29%), Gaps = 41/192 (21%)
Query: 23 GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82
LL H + Q++ L LH + H L+ +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--------------HYGLVHTYLRPVD 236
Query: 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----------GNP 131
I++ +R V + F ++G R S + PE+ +
Sbjct: 237 IVLDQRGGVFLTGFEHLV----RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE--QTSNILSHQVK--VKDILSHQV 187
D W+LG++ + + A +P + ++ + V+ ++ L +
Sbjct: 290 MTFS-FDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPK 348
Query: 188 K----VKDILSH 195
+ +
Sbjct: 349 EDRLLPLQAMET 360
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 19/192 (9%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
H Q ++ + + Y + G+L H+ + E + + +++ LE+LH
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-------- 176
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
I +RD+K ENIL+ +V + DFG ++ V E R + +CG+ Y A
Sbjct: 177 ------KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIEYMA 228
Query: 124 PEVISGNPYN-PKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDI 182
P+++ G K D WSLGV+ + +L A PF K E + IL +
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 183 LSHQVKVKDILS 194
+S KD++
Sbjct: 289 MS--ALAKDLIQ 298
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHI----KRAGPVAESNARTWFSQMLAGLEYLHRE 57
+ + + + M + GD+ HI + E A + +Q+++GLE+LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306
Query: 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG 117
+NI +RDLK EN+L+ NV+I+D G V+ + + ++ Y G
Sbjct: 307 ------------QRNIIYRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTKGYAG 351
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQV 177
+ + APE++ G Y+ D ++LGV + M+ A PF K KE +L V
Sbjct: 352 TPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410
Query: 178 KVKDILSHQVKVKDILS 194
D S KD
Sbjct: 411 TYPDKFS--PASKDFCE 425
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 24/162 (14%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+I + L +++ ++ T Q +GL +LH S
Sbjct: 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--------------SL 137
Query: 72 NIAHRDLKCENILMTK-----RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
NI HRDLK NIL++ + I+DFG + G+ + APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 127 ISGNPYNP--KLADIWSLGVITFIMLNA-AMPFDDSNLKQLF 165
+S + DI+S G + + +++ + PF S +Q
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 37/204 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+HS Q R+F + Y + GDL+ H++R + E +AR + +++ L YLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH------ 170
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSA 119
+ I +RDLK +N+L+ ++K+ D+G KEG + T+CG+
Sbjct: 171 --------ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTP 217
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF---------DDSNLKQLFKEQTS 170
Y APE++ G Y D W+LGV+ F M+ PF D + LF+
Sbjct: 218 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---- 272
Query: 171 NILSHQVKVKDILSHQVKVKDILS 194
IL Q+++ LS VK +L
Sbjct: 273 VILEKQIRIPRSLS--VKAASVLK 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-31
Identities = 36/245 (14%), Positives = 84/245 (34%), Gaps = 44/245 (17%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----PVAESNARTWFSQMLAGLEYLH 55
M+ +S + G LL+ I + + ++ +ML +E +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 56 REITNHTPFTAHLPSKNIAHRDLKCENILMTKRF-----------NVKIADFGFARYCVD 104
I H D+K +N ++ F + + D G + +
Sbjct: 190 --------------DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID-MK 234
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML-NAAMPFDDSN--- 160
+ + C ++ + E++S P+N + D + + + ML M +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 161 -LKQLFK-----EQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILS 214
+ LF+ + + + + D H + D+L ++K + K++ + +
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPD--CHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351
Query: 215 HQVKL 219
+ L
Sbjct: 352 RLIVL 356
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 31/189 (16%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+F+ + GDL H+++ E + + +++ L+YL ++
Sbjct: 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ--------------NQ 134
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--- 128
I HRD+K +NIL+ + +V I DF A + T G+ Y APE+ S
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRK 190
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPF---DDSNLKQLFKEQTSNILSHQVKVKDILSH 185
G Y+ D WSLGV + +L P+ ++ K++ + V S
Sbjct: 191 GAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFETTVVTYPSAWSQ 245
Query: 186 QVKVKDILS 194
+ + +L
Sbjct: 246 E--MVSLLK 252
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-30
Identities = 34/275 (12%), Positives = 66/275 (24%), Gaps = 75/275 (27%)
Query: 13 VFIFMRYA-----DNGDLLDHIKRAGPVAESNARTWFS-QMLAGLEYLHREITNHTPFTA 66
+ M A LD + A + Q++ L
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----------- 211
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
SK + H +N+ + + + D K G R YA E
Sbjct: 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTR--GPASSVPVTYAPREF 262
Query: 127 ISGN--PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILS 184
++ + + + W LG+ + + +P F T I + +
Sbjct: 263 LNASTATFTHA-LNAWQLGLSIYRVWCLFLP---------FGLVTPGIKGSWKRPSLRVP 312
Query: 185 HQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQI 244
+ + VK L+G+
Sbjct: 313 GTDSLAFGSCTPL------------------------------------PDFVKTLIGRF 336
Query: 245 LEPDITKRIRLDAIKAHDWLR-YKSMVRRKVLPGQ 278
L D +R+ ++ + + GQ
Sbjct: 337 LNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 35/174 (20%), Positives = 58/174 (33%), Gaps = 46/174 (26%)
Query: 12 RVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ I Y + G L D I E+ + Q+ GL Y+H
Sbjct: 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH------------ 132
Query: 68 LPSKNIAHRDLKCENILMTK-------------------RFNVKIADFGFARYCVDKEGR 108
S ++ H D+K NI +++ + KI D G R
Sbjct: 133 --SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-------TR 183
Query: 109 RVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161
+ G + + A EV+ N + PK ADI++L + A + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
++ + + GDL H+ + G +E++ R + ++++ GLE++H ++
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--------------NR 311
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-GN 130
+ +RDLK NIL+ + +V+I+D G A + + G+ Y APEV+ G
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
Y+ AD +SLG + F +L PF K E L+ V++ D S + ++
Sbjct: 367 AYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPE--LR 422
Query: 191 DILS 194
+L
Sbjct: 423 SLLE 426
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 49/286 (17%), Positives = 92/286 (32%), Gaps = 94/286 (32%)
Query: 13 VFIFMRYADNGDLLDHIKR-------AGPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65
++I + N +L D ++ E N + Q+ +G+ +LH
Sbjct: 84 LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---------- 132
Query: 66 AHLPSKNIAHRDLKCENILMT-------------KRFNVKIADFGFARYCV-DKEGRRVL 111
S I HRDLK +NIL++ + + I+DFG + + R
Sbjct: 133 ----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 112 SRTYCGSAAYAAPEVISGN-------PYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQ 163
G++ + APE++ + DI+S+G + + +L PF D
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKY--- 244
Query: 164 LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223
+ SNI+ + ++
Sbjct: 245 ---SRESNIIRGIFSLDEM----------------------------------------- 260
Query: 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269
+ L + +L+ Q+++ D KR + H KS
Sbjct: 261 --KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
Q +++ M Y GDL++ + V E AR + ++++ L+ +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIH------------ 185
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S HRD+K +N+L+ K ++K+ADFG + V T G+ Y +PEV+
Sbjct: 186 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVL 241
Query: 128 SGNPYNP---KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
+ + D WS+GV + ML PF +L + I++H+ +
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS----KIMNHKNSLT 293
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 41/190 (21%), Positives = 77/190 (40%), Gaps = 35/190 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPV-AESNARTWFSQMLAGLEYLHREITN 60
Q+H Q +++ M Y GDLL + + G AR + ++++ ++ +H
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----- 179
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR---VLSRTYCG 117
HRD+K +NIL+ + ++++ADFG + R V S G
Sbjct: 180 ---------RLGYVHRDIKPDNILLDRCGHIRLADFGSC-----LKLRADGTVRSLVAVG 225
Query: 118 SAAYAAPEVISG-------NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTS 170
+ Y +PE++ Y D W+LGV + M PF + + +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYG---- 280
Query: 171 NILSHQVKVK 180
I+ ++ +
Sbjct: 281 KIVHYKEHLS 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ + + +G L ++KR + R+W Q+L GL++LH T P
Sbjct: 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPP---- 151
Query: 68 LPSKNIAHRDLKCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
I HRDLKC+NI +T +VKI D G A R ++ G+ + APE+
Sbjct: 152 -----IIHRDLKCDNIFITGPTGSVKIGDLGLA-----TLKRASFAKAVIGTPEFMAPEM 201
Query: 127 ISGNPYNPKLADIWSLGVITFI-MLNAAMPFDD-SNLKQLFK 166
Y+ D+++ G + + M + P+ + N Q+++
Sbjct: 202 YE-EKYDES-VDVYAFG-MCMLEMATSEYPYSECQNAAQIYR 240
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITN 60
+H Q +++ M Y GDLL + + + E AR + ++M+ ++ +H
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----- 192
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ HRD+K +NILM ++++ADFG ++ + S G+
Sbjct: 193 ---------QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPD 241
Query: 121 YAAPEVISGNPYNP----KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQ 176
Y +PE++ D WSLGV + ML PF +L + + I++H+
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHK 297
Query: 177 VKVK 180
+ +
Sbjct: 298 ERFQ 301
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML---AGLEYLHREITNHTPFT 65
+ P + I Y G L + ++G + + R S G+ YLH
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-------- 156
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPE 125
+ I HR+LK N+L+ K++ VK+ DFG +R K + S++ G+ + APE
Sbjct: 157 ----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPE 209
Query: 126 VISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
V+ P N K +D++S GVI + + P+ + N Q
Sbjct: 210 VLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQ 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 8e-29
Identities = 24/147 (16%), Positives = 43/147 (29%), Gaps = 20/147 (13%)
Query: 23 GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCEN 82
LL H + Q++ L LH + H L+ +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--------------HYGLVHTYLRPVD 241
Query: 83 ILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKL----AD 138
I++ +R V + F D A ++ ++P L D
Sbjct: 242 IVLDQRGGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 139 IWSLGVITFIMLNAAMPFDDSNLKQLF 165
W+LG+ + + A +P D
Sbjct: 300 TWTLGLAIYWIWCADLPNTDDAALGGS 326
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 52/176 (29%), Positives = 68/176 (38%), Gaps = 32/176 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNG---DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREI 58
Q + IFM G LL E + Q+L GL+YLH
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--- 139
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENIL-MTKRFNVKIADFGFARYCVDKEGRRVLSRTYCG 117
I HRD+K +N+L T +KI+DFG ++ T+ G
Sbjct: 140 -----------DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT---ETFTG 185
Query: 118 SAAYAAPEVISGNP--YNPKLADIWSLGVITFI-MLNAAMPFDDSNLKQ----LFK 166
+ Y APE+I P Y ADIWSLG T I M PF L + +FK
Sbjct: 186 TLQYMAPEIIDKGPRGYGKA-ADIWSLG-CTIIEMATGKPPF--YELGEPQAAMFK 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ I M + D G L +K+AG + E ++ GL YL +
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK----------- 150
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
I HRD+K NIL+ R +K+ DFG + +D ++ ++ G+ +Y +PE +
Sbjct: 151 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ 203
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
G Y+ + +DIWS+G+ M P + K+L
Sbjct: 204 GTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 27/149 (18%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
+ R+ Y G L IK + R F++ +A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH------------ 125
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD-----------KEGRRVLSRTYC 116
S NI HRDL N L+ + NV +ADFG AR VD K+ R T
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 117 GSAAYAAPEVISGNPYNPKLADIWSLGVI 145
G+ + APE+I+G Y+ K D++S G++
Sbjct: 184 GNPYWMAPEMINGRSYDEK-VDVFSFGIV 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 49/148 (33%), Positives = 70/148 (47%), Gaps = 22/148 (14%)
Query: 15 IFMRYADNGDLLDHIKRAGPVAESNARTWFSQML---AGLEYLHREITNHTPFTAHLPSK 71
+ M YA+ G L + + A P+ A S L G+ YLH + P K
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH----SMQP-------K 124
Query: 72 NIAHRDLKCENILMTKRFNV-KIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
+ HRDLK N+L+ V KI DFG A D + GSAA+ APEV G+
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMT---NNKGSAAWMAPEVFEGS 178
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDD 158
Y+ K D++S G+I + ++ PFD+
Sbjct: 179 NYSEK-CDVFSWGIILWEVITRRKPFDE 205
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
P++ I ++ + L H+ + E ++ A G++YLH
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH------------ 137
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
+K+I HRDLK NI + + VKI DFG A G GS + APEVI
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVI 194
Query: 128 ---SGNPYNPKLADIWSLGVITFIMLNAAMPFDD-SNLKQ 163
NPY+ + +D+++ G++ + ++ +P+ + +N Q
Sbjct: 195 RMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 21/167 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H + ++++ MR + DL ++R GP+A A Q+ + L+ H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA----- 152
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRT--YCGSA 119
HRD+K ENIL++ + DFG A E L++ G+
Sbjct: 153 ---------AGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEK---LTQLGNTVGTL 199
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
Y APE S + + ADI++L + + L + P+ L +
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGA 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 22/160 (13%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ +++I M Y G LD + GP+ E+ T ++L GL+YLH
Sbjct: 91 KDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH------------- 136
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
S+ HRD+K N+L+++ VK+ADFG A D + +R T+ G+ + APEVI
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIK 192
Query: 129 GNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
+ Y+ K ADIWSLG IT I + P + + +K LF
Sbjct: 193 QSAYDSK-ADIWSLG-ITAIELARGEPPHSELHPMKVLFL 230
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 26/158 (16%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ P + + M +A G L + + W Q+ G+ YLH +
Sbjct: 77 KEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLH----DEAIVP--- 128
Query: 69 PSKNIAHRDLKCENILMTKRF--------NVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRDLK NIL+ ++ +KI DFG AR E R + G+ A
Sbjct: 129 ----IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYA 179
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158
+ APEVI + ++ +D+WS GV+ + +L +PF
Sbjct: 180 WMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 54/161 (33%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 9 RGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ ++I M Y G + D I+ R + E T L GLEYLH
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH------------ 142
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
HRD+K NIL+ + K+ADFG A D +R T G+ + APEVI
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVI 197
Query: 128 SGNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
YN ADIWSLG IT I M P+ D + ++ +F
Sbjct: 198 QEIGYNCV-ADIWSLG-ITAIEMAEGKPPYADIHPMRAIFM 236
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 13/141 (9%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++++ Y + G L D+++ + + + +GL +LH EI
Sbjct: 79 TQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIF------GTQGK 131
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY-CGSAAYAAPEVISG 129
IAHRDLK +NIL+ K IAD G A + + G+ Y APEV+
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 130 NPYNP-----KLADIWSLGVI 145
K DIW+ G++
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLV 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 15/150 (10%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
GP +I M Y D L D + GP+ A + L + H+
Sbjct: 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ----------- 134
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
I HRD+K NI+++ VK+ DFG AR D + G+A Y +PE
Sbjct: 135 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFD 157
G+ + + +D++SLG + + +L PF
Sbjct: 192 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFT 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
G +++ M + G L D I + E T +L L YLH
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH------------- 158
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
++ + HRD+K ++IL+T VK++DFGF +R ++ G+ + APEVIS
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVIS 214
Query: 129 GNPYNPKLADIWSLGVITFI-MLNAAMP-FDDSNLKQLFK 166
+ Y + DIWSLG I I M++ P F DS ++ + +
Sbjct: 215 RSLYATE-VDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKR 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
G +++ M Y G L D + + E + L LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH------------- 133
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
S + HRD+K +NIL+ +VK+ DFGF ++ +R T G+ + APEV++
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVT 189
Query: 129 GNPYNPKLADIWSLGVITFI-MLNAAMP-FDDSNLKQLFK 166
Y PK DIWSLG I I M+ P +++ L+ L+
Sbjct: 190 RKAYGPK-VDIWSLG-IMAIEMIEGEPPYLNENPLRALYL 227
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
VFI M + GP+ E ++ L YL +
Sbjct: 95 TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK----------- 143
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI- 127
+ HRD+K NIL+ +R +K+ DFG + VD + + G AAY APE I
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPERID 197
Query: 128 ----SGNPYNPKLADIWSLGVITFI-MLNAAMPFDD--SNLKQLFK 166
+ Y+ + AD+WSLG I+ + + P+ + ++ + L K
Sbjct: 198 PPDPTKPDYDIR-ADVWSLG-ISLVELATGQFPYKNCKTDFEVLTK 241
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 37/167 (22%), Positives = 60/167 (35%), Gaps = 28/167 (16%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
P + I L ++ A V + N +Q + G+ YLH
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH------------ 147
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGSAAYAAPE 125
+K I H+DLK +N+ V I DFG + R R G + APE
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 126 VISG---------NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
+I P++ +D+++LG I + + PF +
Sbjct: 205 IIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEA 250
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 40/142 (28%), Positives = 61/142 (42%), Gaps = 15/142 (10%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++++ Y +NG L D++K + + ++GL +LH EI T P
Sbjct: 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEI----FSTQGKP- 161
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY-CGSAAYAAPEVISG 129
IAHRDLK +NIL+ K IAD G A + + G+ Y PEV+
Sbjct: 162 -AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 130 ------NPYNPKLADIWSLGVI 145
AD++S G+I
Sbjct: 221 SLNRNHFQSYIM-ADMYSFGLI 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-24
Identities = 27/153 (17%), Positives = 52/153 (33%), Gaps = 24/153 (15%)
Query: 10 GPRVFIFMRYADNGDLLD--HIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
P + + G L + H V +S A + M G+ +LH
Sbjct: 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---------- 130
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
I L ++++ + +I+ + A+ APE +
Sbjct: 131 --EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--------GRMYAPAWVAPEAL 180
Query: 128 SGNPYNP--KLADIWSLGVITFIMLNAAMPFDD 158
P + + AD+WS V+ + ++ +PF D
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-24
Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 15/142 (10%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++++ Y ++G L D++ R V +GL +LH EI T P
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI----VGTQGKP- 166
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY-CGSAAYAAPEVISG 129
IAHRDLK +NIL+ K IAD G A ++ + G+ Y APEV+
Sbjct: 167 -AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 130 N------PYNPKLADIWSLGVI 145
+ + ADI+++G++
Sbjct: 226 SINMKHFESFKR-ADIYAMGLV 246
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 15 IFMRYADNGDLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ M + G + D IK + + E ++L GL +LH
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--------------QHK 149
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI----- 127
+ HRD+K +N+L+T+ VK+ DFG + GRR T+ G+ + APEVI
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTPYWMAPEVIACDEN 206
Query: 128 SGNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
Y+ K +D+WSLG IT I M A P D + ++ LF
Sbjct: 207 PDATYDFK-SDLWSLG-ITAIEMAEGAPPLCDMHPMRALFL 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 17/148 (11%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++ M Y + L ++I+ GP++ A + +Q+L G+++ H
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD------------- 129
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
I HRD+K +NIL+ +KI DFG A+ E + G+ Y +PE G
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 130 NPYNPKLADIWSLGVITFIMLNAAMPFD 157
+ DI+S+G++ + ML PF+
Sbjct: 187 EATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 27/157 (17%)
Query: 15 IFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
+ M + GDL + +A P+ S + G+EY+ N P I
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNP--------PI 145
Query: 74 AHRDLKCENILMTKR-----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
HRDL+ NI + K+ADFG ++ V G+ + APE I
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIG 199
Query: 129 GN--PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQ 163
Y K AD +S +I + +L PFD+ + +
Sbjct: 200 AEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 9 RGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+++I + + G + + + E + QML L +LH
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 134
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
SK I HRDLK N+LMT ++++ADFG + + +R ++ G+ + APEV+
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGTPYWMAPEVV 189
Query: 128 -----SGNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
PY+ K ADIWSLG IT I M P + N ++ L K
Sbjct: 190 MCETMKDTPYDYK-ADIWSLG-ITLIEMAQIEPPHHELNPMRVLLK 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 29/170 (17%)
Query: 7 LQRGPRVFIFMRYADNG--DLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
L R V+I M D + + + E ++ LE+LH +
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK------ 128
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
++ HRD+K N+L+ VK+ DFG + Y VD + G Y A
Sbjct: 129 -------LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMA 177
Query: 124 PEVISGN----PYNPKLADIWSLGVITFI-MLNAAMPFDDSN--LKQLFK 166
PE I+ Y+ K +DIWSLG IT I + P+D +QL +
Sbjct: 178 PERINPELNQKGYSVK-SDIWSLG-ITMIELAILRFPYDSWGTPFQQLKQ 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 36/161 (22%), Positives = 61/161 (37%), Gaps = 26/161 (16%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
H+ P +I M Y L + PVAE A + ++L L YLH
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALSYLHS------- 200
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
+ + DLK ENI++T+ +K+ D G ++ G G+ + A
Sbjct: 201 -------IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFG------YLYGTPGFQA 245
Query: 124 PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQL 164
PE++ P DI+++G + + + L
Sbjct: 246 PEIVRTGP-TVA-TDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 45/167 (26%), Positives = 64/167 (38%), Gaps = 45/167 (26%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVA--ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ I M D G+L I+ G A E A + ++YLH S
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--------------S 135
Query: 71 KNIAHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
NIAHRD+K EN+L T + +K+ DFGFA E
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------------KETT 171
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
Y+ D+WSLGVI +I+L PF ++ + + I
Sbjct: 172 GEK-YDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 40/171 (23%), Positives = 61/171 (35%), Gaps = 30/171 (17%)
Query: 7 LQRGPRVFIFMRYADNG--DLLDHIK--RAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
L R +I M ++ + E + L +L
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN----- 144
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
I HRD+K NIL+ + N+K+ DFG + VD + G Y
Sbjct: 145 --------LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYM 192
Query: 123 APEVISGN----PYNPKLADIWSLGVITFI-MLNAAMPFDDSN--LKQLFK 166
APE I + Y+ + +D+WSLG IT + P+ N QL +
Sbjct: 193 APERIDPSASRQGYDVR-SDVWSLG-ITLYELATGRFPYPKWNSVFDQLTQ 241
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 19 YADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78
+ + G L D +K V+ + M GL YLH +I P I+HRD+
Sbjct: 103 FHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDI----PGLKDGHKPAISHRDI 157
Query: 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----NPYN 133
K +N+L+ IADFG A + + G+ Y APEV+ G
Sbjct: 158 KSKNVLLKNNLTACIADFGLAL-KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216
Query: 134 PKLADIWSLGVI 145
+ D++++G++
Sbjct: 217 LR-IDMYAMGLV 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 34/147 (23%), Positives = 56/147 (38%), Gaps = 19/147 (12%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ M Y NG L ++ ++ + GL YLH E+ +
Sbjct: 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK----- 138
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFAR-----YCVDKEGRRVLSRTYCGSAAYAAPE 125
I+HRDL N+L+ I+DFG + V + + G+ Y APE
Sbjct: 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 126 VISG-------NPYNPKLADIWSLGVI 145
V+ G + D+++LG+I
Sbjct: 199 VLEGAVNLRDXESALKQ-VDMYALGLI 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 9 RGPRVFIFMRYADNGDLLDHIK--------RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ M+ G +LD IK ++G + ES T ++L GLEYLH
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----- 138
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSR--TYCGS 118
HRD+K NIL+ + +V+IADFG + + T+ G+
Sbjct: 139 ---------KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 119 AAYAAPEVIS-GNPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLF 165
+ APEV+ Y+ K ADIWS G IT I + A P+ +K L
Sbjct: 190 PCWMAPEVMEQVRGYDFK-ADIWSFG-ITAIELATGAAPYHKYPPMKVLM 237
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-21
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 28/171 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + ++ R ++ + D+ +LD ++ + + + Q++ G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH----- 141
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S NI HRD+K ENIL+++ VK+ DFGFAR Y A
Sbjct: 142 ---------SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------GEVYDDEVA 186
Query: 121 ---YAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y APE++ G Y + D+W++G + M F DS++ QL+
Sbjct: 187 TRWYRAPELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-21
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 28/171 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + +R R+ + Y D+ +L + V E ++ Q L + + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH----- 119
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
N HRD+K ENIL+TK +K+ DFGFAR S Y A
Sbjct: 120 ---------KHNCIHRDVKPENILITKHSVIKLCDFGFARLL------TGPSDYYDDEVA 164
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y +PE++ G+ Y P + D+W++G + +L+ + S++ QL+
Sbjct: 165 TRWYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 30/159 (18%), Positives = 57/159 (35%), Gaps = 25/159 (15%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
+++ + G D I + E +L L+Y+H
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----------- 145
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYA 122
HR +K +IL++ V ++ + R+ + +
Sbjct: 146 ---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 123 APEVI--SGNPYNPKLADIWSLGVITFI-MLNAAMPFDD 158
+PEV+ + Y+ K +DI+S+G IT + N +PF D
Sbjct: 203 SPEVLQQNLQGYDAK-SDIYSVG-ITACELANGHVPFKD 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-20
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
++H +L ++ + + D DL + G + +++ Q+L GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----- 118
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S+N+ HRDLK +N+L+ + +K+A+FG AR + R Y
Sbjct: 119 ---------SRNVLHRDLKPQNLLINRNGELKLANFGLARAF------GIPVRCYSAEVV 163
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFK 166
Y P+V+ G Y+ + D+WS G I + NA P + QL +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 47/164 (28%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 9 RGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
R ++ M Y G D ++ P+ E L GL YLH
Sbjct: 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH------------ 171
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
S N+ HRD+K NIL+++ VK+ DFG A ++ G+ + APEVI
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPA---NSFVGTPYWMAPEVI 222
Query: 128 SG---NPYNPKLADIWSLGVITFI-MLNAAMPFDDSN-LKQLFK 166
Y+ K D+WSLG IT I + P + N + L+
Sbjct: 223 LAMDEGQYDGK-VDVWSLG-ITCIELAERKPPLFNMNAMSALYH 264
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 3 VHSILQRGPRVFIFMRYADNGDL---LDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
S R ++ + + D DL LD + G V + Q+L GL++LH
Sbjct: 84 TVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLH---- 137
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR---RVLSRTYC 116
S + HRDLK +NIL+T +K+ADFG AR + V++
Sbjct: 138 ----------SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW-- 184
Query: 117 GSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y APEV+ + Y + D+WS+G I M F S++ QL K
Sbjct: 185 ----YRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 31/171 (18%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVA--ESNARTWFSQMLAGLEYLHREITN 60
S R +V + + D DL ++ +A P + Q L GL++LH
Sbjct: 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----- 137
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR---RVLSRTYCG 117
+ I HRDLK ENIL+T VK+ADFG AR + V++
Sbjct: 138 ---------ANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLW--- 184
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN--AAMPFDDSNLKQLFK 166
Y APEV+ + Y + D+WS+G I M +S QL K
Sbjct: 185 ---YRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFC-GNSEADQLGK 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ ++ + + + + DL + + +S + + Q+L G+ + H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----- 136
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRDLK +N+L+ +K+ADFG AR + R+Y
Sbjct: 137 ---------QHRILHRDLKPQNLLINSDGALKLADFGLARAF------GIPVRSYTHEVV 181
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y AP+V+ G+ Y+ + DIWS+G I M+ F ++ QL K
Sbjct: 182 TLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-19
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ ++ R+ + + D DL + G + A+++ Q+L G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----- 117
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ + HRDLK +N+L+ + +KIADFG AR + R Y
Sbjct: 118 ---------DRRVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIV 162
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y AP+V+ G+ Y+ + DIWS+G I M+N F S QL +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 32/175 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
++ S++ R+ + YA+N DL ++ + V+ +++ Q++ G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH------ 149
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRF-----NVKIADFGFARYCVDKEGRRVLSRTYC 116
S+ HRDLK +N+L++ +KI DFG AR R +
Sbjct: 150 --------SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP------IRQFT 195
Query: 117 GSAA---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y PE++ G+ Y+ + DIWS+ I ML F DS + QLFK
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 56/269 (20%), Positives = 104/269 (38%), Gaps = 34/269 (12%)
Query: 24 DLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81
+LL IK+ + + Q+L GL+Y+HR I H D+K E
Sbjct: 115 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-------------GIIHTDIKPE 161
Query: 82 NILM------TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPK 135
N+LM +KIAD G A + + + +R Y +PEV+ G P+
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR------EYRSPEVLLGAPWGCG 215
Query: 136 LADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSH 195
ADIWS + F ++ F+ K+ + ++ +++ L + +
Sbjct: 216 -ADIWSTACLIFELITGDFLFEPDEGHSYTKDD--DHIAQIIELLGELPSYLLRNGKYTR 272
Query: 196 QVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRL 255
L + L+D+L+ + K + ++ + + +L+ D KR
Sbjct: 273 TFFNSRGLLRNISKL----KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328
Query: 256 DAIKAHDWLRYKSMVRRKVLPGQKLVHSN 284
+ H WL+ + +P ++L S
Sbjct: 329 GGLVNHPWLKDTLGMEEIRVPDRELYGSG 357
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-18
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 33/176 (18%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDL---LDH---IKRAGPVAESNARTWFSQMLAGLEYLH 55
+++ ++ ++ + + DN DL +D + + + + Q+L GL + H
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 56 REITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTY 115
I HRDLK +N+L+ KR +K+ DFG AR + T+
Sbjct: 126 --------------ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF------GIPVNTF 165
Query: 116 CGSAA---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y AP+V+ G+ Y+ + DIWS G I M+ F ++ +QL
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKL 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 28/171 (16%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITN 60
+H I+ + + Y D DL ++ + N + + Q+L GL Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----- 117
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+ + HRDLK +N+L+ +R +K+ADFG AR ++TY
Sbjct: 118 ---------RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP------TKTYDNEVV 162
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFK 166
Y P+++ G+ Y+ ++ D+W +G I + M F + +QL
Sbjct: 163 TLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREIT 59
+ + + + + + DL IK + + S+ + + L GLEYLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---- 129
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
I HRDLK N+L+ + +K+ADFG A+ +R Y
Sbjct: 130 ----------QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------NRAYTHQV 173
Query: 120 A---YAAPEVISGNP-YNPKLADIWSLGVITFIMLN--AAMPFDDSNLKQLFK 166
Y APE++ G Y + D+W++G I +L +P DS+L QL +
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLP-GDSDLDQLTR 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 41/160 (25%), Positives = 62/160 (38%), Gaps = 33/160 (20%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
Q+ P ++I M GD L ++ G A G+EYL
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--------- 230
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA-- 122
SK HRDL N L+T++ +KI+DFG +R D Y S
Sbjct: 231 -----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV--------YAASGGLRQV 277
Query: 123 -----APEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPF 156
APE ++ Y+ + +D+WS G+ + A P+
Sbjct: 278 PVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPY 316
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTP 63
+ P +I + G+LLD+++ S +Q+ + +EYL
Sbjct: 285 CTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-------- 335
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAA 123
KN HR+L N L+ + VK+ADFG +R + A
Sbjct: 336 ------KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTA 387
Query: 124 PEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
PE ++ N ++ K +D+W+ GV+ + I P+ +L Q+++
Sbjct: 388 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 39/165 (23%), Positives = 62/165 (37%), Gaps = 30/165 (18%)
Query: 11 PRVFIFMRYADNGDL---LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+++ + ++ DL L + S + +L GL Y+H
Sbjct: 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH------------ 141
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA---YAAP 124
I HRD+K N+L+T+ +K+ADFG AR + Y Y P
Sbjct: 142 --RNKILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNRVVTLWYRPP 197
Query: 125 EVISGNP-YNPKLADIWSLGVITFIMLN--AAMPFDDSNLKQLFK 166
E++ G Y P + D+W G I M M ++ QL
Sbjct: 198 ELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQ-GNTEQHQLAL 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 36/149 (24%), Positives = 53/149 (35%), Gaps = 37/149 (24%)
Query: 13 VFIFM-----RYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+F + K+ + ++ Q+L G+ YLH
Sbjct: 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH------------ 145
Query: 68 LPSKNIAHRDLKCENILMTKRFN----VKIADFGFARYCVDKEGRRVLSRTYCGSAA--- 120
+ + HRDLK NIL+ VKIAD GFAR +
Sbjct: 146 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF------NSPLKPLADLDPVVV 197
Query: 121 ---YAAPEVISGNP-YNPKLADIWSLGVI 145
Y APE++ G Y + DIW++G I
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIGCI 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 28/164 (17%)
Query: 10 GPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
V + + G LLD++ + + W Q+ G+ YL
Sbjct: 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE------------- 134
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAA 123
+ + HRDL N+L+ +VKI DFG A+ +E Y + A
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK------EYHAEGGKVPIKWMA 187
Query: 124 PEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E I Y + +D+WS GV + +M + P+D ++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 35/166 (21%), Positives = 65/166 (39%), Gaps = 28/166 (16%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTP 63
I++ ++I Y G L+D+++ G + + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-------- 306
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGRRVLSRTYCGSAAY 121
N HRDL N+L+++ K++DFG + G+ + T
Sbjct: 307 ------GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 353
Query: 122 AAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
APE + ++ K +D+WS G+ + I +P+ LK +
Sbjct: 354 -APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-15
Identities = 38/163 (23%), Positives = 62/163 (38%), Gaps = 32/163 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I Y G LLD +K + +Q+ +G+ Y+
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--------------R 381
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY------AAP 124
N HRDL+ NIL+ + K+ADFG AR D E Y AP
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--------YTARQGAKFPIKWTAP 433
Query: 125 EVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E + K +D+WS G+ +T + +P+ +++
Sbjct: 434 EAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD 475
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 41/171 (23%), Positives = 63/171 (36%), Gaps = 34/171 (19%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFT 65
L + + Y +GDLL I+ F +A G+EYL
Sbjct: 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---------- 141
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA--- 122
+ HRDL N ++ + F VK+ADFG AR +L R Y +
Sbjct: 142 ----EQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHAR 189
Query: 123 ------APEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
A E + + K +D+WS GV + ++ A P+ + L
Sbjct: 190 LPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 38/163 (23%), Positives = 62/163 (38%), Gaps = 32/163 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I Y G LLD +K + +Q+ +G+ Y+
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--------------R 298
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY------AAP 124
N HRDL+ NIL+ + K+ADFG AR D E Y AP
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--------YTARQGAKFPIKWTAP 350
Query: 125 EVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E + K +D+WS G+ +T + +P+ +++
Sbjct: 351 EAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD 392
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+F + +N D + + + + R + ++L L+Y H S
Sbjct: 109 ALVFE-HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCH--------------SMG 150
Query: 73 IAHRDLKCENILM-TKRFNVKIADFGFARYCVDKEGR--RVLSRTYCGSAAYAAPEVI-S 128
I HRD+K N+++ + +++ D+G A + + RV SR Y + PE++
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR-Y-----FKGPELLVD 204
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPF--DDSNLKQLFK 166
Y+ L D+WSLG + M+ PF N QL +
Sbjct: 205 YQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 28/164 (17%)
Query: 10 GPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
V + + G LLD++ + + W Q+ G+ YL
Sbjct: 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE------------- 134
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAA 123
+ + HRDL N+L+ +VKI DFG A+ +E Y + A
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK------EYHAEGGKVPIKWMA 187
Query: 124 PEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E I Y + +D+WS GV + +M + P+D ++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 58/232 (25%), Positives = 85/232 (36%), Gaps = 28/232 (12%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT--KRFNVKIADFGF 98
R + +L L+ LH+ I H DLK ENIL+ R +K+ DFG
Sbjct: 203 RKFAHSILQCLDALHKN--------------RIIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 99 ARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD- 157
+ Y E +RV TY S Y APEVI G Y + D+WSLG I +L
Sbjct: 249 SCY----EHQRVY--TYIQSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPG 301
Query: 158 DSNLKQLFK-EQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQ 216
+ QL + + S ++ + V + V + S +
Sbjct: 302 EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRR 361
Query: 217 VKLKDILSHQVKVKDILSHQV---KNLVGQILEPDITKRIRLDAIKAHDWLR 265
KL+ + + + + Q LE D R+ H WLR
Sbjct: 362 GKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 33/139 (23%), Positives = 56/139 (40%), Gaps = 28/139 (20%)
Query: 13 VFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + M Y G L D++++ + + SQ+ G+EYL +K
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--------------TK 133
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAPE 125
HRDL NIL+ VKI DFG + + + + APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE------FFKVKEPGESPIFWYAPE 187
Query: 126 VISGNPYNPKLADIWSLGV 144
++ + ++ +D+WS GV
Sbjct: 188 SLTESKFSVA-SDVWSFGV 205
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 14/120 (11%)
Query: 26 LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85
L + + ++ + + Q+L GL+Y+H S N+ HRDLK N+L+
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIH--------------SANVLHRDLKPSNLLL 161
Query: 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
++KI DFG AR Y + Y APE++ + K DIWS+G I
Sbjct: 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 37/169 (21%), Positives = 69/169 (40%), Gaps = 34/169 (20%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLA-GLEYLHREITNHTP 63
I++ ++I Y G L+D+++ R V + FS + +EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-------- 134
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVDKEGR---RVLSRTYCGS 118
N HRDL N+L+++ K++DFG + G+ +
Sbjct: 135 ------GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------- 179
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ APE + ++ K +D+WS G++ + I +P+ LK +
Sbjct: 180 --WTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 34/139 (24%), Positives = 56/139 (40%), Gaps = 28/139 (20%)
Query: 13 VFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + M Y G L D++++ + + SQ+ G+EYL +K
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--------------TK 164
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAPE 125
HRDL NIL+ VKI DFG + + Y + APE
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE------YYKVKEPGESPIFWYAPE 218
Query: 126 VISGNPYNPKLADIWSLGV 144
++ + ++ +D+WS GV
Sbjct: 219 SLTESKFSVA-SDVWSFGV 236
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 40/170 (23%), Positives = 70/170 (41%), Gaps = 33/170 (19%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNAR-TWFSQMLA-GLEYLHREITNHTP 63
+ P +I + G+LLD+++ S + + ++ +EYL
Sbjct: 78 CTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-------- 128
Query: 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA--- 120
KN HRDL N L+ + VK+ADFG +R Y A
Sbjct: 129 ------KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 174
Query: 121 ---YAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
+ APE ++ N ++ K +D+W+ GV + I P+ +L Q+++
Sbjct: 175 PIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 31/166 (18%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
+ ++I Y NG LL++++ G E + + G+ +L
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE------------ 121
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------Y 121
S HRDL N L+ + VK++DFG RY +D + Y S +
Sbjct: 122 --SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--------YVSSVGTKFPVKW 171
Query: 122 AAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+APEV Y+ K +D+W+ G++ + + MP+D ++
Sbjct: 172 SAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 28/164 (17%)
Query: 10 GPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
G + + +Y G LLDH++ G + W Q+ G+ YL
Sbjct: 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE------------- 132
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAA 123
+ HR+L N+L+ V++ADFG A + S A + A
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK------QLLYSEAKTPIKWMA 185
Query: 124 PEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E I Y + +D+WS GV + +M A P+ L ++
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 32/163 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I + G LLD +K + + + +Q+ G+ ++
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--------------Q 302
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAP 124
+N HRDL+ NIL++ KIADFG AR D E Y + AP
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--------YTAREGAKFPIKWTAP 354
Query: 125 EVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
E I+ + K +D+WS G+ + I+ +P+ + ++ +
Sbjct: 355 EAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 42/154 (27%), Positives = 59/154 (38%), Gaps = 33/154 (21%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT-- 65
GP + Y GDLL+ ++R + + L ++ + F+
Sbjct: 98 IGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS---FSYQ 153
Query: 66 -----AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR---RV 110
A L SKN HRDL NIL+T KI DFG AR Y V R +
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK- 212
Query: 111 LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ APE I Y + +D+WS G+
Sbjct: 213 ----------WMAPESIFNCVYTFE-SDVWSYGI 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 35/239 (14%)
Query: 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT--KRFNVKIADFGF 98
R + QM L +L P +I H DLK ENIL+ KR +KI DFG
Sbjct: 160 RKFAQQMCTALLFLAT------------PELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207
Query: 99 ARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD- 157
+ G+R+ Y S Y +PEV+ G PY+ + D+WSLG I M F
Sbjct: 208 SCQ----LGQRIY--QYIQSRFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSG 260
Query: 158 DSNLKQL--FKEQTSNILSHQVKV--------KDILSHQVKVKDILSHQVKVKDILSHQV 207
+ + Q+ E +H + + + +K + + K +
Sbjct: 261 ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTR-- 318
Query: 208 KVKDILSHQVKLKDILSHQVKVKDILSHQV-KNLVGQILEPDITKRIRLDAIKAHDWLR 265
K+ +IL + + + K+L+ ++L+ D RI+ H + +
Sbjct: 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 45/152 (29%), Positives = 63/152 (41%), Gaps = 33/152 (21%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESN-ARTWFSQMLAGLEYLHREITNHTPFT- 65
GP V + Y GDLL+ ++R V E++ A + + + LH F+
Sbjct: 121 HGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH--------FSS 171
Query: 66 ------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLS 112
A L SKN HRD+ N+L+T KI DFG AR Y V R +
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 113 RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
APE I Y + +D+WS G+
Sbjct: 232 WM--------APESIFDCVYTVQ-SDVWSYGI 254
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 40/156 (25%), Positives = 60/156 (38%), Gaps = 32/156 (20%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH--TPFT 65
GP +++ Y GDLL++++ + + +Q E +T F
Sbjct: 120 LSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 66 -------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR--- 108
L K+ HRDL N+L+T VKI DFG AR Y V R
Sbjct: 179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 238
Query: 109 RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ + APE + Y K +D+WS G+
Sbjct: 239 K-----------WMAPESLFEGIYTIK-SDVWSYGI 262
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 27/138 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+ M A+ G L ++++ V + N Q+ G++YL E N
Sbjct: 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--E------------ESN 137
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAPEV 126
HRDL N+L+ + KI+DFG ++ E Y + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------YYKAQTHGKWPVKWYAPEC 191
Query: 127 ISGNPYNPKLADIWSLGV 144
I+ ++ K +D+WS GV
Sbjct: 192 INYYKFSSK-SDVWSFGV 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-14
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNAR--TWFSQMLAGLEYLHREITNHTPFTAHLPS 70
++I Y +NG L+D +K + + + +Q+ G+ ++
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--------------E 127
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAP 124
+N HRDL+ NIL++ + KIADFG AR D E Y + AP
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIKWTAP 179
Query: 125 EVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
E I+ + K +D+WS G++ I+ + +P+ ++ +
Sbjct: 180 EAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 38/126 (30%), Positives = 54/126 (42%), Gaps = 20/126 (15%)
Query: 26 LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85
L + + + E + QML GL Y+H + I HRDLK N+ +
Sbjct: 116 LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH--------------AAGIIHRDLKPGNLAV 161
Query: 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ +KI DFG AR + V++R Y APEVI + DIWS+G I
Sbjct: 162 NEDCELKILDFGLARQADSEMTGYVVTRWYR------APEVILNWMRYTQTVDIWSVGCI 215
Query: 146 TFIMLN 151
M+
Sbjct: 216 MAEMIT 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 33/157 (21%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT-- 65
Q GP + + + YA G L ++ + V + S+ + L++
Sbjct: 97 QDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 66 --------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR-- 108
+L + HRDL NIL+ + +KI+DFG +R Y +GR
Sbjct: 156 AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215
Query: 109 -RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ + A E + + Y + +D+WS GV
Sbjct: 216 VK-----------WMAIESLFDHIYTTQ-SDVWSFGV 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-14
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 32/169 (18%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
++ P +FI Y NG LL++++ ++ + + +EYL
Sbjct: 88 CTKQRP-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--------- 137
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA---- 120
SK HRDL N L+ + VK++DFG +RY VL Y S
Sbjct: 138 -----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--------VLDDEYTSSVGSKFP 184
Query: 121 --YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
++ PEV+ + ++ K +DIW+ GV+ + I MP++ + +
Sbjct: 185 VRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 39/106 (36%), Positives = 50/106 (47%), Gaps = 19/106 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML G+++LH S I HRDLK NI++ +KI DFG AR
Sbjct: 135 QMLCGIKHLH--------------SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 176
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151
G + Y + Y APEVI G Y + DIWS+G I M+
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIK 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 39/154 (25%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW---FSQML-------AGLEYLHR 56
Q P + M GDL +++ P +N S+M+ G+ YL+
Sbjct: 98 SQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN- 155
Query: 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KEGRRVL 111
+ HRDL N ++ + F VKI DFG R Y D K G+ +L
Sbjct: 156 -------------ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 112 S-RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
R + +PE + + +D+WS GV
Sbjct: 203 PVR-------WMSPESLKDGVFTTY-SDVWSFGV 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 28/139 (20%)
Query: 13 VFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + M + +G L +++ + + + Q+ G++YL S+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--------------SR 145
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAPE 125
HRDL N+L+ VKI DFG + + Y + APE
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE------YYTVKDDRDSPVFWYAPE 199
Query: 126 VISGNPYNPKLADIWSLGV 144
+ + + +D+WS GV
Sbjct: 200 CLMQSKFYIA-SDVWSFGV 217
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-14
Identities = 35/169 (20%), Positives = 74/169 (43%), Gaps = 32/169 (18%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
L++ P + + + ++G L D+++ + + + G+ YL
Sbjct: 72 CLEQAP-ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--------- 121
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA---- 120
+ HRDL N L+ + +K++DFG R+ +D + Y S
Sbjct: 122 -----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--------YTSSTGTKFP 168
Query: 121 --YAAPEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQLFK 166
+A+PEV S + Y+ K +D+WS GV + + +P+++ + ++ +
Sbjct: 169 VKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 30/170 (17%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFS-QMLAGLEYLHREITNHTPF 64
L+ + + Y +GDL + I+ F Q+ G++YL
Sbjct: 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--------- 145
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA-- 122
SK HRDL N ++ ++F VK+ADFG AR DKE V ++T A
Sbjct: 146 -----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT------GAKL 194
Query: 123 -----APEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
A E + + K +D+WS GV+ + +M A P+ D N +
Sbjct: 195 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 28/160 (17%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
+ + I Y +NG L ++ + +A G++YL
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA------------ 164
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YA 122
+ N HRDL NIL+ K++DFG +R D TY S +
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGGKIPIRWT 217
Query: 123 APEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDD-SN 160
APE IS + +D+WS G+ + +M P+ + SN
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 27/162 (16%)
Query: 9 RGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
RG I Y +NG L ++ G + AG+ YL
Sbjct: 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS------------ 168
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YA 122
HRDL N+L+ K++DFG +R D Y + +
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGKIPIRWT 221
Query: 123 APEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQ 163
APE I+ ++ +D+WS GV + ++ P+ + +
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 43/141 (30%), Positives = 64/141 (45%), Gaps = 32/141 (22%)
Query: 13 VFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + M Y +G L D ++R + S + SQ+ G+EYL S+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG--------------SR 146
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFAR--------YCVDKEGRRVLSRTYCGSAAYAA 123
HRDL NIL+ +VKIADFG A+ Y V +E + Y A
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWY-------A 198
Query: 124 PEVISGNPYNPKLADIWSLGV 144
PE +S N ++ + +D+WS GV
Sbjct: 199 PESLSDNIFSRQ-SDVWSFGV 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 20/120 (16%)
Query: 26 LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85
L++I + + + + + Q+L GL+Y+H S +I HRDLK N+ +
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIH--------------SADIIHRDLKPSNLAV 165
Query: 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ +KI DFG AR+ D+ V +R Y APE++ + + DIWS+G I
Sbjct: 166 NEDCELKILDFGLARHTADEMTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCI 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 17/122 (13%)
Query: 26 LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85
L ++ GP+ E +AR + Q+L GL+Y+H S N+ HRDLK N+ +
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIH--------------SANVLHRDLKPANLFI 153
Query: 86 -TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI-SGNPYNPKLADIWSLG 143
T+ +KI DFG AR + + Y +P ++ S N Y + D+W+ G
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAG 212
Query: 144 VI 145
I
Sbjct: 213 CI 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 20/100 (20%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
QML GL+Y+H S + HRDLK N+ + + +KI DFG AR+ +
Sbjct: 134 QMLKGLKYIH--------------SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
V++R Y APEVI + + DIWS+G I
Sbjct: 180 MTGYVVTR------WYRAPEVILSWMHYNQTVDIWSVGCI 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 36/158 (22%), Positives = 59/158 (37%), Gaps = 29/158 (18%)
Query: 13 VFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+I M G+L +++R + + Q+ + YL S
Sbjct: 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE--------------SI 132
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAAPEV 126
N HRD+ NIL+ VK+ DFG +RY D++ Y S + +PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------YYKASVTRLPIKWMSPES 185
Query: 127 ISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDDSNLKQ 163
I+ + +D+W V + I+ PF K
Sbjct: 186 INFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 31/154 (20%), Positives = 54/154 (35%), Gaps = 44/154 (28%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML-------AGLEYLHREITN 60
R P + + + +GDL + + ++ G+EYL
Sbjct: 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP-LQTLVRFMVDIACGMEYLS----- 154
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR---RV 110
S+N HRDL N ++ + V +ADFG +R Y + +
Sbjct: 155 ---------SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 111 LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ A E ++ N Y +D+W+ GV
Sbjct: 205 ----------WLALESLADNLYTVH-SDVWAFGV 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 26/168 (15%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPF 64
L+ + + Y +GDL + I+ F +A G+++L
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--------- 209
Query: 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA---- 120
SK HRDL N ++ ++F VK+ADFG AR DKE + + A
Sbjct: 210 -----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPV 260
Query: 121 -YAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ A E + + K +D+WS GV+ + +M A P+ D N +
Sbjct: 261 KWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 27/157 (17%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
+ V I Y +NG L +++ + +A G++YL
Sbjct: 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS------------ 164
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YA 122
HRDL NIL+ K++DFG R D Y +
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRGGKIPIRWT 217
Query: 123 APEVISGNPYNPKLADIWSLGV-ITFIMLNAAMPFDD 158
+PE I+ + +D+WS G+ + +M P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-13
Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 23/99 (23%)
Query: 50 GLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR 109
G+ +LH + HRD+K NIL+ + F KI+DFG AR
Sbjct: 145 GINFLHEN--------------HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 110 VLSR---TYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
+ SR T AY APE + G PK +DI+S GV+
Sbjct: 191 MTSRIVGTT----AYMAPEALRGE-ITPK-SDIYSFGVV 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 36/142 (25%), Positives = 51/142 (35%), Gaps = 28/142 (19%)
Query: 10 GPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
P + + A G LLD ++ G + Q+ G+ YL
Sbjct: 92 TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE------------- 138
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA------AYA 122
SK HRDL N+L+ R VKI DFG R + Y A+
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD------HYVMQEHRKVPFAWC 191
Query: 123 APEVISGNPYNPKLADIWSLGV 144
APE + ++ +D W GV
Sbjct: 192 APESLKTRTFSHA-SDTWMFGV 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 42/159 (26%), Positives = 61/159 (38%), Gaps = 44/159 (27%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW--------FSQML-------AGL 51
+ P + + Y +GDL ++ GP A+ A Q+L AG+
Sbjct: 113 TEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 52 EYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KE 106
YL + HRDL N L+ + VKI DFG +R Y D
Sbjct: 172 VYLA--------------GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 107 GRRVLS-RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
GR +L R + PE I + + +D+WS GV
Sbjct: 218 GRTMLPIR-------WMPPESILYRKFTTE-SDVWSFGV 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 40/178 (22%), Positives = 59/178 (33%), Gaps = 42/178 (23%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML-------AGLEYLHREIT 59
LQ P FI M GDL ++ P + +L G +YL
Sbjct: 103 LQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---- 157
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYC 116
+ HRD+ N L+T KI DFG AR + +Y
Sbjct: 158 ----------ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRASYY 199
Query: 117 GSAAYA-------APEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
A PE + K D WS GV+ + I MP+ + +++ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 21/102 (20%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR-FNVKIADFGFARYCVD 104
Q+ L Y+H S I HRD+K +N+L+ +K+ DFG A+ V
Sbjct: 164 QLFRSLAYIH--------------SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVI 145
E + +Y S Y APE+I G Y + D+WS G +
Sbjct: 210 GE----PNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCV 246
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 37/161 (22%), Positives = 62/161 (38%), Gaps = 29/161 (18%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAHLPSK 71
V+I M G+L ++ + + ++ L+ L YL SK
Sbjct: 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--------------SK 135
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAAPEV 126
HRD+ N+L++ VK+ DFG +RY D Y S + APE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPES 188
Query: 127 ISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
I+ + +D+W GV + I+++ PF +
Sbjct: 189 INFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 34/154 (22%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT-- 65
+ G + + + + G+L +++ L + ++
Sbjct: 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT--LEHLIC---YSFQ 156
Query: 66 -----AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR---RV 110
L S+ HRDL NIL++++ VKI DFG AR Y + R +
Sbjct: 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK- 215
Query: 111 LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ APE I Y + +D+WS GV
Sbjct: 216 ----------WMAPETIFDRVYTIQ-SDVWSFGV 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 42/159 (26%), Positives = 59/159 (37%), Gaps = 45/159 (28%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW---------FSQML-------AGL 51
P + + Y +GDL ++ GP A SQML +G+
Sbjct: 88 DGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146
Query: 52 EYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KE 106
YL S++ HRDL N L+ VKI DFG +R Y D
Sbjct: 147 VYLA--------------SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 107 GRRVLS-RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
G +L R + PE I + + +D+WS GV
Sbjct: 193 GHTMLPIR-------WMPPESIMYRKFTTE-SDVWSFGV 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 29/161 (18%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
V+I M G+L + R + ++ + Q+ L YL SK
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE--------------SK 510
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA-----YAAPEV 126
HRD+ N+L++ VK+ DFG +RY D Y S + APE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPES 563
Query: 127 ISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
I+ + +D+W GV + I+++ PF +
Sbjct: 564 INFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 36/150 (24%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML-------AGLEYLHREITN 60
Q P+ + + + GDL ++ + +L G+EYL
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP-LQTLLKFMVDIALGMEYLS----- 164
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYC-GSA 119
++N HRDL N ++ V +ADFG ++ + Y G
Sbjct: 165 ---------NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-------YYRQGRI 208
Query: 120 A-----YAAPEVISGNPYNPKLADIWSLGV 144
A + A E ++ Y K +D+W+ GV
Sbjct: 209 AKMPVKWIAIESLADRVYTSK-SDVWAFGV 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 39/178 (21%), Positives = 58/178 (32%), Gaps = 42/178 (23%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQML-------AGLEYLHREIT 59
LQ P FI + GDL ++ P + +L G +YL
Sbjct: 144 LQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---- 198
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYC 116
+ HRD+ N L+T KI DFG AR + Y
Sbjct: 199 ----------ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRAGYY 240
Query: 117 GSAAYA-------APEVISGNPYNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
A PE + K D WS GV+ + I MP+ + +++ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-13
Identities = 36/145 (24%), Positives = 56/145 (38%), Gaps = 32/145 (22%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ + M Y G L D++ R + + + Q+ G+ YLH
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH------------ 151
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--------YCVDKEGRRVLSRTYCGSA 119
+++ HRDL N+L+ VKI DFG A+ Y V +E Y
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWY---- 204
Query: 120 AYAAPEVISGNPYNPKLADIWSLGV 144
APE + + +D+WS GV
Sbjct: 205 ---APECLKEYKFYYA-SDVWSFGV 225
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 28/100 (28%), Positives = 37/100 (37%), Gaps = 18/100 (18%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
+L GL LH + HRDL NIL+ ++ I DF AR
Sbjct: 142 HILLGLHVLH--------------EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 106 EGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145
Y Y APE++ KL D+WS G +
Sbjct: 188 A----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 36/154 (23%), Positives = 56/154 (36%), Gaps = 25/154 (16%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT- 65
P + + Y GDL + ++ P + A + +
Sbjct: 120 AVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 66 ---------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KEGRRVL 111
A+L + HRDL N L+ + VKIADFG +R Y D +G +
Sbjct: 179 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 238
Query: 112 S-RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
R + PE I N Y + +D+W+ GV
Sbjct: 239 PIR-------WMPPESIFYNRYTTE-SDVWAYGV 264
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 24/147 (16%)
Query: 19 YADNGDLLDHIKRAGPVAESNARTWFSQMLA------GLEYLHREITNHTPFTAHLPSKN 72
Y +NG+L H+ G + + +W ++ GL YLH ++
Sbjct: 116 YMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLH--------------TRA 159
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I HRD+K NIL+ + F KI DFG ++ + + + + G+ Y PE
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK-GTLGYIDPEYFIKGRL 218
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDS 159
K +D++S GV+ F +L A S
Sbjct: 219 TEK-SDVYSFGVVLFEVLCARSAIVQS 244
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 22/124 (17%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM-TKRFNVKIADFGFARYCVD 104
Q+L L Y+H S I HRD+K +N+L+ +K+ DFG A+ +
Sbjct: 149 QLLRSLAYIH--------------SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFD-DSNLK 162
E + +Y S Y APE+I G Y + DIWS G + ++ F +S +
Sbjct: 195 GE----PNVSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGID 249
Query: 163 QLFK 166
QL +
Sbjct: 250 QLVE 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 50/160 (31%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW---------FSQML-------AGL 51
RG +++ + YA +G+LLD ++++ + A Q+L G+
Sbjct: 97 HRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155
Query: 52 EYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR----YCVDKEG 107
+YL K HRDL NIL+ + + KIADFG +R Y G
Sbjct: 156 DYLS--------------QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 108 R---RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
R R + A E ++ + Y +D+WS GV
Sbjct: 202 RLPVR-----------WMAIESLNYSVYTTN-SDVWSYGV 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 36/142 (25%), Positives = 52/142 (36%), Gaps = 35/142 (24%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
+L G ++H I HRDLK N L+ + +VK+ DFG AR +
Sbjct: 137 NLLLGENFIH--------------ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 106 EGRRVLSRTYCGSAA-------------------YAAPEVISGNPYNPKLADIWSLGVIT 146
+ +++ Y APE+I K DIWS G I
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 147 FIMLN--AAMPFDDSNLKQLFK 166
+LN + D +N LF
Sbjct: 243 AELLNMLQSHINDPTNRFPLFP 264
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 28/142 (19%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ + M A G L + + SN Q+ G++YL
Sbjct: 407 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE------------- 453
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YA 122
KN HR+L N+L+ R KI+DFG ++ + Y +A +
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS------YYTARSAGKWPLKWY 506
Query: 123 APEVISGNPYNPKLADIWSLGV 144
APE I+ ++ + +D+WS GV
Sbjct: 507 APECINFRKFSSR-SDVWSYGV 527
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 44/141 (31%), Positives = 60/141 (42%), Gaps = 26/141 (18%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V++ M D +L I+ + QML G+++LH S
Sbjct: 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH--------------SAG 184
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSAAYAAPEVISGN 130
I HRDLK NI++ +KI DFG AR V++R Y APEVI G
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR------APEVILGM 238
Query: 131 PYNPKLADIWSLGVITFIMLN 151
Y + DIWS+G I M+
Sbjct: 239 GYKENV-DIWSVGCIMGEMVR 258
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 35/139 (25%), Positives = 56/139 (40%), Gaps = 28/139 (20%)
Query: 13 VFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + M A G L + + SN Q+ G++YL K
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--------------EK 129
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------YAAPE 125
N HRDL N+L+ R KI+DFG ++ + Y +A + APE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS------YYTARSAGKWPLKWYAPE 183
Query: 126 VISGNPYNPKLADIWSLGV 144
I+ ++ + +D+WS GV
Sbjct: 184 CINFRKFSSR-SDVWSYGV 201
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 35/155 (22%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT- 65
Q GP +++ + YA G+L ++++ P + + +++ + T
Sbjct: 111 TQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLVS---CTY 164
Query: 66 ------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR---R 109
+L S+ HRDL N+L+T+ +KIADFG AR Y GR +
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 110 VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ APE + Y + +D+WS GV
Sbjct: 225 -----------WMAPEALFDRVYTHQ-SDVWSFGV 247
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 25/161 (15%), Positives = 51/161 (31%), Gaps = 33/161 (20%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLA-GLEYLHREITNHTPFTAH 67
G + + G L ++K+ + ++ LA + +L
Sbjct: 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE------------ 130
Query: 68 LPSKNIAHRDLKCENILMTKRFN--------VKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+ H ++ +NIL+ + + +K++D G + + K+ +
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 120 AYAAPEVIS-GNPYNPKLADIWSLGV-ITFIMLNAAMPFDD 158
+ PE I N D WS G + I P
Sbjct: 183 -WVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 23/108 (21%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q L ++ LH N+ HRDLK N+L+ ++K+ DFG AR +
Sbjct: 120 QTLRAVKVLH--------------GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 106 EGRRVLSRT-------YCGSAAYAAPEVI-SGNPYNPKLADIWSLGVI 145
+ + Y APEV+ + Y+ + D+WS G I
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCI 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 31/119 (26%), Positives = 46/119 (38%), Gaps = 34/119 (28%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
Q++ ++YLH S + HRD+K NIL+ +VK+ADFG +R V+
Sbjct: 117 QLIKVIKYLH--------------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 106 EGRRVLSRTYCGSAA------------------YAAPEVI-SGNPYNPKLADIWSLGVI 145
Y APE++ Y + D+WSLG I
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCI 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 35/154 (22%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT-- 65
Q GP +++ + YA G+L ++++ P + L +++ +
Sbjct: 146 QDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS--SKDLVS---CAYQ 199
Query: 66 -----AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGR---RV 110
+L SK HRDL N+L+T+ +KIADFG AR Y GR +
Sbjct: 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK- 258
Query: 111 LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
+ APE + Y + +D+WS GV
Sbjct: 259 ----------WMAPEALFDRIYTHQ-SDVWSFGV 281
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 41/181 (22%), Positives = 64/181 (35%), Gaps = 43/181 (23%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
+++ + AD+ D + + E + +T +L G++Y+H S
Sbjct: 132 LYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH--------------SAG 176
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA------------ 120
I HRDLK N L+ + +VK+ DFG AR E
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 121 ------------YAAPEVI-SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNL--KQLF 165
Y APE+I Y + D+WS+G I +LN + LF
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295
Query: 166 K 166
Sbjct: 296 P 296
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 53/164 (32%)
Query: 7 LQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW---------FSQML-------AG 50
Q GP +++ + YA G+L ++++ P + F ++ G
Sbjct: 157 TQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 51 LEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCV 103
+EYL S+ HRDL N+L+T+ +KIADFG AR Y
Sbjct: 216 MEYLA--------------SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 104 DKEGR---RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
GR + + APE + Y + +D+WS GV
Sbjct: 262 TTNGRLPVK-----------WMAPEALFDRVYTHQ-SDVWSFGV 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 45/159 (28%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTW---------FSQML-------AGL 51
+ P + + Y +GDL + + P ++ + + AG+
Sbjct: 83 KDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 52 EYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR--YCVD---KE 106
EYL S ++ H+DL N+L+ + NVKI+D G R Y D
Sbjct: 142 EYLS--------------SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 107 GRRVLS-RTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144
G +L R + APE I ++ +DIWS GV
Sbjct: 188 GNSLLPIR-------WMAPEAIMYGKFSID-SDIWSYGV 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 17/159 (10%), Positives = 38/159 (23%), Gaps = 47/159 (29%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+V ++ + + G L + + A + A + HR
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAHRA---- 148
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+A + ++ +V +A
Sbjct: 149 ----------GVALSIDHPSRVRVSIDGDVVLAYPATM--------------------PD 178
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
A P+ DI +G + +L P ++
Sbjct: 179 ANPQ-----------DDIRGIGASLYALLVNRWPLPEAG 206
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 21/102 (20%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM-TKRFNVKIADFGFARYCVD 104
Q+ + ++H S I HRD+K +N+L+ +K +K+ DFG A+ +
Sbjct: 149 QLFRAVGFIH--------------SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVI 145
E S Y S Y APE++ G Y P + D+WS+G +
Sbjct: 195 SE----PSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCV 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 19/102 (18%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM-TKRFNVKIADFGFARYCVD 104
Q++ + LH PS N+ HRD+K N+L+ +K+ DFG A+
Sbjct: 137 QLIRSIGCLHL------------PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVI 145
E + Y S Y APE+I GN Y + DIWS+G I
Sbjct: 185 SE----PNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCI 221
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 34/135 (25%), Positives = 50/135 (37%), Gaps = 28/135 (20%)
Query: 19 YADNGDLLDHIKRAGPVAESNARTWFSQM-----LA-GLEYLHREITNHTPFTAHLPSKN 72
Y NG + ++ W + A GL YLH
Sbjct: 108 YMANGSVASCLR--ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK----------- 154
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR---RVLSRTYCGSAAYAAPEVISG 129
I HRD+K NIL+ + F + DFG A+ K+ V G+ + APE +S
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIGHIAPEYLST 209
Query: 130 NPYNPKLADIWSLGV 144
+ K D++ GV
Sbjct: 210 GKSSEK-TDVFGYGV 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 48/242 (19%), Positives = 79/242 (32%), Gaps = 56/242 (23%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT------------------- 86
Q+ + +LH + H DLK ENIL
Sbjct: 126 QICKSVNFLHSN--------------KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 87 KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146
++K+ DFG A Y + V +R Y APEVI ++ D+WS+G I
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTR------HYRAPEVILALGWSQPC-DVWSIGCIL 224
Query: 147 FIMLNAAMPFD-DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVK--DIL 203
F + + L ++ L + K D
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAM---------MERILGPLPKHMIQKTRKRKYFHHDRLDWD 275
Query: 204 SHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDW 263
H + + LK+ + +D+ ++ +L+ ++LE D KRI L H +
Sbjct: 276 EHSSAGRYVSRACKPLKEFM----LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331
Query: 264 LR 265
Sbjct: 332 FD 333
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 33/98 (33%), Positives = 44/98 (44%), Gaps = 17/98 (17%)
Query: 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR-------YCVDKEGRRVLSRTYCGS 118
L S+ HRDL NIL++++ VKI DFG AR Y + R L
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM---- 262
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITF-IMLNAAMP 155
APE I Y + +D+WS GV+ + I A P
Sbjct: 263 ----APETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASP 295
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 52/299 (17%), Positives = 98/299 (32%), Gaps = 89/299 (29%)
Query: 24 DLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81
LL I + + + Q+L GL+YLH + I H D+K E
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-------------RIIHTDIKPE 176
Query: 82 NILMT-------------------------------------------------KRFNVK 92
NIL++ ++ VK
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 93 IADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA 152
IAD G A + + +R Y + EV+ G+ YN ADIWS + F +
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTP-ADIWSTACMAFELATG 289
Query: 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKV-----KDILSHQVKVKDILSHQV 207
F+ + ++ ++ +D ++ +++ + ++ K+ + +
Sbjct: 290 DYLFEPHSGEEYTRD------------EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337
Query: 208 KVKDILS-HQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265
+K I L ++L + + + + + +LE KR H WL
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 50/241 (20%), Positives = 79/241 (32%), Gaps = 54/241 (22%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT------------------- 86
Q+ L +LH + H DLK ENIL
Sbjct: 131 QLCHALRFLHEN--------------QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 87 KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146
K ++++ADFG A + + T + Y PEVI + D+WS+G I
Sbjct: 177 KNTSIRVADFGSATF----DHEHHT--TIVATRHYRPPEVILELGWAQPC-DVWSIGCIL 229
Query: 147 FIMLNAAMPFD-DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 205
F F N + L K+ + + + K L
Sbjct: 230 FEYYRGFTLFQTHENREHLVM---------MEKILGPIPSHMIHRTRKQKYFY-KGGLVW 279
Query: 206 QVKVKDILSHQVKLKDILSHQVKVKDILSH-QVKNLVGQILEPDITKRIRLDAIKAHDWL 264
D + K + ++D L H Q+ +L+ ++LE D +RI L H +
Sbjct: 280 DENSSDGRYVKENCKPL--KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
Query: 265 R 265
Sbjct: 338 A 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 26/119 (21%), Positives = 38/119 (31%), Gaps = 34/119 (28%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDK 105
++L L YL + ++ H DLK ENIL+ + K K
Sbjct: 145 EILKALNYLRKM--------------SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 106 EGRRVLSRTYC-----GSAAYA--------------APEVISGNPYNPKLADIWSLGVI 145
T G A + APEVI ++ D+WS G +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCV 248
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 17/64 (26%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM--TKRFNVKIADFGFA-RYC 102
++L LE+LH H ++ ENI + + V +A +GFA RYC
Sbjct: 167 RLLDALEFLH--------------ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 103 VDKE 106
+
Sbjct: 213 PSGK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 19/83 (22%), Positives = 34/83 (40%), Gaps = 20/83 (24%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM-TKRFN-VKIADFGFA-RYC 102
++L LEY+H H D+K N+L+ K + V + D+G A RYC
Sbjct: 160 RILDILEYIH--------------EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 103 VDKEGRRVLSR---TYCGSAAYA 122
+ + + + G+ +
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-07
Identities = 21/128 (16%), Positives = 44/128 (34%), Gaps = 15/128 (11%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
+ ++FI + + G L+ ++ + + A++ Q+ A L +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASL---------- 181
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYAAPEVI 127
HRDL N+L+ K K+ + + G +V Y S V+
Sbjct: 182 ---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 128 SGNPYNPK 135
+ +
Sbjct: 239 FCDVSMDE 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 17/63 (26%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM--TKRFNVKIADFGFA-RYC 102
+ML LEY+H H D+K N+L+ V +AD+G + RYC
Sbjct: 159 RMLDVLEYIH--------------ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 103 VDK 105
+
Sbjct: 205 PNG 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 24/107 (22%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM----TKRFN-VKIADFGFA- 99
QMLA ++ +H K++ +RD+K +N L+ +K N + + DFG
Sbjct: 114 QMLARVQSIH--------------EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
Query: 100 RYCVDKEGRRVLSRT---YCGSAAYAAPEVISGNPYNPKLADIWSLG 143
Y + + R G+A Y + G + + D+ +LG
Sbjct: 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALG 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 22/105 (20%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM--TKRFN-VKIADFGFARYC 102
QM++ +EY+H SKN HRD+K +N LM K+ N V I DFG A+
Sbjct: 113 QMISRIEYIH--------------SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 103 VDKEGRRVL----SRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143
D + + ++ G+A YA+ G + + D+ SLG
Sbjct: 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLG 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 22/105 (20%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM--TKRFN-VKIADFGFA-RY 101
QM+ +E++H SK+ HRD+K +N LM +R N V I DFG A +Y
Sbjct: 111 QMINRVEFVH--------------SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Query: 102 CVDKEGRRVLSRT---YCGSAAYAAPEVISGNPYNPKLADIWSLG 143
+ + R G+A YA+ G + + D+ SLG
Sbjct: 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLG 200
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 23/86 (26%)
Query: 46 QMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM----TKRFN-VKIADFGFA- 99
Q+++ +EY+H SKN+ +RD+K EN L+ K + I DF A
Sbjct: 113 QLISRMEYVH--------------SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
Query: 100 RYCVDKEGRRVLSRT---YCGSAAYA 122
Y + + + R G+A Y
Sbjct: 159 EYIDPETKKHIPYREHKSLTGTARYM 184
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 9e-05
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 17/124 (13%)
Query: 175 HQVKVKDILSHQVK--VKDILSHQVK--VKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230
HQ + KDILS V + V+ K ILS + ++ I+ KD +S +++
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKE-EIDHII----MSKDAVSGTLRLF 68
Query: 231 DIL----SHQVKNLVGQILEPD---ITKRIRLDAI-KAHDWLRYKSMVRRKVLPGQKLVH 282
L V+ V ++L + + I+ + + Y R Q
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 283 SNLS 286
N+S
Sbjct: 129 YNVS 132
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 5e-04
Identities = 44/281 (15%), Positives = 91/281 (32%), Gaps = 91/281 (32%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++HSI R+ Y + +L ++ NA+ W
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNV--------QNAKAW----------------- 259
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADF-GFARYCV-----------DKEGR 108
F +L C+ IL+T R ++ DF A E +
Sbjct: 260 -NAF------------NLSCK-ILLTTR-FKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 109 RVLSRTYCGSAAYAAP-EVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167
+L + Y P EV++ NP L +I + + +D N K + +
Sbjct: 305 SLLLK-YLDCRPQDLPREVLTTNP----RR----LSIIAESIRDGLATWD--NWKHVNCD 353
Query: 168 QTSNILSHQVKVKD------------ILSHQVKVK----DILSHQVK---VKDILSHQVK 208
+ + I+ + V + + + ++ V V +++ K
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 209 ----VKDILSHQVKLKDI-LSHQVKVKDILS-HQVKNLVGQ 243
K + + I L +VK+++ + H +++V
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALH--RSIVDH 452
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.67 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.49 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.1 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.09 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.09 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 92.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 88.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 84.95 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 83.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 82.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 81.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.69 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 80.17 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=347.79 Aligned_cols=198 Identities=28% Similarity=0.545 Sum_probs=177.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|++++.+|||||||+||+|.++|++.+.+++..++.++.||+.||+||| +++|+||||||
T Consensus 95 v~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH--------------~~~IiHRDlKP 160 (311)
T 4aw0_A 95 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--------------GKGIIHRDLKP 160 (311)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCccCCCCH
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||+++.+..... .....+.+||+.|+|||++.+..++.+ +|+||+||++|+|++|..||.+.+
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCCC-cccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999986643222 123456789999999999998888877 999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+++.++.++...++ ..+++++++|
T Consensus 239 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~dl 264 (311)
T 4aw0_A 239 EGLIFAKIIKLEYDFP------------------------------------------------------EKFFPKARDL 264 (311)
T ss_dssp HHHHHHHHHHTCCCCC------------------------------------------------------TTCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------cccCHHHHHH
Confidence 8888888776654433 5688999999
Q ss_pred HHHhcCCCCCccccHHH------HhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDA------IKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~e------ll~~~wf~~~~ 268 (304)
|.+||+.||++|||++| +++||||++..
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 99999999999999988 58999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=343.07 Aligned_cols=196 Identities=27% Similarity=0.539 Sum_probs=174.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|++++.+|||||||+||+|.++|.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 89 v~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH--------------~~~IiHRDlKp 154 (304)
T 3ubd_A 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH--------------SLGIIYRDLKP 154 (304)
T ss_dssp ECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSSCCG
T ss_pred CeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCcCCCCCH
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+++....... ...+.+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+
T Consensus 155 ~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 155 ENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp GGEEECTTSCEEEESSEEEEC-----C---CCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEcCCCCEEecccccceeccCCCc---cccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcC
Confidence 999999999999999999975443322 3456789999999999999889877 999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+.++.+....++ ..+++++.+|
T Consensus 231 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 256 (304)
T 3ubd_A 231 RKETMTMILKAKLGMP------------------------------------------------------QFLSPEAQSL 256 (304)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------CcCCHHHHHH
Confidence 8888887776544333 6689999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
|.+||+.||++||| ++|+++||||+...
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 99999999999998 47999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=344.95 Aligned_cols=200 Identities=25% Similarity=0.448 Sum_probs=174.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.+|||||||+||+|.+++.+ +.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 134 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH--------------~~~IiHRDlKp 198 (346)
T 4fih_A 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLH--------------AQGVIHRDIKS 198 (346)
T ss_dssp CCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccCCH
Confidence 6899999999999999999999999999976 46999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+++.+..... ...+.+||+.|+|||++.+..|+.+ +|||||||++|+|++|..||.+.+
T Consensus 199 ~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 199 DSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHEEECCCCCEEEecCcCceecCCCCC---cccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999986543322 3456789999999999998889877 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+....... ...+..+++++++|
T Consensus 275 ~~~~~~~i~~~~~~~---------------------------------------------------~~~~~~~s~~~~dl 303 (346)
T 4fih_A 275 PLKAMKMIRDNLPPR---------------------------------------------------LKNLHKVSPSLKGF 303 (346)
T ss_dssp HHHHHHHHHHSSCCC---------------------------------------------------CSCGGGSCHHHHHH
T ss_pred HHHHHHHHHcCCCCC---------------------------------------------------CCccccCCHHHHHH
Confidence 777776665432211 12235689999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
|.+||+.||++|||++|+|+||||+....+
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 999999999999999999999999976643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=337.90 Aligned_cols=193 Identities=36% Similarity=0.684 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.+||||||| +|+|.+++.+.+.+++..++.++.|++.||+||| +++|+||||||
T Consensus 76 v~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH--------------~~~IiHRDiKP 140 (275)
T 3hyh_A 76 IKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH--------------RHKIVHRDLKP 140 (275)
T ss_dssp CCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCT
T ss_pred CeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccCCh
Confidence 68999999999999999999 6799999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||+++...... ...+.+||+.|+|||++.+..++..++||||+||++|+|++|+.||.+.+
T Consensus 141 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 141 ENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp TTEEECTTCCEEECCSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEECCCCCEEEeecCCCeecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999997654332 23467899999999999988876555999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....+..+.++...++ ..+++++++|
T Consensus 217 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 242 (275)
T 3hyh_A 217 IPVLFKNISNGVYTLP------------------------------------------------------KFLSPGAAGL 242 (275)
T ss_dssp HHHHHHHHHHTCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------CCCCHHHHHH
Confidence 8777777765544333 5689999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
|.+||+.||++|||++|+++||||+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=344.74 Aligned_cols=196 Identities=28% Similarity=0.529 Sum_probs=173.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|++|++++.+|||||||+||+|.++|...+ .+++..++.++.||+.||+||| +.+|+||||
T Consensus 86 V~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--------------~~~IiHRDl 151 (350)
T 4b9d_A 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--------------DRKILHRDI 151 (350)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCEETTC
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeccC
Confidence 689999999999999999999999999997643 5799999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+
T Consensus 152 Kp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp CGGGEEECTTCCEEECSTTEESCCCHHHH---HHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred CHHHEEECCCCCEEEcccccceeecCCcc---cccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999986543211 2345689999999999999889887 9999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+.+.++..+..+ ..+..+++++.
T Consensus 228 ~~~~~~~~~i~~~~~~-----------------------------------------------------~~~~~~s~~~~ 254 (350)
T 4b9d_A 228 GSMKNLVLKIISGSFP-----------------------------------------------------PVSLHYSYDLR 254 (350)
T ss_dssp SSHHHHHHHHHHTCCC-----------------------------------------------------CCCTTSCHHHH
T ss_pred cCHHHHHHHHHcCCCC-----------------------------------------------------CCCccCCHHHH
Confidence 8888888777665432 12356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+||.+||+.||++|||++|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=345.76 Aligned_cols=200 Identities=25% Similarity=0.448 Sum_probs=174.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.+|||||||+||+|.+++.. +.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 211 V~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH--------------~~~IiHRDiKp 275 (423)
T 4fie_A 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLH--------------AQGVIHRDIKS 275 (423)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCST
T ss_pred CceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecccCCH
Confidence 6899999999999999999999999999976 46999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||++..+..... ...+.+||+.|+|||++.+..|+.+ +|||||||++|+|++|..||.+.+
T Consensus 276 ~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 276 DSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp TTEEECTTCCEEECCCTTCEECCSSCC---CBCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHEEEcCCCCEEEecCccceECCCCCc---cccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999986543322 3456789999999999999889877 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+....... ...+..+++++++|
T Consensus 352 ~~~~~~~i~~~~~~~---------------------------------------------------~~~~~~~s~~~~dl 380 (423)
T 4fie_A 352 PLKAMKMIRDNLPPR---------------------------------------------------LKNLHKVSPSLKGF 380 (423)
T ss_dssp HHHHHHHHHHSCCCC---------------------------------------------------CSCTTSSCHHHHHH
T ss_pred HHHHHHHHHcCCCCC---------------------------------------------------CcccccCCHHHHHH
Confidence 777776665432211 12235689999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
|.+||+.||++|||++|+|+||||+....+
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999999999976543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=338.64 Aligned_cols=205 Identities=26% Similarity=0.377 Sum_probs=171.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.+|||||||+||+|.++|++.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 113 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH--------------~~~IiHRDlKp 178 (336)
T 4g3f_A 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH--------------TRRILHGDVKA 178 (336)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TTTEECSCCCG
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecccCH
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCC-CeEEEeccCcccccCccccc--ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRF-NVKIADFGFARYCVDKEGRR--VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~-~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+|||++.+| .+||+|||+++......... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus 179 ~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp GGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSST
T ss_pred HHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCC
Confidence 999999988 59999999998665432211 12344679999999999999889887 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+......++....... ...+..+++++
T Consensus 258 ~~~~~~~~~~i~~~~~~~---------------------------------------------------~~~~~~~s~~~ 286 (336)
T 4g3f_A 258 QYFRGPLCLKIASEPPPI---------------------------------------------------REIPPSCAPLT 286 (336)
T ss_dssp TTCCSCCHHHHHHSCCGG---------------------------------------------------GGSCTTSCHHH
T ss_pred CCCHHHHHHHHHcCCCCc---------------------------------------------------hhcCccCCHHH
Confidence 776555555544332111 12346789999
Q ss_pred HHHHHHhcCCCCCccccHHHH-------------hcCcccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAI-------------KAHDWLRYKSMVR 271 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~el-------------l~~~wf~~~~~~~ 271 (304)
.+||.+||+.||++|||+.|+ ++|||++....++
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 999999999999999999997 6799998876654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.16 Aligned_cols=194 Identities=23% Similarity=0.477 Sum_probs=161.7
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--iv 74 (304)
|++|++|.+ ++.++||||||+||+|.+++.+.+.+++..++.++.|++.||+||| +.+ |+
T Consensus 88 V~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH--------------~~~~~Ii 153 (290)
T 3fpq_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH--------------TRTPPII 153 (290)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TSSSCCC
T ss_pred CcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCCEE
Confidence 689999875 4579999999999999999999999999999999999999999999 777 99
Q ss_pred ecCCCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+|||++. ++.+||+|||+++..... ...+.+||+.|+|||++.+ +++.+ +|||||||++|+|++|+
T Consensus 154 HRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~ 226 (290)
T 3fpq_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSS
T ss_pred ecccChhheeEECCCCCEEEEeCcCCEeCCCC-----ccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCC
Confidence 9999999999974 789999999999753221 3446789999999999865 58776 99999999999999999
Q ss_pred CCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.||.+.+ .......+..+..+ ...+..
T Consensus 227 ~Pf~~~~~~~~~~~~i~~~~~~----------------------------------------------------~~~~~~ 254 (290)
T 3fpq_A 227 YPYSECQNAAQIYRRVTSGVKP----------------------------------------------------ASFDKV 254 (290)
T ss_dssp CTTTTCSSHHHHHHHHTTTCCC----------------------------------------------------GGGGGC
T ss_pred CCCCCCCcHHHHHHHHHcCCCC----------------------------------------------------CCCCcc
Confidence 9997654 33444444433221 112245
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 68899999999999999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.70 Aligned_cols=238 Identities=23% Similarity=0.351 Sum_probs=164.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++++|||||||+||+|.+++. .+++.+++.++.|++.||+||| +.||+||||||
T Consensus 83 v~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH--------------~~gIiHRDiKP 145 (361)
T 4f9c_A 83 MGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIH--------------QFGIVHRDVKP 145 (361)
T ss_dssp CCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred ceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCcCCH
Confidence 678999999999999999999999999994 4999999999999999999999 89999999999
Q ss_pred CcEEEecC-CCeEEEeccCcccccCcccc-------------------------cccccCccCCccccccccccCCCCCC
Q psy1812 81 ENILMTKR-FNVKIADFGFARYCVDKEGR-------------------------RVLSRTYCGSAAYAAPEVISGNPYNP 134 (304)
Q Consensus 81 ~nil~~~~-~~~kl~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~ 134 (304)
+|||++.+ +.+||+|||+++........ .......+||+.|+|||++.+.....
T Consensus 146 eNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~ 225 (361)
T 4f9c_A 146 SNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225 (361)
T ss_dssp GGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCC
T ss_pred HHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 99999987 78999999999754332110 01123467999999999998876444
Q ss_pred CCchHHHHHHHHHHHHhCCCCCC-ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchh
Q psy1812 135 KLADIWSLGVITFIMLNAAMPFD-DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDIL 213 (304)
Q Consensus 135 ~~sDvwslG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (304)
.++|+||+||++|+|++|+.||. +.+..++...+....+....... ..... . ........+.....
T Consensus 226 ~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~---------~~~~~---~-~~~~~~~~p~~~~~ 292 (361)
T 4f9c_A 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQA---------AKTFG---K-SILCSKEVPAQDLR 292 (361)
T ss_dssp THHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH---------HHHTT---E-EEEESSCCCCCCHH
T ss_pred CccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhh---------hhhcc---c-cccccccCcchhhh
Confidence 44999999999999999999994 44555666665544332210000 00000 0 00000000000000
Q ss_pred hhh----------h-hhhhh--hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 214 SHQ----------V-KLKDI--LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 214 ~~~----------~-~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
... + ....+ .......+..++++++|||.+||++||++|+|++|+|+||||++.+
T Consensus 293 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 293 KLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0 00000 0001223356889999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=326.78 Aligned_cols=234 Identities=24% Similarity=0.335 Sum_probs=178.1
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++++++.. .+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+||| +.+|+
T Consensus 116 v~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH--------------~~~ii 180 (398)
T 4b99_A 116 IAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH--------------SAQVI 180 (398)
T ss_dssp CCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCB
T ss_pred ceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCcCc
Confidence 578887653 468999999996 689999999899999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCccc-ccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEG-RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+|||++.++.+||+|||+++.+..... ......+.+||+.|+|||++.+..+...++||||+||++|+|++|+
T Consensus 181 HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 999999999999999999999999986543321 1223456789999999999988765444499999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+++..+....+................ ........ .....+. ...+.+
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~-------~~~~~~ 317 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVR-AYIQSLPP---------------RQPVPWE-------TVYPGA 317 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHH-HHHHSSCC---------------CCCCCHH-------HHSTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh-hhhhcCCC---------------cCCCCHH-------HhCCCC
Confidence 999999999998888877766553222111100000 00000000 0000011 122457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++++++||.+||.+||++|||++|+|+||||+....+..
T Consensus 318 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 318 DRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 899999999999999999999999999999998776544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.24 Aligned_cols=194 Identities=25% Similarity=0.466 Sum_probs=168.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|++++.+|||||||+||+|.++|.+.+.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH--------------~~gIiHRDLKP 320 (689)
T 3v5w_A 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--------------NRFVVYRDLKP 320 (689)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCSG
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCch
Confidence 6899999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+|||++.+|.+||+|||++...... ...+.+||+.|+|||++.+ ..|+.+ +|+|||||++|+|++|..||.+.
T Consensus 321 eNILld~~G~vKL~DFGlA~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 321 ANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCGG
T ss_pred HHeEEeCCCCEEecccceeeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999765432 3456789999999999965 457666 99999999999999999999765
Q ss_pred hH---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 160 NL---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 160 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
+. ..+...+.... ...+..++++
T Consensus 395 ~~~~~~~i~~~i~~~~------------------------------------------------------~~~p~~~S~~ 420 (689)
T 3v5w_A 395 KTKDKHEIDRMTLTMA------------------------------------------------------VELPDSFSPE 420 (689)
T ss_dssp GCCCHHHHHHHHHHCC------------------------------------------------------CCCCTTSCHH
T ss_pred ChHHHHHHHHhhcCCC------------------------------------------------------CCCCccCCHH
Confidence 32 22333332222 3344778999
Q ss_pred HHHHHHHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
+++||.+||+.||.+|++ ++||++||||++..
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 999999999999999998 79999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=308.63 Aligned_cols=197 Identities=21% Similarity=0.363 Sum_probs=169.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~ 67 (304)
|++|+++.+++.++||||||++|+|.++|.+.+ .+++.++..++.|++.||+|||
T Consensus 78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH------------ 145 (299)
T 4asz_A 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA------------ 145 (299)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH------------
T ss_pred ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH------------
Confidence 789999999999999999999999999997642 5999999999999999999999
Q ss_pred CCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHH
Q psy1812 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF 147 (304)
Q Consensus 68 ~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~ 147 (304)
+.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +|||||||++|
T Consensus 146 --~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~ 221 (299)
T 4asz_A 146 --SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLW 221 (299)
T ss_dssp --HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHH
T ss_pred --hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHH
Confidence 889999999999999999999999999999765433221 12334568999999999999889887 99999999999
Q ss_pred HHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc
Q psy1812 148 IMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ 226 (304)
Q Consensus 148 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (304)
||++ |+.||.+.+..+....+..+..
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~----------------------------------------------------- 248 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRV----------------------------------------------------- 248 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCC-----------------------------------------------------
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------
Confidence 9998 8999998887777776665432
Q ss_pred ccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 227 VKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 227 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
...+..+++++.+||.+||+.||++|||+++++ +||+...
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~ 288 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA 288 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence 123366889999999999999999999999994 5887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.86 Aligned_cols=200 Identities=26% Similarity=0.474 Sum_probs=176.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|.+++.++||||||+||+|.++|.+ .+.+++.+++.++.||+.||+||| +.+|+|||||
T Consensus 217 v~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH--------------~~~iiHRDlK 282 (573)
T 3uto_A 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--------------ENNYVHLDLK 282 (573)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeccCC
Confidence 6899999999999999999999999999965 457999999999999999999999 8999999999
Q ss_pred CCcEEEecC--CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTKR--FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|||++.+ +.+||+|||+++.+.... .....+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.
T Consensus 283 p~Nill~~~~~~~vKl~DFG~a~~~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp GGGEEESSSSCCCEEECCCSSCEECCTTS----EEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSC
T ss_pred hhhccccCCCCCCEEEeeccceeEccCCC----ceeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCC
Confidence 999999854 789999999998765432 2345689999999999999888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+.+..+......++ ...+..+++++
T Consensus 358 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 387 (573)
T 3uto_A 358 GENDDETLRNVKSCDWNMD--------------------------------------------------DSAFSGISEDG 387 (573)
T ss_dssp CSSHHHHHHHHHTTCCCCC--------------------------------------------------SGGGTTSCHHH
T ss_pred CcCHHHHHHHHHhCCCCCC--------------------------------------------------cccccCCCHHH
Confidence 9988888888776655443 22335689999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++||.+||..||.+|||+.|+|+||||+....
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.90 Aligned_cols=192 Identities=20% Similarity=0.350 Sum_probs=158.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---------------GPVAESNARTWFSQMLAGLEYLHREITNHTPFT 65 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~ 65 (304)
|++|+++.+++.++||||||++|+|.++|++. +++++.++..++.|++.||+|||
T Consensus 106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---------- 175 (329)
T 4aoj_A 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---------- 175 (329)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----------
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----------
Confidence 78999999999999999999999999999764 35899999999999999999999
Q ss_pred CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHH
Q psy1812 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI 145 (304)
Q Consensus 66 ~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~l 145 (304)
+.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +|||||||+
T Consensus 176 ----~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvv 249 (329)
T 4aoj_A 176 ----GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVV 249 (329)
T ss_dssp ----HTTCCCSCCCGGGEEEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHH
T ss_pred ----cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcCCCCCcc-ccccchHHH
Confidence 889999999999999999999999999999865433221 12345679999999999999999887 999999999
Q ss_pred HHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhh
Q psy1812 146 TFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILS 224 (304)
Q Consensus 146 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (304)
+|||++ |+.||.+.+..+.+..+..+..
T Consensus 250 l~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--------------------------------------------------- 278 (329)
T 4aoj_A 250 LWEIFTYGKQPWYQLSNTEAIDCITQGRE--------------------------------------------------- 278 (329)
T ss_dssp HHHHHTTSCCTTCSSCHHHHHHHHHHTCC---------------------------------------------------
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCC---------------------------------------------------
Confidence 999999 8999998877777766654421
Q ss_pred ccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 225 HQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 225 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||++|++++
T Consensus 279 --~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 --LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp --CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred --CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 22346688999999999999999999999999873
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=303.14 Aligned_cols=198 Identities=25% Similarity=0.342 Sum_probs=148.8
Q ss_pred CceeeeeeeCC------------eEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcccCCCCCc
Q psy1812 1 MQVHSILQRGP------------RVFIFMRYADNGDLLDHIKRAGP---VAESNARTWFSQMLAGLEYLHREITNHTPFT 65 (304)
Q Consensus 1 v~~~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~ 65 (304)
|++|++|.+.+ .+|||||||+||+|.+++...+. ..+..++.++.|++.||+|||
T Consensus 66 V~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---------- 135 (299)
T 4g31_A 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---------- 135 (299)
T ss_dssp CCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----------
T ss_pred CeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----------
Confidence 68899887544 47999999999999999987654 455678999999999999999
Q ss_pred CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCccccc---------ccccCccCCccccccccccCCCCCCCC
Q psy1812 66 AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR---------VLSRTYCGSAAYAAPEVISGNPYNPKL 136 (304)
Q Consensus 66 ~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~~~~~~~~ 136 (304)
+.+|+||||||+|||++.++.+||+|||+++......... ....+.+||+.|+|||++.+..++.+
T Consensus 136 ----~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~- 210 (299)
T 4g31_A 136 ----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK- 210 (299)
T ss_dssp ----HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTH-
T ss_pred ----HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-
Confidence 8999999999999999999999999999998654332111 12234679999999999999889877
Q ss_pred chHHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 137 ADIWSLGVITFIMLNAAMPFDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 137 sDvwslG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|||||||++|+|++ ||.+.... .....+..... +
T Consensus 211 ~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~--p--------------------------------------- 246 (299)
T 4g31_A 211 VDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKF--P--------------------------------------- 246 (299)
T ss_dssp HHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCC--C---------------------------------------
T ss_pred HHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCC--C---------------------------------------
Confidence 999999999999996 88654322 22222221111 0
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+...++.+.+||.+||+.||++|||+.|+++||||++...
T Consensus 247 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 247 ------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp ------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred ------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 011334667889999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=304.74 Aligned_cols=192 Identities=21% Similarity=0.355 Sum_probs=165.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++|+++.+++.++||||||++|+|.++|... ..+++..+..++.|++.||+|||
T Consensus 92 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--------- 162 (308)
T 4gt4_A 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--------- 162 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---------
T ss_pred CCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---------
Confidence 68999999999999999999999999999653 35899999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +|||||||
T Consensus 163 -----~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGv 235 (308)
T 4gt4_A 163 -----SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGV 235 (308)
T ss_dssp -----HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHH
T ss_pred -----hCCCCCCCccccceEECCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhCCCCCcc-chhhhHHH
Confidence 889999999999999999999999999999865433222 12345679999999999999889887 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|||++ |..||.+.+..+....+..+..
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~-------------------------------------------------- 265 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-------------------------------------------------- 265 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999998 8999998887777766654432
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++.+.+|+.+||+.||++|||++|++++
T Consensus 266 ---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 ---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12235688999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=302.41 Aligned_cols=196 Identities=22% Similarity=0.364 Sum_probs=153.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+ +.++||||||+||+|.++|... +.+++..+..++.|++.||+||| +.+|+|||||
T Consensus 95 V~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH--------------~~~IiHRDlK 159 (307)
T 3omv_A 95 LLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH--------------AKNIIHRDMK 159 (307)
T ss_dssp CCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCSCCC
T ss_pred eeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccCCccC
Confidence 688998765 5689999999999999999765 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC---CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN---PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|||++.++.+||+|||+++........ ......+||+.|+|||++.+. +++.+ +|||||||++|||++|+.||
T Consensus 160 p~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp SSSEEEETTEEEEECCCSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTT
T ss_pred HHHEEECCCCcEEEeeccCceecccCCcc-eeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999765432221 133456899999999999643 46666 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+.......+.......+. ....+..++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~p~------------------------------------------------~~~~~~~~~~~ 269 (307)
T 3omv_A 238 SHINNRDQIIFMVGRGYASPD------------------------------------------------LSKLYKNCPKA 269 (307)
T ss_dssp TTCCCHHHHHHHHHTTCCCCC------------------------------------------------STTSCTTSCHH
T ss_pred CCCChHHHHHHHHhcCCCCCC------------------------------------------------cccccccchHH
Confidence 876544443333322211110 01233568899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+|+.+||+.||++|||+.|++++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.67 Aligned_cols=197 Identities=32% Similarity=0.612 Sum_probs=175.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||++||+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH--------------~~~ivHrDlkp 142 (328)
T 3fe3_A 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH--------------QKRIVHRDLKA 142 (328)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred eeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeccCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++....... .....+|++.|+|||++.+..+...++|+||+||++|+|++|..||.+.+
T Consensus 143 ~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 143 ENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp GGEEECTTSCEEECSTTCCGGGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEEcCCCCEEEeeccCceecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997544322 23456799999999999988877555999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..+....+ ..+++++.+|
T Consensus 219 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 244 (328)
T 3fe3_A 219 LKELRERVLRGKYRIP------------------------------------------------------FYMSTDCENL 244 (328)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHhCCCCCC------------------------------------------------------CCCCHHHHHH
Confidence 7777776665544333 5578999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||..||.+|||++|+++||||+....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 99999999999999999999999997664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.74 Aligned_cols=192 Identities=21% Similarity=0.370 Sum_probs=159.6
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCC
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTP 63 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~ 63 (304)
|++++++.. ++.++||||||++|+|.++|++. ..+++..+..++.|++.||+|||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH-------- 202 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-------- 202 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--------
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--------
Confidence 689998865 56799999999999999999763 24899999999999999999999
Q ss_pred CcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 64 ~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
+.+|+||||||+|||++.++.+||+|||+++....... .......+||+.|+|||++.+..++.+ +||||||
T Consensus 203 ------~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~G 274 (353)
T 4ase_A 203 ------SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFG 274 (353)
T ss_dssp ------HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHH
T ss_pred ------hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCc-ccEeehH
Confidence 89999999999999999999999999999986543221 113345678999999999999889887 9999999
Q ss_pred HHHHHHHh-CCCCCCChhHHHHHHH-hhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 144 VITFIMLN-AAMPFDDSNLKQLFKE-QTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 144 ~ll~~ll~-g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
|++|||++ |..||.+.+..+.+.+ +..+..
T Consensus 275 v~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~------------------------------------------------ 306 (353)
T 4ase_A 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------------------------------------ 306 (353)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC------------------------------------------------
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC------------------------------------------------
Confidence 99999998 8999987654333332 222211
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||+.++++|
T Consensus 307 -----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 307 -----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 22345678999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.38 Aligned_cols=196 Identities=28% Similarity=0.537 Sum_probs=170.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 87 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~givHrDlkp 152 (353)
T 3txo_A 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH--------------DKGIIYRDLKL 152 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCcccCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 153 ~NILl~~~g~ikL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 153 DNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCC------------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEccccceeecccCCc---cccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCC
Confidence 999999999999999999874332221 3456689999999999988878777 999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+......++ ..+++.+.+|
T Consensus 229 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~~~~~~~l 254 (353)
T 3txo_A 229 EDDLFEAILNDEVVYP------------------------------------------------------TWLHEDATGI 254 (353)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------CCCCHHHHHH
Confidence 8888877776544333 5678999999
Q ss_pred HHHhcCCCCCccccH------HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL------DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~------~ell~~~wf~~~~ 268 (304)
|.+||..||.+||++ +++++||||+...
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 999999999999998 8999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=292.65 Aligned_cols=196 Identities=29% Similarity=0.565 Sum_probs=172.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+.+.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 68 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp 133 (337)
T 1o6l_A 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--------------SRDVVYRDIKL 133 (337)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCcCCH
Confidence 5789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 134 ~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 134 ENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEeeccchhhcccCCC---cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCC
Confidence 999999999999999999875332221 2445679999999999988888777 999999999999999999998887
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... .+..+++++.+|
T Consensus 210 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~s~~~~~l 235 (337)
T 1o6l_A 210 HERLFELILMEEIR------------------------------------------------------FPRTLSPEAKSL 235 (337)
T ss_dssp HHHHHHHHHHCCCC------------------------------------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCCCCCHHHHHH
Confidence 77666666544332 235678999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||+.||++|| +++++++||||+...
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999 999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=295.62 Aligned_cols=199 Identities=28% Similarity=0.537 Sum_probs=174.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||+.||+|.+++...+.+++..++.++.|++.||.||| +.+|+|+||||
T Consensus 78 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~givHrDlkp 143 (361)
T 2yab_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--------------TKKIAHFDLKP 143 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 5799999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCC----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRF----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++ .+||+|||++....... .....+|++.|+|||++.+..++.. +|+|||||++|+|++|..||
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSS
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCC
Confidence 999998877 79999999997654322 2345679999999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+.+..+......++ ...+..++++
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~ 248 (361)
T 2yab_A 219 LGDTKQETLANITAVSYDFD--------------------------------------------------EEFFSQTSEL 248 (361)
T ss_dssp CCSSHHHHHHHHHTTCCCCC--------------------------------------------------HHHHTTSCHH
T ss_pred CCCCHHHHHHHHHhcCCCCC--------------------------------------------------chhccCCCHH
Confidence 98888777777766554433 1122557889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.+||.+||..||.+|||+.|+++||||+...
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 99999999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=295.17 Aligned_cols=196 Identities=31% Similarity=0.556 Sum_probs=173.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp 146 (345)
T 1xjd_A 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH--------------SKGIVYRDLKL 146 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCCCCh
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 147 ~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 147 DNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhEEECCCCCEEEeEChhhhhcccCCC---cccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999875332221 2456789999999999998888777 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....+..+...... .+..+++++.+|
T Consensus 223 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~s~~~~~l 248 (345)
T 1xjd_A 223 EEELFHSIRMDNPF------------------------------------------------------YPRWLEKEAKDL 248 (345)
T ss_dssp HHHHHHHHHHCCCC------------------------------------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHHHhCCCC------------------------------------------------------CCcccCHHHHHH
Confidence 77777666544322 235678999999
Q ss_pred HHHhcCCCCCccccHH-HHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLD-AIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~-ell~~~wf~~~~ 268 (304)
|.+||..||++||++. ++++||||+...
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999999998 999999998763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.24 Aligned_cols=193 Identities=34% Similarity=0.672 Sum_probs=172.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.++..+++||||++||+|.+++.+.+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp 134 (318)
T 1fot_A 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--------------SKDIIYRDLKP 134 (318)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCCG
T ss_pred ceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCh
Confidence 5899999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.+|.+||+|||++..... .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSS------CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred heEEEcCCCCEEEeecCcceecCC------ccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999975432 2335679999999999998888877 999999999999999999998888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....+.++......+ +..+++++.+|
T Consensus 208 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~~~~~~~l 233 (318)
T 1fot_A 208 TMKTYEKILNAELRF------------------------------------------------------PPFFNEDVKDL 233 (318)
T ss_dssp HHHHHHHHHHCCCCC------------------------------------------------------CTTSCHHHHHH
T ss_pred HHHHHHHHHhCCCCC------------------------------------------------------CCCCCHHHHHH
Confidence 777777666544333 25678999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|+ +++++++||||+...
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999 999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.26 Aligned_cols=195 Identities=31% Similarity=0.582 Sum_probs=172.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++++.+.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 84 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~givHrDlkp 149 (353)
T 2i0e_A 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--------------SKGIIYRDLKL 149 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred eeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEeccCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.+|.+||+|||++........ .....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 150 ~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 150 DNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEEcCCCcEEEEeCCcccccccCCc---ccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999975332221 3456689999999999988888777 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+......+ +..++.++.+|
T Consensus 226 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~s~~~~~l 251 (353)
T 2i0e_A 226 EDELFQSIMEHNVAY------------------------------------------------------PKSMSKEAVAI 251 (353)
T ss_dssp HHHHHHHHHHCCCCC------------------------------------------------------CTTSCHHHHHH
T ss_pred HHHHHHHHHhCCCCC------------------------------------------------------CCCCCHHHHHH
Confidence 777777776554333 35689999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~ 267 (304)
|.+||..||.+|| +++++++||||+..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 9999999999999 57999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.88 Aligned_cols=199 Identities=27% Similarity=0.476 Sum_probs=169.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++..++||||+.||+|.+++.+. .+++..++.++.|++.||.||| +.+++||||||
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~Dlkp 144 (297)
T 3fxz_A 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH--------------SNQVIHRDIKS 144 (297)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH--------------hCCceeCCCCH
Confidence 57899999999999999999999999999775 5999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 145 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 145 DNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHEEECCCCCEEEeeCCCceecCCccc---ccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543322 2345679999999999998888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... ...+..+++.+.+|
T Consensus 221 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 221 PLRALYLIATNGTPE---------------------------------------------------LQNPEKLSAIFRDF 249 (297)
T ss_dssp HHHHHHHHHHHCSCC---------------------------------------------------CSCGGGSCHHHHHH
T ss_pred HHHHHHHHHhCCCCC---------------------------------------------------CCCccccCHHHHHH
Confidence 655544433221110 12235678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||+.||.+|||++|+++||||+....
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 99999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=295.32 Aligned_cols=205 Identities=28% Similarity=0.553 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 116 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~givHrDLKp 181 (396)
T 4dc2_A 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--------------ERGIIYRDLKL 181 (396)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred CeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEeccCCH
Confidence 6899999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||+++....... .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 182 ~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 182 DNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC---CBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred HHEEECCCCCEEEeecceeeecccCCC---ccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999975332221 3456789999999999999888877 999999999999999999996432
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....... .........+.......+..+++++.+|
T Consensus 258 ~~~~~~~---------------------------------------------~~~~~~~~~i~~~~~~~p~~~s~~~~~l 292 (396)
T 4dc2_A 258 SSDNPDQ---------------------------------------------NTEDYLFQVILEKQIRIPRSLSVKAASV 292 (396)
T ss_dssp C---------------------------------------------------CCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccch---------------------------------------------hhHHHHHHHHhccccCCCCcCCHHHHHH
Confidence 1110000 0000011122222344557789999999
Q ss_pred HHHhcCCCCCccccH------HHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRL------DAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~------~ell~~~wf~~~~ 268 (304)
|.+||+.||.+||++ +|+++||||+...
T Consensus 293 i~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred HHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 999999999999985 7999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=285.12 Aligned_cols=235 Identities=20% Similarity=0.312 Sum_probs=172.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||+. |+|.+++...+ .+++..++.++.|++.||.||| +.+|+|||||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH~Dik 127 (324)
T 3mtl_A 63 VTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--------------RQKVLHRDLK 127 (324)
T ss_dssp CCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEESSCC
T ss_pred CeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccCCCcC
Confidence 578999999999999999997 59999998754 5999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||++.+. .++.+ +|+|||||++|+|++|..||.+
T Consensus 128 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 128 PQNLLINERGELKLADFGLARAKSIPTK---TYDNEVVTLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp GGGEEECTTCCEEECSSSEEECC---------------CGGGCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHHEEECCCCCEEEccCcccccccCCcc---ccccccCcccccChhhhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999875433221 23345689999999998774 45555 9999999999999999999999
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+............. ...... .. .......+++++.
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~----------~~----~~~~~~~~~~~~~ 259 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN----------YPKYRA----------EA----LLSHAPRLDSDGA 259 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC----------CCCCCC----------CC----HHHHCTTSCHHHH
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc----------cccccc----------hh----hhhhcCCCCHHHH
Confidence 88877777766654443321111110000000000 000000 00 0112245789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQ 278 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~ 278 (304)
+||.+||+.||++|||++|+|+||||........+.....
T Consensus 260 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~ 299 (324)
T 3mtl_A 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTT 299 (324)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTS
T ss_pred HHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCC
Confidence 9999999999999999999999999999887555444333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=289.44 Aligned_cols=192 Identities=30% Similarity=0.601 Sum_probs=172.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp 169 (350)
T 1rdq_E 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH--------------SLDLIYRDLKP 169 (350)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccCcc
Confidence 5789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... ....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 170 ~NIll~~~g~~kL~DFg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 170 ENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceEEECCCCCEEEcccccceeccCC------cccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCC
Confidence 9999999999999999999754332 335679999999999998888777 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+..+...++ ..+++++.+|
T Consensus 243 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~~~~~~~l 268 (350)
T 1rdq_E 243 PIQIYEKIVSGKVRFP------------------------------------------------------SHFSSDLKDL 268 (350)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------CCCCHHHHHH
Confidence 7777777665543332 5678999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
|.+||+.||.+||+ ++++++||||+..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999998 9999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=297.79 Aligned_cols=201 Identities=26% Similarity=0.484 Sum_probs=175.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||+.||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 73 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH--------------~~givHrDlKp 138 (444)
T 3soa_A 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH--------------QMGVVHRNLKP 138 (444)
T ss_dssp CCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCSS
T ss_pred CeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 6899999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEe---cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMT---KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++ .++.+||+|||++........ ......|++.|+|||++.+..++.+ +|+||+||++|+|++|..||.
T Consensus 139 ~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp TTEEESBSSTTCCEEECCCSSCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCC
T ss_pred HHEEEeccCCCCcEEEccCceeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCC
Confidence 999998 457899999999975543221 2345679999999999988888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..+...++ ......+++++
T Consensus 215 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 244 (444)
T 3soa_A 215 DEDQHRLYQQIKAGAYDFP--------------------------------------------------SPEWDTVTPEA 244 (444)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------TTTTTTSCHHH
T ss_pred CccHHHHHHHHHhCCCCCC--------------------------------------------------ccccccCCHHH
Confidence 9888888877776655444 12224678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~ 276 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHRST 276 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCCcc
Confidence 99999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=291.11 Aligned_cols=195 Identities=30% Similarity=0.570 Sum_probs=172.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+|+||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~givHrDlkp 167 (373)
T 2r5t_A 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH--------------SLNIVYRDLKP 167 (373)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred CCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.+|.+||+|||++........ .....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 168 ~NIll~~~g~ikL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 168 ENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp GGEEECTTSCEEECCCCBCGGGBCCCC---CCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred HHEEECCCCCEEEeeCccccccccCCC---ccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999975332221 3456789999999999998888777 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+......+ +..++..+.+|
T Consensus 244 ~~~~~~~i~~~~~~~------------------------------------------------------~~~~~~~~~~l 269 (373)
T 2r5t_A 244 TAEMYDNILNKPLQL------------------------------------------------------KPNITNSARHL 269 (373)
T ss_dssp HHHHHHHHHHSCCCC------------------------------------------------------CSSSCHHHHHH
T ss_pred HHHHHHHHHhcccCC------------------------------------------------------CCCCCHHHHHH
Confidence 777777666543322 36688999999
Q ss_pred HHHhcCCCCCccccH----HHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRL----DAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~----~ell~~~wf~~~ 267 (304)
|.+||..||.+||++ .++++||||+..
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999999987 699999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=287.96 Aligned_cols=196 Identities=30% Similarity=0.586 Sum_probs=166.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 73 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~~ivHrDlkp 138 (345)
T 3a8x_A 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--------------ERGIIYRDLKL 138 (345)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred CeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCH
Confidence 6899999999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||....
T Consensus 139 ~NIll~~~g~~kL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 139 DNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp GGEEECTTSCEEECCGGGCBCSCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred HHEEECCCCCEEEEeccccccccCCCC---cccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcc
Confidence 999999999999999999975332221 2445689999999999998888776 999999999999999999996531
Q ss_pred H---------HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 161 L---------KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 161 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
. ......+. ......+.
T Consensus 215 ~~~~~~~~~~~~~~~~i~------------------------------------------------------~~~~~~p~ 240 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVIL------------------------------------------------------EKQIRIPR 240 (345)
T ss_dssp C-------CHHHHHHHHH------------------------------------------------------HCCCCCCT
T ss_pred cccccccccHHHHHHHHH------------------------------------------------------cCCCCCCC
Confidence 1 11111111 12233446
Q ss_pred cccHHHHHHHHHhcCCCCCccccH------HHHhcCccccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRL------DAIKAHDWLRYKS 268 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~------~ell~~~wf~~~~ 268 (304)
.++.++.+||.+||+.||.+||++ +++++||||++..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 789999999999999999999995 8999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=285.22 Aligned_cols=200 Identities=29% Similarity=0.511 Sum_probs=171.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 77 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivH~Dlkp 142 (326)
T 2y0a_A 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--------------SLQIAHFDLKP 142 (326)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCCG
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH--------------HCCeEcCCCCH
Confidence 5789999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCC----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRF----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++ .+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||
T Consensus 143 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSS
T ss_pred HHEEEecCCCCCCCEEEEECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCC
Confidence 999998887 79999999997654322 2234579999999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+.......+ ...+..++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~ 247 (326)
T 2y0a_A 218 LGDTKQETLANVSAVNYEFE--------------------------------------------------DEYFSNTSAL 247 (326)
T ss_dssp CCSSHHHHHHHHHHTCCCCC--------------------------------------------------HHHHTTSCHH
T ss_pred CCCCHHHHHHHHHhcCCCcC--------------------------------------------------ccccccCCHH
Confidence 88776666665554433222 1122457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||..||++|||+.++++||||+....
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 999999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=287.82 Aligned_cols=200 Identities=23% Similarity=0.417 Sum_probs=172.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+.+..++||||++||+|.+++...+ .+++..++.++.|++.||.||| +.+++|||||
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~givH~Dlk 129 (321)
T 1tki_A 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--------------SHNIGHFDIR 129 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCCcCCCC
Confidence 579999999999999999999999999997754 7999999999999999999999 8999999999
Q ss_pred CCcEEEec--CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTK--RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+||+++. ++.+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 130 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 130 PENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCc
Confidence 99999987 7899999999997654322 2234568999999999988777776 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+......+. ......++.++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 234 (321)
T 1tki_A 205 AETNQQIIENIMNAEYTFD--------------------------------------------------EEAFKEISIEA 234 (321)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------HHHHTTSCHHH
T ss_pred CCCHHHHHHHHHcCCCCCC--------------------------------------------------hhhhccCCHHH
Confidence 8887777777766544433 11124578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||..||.+|||+.|+++||||+....
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 99999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.34 Aligned_cols=196 Identities=30% Similarity=0.562 Sum_probs=171.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~ 79 (304)
|++++++..++.+++||||++||+|.+++.+.+.+++..++.++.|++.||+||| + .+|+|||||
T Consensus 211 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~giiHrDlk 276 (446)
T 4ejn_A 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH--------------SEKNVVYRDLK 276 (446)
T ss_dssp CCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HHTCCCCCCCC
T ss_pred eeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------------hcCCEEECCCC
Confidence 5789999999999999999999999999999889999999999999999999999 6 899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++........ .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.
T Consensus 277 p~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 277 LENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp GGGEEECSSSCEEECCCCCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEccCCCceeccCCCc---ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999875332221 2345689999999999988888877 99999999999999999999888
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+......+ +..+++++.+
T Consensus 353 ~~~~~~~~i~~~~~~~------------------------------------------------------p~~~~~~~~~ 378 (446)
T 4ejn_A 353 DHEKLFELILMEEIRF------------------------------------------------------PRTLGPEAKS 378 (446)
T ss_dssp SHHHHHHHHHHCCCCC------------------------------------------------------CTTSCHHHHH
T ss_pred CHHHHHHHHHhCCCCC------------------------------------------------------CccCCHHHHH
Confidence 7777766665443332 3567899999
Q ss_pred HHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
||.+||+.||.+|| |++|+++||||++..
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 99999999999999 999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=288.75 Aligned_cols=199 Identities=29% Similarity=0.518 Sum_probs=172.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||+.||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivH~Dlkp 156 (362)
T 2bdw_A 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--------------SNGIVHRNLKP 156 (362)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCSG
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCch
Confidence 6899999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++ .+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 157 ~NIll~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 157 ENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp GGEEESCSSTTCCEEECCCTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCCCEEEeecCcceEecCCc----ccccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCC
Confidence 999997654 59999999997654322 2335679999999999988888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..+...++ ......+++++
T Consensus 232 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 261 (362)
T 2bdw_A 232 DEDQHRLYAQIKAGAYDYP--------------------------------------------------SPEWDTVTPEA 261 (362)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------TTGGGGSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------cccccCCCHHH
Confidence 8887777777666544433 12224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||..||++|||+.++|+||||+...
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 292 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRE 292 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=285.63 Aligned_cols=203 Identities=29% Similarity=0.561 Sum_probs=149.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.++...++||||++||+|.+++.+.+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~ivH~Dlkp 134 (325)
T 3kn6_A 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH--------------DVGVVHRDLKP 134 (325)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCCG
T ss_pred eEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCeecCCCH
Confidence 5799999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++ .+||+|||++........ .....+++..|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 135 ~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp GGEEEEC----CEEEECCCTTCEECCC-------------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC
T ss_pred HHEEEecCCCcccEEEeccccceecCCCCC---cccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCC
Confidence 999998766 799999999975443221 2345568999999999988888877 999999999999999999997
Q ss_pred ChhH-------HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 158 DSNL-------KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 158 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
+.+. .+....+..+...+. ...+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~ 240 (325)
T 3kn6_A 211 SHDRSLTCTSAVEIMKKIKKGDFSFE--------------------------------------------------GEAW 240 (325)
T ss_dssp -------CCCHHHHHHHHTTTCCCCC--------------------------------------------------SHHH
T ss_pred CCccccccccHHHHHHHHHcCCCCCC--------------------------------------------------cccc
Confidence 6543 233333333222211 1112
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
..+++++.+||.+||..||.+|||++++++||||+......
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 45789999999999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=284.15 Aligned_cols=196 Identities=28% Similarity=0.538 Sum_probs=167.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++.+++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~ivH~Dlkp 149 (327)
T 3a62_A 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH--------------QKGIIYRDLKP 149 (327)
T ss_dssp CCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCT
T ss_pred cceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEcccCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ .....+|++.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+
T Consensus 150 ~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 150 ENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp TTEEECTTSCEEECCCSCC-------------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHeEECCCCcEEEEeCCcccccccCCc---cccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999864332211 2345679999999999988888776 999999999999999999998887
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... +..+++++.+|
T Consensus 226 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~~~~~~~l 251 (327)
T 3a62_A 226 RKKTIDKILKCKLNL------------------------------------------------------PPYLTQEARDL 251 (327)
T ss_dssp HHHHHHHHHHTCCCC------------------------------------------------------CTTSCHHHHHH
T ss_pred HHHHHHHHHhCCCCC------------------------------------------------------CCCCCHHHHHH
Confidence 766666655443322 35678999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|| ++.++++||||+...
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999 889999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.43 Aligned_cols=195 Identities=31% Similarity=0.585 Sum_probs=175.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
++++++|++.+.++|||||++||+|.+++.+.+.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 405 ~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~gIiHrDLKp 470 (674)
T 3pfq_A 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--------------SKGIIYRDLKL 470 (674)
T ss_dssp CCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTSEECCCCCS
T ss_pred EEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEeccCCh
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||++........ .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+
T Consensus 471 ~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 471 DNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp TTEEECSSSCEEECCCTTCEECCCTTC---CBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhEEEcCCCcEEEeecceeeccccCCc---ccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999975332221 3456789999999999998888877 999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+......++ ..+++++.+|
T Consensus 547 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 572 (674)
T 3pfq_A 547 EDELFQSIMEHNVAYP------------------------------------------------------KSMSKEAVAI 572 (674)
T ss_dssp HHHHHHHHHSSCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHhCCCCCC------------------------------------------------------ccCCHHHHHH
Confidence 8888887776554433 6689999999
Q ss_pred HHHhcCCCCCccccH-----HHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRL-----DAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~-----~ell~~~wf~~~ 267 (304)
|.+||+.||++|+++ +||++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999997 999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=273.36 Aligned_cols=205 Identities=28% Similarity=0.510 Sum_probs=176.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 68 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dikp 133 (284)
T 3kk8_A 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--------------SNGIVHRNLKP 133 (284)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCG
T ss_pred CeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcCcCCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCC---eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++. +||+|||++....... ......|++.|+|||.+.+..++.+ +|+||||+++++|++|..||.
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCc----cccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCC
Confidence 9999976655 9999999997554332 2234568999999999998888777 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..+....+ ......+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 238 (284)
T 3kk8_A 209 DEDQHRLYAQIKAGAYDYP--------------------------------------------------SPEWDTVTPEA 238 (284)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------TTTTTTSCHHH
T ss_pred CCchhHHHHHHHhccccCC--------------------------------------------------chhhcccCHHH
Confidence 8877777766655544333 11224578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
.+||.+||+.||++|||++|+++||||+.........
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 275 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence 9999999999999999999999999999988766543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.35 Aligned_cols=199 Identities=27% Similarity=0.437 Sum_probs=170.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+++||||++||+|.+++.+. .+++..++.++.|++.||+||| +.+|+||||||
T Consensus 132 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH--------------~~givHrDLKp 196 (410)
T 3v8s_A 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIH--------------SMGFIHRDVKP 196 (410)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCCH
Confidence 68999999999999999999999999999764 6999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC----CCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP----YNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++.+||+|||++........ ......+||+.|+|||++.+.. ++.+ +|+|||||++|+|++|..||
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETH-HHHHHHHHHHHHHHHSSCTT
T ss_pred HHeeECCCCCEEEeccceeEeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCc-ceEecchHHHHHHHhCCCCC
Confidence 999999999999999999976543321 1234678999999999997655 4555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+....+.++........ ......++++
T Consensus 274 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~p~~~~~s~~ 303 (410)
T 3v8s_A 274 YADSLVGTYSKIMNHKNSLT--------------------------------------------------FPDDNDISKE 303 (410)
T ss_dssp CCSSHHHHHHHHHTHHHHCC--------------------------------------------------CCTTCCCCHH
T ss_pred CCCChhhHHHHHHhcccccc--------------------------------------------------CCCcccccHH
Confidence 99888888877765432211 1112457999
Q ss_pred HHHHHHHhcCCCCCc--cccHHHHhcCcccccc
Q psy1812 237 VKNLVGQILEPDITK--RIRLDAIKAHDWLRYK 267 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~ 267 (304)
+++||++||..+|.+ |++++|+++||||++.
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999999988 9999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=289.84 Aligned_cols=195 Identities=34% Similarity=0.668 Sum_probs=164.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++..++||||+ +|+|.+++...+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 72 v~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~givH~Dlkp 136 (336)
T 3h4j_B 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--------------RHKIVHRDLKP 136 (336)
T ss_dssp CCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HHTCCCCCCST
T ss_pred CeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCch
Confidence 57999999999999999999 6899999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++....... .....+|++.|+|||++.+..+...++|+|||||++|+|++|..||.+..
T Consensus 137 ~NIll~~~~~~kl~DFG~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 137 ENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TTEEECTTCCEEECCSSCTBTTTTSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred hhEEEcCCCCEEEEEeccceeccCCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999997654332 23456799999999999888775445999999999999999999997653
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......++... ....+..+++++.+|
T Consensus 213 ~~~~~~~i~~~------------------------------------------------------~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 213 IPNLFKKVNSC------------------------------------------------------VYVMPDFLSPGAQSL 238 (336)
T ss_dssp STTCBCCCCSS------------------------------------------------------CCCCCTTSCHHHHHH
T ss_pred HHHHHHHHHcC------------------------------------------------------CCCCcccCCHHHHHH
Confidence 22111111111 122345678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|||++|+++||||+...
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=286.29 Aligned_cols=200 Identities=30% Similarity=0.524 Sum_probs=167.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 79 v~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~givHrDlkp 144 (342)
T 2qr7_A 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH--------------AQGVVHRDLKP 144 (342)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCG
T ss_pred CeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcEeccCCH
Confidence 5799999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecC----CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||++... +.+||+|||++........ .....++++.|+|||++.+..++.. +|+|||||++|+|++|..||
T Consensus 145 ~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 145 SNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp GGEEESSSSCSGGGEEECCCTTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEEecCCCCcCeEEEEECCCcccCcCCCC---ceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCC
Confidence 99998543 3499999999976543322 2345678999999999987767766 99999999999999999999
Q ss_pred CCh---hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 157 DDS---NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 157 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.+. ...+.+..+..+..... ...+..+
T Consensus 221 ~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~ 250 (342)
T 2qr7_A 221 ANGPDDTPEEILARIGSGKFSLS--------------------------------------------------GGYWNSV 250 (342)
T ss_dssp CSSTTSCHHHHHHHHHHCCCCCC--------------------------------------------------STTTTTS
T ss_pred CCCCcCCHHHHHHHHccCCcccC--------------------------------------------------ccccccC
Confidence 753 33444555444433222 2223567
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
++++.+||.+||..||++|||+.++++||||....
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 99999999999999999999999999999997644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=276.62 Aligned_cols=224 Identities=22% Similarity=0.363 Sum_probs=166.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||+.+ +|.+++.. .+.+++..++.++.|++.||+||| +.+|+|||||
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--------------~~~ivH~dik 128 (292)
T 3o0g_A 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--------------SRNVLHRDLK 128 (292)
T ss_dssp CCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred eeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCC
Confidence 5789999999999999999986 66666655 568999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCC-CC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMP-FD 157 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~p-f~ 157 (304)
|+||+++.++.+||+|||++........ ......++..|+|||++.+.. ++.+ +|+|||||++|+|++|..| |.
T Consensus 129 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 129 PQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTH-HHHHHHHHHHHHHTTTSCCSCC
T ss_pred HHHEEEcCCCCEEEeecccceecCCccc---cccCCccccCCcChHHHcCCCCcCch-HHHHHHHHHHHHHHHcCCCCcC
Confidence 9999999999999999999976543221 234557899999999998776 4555 9999999999999987776 55
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+...........+....... ..... . ..............+++.+
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----------~~~~~--------~-------~~~~~~~~~~~~~~~~~~~ 259 (292)
T 3o0g_A 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLP----------DYKPY--------P-------MYPATTSLVNVVPKLNATG 259 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGST----------TCCCC--------C-------CCCTTCCCTTTSTTCCHHH
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhcccc----------ccccc--------c-------cccCCcchhhcccccChHH
Confidence 555556666555544433211111000000 00000 0 0000001122335678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||+.||++|||++|+++||||++..
T Consensus 260 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 260 RDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999999765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.28 Aligned_cols=195 Identities=26% Similarity=0.553 Sum_probs=168.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++|+|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~i~H~dlkp 137 (279)
T 3fdn_A 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--------------SKRVIHRDIKP 137 (279)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TTTCEECCCCG
T ss_pred cchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecccCCh
Confidence 5789999999999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||...+
T Consensus 138 ~Nili~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 138 ENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp GGEEECTTSCEEECSCCEESCC-------------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HhEEEcCCCCEEEEeccccccCCcc-----cccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCc
Confidence 9999999999999999988543222 2234568999999999988877777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+...... .+..+++.+.+|
T Consensus 212 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~l 237 (279)
T 3fdn_A 212 YQETYKRISRVEFT------------------------------------------------------FPDFVTEGARDL 237 (279)
T ss_dssp HHHHHHHHHHTCCC------------------------------------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHHHhCCCC------------------------------------------------------CCCcCCHHHHHH
Confidence 66666555443322 235678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||+.||.+|||++|+++||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=293.08 Aligned_cols=201 Identities=24% Similarity=0.439 Sum_probs=170.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|.+++.+++|||||.||+|.+++.+ .+.+++..++.++.|++.||.||| +.+|+|||||
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH--------------~~giiHrDLK 202 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH--------------QLHYVHRDIK 202 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEecccC
Confidence 5789999999999999999999999999987 468999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+|||++.++.+||+|||++......... .....+||+.|+|||++. ...++.+ +|+|||||++|+|++|..
T Consensus 203 p~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 203 PDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSCE--ECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSC
T ss_pred HHHeeEcCCCCEEEcchhhhhhcccCCCc--ccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCC
Confidence 99999999999999999999755432221 234567999999999986 4456666 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+.+.++......... ......++
T Consensus 280 Pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------------p~~~~~~s 310 (437)
T 4aw2_A 280 PFYAESLVETYGKIMNHKERFQF-------------------------------------------------PTQVTDVS 310 (437)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCCC-------------------------------------------------CSSCCCSC
T ss_pred CCCCCChhHHHHhhhhccccccC-------------------------------------------------CcccccCC
Confidence 99998887777776643221110 11124479
Q ss_pred HHHHHHHHHhcCCCCCc--cccHHHHhcCcccccc
Q psy1812 235 HQVKNLVGQILEPDITK--RIRLDAIKAHDWLRYK 267 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~--R~t~~ell~~~wf~~~ 267 (304)
+++++||++||..+|++ |++++|+++||||++.
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 99999999999999988 9999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.20 Aligned_cols=195 Identities=38% Similarity=0.711 Sum_probs=171.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++...+..++||||++||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~givHrDLkp 144 (476)
T 2y94_A 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH--------------RHMVVHRDLKP 144 (476)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH--------------TTTEECSCCSG
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCCcccccH
Confidence 5899999999999999999999999999998888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++....... .....+|++.|+|||++.+..+...++|+|||||++|+|++|..||.+.+
T Consensus 145 ~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 145 ENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp GGEEECTTCCEEECCCSSCEECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEEecCCCeEEEeccchhhccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999997654322 23456799999999999887765555999999999999999999998887
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......++..+.... +..+++++.+|
T Consensus 221 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~s~~~~~L 246 (476)
T 2y94_A 221 VPTLFKKICDGIFYT------------------------------------------------------PQYLNPSVISL 246 (476)
T ss_dssp SHHHHHHHHTTCCCC------------------------------------------------------CTTCCHHHHHH
T ss_pred HHHHHHHHhcCCcCC------------------------------------------------------CccCCHHHHHH
Confidence 767766665543322 25578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
|.+||..||.+|||++++++||||+..
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=288.77 Aligned_cols=247 Identities=16% Similarity=0.254 Sum_probs=163.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+++.+++||||+++|+|.+++... +.+++..++.++.|++.||+||| +.+|+||||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivHrDl 154 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--------------HMGYVHRSV 154 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCC
Confidence 68999999999999999999999999999876 67999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccc----cccccCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGR----RVLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g 152 (304)
||+||+++.++.+||+|||.+......... ........|+..|+|||++.+ ..++.+ +|+|||||++|+|++|
T Consensus 155 kp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g 233 (389)
T 3gni_B 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANG 233 (389)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHS
T ss_pred CHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHC
Confidence 999999999999999999987644322111 112233478899999999987 456666 9999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||.+.+.......+..+..................... .. ........ ...................+..
T Consensus 234 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 305 (389)
T 3gni_B 234 HVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPS--RS-VANSGLSD-----SLTTSTPRPSNGDSPSHPYHRT 305 (389)
T ss_dssp SCTTTTCCSTTHHHHC----------------------------------------------------------------
T ss_pred CCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccc--cc-cccccccc-----ccccCccccccCCCCCCccccc
Confidence 9999876655555544433322111000000000000000 00 00000000 0000000000000111234566
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+++++.+||.+||+.||++|||++|+|+||||+.....
T Consensus 306 ~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred cCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 89999999999999999999999999999999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=278.72 Aligned_cols=235 Identities=21% Similarity=0.259 Sum_probs=172.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++...+..++||||+ +++|.+++.... .+++..++.++.|++.||+||| +.+|+||||
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDl 163 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--------------KMSLTHTDL 163 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeCCC
Confidence 57899999999999999999 889999998764 5999999999999999999999 899999999
Q ss_pred CCCcEEEec-------------------------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCC
Q psy1812 79 KCENILMTK-------------------------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYN 133 (304)
Q Consensus 79 ~~~nil~~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 133 (304)
||+||+++. ++.+||+|||++...... .....|++.|+|||++.+..++
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCC
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCC
Confidence 999999975 788999999999754332 2345789999999999998888
Q ss_pred CCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchh
Q psy1812 134 PKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDIL 213 (304)
Q Consensus 134 ~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (304)
.+ +|+|||||++|+|++|..||.+.+..+....+.......+............ ... .........++ ...
T Consensus 238 ~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~-----~~~~~~~~~~p--~~~ 308 (360)
T 3llt_A 238 VS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNG-SKY-----VNKDELKLAWP--ENA 308 (360)
T ss_dssp TT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGG-GGG-----EETTTTEECTT--TTC
T ss_pred Cc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccC-ccc-----cCcccceecCc--ccc
Confidence 77 9999999999999999999998887777776666555444222111100000 000 00000000000 000
Q ss_pred hhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 214 SHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
........+...........++.+.+||.+||+.||++|||++|+|+||||+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1111111111222222334568899999999999999999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=281.08 Aligned_cols=200 Identities=24% Similarity=0.476 Sum_probs=168.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+++..++||||+.+|+|.+++... +.+++..++.++.|++.||+||| +.+++||||
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--------------~~givH~Di 157 (327)
T 3lm5_A 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--------------QNNIVHLDL 157 (327)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCcC
Confidence 57899999999999999999999999998653 57999999999999999999999 889999999
Q ss_pred CCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 79 KCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 79 ~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
||+||+++. ++.+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..|
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~p 232 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSP 232 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCS
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCC
Confidence 999999988 7899999999997654322 2234578999999999988888777 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+..+....+........ ......+++
T Consensus 233 f~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~ 262 (327)
T 3lm5_A 233 FVGEDNQETYLNISQVNVDYS--------------------------------------------------EETFSSVSQ 262 (327)
T ss_dssp SCCSSHHHHHHHHHHTCCCCC--------------------------------------------------TTTTTTSCH
T ss_pred CCCCCchHHHHHHHhcccccC--------------------------------------------------chhhcccCH
Confidence 988877766665554433322 222345788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 9999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=271.26 Aligned_cols=199 Identities=25% Similarity=0.466 Sum_probs=171.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~dlkp 134 (277)
T 3f3z_A 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH--------------KLNVAHRDLKP 134 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred eeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccCCCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEE---ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILM---TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||++ +.++.++|+|||++....... ......+++.|+|||.+.+. ++.+ +|+||||+++++|++|..||.
T Consensus 135 ~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCCcEEEEecccceeccCcc----chhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCC
Confidence 99999 788899999999997654332 23445689999999998664 6666 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+..+....+ ......+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 238 (277)
T 3f3z_A 209 APTDSEVMLKIREGTFTFP--------------------------------------------------EKDWLNVSPQA 238 (277)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------HHHHTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------chhhhcCCHHH
Confidence 8877777766665544333 11113578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 99999999999999999999999999987544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=286.36 Aligned_cols=200 Identities=23% Similarity=0.465 Sum_probs=170.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.++...++||||+.||+|.+++...+ .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 111 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~givHrDlk 176 (387)
T 1kob_A 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--------------EHSIVHLDIK 176 (387)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeecccc
Confidence 578999999999999999999999999997654 6999999999999999999999 8999999999
Q ss_pred CCcEEEec--CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTK--RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+||+++. .+.+||+|||++....... ......||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 177 p~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 177 PENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSC
T ss_pred hHHeEEecCCCCceEEEecccceecCCCc----ceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCC
Confidence 99999974 4679999999997654332 1233468999999999988888777 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+......+. ......+++++
T Consensus 252 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 281 (387)
T 1kob_A 252 GEDDLETLQNVKRCDWEFD--------------------------------------------------EDAFSSVSPEA 281 (387)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------SSTTTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------ccccccCCHHH
Confidence 8877666665554433222 12234678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||++|||+.++++||||+....
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.98 Aligned_cols=195 Identities=25% Similarity=0.458 Sum_probs=165.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+++||||+.||+|.+++...+.+++..++.++.|++.||.||| +.||+||||||
T Consensus 78 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~givHrDlkp 143 (384)
T 4fr4_A 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ--------------NQRIIHRDMKP 143 (384)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceeccCcH
Confidence 6789999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++.+||+|||++....... .....+||+.|+|||++.+ ..++.. +|+|||||++|+|++|..||.
T Consensus 144 ~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 144 DNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHeEECCCCCEEEeccceeeeccCCC----ceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCC
Confidence 99999999999999999997654322 3456679999999999964 346666 999999999999999999996
Q ss_pred Chh---HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 158 DSN---LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 158 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
... .......+.... ...+..++
T Consensus 219 ~~~~~~~~~~~~~~~~~~------------------------------------------------------~~~p~~~s 244 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFETTV------------------------------------------------------VTYPSAWS 244 (384)
T ss_dssp CCTTSCHHHHHHHHHHCC------------------------------------------------------CCCCTTSC
T ss_pred CCCCccHHHHHHHHhhcc------------------------------------------------------cCCCCcCC
Confidence 432 222333222222 23346688
Q ss_pred HHHHHHHHHhcCCCCCcccc-HHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIR-LDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t-~~ell~~~wf~~~~ 268 (304)
+.+.+||.+||+.||.+||+ ++++++||||+...
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 99999999999999999998 89999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.90 Aligned_cols=195 Identities=28% Similarity=0.567 Sum_probs=169.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++|+|.+++...+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 77 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 142 (284)
T 2vgo_A 77 LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH--------------ERKVIHRDIKP 142 (284)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCSG
T ss_pred eeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCH
Confidence 5789999999999999999999999999999888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... ......|+..|+|||.+.+..++.. +|+||||+++|+|++|..||...+
T Consensus 143 ~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 143 ENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp GGEEECTTCCEEECCCTTCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HHEEEcCCCCEEEecccccccCccc-----ccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999998654322 2234568999999999998888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ..+..++..+.+|
T Consensus 217 ~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~l 242 (284)
T 2vgo_A 217 HTETHRRIVNVDL------------------------------------------------------KFPPFLSDGSKDL 242 (284)
T ss_dssp HHHHHHHHHTTCC------------------------------------------------------CCCTTSCHHHHHH
T ss_pred HhHHHHHHhcccc------------------------------------------------------CCCCcCCHHHHHH
Confidence 6555544443222 2235678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||+.||.+|||++++++||||+....
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.56 Aligned_cols=201 Identities=28% Similarity=0.523 Sum_probs=165.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||++||+|.+++.....+++..++.++.|++.||+||| +.+|+|+||||
T Consensus 68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~givH~Dlkp 133 (323)
T 3tki_A 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH--------------GIGITHRDIKP 133 (323)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred CeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccccch
Confidence 5789999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ........|++.|+|||++.+..+...++|+|||||++|+|++|..||....
T Consensus 134 ~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 134 ENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred HHEEEeCCCCEEEEEeeccceeccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999975543221 1123456799999999999887764444999999999999999999997654
Q ss_pred HH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 161 LK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 161 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.. ............ ......+++.+.+
T Consensus 213 ~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~ 240 (323)
T 3tki_A 213 DSCQEYSDWKEKKTY----------------------------------------------------LNPWKKIDSAPLA 240 (323)
T ss_dssp TTSHHHHHHHTTCTT----------------------------------------------------STTGGGSCHHHHH
T ss_pred hHHHHHHHHhccccc----------------------------------------------------CCccccCCHHHHH
Confidence 32 111111111000 1112457889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
||.+||..||.+|||++|+++||||+...
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=281.60 Aligned_cols=199 Identities=27% Similarity=0.473 Sum_probs=164.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++++.+++.+++|||||+||+|.+++.+. ..+++..++.++.|++.||.||| +.+|+||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivHr 154 (351)
T 3c0i_A 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--------------DNNIIHR 154 (351)
T ss_dssp CCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECS
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceec
Confidence 68999999999999999999999999888653 25899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCC---eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 77 DLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 77 dl~~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||+||+++.++. +||+|||++........ .....+|++.|+|||++.+..++.+ +|+|||||++|+|++|.
T Consensus 155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~ 230 (351)
T 3c0i_A 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGC 230 (351)
T ss_dssp CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSS
T ss_pred cCChHHeEEecCCCCCcEEEecCcceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCC
Confidence 99999999987655 99999999976544321 2345679999999999988888777 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+... ..+..+..+..... ......+
T Consensus 231 ~pf~~~~~-~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~ 259 (351)
T 3c0i_A 231 LPFYGTKE-RLFEGIIKGKYKMN--------------------------------------------------PRQWSHI 259 (351)
T ss_dssp CSSCSSHH-HHHHHHHHTCCCCC--------------------------------------------------HHHHTTS
T ss_pred CCCCCcHH-HHHHHHHcCCCCCC--------------------------------------------------ccccccC
Confidence 99987543 33444433322221 1111457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
++.+.+||.+||..||++|||+.++++||||+...
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 88999999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=282.10 Aligned_cols=200 Identities=32% Similarity=0.553 Sum_probs=160.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++..++||||+++|+|.+++...+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dikp 176 (349)
T 2w4o_A 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH--------------ENGIVHRDLKP 176 (349)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred cceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEecCCCc
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++. ++.+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 177 ~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 177 ENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp GGEEESSSSTTCCEEECCCC--------------------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTC
T ss_pred ccEEEecCCCCCCEEEccCccccccCccc----ccccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCC
Confidence 9999976 8899999999987543322 2334578999999999998888777 999999999999999999997
Q ss_pred ChhHHH-HHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 158 DSNLKQ-LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...... ....+........ ......++.+
T Consensus 252 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~~ 281 (349)
T 2w4o_A 252 DERGDQFMFRRILNCEYYFI--------------------------------------------------SPWWDEVSLN 281 (349)
T ss_dssp CTTCHHHHHHHHHTTCCCCC--------------------------------------------------TTTTTTSCHH
T ss_pred CCcccHHHHHHHHhCCCccC--------------------------------------------------CchhhhCCHH
Confidence 655433 3444433322211 1122457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||..||++|||+.++++||||++...
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=287.82 Aligned_cols=200 Identities=22% Similarity=0.409 Sum_probs=167.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|++++.+++||||++||+|.+++.+.+ .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~giiHrDLK 189 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH--------------RLGYVHRDIK 189 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecccC
Confidence 578999999999999999999999999998764 7999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-------CCCCCCCCchHHHHHHHHHHHHhC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-------GNPYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~sDvwslG~ll~~ll~g 152 (304)
|+||+++.++.+||+|||++........ ......+||+.|+|||++. ...++.+ +|+|||||++|+|++|
T Consensus 190 p~NILld~~g~vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSlGvilyelltG 266 (412)
T 2vd5_A 190 PDNILLDRCGHIRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWALGVFAYEMFYG 266 (412)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHHHHHHHHHHHS
T ss_pred HHHeeecCCCCEEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHHhHHHHHHHhC
Confidence 9999999999999999999976543221 1234568999999999987 3456666 9999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||.+.+..+.+.++......... ......
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------------p~~~~~ 297 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLSL-------------------------------------------------PLVDEG 297 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCC-------------------------------------------------C----C
T ss_pred CCCCCCCCHHHHHHHHHhcccCcCC-------------------------------------------------CccccC
Confidence 9999988877777766543211110 111246
Q ss_pred ccHHHHHHHHHhcCCCCCcc---ccHHHHhcCcccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKR---IRLDAIKAHDWLRYK 267 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R---~t~~ell~~~wf~~~ 267 (304)
+++++++||++||. +|.+| ++++|+++||||+..
T Consensus 298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 89999999999999 99998 499999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=276.69 Aligned_cols=200 Identities=28% Similarity=0.532 Sum_probs=171.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~ivH~dikp 143 (321)
T 2a2a_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--------------TKKIAHFDLKP 143 (321)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred ceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCh
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCC----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRF----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++ .+||+|||++....... ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSS
T ss_pred HHEEEecCCCCcCCEEEccCccceecCccc----cccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCC
Confidence 999999888 79999999997654322 2234568999999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+.......+ ...+..++..
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~~ 248 (321)
T 2a2a_A 219 LGDTKQETLANITSVSYDFD--------------------------------------------------EEFFSHTSEL 248 (321)
T ss_dssp CCSSHHHHHHHHHTTCCCCC--------------------------------------------------HHHHTTCCHH
T ss_pred CCCCHHHHHHHHHhcccccC--------------------------------------------------hhhhcccCHH
Confidence 88877666666554433222 1112457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||..||++|||++++++||||+....
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=288.89 Aligned_cols=200 Identities=29% Similarity=0.492 Sum_probs=156.5
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++++|.. ++.++||||||+||+|.+++...+ .+++..++.++.|++.||.||| +.+|+
T Consensus 118 v~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~iv 183 (400)
T 1nxk_A 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--------------SINIA 183 (400)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred ceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcc
Confidence 578888875 678999999999999999998754 5999999999999999999999 89999
Q ss_pred ecCCCCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 75 HRDLKCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 75 H~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
||||||+||+++. ++.+||+|||++....... .....+||+.|+|||++.+..++.. +|||||||++|+|++
T Consensus 184 HrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~ 258 (400)
T 1nxk_A 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLC 258 (400)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHH
T ss_pred ccCcCcceEEEecCCCCccEEEEecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHh
Confidence 9999999999988 7889999999997543222 2345678999999999988888877 999999999999999
Q ss_pred CCCCCCChhHHH----HHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 152 AAMPFDDSNLKQ----LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 152 g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|..||.+.+... ....+..+...++ .
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~ 288 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFP--------------------------------------------------N 288 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHHTCCCCC--------------------------------------------------T
T ss_pred CCCCCCCCccccccHHHHHHHHcCcccCC--------------------------------------------------C
Confidence 999997654211 1111221111111 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.....+++++.+||.+||..||.+|||++++++||||.....
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 112457899999999999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.78 Aligned_cols=200 Identities=27% Similarity=0.510 Sum_probs=172.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dl~p 143 (294)
T 2rku_A 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH--------------RNRVIHRDLKL 143 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCCG
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCh
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||....
T Consensus 144 ~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 144 GNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HhEEEcCCCCEEEEeccCceecccCcc---ccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999976543221 2334568999999999988777766 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+..... ..+..+++.+.+|
T Consensus 220 ~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~l 245 (294)
T 2rku_A 220 LKETYLRIKKNEY------------------------------------------------------SIPKHINPVAASL 245 (294)
T ss_dssp HHHHHHHHHTTCC------------------------------------------------------CCCTTSCHHHHHH
T ss_pred HHHHHHHHhhccC------------------------------------------------------CCccccCHHHHHH
Confidence 6555544443322 2235678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
|.+||+.||++|||++++++||||+....+..
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~ 277 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence 99999999999999999999999998776544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=275.30 Aligned_cols=231 Identities=20% Similarity=0.299 Sum_probs=167.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH--------------~~~ivH~dlkp 130 (311)
T 4agu_A 65 VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH--------------KHNCIHRDVKP 130 (311)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred cchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH--------------HCCCcCCCCCh
Confidence 5789999999999999999999999999988888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++........ ......++..|+|||.+.+.. ++.+ +|+||||+++++|++|..||.+.
T Consensus 131 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 131 ENILITKHSVIKLCDFGFARLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPP-VDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------------GGGCCHHHHHTCSCCCTH-HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhEEEcCCCCEEEeeCCCchhccCccc---ccCCCcCCccccChHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999976543221 223456899999999997744 5555 99999999999999999999888
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+................ ........... . ......+ ......++..+.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---~---~~~~~~~-------~~~~~~~~~~~~~ 263 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFS----------TNQYFSGVKIP---D---PEDMEPL-------ELKFPNISYPALG 263 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHH----------TCGGGTTCCCC---C---CSSCCCH-------HHHCTTCCHHHHH
T ss_pred CHHHHHHHHHHHhcccccccccccc----------cccccccCcCC---C---ccccchh-------hhhcccccHHHHH
Confidence 7766666555443332211111100 00000000000 0 0000000 0111457889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
||.+||+.||.+|||++|+++||||++......
T Consensus 264 li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 264 LLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp HHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred HHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=280.35 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=171.8
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++..+ ..+++|||||. |+|.+++.. +.+++..++.++.|++.||+||| +.+|+||||
T Consensus 72 v~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivHrDl 135 (388)
T 3oz6_A 72 VNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH--------------SGGLLHRDM 135 (388)
T ss_dssp CCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred CeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEeCCC
Confidence 5788998754 47999999997 599999976 46999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccc------------------ccccccCccCCccccccccccCC-CCCCCCchH
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEG------------------RRVLSRTYCGSAAYAAPEVISGN-PYNPKLADI 139 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDv 139 (304)
||+||+++.++.+||+|||+++....... ........+||+.|+|||++.+. .++.+ +|+
T Consensus 136 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~Di 214 (388)
T 3oz6_A 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG-IDM 214 (388)
T ss_dssp CGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH-HHH
T ss_pred CHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh-hhH
Confidence 99999999999999999999975432110 01123446799999999999874 45555 999
Q ss_pred HHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 140 WSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 140 wslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|||||++|+|++|..||.+.+.......+..............+.... ................ ... ......+
T Consensus 215 wSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~---~~~~~~~ 288 (388)
T 3oz6_A 215 WSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF-AKTMIESLKEKVEIRQ--SNK---RDIFTKW 288 (388)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSS-HHHHHHHHHHHCC-------C---CCCHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHH-HHHHHHhCcccccccC--CCH---HHhCcch
Confidence 999999999999999999988888877776544333211111100000 0000000000000000 000 0000001
Q ss_pred hhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
..... .......+++++.+||.+||.+||++|||++|+|+||||+....+....
T Consensus 289 ~~~~~-~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~ 342 (388)
T 3oz6_A 289 KNLLL-KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342 (388)
T ss_dssp HHHHH-HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCC
T ss_pred hhhcc-cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCC
Confidence 11100 0112246789999999999999999999999999999998876655433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.01 Aligned_cols=200 Identities=25% Similarity=0.442 Sum_probs=168.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++..++||||++||+|.+++.+ ..+++..++.++.|++.||.||| +.+++|+||||
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dlkp 169 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLH--------------AQGVIHRDIKS 169 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCH
Confidence 5789999999999999999999999999875 46999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.+ +|+||||+++|+|++|..||.+.+
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543221 2345579999999999988888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+....... ......+++.+.+|
T Consensus 246 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~l~~l 274 (321)
T 2c30_A 246 PVQAMKRLRDSPPPK---------------------------------------------------LKNSHKVSPVLRDF 274 (321)
T ss_dssp HHHHHHHHHHSSCCC---------------------------------------------------CTTGGGSCHHHHHH
T ss_pred HHHHHHHHhcCCCCC---------------------------------------------------cCccccCCHHHHHH
Confidence 655554443221110 11124578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
|.+||+.||++|||++++++||||+....+
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred HHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 999999999999999999999999877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=273.64 Aligned_cols=223 Identities=23% Similarity=0.337 Sum_probs=164.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+ +|.+++... +.+++..++.++.|++.||.||| +.+++|||||
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlk 127 (288)
T 1ob3_A 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--------------DRRVLHRDLK 127 (288)
T ss_dssp CCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 5789999999999999999985 999999875 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||++.+.. ++.+ +|+|||||++|+|++|..||.+
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 128 PQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHHEEEcCCCCEEEeECccccccCcccc---ccccccccccccCchheeCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999875432211 223456899999999997654 5555 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+...... ..... .... .....+ ......+++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~----~~~~----~~~~~~-------~~~~~~~~~~~~ 258 (288)
T 1ob3_A 204 VSEADQLMRIFRILGTPNSKNWPNVTEL----------PKYDP----NFTV----YEPLPW-------ESFLKGLDESGI 258 (288)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGS----------TTCCT----TCCC----CCCCCG-------GGTCCSCCHHHH
T ss_pred CCHHHHHHHHHHHHCCCChhhchhhhcc----------ccccc----cccc----ccCccH-------HHHhhhcCHHHH
Confidence 8776666655544332221100000000 00000 0000 000000 112356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+||.+||+.||++|||++|+++||||+..
T Consensus 259 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 259 DLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 99999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=273.48 Aligned_cols=230 Identities=21% Similarity=0.334 Sum_probs=171.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++++++..++..++||||++ |+|.+++... ..+++..++.++.|++.||.||| +.+|+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--------------~~~iv 130 (317)
T 2pmi_A 66 VRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--------------ENKIL 130 (317)
T ss_dssp CCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred ceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--------------HCCee
Confidence 689999999999999999998 5999999764 35899999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+||+++.++.+||+|||++........ ......++..|+|||++.+. .++.+ +|+|||||++|+|++|.
T Consensus 131 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206 (317)
T ss_dssp CCCCCGGGEEECTTCCEEECCCSSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHHSS
T ss_pred eCCCChHHeEEcCCCCEEECcCccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcH-HHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999976543221 23345689999999999765 45555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+....+...........+....... .... ..... ....+..... ......+
T Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----------~~~~----~~~~~----~~~~~~~~~~--~~~~~~~ 266 (317)
T 2pmi_A 207 PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP----------KYNP----NIQQR----PPRDLRQVLQ--PHTKEPL 266 (317)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT----------TCCT----TCCCC----CCCCSHHHHG--GGCSSCC
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh----------hccc----ccccc----cchhHHHhhc--ccccccC
Confidence 9999888777776665544433211111100000 0000 00000 0000111110 1223457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.++.+||.+||+.||++|||++|+++||||+....
T Consensus 267 ~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 267 DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 899999999999999999999999999999987664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=277.30 Aligned_cols=150 Identities=25% Similarity=0.352 Sum_probs=116.5
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++++..++ .++||||||+||+|.++|++. .+++..+..++.|++.||+|||+.. .......+|+||
T Consensus 60 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~------~~~~~~~~IiHR 132 (303)
T 3hmm_A 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI------VGTQGKPAIAHR 132 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCB------CSTTCBCCEECS
T ss_pred CcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhh------hhccCCCCEeec
Confidence 67899987653 689999999999999999764 5899999999999999999999210 000001289999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCC------CCCCCchHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNP------YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~------~~~~~sDvwslG~ll~~l 149 (304)
||||+|||++.++.+||+|||+++........ .......+||+.|+|||++.+.. ++.+ +|||||||++|||
T Consensus 133 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k-~DVwS~Gvvl~El 211 (303)
T 3hmm_A 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI 211 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHH
T ss_pred cCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh-HhhhhHHHHHHHH
Confidence 99999999999999999999999765443221 11233567999999999997642 3445 9999999999999
Q ss_pred HhCCCCCCC
Q psy1812 150 LNAAMPFDD 158 (304)
Q Consensus 150 l~g~~pf~~ 158 (304)
++|..||..
T Consensus 212 ~tg~~~~~~ 220 (303)
T 3hmm_A 212 ARRCSIGGI 220 (303)
T ss_dssp HHTBCBTTB
T ss_pred HHCCCCCCc
Confidence 999877643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=277.00 Aligned_cols=204 Identities=29% Similarity=0.471 Sum_probs=155.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++.+++||||++||+|.+++...+.+++..++.++.|++.||+||| +.+++|+||||
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~dlkp 139 (316)
T 2ac3_A 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH--------------NKGIAHRDLKP 139 (316)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCceeCCCCH
Confidence 5789999999999999999999999999999888999999999999999999999 88999999999
Q ss_pred CcEEEecCCC---eEEEeccCcccccCccc----ccccccCccCCccccccccccC-----CCCCCCCchHHHHHHHHHH
Q psy1812 81 ENILMTKRFN---VKIADFGFARYCVDKEG----RRVLSRTYCGSAAYAAPEVISG-----NPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 81 ~nil~~~~~~---~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~sDvwslG~ll~~ 148 (304)
+||+++.++. +||+|||++........ .........|+..|+|||++.+ ..++.+ +|+|||||++|+
T Consensus 140 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~ 218 (316)
T 2ac3_A 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYI 218 (316)
T ss_dssp GGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHH
T ss_pred HHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHH
Confidence 9999988776 99999999875432211 0111234568999999999864 345666 999999999999
Q ss_pred HHhCCCCCCChhH---------------HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchh
Q psy1812 149 MLNAAMPFDDSNL---------------KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDIL 213 (304)
Q Consensus 149 ll~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (304)
|++|..||.+... ......+..+...++
T Consensus 219 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------------------------------------- 261 (316)
T 2ac3_A 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP------------------------------------- 261 (316)
T ss_dssp HHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-------------------------------------
T ss_pred HHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-------------------------------------
Confidence 9999999976531 111111111111111
Q ss_pred hhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 214 SHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
......++..+.+||.+||..||.+|||+.|+++||||++...
T Consensus 262 -------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 262 -------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp -------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred -------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 0011347889999999999999999999999999999997643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=276.59 Aligned_cols=225 Identities=20% Similarity=0.270 Sum_probs=167.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||+.+ +|.+++.... .+++..++.++.|++.||.||| +.+|+|||||
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivH~Dik 146 (311)
T 3niz_A 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH--------------QHRILHRDLK 146 (311)
T ss_dssp CCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred eeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCc
Confidence 5789999999999999999985 8988887754 5999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......++..|+|||++.+.. ++.+ +|+|||||++|+|++|..||.+
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCCC------CCCCCCTTCCHHHHTTCCSCCTH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred hHhEEECCCCCEEEccCcCceecCCCcc---cccCCcccCCcCCHHHhcCCCCCCch-HHhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999976543221 233456899999999987744 5555 9999999999999999999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+...........+..... ...+.... .... ....+ ......+++++.
T Consensus 223 ~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~-------~~~~~-------~~~~~~~~~~~~ 278 (311)
T 3niz_A 223 VTDDDQLPKIFSILGTPNPREWPQVQE---LPLWKQRT-------FQVF-------EKKPW-------SSIIPGFCQEGI 278 (311)
T ss_dssp SSTTTHHHHHHHHHCCCCTTTSGGGTT---SHHHHSCC-------CCCC-------CCCCH-------HHHSTTCCHHHH
T ss_pred CChHHHHHHHHHHHCCCChHHhhhhhc---cchhhhcc-------cccc-------cCCcH-------HHhCcccCHHHH
Confidence 766666555554433322111110000 00000000 0000 00000 112245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+||.+||+.||++|||++|+++||||++..
T Consensus 279 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 279 DLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 999999999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=276.48 Aligned_cols=199 Identities=27% Similarity=0.504 Sum_probs=171.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~dlkp 169 (335)
T 2owb_A 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH--------------RNRVIHRDLKL 169 (335)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCG
T ss_pred CeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCEecCCCc
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.. +|+||||+++|+|++|..||....
T Consensus 170 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 170 GNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhEEEcCCCCEEEeeccCceecccCcc---cccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCC
Confidence 999999999999999999976543221 2334568999999999988877766 999999999999999999998876
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+..... ..+..+++.+.+|
T Consensus 246 ~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~l 271 (335)
T 2owb_A 246 LKETYLRIKKNEY------------------------------------------------------SIPKHINPVAASL 271 (335)
T ss_dssp HHHHHHHHHHTCC------------------------------------------------------CCCTTSCHHHHHH
T ss_pred HHHHHHHHhcCCC------------------------------------------------------CCCccCCHHHHHH
Confidence 6555544433322 2235678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
|.+||+.||++|||++++++|+||+....+.
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999999877544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=285.45 Aligned_cols=197 Identities=34% Similarity=0.583 Sum_probs=154.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++||||+.||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH--------------~~~ivH~Dlkp 144 (361)
T 3uc3_A 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH--------------SMQICHRDLKL 144 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCSCCCCG
T ss_pred CcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 5799999999999999999999999999998889999999999999999999999 89999999999
Q ss_pred CcEEEecCCC--eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++. +||+|||++....... ......|++.|+|||++.+..++..++|+|||||++|+|++|..||.+
T Consensus 145 ~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 145 ENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp GGEEECSSSSCCEEECCCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred HHEEEcCCCCceEEEeecCccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 9999987765 9999999986432221 234457999999999998888776658999999999999999999976
Q ss_pred hhHH----HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 159 SNLK----QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 159 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
.+.. .....+....... .....++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~s 248 (361)
T 3uc3_A 221 PEEPRDYRKTIQRILSVKYSI----------------------------------------------------PDDIRIS 248 (361)
T ss_dssp ---CCCHHHHHHHHHTTCCCC----------------------------------------------------CTTSCCC
T ss_pred CccHHHHHHHHHHHhcCCCCC----------------------------------------------------CCcCCCC
Confidence 5432 2222222111111 1113578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+++.+||.+||..||.+|||+.|+++||||...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999999999654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=273.22 Aligned_cols=221 Identities=24% Similarity=0.292 Sum_probs=168.2
Q ss_pred CceeeeeeeCC-----eEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGP-----RVFIFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++.... ..++||||+. |+|.+++..... +++..++.++.|++.||+||| +.++
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~i 141 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--------------ANCI 141 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTC
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCc
Confidence 57888888755 5899999997 599999988654 999999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||||+||+++.++.+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|.
T Consensus 142 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 142 VHRDLKPENILVTSGGTVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp CCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSS
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999997554322 2344578999999999988888877 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+......++.......+...+. ........... . ...... ......+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~~~---~----~~~~~~-------~~~~~~~ 269 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWP-------------RDVSLPRGAFP---P----RGPRPV-------QSVVPEM 269 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSC-------------SSCSSCGGGSC---C----CCCCCH-------HHHSCSC
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhcc-------------chhhccccccC---C----CCCCcH-------HHhCccc
Confidence 9999888777777666544433211000 00000000000 0 000000 1123567
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 270 ~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 270 EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred cHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 89999999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=283.72 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=170.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+|||||
T Consensus 149 v~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dlk 214 (373)
T 2x4f_A 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--------------QMYILHLDLK 214 (373)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccccCC
Confidence 67899999999999999999999999999764 36999999999999999999999 8899999999
Q ss_pred CCcEEE--ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILM--TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+||++ +.++.+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.
T Consensus 215 p~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 215 PENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp GGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHEEEecCCCCcEEEEeCCCceecCCcc----ccccccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCC
Confidence 999999 456789999999998654332 2334569999999999988777777 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+........ ......+++++
T Consensus 290 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 319 (373)
T 2x4f_A 290 GDNDAETLNNILACRWDLE--------------------------------------------------DEEFQDISEEA 319 (373)
T ss_dssp CSSHHHHHHHHHHTCCCSC--------------------------------------------------SGGGTTSCHHH
T ss_pred CCCHHHHHHHHHhccCCCC--------------------------------------------------hhhhccCCHHH
Confidence 8887776666654433222 11224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+||.+||..||.+|||+.|+++||||+.....
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence 999999999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=279.29 Aligned_cols=197 Identities=26% Similarity=0.492 Sum_probs=167.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++...+..++||||++|++|.+++.....+++..++.++.|++.||.||| +.|++|+||||
T Consensus 163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~gi~H~Dlkp 228 (365)
T 2y7j_A 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH--------------ANNIVHRDLKP 228 (365)
T ss_dssp CCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCH
Confidence 5788999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC------CCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN------PYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++.++.++|+|||++....... ......|++.|+|||++.+. .++.+ +|+|||||++|+|++|..
T Consensus 229 ~NIl~~~~~~ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 229 ENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSP 303 (365)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCch-hhHHhHHHHHHHHHHCCC
Confidence 99999999999999999987654322 23456799999999998632 35555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+.......+..+..... ...+..++
T Consensus 304 pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~ 333 (365)
T 2y7j_A 304 PFWHRRQILMLRMIMEGQYQFS--------------------------------------------------SPEWDDRS 333 (365)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC--------------------------------------------------HHHHSSSC
T ss_pred CCCCCCHHHHHHHHHhCCCCCC--------------------------------------------------CcccccCC
Confidence 9988776666655554433222 01113568
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
..+.+||.+||+.||++|||++++++||||+.
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 89999999999999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.94 Aligned_cols=199 Identities=30% Similarity=0.526 Sum_probs=172.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++|||||.||+|.+++.....+++..++.++.|++.||.||| +.+|+||||||
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~Dlkp 164 (494)
T 3lij_A 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH--------------KHNIVHRDLKP 164 (494)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred CeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceeccCCh
Confidence 6899999999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEecC---CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.. +.+||+|||++....... .....+|++.|+|||++.+ .++.+ +|+||+||++|+|++|..||.
T Consensus 165 ~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~-~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 165 ENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVLRK-KYDEK-CDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECBTTB----CBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred hhEEEeCCCCCCcEEEEECCCCeECCCCc----cccccCCCcCeeCHHHHcc-cCCCc-hhHHHHHHHHHHHHhCCCCCC
Confidence 99999764 459999999997654332 2345679999999999864 56666 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+...+. ...+..+++.+
T Consensus 239 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 268 (494)
T 3lij_A 239 GQTDQEILRKVEKGKYTFD--------------------------------------------------SPEWKNVSEGA 268 (494)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------SGGGTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------chhcccCCHHH
Confidence 9888887777776655443 12224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||.+|||+.++|+||||+....
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 99999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.37 Aligned_cols=197 Identities=28% Similarity=0.559 Sum_probs=142.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+++++|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~ 139 (278)
T 3cok_A 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--------------SHGILHRDLT 139 (278)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSSCC
T ss_pred EeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCC
Confidence 57899999999999999999999999999875 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||...
T Consensus 140 p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 140 LSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp GGGEEECTTCCEEECCCTTCEECC-------------------------------C-THHHHHHHHHHHHHHSSCSSCCC
T ss_pred HHHEEEcCCCCEEEEeecceeeccCCCC---cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCh
Confidence 9999999999999999999875443221 2234568999999999988877777 99999999999999999999765
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+... ....+..++.++.+
T Consensus 216 ~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 216 TVKNTLNKVVLA------------------------------------------------------DYEMPSFLSIEAKD 241 (278)
T ss_dssp SCC-----CCSS------------------------------------------------------CCCCCTTSCHHHHH
T ss_pred hHHHHHHHHhhc------------------------------------------------------ccCCccccCHHHHH
Confidence 432222221111 01223557889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+||..||++|||++++++||||.....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 999999999999999999999999987664
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.11 Aligned_cols=196 Identities=38% Similarity=0.698 Sum_probs=160.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 139 (276)
T 2h6d_A 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH--------------RHMVVHRDLKP 139 (276)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HHCSSCCCCCG
T ss_pred eEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCccCCCCh
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.++|+|||++....... ......+++.|+|||.+.+..+...++|+||||+++++|++|..||...+
T Consensus 140 ~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 140 ENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp GGEEECTTSCEEECCCCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhEEECCCCCEEEeecccccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999987554322 22345688999999999887664444999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+...... .+..++..+.++
T Consensus 216 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~l~~l 241 (276)
T 2h6d_A 216 VPTLFKKIRGGVFY------------------------------------------------------IPEYLNRSVATL 241 (276)
T ss_dssp HHHHHHHHHHCCCC------------------------------------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHhhcCccc------------------------------------------------------CchhcCHHHHHH
Confidence 65555544433221 225578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|.+||+.||++|||++++++||||+...
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=271.78 Aligned_cols=200 Identities=30% Similarity=0.572 Sum_probs=171.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dikp 134 (304)
T 2jam_A 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH--------------ENGIVHRDLKP 134 (304)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCSCCG
T ss_pred eehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCH
Confidence 5789999999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEE---ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILM---TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||++ +.++.+||+|||++...... ......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.
T Consensus 135 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 135 ENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp GGCEESSSSTTCCEEBCSCSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEEecCCCCCCEEEccCCcceecCCC-----ccccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCC
Confidence 99999 77889999999998653321 1223468999999999988888776 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+.......+..+....+ ......+++.+
T Consensus 209 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 238 (304)
T 2jam_A 209 EETESKLFEKIKEGYYEFE--------------------------------------------------SPFWDDISESA 238 (304)
T ss_dssp TSCHHHHHHHHHHCCCCCC--------------------------------------------------TTTTTTSCHHH
T ss_pred CCCHHHHHHHHHcCCCCCC--------------------------------------------------ccccccCCHHH
Confidence 8777666666655443322 12235578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+||.+||..||++|||++++++||||+.....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 999999999999999999999999999886643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.65 Aligned_cols=225 Identities=22% Similarity=0.307 Sum_probs=164.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++..++||||+.| +|.+++.....+++..++.++.|++.||.||| +.+|+|+||||
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH--------------~~~ivH~Dlkp 160 (329)
T 3gbz_A 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--------------SRRCLHRDLKP 160 (329)
T ss_dssp CCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred ceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEECCCCCH
Confidence 5789999999999999999985 99999999888999999999999999999999 88999999999
Q ss_pred CcEEEe-----cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMT-----KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++ .++.+||+|||++........ ......++..|+|||++.+.. ++.+ +|+|||||++|+|++|..
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCccc---ccCCCcCCccccCHHHhcCCCCCCcH-HHHHHHHHHHHHHHHCCC
Confidence 999995 445599999999976543221 233456799999999998755 5555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+.................... +....+.. ....+. ......++
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~----~~~~~~------~~~~~~~~ 292 (329)
T 3gbz_A 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD--------------WKQSFPKF----RGKTLK------RVLGALLD 292 (329)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--------------CCTTCCCC----CCCCHH------HHHGGGSC
T ss_pred CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh--------------hhhhhhhh----ccccHh------hhcccccC
Confidence 9988877777666655443322111110000000 00000000 000011 11124478
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 293 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 293 DEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 9999999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=267.35 Aligned_cols=200 Identities=29% Similarity=0.460 Sum_probs=169.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++++|.+++.....+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 152 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--------------KLNIVHRDLKP 152 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCc
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc------CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS------GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++.++.+||+|||++....... ......++..|+|||++. ...++.. +|+||||+++++|++|..
T Consensus 153 ~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 153 ENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSC
T ss_pred ceEEEcCCCcEEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcc-cccHhHHHHHHHHHHCCC
Confidence 99999999999999999987654322 233456899999999985 3345555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+.......+..+..... ......++
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~ 257 (298)
T 1phk_A 228 PFWHRKQMLMLRMIMSGNYQFG--------------------------------------------------SPEWDDYS 257 (298)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC--------------------------------------------------TTTGGGSC
T ss_pred CCcCccHHHHHHHHhcCCcccC--------------------------------------------------cccccccC
Confidence 9988776666665554433322 11124578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+.+||.+||+.||.+|||+.++++||||++...
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 89999999999999999999999999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.80 Aligned_cols=199 Identities=31% Similarity=0.548 Sum_probs=170.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++|||||.||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivH~Dlkp 149 (486)
T 3mwu_A 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH--------------KHNIVHRDLKP 149 (486)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCSG
T ss_pred CeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeccCch
Confidence 6899999999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEe---cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMT---KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++ .++.+||+|||++....... ......|++.|+|||++.+ .++.+ +|+||+||++|+|++|..||.
T Consensus 150 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEK-CDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp GGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCCCEEEEECCcCeECCCCC----ccCCCcCCCCCCCHHHhCC-CCCch-hhHHHHHHHHHHHHhCCCCCC
Confidence 999995 45679999999997554322 2345579999999999976 46666 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+...+. ...+..+++++
T Consensus 224 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 253 (486)
T 3mwu_A 224 GKNEYDILKRVETGKYAFD--------------------------------------------------LPQWRTISDDA 253 (486)
T ss_dssp CSSHHHHHHHHHHTCCCSC--------------------------------------------------SGGGGGSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------CcccCCCCHHH
Confidence 9888777777766554433 12225578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||..||.+|||+.++|+||||+....
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=289.89 Aligned_cols=199 Identities=29% Similarity=0.527 Sum_probs=172.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++|||||+||+|.+++.+.+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~Dlkp 174 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH--------------KHNIVHRDIKP 174 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEeCCCcH
Confidence 6899999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.++ .+||+|||++....... ......|++.|+|||++.+ .++.+ +|+||+||++|+|++|..||.
T Consensus 175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 175 ENILLENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp GGEEESSTTCCSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCC
Confidence 999998876 59999999997654332 2345679999999999864 56666 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+...+. ...+..+++++
T Consensus 249 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 278 (504)
T 3q5i_A 249 GQNDQDIIKKVEKGKYYFD--------------------------------------------------FNDWKNISDEA 278 (504)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------HHHHTTSCHHH
T ss_pred CCCHHHHHHHHHcCCCCCC--------------------------------------------------ccccCCCCHHH
Confidence 9888888877776654433 11124578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||..||.+|||++|+|+||||+....
T Consensus 279 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 99999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=271.36 Aligned_cols=190 Identities=24% Similarity=0.335 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||+ +++|.+++...+ .+++..++.++.|++.||+||| +.+|+|+|||
T Consensus 120 v~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dik 184 (311)
T 3p1a_A 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--------------SQGLVHLDVK 184 (311)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred EEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCCCC
Confidence 57899999999999999999 679999988754 6999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++....... ......|++.|+|||++.+ .++.+ +|+|||||++++|++|..|+.+.
T Consensus 185 p~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 185 PANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp GGGEEECGGGCEEECCCTTCEECC----------CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSH
T ss_pred HHHEEECCCCCEEEccceeeeecccCC----CCcccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999987554322 2334568999999999876 57666 99999999999999997776655
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
..... +...... ...+..+++++.+
T Consensus 259 ~~~~~---~~~~~~~----------------------------------------------------~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 259 EGWQQ---LRQGYLP----------------------------------------------------PEFTAGLSSELRS 283 (311)
T ss_dssp HHHHH---HTTTCCC----------------------------------------------------HHHHTTSCHHHHH
T ss_pred cHHHH---HhccCCC----------------------------------------------------cccccCCCHHHHH
Confidence 43221 1111110 1122457899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
||.+||+.||++|||++++++||||++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.53 Aligned_cols=236 Identities=22% Similarity=0.296 Sum_probs=171.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..++..++||||+ +++|.+++...+ .+++..++.++.|++.||+||| +.+++|+||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Dl 144 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--------------SNKLTHTDL 144 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--------------HCCCcCCCC
Confidence 47889999999999999999 789999998875 6899999999999999999999 889999999
Q ss_pred CCCcEEEec-------------------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchH
Q psy1812 79 KCENILMTK-------------------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADI 139 (304)
Q Consensus 79 ~~~nil~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDv 139 (304)
||+||+++. ++.+||+|||++...... .....|+..|+|||++.+..++.+ +|+
T Consensus 145 kp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~Di 217 (339)
T 1z57_A 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQP-CDV 217 (339)
T ss_dssp CGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTH-HHH
T ss_pred CHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcc-hhh
Confidence 999999987 667999999998753321 234578999999999998888777 999
Q ss_pred HHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhh-h
Q psy1812 140 WSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQV-K 218 (304)
Q Consensus 140 wslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 218 (304)
|||||++|+|++|..||...+..+....+.......+..+....... ..... ....+.......... .
T Consensus 218 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---------~~~~~--~~~~~~~~~~~~~~~~~ 286 (339)
T 1z57_A 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKR---------KYFHH--DRLDWDEHSSAGRYVSR 286 (339)
T ss_dssp HHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCG---------GGEET--TEECCCTTSHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccch---------hHHhh--ccccccccccccchhhh
Confidence 99999999999999999887776666555544444332221110000 00000 000000000000000 0
Q ss_pred hhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 219 LKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...............++++.+||.+||+.||.+|||+.|+++||||+..+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 287 ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp HCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred cCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 000000011223446788999999999999999999999999999997653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.60 Aligned_cols=199 Identities=29% Similarity=0.519 Sum_probs=173.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+.+..++||||+.||+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~Dlkp 154 (484)
T 3nyv_A 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH--------------KNKIVHRDLKP 154 (484)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred CcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeCCCCH
Confidence 6899999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEE---ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILM---TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||++ +.++.+||+|||++....... .....+|++.|+|||++.+ .++.+ +|+||+||++|+|++|..||.
T Consensus 155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 155 ENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp GGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCC
Confidence 99999 567889999999997654332 2234568999999999876 56666 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+...+. ...+..+++++
T Consensus 229 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 258 (484)
T 3nyv_A 229 GANEYDILKKVEKGKYTFE--------------------------------------------------LPQWKKVSESA 258 (484)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------SGGGGGSCHHH
T ss_pred CCCHHHHHHHHHcCCCCCC--------------------------------------------------CcccccCCHHH
Confidence 9888888877776654433 12224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||.+|||+.++|+||||+....
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=266.81 Aligned_cols=200 Identities=28% Similarity=0.523 Sum_probs=167.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~p 136 (283)
T 3bhy_A 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH--------------SKRIAHFDLKP 136 (283)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred eehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCCCh
Confidence 5789999999999999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCC----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRF----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++ .+||+|||++....... ......+++.|+|||.+.+..++.+ +|+||||+++++|++|..||
T Consensus 137 ~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECC------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTT
T ss_pred HHEEEecCCCCCCceEEEecccceeccCCC----cccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCC
Confidence 999998877 79999999997554322 1234468999999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+........ ......++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~ 241 (283)
T 3bhy_A 212 LGETKQETLTNISAVNYDFD--------------------------------------------------EEYFSNTSEL 241 (283)
T ss_dssp CCSSHHHHHHHHHTTCCCCC--------------------------------------------------HHHHTTCCHH
T ss_pred CCcchHHHHHHhHhcccCCc--------------------------------------------------chhcccCCHH
Confidence 88776666555544332221 1112456889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||..||++|||+.++++||||+....
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=277.31 Aligned_cols=197 Identities=26% Similarity=0.507 Sum_probs=162.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++|+|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~~~ivH~Dlkp 187 (355)
T 1vzo_A 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH--------------KLGIIYRDIKL 187 (355)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred eEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 5789999999999999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC--CCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN--PYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
+||+++.++.+||+|||++......... .....+|++.|+|||++.+. .++.+ +|+|||||++|+|++|..||..
T Consensus 188 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 188 ENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp GGEEECTTSCEEESCSSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTH-HHHHHHHHHHHHHHHSSCTTSC
T ss_pred HHEEECCCCcEEEeeCCCCeecccCCCC--cccCcccCcCccChhhhcCCCCCCCch-hhHHHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999999755432221 23345799999999999863 34455 9999999999999999999965
Q ss_pred hhH----HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 159 SNL----KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 159 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
.+. ......+.. .....+..++
T Consensus 265 ~~~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~ 290 (355)
T 1vzo_A 265 DGEKNSQAEISRRILK------------------------------------------------------SEPPYPQEMS 290 (355)
T ss_dssp TTSCCCHHHHHHHHHH------------------------------------------------------CCCCCCTTSC
T ss_pred CCccchHHHHHHHHhc------------------------------------------------------cCCCCCcccC
Confidence 432 111111111 1123346678
Q ss_pred HHHHHHHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
..+.+||.+||..||++|| |++++++|+||+...
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 9999999999999999999 999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=275.63 Aligned_cols=191 Identities=30% Similarity=0.548 Sum_probs=162.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||+.+| +|.+++.....+++..++.++.|++.||.||| ..+|+|||||
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dlk 157 (335)
T 3dls_A 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR--------------LKDIIHRDIK 157 (335)
T ss_dssp CCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCS
T ss_pred eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEEeccC
Confidence 57899999999999999999776 99999999888999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++....... ......|++.|+|||++.+..+...++|+|||||++|+|++|..||...
T Consensus 158 p~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 158 DENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred HHHEEEcCCCcEEEeecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999999999999999999997654332 2234568999999999988877444499999999999999999999653
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.. ..... ...+..+++++.+
T Consensus 234 ~~------~~~~~------------------------------------------------------~~~~~~~~~~l~~ 253 (335)
T 3dls_A 234 EE------TVEAA------------------------------------------------------IHPPYLVSKELMS 253 (335)
T ss_dssp GG------GTTTC------------------------------------------------------CCCSSCCCHHHHH
T ss_pred HH------HHhhc------------------------------------------------------cCCCcccCHHHHH
Confidence 21 00000 1223457899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+||..||++|||++++++||||+....
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=269.33 Aligned_cols=195 Identities=27% Similarity=0.530 Sum_probs=160.8
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.. +...++||||+++++|.+++. .+.+++..++.++.|++.||.||| +.+++|+||
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Dl 163 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLH--------------YQKIIHRDI 163 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCC
Confidence 578898886 678999999999999988654 457999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCC--CCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY--NPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+||+++.++.+||+|||++........ ......|++.|+|||.+.+... ...++|+|||||++|+|++|..||
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999976543322 2334579999999999976553 234489999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+.......+.......+ ....+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~ 268 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQALEFP----------------------------------------------------DQPDIAED 268 (298)
T ss_dssp CCSSHHHHHHHHHHCCCCCC----------------------------------------------------SSSCCCHH
T ss_pred CCccHHHHHHHHhcccCCCC----------------------------------------------------CccccCHH
Confidence 87766555444433322211 12457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
+.+||.+||+.||++|||++|+++||||+
T Consensus 269 l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 269 LKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 99999999999999999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=281.97 Aligned_cols=233 Identities=23% Similarity=0.324 Sum_probs=157.9
Q ss_pred Cceeeeee-----eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQ-----RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++. ....+|+||||+. |+|.+++.....+++..++.++.||+.||+||| +.+|+|
T Consensus 115 v~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~~~iiH 179 (458)
T 3rp9_A 115 VKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH--------------SAGILH 179 (458)
T ss_dssp CCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBC
T ss_pred CceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcCC
Confidence 57888884 3467999999985 699999998888999999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccc------------------------cccccCccCCcccccccccc-CC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGR------------------------RVLSRTYCGSAAYAAPEVIS-GN 130 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~PE~~~-~~ 130 (304)
|||||+|||++.++.+||+|||+++........ .......+||+.|+|||++. +.
T Consensus 180 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 259 (458)
T 3rp9_A 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259 (458)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC
T ss_pred CCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC
Confidence 999999999999999999999999865422111 01234457899999999875 44
Q ss_pred CCCCCCchHHHHHHHHHHHHh-----------CCCCCCChhH--------------------HHHHHHhhhccccccchh
Q psy1812 131 PYNPKLADIWSLGVITFIMLN-----------AAMPFDDSNL--------------------KQLFKEQTSNILSHQVKV 179 (304)
Q Consensus 131 ~~~~~~sDvwslG~ll~~ll~-----------g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~ 179 (304)
.++.+ +|||||||++|+|++ |..+|.+.+. ......+....+......
T Consensus 260 ~~~~~-~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 338 (458)
T 3rp9_A 260 NYTEA-IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338 (458)
T ss_dssp CCCTH-HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHH
T ss_pred CCCcH-hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHH
Confidence 56665 999999999999998 6666655432 122222222222111100
Q ss_pred hhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHh
Q psy1812 180 KDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIK 259 (304)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell 259 (304)
...+... ........ .+... ........+.+++++.+||.+||.+||.+|||++|+|
T Consensus 339 ~~~~~~~-~~~~~~~~-----------~~~~~-----------~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L 395 (458)
T 3rp9_A 339 IEALEKE-DAKRYIRI-----------FPKRE-----------GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395 (458)
T ss_dssp HHTSSCH-HHHHHHTT-----------SCCCC-----------CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhhcCCH-HHHHHHHh-----------cCCCC-----------CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 0000000 00000000 00000 0000122245689999999999999999999999999
Q ss_pred cCccccccccccc
Q psy1812 260 AHDWLRYKSMVRR 272 (304)
Q Consensus 260 ~~~wf~~~~~~~~ 272 (304)
+||||+.......
T Consensus 396 ~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 396 AHPFFKEVRIAEV 408 (458)
T ss_dssp HSGGGTTTCCGGG
T ss_pred cCHhhhhcCCCcc
Confidence 9999998876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=291.09 Aligned_cols=194 Identities=25% Similarity=0.424 Sum_probs=165.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+++.+++||||++||+|.+++...+ .+++..++.++.||+.||+||| +.+|+||||
T Consensus 247 v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--------------~~gIvHrDL 312 (576)
T 2acx_A 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--------------RERIVYRDL 312 (576)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeccCC
Confidence 578999999999999999999999999998765 3999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.+|.+||+|||++....... .....+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+
T Consensus 313 KPeNILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 313 KPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSC
T ss_pred chheEEEeCCCCeEEEecccceecccCc----cccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999997654322 2234579999999999998888877 9999999999999999999976
Q ss_pred hhH----HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 159 SNL----KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 159 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
.+. ......+... ....+..++
T Consensus 388 ~~~~~~~~~i~~~i~~~------------------------------------------------------~~~~p~~~s 413 (576)
T 2acx_A 388 RKKKIKREEVERLVKEV------------------------------------------------------PEEYSERFS 413 (576)
T ss_dssp SSSCCCHHHHHHHHHHC------------------------------------------------------CCCCCTTSC
T ss_pred cccchhHHHHHHHhhcc------------------------------------------------------cccCCccCC
Confidence 532 2222222211 123346689
Q ss_pred HHHHHHHHHhcCCCCCccc-----cHHHHhcCcccccc
Q psy1812 235 HQVKNLVGQILEPDITKRI-----RLDAIKAHDWLRYK 267 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~-----t~~ell~~~wf~~~ 267 (304)
+++.+||.+||+.||.+|| +++|+++||||+..
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999999999 89999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=265.40 Aligned_cols=195 Identities=30% Similarity=0.529 Sum_probs=157.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.+++|+
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~ 148 (285)
T 3is5_A 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--------------SQHVVHK 148 (285)
T ss_dssp CCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCC
T ss_pred HhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCEEEC
Confidence 57899999999999999999999999999653 57999999999999999999999 8899999
Q ss_pred CCCCCcEEE---ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 77 DLKCENILM---TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 77 dl~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||+||++ +.++.+||+|||++....... ......++..|+|||.+.+ .++.+ +|+||||+++++|++|.
T Consensus 149 dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~il~~ll~g~ 222 (285)
T 3is5_A 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPEVFKR-DVTFK-CDIWSAGVVMYFLLTGC 222 (285)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCCCCCC--------------CTTGGGCCHHHHTT-CCCHH-HHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCcccccCcCChHHhcc-CCCcc-cCeehHHHHHHHHHhCC
Confidence 999999999 456789999999997544322 2334568999999999864 46655 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+................ .....+
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~ 251 (285)
T 3is5_A 223 LPFTGTSLEEVQQKATYKEPNYA---------------------------------------------------VECRPL 251 (285)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCC---------------------------------------------------C--CCC
T ss_pred CCCCCCCHHHHHhhhccCCcccc---------------------------------------------------cccCcC
Confidence 99988776555544433222111 011336
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
++++.+||.+||+.||++|||+.|+++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 889999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=288.08 Aligned_cols=196 Identities=29% Similarity=0.455 Sum_probs=166.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|+++++|.+...+++||||++||+|.+++.+.+ .+++..++.++.|++.||.||| +.+|+||
T Consensus 248 v~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--------------~~gIvHr 313 (543)
T 3c4z_A 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--------------QRNIIYR 313 (543)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECC
T ss_pred eeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--------------HcCCccc
Confidence 578999999999999999999999999998743 6999999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||||+||+++.+|.+||+|||++........ .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||
T Consensus 314 DLKP~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHHEEEeCCCCEEEeecceeeeccCCCc---ccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCC
Confidence 9999999999999999999999976543321 2344589999999999998888877 99999999999999999999
Q ss_pred CChh----HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 157 DDSN----LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 157 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.+.+ .......+.... ...+..
T Consensus 390 ~~~~~~~~~~~~~~~i~~~~------------------------------------------------------~~~p~~ 415 (543)
T 3c4z_A 390 RARGEKVENKELKQRVLEQA------------------------------------------------------VTYPDK 415 (543)
T ss_dssp CCTTCCCCHHHHHHHHHHCC------------------------------------------------------CCCCTT
T ss_pred CCCccchhHHHHHHHHhhcc------------------------------------------------------cCCCcc
Confidence 7653 233333333222 233467
Q ss_pred ccHHHHHHHHHhcCCCCCcccc-----HHHHhcCccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIR-----LDAIKAHDWLRYKS 268 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~~ 268 (304)
+++.+.+||.+||+.||.+||+ ++++++||||+...
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 8999999999999999999995 58999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=274.97 Aligned_cols=204 Identities=25% Similarity=0.435 Sum_probs=164.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------------------------------CCCCHHHH
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------------------------------GPVAESNA 40 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------~~l~~~~~ 40 (304)
|++++++.+++..++||||++||+|.+++... ..+++..+
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (345)
T 3hko_A 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred ceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence 57999999999999999999999999998521 12468889
Q ss_pred HHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC--CeEEEeccCcccccCcccc-cccccCccC
Q psy1812 41 RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF--NVKIADFGFARYCVDKEGR-RVLSRTYCG 117 (304)
Q Consensus 41 ~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~--~~kl~dfg~~~~~~~~~~~-~~~~~~~~~ 117 (304)
+.++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||++......... ........|
T Consensus 171 ~~i~~qi~~~l~~LH--------------~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 236 (345)
T 3hko_A 171 SNIMRQIFSALHYLH--------------NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHH--------------HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CC
T ss_pred HHHHHHHHHHHHHHH--------------HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCC
Confidence 999999999999999 88999999999999998776 7999999999765432211 112345568
Q ss_pred CccccccccccC--CCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhh
Q psy1812 118 SAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSH 195 (304)
Q Consensus 118 ~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (304)
++.|+|||.+.+ ..++.+ +|+|||||++|+|++|..||.+.+..+....+........
T Consensus 237 t~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 296 (345)
T 3hko_A 237 TPYFVAPEVLNTTNESYGPK-CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE------------------- 296 (345)
T ss_dssp CGGGCCHHHHTCSSSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT-------------------
T ss_pred CccccCchhhccCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC-------------------
Confidence 999999999875 456665 9999999999999999999988877777666655443332
Q ss_pred hhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 196 QVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
......+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 297 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 297 -------------------------------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp -------------------------------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred -------------------------------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 1112347889999999999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=273.70 Aligned_cols=228 Identities=21% Similarity=0.330 Sum_probs=168.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 87 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivH~dlkp 152 (331)
T 4aaa_A 87 VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH--------------SHNIIHRDIKP 152 (331)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred eeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEccCcCh
Confidence 5789999999999999999999999988887788999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.+ +|+|||||++|+|++|..||.+.
T Consensus 153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 153 ENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLVGDVKYGKA-VDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp GGEEECTTSCEEECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTH-HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred heEEEcCCCcEEEEeCCCceeecCCcc---ccCCCcCCccccCcccccCCCCcchH-HHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999975443221 23345689999999999876 45555 99999999999999999999888
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+..............+... ............ ..... ....+.+++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~------~~~~~-------~~~~~~~~~~l~~ 285 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKN----------PVFAGVRLPEIK------EREPL-------ERRYPKLSEVVID 285 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHC----------GGGTTCCCCCCS------SCCCH-------HHHSTTSCHHHHH
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhc----------cccccccCcccc------ccchh-------hhcccchhHHHHH
Confidence 777666666554443331111111100 000000000000 00000 1112457899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+||+.||.+|||+.|+|+||||+....
T Consensus 286 li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 286 LAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred HHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 999999999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=264.94 Aligned_cols=202 Identities=28% Similarity=0.518 Sum_probs=164.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+++..++||||+++++|.+++.....+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~p 133 (276)
T 2yex_A 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH--------------GIGITHRDIKP 133 (276)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred eeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCCh
Confidence 5789999999999999999999999999988778999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ........|+..|+|||.+.+..+...++|+||||+++++|++|..||....
T Consensus 134 ~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 134 ENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred HHEEEccCCCEEEeeCCCccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999875433221 1123455789999999999887764444999999999999999999997654
Q ss_pred HH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 161 LK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 161 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.. ............ ......+++.+.+
T Consensus 213 ~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~ 240 (276)
T 2yex_A 213 DSCQEYSDWKEKKTY----------------------------------------------------LNPWKKIDSAPLA 240 (276)
T ss_dssp TTSHHHHHHHTTCTT----------------------------------------------------STTGGGSCHHHHH
T ss_pred hHHHHHHHhhhcccc----------------------------------------------------cCchhhcCHHHHH
Confidence 32 111111111000 1112457889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+||+.||++|||++++++||||+....
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999999997754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=273.62 Aligned_cols=226 Identities=24% Similarity=0.353 Sum_probs=170.8
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++++++..+ ..+++||||+ +++|.+++.. +.+++..++.++.|++.||+||| +.+|+
T Consensus 87 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH--------------~~~iv 150 (367)
T 1cm8_A 87 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIH--------------AAGII 150 (367)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred CCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCcc
Confidence 4677887765 3569999999 7899999976 56999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+||+++.++.+||+|||+++.... ......++..|+|||++.+ ..++.. +|+||+||++++|++|+
T Consensus 151 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 151 HRDLKPGNLAVNEDCELKILDFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGK 223 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTT-HHHHHHHHHHHHHHHSS
T ss_pred ccCcCHHHEEEcCCCCEEEEeeeccccccc------ccCcCcCCCCcCCHHHHhCCCCCChh-hhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999976432 1334578999999999987 456666 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+....+....+..+......+.... ............ ...+ .......
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~---------------~~~~-------~~~~~~~ 280 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE-AKNYMKGLPELE---------------KKDF-------ASILTNA 280 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH-HHHHHHHSCCCC---------------CCCG-------GGTCTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH-HHHHHHhCCCCC---------------CCCH-------HHHCCCC
Confidence 9999988888887777666554422221111100 000000000000 0000 1223467
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.+||.+||..||++|||++++|+||||+....+..
T Consensus 281 ~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 281 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred CHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 899999999999999999999999999999998776544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=285.10 Aligned_cols=236 Identities=24% Similarity=0.365 Sum_probs=166.8
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++++++... ..+++||||+++ +|.+.+.. .+++..++.++.|++.||+||| +.+|+
T Consensus 124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH--------------~~~ii 186 (464)
T 3ttj_A 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH--------------SAGII 186 (464)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred CcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHH--------------HCCcc
Confidence 5678888644 468999999975 68787754 4999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+||+|||+++...... .....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.
T Consensus 187 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCCC-----CC----CC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSC
T ss_pred cCCCChHhEEEeCCCCEEEEEEEeeeecCCCc----ccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999997654322 2345679999999999999888877 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..++..++....+.........+. .................... ..-..+...........+
T Consensus 262 pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~s 329 (464)
T 3ttj_A 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ--PTVRNYVENRPKYAGLTFPK----------LFPDSLFPADSEHNKLKA 329 (464)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTSC--HHHHHHHTTSCCCCCCCHHH----------HSCGGGSCCSSHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHcc--hhhhhHhhcccccCCCChHH----------hCcccccccccccccccC
Confidence 999998888888887766554322221111 11111111110000000000 000000001111112347
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+++.+||.+||.+||++|||++|+|+||||+....+
T Consensus 330 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 330 SQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 789999999999999999999999999999965543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=262.99 Aligned_cols=194 Identities=23% Similarity=0.475 Sum_probs=157.5
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--iv 74 (304)
+++++++.. +..+++||||+++|+|.+++.+.+.+++..++.++.|++.||.||| +.+ ++
T Consensus 88 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~~~i~ 153 (290)
T 1t4h_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH--------------TRTPPII 153 (290)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TSSSCCC
T ss_pred eeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH--------------cCCCCEE
Confidence 567887765 4679999999999999999999888999999999999999999999 777 99
Q ss_pred ecCCCCCcEEEe-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||||+||+++ .++.+||+|||++...... ......|++.|+|||.+.+ .++.+ +|+|||||++++|++|.
T Consensus 154 H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSS
T ss_pred ECCCCHHHEEEECCCCCEEEeeCCCccccccc-----ccccccCCcCcCCHHHHhc-cCCCc-chHHHHHHHHHHHHhCC
Confidence 999999999997 7889999999998643322 2234568999999998875 46666 99999999999999999
Q ss_pred CCCCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.||...... .....+..+... ...+..
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~ 254 (290)
T 1t4h_A 227 YPYSECQNAAQIYRRVTSGVKP----------------------------------------------------ASFDKV 254 (290)
T ss_dssp CTTTTCSSHHHHHHHHTTTCCC----------------------------------------------------GGGGGC
T ss_pred CCCCCcCcHHHHHHHHhccCCc----------------------------------------------------cccCCC
Confidence 999764433 333333222111 112244
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
.++++.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 67889999999999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.53 Aligned_cols=237 Identities=23% Similarity=0.256 Sum_probs=172.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++.+...+..++||||+. ++|.+++.... .+++..++.++.|++.||+||| +.+|+||||
T Consensus 162 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDl 226 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--------------KNRIIHCDL 226 (429)
T ss_dssp CCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------HHTEECSCC
T ss_pred EEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCC
Confidence 578899999999999999996 69999998764 4999999999999999999999 889999999
Q ss_pred CCCcEEEecCCC--eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+||+++.++. +||+|||++..... ......+++.|+|||++.+..++.+ +|||||||++|+|++|..||
T Consensus 227 Kp~NILl~~~~~~~vkL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 227 KPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTC------CCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHeEEccCCCcceEEeecccceecCC------cccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCC
Confidence 999999999987 99999999865332 2335678999999999998888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccc--------------cchhhhhhhhhhh
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKV--------------KDILSHQVKLKDI 222 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~ 222 (304)
.+.+..+....+.......+..+.. .................+....... .........+.
T Consensus 300 ~~~~~~~~l~~i~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 374 (429)
T 3kvw_A 300 PGEDEGDQLACMIELLGMPSQKLLD---ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG-- 374 (429)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHH---TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHH--
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHH---hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhH--
Confidence 9988877777776654444322211 1111122211111110000000000 00000000011
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.......++++.+||.+||++||++|||++|+|+||||+...
T Consensus 375 ----~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 375 ----NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp ----HHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred ----hhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 112234578999999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=278.55 Aligned_cols=234 Identities=24% Similarity=0.314 Sum_probs=159.9
Q ss_pred CceeeeeeeC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRG-----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++... +.+++||||+. |+|.+++.....+++..++.++.||+.||+||| +.+|+|
T Consensus 88 v~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------------~~givH 152 (432)
T 3n9x_A 88 IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--------------ESGIIH 152 (432)
T ss_dssp CCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred ceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCCC
Confidence 5788888766 67999999996 599999998888999999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccc-------------------cccccCccCCccccccccccCC-CCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGR-------------------RVLSRTYCGSAAYAAPEVISGN-PYNPK 135 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~ 135 (304)
|||||+||+++.++.+||+|||+++........ .......+||..|+|||++... .++.+
T Consensus 153 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~ 232 (432)
T 3n9x_A 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232 (432)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH
T ss_pred CCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc
Confidence 999999999999999999999999865432211 0123566799999999997544 45555
Q ss_pred CchHHHHHHHHHHHHhCCC-----------CCCChh-----------------HHHHHHHhhhccccccchhhhhhhhhh
Q psy1812 136 LADIWSLGVITFIMLNAAM-----------PFDDSN-----------------LKQLFKEQTSNILSHQVKVKDILSHQV 187 (304)
Q Consensus 136 ~sDvwslG~ll~~ll~g~~-----------pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (304)
+|+|||||++|+|++|.. +|.+.+ ...+...+....+.........+....
T Consensus 233 -~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~ 311 (432)
T 3n9x_A 233 -IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311 (432)
T ss_dssp -HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred -cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHH
Confidence 999999999999998543 333322 122233333322222211100000000
Q ss_pred hHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 188 KVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
.......... .....+ ....+.+++++.+||.+||.+||.+|||++|+|+||||+..
T Consensus 312 -~~~~~~~~~~---------------~~~~~~-------~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 312 -VIKYIKLFPH---------------RKPINL-------KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp -HHHHHHTSCC---------------CCCCCH-------HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred -HHHHHHhCCC---------------CCCCCH-------HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 0000000000 000000 01124579999999999999999999999999999999998
Q ss_pred cccccc
Q psy1812 268 SMVRRK 273 (304)
Q Consensus 268 ~~~~~~ 273 (304)
.....+
T Consensus 369 ~~~~~e 374 (432)
T 3n9x_A 369 RKKKLE 374 (432)
T ss_dssp CCTTTC
T ss_pred cCcccC
Confidence 765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=270.51 Aligned_cols=233 Identities=21% Similarity=0.317 Sum_probs=168.3
Q ss_pred Cceeeeeee--------CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQR--------GPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
+++++++.. ++..++||||+.+ +|.+.+... ..+++..++.++.|++.||+||| +.
T Consensus 79 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~ 143 (351)
T 3mi9_A 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--------------RN 143 (351)
T ss_dssp CCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--------------HT
T ss_pred ccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------HC
Confidence 467888776 4579999999975 888888764 57999999999999999999999 88
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~l 149 (304)
+|+||||||+||+++.++.+||+|||++......... ........|++.|+|||++.+.. ++.+ +|+|||||++|+|
T Consensus 144 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwslG~il~el 222 (351)
T 3mi9_A 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEM 222 (351)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTH-HHHHHHHHHHHHH
T ss_pred CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcH-hHHHHHHHHHHHH
Confidence 9999999999999999999999999999765432211 11234557899999999987654 5555 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||.+.+.......+.......+............. ....... .......... .
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~--~~~~~~~~~~-----~ 280 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY---------------EKLELVK--GQKRKVKDRL-----K 280 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG---------------TSSCCCS--SCCCCHHHHH-----H
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh---------------ccccccc--ccccCHHHHh-----h
Confidence 9999999988877777666655444432211111000000 0000000 0000000000 0
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
....++.+.+||.+||+.||++|||++|+|+||||+....+.
T Consensus 281 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 281 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 012377899999999999999999999999999998876643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=279.24 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=158.4
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRAG---------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
|++++++. .+...++||||+. |+|.+++...+ .+++..++.++.||+.||.|||
T Consensus 81 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-------------- 145 (405)
T 3rgf_A 81 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-------------- 145 (405)
T ss_dssp CCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--------------
T ss_pred eeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 57788884 4779999999997 59999886432 4999999999999999999999
Q ss_pred CCceEecCCCCCcEEE----ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHH
Q psy1812 70 SKNIAHRDLKCENILM----TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGV 144 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ 144 (304)
+.+|+||||||+||++ +.++.+||+|||++................+||+.|+|||++.+.. ++.+ +|||||||
T Consensus 146 ~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwSlG~ 224 (405)
T 3rgf_A 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIGC 224 (405)
T ss_dssp HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHH-HHHHHHHH
T ss_pred hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch-hhhHHHHH
Confidence 8899999999999999 6778999999999986543322212334567899999999998755 5555 99999999
Q ss_pred HHHHHHhCCCCCCChhH---------HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 145 ITFIMLNAAMPFDDSNL---------KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 145 ll~~ll~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
++|+|++|..||.+... .+....+...........+..+............. .. .... .
T Consensus 225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~------~ 292 (405)
T 3rgf_A 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF---RR---NTYT------N 292 (405)
T ss_dssp HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC---CG---GGGT------T
T ss_pred HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc---cc---cCCC------c
Confidence 99999999999976543 23333333333322211111111111100000000 00 0000 0
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
......+ .......++.+.+||.+||.+||.+|||++|+|+||||+....+...
T Consensus 293 ~~~~~~~----~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~~~ 346 (405)
T 3rgf_A 293 CSLIKYM----EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSD 346 (405)
T ss_dssp CCHHHHH----HTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCCSS
T ss_pred chhhhhH----hhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCccc
Confidence 0000000 11112347789999999999999999999999999999987665443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=273.39 Aligned_cols=204 Identities=24% Similarity=0.352 Sum_probs=161.0
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++++.... ..++||||++||+|.+++...+.+++..++.++.|++.||.||| +.+++|+
T Consensus 75 v~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~ 140 (311)
T 3ork_A 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH--------------QNGIIHR 140 (311)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCC
T ss_pred ceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCCcC
Confidence 57788877643 45999999999999999998889999999999999999999999 8899999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||||+||+++.++.+||+|||++.................|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp CCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSC
T ss_pred CCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999765443322223344568999999999998888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+...............+ ......++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~ 249 (311)
T 3ork_A 220 TGDSPVSVAYQHVREDPIPP--------------------------------------------------SARHEGLSAD 249 (311)
T ss_dssp CCSSHHHHHHHHHHCCCCCH--------------------------------------------------HHHSTTCCHH
T ss_pred CCCChHHHHHHHhcCCCCCc--------------------------------------------------ccccCCCCHH
Confidence 88776655544443322111 1112457899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||+.||.+||++.+++.|+|++....
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 999999999999999999999999999986553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.86 Aligned_cols=224 Identities=23% Similarity=0.292 Sum_probs=170.5
Q ss_pred Cceeeeee-----eCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQ-----RGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++. .+...++||||+. |+|.+++.... .+++..++.++.|++.||.||| +.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~gi 141 (326)
T 1blx_A 77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--------------SHRV 141 (326)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTC
T ss_pred EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCc
Confidence 56788876 5678999999998 59999998754 4999999999999999999999 8899
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+|||||++|+|++|.
T Consensus 142 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~ 216 (326)
T 1blx_A 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216 (326)
T ss_dssp CCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSS
T ss_pred eeccCCHHHeEEcCCCCEEEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999987544322 2344568999999999988888777 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+.......+...........+. .......... .. ... .........+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~~---~~----~~~-------~~~~~~~~~~ 269 (326)
T 1blx_A 217 PLFRGSSDVDQLGKILDVIGLPGEEDWP-------------RDVALPRQAF---HS----KSA-------QPIEKFVTDI 269 (326)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCGGGSC-------------TTCSSCGGGS---CC----CCC-------CCGGGTCCSC
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCcccCc-------------cccccchhhh---cc----cCc-------chhhhccccC
Confidence 9999887777666665443322100000 0000000000 00 000 0001233567
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+..+.+||.+||+.||++|||+.++++||||+......
T Consensus 270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 89999999999999999999999999999999876533
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=272.44 Aligned_cols=245 Identities=23% Similarity=0.276 Sum_probs=170.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++..++..++||||+. |+|.+++... +.+++..++.++.|++.||.|||+- ..+|+||||
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------------~~~ivHrDl 185 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP------------ELSIIHCDL 185 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST------------TTCEECCCC
T ss_pred EEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC------------CCCEEcCCC
Confidence 568899999999999999996 5999999876 3699999999999999999999931 368999999
Q ss_pred CCCcEEEe--cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMT--KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+||+++ .++.+||+|||++...... .....+++.|+|||++.+..++.+ +|+|||||++|+|++|..||
T Consensus 186 kp~NIll~~~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 186 KPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSS
T ss_pred CcccEEEecCCCCcEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCC
Confidence 99999995 4778999999999765322 234678999999999999888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhc--ccccccccccccchhhhhhhhhhhhhccc-------
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVK--VKDILSHQVKVKDILSHQVKLKDILSHQV------- 227 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (304)
.+.+..+....+.......+..+... ............. +...................+..+.....
T Consensus 259 ~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 335 (382)
T 2vx3_A 259 SGANEVDQMNKIVEVLGIPPAHILDQ---APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335 (382)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHTT---CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHh---hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence 99888888777776655443222111 1111111110000 00000000000000000001111111000
Q ss_pred ----cccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 228 ----KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 228 ----~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
......++++.+||.+||++||++|||++|+|+||||+...
T Consensus 336 ~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred cccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 00111235899999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=266.57 Aligned_cols=234 Identities=21% Similarity=0.276 Sum_probs=169.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++...+..++||||+ +++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--------------~~~ivH~Dl 149 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--------------ENQLTHTDL 149 (355)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCC
T ss_pred EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCC
Confidence 46788899999999999999 678888887754 6999999999999999999999 899999999
Q ss_pred CCCcEEE-------------------ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchH
Q psy1812 79 KCENILM-------------------TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADI 139 (304)
Q Consensus 79 ~~~nil~-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDv 139 (304)
||+||++ +.++.+||+|||++...... .....|+..|+|||++.+..++.+ +|+
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~Di 222 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQP-CDV 222 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTH-HHH
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCc-cch
Confidence 9999999 67889999999999753322 234578999999999998888877 999
Q ss_pred HHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 140 WSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 140 wslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|||||++|+|++|..||.+.+.......+.......+..+...... ..........+..........
T Consensus 223 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 2eu9_A 223 WSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK-------------QKYFYKGGLVWDENSSDGRYV 289 (355)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC-------------GGGEETTEECCCTTSHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc-------------hhhhcccccccccccchhccc
Confidence 9999999999999999988777666655555444433211111000 000000000000000000000
Q ss_pred hh---hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 220 KD---ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 220 ~~---~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.. ............+.++.+||.+||+.||.+|||++|+++||||+....
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred cccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 00 000011122345778999999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=263.07 Aligned_cols=201 Identities=28% Similarity=0.407 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+.+++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~dl~ 152 (314)
T 3com_A 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--------------FMRKIHRDIK 152 (314)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred ccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCCcCCCcC
Confidence 5789999999999999999999999999974 557999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 153 AGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp GGGEEECTTCCEEECCCTTCEECBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHHEEECCCCCEEEeecccchhhhhhcc---ccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999976543221 2334568999999999988888777 99999999999999999999876
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+.......+....... ...+..+++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~l~~ 257 (314)
T 3com_A 229 HPMRAIFMIPTNPPPT---------------------------------------------------FRKPELWSDNFTD 257 (314)
T ss_dssp CHHHHHHHHHHSCCCC---------------------------------------------------CSSGGGSCHHHHH
T ss_pred ChHHHHHHHhcCCCcc---------------------------------------------------cCCcccCCHHHHH
Confidence 5544333222111000 1123456889999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
||.+||..||.+|||+.++++||||+.....
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 9999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=272.72 Aligned_cols=232 Identities=23% Similarity=0.296 Sum_probs=163.0
Q ss_pred Cceeeeee----eCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ce
Q psy1812 1 MQVHSILQ----RGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NI 73 (304)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~i 73 (304)
+++++++. ++..+++||||+ +++|.+++... +.+++..++.++.||+.||.||| +. +|
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~gi 168 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--------------TKCRI 168 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCE
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------------HhCCE
Confidence 46788887 567899999999 56888877664 46999999999999999999999 76 99
Q ss_pred EecCCCCCcEEEecCC-------------------------------------------------CeEEEeccCcccccC
Q psy1812 74 AHRDLKCENILMTKRF-------------------------------------------------NVKIADFGFARYCVD 104 (304)
Q Consensus 74 vH~dl~~~nil~~~~~-------------------------------------------------~~kl~dfg~~~~~~~ 104 (304)
+||||||+||+++.++ .+||+|||++.....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~ 248 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence 9999999999998775 799999999975432
Q ss_pred cccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh------HHHHHHHhhhccccccch
Q psy1812 105 KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN------LKQLFKEQTSNILSHQVK 178 (304)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~ 178 (304)
. .....||..|+|||++.+..++.+ +|||||||++|+|++|..||.+.+ .......+.......+..
T Consensus 249 ~------~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 321 (397)
T 1wak_A 249 H------FTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321 (397)
T ss_dssp C------SCSCCSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHH
T ss_pred c------CccCCCCCcccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChH
Confidence 2 234568999999999998888877 999999999999999999996543 223333333332222211
Q ss_pred hhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHH
Q psy1812 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAI 258 (304)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~el 258 (304)
... ........+. .......... ................+...++.+.+||.+||+.||++|||++|+
T Consensus 322 ~~~---~~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 389 (397)
T 1wak_A 322 LIV---AGKYSKEFFT-----KKGDLKHITK----LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389 (397)
T ss_dssp HHH---HCTTGGGTBC-----TTSSBSSCCC----CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred Hhh---cccccccccC-----Cccccccccc----cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence 100 0000000000 0000000000 001111122222334456678899999999999999999999999
Q ss_pred hcCccccc
Q psy1812 259 KAHDWLRY 266 (304)
Q Consensus 259 l~~~wf~~ 266 (304)
|+||||++
T Consensus 390 l~hp~~~~ 397 (397)
T 1wak_A 390 LRHPWLNS 397 (397)
T ss_dssp HTSGGGGC
T ss_pred hhCccccC
Confidence 99999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=271.15 Aligned_cols=245 Identities=20% Similarity=0.353 Sum_probs=170.9
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ce
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NI 73 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~i 73 (304)
+++++++...+ .+++||||+ +++|.+++... +.+++..++.++.|++.||.||| +. +|
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~~i 153 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--------------RRCGI 153 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--------------hcCCE
Confidence 46777777544 899999999 88999999874 45999999999999999999999 76 99
Q ss_pred EecCCCCCcEEEecC------CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKR------FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITF 147 (304)
Q Consensus 74 vH~dl~~~nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~ 147 (304)
+|+||||+||+++.+ +.+||+|||++...... .....+++.|+|||++.+..++.+ +|+|||||++|
T Consensus 154 vH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ 226 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIF 226 (373)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHH
T ss_pred EecCCChHHeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHH
Confidence 999999999999543 36999999999754332 234568999999999998888777 99999999999
Q ss_pred HHHhCCCCCCChh------HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 148 IMLNAAMPFDDSN------LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 148 ~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
+|++|..||.+.+ .......+.......+.... .................. .. .........
T Consensus 227 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~~~ 294 (373)
T 1q8y_A 227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL---RNGKYTRTFFNSRGLLRN-----IS----KLKFWPLED 294 (373)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH---HHCTTHHHHBCC--CBSS-----CC----CCCBCCHHH
T ss_pred HHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHH---hccchhhhhcCCcchhcc-----cc----cccccchhh
Confidence 9999999997654 22333333333333221110 000001111100000000 00 011112333
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCCc
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQK 279 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~~ 279 (304)
+.......+..++.++.+||.+||+.||++|||++|+++||||+..........+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~ 352 (373)
T 1q8y_A 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 352 (373)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSC
T ss_pred hhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcccccCcchh
Confidence 3444455667788999999999999999999999999999999987765554444433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=270.01 Aligned_cols=234 Identities=23% Similarity=0.358 Sum_probs=171.6
Q ss_pred CceeeeeeeC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRG-----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++... ...++||||+. |+|.+++... .+++..++.++.|++.||.||| +.+|+|
T Consensus 88 v~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH 151 (364)
T 3qyz_A 88 IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH--------------SANVLH 151 (364)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred ccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH--------------HCCeec
Confidence 4677777654 47999999997 5999999764 6999999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|||||+||+++.++.+||+|||++.................|++.|+|||++.+.. ++.+ +|+|||||++|+|++|..
T Consensus 152 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTH-HHHHHHHHHHHHHHHSSC
T ss_pred CCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcc-hhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999986554333222334567999999999876554 5555 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+..............+..... ......... . ....+ ......++
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~----------~~~~~-------~~~~~~~~ 287 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA-RNYLLSLPH-----K----------NKVPW-------NRLFPNAD 287 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH-HHHHHTSCC-----C----------CCCCH-------HHHCTTSC
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH-HHHHHhcCC-----c----------cCCCH-------HHhCCCCC
Confidence 9988877777666655444333111110000000 000000000 0 00000 11224578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
+++.+||.+||+.||.+|||++|+|+||||+....+....
T Consensus 288 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 327 (364)
T 3qyz_A 288 SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc
Confidence 8999999999999999999999999999999886654433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=270.05 Aligned_cols=226 Identities=19% Similarity=0.243 Sum_probs=171.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+.+ +|.+++.... .+++..++.++.|++.||+||| +.+++|+|||
T Consensus 75 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Dlk 139 (346)
T 1ua2_A 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--------------QHWILHRDLK 139 (346)
T ss_dssp CCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH--------------HTTCCCCCCC
T ss_pred CeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--------------HCCEECCCCC
Confidence 5789999999999999999986 9999997754 6899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.++.+||+|||++........ ......+++.|+|||.+.+.. ++.. +|+|||||++|+|++|..||.+
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 140 PNNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHH-HHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEEcCCCCEEEEecccceeccCCcc---cCCcccccccccCchHhhCCCCCCch-hhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999976543221 234557899999999997654 4544 9999999999999999999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+...........+... ....... .....+ ...+ ......+++++.
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~-------~~~~-------~~~~~~~~~~~~ 269 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDM---------CSLPDYV---TFKSFP-------GIPL-------HHIFSAAGDDLL 269 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSST---------TSSTTCC---CCCCCC-------CCCH-------HHHCTTCCHHHH
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhh---------ccCcccc---cccccC-------CCCh-------HHhhccCCHHHH
Confidence 8877777666554433221000000 0000000 000000 0000 112255789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+||.+||..||.+|||++|+++||||+....+.
T Consensus 270 ~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 270 DLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred HHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 999999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=275.56 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=166.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~ivH~dl~ 79 (304)
+++++++..++..++||||++||+|.+++.+.+.+++..++.++.+++.||.||| +. +++|+|||
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh--------------~~~~i~H~dlk 159 (360)
T 3eqc_A 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--------------EKHKIMHRDVK 159 (360)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HHHCCCCSCCS
T ss_pred EEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------------HhCCEEcCCcc
Confidence 5789999999999999999999999999999888999999999999999999999 64 89999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...
T Consensus 160 p~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 160 PSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHHH-----C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCC
T ss_pred HHHEEECCCCCEEEEECCCCcccccc-----cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998644322 2334578999999999998888777 99999999999999999999877
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc--cccccccccHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH--QVKVKDILSHQV 237 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 237 (304)
+.......+................. ............... .........+... .......++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRT---------PGRPLNKFGMDSRPP---MAIFELLDYIVNEPPPKLPSGVFSLEF 301 (360)
T ss_dssp CHHHHHHHHC---------------------------------------C---CCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred CHHHHHHHhcccccccCCCCCCCccc---------CCCcccccccCCCCc---ccchhhhhHHhccCCCCCCcccccHHH
Confidence 65544332221111110000000000 000000000000000 0000111111111 111223478899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||.+|||++++++||||+....
T Consensus 302 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 302 QDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 99999999999999999999999999997653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=259.90 Aligned_cols=191 Identities=24% Similarity=0.330 Sum_probs=154.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++.+++..++||||++||+|.+++.+. +.+++..++.++.|++.||.||| +.+++|+
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivH~ 139 (289)
T 1x8b_A 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--------------SMSLVHM 139 (289)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECS
T ss_pred eeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeec
Confidence 57899999999999999999999999999875 67999999999999999999999 8899999
Q ss_pred CCCCCcEEEecC-------------------CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCc
Q psy1812 77 DLKCENILMTKR-------------------FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLA 137 (304)
Q Consensus 77 dl~~~nil~~~~-------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~s 137 (304)
||||+||+++.+ ..+||+|||.+...... ....++..|+|||.+.+......++
T Consensus 140 Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~ 212 (289)
T 1x8b_A 140 DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKA 212 (289)
T ss_dssp CCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHH
T ss_pred CCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchh
Confidence 999999999844 47899999998754432 2335899999999998764433349
Q ss_pred hHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhh
Q psy1812 138 DIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQV 217 (304)
Q Consensus 138 DvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (304)
|+|||||+++++++|..++....... .+..+..
T Consensus 213 Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~-------------------------------------------- 245 (289)
T 1x8b_A 213 DIFALALTVVCAAGAEPLPRNGDQWH---EIRQGRL-------------------------------------------- 245 (289)
T ss_dssp HHHHHHHHHHHHTTCCCCCSSSHHHH---HHHTTCC--------------------------------------------
T ss_pred hHHHHHHHHHHHhcCCCCCcchhHHH---HHHcCCC--------------------------------------------
Confidence 99999999999999988775543321 1111111
Q ss_pred hhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 218 KLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
...+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 246 ---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred ---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 123356789999999999999999999999999999999765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=272.04 Aligned_cols=237 Identities=24% Similarity=0.371 Sum_probs=162.8
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++...+ ..++||||+.+ +|.+++.. .+++..++.++.|++.||.||| +.+|+
T Consensus 87 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH--------------~~~iv 149 (371)
T 2xrw_A 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH--------------SAGII 149 (371)
T ss_dssp CCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred cceEEeeccccccccccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHH--------------HCCee
Confidence 57788887654 89999999975 89998863 5899999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+..++.+ +|+|||||++|+|++|..
T Consensus 150 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp CSCCCGGGEEECTTSCEEECCCCC--------------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSC
T ss_pred cccCCHHHEEEcCCCCEEEEEeeccccccccc----ccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999997544321 2334578999999999998888877 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh-hhhccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD-ILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (304)
||.+.+..+...++..............+. .................. ...+.. ............
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 291 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ--PTVRTYVENRPKYAGYSF-----------EKLFPDVLFPADSEHNKLK 291 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSC--HHHHHHHHSSCCCCCCCH-----------HHHSCGGGSCCSSHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhh--hHHHHHHhhCccccccch-----------hhhcccccCcccccccccc
Confidence 999988877777776655443321111111 001111110000000000 000000 000011112334
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++++.+||.+||..||++|||++|+++||||+....+..
T Consensus 292 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 330 (371)
T 2xrw_A 292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 330 (371)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred cHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence 788999999999999999999999999999987655443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=271.57 Aligned_cols=216 Identities=21% Similarity=0.306 Sum_probs=161.5
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEE
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENIL 84 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil 84 (304)
.+..+++||||+.+ +|.+.+.. .+.+++..++.++.|++.||.||| +.+|+||||||+||+
T Consensus 109 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~gi~H~Dikp~Nil 173 (383)
T 3eb0_A 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--------------SLGICHRDIKPQNLL 173 (383)
T ss_dssp -CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------TTTEECSCCCGGGEE
T ss_pred CceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCcCccCccCHHHEE
Confidence 34569999999984 87777654 567999999999999999999999 899999999999999
Q ss_pred Ee-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCChhHH
Q psy1812 85 MT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDSNLK 162 (304)
Q Consensus 85 ~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~ 162 (304)
++ .++.+||+|||++....... ......++..|+|||.+.+.. ++.+ +|+||+||++|+|++|..||.+.+..
T Consensus 174 ~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~ 248 (383)
T 3eb0_A 174 VNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPS-IDLWSIGCVFGELILGKPLFSGETSI 248 (383)
T ss_dssp EETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcc-hhhhhHHHHHHHHHhCCCCCCCCChH
Confidence 98 68899999999997654332 233456899999999988765 5555 99999999999999999999988887
Q ss_pred HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHH
Q psy1812 163 QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVG 242 (304)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 242 (304)
+....+............ ................. ..+ ....+..+++++.+||.
T Consensus 249 ~~~~~i~~~~g~p~~~~~------------~~~~~~~~~~~~~~~~~-------~~~------~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 249 DQLVRIIQIMGTPTKEQM------------IRMNPHYTEVRFPTLKA-------KDW------RKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHCCCCHHHH------------HHHCTTC--CCCCCCCC-------CCH------HHHSCTTCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCHHHH------------HHhCcccccccCCccCc-------ccH------HhhCCCCCCHHHHHHHH
Confidence 777777665444331100 00000000000000000 001 11233567899999999
Q ss_pred HhcCCCCCccccHHHHhcCcccccccc
Q psy1812 243 QILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 243 ~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+||..||.+|||+.|+++||||+....
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=261.50 Aligned_cols=197 Identities=28% Similarity=0.478 Sum_probs=166.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+++++|.+++.. +.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dl~p 147 (303)
T 3a7i_A 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH--------------SEKKIHRDIKA 147 (303)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred eEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCCccCCCCh
Confidence 5789999999999999999999999999975 56999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||...+
T Consensus 148 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 148 ANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTBC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heEEECCCCCEEEeecccceecCcccc---ccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcC
Confidence 999999999999999999976543322 2345578999999999988888776 999999999999999999998766
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+..... ...+..++..+.+|
T Consensus 224 ~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 224 PMKVLFLIPKNNP-----------------------------------------------------PTLEGNYSKPLKEF 250 (303)
T ss_dssp HHHHHHHHHHSCC-----------------------------------------------------CCCCSSCCHHHHHH
T ss_pred HHHHHHHhhcCCC-----------------------------------------------------CCCccccCHHHHHH
Confidence 5444433322111 12235678899999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
|.+||+.||.+|||++++++||||.....
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=273.04 Aligned_cols=225 Identities=19% Similarity=0.276 Sum_probs=166.2
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
|+++++|...+ .+++||||+.+ ++.+.+.. .+.+++..++.++.|++.||+||| +
T Consensus 95 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------------~ 159 (394)
T 4e7w_A 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--------------S 159 (394)
T ss_dssp CCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--------------H
T ss_pred ceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------H
Confidence 57888885433 48999999986 55554432 457999999999999999999999 8
Q ss_pred CceEecCCCCCcEEEe-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFI 148 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ 148 (304)
.+|+||||||+||+++ .++.+||+|||++....... ......++..|+|||++.+.. ++.+ +|+||+||++|+
T Consensus 160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlG~il~e 234 (394)
T 4e7w_A 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTN-IDIWSTGCVMAE 234 (394)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTH-HHHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcH-HHHHHHHHHHHH
Confidence 9999999999999999 78999999999997654332 233457899999999997765 5555 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|+.||.+.+..+....+............... ............. ...+. ..
T Consensus 235 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~------------~~~~~~~~~~~~~-------~~~~~------~~ 289 (394)
T 4e7w_A 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM------------NPNYMEHKFPQIR-------PHPFS------KV 289 (394)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH------------CGGGSSSCCCCCC-------CCCHH------HH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh------------Chhhhhhcccccc-------CCcHH------Hh
Confidence 99999999998877777777665544331110000 0000000000000 00000 11
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+..+++++.+||.+||+.||.+|||+.|+++||||+.....
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 290 FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred ccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 234578999999999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=269.44 Aligned_cols=200 Identities=23% Similarity=0.409 Sum_probs=155.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++|||+ .+|+|.+++.+.+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 72 v~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~iiHrDikp 136 (343)
T 3dbq_A 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QHGIVHSDLKP 136 (343)
T ss_dssp CCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred EEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCc
Confidence 5789999999999999995 47899999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----------CCCCCCCchHHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----------NPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~sDvwslG~ll~~l 149 (304)
+||+++ ++.+||+|||++........ ........|++.|+|||++.+ ..++.+ +|||||||++|+|
T Consensus 137 ~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwslG~il~el 213 (343)
T 3dbq_A 137 ANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYM 213 (343)
T ss_dssp GGEEEE-TTEEEECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHH-HHHHHHHHHHHHH
T ss_pred ceEEEE-CCcEEEeecccccccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCch-hhHHHHHHHHHHH
Confidence 999997 67899999999976543221 112335579999999999864 445555 9999999999999
Q ss_pred HhCCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 150 LNAAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 150 l~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
++|..||.... .......+..... ...
T Consensus 214 l~g~~pf~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~ 241 (343)
T 3dbq_A 214 TYGKTPFQQIINQISKLHAIIDPNH----------------------------------------------------EIE 241 (343)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTS----------------------------------------------------CCC
T ss_pred HhCCCcchhhhhHHHHHHHHhcCCc----------------------------------------------------ccC
Confidence 99999996532 2222222211111 022
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+...+.++.+||.+||+.||.+|||+.++++||||+....+
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 334567889999999999999999999999999999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.14 Aligned_cols=202 Identities=27% Similarity=0.478 Sum_probs=162.7
Q ss_pred Cceeeee--eeCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSIL--QRGPRVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++ .+++..++||||+.++ |.+++.. .+.+++..++.++.|++.||.||| +.+++|+
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------------~~~i~H~ 133 (305)
T 2wtk_C 69 IQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--------------SQGIVHK 133 (305)
T ss_dssp CCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECS
T ss_pred eEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--------------HCCeeec
Confidence 5788888 4567899999999875 8888876 346999999999999999999999 8899999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCC-CCCCchHHHHHHHHHHHHhCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY-NPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~sDvwslG~ll~~ll~g~~p 155 (304)
||||+||+++.++.+||+|||++......... .......|+..|+|||++.+... ...++|+||||+++|+|++|..|
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999765432221 12335568999999999976433 23349999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+.......+...... .+..+++
T Consensus 213 ~~~~~~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~ 238 (305)
T 2wtk_C 213 FEGDNIYKLFENIGKGSYA------------------------------------------------------IPGDCGP 238 (305)
T ss_dssp CCCSSHHHHHHHHHHCCCC------------------------------------------------------CCSSSCH
T ss_pred CCCchHHHHHHHHhcCCCC------------------------------------------------------CCCccCH
Confidence 9887766666555443322 2256788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
.+.+||.+||..||.+|||++++++||||+.......
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 275 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence 9999999999999999999999999999998776443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.83 Aligned_cols=233 Identities=22% Similarity=0.279 Sum_probs=168.9
Q ss_pred CceeeeeeeCCe-------EEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQRGPR-------VFIFMRYADNGDLLDHIK----RAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~~~~-------~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
|++++++...+. .++||||+.+ +|.+.+. ....+++..++.++.|++.||.|||..
T Consensus 82 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~------------ 148 (360)
T 3e3p_A 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP------------ 148 (360)
T ss_dssp CCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST------------
T ss_pred ccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC------------
Confidence 577888865333 8999999986 6655544 456799999999999999999999932
Q ss_pred CCceEecCCCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHH
Q psy1812 70 SKNIAHRDLKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITF 147 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~ 147 (304)
+.+|+|+||||+||+++. ++.+||+|||++....... ......|+..|+|||++.+.. ++.+ +|+|||||++|
T Consensus 149 ~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~-~Di~slG~il~ 223 (360)
T 3e3p_A 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTA-VDIWSVGCIFA 223 (360)
T ss_dssp TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTH-HHHHHHHHHHH
T ss_pred CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcH-HHHHHHHHHHH
Confidence 579999999999999997 8999999999997654332 223456899999999997665 5555 99999999999
Q ss_pred HHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 148 IMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 148 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|++|..||.+.+.......+..............+... .......... ...+.... .
T Consensus 224 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~----------~~~~~~~~---~ 281 (360)
T 3e3p_A 224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS---------HTDVDLYNSK----------GIPWSNVF---S 281 (360)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT---------CCCGGGGCCC----------CCCHHHHT---T
T ss_pred HHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc---------hhhccccccc----------cCCccccc---c
Confidence 999999999988887777777665544432211111000 0000000000 00011110 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
......++++.+||.+||+.||.+|||+.|+|+||||+....+...
T Consensus 282 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 282 DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 1223468899999999999999999999999999999998765543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.67 Aligned_cols=230 Identities=16% Similarity=0.291 Sum_probs=161.3
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.. ....++||||+.+++|.++++. +++..++.++.|++.||+||| +.+++||||
T Consensus 94 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Di 156 (330)
T 3nsz_A 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH--------------SMGIMHRDV 156 (330)
T ss_dssp CCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred EEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCC
Confidence 578888887 6789999999999999999864 899999999999999999999 899999999
Q ss_pred CCCcEEEecCC-CeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 79 KCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+||+++.++ .+||+|||++....... ......++..|+|||.+.+ ..++.+ +|+|||||++|+|++|..||
T Consensus 157 kp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHHTCSSS
T ss_pred CHHHEEEcCCCCEEEEEeCCCceEcCCCC----ccccccccccccChhhhcCCCcCCch-hhHHHHHHHHHHHHhCCCCc
Confidence 99999999777 79999999997654332 2334568899999999977 445555 99999999999999999999
Q ss_pred CC-hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DD-SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
.. .+..+....+........ .. ...... ...................+..+. .......+++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~--~~----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 294 (330)
T 3nsz_A 232 FHGHDNYDQLVRIAKVLGTED--LY----------DYIDKY---NIELDPRFNDILGRHSRKRWERFV--HSENQHLVSP 294 (330)
T ss_dssp SCCSSHHHHHHHHHHHHCHHH--HH----------HHHHHT---TCCCCTHHHHHHCCCCCCCGGGGC--CTTTGGGCCH
T ss_pred ccCCchHHHHHHHHHhcCCch--hh----------hHHHHh---ccccccchhhhhhhccccchhhhc--cccccccCCH
Confidence 43 333333333332221110 00 000000 000000000000000000001110 1122345799
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 295 ~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 9999999999999999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=272.21 Aligned_cols=200 Identities=23% Similarity=0.406 Sum_probs=157.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..++.+++|||+ .+++|.+++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 119 v~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH--------------~~~ivHrDlkp 183 (390)
T 2zmd_A 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QHGIVHSDLKP 183 (390)
T ss_dssp CCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH--------------TTTCCCCCCCG
T ss_pred EEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCCH
Confidence 5789999999999999995 57899999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----------CCCCCCCchHHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----------NPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~sDvwslG~ll~~l 149 (304)
+||+++ ++.+||+|||++........ .......+|++.|+|||++.+ ..++.+ +|||||||++|+|
T Consensus 184 ~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwSlGvil~el 260 (390)
T 2zmd_A 184 ANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYM 260 (390)
T ss_dssp GGEEES-SSCEEECCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHH-HHHHHHHHHHHHH
T ss_pred HHEEEE-CCeEEEEecCccccccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCCh-hhHHHHHHHHHHH
Confidence 999995 58999999999976543221 112345679999999999865 245555 9999999999999
Q ss_pred HhCCCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 150 LNAAMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 150 l~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
++|..||.... .......+...... ..
T Consensus 261 l~G~~Pf~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~ 288 (390)
T 2zmd_A 261 TYGKTPFQQIINQISKLHAIIDPNHE----------------------------------------------------IE 288 (390)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHCTTSC----------------------------------------------------CC
T ss_pred HHCCCcchhhhHHHHHHHHHhCcccc----------------------------------------------------CC
Confidence 99999996542 22222222221111 12
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+...+..+.+||.+||+.||++|||+.|+++||||+....+
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 234457889999999999999999999999999999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=270.80 Aligned_cols=228 Identities=23% Similarity=0.359 Sum_probs=158.3
Q ss_pred CceeeeeeeC------CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRG------PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++... ...++||||+ +++|.+++.. +.+++..++.++.|++.||.||| +.+|+
T Consensus 91 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--------------~~giv 154 (367)
T 2fst_X 91 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH--------------SADII 154 (367)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred CcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--------------HCCee
Confidence 4667777543 6789999999 6899999876 56999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+||+++.++.+||+|||+++..... .....++..|+|||++.+ ..++.+ +|+|||||++++|++|+
T Consensus 155 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGR 227 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECC---------------------CCCTTCCHHHHTTCCSCCTT-HHHHHHHHHHHHHHHSS
T ss_pred eCCCCHhhEEECCCCCEEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCch-hhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999754321 234578999999999987 456655 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+.......+....+.........+... ............ ....+ .......
T Consensus 228 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~-~~~~~~~~~~~~---------------~~~~~-------~~~~~~~ 284 (367)
T 2fst_X 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSE-SARNYIQSLTQM---------------PKMNF-------ANVFIGA 284 (367)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH-HHHHHHHTSCCC---------------CCCCH-------HHHTTTC
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH-HHHHHHhccCCC---------------CCCCH-------HHHCCCC
Confidence 999998887777777765554432111111000 000000000000 00000 1112456
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++.+.+||.+||.+||++|||+.++|+||||+....+....
T Consensus 285 ~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 325 (367)
T 2fst_X 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 325 (367)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred CHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC
Confidence 88999999999999999999999999999999887665433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=263.64 Aligned_cols=201 Identities=24% Similarity=0.402 Sum_probs=157.7
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 72 (304)
+++++++.. .+..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ 149 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--------------QHK 149 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--------------HTT
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------------HCC
Confidence 467888876 56899999999999999999874 46999999999999999999999 889
Q ss_pred eEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHH
Q psy1812 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITF 147 (304)
Q Consensus 73 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~ 147 (304)
++|+||+|+||+++.++.+||+|||++........ ......|+..|+|||.+. +..++.+ +|+|||||++|
T Consensus 150 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~ 225 (326)
T 2x7f_A 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAI 225 (326)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHH
T ss_pred ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHH
Confidence 99999999999999999999999999875433221 223456899999999986 4456666 99999999999
Q ss_pred HHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 148 IMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 148 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|++|..||.+.+.......+...... .
T Consensus 226 ~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------------~ 253 (326)
T 2x7f_A 226 EMAEGAPPLCDMHPMRALFLIPRNPAP----------------------------------------------------R 253 (326)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCC----------------------------------------------------C
T ss_pred HHHhCCCCCCCCcHHHHHHHhhcCccc----------------------------------------------------c
Confidence 999999999776654443333221110 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.....+++.+.+||.+||..||.+|||++++++||||+......
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence 11245788999999999999999999999999999999876533
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=260.17 Aligned_cols=198 Identities=31% Similarity=0.554 Sum_probs=165.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||+.+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~i~H~dl~p 149 (287)
T 2wei_A 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH--------------KHNIVHRDLKP 149 (287)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred cEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCh
Confidence 5789999999999999999999999999988888999999999999999999999 88999999999
Q ss_pred CcEEEecC---CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||+++.+ +.+||+|||++....... ......++..|+|||.+.+. ++.+ +|+||||+++++|++|..||.
T Consensus 150 ~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp GGEEESCSSTTCCEEECSTTGGGTBCCCS----SCSCHHHHHTTCCHHHHTTC-CCTH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred hhEEEecCCCcccEEEeccCcceeecCCC----ccccccCcccccChHHhcCC-CCCc-hhhHhHHHHHHHHHhCCCCCC
Confidence 99999764 469999999987544322 12234578899999998764 6655 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+..... ......+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~ 253 (287)
T 2wei_A 224 GKNEYDILKRVETGKYAFD--------------------------------------------------LPQWRTISDDA 253 (287)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------SGGGTTSCHHH
T ss_pred CCCHHHHHHHHHcCCCCCC--------------------------------------------------chhhhhcCHHH
Confidence 8877666665554433222 11124578899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||..||++|||+.++++||||+...
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=261.25 Aligned_cols=200 Identities=24% Similarity=0.397 Sum_probs=161.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+++++|.+++.. .+.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dlk 144 (302)
T 2j7t_A 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--------------SKRIIHRDLK 144 (302)
T ss_dssp CCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCS
T ss_pred eeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--------------cCCcccCCCC
Confidence 5789999999999999999999999999876 457999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.+||+|||++........ ......|+..|+|||.+. +..++.+ +|+||||+++|+|++|..
T Consensus 145 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp GGGEEECTTSCEEECCCHHHHHHHHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTH-HHHHHHHHHHHHHHHSSC
T ss_pred HHHEEECCCCCEEEEECCCCcccccccc---ccccccCChhhcCCeeeccccCCCCCCchh-hhHHHHHHHHHHHhcCCC
Confidence 9999999999999999998753221111 223456899999999983 4556655 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||...+.......+....... ...+..++
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 249 (302)
T 2j7t_A 221 PHHELNPMRVLLKIAKSDPPT---------------------------------------------------LLTPSKWS 249 (302)
T ss_dssp TTTTSCHHHHHHHHHHSCCCC---------------------------------------------------CSSGGGSC
T ss_pred CCccCCHHHHHHHHhccCCcc---------------------------------------------------cCCccccC
Confidence 998776655544443322110 11235578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
..+.+||.+||..||.+|||+.++++||||+....
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 89999999999999999999999999999998664
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=262.08 Aligned_cols=210 Identities=25% Similarity=0.431 Sum_probs=156.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR--------AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 72 (304)
+++++++..++..++||||+++++|.+++.. .+.+++..++.++.|++.||.||| +.+
T Consensus 76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ 141 (303)
T 2vwi_A 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--------------KNG 141 (303)
T ss_dssp CCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--------------HTT
T ss_pred eeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--------------hCC
Confidence 5789999999999999999999999999975 346999999999999999999999 889
Q ss_pred eEecCCCCCcEEEecCCCeEEEeccCcccccCccc--ccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHH
Q psy1812 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 73 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~l 149 (304)
++|+||+|+||+++.++.+||+|||++........ .........|+..|+|||.+.+ ..++.+ +|+||||+++|+|
T Consensus 142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l 220 (303)
T 2vwi_A 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIEL 220 (303)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTH-HHHHHHHHHHHHH
T ss_pred CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCch-hhHHHHHHHHHHH
Confidence 99999999999999999999999999875443211 1112234568999999999865 345555 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||...+................ . ........
T Consensus 221 ~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------------------~-~~~~~~~~ 256 (303)
T 2vwi_A 221 ATGAAPYHKYPPMKVLMLTLQNDPPSL-------------------------------------------E-TGVQDKEM 256 (303)
T ss_dssp HHSSCTTTTSCGGGHHHHHHTSSCCCT-------------------------------------------T-C-----CC
T ss_pred HhCCCCCccCchhhHHHHHhccCCCcc-------------------------------------------c-cccccchh
Confidence 999999977654333322221111000 0 00000122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 3567889999999999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=269.74 Aligned_cols=203 Identities=29% Similarity=0.495 Sum_probs=138.8
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++.. +...++||||++||+|.+++.+.+ .+++..++.++.|++.||.||| +.+++
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------------~~~iv 150 (336)
T 3fhr_A 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--------------SHNIA 150 (336)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred HHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCee
Confidence 467888876 556999999999999999998764 6999999999999999999999 88999
Q ss_pred ecCCCCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 75 HRDLKCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 75 H~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
|+||||+||+++. ++.+||+|||++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~ 224 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLC 224 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------------CHHHHH-HHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceecccc-----ccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHH
Confidence 9999999999976 445999999999754322 2234568999999999988777776 999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 152 AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 152 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
|..||.+.................. .........
T Consensus 225 g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~ 258 (336)
T 3fhr_A 225 GFPPFYSNTGQAISPGMKRRIRLGQ----------------------------------------------YGFPNPEWS 258 (336)
T ss_dssp SSCCC-------------------------------------------------------------------CCCTTTST
T ss_pred CCCCCCCccchhhhhhHHHhhhccc----------------------------------------------cccCchhhc
Confidence 9999976543322111110000000 000011224
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+++++.+||.+||..||.+|||++++++||||++...
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 57899999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=265.26 Aligned_cols=192 Identities=26% Similarity=0.471 Sum_probs=163.4
Q ss_pred CceeeeeeeCCeEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADN-GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++|||++.+ ++|.+++...+.+++..++.++.|++.||+||| +.+++|+|||
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dlk 176 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--------------NCGVLHRDIK 176 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcEeCCCC
Confidence 5789999999999999999986 899999999889999999999999999999999 8999999999
Q ss_pred CCcEEEe-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++ .++.+||+|||++...... ......|+..|+|||++.+..+...++|+|||||++|+|++|..||..
T Consensus 177 p~NIll~~~~~~~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 177 DENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred HHHEEEeCCCCCEEEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999999 7789999999998765432 223456899999999998776654448999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+. +.... ...+..+++++.
T Consensus 252 ~~~------~~~~~------------------------------------------------------~~~~~~~~~~~~ 271 (320)
T 3a99_A 252 DEE------IIRGQ------------------------------------------------------VFFRQRVSSECQ 271 (320)
T ss_dssp HHH------HHHCC------------------------------------------------------CCCSSCCCHHHH
T ss_pred hhh------hhccc------------------------------------------------------ccccccCCHHHH
Confidence 532 11111 112255788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+||.+||+.||++|||++++++||||+....+.
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence 999999999999999999999999999877644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=277.08 Aligned_cols=199 Identities=32% Similarity=0.572 Sum_probs=153.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.. +..++||||+++|+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 203 v~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~ivHrDlkp 267 (419)
T 3i6u_A 203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--------------ENGIIHRDLKP 267 (419)
T ss_dssp CCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred eeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCccccCCCh
Confidence 567888754 568999999999999999988889999999999999999999999 88999999999
Q ss_pred CcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++.++ .+||+|||++....... .....+|++.|+|||++.+ ..++.+ +|+|||||++|+|++|..
T Consensus 268 ~NIll~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 268 ENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYP 342 (419)
T ss_dssp GGEEESSSSSSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHH-HHHHHHHHHHHHHHHSSC
T ss_pred HhEEEecCCCcceEEEeecccceecCCCc----cccccCCCCCccCceeeecCCCCCCCch-hhhHhHHHHHHHHHHCCC
Confidence 999997554 49999999998654322 2345679999999999864 345555 999999999999999999
Q ss_pred CCCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 155 PFDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
||...... .....+..+..... ......+
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~ 372 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFI--------------------------------------------------PEVWAEV 372 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCC--------------------------------------------------HHHHTTS
T ss_pred CCCCCcchHHHHHHHhcCCCCCC--------------------------------------------------chhhccc
Confidence 99654321 22222222221111 1112457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 889999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=267.20 Aligned_cols=215 Identities=26% Similarity=0.458 Sum_probs=168.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-C
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDH------IKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-K 71 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~ 71 (304)
+++++++.+++..++||||+++|+|.++ +.. ...+++..++.++.|++.||.||| + .
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ 171 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--------------NEK 171 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH--------------HTS
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh--------------ccC
Confidence 5788999999999999999999999998 665 567999999999999999999999 7 9
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll 150 (304)
+++|+||+|+||+++.++.+||+|||++...... ......++..|+|||.+.+. .++..++|+|||||++++|+
T Consensus 172 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred CEeecCCChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999764332 23445689999999999877 45552499999999999999
Q ss_pred hCCCCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 NAAMPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+|..||..... .+....+.......+........ . .........
T Consensus 247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~--------------------------~---------~~~~~~~~~ 291 (348)
T 2pml_X 247 YNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLY--------------------------P---------LTNKKSTCS 291 (348)
T ss_dssp HSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTT--------------------------T---------TCC------
T ss_pred hCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhc--------------------------c---------ccccccccc
Confidence 99999987665 55566555544333310000000 0 000000112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 292 ~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp --CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred hhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 2567899999999999999999999999999999998664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.60 Aligned_cols=185 Identities=27% Similarity=0.371 Sum_probs=145.7
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGP---VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
..++|||||+||+|.+++.+... .++..++.++.|++.||.||| +.+++||||||+||+++.+
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dlkp~NIll~~~ 200 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--------------SKGLMHRDLKPSNIFFTMD 200 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCCGGGEEECTT
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH--------------hCCeeecCCCcccEEEeCC
Confidence 48999999999999999988653 566779999999999999999 8999999999999999999
Q ss_pred CCeEEEeccCcccccCccccc---------ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 89 FNVKIADFGFARYCVDKEGRR---------VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+.+||+|||++.......... .......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..|+...
T Consensus 201 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~~ 279 (332)
T 3qd2_B 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQMER 279 (332)
T ss_dssp CCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHHH
T ss_pred CCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhHH
Confidence 999999999998655432111 12234579999999999998888777 99999999999999987765221
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
......+..... .......++.+.+
T Consensus 280 --~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 280 --VRIITDVRNLKF-----------------------------------------------------PLLFTQKYPQEHM 304 (332)
T ss_dssp --HHHHHHHHTTCC-----------------------------------------------------CHHHHHHCHHHHH
T ss_pred --HHHHHHhhccCC-----------------------------------------------------CcccccCChhHHH
Confidence 112221111111 0111345678899
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
||.+||+.||++|||++|+++||||++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 999999999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.81 Aligned_cols=202 Identities=22% Similarity=0.371 Sum_probs=161.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||++|++|.+++.+.+.+++..++.++.|++.||.||| +.+++||||||
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~Dlkp 139 (294)
T 4eqm_A 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH--------------DMRIVHRDIKP 139 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred ceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCCH
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++......... ......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.+.+
T Consensus 140 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 140 QNILIDSNKTLKIFDFGIAKALSETSLT--QTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp GGEEECTTSCEEECCCSSSTTC---------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred HHEEECCCCCEEEEeCCCcccccccccc--ccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999765432211 2334568999999999998888777 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
......+......... .......+++.+.++
T Consensus 217 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 217 AVSIAIKHIQDSVPNV-------------------------------------------------TTDVRKDIPQSLSNV 247 (294)
T ss_dssp HHHHHHHHHSSCCCCH-------------------------------------------------HHHSCTTSCHHHHHH
T ss_pred hHHHHHHHhhccCCCc-------------------------------------------------chhcccCCCHHHHHH
Confidence 6555444333222111 012235678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|.+||+.||.+||+..+.+.+.|.+-..
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 9999999999999666666666655443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=279.97 Aligned_cols=180 Identities=13% Similarity=0.097 Sum_probs=145.9
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEE
Q psy1812 13 VFIFMRYADNGDLLDHIKRAGPVAE-------SNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILM 85 (304)
Q Consensus 13 ~~lv~e~~~~g~L~~~l~~~~~l~~-------~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~ 85 (304)
.++||||+ +|+|.+++...+.+++ ..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDikp~NIll 239 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--------------HYGLVHTYLRPVDIVL 239 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCGGGEEE
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH--------------hCCeecCCCCHHHEEE
Confidence 89999999 5799999988665665 888889999999999999 8899999999999999
Q ss_pred ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-----------CCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 86 TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-----------PYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 86 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----------~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+.++.+||+|||++..... ......| ..|+|||++.+. .++.+ +|+|||||++|+|++|..
T Consensus 240 ~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 240 DQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHHHHHHHHHHSSC
T ss_pred cCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHHHHHHHHHHCCC
Confidence 9999999999999974322 2334567 999999999877 67766 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+.......+ ......++
T Consensus 312 Pf~~~~~~~~~~~~----------------------------------------------------------~~~~~~~~ 333 (377)
T 3byv_A 312 PITKDAALGGSEWI----------------------------------------------------------FRSCKNIP 333 (377)
T ss_dssp CC------CCSGGG----------------------------------------------------------GSSCCCCC
T ss_pred CCcccccccchhhh----------------------------------------------------------hhhccCCC
Confidence 99655421111100 01114578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
+++.+||.+||+.||++|||+.++++||||+......+.
T Consensus 334 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 372 (377)
T 3byv_A 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372 (377)
T ss_dssp HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHHH
Confidence 999999999999999999999999999999987654443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=265.81 Aligned_cols=230 Identities=19% Similarity=0.309 Sum_probs=162.2
Q ss_pred Cceeeeee-----eCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQ-----RGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++. .....++||||+. |+|.+++...+ .+++..++.++.|++.||.||| +.+++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~iv 156 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH--------------EAGVV 156 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCcCE
Confidence 46777773 3457999999997 59999887654 6999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.+ ..++.+ +|+|||||++|+|++|.
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTH-HHHHHHHHHHHHHHHSS
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcH-hHHHhHHHHHHHHHhCC
Confidence 99999999999999999999999997433222 2334568899999999877 445555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+.......+................. ....+..... ...... .. .......+
T Consensus 232 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~------------~~-------~~~~~~~~ 289 (362)
T 3pg1_A 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS-PSARDYLRNS--LSNVPA------------RA-------WTAVVPTA 289 (362)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSC-HHHHHHTTTC--CCCCCC------------CC-------HHHHSTTS
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChHHhhhccc-hhhhHHHHhh--cccCCh------------hh-------HHhhCCCC
Confidence 99998887777776665544433111111000 0000000000 000000 00 01122456
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.+||.+||+.||.+|||+.++++||||+....+..
T Consensus 290 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 290 DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 889999999999999999999999999999998865443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=265.76 Aligned_cols=227 Identities=24% Similarity=0.361 Sum_probs=166.5
Q ss_pred CceeeeeeeCCeE------EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGPRV------FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++...+.. ++||||+. ++|.+++.. .+++..++.++.|++.||+||| +.+|+
T Consensus 104 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH--------------~~~iv 166 (371)
T 4exu_A 104 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIH--------------SAGVV 166 (371)
T ss_dssp CCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred hhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--------------HCCCc
Confidence 4678888776654 99999997 599888743 4999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.+ +|+|||||++++|++|.
T Consensus 167 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 167 HRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp CSCCCGGGEEECTTCCEEECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSS
T ss_pred CCCcCHHHeEECCCCCEEEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcH-HhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999754322 234568999999999987 456665 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+....+..............+..... .......... ....+ ...+..+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------------~~~~~-------~~~~~~~ 296 (371)
T 4exu_A 240 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA-KSYIQSLPQT---------------PRKDF-------TQLFPRA 296 (371)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH-HHHHHHSCCC---------------CCCCH-------HHHSTTS
T ss_pred CCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh-hhhhhccCCC---------------cchhH-------HHhcccc
Confidence 99998887777777665544433222111110000 0000000000 00000 1122457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++.+.+||.+||+.||++|||++|+|+||||+....+....
T Consensus 297 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 337 (371)
T 4exu_A 297 SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET 337 (371)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred ChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccc
Confidence 89999999999999999999999999999999877655443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=264.69 Aligned_cols=199 Identities=32% Similarity=0.574 Sum_probs=158.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..+. .++||||+++++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 78 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~dlkp 142 (322)
T 2ycf_A 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--------------ENGIIHRDLKP 142 (322)
T ss_dssp CCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred ceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCCCH
Confidence 57888887665 8999999999999999998889999999999999999999999 88999999999
Q ss_pred CcEEEecCCC---eEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++.++. +||+|||++....... ......|+..|+|||++. ...++.+ +|+|||||++|+|++|..
T Consensus 143 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 143 ENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYP 217 (322)
T ss_dssp GGEEESSSSSSCCEEECCCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTH-HHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCCeEEEccCccceeccccc----ccccccCCcCccCchhhccCCCCCCCch-hhHHHHHHHHHHHHhCCC
Confidence 9999987665 9999999997654322 123446899999999974 3456555 999999999999999999
Q ss_pred CCCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 155 PFDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
||...... .....+..+..... ...+..+
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~ 247 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYNFI--------------------------------------------------PEVWAEV 247 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCCCC--------------------------------------------------HHHHTTS
T ss_pred CCcccchHHHHHHHHHhCccccC--------------------------------------------------chhhhhc
Confidence 99754322 11122221111110 1112457
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+..+.+||.+||..||++|||+.++++||||+....
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 889999999999999999999999999999998664
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=259.11 Aligned_cols=196 Identities=27% Similarity=0.389 Sum_probs=149.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~ivH 75 (304)
+++++++.+++..++||||++| +|.+++.. ...+++..++.++.|++.||.||| +. +++|
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~~i~H 133 (290)
T 3fme_A 69 VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--------------SKLSVIH 133 (290)
T ss_dssp CCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------HHSCCCC
T ss_pred EEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--------------hcCCeec
Confidence 5789999999999999999974 98888765 457999999999999999999999 76 9999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc----cCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI----SGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
+||||+||+++.++.+||+|||++....... ......|++.|+|||.+ .+..++.+ +|+|||||++++|++
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~ 208 (290)
T 3fme_A 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAI 208 (290)
T ss_dssp CCCSGGGCEECTTCCEEBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHH-HHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEeecCCcccccccc----cccccCCCccccChhhcChhhcCcCCCcH-HHHHHHHHHHHHHHH
Confidence 9999999999999999999999997654332 22334689999999996 34455555 999999999999999
Q ss_pred CCCCCCCh-hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 AAMPFDDS-NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||... ............... ....
T Consensus 209 g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~ 236 (290)
T 3fme_A 209 LRFPYDSWGTPFQQLKQVVEEPSP----------------------------------------------------QLPA 236 (290)
T ss_dssp TSCSSCCCSCHHHHHHHHHHSCCC----------------------------------------------------CCCT
T ss_pred CCCCccccCchHHHHHHHhccCCC----------------------------------------------------Cccc
Confidence 99999753 222222222211110 1112
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 45788999999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=259.89 Aligned_cols=196 Identities=25% Similarity=0.440 Sum_probs=155.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP---VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--ivH 75 (304)
|++++++..++..++||||+++|+|.+++.+.+. +++..++.++.|++.||+||| +.+ ++|
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~~~ivH 162 (309)
T 3p86_A 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--------------NRNPPIVH 162 (309)
T ss_dssp CCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--------------TSSSCCCC
T ss_pred eeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------------cCCCCEEC
Confidence 5789999999999999999999999999987653 999999999999999999999 788 999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..|
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQP 238 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC--------------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCT
T ss_pred CCCChhhEEEeCCCcEEECCCCCCcccccccc---ccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999875433211 2344578999999999998888777 9999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+..+....+...... ...+..+++
T Consensus 239 f~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~ 266 (309)
T 3p86_A 239 WGNLNPAQVVAAVGFKCKR----------------------------------------------------LEIPRNLNP 266 (309)
T ss_dssp TTTSCHHHHHHHHHHSCCC----------------------------------------------------CCCCTTSCH
T ss_pred CCCCCHHHHHHHHHhcCCC----------------------------------------------------CCCCccCCH
Confidence 9887765555443221111 223466889
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhc--Cccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKA--HDWLRY 266 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~--~~wf~~ 266 (304)
++.+||.+||+.||.+|||+.++++ .++++.
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999988 345543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=257.13 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=158.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~d 147 (295)
T 2clq_A 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--------------DNQIVHRD 147 (295)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--------------HTTEECCC
T ss_pred eeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--------------hCCEEccC
Confidence 578999999999999999999999999998752 4679999999999999999999 88999999
Q ss_pred CCCCcEEEec-CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC--CCCCCchHHHHHHHHHHHHhCCC
Q psy1812 78 LKCENILMTK-RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP--YNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 78 l~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+|+||+++. ++.+||+|||++........ ......|+..|+|||.+.+.. ++.+ +|+||||+++|+|++|..
T Consensus 148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~il~~l~~g~~ 223 (295)
T 2clq_A 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKP 223 (295)
T ss_dssp CSGGGEEEETTTCCEEECCTTTCEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHH-HHHHHHHHHHHHHHHTSC
T ss_pred CChhhEEEECCCCCEEEeecccccccCCCCC---cccccCCCccccChhhhcCCCCCCCcH-HHHHHHHHHHHHHHHCCC
Confidence 9999999998 89999999999875543221 233456899999999987643 5555 999999999999999999
Q ss_pred CCCChhHHHH-HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 155 PFDDSNLKQL-FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 155 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
||...+.... ...... . ......+..+
T Consensus 224 pf~~~~~~~~~~~~~~~--~--------------------------------------------------~~~~~~~~~~ 251 (295)
T 2clq_A 224 PFYELGEPQAAMFKVGM--F--------------------------------------------------KVHPEIPESM 251 (295)
T ss_dssp TTGGGSSHHHHHHHHHH--H--------------------------------------------------CCCCCCCTTS
T ss_pred CccCCCchhHHHHhhcc--c--------------------------------------------------cccccccccC
Confidence 9965432211 111000 0 0012334567
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
++++.+||.+||+.||++|||++++++||||+.....
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 8999999999999999999999999999999987753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=258.95 Aligned_cols=224 Identities=23% Similarity=0.364 Sum_probs=158.3
Q ss_pred eeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe-
Q psy1812 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT- 86 (304)
Q Consensus 8 ~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~- 86 (304)
...+..++||||+. |+|.+++.+ +.+++..++.++.|++.||+||| +.+++|+||||+||+++
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIH--------------SANVLHRDLKPANLFINT 155 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCSGGGEEEET
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHH--------------hCCEecCCCCHHHEEEcC
Confidence 34578999999997 599999965 56999999999999999999999 88999999999999998
Q ss_pred cCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHH
Q psy1812 87 KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~ 165 (304)
.++.+||+|||++.................++..|+|||.+.+ ..++.+ +|+|||||++|+|++|..||.+.+..+..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCch-hhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5668999999999765432222222334457889999999876 445555 99999999999999999999988877766
Q ss_pred HHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhc
Q psy1812 166 KEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQIL 245 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 245 (304)
..+..............+...... ..... ..............++.++.+||.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPV--YIRND----------------------MTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCH--HHHHH----------------------TTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcc--ccccc----------------------ccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 666544332221110000000000 00000 000000001122467899999999999
Q ss_pred CCCCCccccHHHHhcCccccccccccc
Q psy1812 246 EPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 246 ~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+.||.+|||++++++||||+....+..
T Consensus 291 ~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 291 TFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp CSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred CCCccccCCHHHHhCCcccccccCccC
Confidence 999999999999999999997766543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=268.61 Aligned_cols=225 Identities=20% Similarity=0.261 Sum_probs=163.6
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
|+++++|.. ...+++||||+.+ +|.+.+.. ...+++..++.++.|++.||.||| +
T Consensus 110 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------------~ 174 (420)
T 1j1b_A 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--------------S 174 (420)
T ss_dssp CCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------T
T ss_pred cceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------H
Confidence 567777743 2347899999975 77776653 457999999999999999999999 8
Q ss_pred CceEecCCCCCcEEEecC-CCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFI 148 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ 148 (304)
.+|+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++.+. .++.+ +|||||||++|+
T Consensus 175 ~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlG~il~e 249 (420)
T 1j1b_A 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 249 (420)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHHHHHHHH
T ss_pred CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCch-hhhHHHHHHHHH
Confidence 999999999999999965 568999999997654322 22345789999999999775 46655 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|+.||.+.+..+.+.++............. ............... ...+. ..
T Consensus 250 ll~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~------------~~~~~~~~~~~p~~~-------~~~~~------~~ 304 (420)
T 1j1b_A 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR------------EMNPNYTEFKFPQIK-------AHPWT------KV 304 (420)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH------------HHCSCCCCCCCCCCC-------CCCHH------HH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH------------hhChhhhhhccCccC-------CCCHH------Hh
Confidence 999999999887777776666544332210000 000000000000000 00000 11
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
.+..+++++.+||.+||..||.+|||+.|+++||||+.....
T Consensus 305 ~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 234578999999999999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=263.57 Aligned_cols=194 Identities=26% Similarity=0.392 Sum_probs=162.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+. |+|.+++.. .+.+++..++.++.|++.||.||| +.+++|||||
T Consensus 117 v~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dlk 181 (348)
T 1u5q_A 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--------------SHNMIHRDVK 181 (348)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCS
T ss_pred eeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCCC
Confidence 578999999999999999997 589888864 457999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.+||+|||++..... .....|++.|+|||++. ...++.+ +|+|||||++++|++|..||
T Consensus 182 p~NIll~~~~~~kL~DfG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~ 253 (348)
T 1u5q_A 182 AGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPL 253 (348)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTT
T ss_pred HHHEEECCCCCEEEeeccCceecCC-------CCcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999875432 23457899999999985 4456666 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+.......+...... ...+..+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~ 281 (348)
T 1u5q_A 254 FNMNAMSALYHIAQNESP----------------------------------------------------ALQSGHWSEY 281 (348)
T ss_dssp TTSCHHHHHHHHHHSCCC----------------------------------------------------CCCCTTSCHH
T ss_pred CCCChHHHHHHHHhcCCC----------------------------------------------------CCCCCCCCHH
Confidence 877655544443332111 1112456889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+||.+||+.||++|||++++++||||.....
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=261.31 Aligned_cols=232 Identities=20% Similarity=0.277 Sum_probs=163.8
Q ss_pred CceeeeeeeC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRG-----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++..+ ...++||||+. |+|.+++.. +.+++..++.++.|++.||.||| +.+++|
T Consensus 72 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--------------~~~ivH 135 (353)
T 2b9h_A 72 ITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH--------------GSNVIH 135 (353)
T ss_dssp CCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred CCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH--------------HCCeec
Confidence 4677776553 78999999997 599999976 46999999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCccccc-------ccccCccCCccccccccccC-CCCCCCCchHHHHHHHHH
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRR-------VLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITF 147 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~ 147 (304)
+||||+||+++.++.+||+|||++.......... .......|+..|+|||++.+ ..++.+ +|+|||||++|
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~Di~slG~il~ 214 (353)
T 2b9h_A 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA-MDVWSCGCILA 214 (353)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHH-HHHHHHHHHHH
T ss_pred CCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccch-hhHHHHHHHHH
Confidence 9999999999999999999999997654322111 01223568999999998765 445555 99999999999
Q ss_pred HHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 148 IMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 148 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|++|..||.+.+.......+................................ ...+ .
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-------~ 272 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP---------------AAPL-------E 272 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC---------------CCCH-------H
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC---------------Ccch-------h
Confidence 99999999988876666555443322221000000000000000000000000 0000 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.....+++++.+||.+||..||++|||++++++||||+....+.
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 12246789999999999999999999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=258.53 Aligned_cols=198 Identities=24% Similarity=0.421 Sum_probs=162.1
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN-- 72 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~-- 72 (304)
+++++++. .++..++||||+++++|.+++.... .+++..++.++.|++.||+||| +.+
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~~~ 133 (279)
T 2w5a_A 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--------------RRSDG 133 (279)
T ss_dssp CCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------HHC--
T ss_pred CeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--------------cccCC
Confidence 57888774 4678999999999999999997643 4999999999999999999999 666
Q ss_pred ---eEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 73 ---IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 73 ---ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.. +|+||||+++|+|
T Consensus 134 ~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l 209 (279)
T 2w5a_A 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYEL 209 (279)
T ss_dssp ----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHH
T ss_pred CCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc---cccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHH
Confidence 99999999999999999999999999875443211 1223468899999999988888776 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||...+..+....+..+.. ...
T Consensus 210 ~~g~~p~~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~ 236 (279)
T 2w5a_A 210 CALMPPFTAFSQKELAGKIREGKF-----------------------------------------------------RRI 236 (279)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCC-----------------------------------------------------CCC
T ss_pred HHCCCCCcccCHHHHHHHHhhccc-----------------------------------------------------ccC
Confidence 999999988776555555443322 122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+..++.++.++|.+||+.||.+|||++++++|+|+.....
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 3457899999999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.01 Aligned_cols=192 Identities=21% Similarity=0.376 Sum_probs=159.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++..++||||++||+|.+++... +.+++..++.++.|++.||.||| +.+|+|||||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dlk 178 (325)
T 3kul_A 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS--------------DLGYVHRDLA 178 (325)
T ss_dssp CCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCS
T ss_pred CcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeCCCCC
Confidence 57899999999999999999999999999765 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 179 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999865543322222233446778999999988888777 999999999999999 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
....+....+..+.. ...+..+++.+.
T Consensus 258 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 284 (325)
T 3kul_A 258 MTNRDVISSVEEGYR-----------------------------------------------------LPAPMGCPHALH 284 (325)
T ss_dssp SCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCcCHHHH
Confidence 877666665544321 122356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||..||++|||++++++
T Consensus 285 ~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=265.69 Aligned_cols=192 Identities=20% Similarity=0.364 Sum_probs=160.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++++++..++.+++||||+.+|+|.+++...+ .+++..++.++.|++.||+|||
T Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------- 220 (370)
T 2psq_A 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--------- 220 (370)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---------
T ss_pred eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---------
Confidence 578999999999999999999999999998753 4789999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+|+||||||+||+++.++.+||+|||++.......... ......+++.|+|||++.+..++.+ +|+|||||
T Consensus 221 -----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~ 293 (370)
T 2psq_A 221 -----SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGV 293 (370)
T ss_dssp -----HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHH
T ss_pred -----hCCeeccccchhhEEECCCCCEEEccccCCcccCccccee-cccCCCcccceECHhHhcCCCCCcH-HHHHHHHH
Confidence 8999999999999999999999999999997554332211 2233456789999999988888877 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||.+.+..+.+..+..+..
T Consensus 294 il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 323 (370)
T 2psq_A 294 LMWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------------- 323 (370)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------------------------------------------
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------------------------------------------------
Confidence 9999999 9999987665554444333211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 324 ---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 324 ---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12235678899999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=251.44 Aligned_cols=191 Identities=21% Similarity=0.376 Sum_probs=161.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+++++|.+++...+ .+++..++.++.|++.||.||| +.+++|+|||
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dik 131 (268)
T 3sxs_A 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE--------------SHQFIHRDLA 131 (268)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTEEESSCS
T ss_pred eeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCcC
Confidence 578999999999999999999999999998764 5999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++++|++ |..||..
T Consensus 132 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYV--SSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp GGGEEECTTCCEEECCTTCEEECCTTCEE--ECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEECCCCCEEEccCccceecchhhhh--cccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999765433221 2233446778999999988778777 999999999999999 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+...... ..+..+++.+.
T Consensus 209 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~l~ 235 (268)
T 3sxs_A 209 YTNSEVVLKVSQGHRL-----------------------------------------------------YRPHLASDTIY 235 (268)
T ss_dssp SCHHHHHHHHHTTCCC-----------------------------------------------------CCCTTSCHHHH
T ss_pred cChHHHHHHHHcCCCC-----------------------------------------------------CCCCcChHHHH
Confidence 7766665554433221 12345688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.||.+|||+++++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=258.09 Aligned_cols=190 Identities=26% Similarity=0.485 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEec-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRY-ADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++...+..++|||| +.+++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlk 166 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH--------------SRGVVHRDIK 166 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HHTEECCCCS
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecCCC
Confidence 5789999999999999999 789999999999888999999999999999999999 8899999999
Q ss_pred CCcEEEe-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++ .++.+||+|||++....... .....++..|+|||.+.+..+...++|+||||+++|+|++|..||..
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999999 88899999999987654322 23456899999999987766655349999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
... +.... ...+..++..+.
T Consensus 242 ~~~------~~~~~------------------------------------------------------~~~~~~~~~~~~ 261 (312)
T 2iwi_A 242 DQE------ILEAE------------------------------------------------------LHFPAHVSPDCC 261 (312)
T ss_dssp HHH------HHHTC------------------------------------------------------CCCCTTSCHHHH
T ss_pred hHH------Hhhhc------------------------------------------------------cCCcccCCHHHH
Confidence 431 11111 122355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+||.+||+.||++|||++++++||||+....
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 9999999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.36 Aligned_cols=192 Identities=32% Similarity=0.485 Sum_probs=145.4
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKR 88 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~ 88 (304)
.+..++||||+++|+|.+++...+ .+++..++.++.|++.||+||| +.+++|+||+|+||+++.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH--------------SQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCGGGEEECTT
T ss_pred CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH--------------hCCeecccCCHHhEEEcCC
Confidence 568999999999999999998654 5789999999999999999999 8899999999999999999
Q ss_pred CCeEEEeccCcccccCccc-----------ccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 89 FNVKIADFGFARYCVDKEG-----------RRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 89 ~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+.+||+|||++........ .........|+..|+|||.+.+. .++.+ +|+|||||++|+|++ ||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK-IDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTH-HHHHHHHHHHHHHHS---CC
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch-hhHHHHHHHHHHHHh---cc
Confidence 9999999999875432210 01122345688999999999865 45555 999999999999998 66
Q ss_pred CChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
.... .......+.......+ ...+...+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~ 258 (303)
T 1zy4_A 229 STGMERVNILKKLRSVSIEFP--------------------------------------------------PDFDDNKMK 258 (303)
T ss_dssp SSHHHHHHHHHHHHSTTCCCC--------------------------------------------------TTCCTTTSH
T ss_pred CCchhHHHHHHhccccccccC--------------------------------------------------ccccccchH
Confidence 5432 2233333322221111 122345678
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+.+||.+||+.||++|||++++++||||+....
T Consensus 259 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 259 VEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 8999999999999999999999999999987654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=255.96 Aligned_cols=203 Identities=22% Similarity=0.399 Sum_probs=153.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++|||+ .+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 91 v~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~dlkp 155 (313)
T 3cek_A 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH--------------QHGIVHSDLKP 155 (313)
T ss_dssp CCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred EEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCceecCCCc
Confidence 5789999999999999995 57899999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-----------CCCCCCCchHHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-----------NPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~sDvwslG~ll~~l 149 (304)
+||+++. +.+||+|||++......... .......|+..|+|||.+.+ ..++.+ +|+||||+++|+|
T Consensus 156 ~NIl~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~Di~slG~il~el 232 (313)
T 3cek_A 156 ANFLIVD-GMLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYM 232 (313)
T ss_dssp GGEEEET-TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHH-HHHHHHHHHHHHH
T ss_pred ccEEEEC-CeEEEeeccccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCch-HHHHHHHHHHHHH
Confidence 9999965 89999999999765432211 12234568999999999865 245555 9999999999999
Q ss_pred HhCCCCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 150 LNAAMPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 150 l~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
++|..||..... ......+...... ..
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~ 260 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLHAIIDPNHE----------------------------------------------------IE 260 (313)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSC----------------------------------------------------CC
T ss_pred HhCCCchhhHHHHHHHHHHHHhcccc----------------------------------------------------cC
Confidence 999999965422 2222222111100 12
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
.+...+..+.+||.+||+.||++|||++++++||||+....+.++
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~ 305 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC------
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhh
Confidence 234567899999999999999999999999999999987765543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=259.24 Aligned_cols=226 Identities=24% Similarity=0.356 Sum_probs=164.6
Q ss_pred CceeeeeeeCCe------EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGPR------VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++..... +++||||+. ++|.+++.. .+++..++.++.|++.||.||| +.+++
T Consensus 86 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH--------------~~~iv 148 (353)
T 3coi_A 86 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIH--------------SAGVV 148 (353)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred ccHhheEecccccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--------------HCCcc
Confidence 467788776543 599999997 599888753 5999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.+ +|+|||||++++|++|.
T Consensus 149 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~-~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp CSSCCGGGEEECTTCCEEECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEeECCCCcEEEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCch-hhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998754321 234568999999999877 455555 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||.+.+..+....+.......+......+.... ........... .. .........+
T Consensus 222 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------------~~-------~~~~~~~~~~ 278 (353)
T 3coi_A 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA-AKSYIQSLPQT---------------PR-------KDFTQLFPRA 278 (353)
T ss_dssp CSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH-HHHHHHTSCBC---------------SS-------CCTTTTCTTS
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH-HHHHHHhCcCC---------------CC-------ccHHHhcCCc
Confidence 9999888777766666544433322111111000 00000000000 00 0001223467
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRK 273 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~ 273 (304)
++++.+||.+||+.||++|||++++++||||+....+...
T Consensus 279 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 279 SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 8999999999999999999999999999999987765543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=251.03 Aligned_cols=191 Identities=20% Similarity=0.394 Sum_probs=161.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+++++|.+++... +.+++..++.++.|++.||.||| +.+++|+|||
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~dik 133 (269)
T 4hcu_A 68 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--------------EACVIHRDLA 133 (269)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH--------------hCCeecCCcc
Confidence 57899999999999999999999999999764 46899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++++|++ |..||..
T Consensus 134 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 134 ARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp GGGEEECGGGCEEECCTTGGGGBCCHHHH--STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEEcCCCCEEeccccccccccccccc--cccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999755432211 2234456788999999988888777 999999999999999 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..... ...+..+++.+.
T Consensus 211 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 237 (269)
T 4hcu_A 211 RSNSEVVEDISTGFR-----------------------------------------------------LYKPRLASTHVY 237 (269)
T ss_dssp CCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTSCHHHH
T ss_pred CCHHHHHHHHhcCcc-----------------------------------------------------CCCCCcCCHHHH
Confidence 877666665544322 122345688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.||.+|||+++++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=252.53 Aligned_cols=191 Identities=23% Similarity=0.387 Sum_probs=161.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+.+++|.+++.. ...+++..++.++.|++.||.||| +.+++|+|||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dik 147 (283)
T 3gen_A 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--------------SKQFLHRDLA 147 (283)
T ss_dssp CCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSSCS
T ss_pred eeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------HCCccCCCCc
Confidence 5789999999999999999999999999987 457999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 148 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp GGGEEECTTSCEEECSTTGGGGBCCHHHH--STTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEEcCCCCEEEccccccccccccccc--cccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999765433211 2233446788999999988778776 999999999999998 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+...... ..+..+++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~l~ 251 (283)
T 3gen_A 225 FTNSETAEHIAQGLRL-----------------------------------------------------YRPHLASEKVY 251 (283)
T ss_dssp SCHHHHHHHHHTTCCC-----------------------------------------------------CCCTTCCHHHH
T ss_pred cChhHHHHHHhcccCC-----------------------------------------------------CCCCcCCHHHH
Confidence 7766666655543221 12245688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+||.+||+.||.+|||+++++++
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=256.36 Aligned_cols=214 Identities=21% Similarity=0.331 Sum_probs=157.3
Q ss_pred CceeeeeeeCC--eEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGP--RVFIFMRYADNGDLLDHIKRAGP---VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++.... ..++||||+++|+|.+++..... +++..++.++.|++.||+||| +.+|+|
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivH 135 (319)
T 4euu_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--------------ENGIVH 135 (319)
T ss_dssp CCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred ceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEec
Confidence 57888887654 88999999999999999987543 999999999999999999999 889999
Q ss_pred cCCCCCcEEE----ecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc--------CCCCCCCCchHHHHH
Q psy1812 76 RDLKCENILM----TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--------GNPYNPKLADIWSLG 143 (304)
Q Consensus 76 ~dl~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~sDvwslG 143 (304)
+||||+||++ +.++.+||+|||++....... ......|+..|+|||++. +..++.+ +|+||||
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG 210 (319)
T 4euu_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIG 210 (319)
T ss_dssp SCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHH
T ss_pred CCCCHHHEEEeccCCCCceEEEccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHH
Confidence 9999999999 677779999999997654332 223456899999999986 4556666 9999999
Q ss_pred HHHHHHHhCCCCCCCh----hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 144 VITFIMLNAAMPFDDS----NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 144 ~ll~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|++|+|++|..||... ...+...++..+...... .. ........+. +
T Consensus 211 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~---~~----------------~~~~~~~~~~----------~ 261 (319)
T 4euu_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI---SG----------------VQKAENGPID----------W 261 (319)
T ss_dssp HHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC---EE----------------EECSTTCCEE----------E
T ss_pred HHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc---hh----------------hhcccCCccc----------c
Confidence 9999999999999632 223333333332211100 00 0000000000 0
Q ss_pred hhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCc
Q psy1812 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
.............++..+.+||.+||+.||++|||++|+++||
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 0001111233456788999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=271.67 Aligned_cols=194 Identities=14% Similarity=0.102 Sum_probs=147.0
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcE
Q psy1812 11 PRVFIFMRYADNGDLLDHIKRAG-PVAESNA------RTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~------~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ni 83 (304)
..+++||||+. |+|.+++...+ .+.+..+ ..++.|++.||+||| +.+|+||||||+||
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH--------------~~~ivHrDikp~NI 225 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--------------SKGLVHGHFTPDNL 225 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH--------------HTTEEETTCSGGGE
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH--------------HCCCccCcCCHHHE
Confidence 34899999998 79999998743 4555555 677899999999999 89999999999999
Q ss_pred EEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhCCCCCCChhH
Q psy1812 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAMPFDDSNL 161 (304)
Q Consensus 84 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~ 161 (304)
+++.++.+||+|||++....... ....+++.|+|||++.+ ..++.+ +|+|||||++|+|++|..||.+...
T Consensus 226 ll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 226 FIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp EECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred EECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 99999999999999997553221 13346699999999987 567766 9999999999999999999976532
Q ss_pred HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHH
Q psy1812 162 KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 241 (304)
... ...... ... .... ..........+++.+.+||
T Consensus 299 ~~~------~~~~~~--------------------------~~~-----~~~~--------~~~~~~~~~~~~~~~~~li 333 (371)
T 3q60_A 299 GIK------GSWKRP--------------------------SLR-----VPGT--------DSLAFGSCTPLPDFVKTLI 333 (371)
T ss_dssp TCT------TCCCBC--------------------------CTT-----SCCC--------CSCCCTTSSCCCHHHHHHH
T ss_pred ccc------cchhhh--------------------------hhh-----hccc--------cccchhhccCCCHHHHHHH
Confidence 100 000000 000 0000 0000111246789999999
Q ss_pred HHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 242 GQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 242 ~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+||+.||++|||+.++++||||+......
T Consensus 334 ~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 334 GRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred HHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 999999999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.28 Aligned_cols=192 Identities=21% Similarity=0.367 Sum_probs=162.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++++++..++..++||||+++|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------- 208 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--------- 208 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---------
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---------
Confidence 678999999999999999999999999998754 4899999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+|+||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.+ +|||||||
T Consensus 209 -----~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~ 281 (382)
T 3tt0_A 209 -----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGV 281 (382)
T ss_dssp -----HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTC-CCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHH
T ss_pred -----hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccc-cccCCCCCcceeCHHHhcCCCCCch-hHHHHHHH
Confidence 8899999999999999999999999999997654332211 2233457788999999998888877 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++++|++ |..||.+.+..+....+..+..
T Consensus 282 il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 311 (382)
T 3tt0_A 282 LLWEIFTLGGSPYPGVPVEELFKLLKEGHR-------------------------------------------------- 311 (382)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999999 9999988776666555443321
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||+++++++
T Consensus 312 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 312 ---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12235678999999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=257.90 Aligned_cols=200 Identities=21% Similarity=0.336 Sum_probs=149.2
Q ss_pred CceeeeeeeCCeE------EEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCC
Q psy1812 1 MQVHSILQRGPRV------FIFMRYADNGDLLDHIKRAG------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68 (304)
Q Consensus 1 v~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~ 68 (304)
+++++++...... ++||||+.+|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH------------- 154 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS------------- 154 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH-------------
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH-------------
Confidence 5678888776554 99999999999999997643 5999999999999999999999
Q ss_pred CCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 69 ~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+.+++|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.+ +|+|||||++|+
T Consensus 155 -~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e 231 (323)
T 3qup_A 155 -SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWE 231 (323)
T ss_dssp -HTTCCCSCCSGGGEEECTTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHH
T ss_pred -cCCcccCCCCcceEEEcCCCCEEEeecccccccccccccc-ccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHH
Confidence 8899999999999999999999999999997654332211 1223346788999999988888777 999999999999
Q ss_pred HHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|++ |..||.+.+..+....+..... .
T Consensus 232 ll~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~ 258 (323)
T 3qup_A 232 IMTRGQTPYAGIENAEIYNYLIGGNR-----------------------------------------------------L 258 (323)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTCC-----------------------------------------------------C
T ss_pred HHhCCCCCccccChHHHHHHHhcCCC-----------------------------------------------------C
Confidence 999 9999987766555544433221 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCcccc-------HHHHhcCcccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIR-------LDAIKAHDWLRYKSM 269 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t-------~~ell~~~wf~~~~~ 269 (304)
..+..+++++.+||.+||+.||++||| ++++++|+|+.....
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 223567889999999999999999999 788899999988653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=249.03 Aligned_cols=195 Identities=17% Similarity=0.252 Sum_probs=156.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+ +++|.+++...+ .+++..++.++.|++.||+||| +.+++|||||
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~Dlk 133 (298)
T 1csn_A 69 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--------------EKSLVYRDIK 133 (298)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCC
T ss_pred CeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCCCC
Confidence 46889999999999999999 899999998754 5999999999999999999999 8999999999
Q ss_pred CCcEEEecCCC-----eEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTKRFN-----VKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++.++. +||+|||++.......... .......|+..|+|||.+.+..++.+ +|+|||||++|+|+
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~ 212 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFL 212 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHH
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHH
Confidence 99999988776 9999999998655432211 12345679999999999988888777 99999999999999
Q ss_pred hCCCCCCChh---HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 151 NAAMPFDDSN---LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 151 ~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|..||.+.+ .......+.......+ ..
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~ 243 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQSTP-------------------------------------------------LR 243 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHSC-------------------------------------------------HH
T ss_pred cCCCCcchhhccccHHHHHHHHhhccCcc-------------------------------------------------HH
Confidence 9999997632 2233333222211111 01
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.....+++++.+|+.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 112457899999999999999999999999977
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=255.31 Aligned_cols=192 Identities=21% Similarity=0.364 Sum_probs=159.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHhhh
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP------------------------VAESNARTWFSQMLAGLEYLHR 56 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------l~~~~~~~i~~~l~~~l~~LH~ 56 (304)
|++++++..++..++||||+++|+|.+++...+. +++..++.++.|++.||.|||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH- 167 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA- 167 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH-
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH-
Confidence 5789999999999999999999999999987543 899999999999999999999
Q ss_pred cccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCC
Q psy1812 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKL 136 (304)
Q Consensus 57 ~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 136 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......+++.|+|||.+.+..++.+
T Consensus 168 -------------~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~- 232 (314)
T 2ivs_A 168 -------------EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFDHIYTTQ- 232 (314)
T ss_dssp -------------HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHHCEECHH-
T ss_pred -------------HCCCcccccchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcCCCcCch-
Confidence 889999999999999999999999999999765433221 12234457788999999988777777
Q ss_pred chHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 137 ADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 137 sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|+|||||++|+|++ |..||.+.+.......+.....
T Consensus 233 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------ 270 (314)
T 2ivs_A 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR------------------------------------------ 270 (314)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------------------------------
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc------------------------------------------
Confidence 999999999999999 9999977665444443332211
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 271 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 -----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12235678999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=265.24 Aligned_cols=198 Identities=19% Similarity=0.255 Sum_probs=164.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
|++++++..+...++||||++||+|.+++...+ .+++..++.++.|++.||+||| +.+|
T Consensus 137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~i 202 (367)
T 3l9p_A 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--------------ENHF 202 (367)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTC
T ss_pred CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--------------hCCe
Confidence 578999999999999999999999999998753 4899999999999999999999 8999
Q ss_pred EecCCCCCcEEEecCC---CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKRF---NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 74 vH~dl~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
+||||||+||+++.++ .+||+|||++......... .......+++.|+|||++.+..++.+ +|+|||||++|+|+
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell 280 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIF 280 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHH
T ss_pred eCCCCChhhEEEecCCCCceEEECCCcccccccccccc-ccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHH
Confidence 9999999999999555 4999999999754322211 12334567889999999988888877 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||.+.+..+....+..+.. ...
T Consensus 281 t~g~~pf~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~ 307 (367)
T 3l9p_A 281 SLGYMPYPSKSNQEVLEFVTSGGR-----------------------------------------------------MDP 307 (367)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCC-----------------------------------------------------CCC
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------CCC
Confidence 8 9999988877666665554322 122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+..+++.+.+||.+||+.||.+|||+.+++++.|+-..
T Consensus 308 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 35678899999999999999999999999999766543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=250.91 Aligned_cols=191 Identities=20% Similarity=0.324 Sum_probs=158.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++ ..+..++||||+.+++|.+++...+.+++..++.++.|++.||.||| +.+++|+||||
T Consensus 81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~i~H~dikp 145 (291)
T 1xbb_A 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE--------------ESNFVHRDLAA 145 (291)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH--------------hCCeEcCCCCc
Confidence 5788888 56789999999999999999999888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.+.
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 146 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999765443322112233446788999999988777766 999999999999999 99999887
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+..+.. ...+..+++.+.+
T Consensus 225 ~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 225 KGSEVTAMLEKGER-----------------------------------------------------MGCPAGCPREMYD 251 (291)
T ss_dssp CHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHHH
T ss_pred CHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHHH
Confidence 66555544433211 1223567899999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|.+||+.||++|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=265.98 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=150.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.++...++|||||. |+|.+++.... .+.+..++.++.|++.||.||| +.+|+|||||
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDlK 145 (432)
T 3p23_A 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--------------SLNIVHRDLK 145 (432)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH--------------HTTCCCCCCS
T ss_pred CeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH--------------HCcCEeCCCC
Confidence 688999999999999999996 59999998764 4666678899999999999999 8899999999
Q ss_pred CCcEEEec---C--CCeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHh
Q psy1812 80 CENILMTK---R--FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 80 ~~nil~~~---~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~ 151 (304)
|+||+++. + ..+||+|||++.................||+.|+|||++.+ ..++.+ +|||||||++|+|++
T Consensus 146 p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~-~DiwSlG~il~ellt 224 (432)
T 3p23_A 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFSAGCVFYYVIS 224 (432)
T ss_dssp TTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTH-HHHHHHHHHHHHHHT
T ss_pred HHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcH-HHHHHHHHHHHHHHc
Confidence 99999953 2 35789999999765433222123345679999999999974 344445 999999999999999
Q ss_pred -CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 152 -AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 152 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
|..||................... ....
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~ 253 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDC---------------------------------------------------LHPE 253 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTT---------------------------------------------------SCTT
T ss_pred CCCCCcchhhHHHHHHHhccCCccc---------------------------------------------------cCcc
Confidence 899996554333222111110000 0111
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
...+..+.+||.+||+.||.+|||++++++||||....
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 33466789999999999999999999999999998644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.31 Aligned_cols=191 Identities=20% Similarity=0.343 Sum_probs=159.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhh
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA------------------------GPVAESNARTWFSQMLAGLEYLHR 56 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~LH~ 56 (304)
+++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||.|||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH- 191 (343)
T 1luf_A 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS- 191 (343)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred EEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 57899999999999999999999999999874 46899999999999999999999
Q ss_pred cccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCC
Q psy1812 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKL 136 (304)
Q Consensus 57 ~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 136 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+
T Consensus 192 -------------~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~- 256 (343)
T 1luf_A 192 -------------ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTE- 256 (343)
T ss_dssp -------------HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHH-
T ss_pred -------------hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhccCCcCcc-
Confidence 889999999999999999999999999999755432211 12234467889999999988888776
Q ss_pred chHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 137 ADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 137 sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|+||||+++|+|++ |..||.+.+..+....+..+..
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------ 294 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI------------------------------------------ 294 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------------------------------------
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc------------------------------------------
Confidence 999999999999999 9999988776665555443322
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.+||.+||+.||++|||+.++++
T Consensus 295 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 295 -----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1223567889999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=255.02 Aligned_cols=189 Identities=21% Similarity=0.362 Sum_probs=158.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++.+++..++||||+++|+|.+++...+ .+++..++.++.|++.||.|||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------- 159 (327)
T 1fvr_A 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--------- 159 (327)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---------
T ss_pred hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---------
Confidence 578999999999999999999999999998754 6999999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+|||||
T Consensus 160 -----~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 229 (327)
T 1fvr_A 160 -----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGV 229 (327)
T ss_dssp -----HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHH-HHHHHHHH
T ss_pred -----hCCccCCCCccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhccccCCch-hcchHHHH
Confidence 8999999999999999999999999999986322211 1233456788999999988777776 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||.+.+..+....+..+..
T Consensus 230 il~ellt~g~~pf~~~~~~~~~~~~~~~~~-------------------------------------------------- 259 (327)
T 1fvr_A 230 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------- 259 (327)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--------------------------------------------------
T ss_pred HHHHHHcCCCCCCCCCcHHHHHHHhhcCCC--------------------------------------------------
Confidence 9999998 9999988776665555443211
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++.+.+||.+||+.||.+|||+++++++
T Consensus 260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12234578899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=257.14 Aligned_cols=194 Identities=21% Similarity=0.340 Sum_probs=158.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----------------------PVAESNARTWFSQMLAGLEYLHRE 57 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~l~~LH~~ 57 (304)
+++++++..++..++||||+++|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-- 189 (344)
T 1rjb_A 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-- 189 (344)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--
T ss_pred eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--
Confidence 578999999999999999999999999998753 2799999999999999999999
Q ss_pred ccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCc
Q psy1812 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLA 137 (304)
Q Consensus 58 ~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~s 137 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......+++.|+|||.+.+..++.+ +
T Consensus 190 ------------~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~ 255 (344)
T 1rjb_A 190 ------------FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIK-S 255 (344)
T ss_dssp ------------HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHH-H
T ss_pred ------------hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhccCCCChh-H
Confidence 899999999999999999999999999999755433211 12234457788999999988888777 9
Q ss_pred hHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhh
Q psy1812 138 DIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQ 216 (304)
Q Consensus 138 DvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (304)
|+|||||++|+|++ |..||.+......+.........
T Consensus 256 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------ 293 (344)
T 1rjb_A 256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK------------------------------------------ 293 (344)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC------------------------------------------
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC------------------------------------------
Confidence 99999999999998 99999776543333332222111
Q ss_pred hhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCc
Q psy1812 217 VKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
...+..+++.+.+||.+||..||.+|||+.+++++-
T Consensus 294 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 294 ----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 122345788999999999999999999999999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=260.70 Aligned_cols=193 Identities=20% Similarity=0.355 Sum_probs=155.9
Q ss_pred CceeeeeeeCC-eEEEEEecCCCCCHHHHHHhcCC---------------------------------------------
Q psy1812 1 MQVHSILQRGP-RVFIFMRYADNGDLLDHIKRAGP--------------------------------------------- 34 (304)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------- 34 (304)
|++++++...+ ..++||||+.||+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 57888887754 59999999999999999987543
Q ss_pred ---------------------CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEE
Q psy1812 35 ---------------------VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKI 93 (304)
Q Consensus 35 ---------------------l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl 93 (304)
+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--------------~~~ivH~Dikp~NIll~~~~~~kl 234 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--------------SRKCIHRDLAARNILLSEKNVVKI 234 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCChhhEEEcCCCcEEE
Confidence 899999999999999999999 889999999999999999999999
Q ss_pred EeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcc
Q psy1812 94 ADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNI 172 (304)
Q Consensus 94 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~ 172 (304)
+|||++......... .......++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+..............
T Consensus 235 ~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 312 (359)
T 3vhe_A 235 CDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312 (359)
T ss_dssp CCCGGGSCTTSCTTC-EEC--CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred Eeccceeeecccccc-hhccccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC
Confidence 999999755432221 12334567889999999988888777 999999999999998 999997765433332222111
Q ss_pred ccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCcc
Q psy1812 173 LSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKR 252 (304)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 252 (304)
.. ...+..+++++.++|.+||+.||.+|
T Consensus 313 ~~----------------------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 313 TR----------------------------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp CC----------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CC----------------------------------------------------CCCCCCCCHHHHHHHHHHccCChhhC
Confidence 11 12235578899999999999999999
Q ss_pred ccHHHHhcC
Q psy1812 253 IRLDAIKAH 261 (304)
Q Consensus 253 ~t~~ell~~ 261 (304)
||++++++|
T Consensus 341 ps~~ell~~ 349 (359)
T 3vhe_A 341 PTFSELVEH 349 (359)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999885
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=251.08 Aligned_cols=194 Identities=20% Similarity=0.294 Sum_probs=156.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||+ +++|.+++... +.+++..++.++.|++.||+||| +.+|+|||||
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~iiHrDlk 132 (330)
T 2izr_A 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH--------------SKNLIYRDVK 132 (330)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccCCC
Confidence 57899999999999999999 89999999874 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCC-----eEEEeccCcccccCcccccc----cccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTKRFN-----VKIADFGFARYCVDKEGRRV----LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++.++. +||+|||++........... ......||+.|+|||++.+..++.+ +|+|||||++|+|+
T Consensus 133 p~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell 211 (330)
T 2izr_A 133 PENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFL 211 (330)
T ss_dssp GGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHH
T ss_pred HHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHh
Confidence 99999998887 99999999986544332111 1245679999999999998888777 99999999999999
Q ss_pred hCCCCCCCh---hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 151 NAAMPFDDS---NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 151 ~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|..||.+. +..+.+..+.......+. .
T Consensus 212 ~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------------------------------~ 242 (330)
T 2izr_A 212 RGSLPWQGLKADTLKERYQKIGDTKRATPI-------------------------------------------------E 242 (330)
T ss_dssp HSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-------------------------------------------------H
T ss_pred cCCCCccccccccHHHHHHHHHhhhccCCH-------------------------------------------------H
Confidence 999999764 333333333322211110 0
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.....++ ++.+++..||+.||.+||+++++++
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0012244 8999999999999999999998876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=260.14 Aligned_cols=192 Identities=19% Similarity=0.363 Sum_probs=149.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+++|+|.+++.+.+ .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dlk 174 (373)
T 2qol_A 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--------------DMGYVHRDLA 174 (373)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred CeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeCCCCC
Confidence 578999999999999999999999999998764 6999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..
T Consensus 175 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 175 ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp GGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTT
T ss_pred cceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999765433221111222335678999999988888877 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..++..+.
T Consensus 254 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 280 (373)
T 2qol_A 254 MSNQDVIKAVDEGYR-----------------------------------------------------LPPPMDCPAALY 280 (373)
T ss_dssp CCHHHHHHHHHTTEE-----------------------------------------------------CCCCTTCBHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCccccHHHH
Confidence 776655554443321 112245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+|+.+||+.||.+|||++++++
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999887
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=248.98 Aligned_cols=192 Identities=22% Similarity=0.331 Sum_probs=149.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..++||||++|++|.+++.+.+.+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dlkp 162 (309)
T 2h34_A 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH--------------AAGATHRDVKP 162 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred eEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCcCCcCCCCh
Confidence 5789999999999999999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.. +|+||||+++|+|++|..||.+.+
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 163 ENILVSADDFAYLVDFGIASATTDEKLT--QLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp GGEEECTTSCEEECSCCC------------------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred HHEEEcCCCCEEEecCccCccccccccc--cccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCch
Confidence 9999999999999999998755432211 2234568999999999988888777 999999999999999999998776
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.......+... .... ...+..+++.+.++
T Consensus 240 ~~~~~~~~~~~-~~~~--------------------------------------------------~~~~~~~~~~l~~l 268 (309)
T 2h34_A 240 LSVMGAHINQA-IPRP--------------------------------------------------STVRPGIPVAFDAV 268 (309)
T ss_dssp HHHHHHHHHSC-CCCG--------------------------------------------------GGTSTTCCTHHHHH
T ss_pred HHHHHHHhccC-CCCc--------------------------------------------------cccCCCCCHHHHHH
Confidence 54333322211 1111 12235678899999
Q ss_pred HHHhcCCCCCccc-cHHHHhc
Q psy1812 241 VGQILEPDITKRI-RLDAIKA 260 (304)
Q Consensus 241 l~~~L~~dP~~R~-t~~ell~ 260 (304)
|.+||+.||++|| |++++++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 8887765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=249.52 Aligned_cols=193 Identities=19% Similarity=0.312 Sum_probs=159.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++ ..+..++||||+.+++|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 73 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlk 137 (287)
T 1u59_A 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--------------EKNFVHRDLA 137 (287)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred eEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH--------------HCCEeeCCCc
Confidence 5788888 556799999999999999999754 46999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 138 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999865443322222334456889999999987777776 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 217 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 243 (287)
T 1u59_A 217 MKGPEVMAFIEQGKR-----------------------------------------------------MECPPECPPELY 243 (287)
T ss_dssp CCTHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHhcCCc-----------------------------------------------------CCCCCCcCHHHH
Confidence 765555544433211 122356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
++|.+||..||.+|||+.+++++.
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=249.69 Aligned_cols=190 Identities=22% Similarity=0.353 Sum_probs=146.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++. ++..++||||+.+|+|.+++...+ .+++..++.++.|++.||.||| +.+++|+|||
T Consensus 79 v~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~i~H~dlk 143 (281)
T 1mp8_A 79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--------------SKRFVHRDIA 143 (281)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCS
T ss_pred ceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeccccc
Confidence 57888874 457899999999999999998754 6999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 144 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp GGGEEEEETTEEEECC---------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HHHEEECCCCCEEECccccccccCccccc--ccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCc
Confidence 99999999999999999999765432211 1223346788999999988778776 999999999999996 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..... ...+..+++.+.
T Consensus 221 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 247 (281)
T 1mp8_A 221 VKNNDVIGRIENGER-----------------------------------------------------LPMPPNCPPTLY 247 (281)
T ss_dssp CCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 655444444332211 122356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
++|.+||+.||++|||+.+++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=253.16 Aligned_cols=193 Identities=20% Similarity=0.373 Sum_probs=154.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++...+..++||||+++|+|.+++... +.+++..++.++.|++.||.||| +.+++|+|||
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dik 174 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--------------NMNYVHRDLA 174 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCCCC
Confidence 57899999999999999999999999999875 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||..
T Consensus 175 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999765433221112223345778999999988888777 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 254 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 280 (333)
T 1mqb_A 254 LSNHEVMKAINDGFR-----------------------------------------------------LPTPMDCPSAIY 280 (333)
T ss_dssp CCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCBHHHH
T ss_pred CCHHHHHHHHHCCCc-----------------------------------------------------CCCcccCCHHHH
Confidence 766655555443311 112245788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
++|.+||+.||++||++.+++++
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.56 Aligned_cols=191 Identities=23% Similarity=0.361 Sum_probs=157.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++..++||||+++|+|.+++...+ .+++..++.++.|++.||+||| +.+++|||||
T Consensus 175 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivHrDlk 240 (377)
T 3cbl_A 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--------------SKCCIHRDLA 240 (377)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCS
T ss_pred EEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCcCCcccC
Confidence 678999999999999999999999999998754 6999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 241 p~Nil~~~~~~~kl~DfG~s~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 241 ARNCLVTEKNVLKISDFGMSREEADGVYA-ASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEECTTSEEE-CCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHEEEcCCCcEEECcCCCceecCCCcee-ecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998754322111 11122235678999999988778777 999999999999998 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 319 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 345 (377)
T 3cbl_A 319 LSNQQTREFVEKGGR-----------------------------------------------------LPCPELCPDAVF 345 (377)
T ss_dssp SCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 766555444433211 122355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||+.||++|||++++++
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=250.86 Aligned_cols=198 Identities=26% Similarity=0.397 Sum_probs=149.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~ivH~dl 78 (304)
+++++++..++..++||||+ ++.+..+... .+.+++..++.++.|++.||.||| .. +++|+||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~~i~H~dl 151 (318)
T 2dyl_A 87 VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--------------EKHGVIHRDV 151 (318)
T ss_dssp CCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--------------HHHCCCCCCC
T ss_pred eeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--------------hhCCEEeCCC
Confidence 57899999999999999999 5566665554 457999999999999999999999 64 9999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||+++.++.+||+|||++....... ......++..|+|||.+. ...++.+ +|+|||||++|+|++|.
T Consensus 152 kp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 152 KPSNILLDERGQIKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQ 226 (318)
T ss_dssp CGGGEEECTTSCEEECCCTTC------------------CCTTCCHHHHC--------CCTH-HHHHHHHHHHHHHHHSS
T ss_pred CHHHEEECCCCCEEEEECCCchhccCCc----cccccCCCccccChhhcccccccccCCccc-cchhhHHHHHHHHHhCC
Confidence 9999999999999999999986543322 223446899999999985 3445555 99999999999999999
Q ss_pred CCCCCh-hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDS-NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.||... ........+....... ......
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~ 255 (318)
T 2dyl_A 227 FPYKNCKTDFEVLTKVLQEEPPL---------------------------------------------------LPGHMG 255 (318)
T ss_dssp CTTTTCCSHHHHHHHHHHSCCCC---------------------------------------------------CCSSSC
T ss_pred CCCCCCCccHHHHHHHhccCCCC---------------------------------------------------CCccCC
Confidence 999763 3333333333221110 011134
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 7889999999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.84 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=158.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+++|+|||
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivH~dlk 135 (310)
T 3s95_A 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH--------------SMNIIHRDLN 135 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCS
T ss_pred ccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCCC
Confidence 5789999999999999999999999999988 457999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCccccc-----------ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRR-----------VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-----------~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
|+||+++.++.+||+|||++.......... .......|++.|+|||.+.+..++.+ +||||||+++|+
T Consensus 136 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~e 214 (310)
T 3s95_A 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCE 214 (310)
T ss_dssp TTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHH
T ss_pred cCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHH
Confidence 999999999999999999997654332211 01125579999999999998888877 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|..||...... ........ .... ...
T Consensus 215 l~~g~~~~~~~~~~---------~~~~~~~~----------------------------------------~~~~--~~~ 243 (310)
T 3s95_A 215 IIGRVNADPDYLPR---------TMDFGLNV----------------------------------------RGFL--DRY 243 (310)
T ss_dssp HHHTCCSSTTTSCB---------CTTSSBCH----------------------------------------HHHH--HHT
T ss_pred HhcCCCCCcchhhh---------HHHHhhhh----------------------------------------hccc--ccc
Confidence 99999988543210 00000000 0000 011
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+..+++.+.++|.+||+.||++|||+.++++ ||+....
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 23567889999999999999999999999988 7765543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=245.41 Aligned_cols=191 Identities=20% Similarity=0.390 Sum_probs=160.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.+++..++||||+++++|.+++... +.+++..++.++.|++.||.||| +.+++|+||+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dl~ 131 (267)
T 3t9t_A 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--------------EACVIHRDLA 131 (267)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSSCC
T ss_pred eeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCc
Confidence 57899999999999999999999999999875 46899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 132 p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp GGGEEECGGGCEEECCTTGGGGBCCHHHH--STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEECCCCCEEEccccccccccccccc--ccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCC
Confidence 99999999999999999998755432211 2233456788999999987777766 999999999999999 8999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+.. ...+..++..+.
T Consensus 209 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 235 (267)
T 3t9t_A 209 RSNSEVVEDISTGFR-----------------------------------------------------LYKPRLASTHVY 235 (267)
T ss_dssp CCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTSCHHHH
T ss_pred CCHHHHHHHHhcCCc-----------------------------------------------------CCCCccCcHHHH
Confidence 776666555543321 112245688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.||.+|||+++++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=254.66 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=141.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-ceE
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK-NIA 74 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~-~iv 74 (304)
+++++++..++..++||||+.+ +|.+++.. ...+++..++.++.|++.||.||| +. +++
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~~iv 148 (327)
T 3aln_A 84 VQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--------------ENLKII 148 (327)
T ss_dssp CCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--------------HHHSCC
T ss_pred eeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--------------ccCCEe
Confidence 5789999999999999999985 89888874 467999999999999999999999 76 999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc----cCCCCCCCCchHHHHHHHHHHHH
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI----SGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~sDvwslG~ll~~ll 150 (304)
|+||||+||+++.++.+||+|||++....... ......|+..|+|||.+ .+..++.+ +|+|||||++|+|+
T Consensus 149 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~ 223 (327)
T 3aln_A 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELA 223 (327)
T ss_dssp CSCCCGGGEEEETTTEEEECCCSSSCC----------------------------------CCSH-HHHHHHHHHHHHHH
T ss_pred ECCCCHHHEEEcCCCCEEEccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHH
Confidence 99999999999999999999999997544322 12334689999999998 34556666 99999999999999
Q ss_pred hCCCCCCChhHH-HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 NAAMPFDDSNLK-QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+|..||.+.+.. +....+..+.... .....
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~ 254 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQLTQVVKGDPPQ-------------------------------------------------LSNSE 254 (327)
T ss_dssp HSCCCSSCC-------CCCCCSCCCC-------------------------------------------------CCCCS
T ss_pred HCCCCCCCcchHHHHHHHHhcCCCCC-------------------------------------------------CCCcc
Confidence 999999764321 1111111100000 00112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...+++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 2457899999999999999999999999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=263.48 Aligned_cols=202 Identities=23% Similarity=0.356 Sum_probs=147.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPV-------AESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l-------~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
|++++++.+++..++|||||. |+|.+++...+.. ++..++.++.|++.||+||| +.+|
T Consensus 72 v~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~i 136 (434)
T 2rio_A 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--------------SLKI 136 (434)
T ss_dssp CCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--------------HTTE
T ss_pred CeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--------------HCCc
Confidence 688999999999999999996 5999999876532 23345789999999999999 8899
Q ss_pred EecCCCCCcEEEecC-------------CCeEEEeccCcccccCcccc-cccccCccCCccccccccccC-------CCC
Q psy1812 74 AHRDLKCENILMTKR-------------FNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISG-------NPY 132 (304)
Q Consensus 74 vH~dl~~~nil~~~~-------------~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~-------~~~ 132 (304)
+||||||+||+++.+ +.+||+|||++......... ........|++.|+|||++.+ ..+
T Consensus 137 vHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 216 (434)
T 2rio_A 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL 216 (434)
T ss_dssp ECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC
T ss_pred cccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc
Confidence 999999999999764 37999999999865433211 111234579999999999975 445
Q ss_pred CCCCchHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccc
Q psy1812 133 NPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKD 211 (304)
Q Consensus 133 ~~~~sDvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (304)
+.+ +|||||||++|+|++ |..||....... ..+..+......
T Consensus 217 ~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~---------------------------------- 259 (434)
T 2rio_A 217 TRS-IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE---------------------------------- 259 (434)
T ss_dssp CTH-HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCC----------------------------------
T ss_pred chh-hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccc----------------------------------
Confidence 555 999999999999998 999997654322 122222111110
Q ss_pred hhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 212 ILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
........+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 260 -------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 260 -------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp -------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred -------------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 0001113467899999999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=251.24 Aligned_cols=192 Identities=20% Similarity=0.353 Sum_probs=160.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
+++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~ 156 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--------------A 156 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--------------H
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--------------H
Confidence 57899999999999999999999999999763 35799999999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
.+++||||||+||+++.++.+||+|||++......... .......+++.|+|||.+.+..++.+ +|+||||+++|+|+
T Consensus 157 ~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~ 234 (322)
T 1p4o_A 157 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIA 234 (322)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHH
T ss_pred CCCccCCCccceEEEcCCCeEEECcCcccccccccccc-ccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHH
Confidence 89999999999999999999999999999755433221 12234456888999999988778776 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||.+.+..+....+..... ...
T Consensus 235 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 261 (322)
T 1p4o_A 235 TLAEQPYQGLSNEQVLRFVMEGGL-----------------------------------------------------LDK 261 (322)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTCC-----------------------------------------------------CCC
T ss_pred hcCCCccccCCHHHHHHHHHcCCc-----------------------------------------------------CCC
Confidence 9 8999988776665555443321 112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 35678899999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=255.21 Aligned_cols=191 Identities=21% Similarity=0.365 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++. ++..++||||+.+|+|.+++... +.+++..++.++.|++.||.||| +.+|+|||||
T Consensus 78 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~Dik 142 (325)
T 3kex_A 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--------------EHGMVHRNLA 142 (325)
T ss_dssp CCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH--------------HTTCCCSCCS
T ss_pred CeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH--------------hCCCCCCccc
Confidence 57888886 45789999999999999999875 47999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 143 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 143 ARNVLLKSPSQVQVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp STTEEESSSSCEEECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEECCCCeEEECCCCcccccCccccc-ccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccc
Confidence 99999999999999999999865443221 12334567889999999988888777 999999999999999 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.........+..... ...+..++.++.
T Consensus 221 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 247 (325)
T 3kex_A 221 LRLAEVPDLLEKGER-----------------------------------------------------LAQPQICTIDVY 247 (325)
T ss_dssp SCTTHHHHHHHTTCB-----------------------------------------------------CCCCTTBCTTTT
T ss_pred cCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCcHHHH
Confidence 665444444333211 122345677899
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
++|.+||..||.+|||+.+++++
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=255.01 Aligned_cols=199 Identities=16% Similarity=0.198 Sum_probs=154.3
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++.. +...++||||+ +++|.+++...+.+++..++.++.|++.||+||| +.+|+||
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~ 175 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH--------------ENEYVHG 175 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH--------------HTTEECS
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCC
Confidence 468888877 78999999999 9999999988888999999999999999999999 8899999
Q ss_pred CCCCCcEEEecCC--CeEEEeccCcccccCcccc----cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRF--NVKIADFGFARYCVDKEGR----RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 77 dl~~~nil~~~~~--~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
||||+||+++.++ .+||+|||+++........ ........|+..|+|||++.+..++.+ +|+|||||++|+|+
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell 254 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWL 254 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHH
Confidence 9999999999887 9999999999765432211 111245579999999999998878777 99999999999999
Q ss_pred hCCCCCCChhH-HHHHHHhhhccc-cccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 151 NAAMPFDDSNL-KQLFKEQTSNIL-SHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 151 ~g~~pf~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
+|..||.+... ............ ..+ ..... ..
T Consensus 255 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~-----~~ 289 (345)
T 2v62_A 255 CGKLPWEQNLKDPVAVQTAKTNLLDELP----------------------------------------QSVLK-----WA 289 (345)
T ss_dssp HSSCTTGGGTTCHHHHHHHHHHHHHTTT----------------------------------------HHHHH-----HS
T ss_pred hCCCCccccccccHHHHHHHHhhccccc----------------------------------------HHHHh-----hc
Confidence 99999954211 111111111100 000 00000 00
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
....++.++.+||.+||..||++|||++++++
T Consensus 290 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 290 PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11267889999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=245.71 Aligned_cols=188 Identities=26% Similarity=0.456 Sum_probs=149.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc---eEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN---IAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~---ivH~d 77 (304)
+++++++..++..++||||+++++|.+++.. +.+++..++.++.|++.||.||| +.+ ++|+|
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH--------------~~~~~~i~H~d 133 (271)
T 3dtc_A 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLH--------------DEAIVPIIHRD 133 (271)
T ss_dssp CCEEEEECCC--CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH--------------HSSSSCCCCSC
T ss_pred eeEEEEEecCCceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--------------hCCCCceeecC
Confidence 5789999999999999999999999999854 57999999999999999999999 667 99999
Q ss_pred CCCCcEEEec--------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 78 LKCENILMTK--------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 78 l~~~nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
|||+||+++. ++.+||+|||++....... .....|+..|+|||.+.+..++.+ +|+||||++++++
T Consensus 134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l 207 (271)
T 3dtc_A 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWEL 207 (271)
T ss_dssp CSGGGEEESSCCSSSCCSSCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHH
T ss_pred CchHHEEEecccccccccCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHH
Confidence 9999999986 6779999999997543322 224568999999999988877776 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||.+.+.......+...... ...
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~ 235 (271)
T 3dtc_A 208 LTGEVPFRGIDGLAVAYGVAMNKLA----------------------------------------------------LPI 235 (271)
T ss_dssp HHCCCTTTTSCHHHHHHHHHTSCCC----------------------------------------------------CCC
T ss_pred HhCCCCCCCCCHHHHHHhhhcCCCC----------------------------------------------------CCC
Confidence 9999999887665554443332211 123
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 35678899999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=252.24 Aligned_cols=192 Identities=20% Similarity=0.364 Sum_probs=160.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
+++++++..++..++||||+++|+|.+++.... .+++..++.++.|++.||.|||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------- 174 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--------- 174 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---------
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---------
Confidence 578999999999999999999999999998754 3899999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.+ +|+|||||
T Consensus 175 -----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ 247 (334)
T 2pvf_A 175 -----SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGV 247 (334)
T ss_dssp -----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHH
T ss_pred -----hCCeeCCCCccceEEEcCCCCEEEcccccccccccccccc-ccCCCCcccceeChHHhcCCCcChH-HHHHHHHH
Confidence 8899999999999999999999999999997654332211 1233456788999999988777776 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||.+.+..+....+..+..
T Consensus 248 il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------- 277 (334)
T 2pvf_A 248 LMWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------------- 277 (334)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------------------------------------------------
T ss_pred HHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--------------------------------------------------
Confidence 9999999 9999988766555544433221
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.++|.+||..||.+|||+.+++++
T Consensus 278 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 278 ---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12235678899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=251.06 Aligned_cols=193 Identities=23% Similarity=0.369 Sum_probs=157.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG------------------PVAESNARTWFSQMLAGLEYLHREITNHT 62 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~ 62 (304)
+++++++..++..++||||+++|+|.+++...+ .+++..++.++.|++.||.|||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH------- 162 (313)
T 1t46_A 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA------- 162 (313)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-------
T ss_pred eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-------
Confidence 578999999999999999999999999998754 4899999999999999999999
Q ss_pred CCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHH
Q psy1812 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142 (304)
Q Consensus 63 ~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwsl 142 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||
T Consensus 163 -------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 233 (313)
T 1t46_A 163 -------SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 233 (313)
T ss_dssp -------HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred -------HCCeecCCCccceEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChH-HHHHHH
Confidence 889999999999999999999999999999765443221 12234456788999999988778777 999999
Q ss_pred HHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 143 GVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 143 G~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
|+++++|++ |..||.+................
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------- 266 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR----------------------------------------------- 266 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-----------------------------------------------
T ss_pred HHHHHHHHhCCCCCCCcccchhHHHHHhccCCC-----------------------------------------------
Confidence 999999998 99999766543333222221111
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 267 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 267 -----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11224578899999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=256.44 Aligned_cols=201 Identities=14% Similarity=0.210 Sum_probs=154.0
Q ss_pred CceeeeeeeC----CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRG----PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++... ...+|||||+ |++|.+++... +.+++..++.++.|++.||+||| +.+|+|
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------------~~~iiH 175 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH--------------EHEYVH 175 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeEE
Confidence 5678887764 5689999999 99999999876 57999999999999999999999 889999
Q ss_pred cCCCCCcEEEe--cCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 76 RDLKCENILMT--KRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 76 ~dl~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
|||||+||+++ .++.+||+|||++.......... .......||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el 254 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQW 254 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHH
Confidence 99999999999 88999999999997654332211 11234559999999999998888777 9999999999999
Q ss_pred HhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 150 LNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 150 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
++|..||.+................. .+..+... ...
T Consensus 255 ~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~-~~~ 291 (364)
T 3op5_A 255 LTGHLPWEDNLKDPKYVRDSKIRYRE------------------------------------------NIASLMDK-CFP 291 (364)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHH------------------------------------------CHHHHHHH-HSC
T ss_pred HhCCCCccccccCHHHHHHHHHHhhh------------------------------------------hHHHHHHH-hcc
Confidence 99999997543222221111110000 00000000 001
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+++++.+||..||..||.+||+++++++
T Consensus 292 ~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 292 AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1457889999999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=251.96 Aligned_cols=191 Identities=21% Similarity=0.327 Sum_probs=155.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..+. .++|+||+.+|+|.+++... +.+++..++.++.|++.||.||| +.+|+|||||
T Consensus 80 v~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivH~Dik 144 (327)
T 3poz_A 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--------------DRRLVHRDLA 144 (327)
T ss_dssp CCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--------------hCCeeCCCCC
Confidence 57889888764 78999999999999999874 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 145 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp GGGEEEEETTEEEECCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEECCCCCEEEccCcceeEccCCcccc-cccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccC
Confidence 999999999999999999997654332211 2223456789999999988888877 999999999999999 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..+.. ...+..++..+.
T Consensus 223 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 249 (327)
T 3poz_A 223 IPASEISSILEKGER-----------------------------------------------------LPQPPICTIDVY 249 (327)
T ss_dssp CCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTBCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCccCCHHHH
Confidence 655444333332211 122355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+++.+||+.||.+|||+++++++
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999886
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=240.86 Aligned_cols=186 Identities=20% Similarity=0.326 Sum_probs=155.1
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eE
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IA 74 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--iv 74 (304)
+++++++.+. +..++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+ ++
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~~~i~ 135 (271)
T 3kmu_A 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--------------TLEPLIP 135 (271)
T ss_dssp ECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--------------TSSSCCT
T ss_pred hheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--------------cCCCcee
Confidence 4788888876 78999999999999999998865 4899999999999999999999 778 99
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCC--CchHHHHHHHHHHHHhC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPK--LADIWSLGVITFIMLNA 152 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~--~sDvwslG~ll~~ll~g 152 (304)
|+||||+||+++.++.++++|||+..... .....+++.|+|||.+.+...... ++|+|||||++|+|++|
T Consensus 136 H~dikp~Nil~~~~~~~~l~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 136 RHALNSRSVMIDEDMTARISMADVKFSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp TCCCSGGGEEECTTSCEEEEGGGSCCTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred cCCCccceEEEcCCcceeEEeccceeeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999988865321 223468899999999987665542 49999999999999999
Q ss_pred CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 153 AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 153 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
..||.+.+.......+...... ...+..
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~ 235 (271)
T 3kmu_A 208 EVPFADLSNMEIGMKVALEGLR----------------------------------------------------PTIPPG 235 (271)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCC----------------------------------------------------CCCCTT
T ss_pred CCCccccChHHHHHHHHhcCCC----------------------------------------------------CCCCCC
Confidence 9999877665554444322211 223356
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+++++.++|.+||+.||++|||++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=247.38 Aligned_cols=207 Identities=17% Similarity=0.282 Sum_probs=150.7
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++.. ...+++||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.+++|+|
T Consensus 74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~ivH~D 139 (295)
T 3ugc_A 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--------------TKRYIHRD 139 (295)
T ss_dssp CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSC
T ss_pred eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh--------------cCCcccCC
Confidence 567887754 467999999999999999998754 5999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++|+|++|..|+.
T Consensus 140 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp CSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTC
T ss_pred CCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccC
Confidence 9999999999999999999999865443322222334457778999999988888777 999999999999999999987
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh-hhccccccccccHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI-LSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (304)
....... ........ ... ........+ .......+..++++
T Consensus 219 ~~~~~~~-~~~~~~~~-~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 260 (295)
T 3ugc_A 219 SPPAEFM-RMIGNDKQ-GQM------------------------------------IVFHLIELLKNNGRLPRPDGCPDE 260 (295)
T ss_dssp SHHHHHH-HHHCTTCC-THH------------------------------------HHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CChHHHH-hhhcCccc-cch------------------------------------hHHHHHHHHhccCcCCCCcCcCHH
Confidence 6543211 11110000 000 000000000 00112334668899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||+.||++|||++++++
T Consensus 261 l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 261 IYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=247.57 Aligned_cols=185 Identities=29% Similarity=0.493 Sum_probs=142.7
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
+++++++.. +...++||||++||+|.+++...+ .+++..++.++.|++.||.||| +.+++
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~ 139 (299)
T 3m2w_A 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--------------SINIA 139 (299)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred hhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcc
Confidence 578888877 778999999999999999998864 6999999999999999999999 88999
Q ss_pred ecCCCCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 75 HRDLKCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 75 H~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
|+||||+||+++. ++.+||+|||++..... ..++.+ +|+|||||++|+|++
T Consensus 140 H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-------------------------~~~~~~-~DiwslG~il~el~t 193 (299)
T 3m2w_A 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-------------------------EKYDKS-CDMWSLGVIMYILLC 193 (299)
T ss_dssp CCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-------------------------CGGGGH-HHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEecCCCCCcEEEecccccccccc-------------------------ccCCch-hhHHHHHHHHHHHHH
Confidence 9999999999998 78899999999853221 234445 999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 152 AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 152 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
|..||.+.+................ .........
T Consensus 194 g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~ 227 (299)
T 3m2w_A 194 GYPPFYSNHGLAISPGMKTRIRMGQ----------------------------------------------YEFPNPEWS 227 (299)
T ss_dssp SSCSCCC-------CCSCCSSCTTC----------------------------------------------CSSCHHHHT
T ss_pred CCCCCCCCcchhhhHHHHHHHhhcc----------------------------------------------ccCCchhcc
Confidence 9999976654322211111000000 000001114
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
.+++++.+||.+||+.||.+|||++|+++||||++.....
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 5789999999999999999999999999999999877543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=246.60 Aligned_cols=190 Identities=23% Similarity=0.393 Sum_probs=158.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+++..++||||+.|++|.+++.... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~di 137 (288)
T 3kfa_A 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--------------KKNFIHRDL 137 (288)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--------------HHTCCCSCC
T ss_pred eeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--------------HCCccCCCC
Confidence 578999999999999999999999999998743 5999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSSSE--EETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred CcceEEEcCCCCEEEccCccceeccCCccc--cccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999765433221 2233446788999999988888777 999999999999999 999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..... ...+..+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l 241 (288)
T 3kfa_A 215 GIDLSQVYELLEKDYR-----------------------------------------------------MERPEGCPEKV 241 (288)
T ss_dssp TCCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred CCCHHHHHHHHhccCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7655444433332211 12235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+||.+||..||.+|||++++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=249.01 Aligned_cols=142 Identities=26% Similarity=0.453 Sum_probs=119.9
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-----
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK----- 71 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~----- 71 (304)
|++++++..+. .+++||||+++|+|.+++++. .+++..++.++.|++.||.||| +.
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH--------------~~~~~l~ 145 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLH--------------EDIPGLK 145 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHT--------------CCEEEET
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH--------------hhccccc
Confidence 57889888744 479999999999999999764 5999999999999999999999 77
Q ss_pred -----ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-----CCCCCCchHHH
Q psy1812 72 -----NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-----PYNPKLADIWS 141 (304)
Q Consensus 72 -----~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~sDvws 141 (304)
+++|+||||+||+++.++.+||+|||++......... .......|++.|+|||++.+. .++.+ +||||
T Consensus 146 ~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~Diws 223 (322)
T 3soc_A 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYA 223 (322)
T ss_dssp TEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH-HHHHH
T ss_pred cccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCcc-chhHH
Confidence 9999999999999999999999999999765433221 123345789999999999764 23334 79999
Q ss_pred HHHHHHHHHhCCCCCCCh
Q psy1812 142 LGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 142 lG~ll~~ll~g~~pf~~~ 159 (304)
|||++|+|++|..||.+.
T Consensus 224 lG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 224 MGLVLWELASRCTAADGP 241 (322)
T ss_dssp HHHHHHHHHTTBTTSSSC
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=248.71 Aligned_cols=184 Identities=16% Similarity=0.257 Sum_probs=149.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP-VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||++||+|.+++...+. +++..++.++.|++.||.||| +.+++|||||
T Consensus 75 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Dlk 140 (289)
T 4fvq_A 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--------------ENTLIHGNVC 140 (289)
T ss_dssp CCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCC
T ss_pred eEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh--------------hCCeECCCcC
Confidence 5789999999999999999999999999987654 999999999999999999999 8899999999
Q ss_pred CCcEEEecCCC--------eEEEeccCcccccCcccccccccCccCCccccccccccC-CCCCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTKRFN--------VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG-NPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++.++. +||+|||++...... ....++..|+|||.+.+ ..++.+ +|+|||||++|+|+
T Consensus 141 p~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~ 212 (289)
T 4fvq_A 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLA-TDKWSFGTTLWEIC 212 (289)
T ss_dssp GGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHH-HHHHHHHHHHHHHH
T ss_pred cceEEEecCCcccccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCch-hHHHHHHHHHHHHH
Confidence 99999999887 999999998644322 12346788999999987 456655 99999999999999
Q ss_pred hCC-CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 NAA-MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+|. .||...+......... .. ...
T Consensus 213 ~g~~~~~~~~~~~~~~~~~~-~~------------------------------------------------------~~~ 237 (289)
T 4fvq_A 213 SGGDKPLSALDSQRKLQFYE-DR------------------------------------------------------HQL 237 (289)
T ss_dssp TTTCCTTTTSCHHHHHHHHH-TT------------------------------------------------------CCC
T ss_pred cCCCCCccccchHHHHHHhh-cc------------------------------------------------------CCC
Confidence 955 5555444333222111 11 122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+...++.+.+||.+||+.||++|||+++++++
T Consensus 238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 24457789999999999999999999999884
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=260.05 Aligned_cols=186 Identities=20% Similarity=0.401 Sum_probs=154.7
Q ss_pred CceeeeeeeCC-eEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGP-RVFIFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|++++++...+ ..++||||+++|+|.+++...+. +++..++.++.|++.||+||| +.+++|||
T Consensus 249 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivHrD 314 (450)
T 1k9a_A 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--------------GNNFVHRD 314 (450)
T ss_dssp CCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSC
T ss_pred EEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCC
Confidence 57888876654 79999999999999999988653 799999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|||+||+++.++.+||+|||+++..... .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||
T Consensus 315 lkp~Nill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~ 387 (450)
T 1k9a_A 315 LAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY 387 (450)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECC------------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSS
T ss_pred CCHhhEEECCCCCEEEeeCCCccccccc------ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998743221 122356789999999998888877 999999999999998 99999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..+.. ...+..+++.
T Consensus 388 ~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~ 414 (450)
T 1k9a_A 388 PRIPLKDVVPRVEKGYK-----------------------------------------------------MDAPDGCPPA 414 (450)
T ss_dssp TTSCTTTHHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCCHH
Confidence 87665555444433311 1233568899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||..||.+|||+.++++
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=272.60 Aligned_cols=191 Identities=20% Similarity=0.325 Sum_probs=157.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.. +..++||||+.+|+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 433 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH--------------~~~iiHrDLkp 497 (635)
T 4fl3_A 433 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE--------------ESNFVHRDLAA 497 (635)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCSG
T ss_pred eeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeCCCCCh
Confidence 678998865 468999999999999999998888999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
+||+++.++.+||+|||+++................+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.
T Consensus 498 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 498 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp GGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred HhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999765443322222233456788999999988888877 999999999999998 99999888
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+..+.. ...+..+++++.+
T Consensus 577 ~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~l~~ 603 (635)
T 4fl3_A 577 KGSEVTAMLEKGER-----------------------------------------------------MGCPAGCPREMYD 603 (635)
T ss_dssp CHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHHH
T ss_pred CHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHHH
Confidence 77666665554422 1223567899999
Q ss_pred HHHHhcCCCCCccccHHHHhc
Q psy1812 240 LVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~ 260 (304)
||.+||+.||++|||+.++++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=252.22 Aligned_cols=198 Identities=20% Similarity=0.263 Sum_probs=161.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-------PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~i 73 (304)
+++++++..+...++||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.++
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--------------~~~i 161 (327)
T 2yfx_A 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--------------ENHF 161 (327)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--------------HTTC
T ss_pred CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--------------hCCe
Confidence 578999999999999999999999999998763 4899999999999999999999 8899
Q ss_pred EecCCCCCcEEEecC---CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 74 AHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 74 vH~dl~~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
+|+||||+||+++.+ ..+||+|||++......... .......++..|+|||.+.+..++.+ +|+||||+++|+|+
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell 239 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIF 239 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHH
T ss_pred ecCcCCHhHEEEecCCCcceEEECcccccccccccccc-ccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHH
Confidence 999999999999844 45999999998754332211 12233457889999999988778776 99999999999999
Q ss_pred h-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 N-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+ |..||...+.......+..+.. ...
T Consensus 240 t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~ 266 (327)
T 2yfx_A 240 SLGYMPYPSKSNQEVLEFVTSGGR-----------------------------------------------------MDP 266 (327)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCC-----------------------------------------------------CCC
T ss_pred cCCCCCCCCcCHHHHHHHHhcCCC-----------------------------------------------------CCC
Confidence 8 9999987766555554443321 112
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
+..++..+.++|.+||+.||.+|||+.+++++.|+-..
T Consensus 267 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 35678899999999999999999999999999876544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=261.88 Aligned_cols=189 Identities=21% Similarity=0.413 Sum_probs=157.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++. ++..++||||+.+|+|.+++...+ .+++..++.++.|++.||+||| +.+|+||||
T Consensus 246 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~ivHrDl 310 (454)
T 1qcf_A 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--------------QRNYIHRDL 310 (454)
T ss_dssp CCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSSC
T ss_pred eeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCC
Confidence 57888886 567899999999999999998643 6899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+||+++.++.+||+|||+++........ ......++..|+|||.+....++.+ +|||||||++|+|++ |..||.
T Consensus 311 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 311 RAANILVSASLVCKIADFGLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp SGGGEEECTTCCEEECSTTGGGGBCCHHHH--TTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred CHHHEEECCCCcEEEeeCCCceEcCCCcee--ccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999765432111 1223346788999999988888877 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+.. ...+..+++++
T Consensus 388 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l 414 (454)
T 1qcf_A 388 GMSNPEVIRALERGYR-----------------------------------------------------MPRPENCPEEL 414 (454)
T ss_dssp TCCHHHHHHHHHHTCC-----------------------------------------------------CCCCTTSCHHH
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 8776666655544321 11235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+||.+||+.||++|||++++++
T Consensus 415 ~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 415 YNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=243.91 Aligned_cols=206 Identities=18% Similarity=0.306 Sum_probs=155.8
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... +.+++||||+++|+|.+++... +.+++..++.++.|++.||+||| +.+++|+|
T Consensus 86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~d 151 (302)
T 4e5w_A 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--------------SRQYVHRD 151 (302)
T ss_dssp CCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSC
T ss_pred eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh--------------cCCcccCC
Confidence 5788888776 7799999999999999999554 57999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++|+|++|..|+.
T Consensus 152 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGG
T ss_pred CchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCc
Confidence 9999999999999999999999866544332223445568888999999988877766 999999999999999999875
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh-hhccccccccccHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI-LSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (304)
.... ....... ...... .. ......+ .......+..+++.
T Consensus 231 ~~~~--~~~~~~~---~~~~~~--------~~--------------------------~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T 4e5w_A 231 SPMA--LFLKMIG---PTHGQM--------TV--------------------------TRLVNTLKEGKRLPCPPNCPDE 271 (302)
T ss_dssp SHHH--HHHHHHC---SCCGGG--------HH--------------------------HHHHHHHHTTCCCCCCTTCCHH
T ss_pred chhh--HHhhccC---Cccccc--------CH--------------------------HHHHHHHhccCCCCCCCCCCHH
Confidence 4321 1111111 000000 00 0000000 00112334568899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||+.||.+|||+.++++
T Consensus 272 l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 272 VYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=244.57 Aligned_cols=192 Identities=23% Similarity=0.358 Sum_probs=157.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+. .++||||+.+++|.+++... +.+++..++.++.|++.||.||| +.+++|+|||
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dik 148 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--------------SKRFIHRDLA 148 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCC
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCCc
Confidence 57888888765 88999999999999999875 56999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++++|++ |..||.+
T Consensus 149 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999765543332222334557788999999988777766 999999999999999 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+....... ..+..++..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~l~ 255 (291)
T 1u46_A 228 LNGSQILHKIDKEGERL----------------------------------------------------PRPEDCPQDIY 255 (291)
T ss_dssp CCHHHHHHHHHTSCCCC----------------------------------------------------CCCTTCCHHHH
T ss_pred CCHHHHHHHHHccCCCC----------------------------------------------------CCCcCcCHHHH
Confidence 77666655554332211 12245789999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
++|.+||..||.+|||+.++++
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=243.55 Aligned_cols=190 Identities=21% Similarity=0.314 Sum_probs=151.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++.++ ..++||||+.+++|.+++.+.+ .+++..++.++.|++.||.||| +.+++|+|||
T Consensus 76 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~dlk 140 (281)
T 3cc6_A 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE--------------SINCVHRDIA 140 (281)
T ss_dssp CCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCS
T ss_pred ceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--------------HCCcccCCCc
Confidence 5788888755 5689999999999999998754 5999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 141 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 141 VRNILVASPECVKLGDFGLSRYIEDEDYY--KASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp GGGEEEEETTEEEECCCCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEECCCCcEEeCccCCCccccccccc--ccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999998765432211 1233456788999999987778776 999999999999998 9999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..... ...+..+++.+.
T Consensus 218 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 244 (281)
T 3cc6_A 218 LENKDVIGVLEKGDR-----------------------------------------------------LPKPDLCPPVLY 244 (281)
T ss_dssp SCGGGHHHHHHHTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CChHHHHHHHhcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 544333333222111 122345788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
++|.+||..||++|||+.+++++
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=241.54 Aligned_cols=193 Identities=20% Similarity=0.254 Sum_probs=152.0
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
+..++..+...++||||+ +++|.+++.. .+.+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~ivH~Dlkp~ 134 (296)
T 4hgt_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--------------SKNFIHRDVKPD 134 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSGG
T ss_pred eeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeecCCCCHH
Confidence 445557788999999999 8999999985 457999999999999999999999 889999999999
Q ss_pred cEEE---ecCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 82 NILM---TKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 82 nil~---~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||++ +.++.+||+|||++.......... .......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..
T Consensus 135 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~ 213 (296)
T 4hgt_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSC
T ss_pred HeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCC
Confidence 9999 788999999999998655432211 12235578999999999998888777 999999999999999999
Q ss_pred CCCChhHH---HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 155 PFDDSNLK---QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 155 pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
||.+.+.. .....+.......+ ......
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~ 244 (296)
T 4hgt_A 214 PWQGLKAATKRQKYERISEKKMSTP-------------------------------------------------IEVLCK 244 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSC-------------------------------------------------HHHHTT
T ss_pred CCcccchhhhhhhhhhhhcccccch-------------------------------------------------hhhhhc
Confidence 99764321 11111111111100 011124
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+.+||.+||+.||++|||++++++
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 57889999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=242.20 Aligned_cols=193 Identities=20% Similarity=0.259 Sum_probs=151.5
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 3 VHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
+..++..++..++||||+ +++|.+++.. .+.+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~ivH~dlkp~ 134 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--------------SKNFIHRDVKPD 134 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCGG
T ss_pred cccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeCCCCHH
Confidence 444556788999999999 8899999985 457999999999999999999999 899999999999
Q ss_pred cEEE---ecCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 82 NILM---TKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 82 nil~---~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||++ +.++.+||+|||++.......... .......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..
T Consensus 135 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~ 213 (296)
T 3uzp_A 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSC
T ss_pred HeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCC
Confidence 9999 488899999999997655432211 11245579999999999998888776 999999999999999999
Q ss_pred CCCChhH---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 155 PFDDSNL---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 155 pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
||.+.+. ......+.......+ ......
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~ 244 (296)
T 3uzp_A 214 PWQGLKAATKRQKYERISEKKMSTP-------------------------------------------------IEVLCK 244 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSC-------------------------------------------------HHHHTT
T ss_pred CCCCcCchhhhhhhhhhcccccCCc-------------------------------------------------hHHHHh
Confidence 9976321 112222221111111 011124
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+.+|+.+||+.||++|||++++++
T Consensus 245 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 57899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=264.01 Aligned_cols=190 Identities=23% Similarity=0.387 Sum_probs=158.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++..++.++|||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+|+||||
T Consensus 279 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ivHrDl 344 (495)
T 1opk_A 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--------------KKNFIHRNL 344 (495)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred eeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCC
Confidence 68999999999999999999999999999874 35899999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCCEE--CCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred ChhhEEECCCCcEEEeecccceeccCCcee--ecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999765432211 1223346788999999988888777 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+.. ...+..+++.+
T Consensus 422 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l 448 (495)
T 1opk_A 422 GIDLSQVYELLEKDYR-----------------------------------------------------MERPEGCPEKV 448 (495)
T ss_dssp TCCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 7665444443332211 12235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+||.+||+.||.+|||+.++++
T Consensus 449 ~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-33 Score=251.56 Aligned_cols=192 Identities=22% Similarity=0.392 Sum_probs=156.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--------------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~ 66 (304)
+++++++..++..++||||+++|+|.+++... ..+++..++.++.|++.||.|||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----------- 181 (333)
T 2i1m_A 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----------- 181 (333)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-----------
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-----------
Confidence 57899999999999999999999999999763 35799999999999999999999
Q ss_pred CCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHH
Q psy1812 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVIT 146 (304)
Q Consensus 67 ~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll 146 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+|||||++
T Consensus 182 ---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il 256 (333)
T 2i1m_A 182 ---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILL 256 (333)
T ss_dssp ---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHH
T ss_pred ---cCCcccCCcccceEEECCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHH
Confidence 889999999999999999999999999999755432211 12234456788999999988778776 9999999999
Q ss_pred HHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhc
Q psy1812 147 FIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSH 225 (304)
Q Consensus 147 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (304)
|+|++ |..||.+.........+......
T Consensus 257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------------------- 285 (333)
T 2i1m_A 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQ--------------------------------------------------- 285 (333)
T ss_dssp HHHTTTSCCSSTTCCSSHHHHHHHHHTCC---------------------------------------------------
T ss_pred HHHHcCCCCCCcccchhHHHHHHHhcCCC---------------------------------------------------
Confidence 99998 99999765443333332222111
Q ss_pred cccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 226 QVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 226 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 286 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 286 -MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1123456889999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=248.53 Aligned_cols=207 Identities=23% Similarity=0.321 Sum_probs=157.0
Q ss_pred Cceeeeee--eCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQ--RGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++. +.+..++||||+++++|.+++... ..+++..++.++.|++.||+||| +.+++|+|
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~ivH~D 152 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG--------------SRRCVHRD 152 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSC
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCC
Confidence 46777775 567799999999999999999874 46999999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+|||||++++|++|..||.
T Consensus 153 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGG
T ss_pred CChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999866543332223344568888999999988777776 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh-hhccccccccccHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI-LSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (304)
................... . .....+ .......+..+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-------------~--------------------------~~~~~~~~~~~~~~~~~~~~~ 272 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPAL-------------S--------------------------RLLELLEEGQRLPAPPACPAE 272 (327)
T ss_dssp SHHHHHHHHCC----CCHH-------------H--------------------------HHHHHHHTTCCCCCCTTCCHH
T ss_pred cccchhhhhcccccccccH-------------H--------------------------HHHHHhhcccCCCCCCcccHH
Confidence 6543221111000000000 0 000000 00112334668999
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+||.+||+.||++|||+++++++
T Consensus 273 l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 273 VHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=240.57 Aligned_cols=183 Identities=27% Similarity=0.411 Sum_probs=149.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
...+++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--------------SKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSGGGEEEEE
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeccCCHHHEEEcC
Confidence 55689999999999999999764 57999999999999999999999 889999999999999999
Q ss_pred CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q psy1812 88 RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKE 167 (304)
Q Consensus 88 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~ 167 (304)
++.+||+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++|+|++|..|+.... .....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~--~~~~~ 230 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS--KFFTD 230 (284)
T ss_dssp TTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHHH--HHHHH
T ss_pred CCCEEECcchhheeccccc----cccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhHH--HHHHH
Confidence 9999999999987654332 2234568999999999988888776 999999999999999998874321 11111
Q ss_pred hhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCC
Q psy1812 168 QTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEP 247 (304)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 247 (304)
+.. ...+..++..+.+||.+||..
T Consensus 231 ~~~--------------------------------------------------------~~~~~~~~~~~~~li~~~l~~ 254 (284)
T 2a19_B 231 LRD--------------------------------------------------------GIISDIFDKKEKTLLQKLLSK 254 (284)
T ss_dssp HHT--------------------------------------------------------TCCCTTSCHHHHHHHHHHTCS
T ss_pred hhc--------------------------------------------------------ccccccCCHHHHHHHHHHccC
Confidence 111 112245688899999999999
Q ss_pred CCCccccHHHHhcCcccccccc
Q psy1812 248 DITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 248 dP~~R~t~~ell~~~wf~~~~~ 269 (304)
||.+|||+.+++++.|.-....
T Consensus 255 dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 255 KPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp SGGGSCCHHHHHHHHHHHTC--
T ss_pred ChhhCcCHHHHHHHHHHHhhCC
Confidence 9999999999999987665543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=249.64 Aligned_cols=193 Identities=20% Similarity=0.355 Sum_probs=155.2
Q ss_pred CceeeeeeeC-CeEEEEEecCCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHhhhcccCCCC
Q psy1812 1 MQVHSILQRG-PRVFIFMRYADNGDLLDHIKRAGP----------------VAESNARTWFSQMLAGLEYLHREITNHTP 63 (304)
Q Consensus 1 v~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~~l~~~l~~LH~~~~~~~~ 63 (304)
+++++++... +.+++||||+++|+|.+++..... +++..++.++.|++.||.|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-------- 165 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-------- 165 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--------
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--------
Confidence 5788887765 459999999999999999987653 899999999999999999999
Q ss_pred CcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 64 ~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.+ +|+||||
T Consensus 166 ------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG 237 (316)
T 2xir_A 166 ------SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFG 237 (316)
T ss_dssp ------HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHH
T ss_pred ------hCCcccccCccceEEECCCCCEEECCCccccccccCccc-eeccCCCcceeecCchhhccccccch-hHHHHHH
Confidence 889999999999999999999999999999755432221 12234457889999999988888777 9999999
Q ss_pred HHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh
Q psy1812 144 VITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI 222 (304)
Q Consensus 144 ~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (304)
|++|+|++ |..||.+................
T Consensus 238 ~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------ 269 (316)
T 2xir_A 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------------------------------------ 269 (316)
T ss_dssp HHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC------------------------------------------------
T ss_pred HHHHHHHhCCCCCCcccchhHHHHHHhccCcc------------------------------------------------
Confidence 99999998 99999765433222221111100
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 270 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 270 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12234578899999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=249.59 Aligned_cols=199 Identities=14% Similarity=0.177 Sum_probs=153.4
Q ss_pred ceeeeeee-CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 2 QVHSILQR-GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 2 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++++.. ++..++||||+ +++|.+++... +.+++..++.++.|++.||.||| +.+++||||
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~ivH~Di 185 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--------------ENEYVHGNV 185 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCSCC
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCC
Confidence 35667766 78999999999 89999999886 68999999999999999999999 889999999
Q ss_pred CCCcEEEecCC--CeEEEeccCcccccCcccc----cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhC
Q psy1812 79 KCENILMTKRF--NVKIADFGFARYCVDKEGR----RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA 152 (304)
Q Consensus 79 ~~~nil~~~~~--~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g 152 (304)
||+||+++.++ .+||+|||++......... ........|++.|+|||.+.+..++.+ +|+|||||++|+|++|
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g 264 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHS
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhC
Confidence 99999999998 8999999999765433221 111234578999999999988888777 9999999999999999
Q ss_pred CCCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 153 AMPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 153 ~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
..||.... ................. . + ........
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------~--------------------~-~~~~~~~~ 300 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPG-----------------------P--------------------F-VGPCGHWI 300 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCC-----------------------C--------------------E-ECTTSCEE
T ss_pred CCCcccCCcCHHHHHHHHHhccCChh-----------------------h--------------------h-hhhccccC
Confidence 99997653 22222111111000000 0 0 00011123
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++++.+||.+||..||++|||++++++
T Consensus 301 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 301 RPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 56899999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=248.46 Aligned_cols=191 Identities=21% Similarity=0.331 Sum_probs=150.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+. .++|++|+.+|+|.+++... +.+++..++.++.|++.||.||| +.+|+|||||
T Consensus 80 v~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~Dik 144 (327)
T 3lzb_A 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--------------DRRLVHRDLA 144 (327)
T ss_dssp CCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--------------hCCCcCCCCC
Confidence 56788887764 88999999999999999874 57999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 145 p~NIl~~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp GGGEEEEETTEEEECCTTC-----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HHHEEEcCCCCEEEccCcceeEccCccccc-cccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999997654332211 2223446788999999988888877 999999999999999 9999987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+.......+..... ...+..++.++.
T Consensus 223 ~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l~ 249 (327)
T 3lzb_A 223 IPASEISSILEKGER-----------------------------------------------------LPQPPICTIDVY 249 (327)
T ss_dssp CCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTBCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCccCCHHHH
Confidence 665444443332211 122355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+||.+||..||.+|||++++++.
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999973
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-32 Score=240.42 Aligned_cols=185 Identities=24% Similarity=0.436 Sum_probs=147.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--ivH~d 77 (304)
+++++++.+.. ++||||+++|+|.+++.+.. .+++..++.++.|++.||.||| +.+ ++|+|
T Consensus 86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--------------~~~~~ivH~d 149 (287)
T 4f0f_A 86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ--------------NQNPPIVHRD 149 (287)
T ss_dssp CCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--------------TSSSCCBCSC
T ss_pred hhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH--------------hCCCCeecCC
Confidence 57888887665 69999999999999887654 7999999999999999999999 788 99999
Q ss_pred CCCCcEEEecCCC-----eEEEeccCcccccCcccccccccCccCCcccccccccc--CCCCCCCCchHHHHHHHHHHHH
Q psy1812 78 LKCENILMTKRFN-----VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS--GNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 78 l~~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~sDvwslG~ll~~ll 150 (304)
|||+||+++.++. +||+|||++..... ......|+..|+|||.+. ...++.+ +|+|||||++|+|+
T Consensus 150 ikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~-~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTIL 222 (287)
T ss_dssp CSGGGEEESCCCTTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHH-HHHHHHHHHHHHHH
T ss_pred CCcceEEEeccCCCCceeEEeCCCCccccccc------cccccCCCccccCchhhccCCCCcCch-hhHHHHHHHHHHHH
Confidence 9999999988776 99999999874332 223456899999999984 3345555 99999999999999
Q ss_pred hCCCCCCChhHHHH--HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 151 NAAMPFDDSNLKQL--FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 151 ~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
+|..||...+.... ...+..... ...
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~ 250 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGL----------------------------------------------------RPT 250 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCC----------------------------------------------------CCC
T ss_pred cCCCCCccccccHHHHHHHHhccCC----------------------------------------------------CCC
Confidence 99999975542221 111111110 022
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+..+++.+.+||.+||+.||.+|||++++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33567899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-31 Score=242.71 Aligned_cols=199 Identities=24% Similarity=0.355 Sum_probs=147.9
Q ss_pred CceeeeeeeC----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC-----
Q psy1812 1 MQVHSILQRG----PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK----- 71 (304)
Q Consensus 1 v~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~----- 71 (304)
+++++++... ...++||||+++|+|.+++++. .+++..++.++.|++.||.||| +.
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH--------------~~~~~~~ 158 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLH--------------TEIFSTQ 158 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHH--------------SCBCSTT
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH--------------Hhhhhhc
Confidence 5678888877 7899999999999999999765 6999999999999999999999 66
Q ss_pred ---ceEecCCCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCCCCCC-----CchHHHH
Q psy1812 72 ---NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNPYNPK-----LADIWSL 142 (304)
Q Consensus 72 ---~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~-----~sDvwsl 142 (304)
+++||||||+||+++.++.+||+|||++......... ........|+..|+|||++.+...... ++|+|||
T Consensus 159 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred cCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 9999999999999999999999999999755433221 112235579999999999987655543 3799999
Q ss_pred HHHHHHHHhC----------CCCCCChhH----HHHHHHhhh-ccccccchhhhhhhhhhhHHHHhhhhhcccccccccc
Q psy1812 143 GVITFIMLNA----------AMPFDDSNL----KQLFKEQTS-NILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQV 207 (304)
Q Consensus 143 G~ll~~ll~g----------~~pf~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (304)
||++|+|++| ..||..... ......... ......
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------- 287 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS------------------------------- 287 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC-------------------------------
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcc-------------------------------
Confidence 9999999999 555533210 011111100 000000
Q ss_pred cccchhhhhhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 208 KVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.........+++++.+||.+||+.||++|||+.+++++
T Consensus 288 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 288 ----------------FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp ----------------CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00011123567889999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=241.62 Aligned_cols=189 Identities=22% Similarity=0.421 Sum_probs=155.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.. +..++||||+.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 71 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------------~~~i~H~di 135 (279)
T 1qpc_A 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--------------ERNYIHRDL 135 (279)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred ceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeccCC
Confidence 567888764 46899999999999999997643 6999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|+||||+++++|++ |..||.
T Consensus 136 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 136 RAANILVSDTLSCKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSCEE--CCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred CHhhEEEcCCCCEEECCCcccccccCcccc--cccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999765433211 2233456788999999987777766 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+..+.. ...+..++..+
T Consensus 213 ~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~l 239 (279)
T 1qpc_A 213 GMTNPEVIQNLERGYR-----------------------------------------------------MVRPDNCPEEL 239 (279)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred ccCHHHHHHHHhcccC-----------------------------------------------------CCCcccccHHH
Confidence 7766555554433211 11235678899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+++.+||..||++|||++++++
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=245.60 Aligned_cols=192 Identities=16% Similarity=0.313 Sum_probs=148.9
Q ss_pred CceeeeeeeCC-----eEEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSILQRGP-----RVFIFMRYADNGDLLDHIKR------AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
+++++++.... ..++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-------------- 164 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-------------- 164 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--------------
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 46778777644 46999999999999999953 346999999999999999999999
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
+.+++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.+ +|+||||+++|+|
T Consensus 165 ~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el 242 (313)
T 3brb_A 165 NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEI 242 (313)
T ss_dssp TTTCCCCCCSGGGEEECTTSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHH
T ss_pred hCCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc-CcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHH
Confidence 899999999999999999999999999998755432211 12233457789999999988888777 9999999999999
Q ss_pred Hh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 150 LN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 150 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
++ |..||.+.+.......+..+.. ..
T Consensus 243 ~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~ 269 (313)
T 3brb_A 243 ATRGMTPYPGVQNHEMYDYLLHGHR-----------------------------------------------------LK 269 (313)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCC-----------------------------------------------------CC
T ss_pred HhcCCCCCccCCHHHHHHHHHcCCC-----------------------------------------------------CC
Confidence 99 8899977665444444333211 12
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.+..+++.+.+||.+||..||.+|||+++++++
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 235678899999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=249.67 Aligned_cols=205 Identities=21% Similarity=0.348 Sum_probs=156.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC---ce
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK---NI 73 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~---~i 73 (304)
+++++++..++..++||||+.+|+|.+++.... .+++..++.++.|++.||.||| +. ++
T Consensus 90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~~~~i 155 (326)
T 3uim_A 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--------------DHCDPKI 155 (326)
T ss_dssp CCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--------------HSSSSCE
T ss_pred cceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCCCCe
Confidence 578999999999999999999999999998753 4999999999999999999999 67 99
Q ss_pred EecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 74 vH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|+||||+||+++.++.+||+|||++......... ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|.
T Consensus 156 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQ 232 (326)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC--EECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCC
T ss_pred EeCCCchhhEEECCCCCEEeccCccccccCccccc--ccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCC
Confidence 99999999999999999999999999765433222 2334568999999999988777776 99999999999999999
Q ss_pred CCCCChhHHH----HHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh--hhccc
Q psy1812 154 MPFDDSNLKQ----LFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI--LSHQV 227 (304)
Q Consensus 154 ~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 227 (304)
.||....... ............. ....+ .....
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~ 271 (326)
T 3uim_A 233 RAFDLARLANDDDVMLLDWVKGLLKEK-----------------------------------------KLEALVDVDLQG 271 (326)
T ss_dssp CSBCHHHHTTTSCSBHHHHHTTTTSSC-----------------------------------------CSTTSSCTTCTT
T ss_pred CcccccccccccchhHHHHHHHHhhch-----------------------------------------hhhhhcChhhcc
Confidence 9996332100 0000000000000 00000 00012
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCcc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDW 263 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~w 263 (304)
..+...+..+.+++.+||+.||.+|||+++++++-+
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 223456788999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=267.80 Aligned_cols=191 Identities=19% Similarity=0.316 Sum_probs=154.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.. +.+++||||+.+|+|.+++... +.+++..++.++.|++.||+||| +.+|+|||||
T Consensus 399 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~iiHrDlk 463 (613)
T 2ozo_A 399 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--------------EKNFVHRNLA 463 (613)
T ss_dssp CCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCS
T ss_pred eeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEcCcCC
Confidence 678999876 5699999999999999999764 46999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++................+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 464 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp GGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999765433221111222345688999999988888877 999999999999998 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++++.
T Consensus 543 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~l~ 569 (613)
T 2ozo_A 543 MKGPEVMAFIEQGKR-----------------------------------------------------MECPPECPPELY 569 (613)
T ss_dssp CCSHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCCHHHH
Confidence 776666665554321 122356889999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||+.||++|||++++++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999998854
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=243.26 Aligned_cols=192 Identities=23% Similarity=0.363 Sum_probs=153.3
Q ss_pred Cceeee-eeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSI-LQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++++ +..++..++||||+.+|+|.+++.+. ..+++..++.++.|++.||.||| +.+++|+||
T Consensus 89 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH--------------~~~i~H~di 154 (298)
T 3f66_A 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--------------SKKFVHRDL 154 (298)
T ss_dssp CCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCC
Confidence 467887 45667899999999999999999764 46899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
||+||+++.++.+||+|||++......... ........++..|+|||.+.+..++.+ +|+||||++++++++ |..||
T Consensus 155 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 155 AARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp SGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSS
T ss_pred chheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999765433221 112234457788999999988888777 999999999999999 56677
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..+.. ...+..+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 260 (298)
T 3f66_A 234 PDVNTFDITVYLLQGRR-----------------------------------------------------LLQPEYCPDP 260 (298)
T ss_dssp TTSCTTTHHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred ccCCHHHHHHHHhcCCC-----------------------------------------------------CCCCccCCHH
Confidence 66554444443333221 1123457889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+++.+||+.||++|||++++++
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=244.81 Aligned_cols=204 Identities=25% Similarity=0.422 Sum_probs=154.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA---GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+++|+|
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~i~H~d 158 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--------------ENHHIHRD 158 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSC
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--------------cCCeecCC
Confidence 57899999999999999999999999999753 46999999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.+||+|||++......... .......|+..|+|||.+.+ .++.+ +|+||||+++|+|++|..||.
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~-~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPK-SDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTH-HHHHHHHHHHHHHHHCCCSBC
T ss_pred CCHHHEEEcCCCcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCcc-chhHHHHHHHHHHHHCCCCcc
Confidence 9999999999999999999998765432221 12334568999999999865 45555 999999999999999999997
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh-hccccccccccHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL-SHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (304)
..........+........ ..+.... ......+...+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~~~~~~ 275 (307)
T 2nru_A 236 EHREPQLLLDIKEEIEDEE----------------------------------------KTIEDYIDKKMNDADSTSVEA 275 (307)
T ss_dssp TTBSSSBTTHHHHHHHTTS----------------------------------------CCHHHHSCSSCSCCCHHHHHH
T ss_pred cCcchHHHHHHHHHhhhhh----------------------------------------hhhhhhccccccccchHHHHH
Confidence 6543221111111000000 0000000 0001223456788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+++.+||..||.+|||+++++++
T Consensus 276 l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 276 MYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-33 Score=250.13 Aligned_cols=209 Identities=21% Similarity=0.302 Sum_probs=156.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++..++..++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+++|+
T Consensus 98 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------~~~ivH~ 163 (321)
T 2qkw_B 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--------------TRAIIHR 163 (321)
T ss_dssp CCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECS
T ss_pred eeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--------------CCCeecC
Confidence 578999999999999999999999999997653 5899999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||||+||+++.++.+||+|||++......... .......|+..|+|||.+.+..++.+ +|+|||||++|+|++|+.||
T Consensus 164 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 164 DVKSINILLDENFVPKITDFGISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp CCCSTTEEECTTCCEEECCCTTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTC
T ss_pred CCCHHHEEECCCCCEEEeeccccccccccccc-ccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999754432221 12234458899999999988888777 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+....+....... ................ ..........+..
T Consensus 242 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~ 284 (321)
T 2qkw_B 242 VQSLPREMVNLAEW-------------------AVESHNNGQLEQIVDP------------------NLADKIRPESLRK 284 (321)
T ss_dssp SCSSSSSCCCHHHH-------------------THHHHTTTCCCSSSSS------------------SCTTCSCHHHHHH
T ss_pred cccCcHHHHHHHHH-------------------hhhccccccHHHhcCh------------------hhccccCHHHHHH
Confidence 65432110000000 0000000000000000 0001223456788
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
+.+++.+||+.||++|||+++++++-
T Consensus 285 l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 285 FGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=244.90 Aligned_cols=204 Identities=21% Similarity=0.326 Sum_probs=155.2
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
+++++++.+ ...+++||||+++|+|.+++.+.. +++..++.++.|++.||.||| +.+++|+||
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH--------------~~~ivH~Di 160 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH--------------AQHYIHRDL 160 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHH--------------hCCccCCCC
Confidence 578898887 468999999999999999997654 999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++++|++|..||..
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGS
T ss_pred chheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccc
Confidence 999999999999999999999866543322223344567888999999988777766 9999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh--hccccccccccHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL--SHQVKVKDILSHQ 236 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 236 (304)
........... .... . ......... ......+..++.+
T Consensus 240 ~~~~~~~~~~~---~~~~---~----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 279 (318)
T 3lxp_A 240 PPTKFLELIGI---AQGQ---M----------------------------------TVLRLTELLERGERLPRPDKCPAE 279 (318)
T ss_dssp HHHHHHHHHCS---CCHH---H----------------------------------HHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cchhhhhhhcc---cccc---h----------------------------------hHHHHHHHHhcccCCCCCccccHH
Confidence 54321111000 0000 0 000000000 0012334568899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||+.||.+|||++++++
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=258.86 Aligned_cols=189 Identities=22% Similarity=0.382 Sum_probs=153.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+ +..++||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+++||||
T Consensus 242 v~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~ivHrDl 306 (452)
T 1fmk_A 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--------------RMNYVHRDL 306 (452)
T ss_dssp CCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCCC
Confidence 578888876 6789999999999999999753 46999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.
T Consensus 307 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 307 RAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp SGGGEEECGGGCEEECCCCTTC----------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred ChhhEEECCCCCEEECCCccceecCCCcee--cccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999765432211 1223346788999999988888877 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....+....+..+.. ...+..+++.+
T Consensus 384 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l 410 (452)
T 1fmk_A 384 GMVNREVLDQVERGYR-----------------------------------------------------MPCPPECPESL 410 (452)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTSCHHH
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 8776666555543321 12235678899
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+||.+||+.||++|||++++++
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=242.15 Aligned_cols=190 Identities=29% Similarity=0.460 Sum_probs=145.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++..++..++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+++|+
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~i~H~ 160 (310)
T 2wqm_A 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--------------SRRVMHR 160 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCC
T ss_pred eeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--------------hCCeeCC
Confidence 5789999999999999999999999999975 356999999999999999999999 8899999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||
T Consensus 161 dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp CCCGGGEEECTTSCEEECCC---------------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTT
T ss_pred CCcHHHEEEcCCCCEEEEeccceeeecCCCc---cccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999875443221 2234568899999999988888777 99999999999999999999
Q ss_pred CChh--HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 157 DDSN--LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 157 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
.+.. .......+...... ......++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~ 264 (310)
T 2wqm_A 237 YGDKMNLYSLCKKIEQCDYP----------------------------------------------------PLPSDHYS 264 (310)
T ss_dssp C---CCHHHHHHHHHTTCSC----------------------------------------------------CCCTTTSC
T ss_pred cccchhHHHHHHHhhcccCC----------------------------------------------------CCcccccC
Confidence 6542 12222222211110 11124578
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.++.+||.+||..||++|||++++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 89999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=240.47 Aligned_cols=192 Identities=23% Similarity=0.371 Sum_probs=153.3
Q ss_pred CceeeeeeeCCeE-EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRV-FIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+.+.. ++||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+++|+||
T Consensus 85 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------------~~~i~H~di 150 (298)
T 3pls_A 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--------------EQKFVHRDL 150 (298)
T ss_dssp CCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCC
Confidence 5788888766554 9999999999999999873 46899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC-CCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~-~pf 156 (304)
||+||+++.++.+||+|||++......... ........++..|+|||.+.+..++.+ +|+||||+++|+|++|. .||
T Consensus 151 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp SGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTT
T ss_pred CcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCC
Confidence 999999999999999999999755432211 112234567889999999988888877 99999999999999955 555
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+.......+..... ...+..+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 256 (298)
T 3pls_A 230 RHIDPFDLTHFLAQGRR-----------------------------------------------------LPQPEYCPDS 256 (298)
T ss_dssp TTSCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred ccCCHHHHHHHhhcCCC-----------------------------------------------------CCCCccchHH
Confidence 54444333333322211 1223557889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||+.||.+|||++++++
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=241.15 Aligned_cols=194 Identities=26% Similarity=0.449 Sum_probs=142.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
++++++ ...+..++||||+.+++|.+++... ..+++..++.++.|++.||.||| +.+++|+|||
T Consensus 83 v~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--------------~~~i~H~Dlk 147 (289)
T 3og7_A 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--------------AKSIIHRDLK 147 (289)
T ss_dssp CCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred EEEEee-ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccccCc
Confidence 456774 4566789999999999999999654 46999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc---CCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS---GNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+||+++.++.+||+|||++......... .......|+..|+|||.+. +..++.+ +|+||||+++++|++|..||
T Consensus 148 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp GGGEEEETTTEEEECCCC-------------------CCCTTCCHHHHC----CCSCHH-HHHHHHHHHHHHHHHSSCTT
T ss_pred cceEEECCCCCEEEccceecccccccccc-ccccccCCCccccCchhhcccCCCCCCcc-cchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999998754432211 1233456899999999986 4455555 99999999999999999999
Q ss_pred CChhHHHHHHHh-hhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 157 DDSNLKQLFKEQ-TSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
...+........ ........ .......+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~ 256 (289)
T 3og7_A 226 SNINNRDQIIEMVGRGSLSPD-------------------------------------------------LSKVRSNCPK 256 (289)
T ss_dssp SSCCCHHHHHHHHHHTSCCCC-------------------------------------------------TTSSCTTSCH
T ss_pred cccchHHHHHHHhcccccCcc-------------------------------------------------hhhccccCCH
Confidence 775544333322 22211111 0122346789
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+.+||.+||+.||.+|||+.++++
T Consensus 257 ~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=241.34 Aligned_cols=186 Identities=20% Similarity=0.394 Sum_probs=147.4
Q ss_pred Cceeeeee-eCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQ-RGPRVFIFMRYADNGDLLDHIKRAGP--VAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++. .++..++||||+++|+|.+++.+.+. +++..++.++.|++.||.||| +.+++|+|
T Consensus 77 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------------~~~i~H~d 142 (278)
T 1byg_A 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--------------GNNFVHRD 142 (278)
T ss_dssp CCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSC
T ss_pred eeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--------------hCCccccC
Confidence 56788754 44589999999999999999987643 899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|||+||+++.++.+||+|||++...... .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~ 215 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY 215 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC------------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSC
T ss_pred CCcceEEEeCCCcEEEeecccccccccc------ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998754322 123356788999999988778777 999999999999998 99999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+..+....+..+.. ...+..+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 242 (278)
T 1byg_A 216 PRIPLKDVVPRVEKGYK-----------------------------------------------------MDAPDGCPPA 242 (278)
T ss_dssp TTSCGGGHHHHHTTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHhcCCC-----------------------------------------------------CCCcccCCHH
Confidence 77654444433332211 1223567899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.++|.+||..||.+|||+.++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=251.78 Aligned_cols=193 Identities=22% Similarity=0.352 Sum_probs=145.6
Q ss_pred Cceeeee-eeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSIL-QRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++ ..++..++||||+++|+|.+++.+.+ .+++..++.++.|++.||.||| +.+|+||||
T Consensus 153 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivHrDl 218 (373)
T 3c1x_A 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--------------SKKFVHRDL 218 (373)
T ss_dssp CCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred ceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEecCcc
Confidence 5678875 45678899999999999999998754 5899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
||+||+++.++.+||+|||++.......... .......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||
T Consensus 219 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~ 297 (373)
T 3c1x_A 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297 (373)
T ss_dssp CGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSC
T ss_pred chheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCC
Confidence 9999999999999999999997554322111 11233456788999999988888777 999999999999999 67888
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..+.. ...+..+++.
T Consensus 298 ~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~p~~~~~~ 324 (373)
T 3c1x_A 298 PDVNTFDITVYLLQGRR-----------------------------------------------------LLQPEYCPDP 324 (373)
T ss_dssp TTSCSSCHHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHH
Confidence 66544333333322211 1123557889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.++|.+||+.||++|||+++++++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=267.08 Aligned_cols=223 Identities=23% Similarity=0.356 Sum_probs=161.3
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 71 (304)
|++++++.. ++..++||||++||+|.+++...+ .+++..++.++.|++.||.||| +.
T Consensus 75 V~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--------------s~ 140 (676)
T 3qa8_A 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--------------EN 140 (676)
T ss_dssp CCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--------------HT
T ss_pred CceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--------------HC
Confidence 456777654 778899999999999999998754 5999999999999999999999 88
Q ss_pred ceEecCCCCCcEEEecCCC---eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHH
Q psy1812 72 NIAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ 148 (304)
+++|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.+..++.+ +|+|||||++|+
T Consensus 141 gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLye 215 (676)
T 3qa8_A 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFE 215 (676)
T ss_dssp TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHH
T ss_pred CCccCCCCHHHeEeecCCCceeEEEccccccccccccc----ccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHH
Confidence 9999999999999997765 8999999997654332 2345678999999999988888877 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
+++|..||.+.................. ............+.........
T Consensus 216 LltG~~Pf~~~~~~~~~~~~i~~~~~~~------------------------------~~~~~~l~g~~~~~~~lp~p~~ 265 (676)
T 3qa8_A 216 CITGFRPFLPNWQPVQWHGKVREKSNEH------------------------------IVVYDDLTGAVKFSSVLPTPNH 265 (676)
T ss_dssp HHSSCSSCCSSCHHHHSSTTCC------------------------------------CCSCCCCSSSCCCCSSSCCSCC
T ss_pred HHHCCCCCCcccchhhhhhhhhcccchh------------------------------hhhhhhhccccccccccCCchh
Confidence 9999999976543221110000000000 0000000000000011111123
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
....+++.+.+||.+||..||.+|||+.++++||||+......+
T Consensus 266 l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 266 LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 44567899999999999999999999999999999998766444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=239.09 Aligned_cols=185 Identities=28% Similarity=0.433 Sum_probs=144.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC---CceE
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS---KNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~---~~iv 74 (304)
|++++++.+ ..++||||++||+|.+++...+ .+++..++.++.|++.||.||| + .+++
T Consensus 64 v~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--------------~~~~~~iv 127 (307)
T 2eva_A 64 VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--------------SMQPKALI 127 (307)
T ss_dssp CCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH--------------TCSSSCCC
T ss_pred CeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH--------------hCCCCCee
Confidence 567887763 4789999999999999998765 3789999999999999999999 5 7999
Q ss_pred ecCCCCCcEEEecCCC-eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMTKRFN-VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|+||||+||+++.++. +||+|||++...... .....|+..|+|||.+.+..++.+ +|+||||+++|+|++|.
T Consensus 128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~ 200 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRR 200 (307)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCCC------------------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTC
T ss_pred cCCCChhHEEEeCCCCEEEEcccccccccccc------cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCC
Confidence 9999999999999887 799999998644321 223458999999999988888777 99999999999999999
Q ss_pred CCCCChhH--HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccc
Q psy1812 154 MPFDDSNL--KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKD 231 (304)
Q Consensus 154 ~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (304)
.||..... .........+.. ...+.
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------------------~~~~~ 227 (307)
T 2eva_A 201 KPFDEIGGPAFRIMWAVHNGTR-----------------------------------------------------PPLIK 227 (307)
T ss_dssp CTTTTTCSSHHHHHHHHHTTCC-----------------------------------------------------CCCBT
T ss_pred CCchhhCccHHHHHHHHhcCCC-----------------------------------------------------CCccc
Confidence 99965321 111111111100 12235
Q ss_pred cccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 232 ILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 232 ~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.++..+.++|.+||+.||++|||+++++++
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 678899999999999999999999999883
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=238.79 Aligned_cols=206 Identities=22% Similarity=0.277 Sum_probs=148.2
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++.. ....++||||+++|+|.++++. +.+++..++.++.|++.||.|||+...+ ...+.+++||
T Consensus 65 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~------~~~~~~ivH~ 137 (301)
T 3q4u_A 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFG------TQGKPAIAHR 137 (301)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCS------TTCBCEEECS
T ss_pred eeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhh------ccCCCCeecC
Confidence 466776543 4579999999999999999965 4699999999999999999999932110 1115799999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCC------CCCCCchHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNP------YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~------~~~~~sDvwslG~ll~~l 149 (304)
||||+||+++.++.+||+|||++.......... .......|++.|+|||.+.+.. ++.+ +|+|||||++|+|
T Consensus 138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DvwslG~il~el 216 (301)
T 3q4u_A 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEV 216 (301)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH-HHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch-hhHHHHHHHHHHH
Confidence 999999999999999999999997654332221 1223457999999999998763 2234 9999999999999
Q ss_pred HhC----------CCCCCChh----HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 150 LNA----------AMPFDDSN----LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 150 l~g----------~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
++| ..||.... ...............+
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 257 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP--------------------------------------- 257 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC---------------------------------------
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC---------------------------------------
Confidence 999 77774321 1111111111100000
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..........+++.+.+||.+||+.||++|||+.++++
T Consensus 258 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 258 -------NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp -------CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -------CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 00001122346788999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=242.35 Aligned_cols=198 Identities=19% Similarity=0.290 Sum_probs=154.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..++..++||||++|++|.+++...+ .+++..++.++.|++.||+||| +.+++|+|||
T Consensus 92 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--------------~~~i~H~dlk 157 (319)
T 2y4i_B 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--------------AKGILHKDLK 157 (319)
T ss_dssp CCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCC
T ss_pred eEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccccCCC
Confidence 578899999999999999999999999998765 6999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCccc--ccccccCccCCccccccccccC---------CCCCCCCchHHHHHHHHHH
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEG--RRVLSRTYCGSAAYAAPEVISG---------NPYNPKLADIWSLGVITFI 148 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~sDvwslG~ll~~ 148 (304)
|+||+++ ++.+||+|||++........ .........|+..|+|||.+.+ ..++.+ +|+|||||++|+
T Consensus 158 p~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~-~Di~slG~il~e 235 (319)
T 2y4i_B 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYE 235 (319)
T ss_dssp STTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH-HHHHHHHHHHHH
T ss_pred hhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCch-hhHHHHHHHHHH
Confidence 9999998 67999999999865432211 1112234458899999999875 234555 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|..||...........+..+.... .
T Consensus 236 l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------------------~ 263 (319)
T 2y4i_B 236 LHAREWPFKTQPAEAIIWQMGTGMKPN----------------------------------------------------L 263 (319)
T ss_dssp HHHSSCSSSSCCHHHHHHHHHTTCCCC----------------------------------------------------C
T ss_pred HHhCCCCCCCCCHHHHHHHhccCCCCC----------------------------------------------------C
Confidence 999999998877665555444332211 1
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
....++..+.++|.+||..||++|||++++++ .|+...
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 11346788999999999999999999999987 444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=261.38 Aligned_cols=190 Identities=22% Similarity=0.380 Sum_probs=158.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+ +..+|||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+|+||||
T Consensus 325 v~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~ivHrDl 389 (535)
T 2h8h_A 325 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--------------RMNYVHRDL 389 (535)
T ss_dssp CCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeCCCC
Confidence 578888876 6789999999999999999753 46999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~ 157 (304)
||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.
T Consensus 390 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 390 RAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp SGGGEEECGGGCEEECCTTSTTTCCCHHHH--TTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSST
T ss_pred CHhhEEEcCCCcEEEcccccceecCCCcee--cccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999765432111 1223446788999999988888777 999999999999999 999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+....+....+..+.. ...+..++..+
T Consensus 467 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l 493 (535)
T 2h8h_A 467 GMVNREVLDQVERGYR-----------------------------------------------------MPCPPECPESL 493 (535)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred CCCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHH
Confidence 8776666655543321 11235678899
Q ss_pred HHHHHHhcCCCCCccccHHHHhcC
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
.+||.+||+.||++|||++++++.
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=245.03 Aligned_cols=143 Identities=17% Similarity=0.233 Sum_probs=125.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
+++++++..++..++||||++||+|.+++.. .+.+++..++.++.|++.||+||| +.+|+|
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--------------~~~ivH 195 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--------------DCEIIH 195 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--------------TTTEEC
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--------------hCCeec
Confidence 5788999999999999999999999999974 456999999999999999999999 899999
Q ss_pred cCCCCCcEEEec-----------CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 76 RDLKCENILMTK-----------RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 76 ~dl~~~nil~~~-----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
|||||+||+++. ++.+||+|||++......... ......+||..|+|||++.+..++.+ +|+|||||
T Consensus 196 rDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~ 273 (365)
T 3e7e_A 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAA 273 (365)
T ss_dssp CCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHH
T ss_pred CCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHH
Confidence 999999999998 899999999999754322211 13345679999999999999888777 99999999
Q ss_pred HHHHHHhCCCCCCCh
Q psy1812 145 ITFIMLNAAMPFDDS 159 (304)
Q Consensus 145 ll~~ll~g~~pf~~~ 159 (304)
++|+|++|+.||...
T Consensus 274 il~elltg~~pf~~~ 288 (365)
T 3e7e_A 274 TVYCMLFGTYMKVKN 288 (365)
T ss_dssp HHHHHHHSSCCCEEE
T ss_pred HHHHHHhCCCccccC
Confidence 999999999999544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=248.76 Aligned_cols=132 Identities=24% Similarity=0.380 Sum_probs=108.7
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCC---------ceEecCCCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK---------NIAHRDLKC 80 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~---------~ivH~dl~~ 80 (304)
...+++||||+++|+|.+++.... .++..++.++.|++.||.||| +. +|+||||||
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH--------------~~~~~~~~~~~~ivH~Dikp 148 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLH--------------TELPRGDHYKPAISHRDLNS 148 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHH--------------CCBCCGGGCBCCEECSSCSG
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHH--------------hhhccccccccceeeccccc
Confidence 447899999999999999997654 689999999999999999999 77 999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCccc-----ccccccCccCCccccccccccCC-------CCCCCCchHHHHHHHHHH
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEG-----RRVLSRTYCGSAAYAAPEVISGN-------PYNPKLADIWSLGVITFI 148 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~sDvwslG~ll~~ 148 (304)
+||+++.++.+||+|||++........ .........|+..|+|||++.+. .++.+ +|||||||++|+
T Consensus 149 ~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~il~e 227 (336)
T 3g2f_A 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ-VDMYALGLIYWE 227 (336)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH-HHHHHHHHHHHH
T ss_pred ceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc-cchHHHHHHHHH
Confidence 999999999999999999976543221 11122345799999999999763 33344 899999999999
Q ss_pred HHhCCCCCC
Q psy1812 149 MLNAAMPFD 157 (304)
Q Consensus 149 ll~g~~pf~ 157 (304)
|++|..||.
T Consensus 228 ll~g~~p~~ 236 (336)
T 3g2f_A 228 IFMRCTDLF 236 (336)
T ss_dssp HHTTBGGGS
T ss_pred HHhcCCcCC
Confidence 999977663
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=259.01 Aligned_cols=181 Identities=15% Similarity=0.116 Sum_probs=145.4
Q ss_pred CeEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcE
Q psy1812 11 PRVFIFMRYADNGDLLDHIKR-------AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENI 83 (304)
Q Consensus 11 ~~~~lv~e~~~~g~L~~~l~~-------~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ni 83 (304)
..++++|+++ +++|.++++. .+.+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~iiHrDiKp~NI 242 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--------------HYGLVHTYLRPVDI 242 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCGGGE
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCCcccceE
Confidence 3578888887 5799999952 224788899999999999999999 89999999999999
Q ss_pred EEecCCCeEEEeccCcccccCcccccccccCccCCccccccccc----------cCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 84 LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI----------SGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 84 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
|++.++.+||+|||++...... ....+| +.|+|||++ .+..++.+ +|||||||++|+|++|+
T Consensus 243 Ll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 243 VLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA-FDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp EECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH-HHHHHHHHHHHHHHHSS
T ss_pred EEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCch-hhHHHHHHHHHHHHHCC
Confidence 9999999999999998754322 334567 999999999 44446556 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||...+.......+ ......+
T Consensus 315 ~Pf~~~~~~~~~~~~----------------------------------------------------------~~~~~~~ 336 (413)
T 3dzo_A 315 LPNTDDAALGGSEWI----------------------------------------------------------FRSCKNI 336 (413)
T ss_dssp CCCCTTGGGSCSGGG----------------------------------------------------------GSSCCCC
T ss_pred CCCCCcchhhhHHHH----------------------------------------------------------HhhcccC
Confidence 999766421111000 0011356
Q ss_pred cHHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
++.+.+||.+||+.||++|||+.++++||||+.......
T Consensus 337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~~ 375 (413)
T 3dzo_A 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375 (413)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHHH
Confidence 889999999999999999999999999999998765443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=250.39 Aligned_cols=194 Identities=20% Similarity=0.279 Sum_probs=153.6
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
.++.++..+...+|||||+ +++|.+++.. .+.+++..++.++.||+.||+||| ..+|+||||||
T Consensus 67 ~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH--------------~~gIvHrDIKP 131 (483)
T 3sv0_A 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------------SKSFLHRDIKP 131 (483)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCCG
T ss_pred eEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEeecccCc
Confidence 3556667788999999999 8999999986 457999999999999999999999 89999999999
Q ss_pred CcEEE---ecCCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 81 ENILM---TKRFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 81 ~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|||+ +.++.+||+|||++.......... .......|+..|+|||.+.+..++.+ +|||||||++|+|++|.
T Consensus 132 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~ 210 (483)
T 3sv0_A 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGS 210 (483)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSS
T ss_pred ceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCC
Confidence 99999 588999999999998655433211 11235679999999999998888777 99999999999999999
Q ss_pred CCCCChhH---HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 154 MPFDDSNL---KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 154 ~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
.||.+... ...+.++........ . ....
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------------------------~-------~~l~ 241 (483)
T 3sv0_A 211 LPWQGLKAGTKKQKYEKISEKKVATS------------------------------------------I-------EALC 241 (483)
T ss_dssp CTTSSCCCSSHHHHHHHHHHHHHHSC------------------------------------------H-------HHHH
T ss_pred CCCccccchhHHHHHHHHhhcccccc------------------------------------------H-------HHHh
Confidence 99976432 222222222111100 0 1112
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..++.++.+||..||..||++||+++++++
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 457889999999999999999999988765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=261.41 Aligned_cols=189 Identities=22% Similarity=0.353 Sum_probs=154.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++. ++..++||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.+|+|||||
T Consensus 454 v~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~givHrDik 518 (656)
T 2j0j_A 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE--------------SKRFVHRDIA 518 (656)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCS
T ss_pred CeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccccccc
Confidence 57888885 456899999999999999998754 6899999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 519 p~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp GGGEEEEETTEEEECCCCCCCSCCC------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hHhEEEeCCCCEEEEecCCCeecCCCcce--eccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999765433211 1223456789999999988878777 999999999999997 9999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 596 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 622 (656)
T 2j0j_A 596 VKNNDVIGRIENGER-----------------------------------------------------LPMPPNCPPTLY 622 (656)
T ss_dssp CCHHHHHHHHHHTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCccccHHHH
Confidence 776666555543321 122356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||+.||.+|||+.++++
T Consensus 623 ~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 623 SLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=242.40 Aligned_cols=190 Identities=24% Similarity=0.419 Sum_probs=131.5
Q ss_pred Cceeeee--------eeCCeEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCC
Q psy1812 1 MQVHSIL--------QRGPRVFIFMRYADNGDLLDHIKR---AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69 (304)
Q Consensus 1 v~~~~~~--------~~~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~ 69 (304)
+++++++ .....+++||||+. |+|.+++.. .+.+++..++.++.|++.||.|||
T Consensus 89 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-------------- 153 (337)
T 3ll6_A 89 VQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-------------- 153 (337)
T ss_dssp CCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--------------
T ss_pred hhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------
Confidence 4677777 34556999999996 699999876 457999999999999999999999
Q ss_pred CCc--eEecCCCCCcEEEecCCCeEEEeccCcccccCccccc---------ccccCccCCccccccccc---cCCCCCCC
Q psy1812 70 SKN--IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR---------VLSRTYCGSAAYAAPEVI---SGNPYNPK 135 (304)
Q Consensus 70 ~~~--ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~---~~~~~~~~ 135 (304)
..+ ++|+||||+||+++.++.+||+|||++.......... .......+++.|+|||++ .+..++.+
T Consensus 154 ~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~ 233 (337)
T 3ll6_A 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233 (337)
T ss_dssp TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHH
T ss_pred hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH
Confidence 778 9999999999999999999999999997654332110 011244689999999998 44455555
Q ss_pred CchHHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 136 LADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 136 ~sDvwslG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|+|||||++|+|++|..||.......... ....
T Consensus 234 -~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~----------------------------------------- 267 (337)
T 3ll6_A 234 -QDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYS----------------------------------------- 267 (337)
T ss_dssp -HHHHHHHHHHHHHHHSSCCC----------------CC-----------------------------------------
T ss_pred -HhHHHHHHHHHHHHhCCCCCcchhHHHhhc----Cccc-----------------------------------------
Confidence 999999999999999999996544322111 1110
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
.......+..+.+||.+||+.||.+|||+.+++++-
T Consensus 268 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 268 -----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111234566789999999999999999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=239.10 Aligned_cols=207 Identities=18% Similarity=0.315 Sum_probs=152.7
Q ss_pred CceeeeeeeC--CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQRG--PRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
+++++++... ...++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+|
T Consensus 105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------------~~~ivH~d 170 (326)
T 2w1i_A 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--------------TKRYIHRD 170 (326)
T ss_dssp CCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSC
T ss_pred eeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeccC
Confidence 4677877654 47899999999999999998764 6999999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|||+||+++.++.+||+|||++.................++..|+|||.+.+..++.+ +|+||||+++++|++|..||.
T Consensus 171 ikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGG
T ss_pred CCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999865443322122234457778999999988777766 999999999999999999986
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh-hccccccccccHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL-SHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (304)
..... ........ ..... . . ......+. ......+..++++
T Consensus 250 ~~~~~-~~~~~~~~-~~~~~-~---------~--------------------------~~~~~~~~~~~~~~~~~~~~~~ 291 (326)
T 2w1i_A 250 SPPAE-FMRMIGND-KQGQM-I---------V--------------------------FHLIELLKNNGRLPRPDGCPDE 291 (326)
T ss_dssp SHHHH-HHHHHCTT-CCTHH-H---------H--------------------------HHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCHHH-HHHhhccc-cchhh-h---------H--------------------------HHHHHHhhcCCCCCCCCcccHH
Confidence 54221 11111000 00000 0 0 00000000 0012234568899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||+.||++|||+.++++
T Consensus 292 l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 292 IYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=249.76 Aligned_cols=213 Identities=20% Similarity=0.324 Sum_probs=153.9
Q ss_pred CceeeeeeeCC--eEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGP--RVFIFMRYADNGDLLDHIKRAG---PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++...+ ..++||||++||+|.+++.... .+++..++.++.|++.||+||| +.+|+|
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------~~~ivH 135 (396)
T 4eut_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--------------ENGIVH 135 (396)
T ss_dssp CCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred CeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEE
Confidence 57888888654 7899999999999999998754 3999999999999999999999 889999
Q ss_pred cCCCCCcEEE----ecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC--------CCCCCCCchHHHHH
Q psy1812 76 RDLKCENILM----TKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG--------NPYNPKLADIWSLG 143 (304)
Q Consensus 76 ~dl~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~sDvwslG 143 (304)
|||||+||++ +.++.+||+|||++....... ......|+..|+|||++.+ ..++.+ +|+||||
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwSlG 210 (396)
T 4eut_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIG 210 (396)
T ss_dssp CCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHH-HHHHHHH
T ss_pred CCcCHHHEEEeecCCCceeEEEecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcH-HHHHHHH
Confidence 9999999999 677779999999997654332 2334579999999999864 344555 9999999
Q ss_pred HHHHHHHhCCCCCCCh----hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhh
Q psy1812 144 VITFIMLNAAMPFDDS----NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKL 219 (304)
Q Consensus 144 ~ll~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (304)
|++|+|++|..||... ...+...++..+...... .... ......+.+
T Consensus 211 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~----------------~~~~~~~~~---------- 261 (396)
T 4eut_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI---SGVQ----------------KAENGPIDW---------- 261 (396)
T ss_dssp HHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC---EEEE----------------CSTTCCEEE----------
T ss_pred HHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc---hhhe----------------eccCCCccc----------
Confidence 9999999999999542 223344443332211100 0000 000000000
Q ss_pred hhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
..........+..++..+.+||.+||+.||++|||+++++++
T Consensus 262 ~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 000011123335678899999999999999999999998554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=238.26 Aligned_cols=193 Identities=22% Similarity=0.309 Sum_probs=148.1
Q ss_pred Cceeeeee----eCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc
Q psy1812 1 MQVHSILQ----RGPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72 (304)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 72 (304)
+++++++. .....++||||+.+|+|.+++.. ...+++..++.++.|++.||.||| +.+
T Consensus 89 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------------~~~ 154 (317)
T 2buj_A 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--------------AKG 154 (317)
T ss_dssp CCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTT
T ss_pred eeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------hCC
Confidence 46777776 34589999999999999999986 457999999999999999999999 889
Q ss_pred eEecCCCCCcEEEecCCCeEEEeccCcccccCccccc------ccccCccCCccccccccccCCC---CCCCCchHHHHH
Q psy1812 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRR------VLSRTYCGSAAYAAPEVISGNP---YNPKLADIWSLG 143 (304)
Q Consensus 73 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~---~~~~~sDvwslG 143 (304)
++|+||||+||+++.++.+||+|||++.......... .......|+..|+|||.+.+.. ++.+ +|+||||
T Consensus 155 ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG 233 (317)
T 2buj_A 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER-TDVWSLG 233 (317)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH-HHHHHHH
T ss_pred cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch-hhHHHHH
Confidence 9999999999999999999999999986543211100 0012335789999999987654 4555 9999999
Q ss_pred HHHHHHHhCCCCCCChhHH--HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 144 VITFIMLNAAMPFDDSNLK--QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 144 ~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
+++|+|++|..||...... .....+. ....
T Consensus 234 ~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~----------------------------------------------- 265 (317)
T 2buj_A 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLS----------------------------------------------- 265 (317)
T ss_dssp HHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC-------------------------------------------------
T ss_pred HHHHHHHhCCCChhhhhcccchhhHHhh-ccCC-----------------------------------------------
Confidence 9999999999999532110 0000000 0000
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
......++..+.+||.+||+.||.+|||+++++++
T Consensus 266 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 266 -----IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11124578899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=235.13 Aligned_cols=207 Identities=22% Similarity=0.294 Sum_probs=151.1
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
+++++++.... ..++||||+++|+|.+++.+. .+++..++.++.|++.||.|||+...+ ...+.+++|+
T Consensus 99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~------~~~~~~ivH~ 171 (342)
T 1b6c_B 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVG------TQGKPAIAHR 171 (342)
T ss_dssp CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCS------TTCBCEEECS
T ss_pred EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhh------hcccCCeeeC
Confidence 57888888765 899999999999999999764 699999999999999999999932110 0114689999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCCCCC-----CCchHHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNPYNP-----KLADIWSLGVITFIML 150 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~-----~~sDvwslG~ll~~ll 150 (304)
||||+||+++.++.+||+|||++.......... .......|+..|+|||.+.+..... .++|+|||||++|+|+
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999999999999999999997654332211 1234557899999999997653221 2499999999999999
Q ss_pred hC----------CCCCCChh-----HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 151 NA----------AMPFDDSN-----LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 151 ~g----------~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+| ..||.... .......+......... +
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~------- 294 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI------------------------------P------- 294 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC------------------------------C-------
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCC------------------------------c-------
Confidence 99 67775431 11222211111110000 0
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
........++.+.+||.+||+.||++|||+.+++++
T Consensus 295 ----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 295 ----------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp ----------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ----------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 000113456789999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-31 Score=240.71 Aligned_cols=180 Identities=16% Similarity=0.236 Sum_probs=137.9
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCC
Q psy1812 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRF 89 (304)
Q Consensus 10 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~ 89 (304)
++.++||||||++|++.+.+.+ +.+++..++.++.|++.||+|||+ +.+|+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~-------------~~~ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEA-------------SLRFEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHH-------------HHCCBCSCCCGGGEEEEECS
T ss_pred cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-------------hCCEeECCCCHHHEEEeccC
Confidence 7899999999999987777754 568999999999999999999993 46899999999999999987
Q ss_pred --------------------CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHH-HHH
Q psy1812 90 --------------------NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVI-TFI 148 (304)
Q Consensus 90 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~l-l~~ 148 (304)
.+||+|||+++..... ..+||..|+|||++.+.. +.. +||||++++ .++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~g~~-~~~-~Diwsl~~~~~~~ 269 (336)
T 2vuw_A 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFTGDG-DYQ-FDIYRLMKKENNN 269 (336)
T ss_dssp CSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGCCCS-SHH-HHHHHHHHHHHTT
T ss_pred CcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccChhhhcCCC-ccc-eehhhhhCCCCcc
Confidence 8999999999754421 346899999999998766 554 999998776 778
Q ss_pred HHhCCCCCCChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 149 MLNAAMPFDDSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 149 ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
++.|..||..... ......+........ ....
T Consensus 270 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~ 302 (336)
T 2vuw_A 270 RWGEYHPYSNVLWLHYLTDKMLKQMTFKT-----------------------------------------------KCNT 302 (336)
T ss_dssp CTTSCCTHHHHHHHHHHHHHHHHTCCCSS-----------------------------------------------CCCS
T ss_pred cccccCCCcchhhhhHHHHhhhhhhccCc-----------------------------------------------ccch
Confidence 8889999854321 111112111100000 0001
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHh-cCcccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIK-AHDWLR 265 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell-~~~wf~ 265 (304)
..+..+++++.+||.+||+.| |++|+| +||||+
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 122457899999999999976 999999 999996
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=247.49 Aligned_cols=182 Identities=19% Similarity=0.288 Sum_probs=145.6
Q ss_pred CceeeeeeeCCe-----EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGPR-----VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++...+. .||||||++|++|.+++.. .+++..++.++.|++.||.||| +.+|+|
T Consensus 142 v~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH--------------~~giiH 205 (681)
T 2pzi_A 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH--------------SIGLVY 205 (681)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred CeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--------------HCCCee
Confidence 578999887655 7999999999999998865 6999999999999999999999 889999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||+||+++.+ .+||+|||++...... ....||+.|+|||++.+.. +.+ +|||||||++++|++|..|
T Consensus 206 rDlkp~NIll~~~-~~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~-sDi~slG~~l~~l~~g~~~ 275 (681)
T 2pzi_A 206 NDLKPENIMLTEE-QLKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGP-TVA-TDIYTVGRTLAALTLDLPT 275 (681)
T ss_dssp CCCSGGGEEECSS-CEEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCS-CHH-HHHHHHHHHHHHHHSCCCE
T ss_pred cccChHHeEEeCC-cEEEEecccchhcccC-------CccCCCccccCHHHHcCCC-CCc-eehhhhHHHHHHHHhCCCC
Confidence 9999999999885 8999999999754332 3456899999999987654 444 9999999999999999888
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+... .. .+. .......++
T Consensus 276 ~~~~~~--------~~---~~~-------------------------------------------------~~~~~~~~~ 295 (681)
T 2pzi_A 276 RNGRYV--------DG---LPE-------------------------------------------------DDPVLKTYD 295 (681)
T ss_dssp ETTEEC--------SS---CCT-------------------------------------------------TCHHHHHCH
T ss_pred Cccccc--------cc---ccc-------------------------------------------------cccccccCH
Confidence 864310 00 000 000122467
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+.+||.+||+.||.+||++.+++.|+|+...+
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 899999999999999999999999999987654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=216.06 Aligned_cols=170 Identities=11% Similarity=0.168 Sum_probs=130.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++..++..|+||||++|++|.++++++ .....+..++.|++.||+||| +.+|+||||||
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH--------------~~givH~Dikp 157 (286)
T 3uqc_A 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAH--------------RAGVALSIDHP 157 (286)
T ss_dssp CCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCSG
T ss_pred ceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHH--------------HCCCccCCCCc
Confidence 57999999999999999999999999999653 466678999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||++++.. + +++.+ +|+|||||++|+|++|..||.+.+
T Consensus 158 ~NIll~~~g~~kl~~~~~~-----------------------~-------~~~~~-~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 158 SRVRVSIDGDVVLAYPATM-----------------------P-------DANPQ-DDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp GGEEEETTSCEEECSCCCC-----------------------T-------TCCHH-HHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ccEEEcCCCCEEEEecccc-----------------------C-------CCCch-hHHHHHHHHHHHHHHCCCCCCcCC
Confidence 9999999999999744321 1 24445 999999999999999999997654
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
.............. .... .......+++++.+|
T Consensus 207 ~~~~~~~~~~~~~~----------------------------------------~~~~-------~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 207 VRSGLAPAERDTAG----------------------------------------QPIE-------PADIDRDIPFQISAV 239 (286)
T ss_dssp BCCCSEECCBCTTS----------------------------------------CBCC-------HHHHCTTSCHHHHHH
T ss_pred cchhhHHHHHHhcc----------------------------------------CCCC-------hhhcccCCCHHHHHH
Confidence 21100000000000 0000 011225678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
|.+||+.||++| |+.++++ .++..
T Consensus 240 i~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred HHHHcccCCccC-CHHHHHH--HHHHH
Confidence 999999999999 9999988 44443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-27 Score=230.16 Aligned_cols=131 Identities=15% Similarity=0.115 Sum_probs=98.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++++++.+||||||++|++|.++|.+.+++++. .|+.||+.||+|+| +.|||||||||
T Consensus 305 ~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH--------------~~GIIHRDIKP 367 (569)
T 4azs_A 305 PAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALE--------------KQGFWHDDVRP 367 (569)
T ss_dssp CCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHH--------------HTTCEESCCCG
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHH--------------HCCceeccCch
Confidence 57999999999999999999999999999999888865 47899999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+|||++.+|.+||+|||+++....... ...+.+||+.|++||++.+. +... +|+||+|++++.+..+.
T Consensus 368 eNILL~~dg~vKL~DFGlAr~~~~~~~---~~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 368 WNVMVDARQHARLIDFGSIVTTPQDCS---WPTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp GGEEECTTSCEEECCCTTEESCC---C---CSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred HhEEECCCCCEEEeecccCeeCCCCCc---cccCceechhhccHHHhCCC-CCCc-ccccccccchhhhcccc
Confidence 999999999999999999975543221 24456799999999999764 3444 89999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-18 Score=165.32 Aligned_cols=124 Identities=18% Similarity=0.234 Sum_probs=101.0
Q ss_pred eeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEec
Q psy1812 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTK 87 (304)
Q Consensus 8 ~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~ 87 (304)
..++..+|||||++|++|.+++.+ +..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 409 ~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH--------------~~gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 409 VDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLH--------------KNDVIHNDLTTSNFIFDK 466 (540)
T ss_dssp EETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHH--------------HTTEECTTCCTTSEEESS
T ss_pred EeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHH--------------HCcCccCCCCHHHEEECC
Confidence 356677999999999999999876 6689999999999999 899999999999999998
Q ss_pred CCCeEEEeccCcccccCccccc----ccccCccCCccccccccccC--CCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 88 RFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISG--NPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 88 ~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~--~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
.+||+|||+++......... .......||+.|+|||++.. ..|+.. +|+|+..+-..+-..++.+|
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 99999999998765432211 01235679999999999976 456555 79999888777777766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-15 Score=132.49 Aligned_cols=76 Identities=20% Similarity=0.283 Sum_probs=64.8
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCE 81 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~ 81 (304)
++++++.. +..++||||++||+|.+ +. ......++.|++.||.||| +.+|+||||||+
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH--------------~~giiHrDlkp~ 222 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFY--------------HRGIVHGDLSQY 222 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHH--------------HTTEECSCCSTT
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHH--------------HCCCEeCCCCHH
Confidence 45665554 45699999999999988 42 1345579999999999999 899999999999
Q ss_pred cEEEecCCCeEEEeccCcc
Q psy1812 82 NILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 82 nil~~~~~~~kl~dfg~~~ 100 (304)
||+++ ++.+||+|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp SEEEE-TTEEEECCCTTCE
T ss_pred HEEEE-CCcEEEEECCCCe
Confidence 99999 9999999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=6e-11 Score=103.79 Aligned_cols=72 Identities=19% Similarity=0.340 Sum_probs=59.7
Q ss_pred eEEEEEecCCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe
Q psy1812 12 RVFIFMRYADN-G----DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMT 86 (304)
Q Consensus 12 ~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~ 86 (304)
..+|||||+.+ | +|.++... .++..+..++.|++.||.|||. ..+|+||||||+|||++
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~-------------~~givHrDlkp~NILl~ 205 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQ-------------EAELVHADLSEYNIMYI 205 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHH-------------TSCEECSSCSTTSEEES
T ss_pred CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHH-------------HCCEEeCCCCHHHEEEc
Confidence 45899999932 3 77766533 3456788999999999999994 57999999999999998
Q ss_pred cCCCeEEEeccCccc
Q psy1812 87 KRFNVKIADFGFARY 101 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~ 101 (304)
. .++|+|||++..
T Consensus 206 ~--~~~liDFG~a~~ 218 (258)
T 1zth_A 206 D--KVYFIDMGQAVT 218 (258)
T ss_dssp S--SEEECCCTTCEE
T ss_pred C--cEEEEECccccc
Confidence 8 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.2e-09 Score=99.12 Aligned_cols=68 Identities=18% Similarity=0.192 Sum_probs=56.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCC---
Q psy1812 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFN--- 90 (304)
Q Consensus 14 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~--- 90 (304)
+|||||++|++|.++. .......++.|++.+|.+|| ..|||||||||.|||++.++.
T Consensus 187 ~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH--------------~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLA--------------KHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHH--------------HTTEECSCCSTTSEEEEEEECSSC
T ss_pred eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHH--------------HCCCcCCCCCHHHEEEeCCCCccc
Confidence 6999999998886543 22345678899999999999 889999999999999988763
Q ss_pred -------eEEEeccCccc
Q psy1812 91 -------VKIADFGFARY 101 (304)
Q Consensus 91 -------~kl~dfg~~~~ 101 (304)
+.|+||+-+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 78999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=2.1e-07 Score=80.71 Aligned_cols=94 Identities=16% Similarity=0.138 Sum_probs=68.1
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc----------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT---------------- 65 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~---------------- 65 (304)
++++++..++..|+||||++|.+|.+.+. +......++.+++.+|..||+......|+.
T Consensus 74 ~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T 3tm0_A 74 KVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhc
Confidence 57888888899999999999999877531 223345778899999999997321111110
Q ss_pred -----------------------------CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 66 -----------------------------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 66 -----------------------------~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
.+.....++|+|+++.||+++.+..+.|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 00123679999999999999876556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.29 E-value=1.3e-06 Score=74.99 Aligned_cols=91 Identities=20% Similarity=0.202 Sum_probs=63.3
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc----------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT---------------- 65 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~---------------- 65 (304)
+++++...++..++||||++|.+|. . .... ...++.+++..|..||+......|+.
T Consensus 79 ~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (264)
T 1nd4_A 79 AVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEA 150 (264)
T ss_dssp CEEEEEECSSCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHT
T ss_pred eEEEeccCCCCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhc
Confidence 4677777788899999999998883 2 1122 23567888889999996421111110
Q ss_pred ----------------------------CCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 66 ----------------------------AHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 66 ----------------------------~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
+......++|+|+++.||+++.++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 151 GLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 00113459999999999999877666799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.19 E-value=2e-06 Score=78.24 Aligned_cols=98 Identities=12% Similarity=0.225 Sum_probs=70.4
Q ss_pred ceeeeeeeC---CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC---cC---------
Q psy1812 2 QVHSILQRG---PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPF---TA--------- 66 (304)
Q Consensus 2 ~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~---~~--------- 66 (304)
+++.++.+. +..|+||||++|..+.+. ....++......++.+++..|..||+........ ++
T Consensus 102 ~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3dxp_A 102 KMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQI 179 (359)
T ss_dssp CEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHH
T ss_pred cEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHH
Confidence 466666665 458999999999877442 1224778888999999999999999742211110 00
Q ss_pred ------------------------------CC--CCCceEecCCCCCcEEEecCCC--eEEEeccCccc
Q psy1812 67 ------------------------------HL--PSKNIAHRDLKCENILMTKRFN--VKIADFGFARY 101 (304)
Q Consensus 67 ------------------------------~~--~~~~ivH~dl~~~nil~~~~~~--~kl~dfg~~~~ 101 (304)
.. ....++|+|+++.||+++.++. +.|+||+.+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 180 ERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 00 0367999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.09 E-value=4.6e-07 Score=80.61 Aligned_cols=142 Identities=16% Similarity=0.104 Sum_probs=88.1
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCc--------------------------
Q psy1812 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFT-------------------------- 65 (304)
Q Consensus 12 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~-------------------------- 65 (304)
..|+||++++|.+|.+... ..++.++...++.+++..+..||+.....-+..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 4588999999988875433 247888899999999999999997422111100
Q ss_pred ------------------CCCCCCceEecCCCCCcEEEec--CCCeEEEeccCcccccCcccccccccCc--cCCc----
Q psy1812 66 ------------------AHLPSKNIAHRDLKCENILMTK--RFNVKIADFGFARYCVDKEGRRVLSRTY--CGSA---- 119 (304)
Q Consensus 66 ------------------~~~~~~~ivH~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~--~~~~---- 119 (304)
+......++|+|+++.||+++. ...+.++||+.+........-....... .+..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 0112357999999999999998 4557899999986533211100000000 0000
Q ss_pred -----cccc-cccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 120 -----AYAA-PEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 120 -----~~~~-PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
.... |+..... ... .+.|+++.+++.+.+|..+|..
T Consensus 248 ~l~~Y~~~~~~~~~~r~--~~~-~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKY--RMK-EKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHTCSCHHHHHHHH--HHH-HHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHcCCCCcHHHHHHH--HHH-HHHHHHHHHHHHHHcCCHHHHH
Confidence 0011 1211111 111 5789999999999999887743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00014 Score=62.83 Aligned_cols=95 Identities=12% Similarity=0.225 Sum_probs=69.0
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcC---------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA--------------- 66 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~--------------- 66 (304)
+++.+..+++..++|||+++|.++.+.... .......+..+++..|..||+......++..
T Consensus 84 ~v~~~~~~~~~~~lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (272)
T 4gkh_A 84 TIKHFIRTPDDAWLLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNN 159 (272)
T ss_dssp CEEEEEEETTEEEEEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHT
T ss_pred eEEEEEEECCeEEEEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHH
Confidence 567888889999999999999888877654 2234456778888888899965322211110
Q ss_pred -----------------------------CCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 67 -----------------------------HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 67 -----------------------------~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
......++|+|+.+.||+++..+.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 160 GLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1113458999999999999987666799999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00076 Score=56.81 Aligned_cols=102 Identities=20% Similarity=0.163 Sum_probs=63.2
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 23 GDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 23 g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
.+|.+.|+.. .+++|+++|.++.|.+.+|.-+-. .+.-...=+.+..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~-------------~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR-------------RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-------------TTCCCCCCCSGGGEEEETTSCEEECC-C----
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh-------------cccCCceecCCcceEEecCCceeccc-cccc-
Confidence 4799999875 489999999999999999877621 00001223446889999999988653 1110
Q ss_pred ccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 102 CVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
.....+.+||... ...+.. .-|||||+++|..+--..|
T Consensus 98 --------------~~~~~~~~pe~~~-~~~te~-~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --------------AGEPPPVAGKLGY-SQCMET-EVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------------------CCSS-SSSCHH-HHHHHHHHHHHHHHTTTCC
T ss_pred --------------ccccCCCChhhcc-ccchHH-HHHHHHHHHHHHHhhcCCC
Confidence 1123456777763 112233 6799999999988874444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0013 Score=58.36 Aligned_cols=91 Identities=16% Similarity=0.114 Sum_probs=64.4
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCC-----CCC------------------c
Q psy1812 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH-----TPF------------------T 65 (304)
Q Consensus 9 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~-----~~~------------------~ 65 (304)
..+..++|||+++|.+|.+..- ..++......++.++...|..||+..... -|. .
T Consensus 84 ~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~ 161 (306)
T 3tdw_A 84 SDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF 161 (306)
T ss_dssp TTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred CCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence 3456789999999988876422 24677888888899999999999653210 000 0
Q ss_pred C-----------------------CCCCCceEecCCCCCcEEEec---CCCe-EEEeccCccc
Q psy1812 66 A-----------------------HLPSKNIAHRDLKCENILMTK---RFNV-KIADFGFARY 101 (304)
Q Consensus 66 ~-----------------------~~~~~~ivH~dl~~~nil~~~---~~~~-kl~dfg~~~~ 101 (304)
+ ......++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 0 002457899999999999987 4554 7999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0027 Score=57.15 Aligned_cols=100 Identities=19% Similarity=0.222 Sum_probs=62.0
Q ss_pred ceeeeeeeC---CeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcccCC---CCCc----
Q psy1812 2 QVHSILQRG---PRVFIFMRYADNGDLLDHIKRA------GPVAESNARTWFSQMLAGLEYLHREITNH---TPFT---- 65 (304)
Q Consensus 2 ~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~---~~~~---- 65 (304)
+++.+..++ +..++||||++|.++.+.+... ..++..+...++.+++..|.-||+..... ..++
T Consensus 94 ~v~~~~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~ 173 (357)
T 3ats_A 94 RVRWIETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRT 173 (357)
T ss_dssp CEEEEECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC----
T ss_pred cEEEEccCCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCC
Confidence 355555544 4578999999987765432100 02455555667777777777777532100 0000
Q ss_pred -------------------------------------CCC------CCCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 66 -------------------------------------AHL------PSKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 66 -------------------------------------~~~------~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
... ....++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 174 SDTTLHRHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CCchHHHHHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 000 146899999999999999644478999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.76 E-value=0.038 Score=48.76 Aligned_cols=31 Identities=23% Similarity=0.347 Sum_probs=28.0
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888889999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.09 E-value=0.23 Score=43.89 Aligned_cols=32 Identities=28% Similarity=0.420 Sum_probs=27.4
Q ss_pred CCceEecCCCCCcEEEecC----CCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKR----FNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~----~~~kl~dfg~~~~ 101 (304)
...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4589999999999999874 6789999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.12 Score=45.02 Aligned_cols=31 Identities=26% Similarity=0.387 Sum_probs=26.3
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 457999999999999 6677889999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=92.81 E-value=0.24 Score=43.85 Aligned_cols=27 Identities=19% Similarity=0.213 Sum_probs=23.6
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEecc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFG 97 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg 97 (304)
...++|+|+.+.|++++.++ +.|+|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 56899999999999999887 7888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.80 E-value=0.11 Score=47.71 Aligned_cols=32 Identities=22% Similarity=0.430 Sum_probs=28.3
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYC 102 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~ 102 (304)
...++|||+++.||+++.++ +.++||+.+.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 67899999999999998776 999999998653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.54 E-value=0.16 Score=44.48 Aligned_cols=31 Identities=26% Similarity=0.319 Sum_probs=26.7
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4689999999999999887556899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.27 E-value=0.58 Score=40.94 Aligned_cols=30 Identities=27% Similarity=0.205 Sum_probs=25.8
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 46789999999999998 4 889999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.81 E-value=0.73 Score=40.94 Aligned_cols=32 Identities=19% Similarity=0.310 Sum_probs=28.4
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 56899999999999999888899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=84.95 E-value=0.85 Score=42.56 Aligned_cols=17 Identities=35% Similarity=0.413 Sum_probs=15.6
Q ss_pred CCceEecCCCCCcEEEe
Q psy1812 70 SKNIAHRDLKCENILMT 86 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~ 86 (304)
...++|+|+.+.||+++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 46899999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=83.56 E-value=0.47 Score=42.56 Aligned_cols=31 Identities=26% Similarity=0.575 Sum_probs=25.6
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.+ .+.++||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNK-CLRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC--CEEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCC-cEEEEEecCCCC
Confidence 4679999999999999755 489999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=82.82 E-value=0.57 Score=42.36 Aligned_cols=31 Identities=29% Similarity=0.515 Sum_probs=25.9
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
...++|||+.+.||+++.+ .+.++||..+.+
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4689999999999999765 488999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=81.83 E-value=0.58 Score=43.21 Aligned_cols=32 Identities=34% Similarity=0.577 Sum_probs=25.4
Q ss_pred CCceEecCCCCCcEEEecC----------------------------CCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKR----------------------------FNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~----------------------------~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.+ +.+.++||..+.+
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 4679999999999999875 5678888887753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.22 E-value=5 Score=33.42 Aligned_cols=104 Identities=8% Similarity=0.054 Sum_probs=70.9
Q ss_pred eeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HhhhcccCCCCCcCCCCCCceEecCCCCCcEEEe
Q psy1812 8 QRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLE-YLHREITNHTPFTAHLPSKNIAHRDLKCENILMT 86 (304)
Q Consensus 8 ~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~-~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~ 86 (304)
.+++.+.+.++.-.++.=+..++. ++....+.++.+|+.... +++ .-+|.-+.|+|++++
T Consensus 58 ~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~~----------------~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 58 VSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHSA----------------RRLIFIVCPENLMFN 118 (219)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCCS----------------SSEECCCCGGGEEEC
T ss_pred EeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhhh----------------CceeEEEeCceEEEe
Confidence 445677777777755544445543 788999999999988666 554 347888999999999
Q ss_pred cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHH-HHHHHHHHHHhCCCCCC
Q psy1812 87 KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIW-SLGVITFIMLNAAMPFD 157 (304)
Q Consensus 87 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvw-slG~ll~~ll~g~~pf~ 157 (304)
.++.+++.-.|.-.. ++|..+ ...|.| ..=|++..++.++..|.
T Consensus 119 ~~~~p~i~hRGi~~~--------------------lpP~e~-------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RALEPFFLHVGVKES--------------------LPPDEW-------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TTCCEEESCCEETTT--------------------BSSCSC-------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CCCcEEEEEcCCccc--------------------CCCCCC-------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999986665321 222221 113443 36678888888887773
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=80.17 E-value=1.4 Score=39.99 Aligned_cols=32 Identities=25% Similarity=0.498 Sum_probs=28.1
Q ss_pred CCceEecCCCCCcEEEecC----CCeEEEeccCccc
Q psy1812 70 SKNIAHRDLKCENILMTKR----FNVKIADFGFARY 101 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~----~~~kl~dfg~~~~ 101 (304)
...++|+|+.+.||+++.+ +.+.++||.++..
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 5689999999999999876 6899999998853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 304 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-34 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.004 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-24 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-23 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-44
Identities = 48/265 (18%), Positives = 97/265 (36%), Gaps = 29/265 (10%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + + I M + D G L +K+AG + E ++ GL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--- 123
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRD+K NIL+ R +K+ DFG + +D ++ ++ G+ +
Sbjct: 124 ----------HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRS 168
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y +PE + G Y+ + +DIWS+G+ M P + K+L +
Sbjct: 169 YMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEL----------ELMFGC 217
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
+ + + + + + + S + ++
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
V + L + +R L + H +++
Sbjct: 278 VNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-40
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+++ RV++ + YA G + +++ E T+ +++ L Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH------ 123
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK + HRD+K EN+L+ +KIADFG++ + T CG+ Y
Sbjct: 124 --------SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDY 170
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
PE+I G ++ K D+WSLGV+ + L PF+ + ++ +K I + D
Sbjct: 171 LPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVEFTFPD 225
Query: 182 ILSHQVK--VKDILSHQVK----VKDILSH 205
++ + + +L H ++++L H
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEH 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-35
Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 66/265 (24%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++ + + G ++F+ Y G+L D I+ + E +A+ +F Q++AG+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH----- 120
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRD+K EN+L+ +R N+KI+DFG A R L CG+
Sbjct: 121 ---------GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 170
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APE++ ++ + D+WS G++ ML +P+D + + S + K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-------DSCQEYSDWKEKK 223
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
L+ K+ L
Sbjct: 224 TYLNPWKKI--------------------------------------------DSAPLAL 239
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
+ +IL + + RI + IK W
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYN 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-35
Identities = 49/195 (25%), Positives = 99/195 (50%), Gaps = 22/195 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
++++ Q +++ + YA NG+LL +I++ G E+ R + +++++ LEYLH
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH----- 125
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
K I HRDLK ENIL+ + +++I DFG A+ E ++ + ++ G+A
Sbjct: 126 ---------GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQ 175
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y +PE+++ +D+W+LG I + ++ PF N +F+ I+ +
Sbjct: 176 YVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----KIIKLEYDFP 230
Query: 181 DILSHQVKVKDILSH 195
+ + +D++
Sbjct: 231 EKFFPK--ARDLVEK 243
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-35
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 6 ILQRGPRVFIFMRYADNGDLLDHIKRA----GPVAESNARTWFSQMLAGLEYLHREITNH 61
I + ++I M Y + GDL I + + E +Q+ L+ HR
Sbjct: 73 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---- 128
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+ HRDLK N+ + + NVK+ DFG AR ++ + G+ Y
Sbjct: 129 -----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTPYY 180
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFK 166
+PE ++ YN K +DIWSLG + + + PF + K+L
Sbjct: 181 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAG 224
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (313), Expect = 1e-34
Identities = 58/270 (21%), Positives = 91/270 (33%), Gaps = 73/270 (27%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+Q+ + F+ G+L D++ ++E R +L + LH
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH----- 127
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
NI HRDLK ENIL+ N+K+ DFGF+ E R CG+ +
Sbjct: 128 ---------KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPS 174
Query: 121 YAAPEVISGNPYNPKL-----ADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSH 175
Y APE+I + + D+WS GVI + +L + PF + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 176 QVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235
I+S + D S
Sbjct: 227 ------------------------------------IMSGNYQFGS------PEWDDYSD 244
Query: 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLR 265
VK+LV + L KR + AH + +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-34
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTP 63
S ++ + + +G L ++KR + R+W Q+L GL++LH
Sbjct: 78 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR------ 131
Query: 64 FTAHLPSKNIAHRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYA 122
+ I HRDLKC+NI +T +VKI D G A ++ G+ +
Sbjct: 132 ------TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFM 180
Query: 123 APEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS-NLKQLFKEQTSNILSHQVKVKD 181
APE+ Y+ D+++ G+ M + P+ + N Q+++ TS +
Sbjct: 181 APEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK 236
Query: 182 ILSHQVK--VKDILSHQVK----VKDILSH 205
+ +VK ++ + +KD+L+H
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 8 QRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
P++ I ++ + L H+ Q G++YLH
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---------- 122
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
K+I HRDLK NI + + VKI DFG A G GS + APEV
Sbjct: 123 ----KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEV 177
Query: 127 ISG---NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
I NPY+ + +D+++ G++ + ++ +P+ + N +
Sbjct: 178 IRMQDKNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-33
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+ Q +F M Y + GDL+ HI+ S A + ++++ GL++LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH------ 120
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
SK I +RDLK +NIL+ K ++KIADFG + + + + T+CG+ Y
Sbjct: 121 --------SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDY 169
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
APE++ G YN D WS GV+ + ML PF + ++LF +I
Sbjct: 170 IAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMDNPFYPR 224
Query: 182 ILSHQVK 188
L + K
Sbjct: 225 WLEKEAK 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-33
Identities = 53/271 (19%), Positives = 89/271 (32%), Gaps = 75/271 (27%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ ++I + + G + + + P+ ES + Q L L YLH
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---- 127
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
I HRDLK NIL T ++K+ADFG + RR ++ G+
Sbjct: 128 ----------DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTP 174
Query: 120 AYAAPEVISGN-----PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILS 174
+ APEV+ PY+ K AD+WSLG+ M P + N ++ I
Sbjct: 175 YWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLL----KIAK 229
Query: 175 HQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234
+ S S
Sbjct: 230 SEPPTLAQPSR-----------------------------------------------WS 242
Query: 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265
K+ + + LE ++ R + H ++
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (303), Expect = 2e-32
Identities = 57/293 (19%), Positives = 103/293 (35%), Gaps = 73/293 (24%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+H + + + + G+L + + ++E A + Q+ GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----- 141
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCGS 118
N H DLK ENI+ T + + +K+ DFG + K+ + G+
Sbjct: 142 ---------ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK----VTTGT 188
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
A +AAPEV G P D+WS+GV+++I+L+ PF N + + N+ S
Sbjct: 189 AEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLR----NVKSCDWN 243
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
+ D + S K
Sbjct: 244 MDDSAFSGI----------------------------------------------SEDGK 257
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR-YKSMVRRKVLPGQKLVHSNLSVKQT 290
+ + ++L D R+ + H WL + R +P + S+K
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK 310
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (295), Expect = 1e-31
Identities = 43/173 (24%), Positives = 62/173 (35%), Gaps = 25/173 (14%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
Q R ++ M Y P+ E L GL YLH
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH------ 132
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
S N+ HRD+K NIL+++ VK+ DFG A + ++ G+ +
Sbjct: 133 --------SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYW 177
Query: 122 AAPEVISG---NPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
APEVI Y+ K D+WSLG+ + P + N N
Sbjct: 178 MAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 116 bits (292), Expect = 7e-31
Identities = 49/282 (17%), Positives = 98/282 (34%), Gaps = 72/282 (25%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITN 60
+H + + + + + G+L D I ++E+ + Q GL+++H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----- 144
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCGS 118
+I H D+K ENI+ + VKI DFG A E + + +
Sbjct: 145 ---------EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTAT 191
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
A +AAPE++ P D+W++GV+ +++L+ PF + + + N+ +
Sbjct: 192 AEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKRCDWE 246
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
+ V S + K
Sbjct: 247 FDEDAFSSV----------------------------------------------SPEAK 260
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKL 280
+ + +L+ + KR+ + H WL+ +P +
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 4e-30
Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 72/299 (24%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+ I + G +++ M+ G+L D I G E +A Q+L ++YLH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH------ 124
Query: 62 TPFTAHLPSKNIAHRDLKCENIL---MTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
I HRDLK EN+L + + + I+DFG ++ + T CG+
Sbjct: 125 --------DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGT 172
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
Y APEV++ PY+ D WS+GVI +I+L PF D N +LF++
Sbjct: 173 PGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQ----------- 220
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
IL + + D +S K
Sbjct: 221 ---------------------------------ILKAEYEFDS------PYWDDISDSAK 241
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSNLSVKQTPKTAFTA 297
+ + ++E D KR + H W+ + + + + K K AF A
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNA 300
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-30
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 19/171 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ G +++ M Y G L D + + E + L LE+LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH----- 133
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S + HRD+K +NIL+ +VK+ DFGF ++ +R T G+
Sbjct: 134 ---------SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPY 181
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSN 171
+ APEV++ Y PK DIWSLG++ M+ P+ + N + +N
Sbjct: 182 WMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 1e-29
Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 15/180 (8%)
Query: 9 RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
GP +I M Y D L D + GP+ A + L + H
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH------------- 128
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
I HRD+K NI+++ VK+ DFG AR D + G+A Y +PE
Sbjct: 129 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 129 GNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVK 188
G+ + + +D++SLG + + +L PF + + + + LS +
Sbjct: 188 GDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 61/267 (22%), Positives = 97/267 (36%), Gaps = 70/267 (26%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNH 61
++ + I M D G+L I+ G E A + ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH------ 128
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFN---VKIADFGFARYCVDKEGRRVLSRTYCGS 118
S NIAHRD+K EN+L T + +K+ DFGFA+ T C +
Sbjct: 129 --------SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYT 176
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
Y APEV+ Y+ D+WSLGVI +I+L PF ++ + + I Q +
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 179 VKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238
+ +V S +VK
Sbjct: 236 FPNPEWSEV----------------------------------------------SEEVK 249
Query: 239 NLVGQILEPDITKRIRLDAIKAHDWLR 265
L+ +L+ + T+R+ + H W+
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 47/268 (17%), Positives = 94/268 (35%), Gaps = 72/268 (26%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREIT 59
+ +H + + + + D+ + I + + E ++ Q+ L++LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---- 119
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFN--VKIADFGFARYCVDKEGRRVLSRTYCG 117
S NI H D++ ENI+ R + +KI +FG AR + R
Sbjct: 120 ----------SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR----LLFT 165
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQV 177
+ Y APEV + + D+WSLG + +++L+ PF +Q+ + NI++ +
Sbjct: 166 APEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIE----NIMNAEY 220
Query: 178 KVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237
+ ++ S +
Sbjct: 221 TFDEEAFKEI----------------------------------------------SIEA 234
Query: 238 KNLVGQILEPDITKRIRLDAIKAHDWLR 265
+ V ++L + R+ H WL+
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (275), Expect = 2e-28
Identities = 47/217 (21%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + ++ + + GDL H+ + G +E++ R + ++++ GLE++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH----- 124
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
++ + +RDLK NIL+ + +V+I+D G A K+ G+
Sbjct: 125 ---------NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHG 170
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEV+ AD +SLG + F +L PF K E L+ V++
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELP 229
Query: 181 DILSHQVK--VKDILSHQVKVKDILSHQVKVKDILSH 215
D S +++ ++ +L V + + +++
Sbjct: 230 DSFSPELRSLLEGLLQRDVN-RRLGCLGRGAQEVKES 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 53/252 (21%), Positives = 93/252 (36%), Gaps = 38/252 (15%)
Query: 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
+ + DL +K ++ + + Q+L GL+Y+H S N+
Sbjct: 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH--------------SANV 130
Query: 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYN 133
HRDLK N+L+ ++KI DFG AR Y + Y APE++ +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 134 PKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDIL 193
K DIWS+G I ML+ F + + S + + + + +L
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 194 SHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI 253
S K K + ++ + +L+ ++L + KRI
Sbjct: 251 SLPHKNKVPWN-----------------------RLFPNADSKALDLLDKMLTFNPHKRI 287
Query: 254 RLDAIKAHDWLR 265
++ AH +L
Sbjct: 288 EVEQALAHPYLE 299
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-28
Identities = 68/235 (28%), Positives = 117/235 (49%), Gaps = 34/235 (14%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ Q ++F+ M Y + G+L ++++ A+ + +++ LEYLH
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---- 122
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
K+I +RDLK ENIL+ K ++KI DFGFA+Y D T CG+
Sbjct: 123 ----------KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLCGTPD 166
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEV+S PYN D WS G++ + ML PF DSN + ++ IL+ +++
Sbjct: 167 YIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFP 221
Query: 181 DILSHQVKVKDILSHQVKV---KDILSHQVKVKDILSH----QVKLKDILSHQVK 228
+ VKD+LS + + + + Q +D+ +H +V + +LS ++
Sbjct: 222 PFFNED--VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-28
Identities = 46/255 (18%), Positives = 85/255 (33%), Gaps = 37/255 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+++ + ++ S + +L GL Y+H
Sbjct: 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--------------RN 136
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFAR-YCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K N+L+T+ +K+ADFG AR + + K + + Y PE++ G
Sbjct: 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
D+W G I M + + + + +
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA-----------LISQLC------G 239
Query: 191 DILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250
I D K++ + + K+KD L + +L+ ++L D
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-----AYVRDPYALDLIDKLLVLDPA 294
Query: 251 KRIRLDAIKAHDWLR 265
+RI D HD+
Sbjct: 295 QRIDSDDALNHDFFW 309
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-28
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 16/157 (10%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70
+ M A+ G L ++++ V + N Q+ G++YL
Sbjct: 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-------------- 125
Query: 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
N HRDL N+L+ + KI+DFG ++ E + APE I+
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 131 PYNPKLADIWSLGVITFIMLNA-AMPFDDSNLKQLFK 166
++ K +D+WS GV+ + + P+ ++
Sbjct: 186 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 45/266 (16%), Positives = 84/266 (31%), Gaps = 45/266 (16%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ + + + + + + + + S+ + + L GLEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----- 117
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I HRDLK N+L+ + +K+ADFG A+ +
Sbjct: 118 ---------QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY---THQVVTRW 165
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD-DSNLKQLFKEQTSNILSHQVKV 179
Y APE++ G D+W++G I +L DS+L QL + + + +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225
Query: 180 KDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239
D+ S V + + I S + +
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSA---------------------------AGDDLLD 258
Query: 240 LVGQILEPDITKRIRLDAIKAHDWLR 265
L+ + + RI +
Sbjct: 259 LIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-27
Identities = 39/230 (16%), Positives = 86/230 (37%), Gaps = 38/230 (16%)
Query: 3 VHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITN 60
+ I++ ++I Y G L+D+++ G + + + +EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----- 120
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
N HRDL N+L+++ K++DFG + + T
Sbjct: 121 ---------GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVK 165
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
+ APE + ++ K +D+WS G++ + + +P+ LK + +++
Sbjct: 166 WTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDA 221
Query: 180 KDILSHQVKVKDILSH--QVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227
D V +++ + + S + L+ I +H++
Sbjct: 222 PDGCPPA--VYEVMKNCWHLDAAMRPS----FLQLREQ---LEHIKTHEL 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-27
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 17/160 (10%)
Query: 9 RGPRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAH 67
+ + + M A G L + + + SN Q+ G++YL
Sbjct: 79 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----------- 127
Query: 68 LPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
KN HRDL N+L+ R KI+DFG ++ + + APE I
Sbjct: 128 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 128 SGNPYNPKLADIWSLGVITFIMLNA-AMPFDDSNLKQLFK 166
+ ++ + +D+WS GV + L+ P+ ++
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-26
Identities = 58/234 (24%), Positives = 111/234 (47%), Gaps = 29/234 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ Q R+ M YA+ G+L H+ R E AR + +++++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---- 123
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
+++ +RD+K EN+++ K ++KI DFG + + +T+CG+
Sbjct: 124 ----------RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPE 170
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEV+ N Y D W LGV+ + M+ +PF + + ++LF+ IL +++
Sbjct: 171 YLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP 225
Query: 181 DILSHQVK--VKDILSHQVKVKDILSHQVKVKDILSH----QVKLKDILSHQVK 228
LS + K + +L K + + K+++ H + +D++ ++
Sbjct: 226 RTLSPEAKSLLAGLLKKDPK-QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-26
Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 1 MQVHSILQRGPRVFIFMRYADNG-DLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ +R + + + DL D I G + E AR++F Q+L + + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---- 127
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+ + HRD+K ENIL+ R +K+ DFG D + G+
Sbjct: 128 ----------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGT 172
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVK 178
Y+ PE I + Y+ + A +WSLG++ + M+ +PF+ I+ QV
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVF 222
Query: 179 VKDILSHQVK--VKDILSHQVK----VKDILSH 205
+ +S + + ++ L+ + ++I +H
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.8 bits (82), Expect = 0.004
Identities = 10/46 (21%), Positives = 24/46 (52%)
Query: 220 KDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265
++I+ QV + +S + ++L+ L + R + I+ H W++
Sbjct: 214 EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (255), Expect = 4e-26
Identities = 47/264 (17%), Positives = 90/264 (34%), Gaps = 42/264 (15%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+++ ++ R+ + + D G + A+++ Q+L G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH------ 117
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+ + HRDLK +N+L+ + +KIADFG AR + + Y
Sbjct: 118 --------DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEIVTLWY 166
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
AP+V+ G+ DIWS+G I M+N F + + + K
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 182 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241
++ K + + L +L+
Sbjct: 227 NVTELPKYDPNFTVYEPLP-------------------------WESFLKGLDESGIDLL 261
Query: 242 GQILEPDITKRIRLDAIKAHDWLR 265
++L+ D +RI H + +
Sbjct: 262 SKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 5e-26
Identities = 52/259 (20%), Positives = 91/259 (35%), Gaps = 47/259 (18%)
Query: 8 QRGPRVFIFMRYADNGDL-LDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA 66
R ++ + + D V + Q+L GL++LH
Sbjct: 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----------- 133
Query: 67 HLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEV 126
S + HRDLK +NIL+T +K+ADFG AR + + + Y APEV
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----TSVVVTLWYRAPEV 186
Query: 127 ISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQ 186
+ + Y D+WS+G I M F S+ D L
Sbjct: 187 LLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSD------------------VDQLGKI 227
Query: 187 VKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILE 246
+ V + + +D+ + + ++ K + K+L+ + L
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE---------KFVTDIDELGKDLLLKCLT 278
Query: 247 PDITKRIRLDAIKAHDWLR 265
+ KRI + +H + +
Sbjct: 279 FNPAKRISAYSALSHPYFQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 6e-26
Identities = 38/194 (19%), Positives = 70/194 (36%), Gaps = 40/194 (20%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKR-----------------------AGPVAES 38
+ +++ Y GDLL++++ +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 39 NARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGF 98
+ + Q+ G+E+L K+ HRDL N+L+T VKI DFG
Sbjct: 165 DLLCFAYQVAKGMEFLE--------------FKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 99 ARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA-AMPFD 157
AR + + V+ + APE + Y K +D+WS G++ + + + P+
Sbjct: 211 AR-DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYP 268
Query: 158 DSNLKQLFKEQTSN 171
+ F + N
Sbjct: 269 GIPVDANFYKLIQN 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-25
Identities = 41/158 (25%), Positives = 59/158 (37%), Gaps = 17/158 (10%)
Query: 11 PRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
P + + A G LLD + K G + Q+ G+ YL
Sbjct: 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-------------- 128
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
SK HRDL N+L+ R VKI DFG R + V+ A+ APE +
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 130 NPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFK 166
++ +D W GV + M P+ N Q+
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 2e-25
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+++ + +++ M Y G++ H++R G +E +AR + +Q++ EYLH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH----- 158
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S ++ +RDLK EN+L+ ++ +++ DFGFA+ + T CG+
Sbjct: 159 ---------SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLCGTPE 203
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
APE+I YN D W+LGV+ + M PF Q+++ I+S +V+
Sbjct: 204 ALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYE----KIVSGKVRFP 258
Query: 181 DILSHQVK--VKDILSHQVKVKDILSHQVKVKDILSH 215
S +K ++++L + K + + V DI +H
Sbjct: 259 SHFSSDLKDLLRNLLQVDLT-KRFGNLKNGVNDIKNH 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 100 bits (250), Expect = 3e-25
Identities = 38/255 (14%), Positives = 86/255 (33%), Gaps = 38/255 (14%)
Query: 12 RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
+ + +N D + + + + R + ++L L+Y H S
Sbjct: 106 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH--------------SM 148
Query: 72 NIAHRDLKCENILMTKRFN-VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN 130
I HRD+K N+++ +++ D+G A + + S + PE++
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDY 204
Query: 131 PYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVK 190
D+WSLG + M+ PF + + + +L + I +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN---- 260
Query: 191 DILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDIT 250
+ + DIL + + + + ++S + + + ++L D
Sbjct: 261 ------------IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 251 KRIRLDAIKAHDWLR 265
R+ H +
Sbjct: 309 SRLTAREAMEHPYFY 323
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 4e-25
Identities = 58/268 (21%), Positives = 99/268 (36%), Gaps = 73/268 (27%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+H + + V + + G+L D + + E A + Q+L G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH------ 130
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKR----FNVKIADFGFARYCVDKEGRRVLSRTYCG 117
S IAH DLK ENI++ R +KI DFG A + G
Sbjct: 131 --------SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFG 178
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQV 177
+ + APE+++ P + AD+WS+GVIT+I+L+ A PF ++ N+ +
Sbjct: 179 TPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNY 233
Query: 178 KVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237
+ +D + S
Sbjct: 234 EFED----------------------------------------------EYFSNTSALA 247
Query: 238 KNLVGQILEPDITKRIRLDAIKAHDWLR 265
K+ + ++L D KR+ + H W++
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 7e-25
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 20/159 (12%)
Query: 11 PRVFIFMRYADNGDLLDHI--KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
++I Y G LLD + + + +Q+ +G+ Y+ R
Sbjct: 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER------------ 131
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
N HRDL+ NIL+ + K+ADFG AR D E + + APE
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAAL 187
Query: 129 GNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFK 166
+ K +D+WS G++ + +P+ +++
Sbjct: 188 YGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-24
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 13/183 (7%)
Query: 10 GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
++++ Y ++G L D++ R V +GL +LH EI
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGT------QG 125
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGF-ARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
IAHRDLK +NIL+ K IAD G R+ + + G+ Y APEV+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 129 GNPYNPKL-----ADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDIL 183
+ ADI+++G++ + + QL +++ ++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 184 SHQ 186
Q
Sbjct: 246 CEQ 248
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-24
Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREIT 59
+Q++ + + +FI Y NG LL++++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
K HRDL N L+ + VK++DFG +RY +D E S
Sbjct: 119 -----------KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPV 165
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPFDDSNLKQLFK 166
++ PEV+ + ++ K +DIW+ GV+ + + + MP++ + +
Sbjct: 166 RWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 2e-24
Identities = 45/254 (17%), Positives = 78/254 (30%), Gaps = 44/254 (17%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
V ++ + + + + + Q+ L Y+H S
Sbjct: 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--------------SFG 142
Query: 73 IAHRDLKCENI-LMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
I HRD+K +N+ L +K+ DFG A+ V E + +Y S Y APE+I G
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGAT 198
Query: 132 YNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKD 191
D+WS G + +L F + E + + + I +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIREMNPNYTE 256
Query: 192 ILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITK 251
Q+K + + L ++LE T
Sbjct: 257 FKFPQIKAHPWTK-----------------------VFRPRTPPEAIALCSRLLEYTPTA 293
Query: 252 RIRLDAIKAHDWLR 265
R+ AH +
Sbjct: 294 RLTPLEACAHSFFD 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 4e-24
Identities = 35/169 (20%), Positives = 71/169 (42%), Gaps = 8/169 (4%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHRE--I 58
+ + + +++ + YA +G+LLD ++++ + A + + L
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
+ +L K HRDL NIL+ + + KIADFG +R V
Sbjct: 134 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLP 189
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFK 166
+ A E ++ + Y +D+WS GV+ + ++ P+ +L++
Sbjct: 190 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.1 bits (241), Expect = 5e-24
Identities = 34/170 (20%), Positives = 64/170 (37%), Gaps = 19/170 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDH-IKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+ + ++ + V I + +NG L + G + AG++YL
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD--- 146
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRT--YCG 117
N HRDL NIL+ K++DFG +R+ D +
Sbjct: 147 -----------MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 118 SAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPFDDSNLKQLFK 166
+ APE I + +D+WS G++ + +++ P+ D + +
Sbjct: 196 PIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 6e-24
Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 24/235 (10%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
+ +H Q ++ + + Y + G+L H+ + E + + +++ LE+LH+
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---- 147
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
I +RD+K ENIL+ +V + DFG ++ V E R + +CG+
Sbjct: 148 ----------LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIE 195
Query: 121 YAAPEVISGNPYNP-KLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y AP+++ G K D WSLGV+ + +L A PF K E + IL +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 180 KDILSHQVK--VKDILSHQVKVKDILSHQVKVKDILSH----QVKLKDILSHQVK 228
+S K ++ +L K K + +I H ++ D+ + +V
Sbjct: 256 PQEMSALAKDLIQRLLMKDPK-KRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 8e-24
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 18/158 (11%)
Query: 11 PRVFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLP 69
V + + G LLD++ + + W Q+ G+ YL
Sbjct: 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED------------- 129
Query: 70 SKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG 129
+ + HRDL N+L+ +VKI DFG A+ E + + + A E I
Sbjct: 130 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYHAEGGKVPIKWMALESILH 187
Query: 130 NPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFK 166
Y + +D+WS GV + ++ + P+D ++
Sbjct: 188 RIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS 224
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.0 bits (238), Expect = 1e-23
Identities = 27/174 (15%), Positives = 59/174 (33%), Gaps = 24/174 (13%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
V+ Q G + + + QMLA ++ +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----- 118
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRF-----NVKIADFGFARYCVDKEGRRVL---- 111
K++ +RD+K +N L+ + + + DFG ++ D ++ +
Sbjct: 119 ---------EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 112 SRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
+ G+A Y + G + + D+ +LG + L ++P+
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNK 222
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.1 bits (238), Expect = 1e-23
Identities = 35/191 (18%), Positives = 69/191 (36%), Gaps = 41/191 (21%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG------------------------PVA 36
+++ + G + + Y GDL + ++ P++
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 37 ESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADF 96
+ Q+ AG+ YL + HRDL N L+ + VKIADF
Sbjct: 139 CAEQLCIARQVAAGMAYLS--------------ERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 97 GFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM-P 155
G +R + + + PE I N Y + +D+W+ GV+ + + + + P
Sbjct: 185 GLSRNIYSADYYKA-DGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQP 242
Query: 156 FDDSNLKQLFK 166
+ +++
Sbjct: 243 YYGMAHEEVIY 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 2e-23
Identities = 50/266 (18%), Positives = 88/266 (33%), Gaps = 43/266 (16%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDL-LDHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ ++ ++++ + + +++ Q+L GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---- 119
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
S + HRDLK +N+L+ +K+ADFG AR +
Sbjct: 120 ----------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTL 166
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKV 179
Y APE++ G Y DIWSLG I M+ F + + + V
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 180 KDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239
++ K + KV L ++
Sbjct: 227 WPGVTSMPDYKPSFPKWAR-------------------------QDFSKVVPPLDEDGRS 261
Query: 240 LVGQILEPDITKRIRLDAIKAHDWLR 265
L+ Q+L D KRI A AH + +
Sbjct: 262 LLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 3e-23
Identities = 34/171 (19%), Positives = 58/171 (33%), Gaps = 22/171 (12%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
+ G + M + + QM++ +EY+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH------ 120
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKR---FNVKIADFGFARYCVDKEGRRVL----SRT 114
SKN HRD+K +N LM V I DFG A+ D + + ++
Sbjct: 121 --------SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 115 YCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLF 165
G+A YA+ G + + D+ SLG + ++P+
Sbjct: 173 LTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKR 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 6e-23
Identities = 35/159 (22%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 11 PRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHL 68
++I Y +NG L+D +K + + +Q+ G+ ++
Sbjct: 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE------------- 126
Query: 69 PSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS 128
+N HRDL+ NIL++ + KIADFG AR ++ + APE I+
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAIN 183
Query: 129 GNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFK 166
+ K +D+WS G++ ++ + +P+ ++ +
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.6 bits (232), Expect = 6e-23
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHI--KRAGPVAESNARTWFSQMLAGLEYLHREI 58
+Q+ + R P +I + G+LLD++ V+ +Q+ + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 59 TNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGS 118
KN HRDL N L+ + VK+ADFG +R
Sbjct: 133 -----------KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFP 179
Query: 119 AAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM-PFDDSNLKQLFK 166
+ APE ++ N ++ K +D+W+ GV+ + + M P+ +L Q+++
Sbjct: 180 IKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 1e-22
Identities = 34/161 (21%), Positives = 68/161 (42%), Gaps = 18/161 (11%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDH-IKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+Q++ + + + + ++G L D+ + G A + G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---- 118
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+ HRDL N L+ + +K++DFG R+ +D + S
Sbjct: 119 ----------EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPV 166
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+A+PEV S + Y+ K +D+WS GV+ + + + ++
Sbjct: 167 KWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENR 206
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 1e-21
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIK-RAGPVAESNARTWFSQMLAGLEYLHREITNHT 62
L+ + + Y +GDL + I+ + + Q+ G+++L
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS------ 148
Query: 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRT-YCGSAAY 121
K HRDL N ++ ++F VK+ADFG AR DKE V ++T +
Sbjct: 149 --------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIML-NAAMPFDDSNLKQLFK 166
A E + + K +D+WS GV+ + ++ A P+ D N +
Sbjct: 201 MALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-21
Identities = 40/183 (21%), Positives = 76/183 (41%), Gaps = 33/183 (18%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGP----------------VAESNARTWF 44
+ + + +++ + YA G+L ++++ P ++ + +
Sbjct: 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 45 SQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVD 104
Q+ G+EYL SK HRDL N+L+T+ +KIADFG AR +
Sbjct: 142 YQVARGMEYLA--------------SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-DIH 186
Query: 105 KEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA-AMPFDDSNLKQ 163
+ + APE + Y + +D+WS GV+ + + P+ +++
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 164 LFK 166
LFK
Sbjct: 246 LFK 248
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 2e-21
Identities = 47/264 (17%), Positives = 92/264 (34%), Gaps = 41/264 (15%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNH 61
++H +L ++ + + D G + +++ Q+L GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS----- 119
Query: 62 TPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAY 121
+N+ HRDLK +N+L+ + +K+A+FG AR + Y
Sbjct: 120 ---------RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWY 167
Query: 122 AAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKD 181
P+V+ G D+WS G I + NA P N V D
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----------------DVDD 210
Query: 182 ILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLV 241
L ++ + + K + L +++ L+ ++L+
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK-------LNATGRDLL 263
Query: 242 GQILEPDITKRIRLDAIKAHDWLR 265
+L+ + +RI + H +
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 2e-21
Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 16/161 (9%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDH-IKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
+++ ++ + + I Y +NG L ++ G + + AG++YL
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN--- 128
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
N HRDL NIL+ K++DFG +R D +
Sbjct: 129 -----------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 120 AYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+ APE IS + +D+WS G++ + ++
Sbjct: 178 RWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWEL 217
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-21
Identities = 53/253 (20%), Positives = 83/253 (32%), Gaps = 45/253 (17%)
Query: 13 VFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72
++ M + G L + + + E + QML GL Y+H +
Sbjct: 98 FYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH--------------AAG 141
Query: 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPY 132
I HRDLK N+ + + +KI DFG AR + Y + Y APEVI
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMR 195
Query: 133 NPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDI 192
+ DIWS+G I M+ F S+ KE + + L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 193 LSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKR 252
K + + S NL+ ++L D +R
Sbjct: 256 KGLPELEKKDFA-----------------------SILTNASPLAVNLLEKMLVLDAEQR 292
Query: 253 IRLDAIKAHDWLR 265
+ AH +
Sbjct: 293 VTAGEALAHPYFE 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 3e-21
Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 34/265 (12%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITN 60
L+ V++ M D QML G+++LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIKHLH----- 136
Query: 61 HTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAA 120
S I HRDLK NI++ +KI DFG AR + Y +
Sbjct: 137 ---------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRY 183
Query: 121 YAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVK 180
Y APEVI G Y DIWS+G I M+ + F + + + + + +
Sbjct: 184 YRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 181 DILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240
L V++ + ++ K + ++ + + + + Q ++L
Sbjct: 243 KKLQP------------TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 241 VGQILEPDITKRIRLDAIKAHDWLR 265
+ ++L D KRI +D H ++
Sbjct: 291 LSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-20
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 13 VFIFMRYADNGDLLDHI-KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSK 71
V+I M G+L + R + ++ + Q+ L YL K
Sbjct: 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--------------K 127
Query: 72 NIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP 131
HRD+ N+L++ VK+ DFG +RY D + + + APE I+
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK--ASKGKLPIKWMAPESINFRR 185
Query: 132 YNPKLADIWSLGVITF-IMLNAAMPFDDSNLKQLFK 166
+ +D+W GV + I+++ PF +
Sbjct: 186 FTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 3e-20
Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 32/276 (11%)
Query: 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
+F +N L + + Q+L GL+Y+HR I
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-------------CGI 147
Query: 74 AHRDLKCENILMT------KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVI 127
H D+K EN+LM +KIAD G A + + + Y +PEV+
Sbjct: 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVL 201
Query: 128 SGNPYNPKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQV 187
G P+ ADIWS + F ++ F+ K+ + L ++
Sbjct: 202 LGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDD------DHIAQIIELLGEL 254
Query: 188 KVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEP 247
+ + + S + L+D+L+ + K + ++ + + +L+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 248 DITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHS 283
D KR + H WL+ + +P ++L S
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 1e-19
Identities = 52/252 (20%), Positives = 94/252 (37%), Gaps = 43/252 (17%)
Query: 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNI 73
+++ G L++I + + + + + Q+L GL+Y+H S +I
Sbjct: 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--------------SADI 142
Query: 74 AHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYN 133
HRDLK N+ + + +KI DFG AR+ D+ Y + Y APE++ +
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIMLNWMHY 196
Query: 134 PKLADIWSLGVITFIMLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDIL 193
+ DIWS+G I +L F ++ K + + ++ +S + I
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 194 SHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRI 253
S K + V + +L+ ++L D KRI
Sbjct: 257 SLTQMPKMNFA-----------------------NVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 254 RLDAIKAHDWLR 265
AH +
Sbjct: 294 TAAQALAHAYFA 305
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-19
Identities = 38/177 (21%), Positives = 62/177 (35%), Gaps = 34/177 (19%)
Query: 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKR------------------AGPVAESNARTW 43
+ G + Y GDLL+ ++R + + ++
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 44 FSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCV 103
Q+ G+ +L SKN HRDL NIL+T KI DFG AR +
Sbjct: 151 SYQVAKGMAFLA--------------SKNCIHRDLAARNILLTHGRITKICDFGLAR-DI 195
Query: 104 DKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160
+ V+ + APE I Y + +D+WS G+ + + +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM 251
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 8e-19
Identities = 38/182 (20%), Positives = 72/182 (39%), Gaps = 33/182 (18%)
Query: 4 HSILQRGPRVFIFMRYADNGDLLDHIKR----------------AGPVAESNARTWFSQM 47
+ + G + + + + G+L +++ + + + Q+
Sbjct: 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143
Query: 48 LAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEG 107
G+E+L S+ HRDL NIL++++ VKI DFG AR K+
Sbjct: 144 AKGMEFLA--------------SRKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDP 188
Query: 108 RRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFK 166
V + APE I Y + +D+WS GV+ + + + A P+ + + F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 167 EQ 168
+
Sbjct: 248 RR 249
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 1e-18
Identities = 34/177 (19%), Positives = 69/177 (38%), Gaps = 27/177 (15%)
Query: 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIK----------RAGPVAESNARTWFSQMLAG 50
+++ ++ +G + M GDL +++ P + S ++ G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 51 LEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRV 110
+ YL+ + HRDL N ++ + F VKI DFG R + + R
Sbjct: 146 MAYLN--------------ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 111 LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDSNLKQLFK 166
+ +PE + + +D+WS GV+ + + A P+ + +Q+ +
Sbjct: 192 -GGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.0 bits (116), Expect = 1e-07
Identities = 26/144 (18%), Positives = 45/144 (31%), Gaps = 26/144 (18%)
Query: 4 HSILQRGPRVFIFMRYADNGDLL----DHIKRAGPVAESNARTWFSQMLAGLEYLHREIT 59
LQ+ + + YA G+ + K V N +L + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH--- 121
Query: 60 NHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSA 119
+ I H DL N+L+++ + I DF + ++ R +L R
Sbjct: 122 -----------RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNII 169
Query: 120 AYAAPEVISGNPYNPKLADIWSLG 143
Y Y + DI S
Sbjct: 170 TYF------SRTYRTE-KDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.37 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.94 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 85.1 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=328.24 Aligned_cols=193 Identities=26% Similarity=0.561 Sum_probs=173.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|+++.+++.+++|||||+||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 69 v~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH--------------~~~ivHrDiKp 134 (263)
T d2j4za1 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--------------SKRVIHRDIKP 134 (263)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred CeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeeeeecc
Confidence 6899999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+
T Consensus 135 ~Nill~~~~~~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 135 ENLLLGSAGELKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp GGEEECTTSCEEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccceecCCCCEeecccceeeecCCC-----cccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999754322 2345679999999999999888877 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+.+....+ +..+++++.+|
T Consensus 209 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~s~~~~~l 234 (263)
T d2j4za1 209 YQETYKRISRVEFTF------------------------------------------------------PDFVTEGARDL 234 (263)
T ss_dssp HHHHHHHHHTTCCCC------------------------------------------------------CTTSCHHHHHH
T ss_pred HHHHHHHHHcCCCCC------------------------------------------------------CccCCHHHHHH
Confidence 777777665543332 35678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~ 267 (304)
|.+||+.||++|||++|+|+||||+..
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=326.56 Aligned_cols=199 Identities=28% Similarity=0.531 Sum_probs=166.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|+++.+++.++||||||+||+|.+++++.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 66 v~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH--------------~~~IiHrDiKp 131 (271)
T d1nvra_ 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH--------------GIGITHRDIKP 131 (271)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCG
T ss_pred eeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HcCCccCcccH
Confidence 6899999999999999999999999999988888999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||+++....... .......+||+.|+|||++.+..+...++||||+||++|+|++|+.||....
T Consensus 132 ~NILl~~~~~~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 132 ENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred HHEEECCCCCEEEccchhheeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999986543322 1234567899999999999888876555999999999999999999997654
Q ss_pred HHHH-HHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 161 LKQL-FKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 161 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
.... ...+... ... ......+++++.+
T Consensus 211 ~~~~~~~~~~~~-~~~---------------------------------------------------~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 211 DSCQEYSDWKEK-KTY---------------------------------------------------LNPWKKIDSAPLA 238 (271)
T ss_dssp TTSHHHHHHHTT-CTT---------------------------------------------------STTGGGSCHHHHH
T ss_pred hHHHHHHHHhcC-CCC---------------------------------------------------CCccccCCHHHHH
Confidence 3222 2111111 000 1122457899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
||.+||+.||++|||++|+++||||+.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=321.71 Aligned_cols=198 Identities=27% Similarity=0.478 Sum_probs=170.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.++||||||+||+|.+++.+ +.+++.+++.++.|++.||+||| +.||+||||||
T Consensus 80 v~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH--------------~~~iiHrDiKp 144 (293)
T d1yhwa1 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH--------------SNQVIHRDIKS 144 (293)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred eeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--------------HCCCcccCCcH
Confidence 6899999999999999999999999998866 46999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||++........ .....+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+
T Consensus 145 ~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 145 DNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHeEECCCCcEeeccchhheeeccccc---cccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCC
Confidence 999999999999999999986543322 3445679999999999999888877 999999999999999999998877
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+....+....... ...+..+++++++|
T Consensus 221 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 221 PLRALYLIATNGTPE---------------------------------------------------LQNPEKLSAIFRDF 249 (293)
T ss_dssp HHHHHHHHHHHCSCC---------------------------------------------------CSSGGGSCHHHHHH
T ss_pred HHHHHHHHHhCCCCC---------------------------------------------------CCCcccCCHHHHHH
Confidence 665555444322110 12235689999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
|.+||+.||++|||++|+|+||||+...
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999999998543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=323.35 Aligned_cols=197 Identities=28% Similarity=0.546 Sum_probs=171.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.+|+|||||+||+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 71 v~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH--------------~~~iiHrDiKp 136 (288)
T d1uu3a_ 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--------------GKGIIHRDLKP 136 (288)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc--------------cccEEcCcCCc
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||+++........ ......+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+
T Consensus 137 ~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 137 ENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp GGEEECTTSCEEECCCTTCEECC-----------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCceEEecccccceecccCCcc-cccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcC
Confidence 9999999999999999999865433221 13345679999999999999888877 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+...++.+....+ +..+++++++|
T Consensus 215 ~~~~~~~i~~~~~~~------------------------------------------------------p~~~s~~~~~l 240 (288)
T d1uu3a_ 215 EYLIFQKIIKLEYDF------------------------------------------------------PEKFFPKARDL 240 (288)
T ss_dssp HHHHHHHHHTTCCCC------------------------------------------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHcCCCCC------------------------------------------------------CccCCHHHHHH
Confidence 877777776554333 25678999999
Q ss_pred HHHhcCCCCCccccHHH------HhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLDA------IKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~e------ll~~~wf~~~ 267 (304)
|.+||+.||++|||++| +++||||+..
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999999988 5889999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=325.28 Aligned_cols=200 Identities=31% Similarity=0.558 Sum_probs=165.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.++||||||+||+|.++|.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 70 v~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH--------------~~~iiHrDiKp 135 (307)
T d1a06a_ 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--------------DLGIVHRDLKP 135 (307)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh--------------hceeeeEEecc
Confidence 6899999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEe---cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMT---KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+||++. .++.+||+|||+++...... .....+||+.|+|||++.+..++.+ +||||+||++|+|++|..||.
T Consensus 136 ~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 136 ENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp GGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCC
T ss_pred cceeecccCCCceEEEeccceeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCC
Confidence 999995 47889999999997654332 2345679999999999999888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+....+.......+ ...+..+++++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 240 (307)
T d1a06a_ 211 DENDAKLFEQILKAEYEFD--------------------------------------------------SPYWDDISDSA 240 (307)
T ss_dssp CSSHHHHHHHHHTTCCCCC--------------------------------------------------TTTTTTSCHHH
T ss_pred CCCHHHHHHHHhccCCCCC--------------------------------------------------CccccCCCHHH
Confidence 8888777777776554433 22335688999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||++|||++|+++||||++...
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 99999999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=323.89 Aligned_cols=195 Identities=29% Similarity=0.565 Sum_probs=176.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|++++.+|+|||||+||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 68 v~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH--------------~~~iiHRDlKP 133 (337)
T d1o6la_ 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--------------SRDVVYRDIKL 133 (337)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred EEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh--------------hcCccccccCH
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~---~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEecCCCCEEEeecccccccccCCc---ccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcC
Confidence 999999999999999999975443222 3456789999999999999999877 999999999999999999999998
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+.+..+..+...++ ..+++++++|
T Consensus 210 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~dl 235 (337)
T d1o6la_ 210 HERLFELILMEEIRFP------------------------------------------------------RTLSPEAKSL 235 (337)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHhcCCCCCC------------------------------------------------------ccCCHHHHHH
Confidence 8888777766554433 6789999999
Q ss_pred HHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 241 VGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
|.+||+.||.+|++ ++|+++||||++.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999994 8999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=317.36 Aligned_cols=199 Identities=25% Similarity=0.424 Sum_probs=168.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++.+++.+++|||||+||+|.+++.+. +.+++..++.++.|++.||+||| +.+|+|||||
T Consensus 72 v~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH--------------~~~ivHrDiK 137 (288)
T d2jfla1 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--------------DNKIIHRDLK 137 (288)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred CeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCEEEeecC
Confidence 68999999999999999999999999998764 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCcccccccccc-----CCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVIS-----GNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
|+||+++.++.+||+|||++........ ......||+.|+|||++. +..++.+ +|||||||++|+|++|..
T Consensus 138 p~NIll~~~~~~Kl~DFG~a~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 138 AGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECHHHHH---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHHHHHHHHHHHSSC
T ss_pred hhheeECCCCCEEEEechhhhccCCCcc---cccccccccccCCHHHHhhcccCCCCCChh-hhHHHHHHHHHHHhhCCC
Confidence 9999999999999999999875433211 234567999999999984 3345665 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+.+.++..+.... ...+..++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~---------------------------------------------------~~~~~~~s 242 (288)
T d2jfla1 214 PHHELNPMRVLLKIAKSEPPT---------------------------------------------------LAQPSRWS 242 (288)
T ss_dssp TTTTSCGGGHHHHHHHSCCCC---------------------------------------------------CSSGGGSC
T ss_pred CCCCCCHHHHHHHHHcCCCCC---------------------------------------------------CCccccCC
Confidence 998877666666555432211 12235678
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+++.+||.+||+.||++|||++|+++||||+...
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=316.39 Aligned_cols=199 Identities=29% Similarity=0.514 Sum_probs=173.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|++|.+++.++||||||+||+|.+++.+.+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 76 v~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH--------------~~~ivHrDiKp 141 (293)
T d1jksa_ 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--------------SLQIAHFDLKP 141 (293)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred CcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh--------------hcceeeccccc
Confidence 6899999999999999999999999999999889999999999999999999999 89999999999
Q ss_pred CcEEEecCC----CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 81 ENILMTKRF----NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 81 ~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
+||+++.++ .+|++|||++....... ......|++.|+|||++.+..++.+ +||||+||++|+|++|..||
T Consensus 142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSS
T ss_pred ceEEEecCCCcccceEecchhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCC
Confidence 999998876 49999999997654332 2345678999999999998888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+......++ ...+..+++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~ 246 (293)
T d1jksa_ 217 LGDTKQETLANVSAVNYEFE--------------------------------------------------DEYFSNTSAL 246 (293)
T ss_dssp CCSSHHHHHHHHHTTCCCCC--------------------------------------------------HHHHTTSCHH
T ss_pred CCCCHHHHHHHHHhcCCCCC--------------------------------------------------chhcCCCCHH
Confidence 98888777777766544433 1223567899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.+||.+||+.||++|||++|+++||||+...
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-43 Score=311.49 Aligned_cols=197 Identities=29% Similarity=0.469 Sum_probs=172.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+|||||||+||+|.++|...+.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH--------------~~~ivHrDlkp 138 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--------------KLNIVHRDLKP 138 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------HcCCccccccc
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC------CCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG------NPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
+||+++.++.+||+|||+++...... ......||..|+|||.+.+ ..++.+ +|+||+||++|+|++|+.
T Consensus 139 ~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~-~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 139 ENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSC
T ss_pred ceEEEcCCCCeEEccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCch-heEcccchhhhhhccCCC
Confidence 99999999999999999998665432 2345679999999999853 234444 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+.......+..+....+ ......++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s 243 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFG--------------------------------------------------SPEWDDYS 243 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCC--------------------------------------------------TTTGGGSC
T ss_pred CCCCCCHHHHHHHHHhCCCCCC--------------------------------------------------CcccccCC
Confidence 9999888777777766544333 22235689
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
+++++||.+||+.||++|||++|+++||||+.
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=309.81 Aligned_cols=192 Identities=23% Similarity=0.486 Sum_probs=160.6
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc--eE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN--IA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~--iv 74 (304)
|++|++|.+ ++.+++|||||+||+|.+++.+.+.+++..++.++.|++.||+||| +.+ |+
T Consensus 71 v~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH--------------~~~~~Ii 136 (270)
T d1t4ha_ 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH--------------TRTPPII 136 (270)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------TSSSCCC
T ss_pred eeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH--------------HCCCCEE
Confidence 688999865 4578999999999999999999889999999999999999999999 667 99
Q ss_pred ecCCCCCcEEEe-cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 75 HRDLKCENILMT-KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 75 H~dl~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
||||||+|||++ .++.+||+|||+++..... .....+||+.|+|||++.+ +++.+ +|||||||++|+|++|+
T Consensus 137 HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~ 209 (270)
T d1t4ha_ 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSE 209 (270)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSS
T ss_pred eCCcChhhceeeCCCCCEEEeecCcceeccCC-----ccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCC
Confidence 999999999996 5789999999999753322 2345679999999999875 57776 99999999999999999
Q ss_pred CCCCChh-HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccc
Q psy1812 154 MPFDDSN-LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDI 232 (304)
Q Consensus 154 ~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (304)
.||.+.. .......+..+..+ ...+..
T Consensus 210 ~Pf~~~~~~~~~~~~i~~~~~~----------------------------------------------------~~~~~~ 237 (270)
T d1t4ha_ 210 YPYSECQNAAQIYRRVTSGVKP----------------------------------------------------ASFDKV 237 (270)
T ss_dssp CTTTTCSSHHHHHHHHTTTCCC----------------------------------------------------GGGGGC
T ss_pred CCCCCcccHHHHHHHHHcCCCC----------------------------------------------------cccCcc
Confidence 9997654 34444444433221 112245
Q ss_pred ccHHHHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 233 LSHQVKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 233 ~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
.++++.+||.+||+.||++|||++|+|+||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 688999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=325.54 Aligned_cols=236 Identities=22% Similarity=0.345 Sum_probs=165.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC-CceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS-KNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~-~~ivH~dl~ 79 (304)
|+++++|.++++++||||||+||+|.+++.+.+.+++..++.++.|++.||.||| + .+|+|||||
T Consensus 67 v~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH--------------~~~~IiHRDiK 132 (322)
T d1s9ja_ 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--------------EKHKIMHRDVK 132 (322)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HHHCCCCSCCS
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------HhCCEEccccC
Confidence 6899999999999999999999999999999889999999999999999999999 6 489999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
|+|||++.++.+||+|||++...... ...+.+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.
T Consensus 133 P~NILl~~~~~vkl~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 133 PSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCC
T ss_pred HHHeeECCCCCEEEeeCCCccccCCC-----ccccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999754332 2346789999999999999999888 99999999999999999999776
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcc-c-cccccccHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQ-V-KVKDILSHQV 237 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 237 (304)
+.............................. ...................+.... . .....++.++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 274 (322)
T d1s9ja_ 207 DAKELELMFGCQVEGDAAETPPRPRTPGRPL------------SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274 (322)
T ss_dssp CTTHHHHHC------------------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHH
T ss_pred CHHHHHHHHHHHhcCCcccCCcccccccccc------------cccccccccchhHHHHHhhhhccCCccCccccCCHHH
Confidence 5332211111100000000000000000000 000000000000011111111110 1 1113468999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||.+||++|||++|+|+||||+...
T Consensus 275 ~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 275 QDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 9999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-43 Score=323.03 Aligned_cols=200 Identities=26% Similarity=0.469 Sum_probs=174.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|.+++.++||||||+||+|.+++.+ .+.+++..++.++.||+.||+||| +.+|+|||||
T Consensus 86 v~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH--------------~~~iiHrDiK 151 (350)
T d1koaa2 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--------------ENNYVHLDLK 151 (350)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------hcCCeeeeec
Confidence 6899999999999999999999999999954 457999999999999999999999 8999999999
Q ss_pred CCcEEEec--CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTK--RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus 152 p~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSC
T ss_pred hhHeeeccCCCCeEEEeecchheeccccc----ccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCC
Confidence 99999964 5789999999998654432 2345679999999999999888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+.+..+.......+ ......+++++
T Consensus 227 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 256 (350)
T d1koaa2 227 GENDDETLRNVKSCDWNMD--------------------------------------------------DSAFSGISEDG 256 (350)
T ss_dssp CSSHHHHHHHHHHTCCCSC--------------------------------------------------CGGGGGCCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------cccccCCCHHH
Confidence 8888888777766544333 22235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++||.+||+.||++|||++|+|+||||+....
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-43 Score=322.83 Aligned_cols=199 Identities=24% Similarity=0.474 Sum_probs=175.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|++|.+++.+|||||||+||+|.+++.+.+ .+++.+++.++.||+.||+||| +.||+|||||
T Consensus 89 v~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH--------------~~~iiHRDiK 154 (352)
T d1koba_ 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--------------EHSIVHLDIK 154 (352)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HCCeeecccc
Confidence 689999999999999999999999999887654 6999999999999999999999 8999999999
Q ss_pred CCcEEEe--cCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMT--KRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+|||++ .++.+||+|||++....... ......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus 155 p~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 155 PENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSC
T ss_pred cccccccccCCCeEEEeecccceecCCCC----ceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCC
Confidence 9999997 57889999999998655432 2345678999999999999888887 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+.+..+......++ ...+..+++++
T Consensus 230 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 259 (352)
T d1koba_ 230 GEDDLETLQNVKRCDWEFD--------------------------------------------------EDAFSSVSPEA 259 (352)
T ss_dssp CSSHHHHHHHHHHCCCCCC--------------------------------------------------SSTTTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------cccccCCCHHH
Confidence 9888888877776655443 22335689999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.+||.+||+.||++|||++|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-43 Score=314.47 Aligned_cols=193 Identities=34% Similarity=0.667 Sum_probs=174.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+|+|||||.||+|..++.....+++..++.++.|++.||+||| +.+|+||||||
T Consensus 67 v~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--------------~~~iiHrDiKp 132 (316)
T d1fota_ 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--------------SKDIIYRDLKP 132 (316)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCCG
T ss_pred hheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhc--------------cCcEEccccCc
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+
T Consensus 133 ~NILl~~~g~vkL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 133 ENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hheeEcCCCCEEEecCccceEeccc------cccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcC
Confidence 9999999999999999999865432 345689999999999999888877 999999999999999999999988
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+...++..+...++ ..+++++.++
T Consensus 206 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 231 (316)
T d1fota_ 206 TMKTYEKILNAELRFP------------------------------------------------------PFFNEDVKDL 231 (316)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTSCHHHHHH
T ss_pred HHHHHHHHHcCCCCCC------------------------------------------------------CCCCHHHHHH
Confidence 8777777766544333 6688999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||..||.+|+ |++++++||||++..
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 9999999999996 999999999999853
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=316.79 Aligned_cols=195 Identities=31% Similarity=0.558 Sum_probs=174.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++|+++.+++.+|||||||+||+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 66 v~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH--------------~~~iiHrDikp 131 (320)
T d1xjda_ 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH--------------SKGIVYRDLKL 131 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCCG
T ss_pred EEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCeeeccCcc
Confidence 6899999999999999999999999999999999999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+
T Consensus 132 ~NiL~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 132 DNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeecCCCceeccccchhhhcccccc---cccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999975443322 3445679999999999999999876 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+...++..+... .+..+++++.+|
T Consensus 208 ~~~~~~~i~~~~~~------------------------------------------------------~p~~~s~~~~dl 233 (320)
T d1xjda_ 208 EEELFHSIRMDNPF------------------------------------------------------YPRWLEKEAKDL 233 (320)
T ss_dssp HHHHHHHHHHCCCC------------------------------------------------------CCTTSCHHHHHH
T ss_pred HHHHHHHHHcCCCC------------------------------------------------------CCccCCHHHHHH
Confidence 87777766554332 235689999999
Q ss_pred HHHhcCCCCCccccHH-HHhcCcccccc
Q psy1812 241 VGQILEPDITKRIRLD-AIKAHDWLRYK 267 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~-ell~~~wf~~~ 267 (304)
|++||+.||++|||+. ++++||||++.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999996 89999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=311.37 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=154.3
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKR----AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++|+++.+ ++.+|||||||+||+|.+++.+ .+.+++..++.++.|++.||+|||+. +....+|+
T Consensus 66 v~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---------~~~~~~Ii 136 (269)
T d2java1 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---------SDGGHTVL 136 (269)
T ss_dssp CCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH---------CC------
T ss_pred eeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh---------cCCCCCEE
Confidence 689998864 5679999999999999999965 35799999999999999999999931 00013499
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMP 212 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCC---ccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCC
Confidence 999999999999999999999999986543221 2345679999999999988888877 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+...++..+... ..+..++
T Consensus 213 Pf~~~~~~~~~~~i~~~~~~-----------------------------------------------------~~~~~~s 239 (269)
T d2java1 213 PFTAFSQKELAGKIREGKFR-----------------------------------------------------RIPYRYS 239 (269)
T ss_dssp SCCCSSHHHHHHHHHHTCCC-----------------------------------------------------CCCTTSC
T ss_pred CCCCCCHHHHHHHHHcCCCC-----------------------------------------------------CCCcccC
Confidence 99988877777666544321 2235678
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWL 264 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf 264 (304)
+++.+||.+||+.||++|||++|+++|||+
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=316.34 Aligned_cols=193 Identities=30% Similarity=0.599 Sum_probs=174.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+.+..++||||+.||+|.+++.+.+.+++..++.++.||+.||.||| +.+|+||||||
T Consensus 104 v~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH--------------~~~iiHRDIKP 169 (350)
T d1rdqe_ 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH--------------SLDLIYRDLKP 169 (350)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred eecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEecCcCCH
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+|||++.+|.+||+|||+++..... .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+
T Consensus 170 ~NILl~~~g~ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 170 ENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHcccCCCCCEEeeeceeeeecccc------cccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999865432 335679999999999999888877 999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
....+.++.......+ ..+++++.+|
T Consensus 243 ~~~~~~~i~~~~~~~p------------------------------------------------------~~~s~~~~~l 268 (350)
T d1rdqe_ 243 PIQIYEKIVSGKVRFP------------------------------------------------------SHFSSDLKDL 268 (350)
T ss_dssp HHHHHHHHHHCCCCCC------------------------------------------------------TTCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCC------------------------------------------------------ccCCHHHHHH
Confidence 8777777766544333 5689999999
Q ss_pred HHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 241 VGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 241 l~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
|.+||+.||.+|+ |++++++||||++..
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 9999999999995 999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-42 Score=316.13 Aligned_cols=193 Identities=26% Similarity=0.477 Sum_probs=165.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|.+++.+|+|||||+||+|.++|.+.+.+++..++.++.||+.||+||| +.+|+||||||
T Consensus 70 v~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH--------------~~~iiHrDlKP 135 (364)
T d1omwa3 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--------------NRFVVYRDLKP 135 (364)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred EEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH--------------HCCccceeecc
Confidence 6899999999999999999999999999999999999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC-CCCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN-PYNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+|||++.+|.+||+|||++...... .....+||+.|+|||++... .++.+ +|||||||++|+|++|..||.+.
T Consensus 136 ~NILl~~~g~iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 136 ANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp GGEEECSSSCEEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ceeEEcCCCcEEEeeeceeeecCCC-----cccccccccccchhHHhhcCCCCCcc-cchhHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999765432 23456799999999999754 46665 99999999999999999999765
Q ss_pred hHH---HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 160 NLK---QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 160 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
+.. .....+... ....+..++++
T Consensus 210 ~~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~s~~ 235 (364)
T d1omwa3 210 KTKDKHEIDRMTLTM------------------------------------------------------AVELPDSFSPE 235 (364)
T ss_dssp CSSCHHHHHHHSSSC------------------------------------------------------CCCCCSSSCHH
T ss_pred CHHHHHHHHHhcccC------------------------------------------------------CCCCCCCCCHH
Confidence 322 112111111 12334678999
Q ss_pred HHHHHHHhcCCCCCcccc-----HHHHhcCcccccc
Q psy1812 237 VKNLVGQILEPDITKRIR-----LDAIKAHDWLRYK 267 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t-----~~ell~~~wf~~~ 267 (304)
+.+||.+||..||++||| |+|+++||||++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999999999 7999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-42 Score=311.67 Aligned_cols=195 Identities=25% Similarity=0.351 Sum_probs=168.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+++.+++|||||.||+|..++...+.+++..++.++.|++.||.||| +.+|+||||||
T Consensus 78 v~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH--------------~~~iiHrDiKp 143 (309)
T d1u5ra_ 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--------------SHNMIHRDVKA 143 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCBCCCCSG
T ss_pred eeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEeccCCCc
Confidence 6899999999999999999999999888888889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccC---CCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISG---NPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
+|||++.++.+||+|||++..... .....||+.|+|||++.+ ..++.+ +|||||||++|+|++|..||.
T Consensus 144 ~NILl~~~~~~Kl~DFG~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 144 GNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp GGEEEETTTEEEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTT
T ss_pred ceEEECCCCCEEEeecccccccCC-------CCccccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCC
Confidence 999999999999999999975432 234579999999999864 346666 999999999999999999998
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+...++........ .+..+++++
T Consensus 216 ~~~~~~~~~~i~~~~~~~~----------------------------------------------------~~~~~s~~~ 243 (309)
T d1u5ra_ 216 NMNAMSALYHIAQNESPAL----------------------------------------------------QSGHWSEYF 243 (309)
T ss_dssp TSCHHHHHHHHHHSCCCCC----------------------------------------------------SCTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC----------------------------------------------------CCCCCCHHH
Confidence 8777666665554322211 124578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
.+||.+||+.||++|||++|+|+||||.....
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 99999999999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=311.00 Aligned_cols=229 Identities=16% Similarity=0.184 Sum_probs=175.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.++++++|||||+.|+++..++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 63 v~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH--------------~~~iiHrDiKp 128 (299)
T d1ua2a_ 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--------------QHWILHRDLKP 128 (299)
T ss_dssp CCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred eEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--------------ccceecccCCc
Confidence 6899999999999999999998877777766778999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+||+|||+++....... .....+||+.|+|||++.+......++|||||||++|+|++|..||.+.+
T Consensus 129 ~NIli~~~~~~KL~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 129 NNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp GGEEECTTCCEEECCCGGGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceEEecCCCccccccCccccccCCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 999999999999999999976543322 23456799999999998766543344999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+...++....+......... ... .......... ....+ ......+++++.+|
T Consensus 206 ~~~~l~~i~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~-------~~~~~-------~~~~~~~s~~~~dl 259 (299)
T d1ua2a_ 206 DLDQLTRIFETLGTPTEEQWPD---------MCS---LPDYVTFKSF-------PGIPL-------HHIFSAAGDDLLDL 259 (299)
T ss_dssp HHHHHHHHHHHHCCCCTTTSSS---------TTS---STTCCCCCCC-------CCCCH-------HHHCTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCCChhhccc---------hhc---cchhhhhccC-------CCCCh-------HHhcccCCHHHHHH
Confidence 8887777766544333110000 000 0000000000 00001 11124578899999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
|.+||..||++||||+|+|+||||+..+.+.+
T Consensus 260 l~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 260 IQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred HHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 99999999999999999999999998776544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=312.93 Aligned_cols=200 Identities=23% Similarity=0.425 Sum_probs=174.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|++++++|||||||+||+|.++|.+.+ .+++.+++.++.||+.||+||| +.+|+|||||
T Consensus 64 v~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH--------------~~~iiHrDlK 129 (321)
T d1tkia_ 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--------------SHNIGHFDIR 129 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCC
T ss_pred CeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------------HcCCCccccc
Confidence 689999999999999999999999999998765 7999999999999999999999 8999999999
Q ss_pred CCcEEEecC--CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 80 CENILMTKR--FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 80 ~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
|+||+++.+ +.+||+|||++....... ......+++.|+|||.+.+..++.+ +|+||+||++|+|++|..||.
T Consensus 130 p~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 130 PENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTC
T ss_pred ccceeecCCCceEEEEcccchhhccccCC----cccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCC
Confidence 999999854 479999999997654322 2344568999999999998888877 999999999999999999999
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+..+.+..+.+....++ ...+..+++++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~--------------------------------------------------~~~~~~~s~~~ 234 (321)
T d1tkia_ 205 AETNQQIIENIMNAEYTFD--------------------------------------------------EEAFKEISIEA 234 (321)
T ss_dssp CSSHHHHHHHHHHTCCCCC--------------------------------------------------HHHHTTSCHHH
T ss_pred CCCHHHHHHHHHhCCCCCC--------------------------------------------------hhhccCCCHHH
Confidence 9888888888776655444 12224578999
Q ss_pred HHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
++||.+||..||++|||++|+++||||+....
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999986543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=301.81 Aligned_cols=192 Identities=24% Similarity=0.456 Sum_probs=164.0
Q ss_pred CceeeeeeeCCeEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADN-GDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|+++++|.+++..++||||+.+ +++.+++.+.+.+++.+++.++.|++.||+||| +.+|+|||||
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH--------------~~~iiHrDiK 137 (273)
T d1xwsa_ 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--------------NCGVLHRDIK 137 (273)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCS
T ss_pred cEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------------HCCCccccCc
Confidence 6899999999999999999986 688999998889999999999999999999999 8999999999
Q ss_pred CCcEEEecC-CCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 80 CENILMTKR-FNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
|+||+++.+ +.+||+|||++...... ......||+.|+|||++.+..+...++||||+||++|+|++|+.||.+
T Consensus 138 p~NIll~~~~~~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 138 DENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccceEEecCCCeEEECccccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 999999855 78999999999754332 234567999999999998777665558999999999999999999976
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+. +..+.. ..+..+++++.
T Consensus 213 ~~~------i~~~~~------------------------------------------------------~~~~~~s~~~~ 232 (273)
T d1xwsa_ 213 DEE------IIRGQV------------------------------------------------------FFRQRVSSECQ 232 (273)
T ss_dssp HHH------HHHCCC------------------------------------------------------CCSSCCCHHHH
T ss_pred chH------Hhhccc------------------------------------------------------CCCCCCCHHHH
Confidence 531 222211 22356899999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+||.+||+.||++|||++|+++||||++...++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~ 265 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCCCCC
Confidence 999999999999999999999999999865433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=312.56 Aligned_cols=199 Identities=29% Similarity=0.489 Sum_probs=161.2
Q ss_pred Cceeeeeee----CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR----GPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|++|++|++ ++.+|||||||+||+|.++|.+. ..+++.+++.++.|++.||+||| +.+|+
T Consensus 68 v~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--------------~~~ii 133 (335)
T d2ozaa1 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--------------SINIA 133 (335)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred CeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--------------HcCCc
Confidence 688999876 46799999999999999999875 36999999999999999999999 89999
Q ss_pred ecCCCCCcEEEec---CCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh
Q psy1812 75 HRDLKCENILMTK---RFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN 151 (304)
Q Consensus 75 H~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~ 151 (304)
||||||+||+++. .+.+||+|||+++...... .....+||+.|+|||++.+..++.+ +|+|||||++|+|++
T Consensus 134 HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~llt 208 (335)
T d2ozaa1 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLC 208 (335)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhh
Confidence 9999999999986 4569999999997654432 2345679999999999988888877 999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhh----ccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 152 AAMPFDDSNLKQLFKEQTS----NILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 152 g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
|+.||.+.+.......+.. ....++ .
T Consensus 209 g~~Pf~~~~~~~~~~~~~~~i~~~~~~~~--------------------------------------------------~ 238 (335)
T d2ozaa1 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFP--------------------------------------------------N 238 (335)
T ss_dssp SSCSCEETTCC--------CCCSCSSSCC--------------------------------------------------T
T ss_pred CCCCCCCCCHHHHHHHHHHHHhcCCCCCC--------------------------------------------------C
Confidence 9999976653332222211 111111 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
.....+++++.+||++||+.||++|||+.|+++||||+...
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 11245789999999999999999999999999999997654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=300.07 Aligned_cols=227 Identities=22% Similarity=0.307 Sum_probs=171.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|++|.+++.+++||||+.+ ++.+++.. .+.+++..++.++.|++.||+||| +.+|+||||
T Consensus 64 v~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--------------~~~IiHrDi 128 (298)
T d1gz8a_ 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--------------SHRVLHRDL 128 (298)
T ss_dssp CCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred EEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--------------cCCEEcccc
Confidence 6899999999999999999975 55555543 346999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDD 158 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~ 158 (304)
||+||+++.++.+||+|||+++....... ......|++.|+|||.+....+...++|+||+||++|+|++|+.||.+
T Consensus 129 KpeNIl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 129 KPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CGGGEEECTTSCEEECSTTHHHHHCCCSB---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CchheeecccCcceeccCCcceeccCCcc---cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 99999999999999999999976543222 344567999999999988877665569999999999999999999998
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++.................. ......... ...... ......+++++.
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~----~~~~~~-------~~~~~~~s~~~~ 260 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSM--------------PDYKPSFPK----WARQDF-------SKVVPPLDEDGR 260 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGS--------------TTCCTTSCC----CCCCCH-------HHHSTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccc--------------ccccccccc----ccccch-------hhhccCCCHHHH
Confidence 8877776666555443331111100000 000000000 000000 112245789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
+||.+||.+||++|||++|+++||||++...+
T Consensus 261 dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 261 SLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 99999999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=297.61 Aligned_cols=196 Identities=20% Similarity=0.315 Sum_probs=164.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++..+ ..+||||||++|+|.+++.+.+.+++..+..++.|++.||+||| +.+|+||||||
T Consensus 71 v~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH--------------~~~iiHrDlKp 135 (277)
T d1xbba_ 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE--------------ESNFVHRDLAA 135 (277)
T ss_dssp CCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCSG
T ss_pred ceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH--------------hCCcccCCCcc
Confidence 6899998654 57899999999999999999889999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~~ 159 (304)
+||+++.++.+||+|||+++................||+.|+|||.+.+..++.+ +|||||||++|||++ |..||.+.
T Consensus 136 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCC
Confidence 9999999999999999999866544333333445678999999999988888877 999999999999998 89999888
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+.++.. ...+..+++++.+
T Consensus 215 ~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~~~~ 241 (277)
T d1xbba_ 215 KGSEVTAMLEKGER-----------------------------------------------------MGCPAGCPREMYD 241 (277)
T ss_dssp CHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHHH
T ss_pred CHHHHHHHHHcCCC-----------------------------------------------------CCCCcccCHHHHH
Confidence 77666665554321 2233567899999
Q ss_pred HHHHhcCCCCCccccHHHH---hcCcccc
Q psy1812 240 LVGQILEPDITKRIRLDAI---KAHDWLR 265 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~el---l~~~wf~ 265 (304)
||.+||+.||++|||++++ |+|+|++
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999998 4566654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=296.71 Aligned_cols=223 Identities=23% Similarity=0.250 Sum_probs=169.6
Q ss_pred Cceeeeeee-----CCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQR-----GPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++++|.. +...+++|||+.++.+...... ...+++..++.++.|++.||+||| +.+|+
T Consensus 73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--------------~~~iv 138 (305)
T d1blxa_ 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--------------SHRVV 138 (305)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred ceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCEE
Confidence 578888853 4579999999998766544433 346999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+.+++.+ +||||+||++|+|++|+.
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSC
T ss_pred ecCCCccEEEEcCCCCeeecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCC
Confidence 99999999999999999999999987543222 3456789999999999999999887 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+..+....+............. ........... .............++
T Consensus 214 pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------~~~~~~~~~~~--------------~~~~~~~~~~~~~~s 266 (305)
T d1blxa_ 214 LFRGSSDVDQLGKILDVIGLPGEEDWP-------------RDVALPRQAFH--------------SKSAQPIEKFVTDID 266 (305)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCGGGSC-------------TTCSSCGGGSC--------------CCCCCCGGGTCCSCC
T ss_pred CCCCCCHHHHHHHHHHhhCCCchhccc-------------ccccchhhhhc--------------cccccchhhccccCC
Confidence 999988877777766544432210000 00000000000 000000122335678
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
+.+.+||.+||++||++|||++|+|+||||+....
T Consensus 267 ~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 99999999999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.1e-41 Score=296.88 Aligned_cols=224 Identities=21% Similarity=0.252 Sum_probs=169.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|+++++|..++..+++|||+.++.+..+....+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 63 v~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------------~~~IvHrDiKp 128 (286)
T d1ob3a_ 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--------------DRRVLHRDLKP 128 (286)
T ss_dssp CCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCCG
T ss_pred EeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc--------------cCcEEecCCCC
Confidence 6899999999999999999998777777777788999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCCChh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFDDSN 160 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~~~~ 160 (304)
+||+++.++.+|++|||.+........ ......+++.|+|||.+.+..+.+.++|+||+||++|+|++|+.||.+.+
T Consensus 129 ~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 129 QNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp GGEEECTTSCEEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeeEcCCCCEEecccccceecccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 999999999999999999976543322 23345688999999999876655455999999999999999999999888
Q ss_pred HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHHH
Q psy1812 161 LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKNL 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (304)
..+...++................... .... .... ... .........+++.+.||
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~----------~~~~---~~~~-----~~~-------~~~~~~~~~~s~~~~dl 260 (286)
T d1ob3a_ 206 EADQLMRIFRILGTPNSKNWPNVTELP----------KYDP---NFTV-----YEP-------LPWESFLKGLDESGIDL 260 (286)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGST----------TCCT---TCCC-----CCC-------CCGGGTCCSCCHHHHHH
T ss_pred HHHHHHHHHHhhCCCChhhccchhhhh----------hccc---cccc-----ccC-------cchhhhcccCCHHHHHH
Confidence 777777666554443311111000000 0000 0000 000 00122335678999999
Q ss_pred HHHhcCCCCCccccHHHHhcCccccc
Q psy1812 241 VGQILEPDITKRIRLDAIKAHDWLRY 266 (304)
Q Consensus 241 l~~~L~~dP~~R~t~~ell~~~wf~~ 266 (304)
|.+||.+||++|||++|+++||||++
T Consensus 261 i~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 261 LSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCc
Confidence 99999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=295.05 Aligned_cols=200 Identities=20% Similarity=0.301 Sum_probs=168.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++..+ .++||||||+||+|.+++... +.+++..+..++.|++.||+||| +++|+|||||
T Consensus 72 v~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH--------------~~~iiHrDlK 136 (285)
T d1u59a_ 72 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--------------EKNFVHRDLA 136 (285)
T ss_dssp CCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCS
T ss_pred eeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--------------hCCeecCcCc
Confidence 6899998754 689999999999999998664 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++................||+.|+|||++.+..++.+ +|||||||++|||++ |..||.+
T Consensus 137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCC
Confidence 99999999999999999999876554433333445678999999999988888877 999999999999998 8999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++++.
T Consensus 216 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~l~ 242 (285)
T d1u59a_ 216 MKGPEVMAFIEQGKR-----------------------------------------------------MECPPECPPELY 242 (285)
T ss_dssp CCTHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCcCCHHHH
Confidence 776666665554322 123466889999
Q ss_pred HHHHHhcCCCCCccccHHHH---hcCcccccccc
Q psy1812 239 NLVGQILEPDITKRIRLDAI---KAHDWLRYKSM 269 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~el---l~~~wf~~~~~ 269 (304)
+||.+||+.||++|||+.++ |+|+|+.....
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 99999999999999999887 67788765544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=300.19 Aligned_cols=193 Identities=21% Similarity=0.348 Sum_probs=162.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhc
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-----------------------PVAESNARTWFSQMLAGLEYLHRE 57 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~l~~LH~~ 57 (304)
|++|+++.+.+.+++|||||+||+|.++|+... .+++..++.++.|++.||+|||
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-- 181 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-- 181 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 689999999999999999999999999997642 4899999999999999999999
Q ss_pred ccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCc
Q psy1812 58 ITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLA 137 (304)
Q Consensus 58 ~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~s 137 (304)
+.+|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +
T Consensus 182 ------------~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~-~ 247 (325)
T d1rjba_ 182 ------------FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIK-S 247 (325)
T ss_dssp ------------HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHH-H
T ss_pred ------------hCCeeeccCchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCCCCcc-e
Confidence 899999999999999999999999999999765433221 12335568999999999988888877 9
Q ss_pred hHHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhh
Q psy1812 138 DIWSLGVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQ 216 (304)
Q Consensus 138 DvwslG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (304)
|||||||++|||++ |..||.+.+....+.++......
T Consensus 248 DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------ 285 (325)
T d1rjba_ 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK------------------------------------------ 285 (325)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC------------------------------------------
T ss_pred eccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------------------------------------
Confidence 99999999999998 89999876655444444433221
Q ss_pred hhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 217 VKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||++||++|
T Consensus 286 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 286 ----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12335678999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=287.67 Aligned_cols=196 Identities=24% Similarity=0.397 Sum_probs=152.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++. ++.++||||||+||+|.+++... +.+++..+..++.|++.||+||| +.+|+|||||
T Consensus 67 v~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH--------------~~~ivHrDlK 131 (276)
T d1uwha_ 67 LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--------------AKSIIHRDLK 131 (276)
T ss_dssp CCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh--------------cCCEeccccC
Confidence 57888765 45789999999999999999765 56999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCC---CCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGN---PYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
|+|||++.++.+||+|||+++........ .......||+.|+|||++.+. +++.+ +|||||||++|||++|+.||
T Consensus 132 p~NiLl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~-sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQ-SDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp GGGEEEETTSSEEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHH-HHHHHHHHHHHHHHHSSCTT
T ss_pred HHHEEEcCCCCEEEccccceeeccccCCc-ccccccccCcccCCHHHHhcccCCCCCch-hhhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999765433221 133456799999999998653 35555 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+...............+ .....+..++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~p------------------------------------------------~~~~~~~~~~~~ 241 (276)
T d1uwha_ 210 SNINNRDQIIFMVGRGYLSP------------------------------------------------DLSKVRSNCPKA 241 (276)
T ss_dssp TTCCCHHHHHHHHHHTSCCC------------------------------------------------CGGGSCTTCCHH
T ss_pred CCCChHHHHHHHHhcCCCCC------------------------------------------------cchhccccchHH
Confidence 87654444333322211111 001233567899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+||.+||+.||++|||++|++++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=292.85 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=164.8
Q ss_pred Cceeeeeee------CCeEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQR------GPRVFIFMRYADNGDLLDHI----KRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~g~L~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
|+++++|.. ..+++||||||.++ +.+.+ .....+++..++.++.|++.||+||| +
T Consensus 76 v~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--------------~ 140 (350)
T d1q5ka_ 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--------------S 140 (350)
T ss_dssp CCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--------------T
T ss_pred CcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--------------h
Confidence 577888743 34689999999865 43333 33457999999999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCC-CeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFI 148 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ 148 (304)
.||+||||||+|||++.++ .+||+|||++....... ......|+..|+|||.+.+.. ++.+ +||||+||++|+
T Consensus 141 ~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~-~DIwSlG~il~e 215 (350)
T d1q5ka_ 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAE 215 (350)
T ss_dssp TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHHHHHHHH
T ss_pred cCCcccCCCcceEEEecCCCceeEecccchhhccCCc----ccccccccccccChHHhhcccCCCcc-eeecccceEEEe
Confidence 9999999999999999875 79999999997654332 234567999999999987654 5555 999999999999
Q ss_pred HHhCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccc
Q psy1812 149 MLNAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVK 228 (304)
Q Consensus 149 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (304)
|++|..||...+..+...++....+........ ................. .+ ...
T Consensus 216 l~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~------------~~~~~~~~~~~~~~~~~-------~~------~~~ 270 (350)
T d1q5ka_ 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR------------EMNPNYTEFKFPQIKAH-------PW------TKV 270 (350)
T ss_dssp HHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH------------HHCC---CCCCCCCCCC-------CG------GGT
T ss_pred hhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh------------hhccchhhccccccccC-------ch------hhh
Confidence 999999998888777777766554443311110 00000000000000000 00 011
Q ss_pred ccccccHHHHHHHHHhcCCCCCccccHHHHhcCccccccccc
Q psy1812 229 VKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMV 270 (304)
Q Consensus 229 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~ 270 (304)
....+++++.+||.+||.+||++|||+.|+|+||||+....+
T Consensus 271 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 224578999999999999999999999999999999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-39 Score=290.19 Aligned_cols=193 Identities=20% Similarity=0.377 Sum_probs=154.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++.+++|||||++|+|.+++... +.+++.++..++.|++.||+||| +.+|+|||||
T Consensus 90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--------------~~~iiHrDlK 155 (299)
T d1jpaa_ 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA--------------DMNYVHRDLA 155 (299)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred ccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh--------------hCCCccCccc
Confidence 68999999999999999999999999998875 46999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccc--cccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRV--LSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|+|||++.++.+||+|||+++.......... ......+++.|+|||.+.+..++.+ +|||||||++|||++ |..||
T Consensus 156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf 234 (299)
T d1jpaa_ 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPY 234 (299)
T ss_dssp GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTT
T ss_pred cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCC
Confidence 9999999999999999999986543322111 1123457899999999998888877 999999999999998 89999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+....+..+.. ...+..+++.
T Consensus 235 ~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~ 261 (299)
T d1jpaa_ 235 WDMTNQDVINAIEQDYR-----------------------------------------------------LPPPMDCPSA 261 (299)
T ss_dssp TTCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------------------------------------CCCCccchHH
Confidence 88877776666554322 1223557899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+||.+||+.||++|||++|+++.
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-39 Score=287.29 Aligned_cols=200 Identities=24% Similarity=0.364 Sum_probs=157.7
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++++++...+ .+|||||||+||+|.+++...+.+++.+++.++.|++.||+||| +.+|+||
T Consensus 70 v~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--------------~~~iiHr 135 (277)
T d1o6ya_ 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH--------------QNGIIHR 135 (277)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECC
T ss_pred CcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH--------------hCCccCc
Confidence 57888887643 48999999999999999999999999999999999999999999 8999999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF 156 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf 156 (304)
||||+||+++.++..+++|||.+................+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 136 DiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf 214 (277)
T d1o6ya_ 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 214 (277)
T ss_dssp CCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSC
T ss_pred cccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCC
Confidence 99999999999999999999998755443333334456689999999999998888877 99999999999999999999
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.+.+..+...++.......+ ......++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~s~~ 244 (277)
T d1o6ya_ 215 TGDSPVSVAYQHVREDPIPP--------------------------------------------------SARHEGLSAD 244 (277)
T ss_dssp CCSSHHHHHHHHHHCCCCCG--------------------------------------------------GGTSSSCCHH
T ss_pred CCcCHHHHHHHHHhcCCCCC--------------------------------------------------chhccCCCHH
Confidence 98877776665554433222 2223568999
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCcccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLR 265 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~ 265 (304)
+.+||.+||+.||++||+..+.+.|+|.+
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999544455567764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=291.97 Aligned_cols=202 Identities=28% Similarity=0.510 Sum_probs=167.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
+++++++.+...+++||||+.+|+|.+++...+.+++..++.++.|++.||+||| +.+|+||||||
T Consensus 92 v~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH--------------~~~ivHrDiKp 157 (322)
T d1vzoa_ 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH--------------KLGIIYRDIKL 157 (322)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCCCCCG
T ss_pred EEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh--------------cCCEEeccCCc
Confidence 5789999999999999999999999999999999999999999999999999999 88999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHHhCCCCCCCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIMLNAAMPFDDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll~g~~pf~~~ 159 (304)
+||+++.++.+||+|||++......... ......|++.|++||.+.+.. ....++|||||||++|+|++|..||.+.
T Consensus 158 ~Nill~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 158 ENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp GGEEECTTSCEEESCSSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred cceeecCCCCEEEeeccchhhhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999765433322 244567999999999997654 2233499999999999999999999776
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+....+....... ....+..+++++.+
T Consensus 236 ~~~~~~~~i~~~~~~~--------------------------------------------------~~~~~~~~s~~~~~ 265 (322)
T d1vzoa_ 236 GEKNSQAEISRRILKS--------------------------------------------------EPPYPQEMSALAKD 265 (322)
T ss_dssp TSCCCHHHHHHHHHHC--------------------------------------------------CCCCCTTSCHHHHH
T ss_pred CHHHHHHHHHHhcccC--------------------------------------------------CCCCcccCCHHHHH
Confidence 5433333333222111 12334668999999
Q ss_pred HHHHhcCCCCCccc-----cHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRI-----RLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~-----t~~ell~~~wf~~~~ 268 (304)
||.+||..||++|| |++|+++||||++..
T Consensus 266 li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999999999999 589999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=284.72 Aligned_cols=191 Identities=20% Similarity=0.395 Sum_probs=153.0
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++++++..++.+++|||||++|+|.+++... ..+++..+..++.|++.||+||| +.+|+|||||
T Consensus 63 v~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH--------------~~~iiHrDlK 128 (263)
T d1sm2a_ 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--------------EACVIHRDLA 128 (263)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCTTCS
T ss_pred ccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh--------------ccceeecccc
Confidence 68999999999999999999999999998765 46899999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.+ +|||||||++|||++ |..||..
T Consensus 129 p~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp GGGEEECGGGCEEECSCC--------------------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCS
T ss_pred hhheeecCCCCeEecccchheeccCCCce--eecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999765443222 2334568999999999999888877 999999999999999 5677777
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++++.
T Consensus 206 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 206 RSNSEVVEDISTGFR-----------------------------------------------------LYKPRLASTHVY 232 (263)
T ss_dssp CCHHHHHHHHHHTCC-----------------------------------------------------CCCCTTSCHHHH
T ss_pred CCHHHHHHHHHhcCC-----------------------------------------------------CCCccccCHHHH
Confidence 766666665554322 122355688999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+|+.+||+.||++|||++|++++
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=288.86 Aligned_cols=226 Identities=23% Similarity=0.304 Sum_probs=169.8
Q ss_pred CceeeeeeeCC------eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQRGP------RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++++|...+ .+++||||| +++|..++++ +.+++..++.++.|++.||+||| +.+|+
T Consensus 80 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH--------------~~~Ii 143 (346)
T d1cm8a_ 80 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIH--------------AAGII 143 (346)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTEE
T ss_pred eEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHH--------------hCCCc
Confidence 57888887654 579999999 5677777654 57999999999999999999999 89999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+|||++.++.+|++|||++...... .....|++.|+|||++.+..+...++|+||+||++|+|++|..
T Consensus 144 HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~ 217 (346)
T d1cm8a_ 144 HRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcchhhcccccccccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcC
Confidence 9999999999999999999999999754332 3456799999999999876554444999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+.......+.......+....................... ... .......++
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~-------~~~~~~~~s 274 (346)
T d1cm8a_ 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE----------------KKD-------FASILTNAS 274 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC----------------CCC-------GGGTCTTCC
T ss_pred CCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccc----------------ccc-------hHHhccCCC
Confidence 999988877777766665554432222111111100000000000 000 012235678
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCcccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVR 271 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~ 271 (304)
+++.+||.+||.+||++|||++|||+||||+......
T Consensus 275 ~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 275 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 9999999999999999999999999999999876543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=287.05 Aligned_cols=235 Identities=23% Similarity=0.332 Sum_probs=168.9
Q ss_pred CceeeeeeeCC-----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQRGP-----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++.... .++++ +|+.||+|.++++.. .+++..++.++.|++.||+||| +.+|+|
T Consensus 69 v~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH--------------~~~iiH 132 (345)
T d1pmea_ 69 IGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH--------------SANVLH 132 (345)
T ss_dssp CCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH--------------HTTEEC
T ss_pred CcEEEEEeeccccccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHH--------------HCCCcC
Confidence 46777776542 35555 455689999999764 6999999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||+|||++.++.+||+|||++................+|++.|+|||++........++|+||+||++|+|++|..|
T Consensus 133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p 212 (345)
T d1pmea_ 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212 (345)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence 99999999999999999999999986655444333445677999999999986655444449999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+..+................................... ....+ ......+++
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~-------~~~~~~~s~ 269 (345)
T d1pmea_ 213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK----------------NKVPW-------NRLFPNADS 269 (345)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC----------------CCCCH-------HHHCTTSCH
T ss_pred CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCcc----------------CCCCH-------HHhCCCCCH
Confidence 9888776666555443333221111100000000000000000 00000 112245788
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++++||.+||+.||++|||++|+|+||||+....+....
T Consensus 270 ~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~ 308 (345)
T d1pmea_ 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 308 (345)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc
Confidence 999999999999999999999999999999777655443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=284.32 Aligned_cols=195 Identities=22% Similarity=0.420 Sum_probs=161.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.+ +..++|||||++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||
T Consensus 71 v~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--------------~~~ivHrDi 135 (272)
T d1qpca_ 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--------------ERNYIHRDL 135 (272)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCC
T ss_pred eEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------hCCcccCcc
Confidence 688998765 56789999999999999886543 6999999999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhC-CCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNA-AMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g-~~pf~ 157 (304)
||+||+++.++.+||+|||+++........ ......|++.|+|||++.+..++.+ +|||||||++|||++| ..|+.
T Consensus 136 Kp~NIll~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 136 RAANILVSDTLSCKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSCEE--CCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred chhheeeecccceeeccccceEEccCCccc--cccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999865443221 2334568899999999988888877 9999999999999995 55666
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
..+..+....+..+.. ...+..+++++
T Consensus 213 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~l 239 (272)
T d1qpca_ 213 GMTNPEVIQNLERGYR-----------------------------------------------------MVRPDNCPEEL 239 (272)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred CCCHHHHHHHHHhcCC-----------------------------------------------------CCCcccChHHH
Confidence 6666666655544322 12235678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc--Cccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA--HDWLRY 266 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~--~~wf~~ 266 (304)
.+|+.+||+.||++|||++++++ ++||..
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=279.16 Aligned_cols=191 Identities=23% Similarity=0.386 Sum_probs=165.7
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++.+++.+++||||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+|+|||||
T Consensus 62 v~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH--------------~~~iiH~dlk 127 (258)
T d1k2pa_ 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--------------SKQFLHRDLA 127 (258)
T ss_dssp CCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--------------HTTBCCSCCS
T ss_pred eeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh--------------hcCccccccc
Confidence 68999999999999999999999999997664 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.+ +|||||||++|||++ |+.||.+
T Consensus 128 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp GGGEEECTTCCEEECCCSSCCBCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceeEEEcCCCcEEECcchhheeccCCCce--eecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCC
Confidence 99999999999999999999765443322 2334568999999999998888877 999999999999998 8999998
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++..+... ..+...+.++.
T Consensus 205 ~~~~~~~~~i~~~~~~-----------------------------------------------------~~p~~~~~~l~ 231 (258)
T d1k2pa_ 205 FTNSETAEHIAQGLRL-----------------------------------------------------YRPHLASEKVY 231 (258)
T ss_dssp SCHHHHHHHHHTTCCC-----------------------------------------------------CCCTTCCHHHH
T ss_pred CCHHHHHHHHHhCCCC-----------------------------------------------------CCcccccHHHH
Confidence 8877777766654321 22355788999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+||.+||+.||++|||++++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=281.11 Aligned_cols=226 Identities=21% Similarity=0.307 Sum_probs=171.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
|++++++.+....++|++++.|++|..++...+.+++..++.++.|++.||+||| ..+|+||||||
T Consensus 64 v~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH--------------~~~IvHrDiKP 129 (292)
T d1unla_ 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--------------SRNVLHRDLKP 129 (292)
T ss_dssp CCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCCSG
T ss_pred EeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhh--------------cCCEeeecccC
Confidence 6789999999999999999999999999988889999999999999999999999 89999999999
Q ss_pred CcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC-CCh
Q psy1812 81 ENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-DDS 159 (304)
Q Consensus 81 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf-~~~ 159 (304)
+||+++.++.+|++|||.+........ ......++..|+|||.+.+..+.+.++|+||+||++|+|++|+.|| .+.
T Consensus 130 ~NIli~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 206 (292)
T d1unla_ 130 QNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred cccccccCCceeeeecchhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC
Confidence 999999999999999999986543322 2334457788999999887765445599999999999999999885 555
Q ss_pred hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHHH
Q psy1812 160 NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVKN 239 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (304)
+..+...++.................. .. ... ................+++.+.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~-----~~~-------~~~~~~~~~~~~~~~~~s~~~~d 261 (292)
T d1unla_ 207 DVDDQLKRIFRLLGTPTEEQWPSMTKL-------------PD-----YKP-------YPMYPATTSLVNVVPKLNATGRD 261 (292)
T ss_dssp SHHHHHHHHHHHHCCCCTTTCTTGGGS-------------TT-----CCC-------CCCCCTTCCCTTTSTTCCHHHHH
T ss_pred CHHHHHHHHHhhcCCCChhhhhhhhhc-------------cc-----ccc-------cccccccchhhhccccCCHHHHH
Confidence 555666655544443321111000000 00 000 00000011113334567899999
Q ss_pred HHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 240 LVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 240 ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
||.+||+.||++||||+|+|+||||++..
T Consensus 262 ll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 262 LLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred HHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 99999999999999999999999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=285.73 Aligned_cols=232 Identities=21% Similarity=0.277 Sum_probs=165.1
Q ss_pred Cceeeeeee--------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCc
Q psy1812 1 MQVHSILQR--------GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKN 72 (304)
Q Consensus 1 v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 72 (304)
+++++++.. +...++||||+.++.+..+......+++..++.++.|++.||.||| +.+
T Consensus 72 i~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH--------------~~~ 137 (318)
T d3blha1 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--------------RNK 137 (318)
T ss_dssp CCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH--------------HTT
T ss_pred cceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc--------------cCC
Confidence 356666643 4578999999988766666566678999999999999999999999 899
Q ss_pred eEecCCCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCC-CCCCCchHHHHHHHHHHHH
Q psy1812 73 IAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNP-YNPKLADIWSLGVITFIML 150 (304)
Q Consensus 73 ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~-~~~~~sDvwslG~ll~~ll 150 (304)
|+||||||+||+++.++.+|++|||++......... .......+||+.|+|||++.+.. ++.+ +|+||+||++|+|+
T Consensus 138 ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k-~DiwSlGvil~el~ 216 (318)
T d3blha1 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMW 216 (318)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH-HHHHHHHHHHHHHH
T ss_pred EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcH-HHcccCCceeeeHh
Confidence 999999999999999999999999999765432211 11234457999999999987764 5555 99999999999999
Q ss_pred hCCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccc
Q psy1812 151 NAAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVK 230 (304)
Q Consensus 151 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (304)
+|+.||.+.+.......+........................ .............. ..
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~-----~~ 274 (318)
T d3blha1 217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL-----------------ELVKGQKRKVKDRL-----KA 274 (318)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC------------------------CCSSCCBCHHHHH-----HH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhh-----------------cccccccccchhhh-----cc
Confidence 999999988877777766665554442211111000000000 00000000000000 01
Q ss_pred ccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccc
Q psy1812 231 DILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSM 269 (304)
Q Consensus 231 ~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~ 269 (304)
...++++.|||.+||++||++|||++|+|+||||+..+.
T Consensus 275 ~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp HHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 224778999999999999999999999999999997655
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-38 Score=283.97 Aligned_cols=190 Identities=23% Similarity=0.370 Sum_probs=158.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA--GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|+++.+++.++||||||++|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||
T Consensus 76 v~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------------~~~iiHrDl 141 (287)
T d1opja_ 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--------------KKNFIHRDL 141 (287)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred ecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--------------HCCcccCcc
Confidence 68999999999999999999999999999764 46899999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCC-C
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPF-D 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf-~ 157 (304)
||+|||++.++.+||+|||+++........ ......|++.|+|||++.+..++.+ +|||||||++|+|++|..|| .
T Consensus 142 Kp~NILl~~~~~~Kl~DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 142 AARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SGGGEEECGGGCEEECCCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred ccCeEEECCCCcEEEccccceeecCCCCce--eeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999865433221 2233457889999999998888877 99999999999999976555 4
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
+.+.......+..+.. ...+..+++.+
T Consensus 219 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l 245 (287)
T d1opja_ 219 GIDLSQVYELLEKDYR-----------------------------------------------------MERPEGCPEKV 245 (287)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHH
T ss_pred cchHHHHHHHHhcCCC-----------------------------------------------------CCCCccchHHH
Confidence 4454444443332211 22345688999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.+||.+||+.||++|||++++++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-37 Score=282.17 Aligned_cols=230 Identities=16% Similarity=0.269 Sum_probs=159.7
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
++++++|.. ...+++|||||.+++|..+. +.+++..++.++.||+.||+||| +.+|+||||
T Consensus 93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH--------------~~gIvHrDi 155 (328)
T d3bqca1 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH--------------SMGIMHRDV 155 (328)
T ss_dssp CCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHH--------------HTTEECCCC
T ss_pred cEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHh--------------hcccccccc
Confidence 578899874 46799999999999997764 45999999999999999999999 899999999
Q ss_pred CCCcEEEecCC-CeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 79 KCENILMTKRF-NVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
||+|||++.++ .+||+|||++....... .....++|..|+|||.+.+......++|+||+||+++++++|..||.
T Consensus 156 Kp~NILi~~~~~~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp SGGGEEEETTTTEEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccceEEcCCCCeeeecccccceeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 99999999765 58999999998654332 23456789999999998876543344999999999999999999996
Q ss_pred ChhH-HHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 158 DSNL-KQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.... ......+........ ........ ...................+.... .......++++
T Consensus 232 ~~~~~~~~~~~i~~~~g~~~------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 294 (328)
T d3bqca1 232 HGHDNYDQLVRIAKVLGTED------------LYDYIDKY---NIELDPRFNDILGRHSRKRWERFV--HSENQHLVSPE 294 (328)
T ss_dssp CCSSHHHHHHHHHHHHCHHH------------HHHHHHHT---TCCCCGGGGGTCCCCCCCCGGGGC--CTTTGGGCCHH
T ss_pred CCchhHHHHHHHHHHHCCch------------hhhhhhhc---ccccCcccchhcccccccchhhcc--cccccccCCHH
Confidence 5432 233332222111100 00000000 000000000000000000011111 11223457899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcCccccccc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAHDWLRYKS 268 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~ 268 (304)
+.|||++||.+||++|||++|||+||||+...
T Consensus 295 ~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 295 ALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=276.91 Aligned_cols=192 Identities=20% Similarity=0.375 Sum_probs=152.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++.+++..++|||||.+|+|.+++... ..+++.++..++.|++.||+||| +.+|+|||||
T Consensus 72 v~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH--------------~~~iiHrDlK 137 (283)
T d1mqba_ 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--------------NMNYVHRDLA 137 (283)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc--------------ccccccCccc
Confidence 68999999999999999999999999988765 57999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC-CCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~-~pf~~ 158 (304)
|+|||++.++.+||+|||+++................||+.|+|||++.+..++.+ +|||||||++|||+++. .|+..
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCcccc
Confidence 99999999999999999999865543332223334568999999999998888887 99999999999999955 55555
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 217 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l~ 243 (283)
T d1mqba_ 217 LSNHEVMKAINDGFR-----------------------------------------------------LPTPMDCPSAIY 243 (283)
T ss_dssp CCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTCBHHHH
T ss_pred CCHHHHHHHHhccCC-----------------------------------------------------CCCchhhHHHHH
Confidence 555555554443321 123356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||+.||++|||+.|+++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=282.44 Aligned_cols=193 Identities=21% Similarity=0.362 Sum_probs=149.8
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCC
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTP 63 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~ 63 (304)
|++++++.. ++.+++|||||++|+|.++|...+ .+++..++.++.|++.||+|||
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-------- 151 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-------- 151 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--------
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--------
Confidence 356666544 567999999999999999997532 4889999999999999999999
Q ss_pred CcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHH
Q psy1812 64 FTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLG 143 (304)
Q Consensus 64 ~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG 143 (304)
+.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +||||||
T Consensus 152 ------~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~G 223 (299)
T d1ywna1 152 ------SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFG 223 (299)
T ss_dssp ------HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHH
T ss_pred ------hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcc-cceeehH
Confidence 899999999999999999999999999999765433221 13345679999999999998888877 9999999
Q ss_pred HHHHHHHhC-CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhh
Q psy1812 144 VITFIMLNA-AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDI 222 (304)
Q Consensus 144 ~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (304)
|++|+|++| ..||.+.+..+.+.........
T Consensus 224 vil~ellt~~~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------ 255 (299)
T d1ywna1 224 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------------------------------------ 255 (299)
T ss_dssp HHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC------------------------------------------------
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------------------------------------------
Confidence 999999986 5678665543333332221111
Q ss_pred hhccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 223 LSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 223 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 256 ----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 256 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22335678999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=278.22 Aligned_cols=190 Identities=22% Similarity=0.348 Sum_probs=150.9
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++. ++.+++||||+.+|+|.+++... +.+++..++.++.|++.||.||| +.+++|||||
T Consensus 71 v~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--------------~~~iiHrDlK 135 (273)
T d1mp8a_ 71 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--------------SKRFVHRDIA 135 (273)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCS
T ss_pred eeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc--------------ccCeeccccc
Confidence 68999986 46789999999999999988664 46999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 136 p~NIll~~~~~~Kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp GGGEEEEETTEEEECC---------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhheeecCCCcEEEccchhheeccCCcce--eccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCC
Confidence 99999999999999999999765433221 2334568899999999988888877 999999999999998 8999988
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++..+.. ...+..+++.+.
T Consensus 213 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~~~ 239 (273)
T d1mp8a_ 213 VKNNDVIGRIENGER-----------------------------------------------------LPMPPNCPPTLY 239 (273)
T ss_dssp CCGGGHHHHHHTTCC-----------------------------------------------------CCCCTTCCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCCCCCHHHH
Confidence 777666665554322 223467899999
Q ss_pred HHHHHhcCCCCCccccHHHHhcC
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+||.+||+.||++|||++|++++
T Consensus 240 ~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 240 SLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=282.46 Aligned_cols=230 Identities=21% Similarity=0.288 Sum_probs=166.7
Q ss_pred Cceeeeeee-----CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQR-----GPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++.. ....++||+|+.||+|.+++.. +.+++..++.++.||+.||+||| +.||+|
T Consensus 80 v~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH--------------~~giiH 144 (348)
T d2gfsa1 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH--------------SADIIH 144 (348)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH--------------HTTCCC
T ss_pred eeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHH--------------hCCCcc
Confidence 467777753 2344566677789999999965 46999999999999999999999 899999
Q ss_pred cCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCC
Q psy1812 76 RDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMP 155 (304)
Q Consensus 76 ~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~p 155 (304)
|||||+||+++.++.+|++|||++..... ......|+..|+|||...+..+...++|+||+||++|+|++|..|
T Consensus 145 rDiKp~NILi~~~~~~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 145 RDLKPSNLAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp CCCCGGGEEECTTCCEEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCccccccccccccccccchhcccCc------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence 99999999999999999999999865432 234567889999999988776555559999999999999999999
Q ss_pred CCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccH
Q psy1812 156 FDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSH 235 (304)
Q Consensus 156 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (304)
|.+.+.......+..........+........ ........... . ...+ ......+++
T Consensus 219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~-------~~~~-------~~~~~~~s~ 275 (348)
T d2gfsa1 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSES-ARNYIQSLTQM--------P-------KMNF-------ANVFIGANP 275 (348)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH-HHHHHTTSCCC--------C-------CCCH-------HHHSTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhccchh-hhhhhhhcccC--------C-------Ccch-------hhhcCCCCH
Confidence 99988887777777665544422211110000 00000000000 0 0000 111245789
Q ss_pred HHHHHHHHhcCCCCCccccHHHHhcCccccccccccccc
Q psy1812 236 QVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKV 274 (304)
Q Consensus 236 ~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~ 274 (304)
++++||.+||..||++|||++|||+||||++...+..+.
T Consensus 276 ~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred HHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 999999999999999999999999999999877654433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=282.62 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=165.1
Q ss_pred Cceeeeee------eCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceE
Q psy1812 1 MQVHSILQ------RGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIA 74 (304)
Q Consensus 1 v~~~~~~~------~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~iv 74 (304)
|+++++|. +.+.+|+|||||.+ ++.+.+. +.+++..++.++.|++.||.||| +.||+
T Consensus 79 v~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH--------------~~gii 141 (355)
T d2b1pa1 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLH--------------SAGII 141 (355)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH--------------HTTCC
T ss_pred eEEEEEEecccccccCceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhh--------------hcccc
Confidence 56788885 34789999999976 5666554 45999999999999999999999 88999
Q ss_pred ecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCC
Q psy1812 75 HRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAM 154 (304)
Q Consensus 75 H~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~ 154 (304)
||||||+||+++.++.+|++|||++....... .....++|+.|+|||++.+..++.+ +|+||+||++++|++|+.
T Consensus 142 HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-------------------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccceeeechhhhhcccccc----ccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCC
Confidence 99999999999999999999999987544322 3445678999999999999888887 999999999999999999
Q ss_pred CCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhcccccccccc
Q psy1812 155 PFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILS 234 (304)
Q Consensus 155 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (304)
||.+.+......++................ ................... ..................+
T Consensus 217 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~s 284 (355)
T d2b1pa1 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ--PTVRNYVENRPKYAGLTFP----------KLFPDSLFPADSEHNKLKA 284 (355)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHTTSC--HHHHHHHHTSCCCCCCCHH----------HHSCGGGSCCSSHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhccCCCHHHHHHhh--hhHHHHhhcCccccccccc----------cccccccccccccccccCC
Confidence 999888777777776655543322221111 1111111111111100000 0000111111122234468
Q ss_pred HHHHHHHHHhcCCCCCccccHHHHhcCccccccccccc
Q psy1812 235 HQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRR 272 (304)
Q Consensus 235 ~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~ 272 (304)
+++++||.+||.+||++||||+|||+||||+....+..
T Consensus 285 ~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 285 SQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 322 (355)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccc
Confidence 89999999999999999999999999999998665444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=276.87 Aligned_cols=197 Identities=21% Similarity=0.384 Sum_probs=157.3
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKR--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++|+++.+ +..++|||||++|+|..++.. ...+++.++..++.|++.||+||| +.+|+||||
T Consensus 75 v~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--------------~~~ivH~Dl 139 (285)
T d1fmka3 75 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--------------RMNYVHRDL 139 (285)
T ss_dssp CCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--------------hhheecccc
Confidence 689999865 457899999999999999865 357999999999999999999999 889999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC-CCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA-MPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~-~pf~ 157 (304)
||+||+++.++.+||+|||+++........ ......|++.|+|||++....++.+ +|||||||++|+|++|. .|+.
T Consensus 140 Kp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 140 RAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp SGGGEEECGGGCEEECCCCTTC----------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred cceEEEECCCCcEEEcccchhhhccCCCce--eeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999765433221 2334568999999999998888877 99999999999999955 5556
Q ss_pred ChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHH
Q psy1812 158 DSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQV 237 (304)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (304)
.....+....+..+.. ...+..++.++
T Consensus 217 ~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~l 243 (285)
T d1fmka3 217 GMVNREVLDQVERGYR-----------------------------------------------------MPCPPECPESL 243 (285)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------------------------------------CCCCTTSCHHH
T ss_pred CCCHHHHHHHHHhcCC-----------------------------------------------------CCCCcccCHHH
Confidence 6666566655544321 12336678999
Q ss_pred HHHHHHhcCCCCCccccHHHHhc--Cccccccc
Q psy1812 238 KNLVGQILEPDITKRIRLDAIKA--HDWLRYKS 268 (304)
Q Consensus 238 ~~ll~~~L~~dP~~R~t~~ell~--~~wf~~~~ 268 (304)
.+||.+||+.||++|||++++++ ++||....
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 99999999999999999999988 88887643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=278.05 Aligned_cols=189 Identities=21% Similarity=0.362 Sum_probs=161.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------------GPVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++|+++.+++.+++||||++||+|.++|++. ..+++..+..++.|++.||.|||
T Consensus 74 v~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--------- 144 (309)
T d1fvra_ 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--------- 144 (309)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---------
T ss_pred eeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---------
Confidence 68999999999999999999999999999754 46899999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+++||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.+ +|||||||
T Consensus 145 -----~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGv 214 (309)
T d1fvra_ 145 -----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGV 214 (309)
T ss_dssp -----HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHH-HHHHHHHH
T ss_pred -----cCCccccccccceEEEcCCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCcc-ceeehhHH
Confidence 8999999999999999999999999999997543322 2234568999999999998888877 99999999
Q ss_pred HHHHHHhCC-CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLNAA-MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++|. .||.+.+..+....+..+..
T Consensus 215 il~ell~~~~~p~~~~~~~~~~~~i~~~~~-------------------------------------------------- 244 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------- 244 (309)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--------------------------------------------------
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--------------------------------------------------
Confidence 999999965 67888887777766654322
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
...+..+++++.+||.+||+.||++|||+++++++
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22335688999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=275.88 Aligned_cols=191 Identities=21% Similarity=0.360 Sum_probs=164.4
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcccCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG----------------PVAESNARTWFSQMLAGLEYLHREITNHTPF 64 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~ 64 (304)
|++++++.+++..++|||||++|+|.++|.... .+++..++.++.|++.||+|||
T Consensus 82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--------- 152 (299)
T d1fgka_ 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--------- 152 (299)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---------
T ss_pred EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---------
Confidence 689999999999999999999999999997543 4899999999999999999999
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHH
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGV 144 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ 144 (304)
+.+||||||||+|||++.++.+||+|||++......... .......+++.|+|||.+.+..++.+ +|||||||
T Consensus 153 -----~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gv 225 (299)
T d1fgka_ 153 -----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGV 225 (299)
T ss_dssp -----HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHH
T ss_pred -----hCCEEeeeecccceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCch-hhhHHhHH
Confidence 899999999999999999999999999999865543322 13345678899999999988888887 99999999
Q ss_pred HHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 145 ITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 145 ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+|++ |..||.+.+..+.+..+..+..
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~-------------------------------------------------- 255 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHR-------------------------------------------------- 255 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------------------------------------------------
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999998 7899988887776665554322
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 256 ---~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 256 ---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2233567899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=273.64 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=160.8
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++.++ ..++|||||++|+|.+++... +.+++..+..++.|++.||.||| +++|+|||||
T Consensus 74 v~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--------------~~~iiHrDik 138 (273)
T d1u46a_ 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--------------SKRFIHRDLA 138 (273)
T ss_dssp CCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCC
T ss_pred EEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh--------------hCCEeeeeec
Confidence 6899999764 678999999999999988664 47999999999999999999999 8999999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++................++..|+|||.+.+..++.+ +|||||||++|||++ |..||.+
T Consensus 139 p~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999876554444334455668889999999998888877 999999999999998 8999998
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+...++....... ..+..+++.+.
T Consensus 218 ~~~~~~~~~i~~~~~~~----------------------------------------------------~~~~~~~~~l~ 245 (273)
T d1u46a_ 218 LNGSQILHKIDKEGERL----------------------------------------------------PRPEDCPQDIY 245 (273)
T ss_dssp CCHHHHHHHHHTSCCCC----------------------------------------------------CCCTTCCHHHH
T ss_pred cCHHHHHHHHHhCCCCC----------------------------------------------------CCcccccHHHH
Confidence 88887777765543222 22356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+||.+||+.||++|||+.++++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-36 Score=272.45 Aligned_cols=191 Identities=20% Similarity=0.338 Sum_probs=161.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHhhh
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG------------------------PVAESNARTWFSQMLAGLEYLHR 56 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~~l~~~l~~LH~ 56 (304)
+++++++..++..++||||+.+|+|.+++...+ .+++..+..++.|++.||+|||
T Consensus 79 v~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH- 157 (301)
T d1lufa_ 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS- 157 (301)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-
Confidence 578999999999999999999999999997532 3889999999999999999999
Q ss_pred cccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCC
Q psy1812 57 EITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKL 136 (304)
Q Consensus 57 ~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 136 (304)
+.+++||||||+|||++.++.+||+|||+++........ .......+++.|+|||.+.+..++.+
T Consensus 158 -------------~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~t~k- 222 (301)
T d1lufa_ 158 -------------ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNRYTTE- 222 (301)
T ss_dssp -------------HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCCCCHH-
T ss_pred -------------cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHccCCCChh-
Confidence 899999999999999999999999999999755433222 12345678899999999999888877
Q ss_pred chHHHHHHHHHHHHhCC-CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhh
Q psy1812 137 ADIWSLGVITFIMLNAA-MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSH 215 (304)
Q Consensus 137 sDvwslG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (304)
+|||||||++|||++|. .||.+.+..+....+..+...
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~----------------------------------------- 261 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----------------------------------------- 261 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------------------
T ss_pred hhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------
Confidence 99999999999999985 688888877777766554321
Q ss_pred hhhhhhhhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 216 QVKLKDILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 262 ------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 ------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223567899999999999999999999999965
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=274.24 Aligned_cols=192 Identities=21% Similarity=0.318 Sum_probs=157.2
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA-GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
|++|+++.++ ..++++||+.+|+|.+++... ..+++..++.++.|++.||+||| +.+|+|||||
T Consensus 74 v~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH--------------~~~iiHrDlK 138 (317)
T d1xkka_ 74 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--------------DRRLVHRDLA 138 (317)
T ss_dssp CCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCCC
T ss_pred eeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH--------------HcCcccCcch
Confidence 6899999865 567888999999999988775 47999999999999999999999 8899999999
Q ss_pred CCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCCCC
Q psy1812 80 CENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPFDD 158 (304)
Q Consensus 80 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf~~ 158 (304)
|+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.+ +|||||||++|||++ |..||.+
T Consensus 139 p~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp GGGEEEEETTEEEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhcceeCCCCCeEeeccccceeccccccc-ccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999865433221 12234468999999999998888877 999999999999998 8899987
Q ss_pred hhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHHHH
Q psy1812 159 SNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQVK 238 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (304)
.+..+....+..+.. ...+..+++.+.
T Consensus 217 ~~~~~~~~~i~~~~~-----------------------------------------------------~~~p~~~~~~~~ 243 (317)
T d1xkka_ 217 IPASEISSILEKGER-----------------------------------------------------LPQPPICTIDVY 243 (317)
T ss_dssp SCGGGHHHHHHHTCC-----------------------------------------------------CCCCTTBCHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------------------------------------CCCCcccCHHHH
Confidence 766555554443321 122356789999
Q ss_pred HHHHHhcCCCCCccccHHHHhcCc
Q psy1812 239 NLVGQILEPDITKRIRLDAIKAHD 262 (304)
Q Consensus 239 ~ll~~~L~~dP~~R~t~~ell~~~ 262 (304)
+|+.+||+.||++|||++|+++|-
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999999883
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=268.26 Aligned_cols=186 Identities=20% Similarity=0.392 Sum_probs=151.3
Q ss_pred Cceeeeee-eCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecC
Q psy1812 1 MQVHSILQ-RGPRVFIFMRYADNGDLLDHIKRAG--PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRD 77 (304)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~d 77 (304)
|++|+++. ..+.+++||||+++|+|.++|...+ .+++..++.++.|++.||.||| +.+++|||
T Consensus 63 v~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--------------~~~ivH~d 128 (262)
T d1byga_ 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--------------GNNFVHRD 128 (262)
T ss_dssp CCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--------------HTTCCCSC
T ss_pred eeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--------------cCceeccc
Confidence 68899874 4567899999999999999997643 5899999999999999999999 88999999
Q ss_pred CCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHh-CCCCC
Q psy1812 78 LKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLN-AAMPF 156 (304)
Q Consensus 78 l~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~-g~~pf 156 (304)
|||+||+++.++.+|++|||+++..... .....++..|+|||++.+..++.+ +|||||||++|||++ |..||
T Consensus 129 lkp~Nil~~~~~~~kl~dfg~s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~ 201 (262)
T d1byga_ 129 LAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY 201 (262)
T ss_dssp CSGGGEEECTTSCEEECCCCC------------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSC
T ss_pred cchHhheecCCCCEeecccccceecCCC------CccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999754322 233457889999999988888877 999999999999998 78888
Q ss_pred CChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 157 DDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
...+..+....+.++.. ...+..++++
T Consensus 202 ~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~~~~~~~~ 228 (262)
T d1byga_ 202 PRIPLKDVVPRVEKGYK-----------------------------------------------------MDAPDGCPPA 228 (262)
T ss_dssp TTSCGGGHHHHHTTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------------------------------------CCCCccCCHH
Confidence 87776666665544322 2234567899
Q ss_pred HHHHHHHhcCCCCCccccHHHHhc
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
+.+||.+||..||++|||+.++++
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHH
Confidence 999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-36 Score=268.54 Aligned_cols=199 Identities=20% Similarity=0.335 Sum_probs=167.5
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRA----------GPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPS 70 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~ 70 (304)
|++++++..++..++|||||.+|+|.+++... ..+++..+..++.|++.||.||| +
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--------------~ 151 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--------------A 151 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--------------H
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--------------h
Confidence 68999999999999999999999999999753 24689999999999999999999 8
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
++|+||||||+|||++.++.+||+|||+++........ .......+++.|++||.+.+..++.+ +|+|||||++|||+
T Consensus 152 ~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 152 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIA 229 (308)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHH
T ss_pred CCeeeceEcCCceeecCCceEEEeecccceeccCCcce-eeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHH
Confidence 89999999999999999999999999999765443222 22344568999999999998888877 99999999999999
Q ss_pred hC-CCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccc
Q psy1812 151 NA-AMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKV 229 (304)
Q Consensus 151 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (304)
+| ..||.+.+..+....+.++.. ...
T Consensus 230 t~~~~p~~~~~~~~~~~~i~~~~~-----------------------------------------------------~~~ 256 (308)
T d1p4oa_ 230 TLAEQPYQGLSNEQVLRFVMEGGL-----------------------------------------------------LDK 256 (308)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTCC-----------------------------------------------------CCC
T ss_pred hCCCCCCCCCCHHHHHHHHHhCCC-----------------------------------------------------CCC
Confidence 97 588888887777776655432 122
Q ss_pred cccccHHHHHHHHHhcCCCCCccccHHHHhc------Cccccccc
Q psy1812 230 KDILSHQVKNLVGQILEPDITKRIRLDAIKA------HDWLRYKS 268 (304)
Q Consensus 230 ~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~------~~wf~~~~ 268 (304)
+..+++.+.++|.+||+.||++|||++++++ +|+|+...
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 3567899999999999999999999999998 56665433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-36 Score=269.76 Aligned_cols=192 Identities=23% Similarity=0.374 Sum_probs=160.1
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcccCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG------------------PVAESNARTWFSQMLAGLEYLHREITNHT 62 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~LH~~~~~~~ 62 (304)
|++|+++.++...++|||||++|+|.+++.... .+++..+..++.|++.||+|||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH------- 162 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA------- 162 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-------
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-------
Confidence 689999999999999999999999999997643 5899999999999999999999
Q ss_pred CCcCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHH
Q psy1812 63 PFTAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSL 142 (304)
Q Consensus 63 ~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwsl 142 (304)
+.+++||||||+||+++.++.+|++|||.++....... ........|++.|+|||.+.+..++.+ +|||||
T Consensus 163 -------~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~ 233 (311)
T d1t46a_ 163 -------SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 233 (311)
T ss_dssp -------HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred -------hCCeeecccccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCc-ccccch
Confidence 88999999999999999999999999999986554332 223445678999999999988888877 999999
Q ss_pred HHHHHHHHh-CCCCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhh
Q psy1812 143 GVITFIMLN-AAMPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKD 221 (304)
Q Consensus 143 G~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (304)
||++|+|++ |..||...+....+.++......
T Consensus 234 G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~----------------------------------------------- 266 (311)
T d1t46a_ 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR----------------------------------------------- 266 (311)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-----------------------------------------------
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----------------------------------------------
Confidence 999999998 66667665554444444332221
Q ss_pred hhhccccccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 222 ILSHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
...+..+++.+.+||.+||+.||++|||++++++
T Consensus 267 -----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 267 -----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1223457899999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=260.90 Aligned_cols=193 Identities=21% Similarity=0.327 Sum_probs=154.6
Q ss_pred Cceeeeeee-CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCC
Q psy1812 1 MQVHSILQR-GPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDL 78 (304)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl 78 (304)
|++++++.. ++..++|||||++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||
T Consensus 91 v~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH--------------~~~iiHrDL 156 (311)
T d1r0pa_ 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--------------SKKFVHRDL 156 (311)
T ss_dssp CCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--------------HTTCCCSCC
T ss_pred eEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc--------------ccCcccCCc
Confidence 578888765 578999999999999999998654 5778899999999999999999 899999999
Q ss_pred CCCcEEEecCCCeEEEeccCcccccCccccc-ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCCCCCC
Q psy1812 79 KCENILMTKRFNVKIADFGFARYCVDKEGRR-VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAAMPFD 157 (304)
Q Consensus 79 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~~pf~ 157 (304)
||+|||+++++.+||+|||+++......... .......|+..|+|||.+....++.+ +||||||+++|||++|..||.
T Consensus 157 K~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp SGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSC
T ss_pred cHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCC
Confidence 9999999999999999999998654433221 12234568999999999988888877 999999999999999777765
Q ss_pred Ch-hHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccccHH
Q psy1812 158 DS-NLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDILSHQ 236 (304)
Q Consensus 158 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (304)
.. +..+....+..+.. ...+..+++.
T Consensus 236 ~~~~~~~~~~~i~~g~~-----------------------------------------------------~~~p~~~~~~ 262 (311)
T d1r0pa_ 236 PDVNTFDITVYLLQGRR-----------------------------------------------------LLQPEYCPDP 262 (311)
T ss_dssp C------CHHHHHTTCC-----------------------------------------------------CCCCTTCCHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------------------------------------CCCcccCcHH
Confidence 43 33233333332211 1233567889
Q ss_pred HHHHHHHhcCCCCCccccHHHHhcC
Q psy1812 237 VKNLVGQILEPDITKRIRLDAIKAH 261 (304)
Q Consensus 237 ~~~ll~~~L~~dP~~R~t~~ell~~ 261 (304)
+.+||.+||+.||++|||++|++++
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-34 Score=253.65 Aligned_cols=150 Identities=25% Similarity=0.352 Sum_probs=118.6
Q ss_pred CceeeeeeeCC----eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEec
Q psy1812 1 MQVHSILQRGP----RVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHR 76 (304)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~ 76 (304)
|++|+++..++ .+++|||||++|+|.++|++. .+++..++.++.|++.||+|||+.. -..+...+|+||
T Consensus 60 v~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~------~~~~~~~~IvHr 132 (303)
T d1vjya_ 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI------VGTQGKPAIAHR 132 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCB------CSTTCBCEEECS
T ss_pred cceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhh------hhhccCCCeecc
Confidence 57888887643 689999999999999999875 5899999999999999999999310 001113699999
Q ss_pred CCCCCcEEEecCCCeEEEeccCcccccCcccc-cccccCccCCccccccccccCCC------CCCCCchHHHHHHHHHHH
Q psy1812 77 DLKCENILMTKRFNVKIADFGFARYCVDKEGR-RVLSRTYCGSAAYAAPEVISGNP------YNPKLADIWSLGVITFIM 149 (304)
Q Consensus 77 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~------~~~~~sDvwslG~ll~~l 149 (304)
||||+|||++.++.+||+|||++......... ........||+.|+|||++.... ++.+ +|||||||++|||
T Consensus 133 DlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k-~Di~S~Gvvl~el 211 (303)
T d1vjya_ 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEI 211 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHH
T ss_pred ccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcc-hhhhhhHHHHHHH
Confidence 99999999999999999999999866443221 12334567999999999987543 3344 8999999999999
Q ss_pred HhCCCCCCC
Q psy1812 150 LNAAMPFDD 158 (304)
Q Consensus 150 l~g~~pf~~ 158 (304)
++|..||..
T Consensus 212 ~tg~~~~~~ 220 (303)
T d1vjya_ 212 ARRCSIGGI 220 (303)
T ss_dssp HHTBCBTTB
T ss_pred hhCCCCCCc
Confidence 999888744
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-34 Score=253.70 Aligned_cols=204 Identities=18% Similarity=0.184 Sum_probs=152.7
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCC
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKR-AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKC 80 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~ 80 (304)
.+++++.+++..++||||+. ++|.+.+.. .+.+++..+..++.|++.||+||| +.+|+||||||
T Consensus 67 ~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------------~~~iiHrDiKp 131 (299)
T d1ckia_ 67 TIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--------------SKNFIHRDVKP 131 (299)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------HTTEECSCCCG
T ss_pred EEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH--------------HCCeeeccCCH
Confidence 45677788999999999995 577776655 457999999999999999999999 89999999999
Q ss_pred CcEEEec---CCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHHhCC
Q psy1812 81 ENILMTK---RFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIMLNAA 153 (304)
Q Consensus 81 ~nil~~~---~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll~g~ 153 (304)
+||+++. +..+|++|||+++......... .......||+.|+|||.+.+..++.+ +|||||||++|+|++|.
T Consensus 132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~ 210 (299)
T d1ckia_ 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGS 210 (299)
T ss_dssp GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSS
T ss_pred hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCC
Confidence 9999864 4569999999998765433221 12345679999999999998888877 99999999999999999
Q ss_pred CCCCChhHHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccccccccc
Q psy1812 154 MPFDDSNLKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQVKVKDIL 233 (304)
Q Consensus 154 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (304)
.||...........+........ ..........+
T Consensus 211 ~P~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~ 244 (299)
T d1ckia_ 211 LPWQGLKAATKRQKYERISEKKM----------------------------------------------STPIEVLCKGY 244 (299)
T ss_dssp CTTCCCC-------HHHHHHHHH----------------------------------------------HSCHHHHTTTS
T ss_pred CcccccchHHHHHHHHHhhcccC----------------------------------------------CCChhHhccCC
Confidence 99976544333222211100000 00001123568
Q ss_pred cHHHHHHHHHhcCCCCCccccHH---HHhcCcccccc
Q psy1812 234 SHQVKNLVGQILEPDITKRIRLD---AIKAHDWLRYK 267 (304)
Q Consensus 234 ~~~~~~ll~~~L~~dP~~R~t~~---ell~~~wf~~~ 267 (304)
++++.+||.+||+.||++||+++ ++|+|.|.+..
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 89999999999999999999987 45677766543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-33 Score=253.94 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=164.4
Q ss_pred Cceeeeeee--CCeEEEEEecCCCCCHHHHHH-h--cCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEe
Q psy1812 1 MQVHSILQR--GPRVFIFMRYADNGDLLDHIK-R--AGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAH 75 (304)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~-~--~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH 75 (304)
|++++++.. ....+++|+++..+....... . ...+++..++.++.|++.||+|||+ ..+|+|
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-------------~~~IvH 149 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-------------RCGIIH 149 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-------------TTCEEC
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-------------hcCccc
Confidence 456777654 467777777776654333332 2 3478999999999999999999993 389999
Q ss_pred cCCCCCcEEEecCCC------eEEEeccCcccccCcccccccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHH
Q psy1812 76 RDLKCENILMTKRFN------VKIADFGFARYCVDKEGRRVLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIM 149 (304)
Q Consensus 76 ~dl~~~nil~~~~~~------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~l 149 (304)
|||||+||+++.++. ++++|||.+..... .....+|++.|+|||++.+..++.+ +|+||+||++++|
T Consensus 150 rDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el 222 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFEL 222 (362)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHH
T ss_pred ccCChhHeeeeccCcccccceeeEeeccccccccc------ccccccccccccChhhccccCCCcc-ccccchHHHHHHH
Confidence 999999999987654 89999999864332 2345679999999999998888876 9999999999999
Q ss_pred HhCCCCCCChhHH------HHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhh
Q psy1812 150 LNAAMPFDDSNLK------QLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDIL 223 (304)
Q Consensus 150 l~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (304)
++|+.||...+.. +.........+..+.. .................... .............
T Consensus 223 ~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~---~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 290 (362)
T d1q8ya_ 223 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY---LLRNGKYTRTFFNSRGLLRN---------ISKLKFWPLEDVL 290 (362)
T ss_dssp HHSSCCC---------CHHHHHHHHHHHHCSCCHH---HHHHCTTHHHHBCC--CBSS---------CCCCCBCCHHHHH
T ss_pred HHCCCCCCCCccccccchhHHHHHHHHHhCCCCHH---Hhhcccccccccccchhhhc---------cccccCCchhhhc
Confidence 9999999654321 1222222222221110 00000000000000000000 0001111223333
Q ss_pred hccccccccccHHHHHHHHHhcCCCCCccccHHHHhcCcccccccccccccCCCCceeccC
Q psy1812 224 SHQVKVKDILSHQVKNLVGQILEPDITKRIRLDAIKAHDWLRYKSMVRRKVLPGQKLVHSN 284 (304)
Q Consensus 224 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~~~wf~~~~~~~~~~~~~~~~~~~~ 284 (304)
..........++++.|||.+||.+||.+||||+|||+||||+......+...|......+.
T Consensus 291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccCCCC
Confidence 3334555678899999999999999999999999999999997766555556655554433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-32 Score=244.44 Aligned_cols=195 Identities=18% Similarity=0.256 Sum_probs=154.6
Q ss_pred CceeeeeeeCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCC
Q psy1812 1 MQVHSILQRGPRVFIFMRYADNGDLLDHIKRAG-PVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLK 79 (304)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~ 79 (304)
+++++++..+...++||||+ +++|.+++...+ .+++..+..++.|++.||+||| +.||+|||||
T Consensus 64 ~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH--------------~~giiHrDiK 128 (293)
T d1csna_ 64 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--------------EKSLVYRDIK 128 (293)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--------------TTTEECCCCC
T ss_pred CEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH--------------HCCceeccCC
Confidence 46889999999999999999 689999997754 6999999999999999999999 8999999999
Q ss_pred CCcEEEec-----CCCeEEEeccCcccccCccccc----ccccCccCCccccccccccCCCCCCCCchHHHHHHHHHHHH
Q psy1812 80 CENILMTK-----RFNVKIADFGFARYCVDKEGRR----VLSRTYCGSAAYAAPEVISGNPYNPKLADIWSLGVITFIML 150 (304)
Q Consensus 80 ~~nil~~~-----~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~sDvwslG~ll~~ll 150 (304)
|+||+++. .+.+||+|||+++......... ......+||+.|+|||.+.+..++.+ +|+|||||++|+|+
T Consensus 129 p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~ell 207 (293)
T d1csna_ 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFL 207 (293)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHH
T ss_pred ccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHH
Confidence 99999975 5679999999998765432211 12345679999999999999888877 99999999999999
Q ss_pred hCCCCCCChh---HHHHHHHhhhccccccchhhhhhhhhhhHHHHhhhhhcccccccccccccchhhhhhhhhhhhhccc
Q psy1812 151 NAAMPFDDSN---LKQLFKEQTSNILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKVKDILSHQVKLKDILSHQV 227 (304)
Q Consensus 151 ~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (304)
+|..||.+.. ......++.......+ . .
T Consensus 208 tg~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------------------------~-------~ 238 (293)
T d1csna_ 208 RGSLPWQGLKAATNKQKYERIGEKKQSTP------------------------------------------L-------R 238 (293)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHSC------------------------------------------H-------H
T ss_pred hCCCcCCCccchhHHHHHHHHHhccCCCC------------------------------------------h-------H
Confidence 9999996543 2222222221111000 0 1
Q ss_pred cccccccHHHHHHHHHhcCCCCCccccHHHHhc
Q psy1812 228 KVKDILSHQVKNLVGQILEPDITKRIRLDAIKA 260 (304)
Q Consensus 228 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ell~ 260 (304)
.....+++++.+++..|+..+|++||+++.+.+
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 122557889999999999999999999877654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.37 E-value=2.4e-14 Score=117.80 Aligned_cols=68 Identities=22% Similarity=0.298 Sum_probs=57.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcCCCCCCceEecCCCCCcEEEecCCCeEE
Q psy1812 14 FIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTAHLPSKNIAHRDLKCENILMTKRFNVKI 93 (304)
Q Consensus 14 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ivH~dl~~~nil~~~~~~~kl 93 (304)
+++|||++++.+.+ +++..+..++.|++.+|.||| ..+|+||||||+||+++.+ .+++
T Consensus 86 ~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH--------------~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 86 AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFY--------------HRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHH--------------HTTEECSCCSTTSEEEETT-EEEE
T ss_pred EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHh--------------hCCEEEccCChhheeeeCC-CEEE
Confidence 79999998865432 566677889999999999999 8999999999999999865 5899
Q ss_pred EeccCccccc
Q psy1812 94 ADFGFARYCV 103 (304)
Q Consensus 94 ~dfg~~~~~~ 103 (304)
+|||.+....
T Consensus 144 iDFG~a~~~~ 153 (191)
T d1zara2 144 IDFPQSVEVG 153 (191)
T ss_dssp CCCTTCEETT
T ss_pred EECCCcccCC
Confidence 9999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.51 E-value=0.00011 Score=61.08 Aligned_cols=94 Identities=16% Similarity=0.139 Sum_probs=66.1
Q ss_pred ceeeeeeeCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcccCCCCCcC---------------
Q psy1812 2 QVHSILQRGPRVFIFMRYADNGDLLDHIKRAGPVAESNARTWFSQMLAGLEYLHREITNHTPFTA--------------- 66 (304)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~~~~~~~~~--------------- 66 (304)
+++.+..+++..++||++++|.++.+.... ......++.+++..+..||+....+.|...
T Consensus 74 ~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 74 KVLHFERHDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred cEEEEEecCCceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 466777888999999999999888665432 223344567788888888865433322111
Q ss_pred ------------------------------CCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 67 ------------------------------HLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 67 ------------------------------~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
......++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1113458999999999999976666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.94 E-value=0.0042 Score=50.76 Aligned_cols=30 Identities=20% Similarity=0.134 Sum_probs=25.5
Q ss_pred CceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 71 KNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 71 ~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..++|+|+.+.||+++.+..+-|+||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 458999999999999987667799999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.62 E-value=0.026 Score=49.49 Aligned_cols=29 Identities=31% Similarity=0.524 Sum_probs=25.0
Q ss_pred ceEecCCCCCcEEEecCCCeEEEeccCccc
Q psy1812 72 NIAHRDLKCENILMTKRFNVKIADFGFARY 101 (304)
Q Consensus 72 ~ivH~dl~~~nil~~~~~~~kl~dfg~~~~ 101 (304)
.++|||+.+.||+++.+ .++|+||.++.+
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 68999999999999876 489999988753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.12 E-value=0.02 Score=48.25 Aligned_cols=35 Identities=26% Similarity=0.321 Sum_probs=30.1
Q ss_pred cCCCCCCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 65 TAHLPSKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 65 ~~~~~~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
++++ ..|++|+|+.+.||+++.+...-|+||+.+.
T Consensus 178 ~~~L-~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDL-PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CCSS-CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccc-ccccccCCcchhhhhcccccceeEecccccc
Confidence 3455 6899999999999999988777899999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=85.10 E-value=0.6 Score=39.05 Aligned_cols=29 Identities=28% Similarity=0.173 Sum_probs=24.0
Q ss_pred CCceEecCCCCCcEEEecCCCeEEEeccCcc
Q psy1812 70 SKNIAHRDLKCENILMTKRFNVKIADFGFAR 100 (304)
Q Consensus 70 ~~~ivH~dl~~~nil~~~~~~~kl~dfg~~~ 100 (304)
..+++|+|+.+.||+++. + ..++||+.+.
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 568999999999999964 3 4588999875
|